Citrus Sinensis ID: 021947
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 305 | 2.2.26 [Sep-21-2011] | |||||||
| O49840 | 426 | Protein kinase 2B, chloro | yes | no | 1.0 | 0.715 | 0.787 | 1e-141 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 1.0 | 0.715 | 0.775 | 1e-135 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.973 | 0.720 | 0.626 | 1e-107 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.829 | 0.617 | 0.705 | 1e-105 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.904 | 0.709 | 0.635 | 1e-101 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.822 | 0.612 | 0.685 | 1e-98 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.927 | 0.727 | 0.595 | 4e-96 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.875 | 0.675 | 0.623 | 4e-95 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.852 | 0.530 | 0.629 | 8e-95 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.852 | 0.527 | 0.625 | 2e-94 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 499 bits (1286), Expect = e-141, Method: Compositional matrix adjust.
Identities = 245/311 (78%), Positives = 273/311 (87%), Gaps = 6/311 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VVAVKKLK EG+QGHKEWLTEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLE
Sbjct: 116 IVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLE 175
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDF
Sbjct: 176 NHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+
Sbjct: 296 SKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPK 355
Query: 241 MSEVLAILERLEAPKNSAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASP 294
MSEVLA L++LE+ K + +Q + R + V+KSP R R L++TP ASP
Sbjct: 356 MSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSIVQKSPRRYSYDRPLLHITPGASP 415
Query: 295 LPSHRQSPRVR 305
LP+H SPRVR
Sbjct: 416 LPTHNHSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 482 bits (1241), Expect = e-135, Method: Compositional matrix adjust.
Identities = 239/308 (77%), Positives = 264/308 (85%), Gaps = 3/308 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VVAVK+LKPEGFQGHKEWLTEVNYLGQL HPNLV L+GYC EGENRLLVYEFMPKGSLE
Sbjct: 119 IVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLE 178
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRG QPL+WA+RMKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDF
Sbjct: 179 NHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDF 238
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGD THVST+V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D
Sbjct: 239 GLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDN 298
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+ G E SLVDWA PYL DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+
Sbjct: 299 SNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPK 358
Query: 241 MSEVLAILERLEA-PKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPS 297
MSEVL LE+LE+ K K +Q E R ++KSP+R R L+MTP ASPLPS
Sbjct: 359 MSEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPS 418
Query: 298 HRQSPRVR 305
+ QSPRVR
Sbjct: 419 YTQSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 387 bits (993), Expect = e-107, Method: Compositional matrix adjust.
Identities = 191/305 (62%), Positives = 238/305 (78%), Gaps = 8/305 (2%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVKKL +G+QGH+EWL EVNYLGQ HPNLVKLIGYCLE E+RLLVYEFMP+GSLE
Sbjct: 102 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 161
Query: 61 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
NHLFRRG QPLSW +R+KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKLS
Sbjct: 162 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLS 221
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGLAK GPTGD++HVST++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR AV
Sbjct: 222 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 281
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
DK + EQ LV+WA+P L++KRKLFR++D +L QY + A ATLAL+CL E KLR
Sbjct: 282 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 341
Query: 239 PRMSEVLAILERL----EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTA 292
P M+EV++ LE + EA + + Q R++ V + + P +++ + + TA
Sbjct: 342 PNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATA 401
Query: 293 SPLPS 297
P PS
Sbjct: 402 YPRPS 406
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (977), Expect = e-105, Method: Compositional matrix adjust.
Identities = 180/255 (70%), Positives = 217/255 (85%), Gaps = 2/255 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVKKL +G+QGH+EWL EVNYLGQ H +LVKLIGYCLE E+RLLVYEFMP+GSLE
Sbjct: 101 LVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLE 160
Query: 61 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
NHLFRRG QPLSW +R+KVA+GAAKGL FLH +E++VIYRDFK SNILLD+E+NAKLS
Sbjct: 161 NHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLS 220
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGLAK GP GD++HVST+VMGTHGYAAPEY+ATG LTTKSDVYSFGVVLLELLSGR AV
Sbjct: 221 DFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAV 280
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
DK + E++LV+WAKPYL +KRK+FR++D +L QY + A ATL+L+CL E KLR
Sbjct: 281 DKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLR 340
Query: 239 PRMSEVLAILERLEA 253
P MSEV++ LE +++
Sbjct: 341 PNMSEVVSHLEHIQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 369 bits (948), Expect = e-101, Method: Compositional matrix adjust.
Identities = 178/280 (63%), Positives = 219/280 (78%), Gaps = 4/280 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVK+L EGFQGH+EWL E+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM +GSLE
Sbjct: 101 IVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLE 160
Query: 61 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
NHLFRRG QPLSW R+++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLS
Sbjct: 161 NHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGLA+ GP GD +HVST+VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
DK + E +LVDWA+PYL++KR+L R+MD +L GQY A A LAL C++ + K R
Sbjct: 281 DKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSR 340
Query: 239 PRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 278
P M+E++ +E L K ++K Q P + + KSP
Sbjct: 341 PTMNEIVKTMEELHIQKEASK-EQQNPQISIDNI-INKSP 378
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (922), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 172/251 (68%), Positives = 204/251 (81%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK L EG QGH+EWLTEVN+LGQL HPNLVKLIGYC E ++RLLVYEFM +GSLENH
Sbjct: 101 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENH 160
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
LFR+ PLSW+ RM +A+GAAKGL FLH+AE VIYRDFK SNILLD+++ AKLSDFGL
Sbjct: 161 LFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 220
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
AKAGP GD THVST+VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+
Sbjct: 221 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTR 280
Query: 183 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 242
EQ+LVDWA+P L+DKRKL +I+D +L QY +AA A +LA CL+ PK RP MS
Sbjct: 281 PSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS 340
Query: 243 EVLAILERLEA 253
+V+ LE L+
Sbjct: 341 DVVETLEPLQC 351
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 175/294 (59%), Positives = 219/294 (74%), Gaps = 11/294 (3%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVK+L P+GFQGH+EWLTE+NYLGQL HPNLVKLIGYCLE E RLLVYEFM KGSLE
Sbjct: 94 LVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLE 153
Query: 61 NHLFRRGPQ---PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
NHLF G + PLSW +R+KVA+ AAKGL FLH +VIYRD KASNILLD++FNAKL
Sbjct: 154 NHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKL 213
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
SDFGLA+ GP G++++VST+VMGT GYAAPEYV+TG L +SDVYSFGVVLLELL GR A
Sbjct: 214 SDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQA 273
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
+D + EQ+LVDWA+PYL+ +RK+ I+DT+L QY + A A++A+QCL+ EPK
Sbjct: 274 LDHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKS 333
Query: 238 RPRMSEVLAILERLE----APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 287
RP M +V+ L +L+ P N L + + G K+ + QR+ LN
Sbjct: 334 RPTMDQVVRALVQLQDSVVKPANVDPLKVKDTKKLVG----LKTEDKYQRNGLN 383
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 169/271 (62%), Positives = 214/271 (78%), Gaps = 4/271 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVKKL EGFQGH+EWLTE+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM KGSLE
Sbjct: 100 LVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLE 159
Query: 61 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
NHLFRRG +PL W +R+ VA+ AAKGL FLH +VIYRD KASNILLDA++NAKLS
Sbjct: 160 NHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLS 219
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGLA+ GP GD ++VST+VMGT+GYAAPEY+++G L +SDVYSFGV+LLE+LSG+ A+
Sbjct: 220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRAL 279
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
D + E++LVDWA+PYL+ KRK+ I+D +L QY + A A++A+QCL+ EPK R
Sbjct: 280 DHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSR 339
Query: 239 PRMSEVLAILERLEAPKNSAKLSQSEPHRQT 269
P M +V+ L++L+ N K SQ+ P + T
Sbjct: 340 PTMDQVVRALQQLQ--DNLGKPSQTNPVKDT 368
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 8e-95, Method: Compositional matrix adjust.
Identities = 165/262 (62%), Positives = 206/262 (78%), Gaps = 2/262 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ VAVK L P+G QGHKEWL E+NYLG L HPNLVKL+GYC+E + RLLVYEFMP+GSLE
Sbjct: 169 LTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 228
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSD 119
NHLFRR PL W++RMK+A+GAAKGL+FLH+ A VIYRDFK SNILLD E+NAKLSD
Sbjct: 229 NHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSD 287
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLAK P +THVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GR ++D
Sbjct: 288 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
K + E +LV+WA+P+L DKR+ +R++D +L G + K A LA QCL+ + K+RP
Sbjct: 348 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRP 407
Query: 240 RMSEVLAILERLEAPKNSAKLS 261
+MSEV+ +L+ L K+ A S
Sbjct: 408 KMSEVVEVLKPLPHLKDMASAS 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 164/262 (62%), Positives = 207/262 (79%), Gaps = 2/262 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ VAVK L P+G QGHKEWL E+N+LG L HPNLVKL+GYC+E + RLLVYEFMP+GSLE
Sbjct: 175 LTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 234
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSD 119
NHLFRR PL W++RMK+A+GAAKGL+FLH+ A VIYRDFK SNILLDA++NAKLSD
Sbjct: 235 NHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSD 293
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLAK P +THVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GR ++D
Sbjct: 294 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 353
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
K + E +LV+WA+P+L DKR+ +R++D +L G + K A LA QCL+ +PK+RP
Sbjct: 354 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRP 413
Query: 240 RMSEVLAILERLEAPKNSAKLS 261
+MS+V+ L+ L K+ A S
Sbjct: 414 KMSDVVEALKPLPHLKDMASSS 435
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 305 | ||||||
| 225425762 | 420 | PREDICTED: protein kinase 2B, chloroplas | 0.993 | 0.721 | 0.868 | 1e-155 | |
| 255558180 | 419 | Protein kinase APK1A, chloroplast precur | 0.990 | 0.720 | 0.875 | 1e-154 | |
| 224099729 | 418 | predicted protein [Populus trichocarpa] | 0.993 | 0.724 | 0.849 | 1e-149 | |
| 224111270 | 417 | predicted protein [Populus trichocarpa] | 0.993 | 0.726 | 0.842 | 1e-148 | |
| 356498210 | 422 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.963 | 0.696 | 0.851 | 1e-145 | |
| 356500447 | 414 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.963 | 0.710 | 0.851 | 1e-145 | |
| 48209875 | 420 | putative protein kinase [Solanum demissu | 0.993 | 0.721 | 0.809 | 1e-143 | |
| 113205211 | 401 | Protein kinase APK1B, chloroplast precur | 0.993 | 0.755 | 0.809 | 1e-143 | |
| 357486685 | 410 | Protein kinase 2B [Medicago truncatula] | 0.986 | 0.734 | 0.815 | 1e-142 | |
| 217071950 | 410 | unknown [Medicago truncatula] | 0.963 | 0.717 | 0.818 | 1e-140 |
| >gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1426), Expect = e-155, Method: Compositional matrix adjust.
Identities = 265/305 (86%), Positives = 285/305 (93%), Gaps = 2/305 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MV+AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 118 MVIAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 177
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSWAVR++VAIGAA+GL+FLHDAESQVIYRDFKASNILLDAEFNAKLSDF
Sbjct: 178 NHLFRRGPQPLSWAVRIRVAIGAARGLSFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 237
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 238 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 297
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
TK+G+EQ+LVDWAKPYL DKR+LFRIMDTKL GQYPQK A AATLALQCLN E K+RPR
Sbjct: 298 TKIGVEQNLVDWAKPYLGDKRRLFRIMDTKLEGQYPQKGAFMAATLALQCLNTEAKVRPR 357
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
MSEVLA LE++++PKN+AK QSE H T + V+KSP+RQQ SPLN+TP ASPLPS+RQ
Sbjct: 358 MSEVLATLEQIQSPKNAAKHIQSEQH--TVSIPVQKSPLRQQHSPLNLTPRASPLPSYRQ 415
Query: 301 SPRVR 305
SPRVR
Sbjct: 416 SPRVR 420
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 268/306 (87%), Positives = 284/306 (92%), Gaps = 4/306 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVKKLKPEGFQGHKEWLTEV YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 117 MVVAVKKLKPEGFQGHKEWLTEVRYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 176
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSWAVR+KVA+GAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDF
Sbjct: 177 NHLFRRGPQPLSWAVRIKVAVGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDF 236
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAK GPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 237 GLAKEGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 296
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
TKVGIEQ+LVDWAKPYLSDKRKLFRIMDTKLGGQYPQK+AH AA LALQCL+ E K RPR
Sbjct: 297 TKVGIEQNLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKSAHMAANLALQCLSTEAKARPR 356
Query: 241 MSEVLAILERLEAPKNSAKLSQSE-PHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 299
MSEVLA LE++E+PK + +LS SE P Q + VRKSPMRQ SPLN+TP+ASPLPSHR
Sbjct: 357 MSEVLATLEQIESPKTAGRLSHSEHPSIQ---IPVRKSPMRQHHSPLNLTPSASPLPSHR 413
Query: 300 QSPRVR 305
QSPRVR
Sbjct: 414 QSPRVR 419
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1372), Expect = e-149, Method: Compositional matrix adjust.
Identities = 259/305 (84%), Positives = 277/305 (90%), Gaps = 2/305 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC+EGENRLLVYEFMPKGSLE
Sbjct: 116 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCVEGENRLLVYEFMPKGSLE 175
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSWAVR+KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDF
Sbjct: 176 NHLFRRGPQPLSWAVRVKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDF 235
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 236 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
TKVG+EQ+L DWAKPYL DKRKLFRIMDTKLGGQYPQK A AA LALQCL+NE K+RPR
Sbjct: 296 TKVGVEQNLADWAKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSNEAKVRPR 355
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
MSEVLA LE +E+PK +AK S+SE +QT VR+SPMR +P +ASPLPSH Q
Sbjct: 356 MSEVLATLENIESPKGAAKNSRSE--QQTVQTPVRQSPMRHHHAPGTPPASASPLPSHHQ 413
Query: 301 SPRVR 305
SPR+R
Sbjct: 414 SPRLR 418
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 530 bits (1366), Expect = e-148, Method: Compositional matrix adjust.
Identities = 257/305 (84%), Positives = 275/305 (90%), Gaps = 2/305 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 115 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 174
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSWA+R+KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDF
Sbjct: 175 NHLFRRGPQPLSWAIRIKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDF 234
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLE LSGR AVDK
Sbjct: 235 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEFLSGRRAVDK 294
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+KVG+EQ+LVDW KPYL DKRKLFRIMDTKLGGQYPQK A AA LALQCL+ E K+RPR
Sbjct: 295 SKVGVEQNLVDWVKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSTEAKVRPR 354
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
MSEVLA LE++E+PK + K Q E QT VR+SPMR RSP+ T +ASPLPSH Q
Sbjct: 355 MSEVLATLEQIESPKGAVKNIQLE--HQTVQTPVRQSPMRHHRSPVIPTASASPLPSHHQ 412
Query: 301 SPRVR 305
SPR+R
Sbjct: 413 SPRLR 417
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1338), Expect = e-145, Method: Compositional matrix adjust.
Identities = 253/297 (85%), Positives = 272/297 (91%), Gaps = 3/297 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVK+LKPEGFQGHKEWLTEVNYLGQL+HPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 110 MVVAVKRLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 169
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSW+VRMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDF
Sbjct: 170 NHLFRRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDF 229
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 230 GLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 289
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
T G+EQ+LVDWAKPYLSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP
Sbjct: 290 TITGMEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPP 349
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 297
M+EVLA LE++EAPK + + S SE HR P VRKSP R RSPLN+TPTASPLP+
Sbjct: 350 MTEVLATLEQIEAPKTAGRNSHSEHHRVQTP--VRKSPAR-NRSPLNLTPTASPLPA 403
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-145, Method: Compositional matrix adjust.
Identities = 253/297 (85%), Positives = 272/297 (91%), Gaps = 3/297 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVK+LKPEGFQGHKEWLTEVNYLGQL+HPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 110 MVVAVKRLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 169
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSW+VRMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDF
Sbjct: 170 NHLFRRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDF 229
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 230 GLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 289
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
T G+EQ+LVDWAKPYLSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP
Sbjct: 290 TITGMEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPP 349
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 297
M+EVLA LE++EAPK + + S SE HR P VRKSP R RSPLN+TPTASPLP+
Sbjct: 350 MTEVLATLEQIEAPKTAGRNSHSEHHRLQTP--VRKSPAR-NRSPLNLTPTASPLPA 403
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|48209875|gb|AAT40481.1| putative protein kinase [Solanum demissum] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1323), Expect = e-143, Method: Compositional matrix adjust.
Identities = 247/305 (80%), Positives = 271/305 (88%), Gaps = 2/305 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVKKLKPEGFQGHKEWLTEVNYLGQL HPNLVKLIGYC++G+N LLVYEFMPKGSLE
Sbjct: 118 IVIAVKKLKPEGFQGHKEWLTEVNYLGQLRHPNLVKLIGYCIDGDNHLLVYEFMPKGSLE 177
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPL+WA R+KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDF
Sbjct: 178 NHLFRRGPQPLNWATRIKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDF 237
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD
Sbjct: 238 GLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDN 297
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
TKVGIEQ+LVDWAKPYL DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+
Sbjct: 298 TKVGIEQNLVDWAKPYLGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPK 357
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
MSEVL LE L++PK +KLS +E PV V SPMR RSPL+MTP+ASP ++++
Sbjct: 358 MSEVLTALEELQSPKGVSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPFQAYQK 415
Query: 301 SPRVR 305
SPR R
Sbjct: 416 SPRGR 420
|
Source: Solanum demissum Species: Solanum demissum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|113205211|gb|AAT39953.2| Protein kinase APK1B, chloroplast precursor, putative [Solanum demissum] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1318), Expect = e-143, Method: Compositional matrix adjust.
Identities = 247/305 (80%), Positives = 271/305 (88%), Gaps = 2/305 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVKKLKPEGFQGHKEWLTEVNYLGQL HPNLVKLIGYC++G+N LLVYEFMPKGSLE
Sbjct: 99 IVIAVKKLKPEGFQGHKEWLTEVNYLGQLRHPNLVKLIGYCIDGDNHLLVYEFMPKGSLE 158
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPL+WA R+KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDF
Sbjct: 159 NHLFRRGPQPLNWATRIKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDF 218
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD
Sbjct: 219 GLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDN 278
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
KVGIEQ+LVDWAKPYL DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+
Sbjct: 279 AKVGIEQNLVDWAKPYLGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPK 338
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
MSEVL LE L++PK +KLS +E PV V SPMR RSPL+MTP+ASPL ++++
Sbjct: 339 MSEVLTALEELQSPKGVSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPLQAYQK 396
Query: 301 SPRVR 305
SPR R
Sbjct: 397 SPRGR 401
|
Source: Solanum demissum Species: Solanum demissum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1317), Expect = e-142, Method: Compositional matrix adjust.
Identities = 248/304 (81%), Positives = 274/304 (90%), Gaps = 3/304 (0%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVK+LKPEG+QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 109 MVVAVKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 168
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSW++RMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDF
Sbjct: 169 NHLFRRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDF 228
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQV+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLSGR AVDK
Sbjct: 229 GLAKAGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDK 288
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
T G++Q+LVDWAKPYL DKR+LFRIMD+KL GQYPQK A AATLALQCLN E K RP
Sbjct: 289 TIAGVDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPS 348
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
M+EVLA LE++EAPK++++ S SE HR P VR+SP R R+P +TPTASPLPS RQ
Sbjct: 349 MTEVLATLEQIEAPKHASRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTASPLPSVRQ 405
Query: 301 SPRV 304
SPR
Sbjct: 406 SPRA 409
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217071950|gb|ACJ84335.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1295), Expect = e-140, Method: Compositional matrix adjust.
Identities = 243/297 (81%), Positives = 269/297 (90%), Gaps = 3/297 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVK+LKPEG+QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE
Sbjct: 109 MVVAVKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 168
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRGPQPLSW++RMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDF
Sbjct: 169 NHLFRRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDF 228
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHVSTQV+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLSGR AVDK
Sbjct: 229 GLAKAGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDK 288
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
T G++Q+LVDWAKPYL DKR+LFRIMD+KL GQYPQK A AATLALQCLN E K RP
Sbjct: 289 TIAGVDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPS 348
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 297
M+EVLA LE++EAPK++++ S SE HR P VR+SP R R+P +TPTASPLPS
Sbjct: 349 MTEVLATLEQIEAPKHASRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTASPLPS 402
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 305 | ||||||
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.996 | 0.713 | 0.785 | 5.3e-127 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 1.0 | 0.715 | 0.775 | 3.5e-123 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.970 | 0.718 | 0.705 | 1e-107 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.852 | 0.671 | 0.761 | 1.2e-106 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.973 | 0.702 | 0.626 | 3.2e-97 | |
| TAIR|locus:2019180 | 399 | AT1G74490 [Arabidopsis thalian | 0.855 | 0.654 | 0.698 | 2e-95 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.901 | 0.706 | 0.640 | 1.9e-92 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.986 | 0.664 | 0.585 | 9.3e-91 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.819 | 0.609 | 0.688 | 4e-90 | |
| TAIR|locus:2064712 | 462 | RIPK "RPM1-induced protein kin | 0.819 | 0.541 | 0.688 | 7.1e-90 |
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 5.3e-127, P = 5.3e-127
Identities = 245/312 (78%), Positives = 272/312 (87%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VVAVKKLK EG+QGHKEWLTEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLE
Sbjct: 116 IVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLE 175
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDF
Sbjct: 176 NHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+
Sbjct: 296 SKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPK 355
Query: 241 MSEVLAILERLEAPKNSAKLSQSE-----PHRQTGPVTVRKSPMRQQ--RSPLNMTPTAS 293
MSEVLA L++LE+ K + + P G + V+KSP R R L++TP AS
Sbjct: 356 MSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSI-VQKSPRRYSYDRPLLHITPGAS 414
Query: 294 PLPSHRQSPRVR 305
PLP+H SPRVR
Sbjct: 415 PLPTHNHSPRVR 426
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
Identities = 239/308 (77%), Positives = 264/308 (85%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VVAVK+LKPEGFQGHKEWLTEVNYLGQL HPNLV L+GYC EGENRLLVYEFMPKGSLE
Sbjct: 119 IVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLE 178
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRG QPL+WA+RMKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDF
Sbjct: 179 NHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDF 238
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGD THVST+V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D
Sbjct: 239 GLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDN 298
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+ G E SLVDWA PYL DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+
Sbjct: 299 SNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPK 358
Query: 241 MSEVLAILERLEA-PKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPS 297
MSEVL LE+LE+ K K +Q E R ++KSP+R R L+MTP ASPLPS
Sbjct: 359 MSEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPS 418
Query: 298 HRQSPRVR 305
+ QSPRVR
Sbjct: 419 YTQSPRVR 426
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 216/306 (70%), Positives = 243/306 (79%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSL 59
MVVAVKKLK EGFQGH++WL EV+ LG+LHH NLVKLIGYC +G++ RLLVYE+MPKGSL
Sbjct: 116 MVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSL 175
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
ENHLFRRG +P+ W R+KVAIGAA+GL FLH+A QVIYRDFKASNILLD+EFNAKLSD
Sbjct: 176 ENHLFRRGAEPIPWRTRIKVAIGAARGLAFLHEA--QVIYRDFKASNILLDSEFNAKLSD 233
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLAK GPTGDRTHVSTQVMGT GYAAPEYVATGR+T KSDVYSFGVVLLELLSGR VD
Sbjct: 234 FGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVD 293
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
KTKVG+E++LVDWA PYL DKRK+FRIMDTKLGGQYP K A A ALQCLN EPKLRP
Sbjct: 294 KTKVGVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRP 353
Query: 240 RMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 299
+MS+VL+ LE LE S +S S + S +QR TP A P+ S R
Sbjct: 354 KMSDVLSTLEELEMTLKSGSISNSVMKLTSSS----SSFTAKQRV---RTPVADPVLSSR 406
Query: 300 QSPRVR 305
+ RVR
Sbjct: 407 RCRRVR 412
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
Identities = 201/264 (76%), Positives = 233/264 (88%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
MVVAVKKLK EGFQGHKEWLTEV+YLG+LHH NLVKLIGYCLEGE RLLVYE+MPKGSLE
Sbjct: 117 MVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLE 176
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLFRRG +P+ W RMKVA AA+GL+FLH+A+ VIYRDFKASNILLD +FNAKLSDF
Sbjct: 177 NHLFRRGAEPIPWKTRMKVAFSAARGLSFLHEAK--VIYRDFKASNILLDVDFNAKLSDF 234
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAKAGPTGDRTHV+TQV+GT GYAAPEY+ATGRLT+KSDVYSFGVVLLELLSGR +DK
Sbjct: 235 GLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDK 294
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+KVG+E++LVDWA PYL D+RK+FRIMDTKLGGQYP K A AA +AL+CLN EPKLRP
Sbjct: 295 SKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPD 354
Query: 241 MSEVLAILERLEAPKNSAKLSQSE 264
M++VL+ L++LE +S K+ ++
Sbjct: 355 MADVLSTLQQLET--SSKKMGSTQ 376
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 191/305 (62%), Positives = 238/305 (78%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVKKL +G+QGH+EWL EVNYLGQ HPNLVKLIGYCLE E+RLLVYEFMP+GSLE
Sbjct: 113 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 172
Query: 61 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
NHLFRRG QPLSW +R+KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKLS
Sbjct: 173 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGLAK GPTGD++HVST++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR AV
Sbjct: 233 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 292
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
DK + EQ LV+WA+P L++KRKLFR++D +L QY + A ATLAL+CL E KLR
Sbjct: 293 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 352
Query: 239 PRMSEVLAILERL----EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTA 292
P M+EV++ LE + EA + + Q R++ V + + P +++ + + TA
Sbjct: 353 PNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATA 412
Query: 293 SPLPS 297
P PS
Sbjct: 413 YPRPS 417
|
|
| TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 2.0e-95, P = 2.0e-95
Identities = 183/262 (69%), Positives = 216/262 (82%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ VAVKKLK EG QGHKEWL EVNYLG+LHHPNLVKLIGY LE E+RLLVYE +P GSLE
Sbjct: 118 LAVAVKKLKTEGLQGHKEWLREVNYLGRLHHPNLVKLIGYSLENEHRLLVYEHLPNGSLE 177
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
NHLF R LSW++RMKVAIGAA+GL FLH+A QVIYRDFKA+NILLD+ FNAKLSDF
Sbjct: 178 NHLFERSSSVLSWSLRMKVAIGAARGLCFLHEANDQVIYRDFKAANILLDSGFNAKLSDF 237
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLAK GP +R+HV+T+VMGT GYAAPEY+ATG LTTK DVYSFGVVLLE+LSGR +DK
Sbjct: 238 GLAKEGPKDNRSHVTTEVMGTEGYAAPEYLATGHLTTKCDVYSFGVVLLEILSGRRVIDK 297
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+K E++LVDWA PYL DKRK+FRIMDTKL GQYPQKAA + LALQC+ + K+RP
Sbjct: 298 SKSREEENLVDWATPYLRDKRKVFRIMDTKLVGQYPQKAAFMMSFLALQCIG-DVKVRPS 356
Query: 241 MSEVLAILERLEAPKNSAKLSQ 262
M EV+++LE++ P++ S+
Sbjct: 357 MLEVVSLLEKVPIPRHRKSRSK 378
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 1.9e-92, P = 1.9e-92
Identities = 180/281 (64%), Positives = 221/281 (78%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V+AVK+L EGFQGH+EWL E+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM +GSLE
Sbjct: 101 IVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLE 160
Query: 61 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
NHLFRRG QPLSW R+++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLS
Sbjct: 161 NHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGLA+ GP GD +HVST+VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 179 DKTK-VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
DK + VG E +LVDWA+PYL++KR+L R+MD +L GQY A A LAL C++ + K
Sbjct: 281 DKNQPVG-EHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339
Query: 238 RPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 278
RP M+E++ +E L K ++K Q P + + KSP
Sbjct: 340 RPTMNEIVKTMEELHIQKEASK-EQQNPQISIDNI-INKSP 378
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
Identities = 184/314 (58%), Positives = 227/314 (72%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ VAVK L P+G QGHKEWL E+N+LG L HP+LVKL+GYC+E + RLLVYEFMP+GSLE
Sbjct: 136 LTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLE 195
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSD 119
NHLFRR PL W+VRMK+A+GAAKGL FLH+ AE VIYRDFK SNILLD E+NAKLSD
Sbjct: 196 NHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 254
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLAK P ++HVST+VMGT+GYAAPEYV TG LTTKSDVYSFGVVLLE+L+GR +VD
Sbjct: 255 FGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVD 314
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
K++ EQ+LV+W +P+L DK++ +R++D +L G Y K A A +A QCLN + K RP
Sbjct: 315 KSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARP 374
Query: 240 RMSEVLAILERLEAPKNSAKLSQS----EP------HRQTGPVTVRKSPMRQQRSPLNMT 289
+MSEV+ L+ L K+ A S S +P Q G R P + S LN+
Sbjct: 375 KMSEVVEALKPLPNLKDFASSSSSFQTMQPVAKNGVRTQGGGFVSRNGPPMRSLSSLNL- 433
Query: 290 PTASPLPSHRQSPR 303
P ASP RQSP+
Sbjct: 434 PQASPYRYARQSPK 447
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 4.0e-90, P = 4.0e-90
Identities = 172/250 (68%), Positives = 204/250 (81%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK L EG QGH+EWLTEVN+LGQL HPNLVKLIGYC E ++RLLVYEFM +GSLENH
Sbjct: 101 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENH 160
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
LFR+ PLSW+ RM +A+GAAKGL FLH+AE VIYRDFK SNILLD+++ AKLSDFGL
Sbjct: 161 LFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 220
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
AKAGP GD THVST+VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+
Sbjct: 221 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTR 280
Query: 183 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 242
EQ+LVDWA+P L+DKRKL +I+D +L QY +AA A +LA CL+ PK RP MS
Sbjct: 281 PSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS 340
Query: 243 EVLAILERLE 252
+V+ LE L+
Sbjct: 341 DVVETLEPLQ 350
|
|
| TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 7.1e-90, Sum P(2) = 7.1e-90
Identities = 172/250 (68%), Positives = 199/250 (79%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK L EG QGH+EWLTEV +LGQL H NLVKLIGYC E E+R LVYEFMP+GSLEN
Sbjct: 119 VAVKLLDLEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQ 178
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
LFRR L W+ RMK+A GAA GL FLH+AE+ VIYRDFKASNILLD+++ AKLSDFGL
Sbjct: 179 LFRRYSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGL 238
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
AK GP GD THVST+VMGT GYAAPEY+ TG LT +SDVYSFGVVLLELL+GR +VDK +
Sbjct: 239 AKDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKR 298
Query: 183 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 242
EQ+LVDWA+P L+D RKL RIMD +L GQY + A AATLA QCL++ PK RP MS
Sbjct: 299 SSREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMS 358
Query: 243 EVLAILERLE 252
V++IL L+
Sbjct: 359 AVVSILNDLK 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49840 | APK2B_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7877 | 1.0 | 0.7159 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 305 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-45 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-50
Identities = 79/256 (30%), Positives = 125/256 (48%), Gaps = 38/256 (14%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK + +E+L E + + +L HPN+V+L+G C +GE +V E+MP G L +
Sbjct: 31 VAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLD 90
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L R+ + L+ +++A+ AKG+ +L ++RD A N L+ K+SDFG
Sbjct: 91 FL-RKHGEKLTLKDLLQMALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFG 147
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYA-----APEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
L++ D G APE + G+ T+KSDV+SFGV+L E+ +
Sbjct: 148 LSRDIYEDDYY-----RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL-- 200
Query: 177 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLN 232
G +PY +S++ L + D G + P+ L LQC
Sbjct: 201 -------G--------EQPYPGMSNEEVLELLED---GYRLPRPENCPDELYELMLQCWA 242
Query: 233 NEPKLRPRMSEVLAIL 248
+P+ RP SE++ L
Sbjct: 243 YDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 7e-50
Identities = 83/257 (32%), Positives = 125/257 (48%), Gaps = 40/257 (15%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK + Q +E+L E + +L HPN+VKL+G C E E ++V E+MP G L +
Sbjct: 31 VAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD 90
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L + P+ LS + + A+ A+G+ +L I+RD A N L+ K+SDFG
Sbjct: 91 YLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFG 148
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
L++ D V G + APE + G+ T+KSDV+SFGV+L E+ +
Sbjct: 149 LSRDLYDDDYYKVK------GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-- 200
Query: 177 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCL 231
G +PY +S+ L + G K + L LQC
Sbjct: 201 -------G--------EEPYPGMSNAEVLEYLKK----GYRLPKPPNCPPELYKLMLQCW 241
Query: 232 NNEPKLRPRMSEVLAIL 248
+P+ RP SE++ IL
Sbjct: 242 AEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 2e-48
Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 41/257 (15%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK + Q +E+L E + +L HPN+VKL+G C E E +V E+M G L +
Sbjct: 31 VAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLS 90
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L + P+ LS + + A+ A+G+ +L I+RD A N L+ K+SDFG
Sbjct: 91 YLRKNRPK-LSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFG 147
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
L++ D G + APE + G+ T+KSDV+SFGV+L E+ +
Sbjct: 148 LSRDLYDDDYYRK------RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-- 199
Query: 177 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCL 231
G +PY +S++ L + + G + + L LQC
Sbjct: 200 -------G--------EQPYPGMSNEEVLEYLKN----GYRLPQPPNCPPELYDLMLQCW 240
Query: 232 NNEPKLRPRMSEVLAIL 248
+P+ RP SE++ IL
Sbjct: 241 AEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 9e-47
Identities = 62/173 (35%), Positives = 93/173 (53%), Gaps = 8/173 (4%)
Query: 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K +K E E L E+ L +L+HPN+VKL G + + LV E+ GSL+
Sbjct: 20 KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSD 119
+ L LS +++ + +GL +LH + +I+RD K NILLD+ KL+D
Sbjct: 80 DLLKEN-EGKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLEL 171
FGL+K + ++GT Y APE + G + KSD++S GV+L EL
Sbjct: 137 FGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-46
Identities = 82/267 (30%), Positives = 120/267 (44%), Gaps = 46/267 (17%)
Query: 1 MVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VAVK LK + + K++L E + +L HPN+V+L+G C E E LV E+M G L
Sbjct: 24 TEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDL 83
Query: 60 ENHL-------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
++L LS + AI AKG+ +L + ++RD A N L+ +
Sbjct: 84 LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGED 141
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVV 167
K+SDFGL++ D T G + APE + G T+KSDV+SFGV+
Sbjct: 142 LVVKISDFGLSRDVYDDDYY-----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVL 196
Query: 168 LLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225
L E+ + G A PY LS++ L + G K +
Sbjct: 197 LWEIFTL---------G--------ATPYPGLSNEEVLEYLRK----GYRLPKPEYCPDE 235
Query: 226 LA---LQCLNNEPKLRPRMSEVLAILE 249
L L C +P+ RP SE++ LE
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-45
Identities = 83/250 (33%), Positives = 123/250 (49%), Gaps = 26/250 (10%)
Query: 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+VAVK LK + + E+ L +L HPN+V+LI + ++ LV E+ G L
Sbjct: 26 IVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL 85
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLS 118
++L R G PLS K+A+ +GL +LH S +I+RD K NILLD K++
Sbjct: 86 FDYLSRGG--PLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIA 140
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCA 177
DFGLAK + ++T V GT Y APE + G K DV+S GV+L ELL+G+
Sbjct: 141 DFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-- 196
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEP 235
+ L + + RI+ L P+ ++ + L +CLN +P
Sbjct: 197 -----------PPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDP 245
Query: 236 KLRPRMSEVL 245
RP E+L
Sbjct: 246 SKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-45
Identities = 70/251 (27%), Positives = 107/251 (42%), Gaps = 32/251 (12%)
Query: 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K +K + + +E L E+ L +L HPN+V+L + + LV E+ G L
Sbjct: 26 LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF 85
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ L +RG A I L +LH +++RD K NILLD + + KL+DF
Sbjct: 86 DLLKKRGRLSEDEARFYLRQI--LSALEYLHSK--GIVHRDLKPENILLDEDGHVKLADF 141
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GLA+ G++ T V GT Y APE + D++S GV+L ELL+G+
Sbjct: 142 GLARQLDPGEKLT--TFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK----- 193
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH-----TAATLALQCLNNEP 235
P +L + + P A L + L +P
Sbjct: 194 --------------PPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239
Query: 236 KLRPRMSEVLA 246
+ R E L
Sbjct: 240 EKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 65/177 (36%), Positives = 100/177 (56%), Gaps = 15/177 (8%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LK + + +L E + + L HPNLV+L+G L+G +V E+M KGSL ++
Sbjct: 32 VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L RG ++ A ++ A+ +G+ +L E ++RD A N+L+ + AK+SDFGL
Sbjct: 91 LRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGL 148
Query: 123 AKA---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
AK G + V + APE + + +TKSDV+SFG++L E+ S GR
Sbjct: 149 AKEASQGQDSGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 75/261 (28%), Positives = 127/261 (48%), Gaps = 23/261 (8%)
Query: 2 VVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGS 58
VAVK L G + H ++ E+ L L H N+VK G C + G + L+ E++P GS
Sbjct: 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L ++L R Q ++ + + KG+ +L + I+RD A NIL+++E K+S
Sbjct: 95 LRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKIS 151
Query: 119 DFGLAKAGPTGDRTHVSTQ-----VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
DFGLAK P + + + + APE + T + ++ SDV+SFGV L EL +
Sbjct: 152 DFGLAKVLPEDKDYYYVKEPGESPIF----WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
Query: 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLAL--QC 230
D ++ + L + + R+++ K G + P+ + L C
Sbjct: 208 -YG--DPSQSPPAEFLRMIGIA--QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLC 262
Query: 231 LNNEPKLRPRMSEVLAILERL 251
EP+ RP ++++ I++RL
Sbjct: 263 WEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 75/251 (29%), Positives = 116/251 (46%), Gaps = 35/251 (13%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VA+K++ E + K + E++ L L HPN+VK IG ++ ++ E+ GSL
Sbjct: 27 FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSL 86
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ + GP P S + +GL +LH E VI+RD KA+NIL + KL+D
Sbjct: 87 RQIIKKFGPFPESLVAVYVYQV--LQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLAD 142
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FG+ A D + V+GT + APE + +T SD++S G ++ELL+G
Sbjct: 143 FGV--ATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN---- 196
Query: 180 KTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNE 234
PY L+ LFRI+ +P + L +QC +
Sbjct: 197 --------------PPYYDLNPMAALFRIVQD----DHPPLPEGISPELKDFLMQCFQKD 238
Query: 235 PKLRPRMSEVL 245
P LRP ++L
Sbjct: 239 PNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 58/175 (33%), Positives = 93/175 (53%), Gaps = 8/175 (4%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K +K E + ++ + E+ L + HPN+VK G L+ + +V EF GSL++
Sbjct: 27 EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L + Q L+ + V KGL +LH + +I+RD KA+NILL ++ KL DFG
Sbjct: 87 -LLKSTNQTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFG 143
Query: 122 LAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
L+ T R ++GT + APE + K+D++S G+ +EL G+
Sbjct: 144 LSAQLSDTKARNT----MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 31/252 (12%)
Query: 2 VVAVKK--LKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVY-EFMPKG 57
++AVK L + + + E+ L L HPN+V+ G E +N L ++ E++ G
Sbjct: 27 LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
SL + L + G P +R K +GL +LH +++RD K +NIL+D++ KL
Sbjct: 87 SLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLHSN--GIVHRDIKGANILVDSDGVVKL 142
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
+DFG AK + + V GT + APE + +D++S G ++E+ +G
Sbjct: 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG--- 199
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRK----LFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233
KP S+ L++I + + P+ + A +CL
Sbjct: 200 ----------------KPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243
Query: 234 EPKLRPRMSEVL 245
+PK RP E+L
Sbjct: 244 DPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 42/261 (16%)
Query: 3 VAVKKLKPEGFQGHKEW--LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K LK G + LTE + +GQ HPN+++L G + +++ E+M GSL+
Sbjct: 35 VAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLD 93
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
L R + + + G A G+ +L +E ++RD A NIL+++ K+SDF
Sbjct: 94 KFL-RENDGKFTVGQLVGMLRGIASGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDF 150
Query: 121 GLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS- 173
GL++ R S T G + APE +A + T+ SDV+SFG+V+ E++S
Sbjct: 151 GLSR------RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSY 204
Query: 174 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQC 230
G +PY +S++ + + D +L P L L C
Sbjct: 205 GE------------------RPYWDMSNQDVIKAVEDGYRL--PPPMDCPSALYQLMLDC 244
Query: 231 LNNEPKLRPRMSEVLAILERL 251
+ RP S++++ L+++
Sbjct: 245 WQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 77/253 (30%), Positives = 119/253 (47%), Gaps = 26/253 (10%)
Query: 1 MVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VAVK + K +L E L Q HPN+VKLIG C++ + +V E +P GSL
Sbjct: 20 TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLS 118
L R+ L+ +++++ AA G+ +L ES+ I+RD A N L+ K+S
Sbjct: 80 LTFL-RKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKIS 135
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFG+++ G T + APE + GR T++SDV+S+G++L E S
Sbjct: 136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG--- 192
Query: 179 DKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
PY +S+++ RI ++ PQ L LQC +P+
Sbjct: 193 --------------DTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237
Query: 237 LRPRMSEVLAILE 249
RP SE+ L+
Sbjct: 238 NRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 73/227 (32%), Positives = 110/227 (48%), Gaps = 40/227 (17%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLS--WA 74
LTE N L +++HP +VKL Y + E +L LV E+ P G L +HL + G + + +A
Sbjct: 41 LTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYA 99
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTH 133
+ +A+ +LH +IYRD K NILLDA+ + KL+DFGLAK G RT+
Sbjct: 100 AEIVLALE------YLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151
Query: 134 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 193
GT Y APE + D +S GV+L E+L+G+
Sbjct: 152 ---TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------ 190
Query: 194 KPYLSDKRKLF--RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
P+ ++ RK +I+ L ++P+ + A L L +P R
Sbjct: 191 PPFYAEDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 84/262 (32%), Positives = 124/262 (47%), Gaps = 47/262 (17%)
Query: 3 VAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK E G KE+L E + + QL HP +V+LIG C GE +LV E P G L
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLK 84
Query: 62 HLFRRGPQPLS----WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
+L +R P+S A ++ A G+ +L ++RD A N+LL AK+
Sbjct: 85 YLKKRREIPVSDLKELAHQV------AMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKI 136
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELL 172
SDFG+++A G + +T T G + APE + G+ ++KSDV+S+GV L E
Sbjct: 137 SDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192
Query: 173 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLAL 228
S G AKPY + K ++ G+ P++ ++ L
Sbjct: 193 SYG------------------AKPY--GEMKGAEVIAMLESGERLPRPEECPQEIYSIML 232
Query: 229 QCLNNEPKLRPRMSEVLAILER 250
C P+ RP SE+ + R
Sbjct: 233 SCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 77/252 (30%), Positives = 121/252 (48%), Gaps = 11/252 (4%)
Query: 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGS 58
+VAVK LK E Q + W E+N L L+H N+VK G C E + L+ E++P GS
Sbjct: 35 MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L ++L + L+ A + A +G+ +LH I+RD A N+LLD + K+
Sbjct: 95 LRDYLPK---HKLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIG 149
Query: 119 DFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
DFGLAKA P G + V + A E + + + SDV+SFGV L ELL+ C
Sbjct: 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCD 208
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
++ + ++ + ++ R L +++ + P+ L C E K
Sbjct: 209 SKQSPPKKFEEMIGPKQGQMTVVR-LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKF 267
Query: 238 RPRMSEVLAILE 249
RP ++ IL+
Sbjct: 268 RPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 79/241 (32%), Positives = 117/241 (48%), Gaps = 17/241 (7%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
+E+ +G+L HPN+VKLIG C + L++E++ +L L R LSW R K+
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RN---LSWERRRKI 785
Query: 80 AIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138
AIG AK L FLH V+ + I++D + L L T + +S+
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-- 842
Query: 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 198
Y APE T +T KSD+Y FG++L+ELL+G+ D + G+ S+V+WA+ S
Sbjct: 843 ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYS 897
Query: 199 DKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 256
D L +D + G Q LAL C +P RP ++VL LE +
Sbjct: 898 DCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
Query: 257 S 257
S
Sbjct: 957 S 957
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 2e-27
Identities = 86/318 (27%), Positives = 124/318 (38%), Gaps = 25/318 (7%)
Query: 1 MVVAVKKLKPEGFQGHKEW---LTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPK 56
+VA+K L + KE L E+ L L H PN+VKL + + + LV E++
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 57 GSLE---NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE- 112
GSLE + R+GP S A+ + I L +LH +I+RD K NILLD +
Sbjct: 83 GSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLH--SKGIIHRDIKPENILLDRDG 138
Query: 113 FNAKLSDFGLAK----AGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFG 165
KL DFGLAK G T + + +GT GY APE + ++ SD++S G
Sbjct: 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG 198
Query: 166 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225
+ L ELL+G + K S L + + A+
Sbjct: 199 ITLYELLTGLPPFEGEKNSSATSQT-LKIILELPTPSLASPLSPSNPELISKAASD---- 253
Query: 226 LALQCLNNEPKLRPRMSEVLAI-LERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRS 284
L + L +PK R S L+ L K S +P + S
Sbjct: 254 LLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313
Query: 285 PLNMTPTASPLPSHRQSP 302
LN + S
Sbjct: 314 SLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 57/186 (30%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 1 MVVAVKKLK-PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+VAVK LK K++ E L H N+VK G C EG+ ++V+E+M G L
Sbjct: 36 ELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95
Query: 60 ENHLFRRGPQ------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
L GP L+ + +++A+ A G+ +L A ++RD N
Sbjct: 96 NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNC 153
Query: 108 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
L+ + K+ DFG+++ T D V M + PE + + TT+SDV+SFGVV
Sbjct: 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213
Query: 168 LLELLS 173
L E+ +
Sbjct: 214 LWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 57/175 (32%), Positives = 90/175 (51%), Gaps = 11/175 (6%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K ++ EG +++ E + +L HPNLV+L G C + +V E+M G L N+
Sbjct: 31 VAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L R L + + + + +L + I+RD A N L+ + K+SDFGL
Sbjct: 90 L-RERKGKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGL 146
Query: 123 AKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A+ D + S+Q GT +A PE R ++KSDV+SFGV++ E+ S
Sbjct: 147 ARY--VLDDQYTSSQ--GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 66/181 (36%), Positives = 93/181 (51%), Gaps = 17/181 (9%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LKP G + +L E + +L H LV+L C E E +V E+M KGSL +
Sbjct: 33 VAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91
Query: 63 LFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
L + G L V M I A+G+ +L I+RD A NIL+ K++D
Sbjct: 92 L-KSGEGKKLRLPQLVDMAAQI--AEGMAYLE--SRNYIHRDLAARNILVGENLVCKIAD 146
Query: 120 FGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
FGLA+ D + + + G + APE GR T KSDV+SFG++L E+++ GR
Sbjct: 147 FGLARL--IEDDEYTARE--GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
Query: 176 C 176
Sbjct: 203 V 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 3 VAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK + +E+ E + L HPN+V L+G C + + +++E++ G L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 62 HLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
L R P L + + +AI A G+ +L + ++RD A N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNC 155
Query: 108 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
L+ K+SDFGL++ + D V ++ + + PE + G+ TT+SD++SFGVV
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215
Query: 168 LLELLS 173
L E+ S
Sbjct: 216 LWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-24
Identities = 77/250 (30%), Positives = 124/250 (49%), Gaps = 30/250 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK +K + + +L E + +LHH NLV+L+G L +V E M KG+L N
Sbjct: 32 VAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNF 88
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L RG +S ++ ++ A+G+ +L ++++RD A NIL+ + AK+SDFGL
Sbjct: 89 LRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGL 146
Query: 123 AKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDK 180
A+ G G D + + + + APE + + ++KSDV+S+GV+L E+ S GR K
Sbjct: 147 ARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+ + V+ K +R M+ P+ L C EPK RP
Sbjct: 201 MSLKEVKECVE----------KGYR-MEP------PEGCPADVYVLMTSCWETEPKKRPS 243
Query: 241 MSEVLAILER 250
++ LE+
Sbjct: 244 FHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-24
Identities = 75/257 (29%), Positives = 112/257 (43%), Gaps = 45/257 (17%)
Query: 4 AVK--KLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
AVK L +G G K+ E+ L +L HPN+V+ +G E +N + E +P GS
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L L + G P +R+ GL +LHD ++RD K +NIL+D KL+
Sbjct: 89 LAKLLKKYGSFPEP-VIRLYTR-QILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLA 144
Query: 119 DFGLAKAGPTGDRTHVSTQVM-----GTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELL 172
DFG+AK V G+ + APE +A G +D++S G +LE+
Sbjct: 145 DFGMAK--------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA 196
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQ 229
+G KP S +F+I +K P + A L+
Sbjct: 197 TG-------------------KPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 230 CLNNEPKLRPRMSEVLA 246
CL +P LRP +E+L
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 57/177 (32%), Positives = 95/177 (53%), Gaps = 15/177 (8%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL-- 59
VA+K L+ E + +KE L E + + HP++V+L+G CL L+ + MP G L
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLD 97
Query: 60 --ENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
NH G Q L+W V++ AKG+++L E ++++RD A N+L+ + K
Sbjct: 98 YVRNHKDNIGSQYLLNWCVQI------AKGMSYLE--EKRLVHRDLAARNVLVKTPQHVK 149
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
++DFGLAK ++ + + + A E + T KSDV+S+GV + EL++
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 43/272 (15%)
Query: 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VAVK LK E ++ E + + HPN+VKL+G C G+ L++E+M G L
Sbjct: 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 61 NHLFRRGPQ--------------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 100
L R P+ PLS ++ +A A G+ +L +E + ++R
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHR 154
Query: 101 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160
D N L+ K++DFGL++ + D S + PE + R TT+SD
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESD 214
Query: 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQK 218
V+++GVVL E+ S G++ PY ++ + ++ + D + P
Sbjct: 215 VWAYGVVLWEIFS---------YGMQ--------PYYGMAHEEVIYYVRDGNVLS-CPDN 256
Query: 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILER 250
L C + P RP + + IL+R
Sbjct: 257 CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 76/261 (29%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRL-LVYEFMPKGSL 59
VVAVKKL+ + +++ E+ L L H N+VK G C G L LV E++P GSL
Sbjct: 35 VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL 94
Query: 60 ENHLFRR-----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
++L + + L +A ++ KG+ +L + ++RD NIL+++E
Sbjct: 95 RDYLQKHRERLDHRKLLLYASQI------CKGMEYL--GSKRYVHRDLATRNILVESENR 146
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELL 172
K+ DFGL K P D+ + + G + APE + + + SDV+SFGVVL EL
Sbjct: 147 VKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 205
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--QC 230
+ + ++ K L ++ K G+ P A A+ +C
Sbjct: 206 T-YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL--KNNGRLPAPPGCPAEIYAIMKEC 262
Query: 231 LNNEPKLRPRMSEVLAILERL 251
NN+P RP SE+ +E +
Sbjct: 263 WNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 3e-24
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 43/240 (17%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPL 71
L EV L +L+HPN++K E +V E+ G L + ++ Q L
Sbjct: 47 LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL 106
Query: 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGD 130
W V++ L +LH ++++RD K NI L + KL DFG++K T D
Sbjct: 107 DWFVQL------CLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158
Query: 131 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 190
T V GT Y +PE KSD++S G VL EL + + + + L
Sbjct: 159 --LAKTVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELA 212
Query: 191 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAI 247
+I+ GQYP + ++ L L +P+ RP ++++L
Sbjct: 213 -------------LKILK----GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 5e-24
Identities = 61/181 (33%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LKP G K++L E + +L HP L++L C E +V E M GSL +
Sbjct: 33 VAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFG 121
L + L + +A A G+ +L E+Q I+RD A N+L+ K++DFG
Sbjct: 92 LQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFG 148
Query: 122 LAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 174
LA R G + APE R + KSDV+SFG++L E+++ G
Sbjct: 149 LA-------RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201
Query: 175 R 175
R
Sbjct: 202 R 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 6e-24
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 5/173 (2%)
Query: 3 VAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK + ++L E + L H NL++L G L ++V E P GSL +
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L + + A+ A G+ +L + I+RD A NILL ++ K+ DFG
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFG 142
Query: 122 LAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
L +A P + +V + + APE + T + SDV+ FGV L E+ +
Sbjct: 143 LMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 35/261 (13%)
Query: 3 VAVKKLKP-EGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K + + E+L E + + + + ++V+L+G G+ L+V E M KG L++
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS 98
Query: 62 HL--------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
+L G P + +++A A G+ +L A + ++RD A N ++ +
Sbjct: 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL--AAKKFVHRDLAARNCMVAEDL 156
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFG+ + D + + + APE + G TTKSDV+SFGVVL E+
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA- 215
Query: 174 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQ 229
+L +PY LS++ L ++D GG P+ L
Sbjct: 216 --------------TLA--EQPYQGLSNEEVLKFVID---GGHLDLPENCPDKLLELMRM 256
Query: 230 CLNNEPKLRPRMSEVLAILER 250
C PK+RP E+++ L+
Sbjct: 257 CWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 7e-24
Identities = 60/173 (34%), Positives = 94/173 (54%), Gaps = 8/173 (4%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LK + +++ EV L +L H +L+ L C GE ++ E M KGSL
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--L 90
Query: 63 LFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
F R P Q L A + +A A+G+ +L E I+RD A NIL+ + K++DF
Sbjct: 91 AFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADF 148
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
GLA+ + ++S+ + + APE + G +TKSDV+SFG++L E+ +
Sbjct: 149 GLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 9e-24
Identities = 65/251 (25%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK + + E+L E + ++ HPNLV+L+G C ++ EFM G+L +
Sbjct: 33 TVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 91
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L Q ++ V + +A + + +L + I+RD A N L+ K++DFG
Sbjct: 92 YLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFG 149
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
L++ TGD + APE +A + + KSDV++FGV+L E+ + +
Sbjct: 150 LSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---- 204
Query: 182 KVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
PY D +++ +++ + P+ L C P RP
Sbjct: 205 -------------PYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPS 251
Query: 241 MSEVLAILERL 251
+E+ E +
Sbjct: 252 FAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-23
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 21/228 (9%)
Query: 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77
E + E L +L +++ L+ +V E+ G L L + +PL
Sbjct: 45 EAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW 104
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+ I GL LH ++++RD K+ N+ LDA N K+ D G+AK D T+ +
Sbjct: 105 RFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANT 160
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 197
++GT Y +PE KSDV++ GVVL E +G+ D G +L+
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI------- 210
Query: 198 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
K+ R + + Y Q+ A L QCL + + RP ++L
Sbjct: 211 ---LKIIRGVFPPVSQMYSQQLAQ----LIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 6e-23
Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 17/177 (9%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K ++ EG ++++ E + +L HP LV+L G C E LV+EFM G L ++
Sbjct: 31 VAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY 89
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L R S + + + +G+ +L S VI+RD A N L+ K+SDFG+
Sbjct: 90 L-RAQRGKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGM 146
Query: 123 AKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
R + Q + G +++PE + + ++KSDV+SFGV++ E+ S
Sbjct: 147 T-------RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-22
Identities = 66/253 (26%), Positives = 122/253 (48%), Gaps = 33/253 (13%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K +K EG E++ E + +L H LV+L G C + +V E+M G L N+
Sbjct: 31 VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89
Query: 63 L--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
L + QP + +++ +G+ +L Q I+RD A N L+D + K+SDF
Sbjct: 90 LREHGKRFQP---SQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDF 144
Query: 121 GLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC 176
GL++ D + S+ +G+ ++ PE + + ++KSDV++FGV++ E+ S G+
Sbjct: 145 GLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
++ V+ +S +L+R P A+ + C + + +
Sbjct: 201 PYERFN---NSETVE----KVSQGLRLYR----------PHLASEKVYAIMYSCWHEKAE 243
Query: 237 LRPRMSEVLAILE 249
RP ++L+ +E
Sbjct: 244 ERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 43/273 (15%)
Query: 3 VAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK ++ L+E N L Q++HP+++KL G C + LL+ E+ GSL +
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 62 HL----------------------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 99
L + L+ + A ++G+ +L AE ++++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVH 150
Query: 100 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159
RD A N+L+ K+SDFGL++ D ++ + A E + TT+S
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS 210
Query: 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQK 218
DV+SFGV+L E+++ +G PY +LF ++ T + P+
Sbjct: 211 DVWSFGVLLWEIVT---------LG--------GNPYPGIAPERLFNLLKTGYRMERPEN 253
Query: 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ L L C EP RP +++ LE++
Sbjct: 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 35/253 (13%)
Query: 2 VVAVKKLK-PEGFQGHKEWLTEVNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSL 59
+ A+KK+ + K+ L E+ L P +VK G + EGE + V E+M GSL
Sbjct: 28 IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSL 86
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ L + G + V +A KGL +LH + +I+RD K SN+L++++ K++D
Sbjct: 87 ADLLKKVGK--IPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKGEVKIAD 143
Query: 120 FGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
FG++K T D+ + T V GT Y +PE + + +D++S G+ LLE G+
Sbjct: 144 FGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF-- 198
Query: 179 DKTKVGIEQSLVDWAKPYLSDKR-KLFRIMDTKLGGQYP-----QKAAHTAATLALQCLN 232
P+L + F +M G P + + ++ CL
Sbjct: 199 ----------------PFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA-CLQ 241
Query: 233 NEPKLRPRMSEVL 245
+PK RP +E+L
Sbjct: 242 KDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 64/175 (36%), Positives = 92/175 (52%), Gaps = 7/175 (4%)
Query: 3 VAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSL 59
VAVK LKPE H L E+ L L+H N+VK G C E L+ EF+P GSL
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ +L R ++ ++K A+ KG+ +L Q ++RD A N+L+++E K+ D
Sbjct: 96 KEYL-PRNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGD 152
Query: 120 FGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
FGL KA T + V + + APE + + SDV+SFGV L ELL+
Sbjct: 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 34/269 (12%)
Query: 1 MVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
++VAVK L+P+ + + ++L EV L +L PN+++L+G C++ + ++ E+M G L
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 60 ENHLFRR----------------GPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 102
L P +S++ + VA+ A G+ +L + ++RD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDL 164
Query: 103 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 162
N L+ K++DFG+++ GD + + + + A E + G+ TT SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 163 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKA 219
+FGV L E+L C ++ +++ A + D+ + LFR P
Sbjct: 225 AFGVTLWEILM-LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFR----------PPPC 273
Query: 220 AHTAATLALQCLNNEPKLRPRMSEVLAIL 248
L LQC + + + RP S++ A L
Sbjct: 274 PQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 30/252 (11%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLEN 61
VAVK +K + + +L E + + QL H NLV+L+G +E + L +V E+M KGSL +
Sbjct: 32 VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L RG L +K ++ + + +L + ++RD A N+L+ + AK+SDFG
Sbjct: 90 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFG 147
Query: 122 LAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVD 179
L K A T D + + + APE + + +TKSDV+SFG++L E+ S GR V
Sbjct: 148 LTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VP 199
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
++ ++ + K Y D P + QC + + RP
Sbjct: 200 YPRIPLKDVVPRVEKGYKMDA---------------PDGCPPVVYDVMKQCWHLDAATRP 244
Query: 240 RMSEVLAILERL 251
++ LE +
Sbjct: 245 SFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 16 HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLEN---HLFRRGPQP 70
K+ L E+ P +VK G L+ + + E+ GSL++ + +RG +
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR- 101
Query: 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 129
+ V K+A KGL++LH ++I+RD K SNILL + KL DFG++ + +
Sbjct: 102 IGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159
Query: 130 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
T GT Y APE + + SDV+S G+ LLE+ R
Sbjct: 160 AGTFT-----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-22
Identities = 58/187 (31%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
M+VAVK LK K++ E L L H ++VK G C +G+ ++V+E+M G L
Sbjct: 36 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 61 NHLFRRGP--------QP------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 106
L GP QP L + + +A A G+ +L A ++RD N
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRN 153
Query: 107 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 166
L+ A K+ DFG+++ + D V M + PE + + TT+SDV+SFGV
Sbjct: 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213
Query: 167 VLLELLS 173
+L E+ +
Sbjct: 214 ILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 6e-22
Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 30/189 (15%)
Query: 2 VVAVKKLKP----EGFQGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYE 52
+VA+KK++ EGF +T E+ L +L HPN+V+L + +V+E
Sbjct: 26 LVALKKIRMENEKEGFP-----ITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80
Query: 53 FMP---KGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
+M G L++ + Q + ++ +GL +LH +++RD K SNIL
Sbjct: 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQL------LEGLQYLHSN--GILHRDIKGSNIL 132
Query: 109 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGV 166
++ + KL+DFGLA+ T + T + T Y PE + AT R + D++S G
Sbjct: 133 INNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGC 190
Query: 167 VLLELLSGR 175
+L EL G+
Sbjct: 191 ILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-22
Identities = 63/182 (34%), Positives = 96/182 (52%), Gaps = 13/182 (7%)
Query: 3 VAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK L+ Q KE+L E + + +HPN+VKL+G CL E + ++ E M G L +
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88
Query: 62 HL-----FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DA 111
+L R GP L+ + + + AKG +L I+RD A N L+ DA
Sbjct: 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDA 146
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171
+ K+ DFGLA+ D + + + APE + G+ TT+SDV+SFGV++ E+
Sbjct: 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEI 206
Query: 172 LS 173
L+
Sbjct: 207 LT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-22
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 47/265 (17%)
Query: 3 VAVKKL-KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR-LLVYEFMPKGSLE 60
AVK L + + +++L E + HPN++ L+G CL E L+V +M G L
Sbjct: 26 CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR 85
Query: 61 NHLFRRGPQ--PLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
N F R P V+ + G AKG+ +L A + ++RD A N +LD F K
Sbjct: 86 N--FIRSETHNP---TVKDLIGFGLQVAKGMEYL--ASKKFVHRDLAARNCMLDESFTVK 138
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLEL 171
++DFGLA+ D+ + S T + A E + T + TTKSDV+SFGV+L EL
Sbjct: 139 VADFGLAR--DIYDKEYYSVH-NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195
Query: 172 LSGRCA-----VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226
++ R A VD + + YL R+L + P+ +
Sbjct: 196 MT-RGAPPYPDVDSFDITV----------YLLQGRRLLQ----------PEYCPDPLYEV 234
Query: 227 ALQCLNNEPKLRPRMSEVLAILERL 251
L C + +P++RP SE+++ +E++
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 52/160 (32%), Positives = 90/160 (56%), Gaps = 9/160 (5%)
Query: 17 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76
K+ L E+ + + P +V G L N + EFM GSL+ + GP P+ +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE--IL 105
Query: 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VS 135
K+A+ +GLT+L++ ++++RD K SNIL+++ KL DFG+ +G+ + ++
Sbjct: 106 GKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIA 159
Query: 136 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+GT Y +PE + G+ T KSDV+S G+ ++EL G+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 68/268 (25%), Positives = 116/268 (43%), Gaps = 44/268 (16%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFM 54
VAVK +K + +E+L+E + HPN++KLIG C E + +++ FM
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 55 PKGSLENHLF--RRGPQPLSWAVRM--KVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
G L + L R G P ++ K + A G+ +L + I+RD A N +L
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--SNRNFIHRDLAARNCMLR 147
Query: 111 AEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
+ ++DFGL+K +GD + ++ + + A E +A T+KSDV++FGV
Sbjct: 148 EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVT 204
Query: 168 LLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226
+ E+ + G+ G+E I D G ++ L
Sbjct: 205 MWEIATRGQTPYP----GVENH----------------EIYDYLRHGNRLKQPEDCLDEL 244
Query: 227 ---ALQCLNNEPKLRPRMSEVLAILERL 251
C +PK RP +++ +LE +
Sbjct: 245 YDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 42/259 (16%)
Query: 1 MVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
++AVK ++ E K+ L E++ L + + P +V G + + E+M GSL
Sbjct: 27 KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ + + + + K+A+ KGLT+LH+ + ++I+RD K SNIL+++ KL D
Sbjct: 87 DK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCD 144
Query: 120 FGLAKAGPTGDRTHVSTQVM--------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171
FG VS Q++ GT Y APE + + KSD++S G+ L+EL
Sbjct: 145 FG------------VSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
Query: 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT---KL-GGQYPQKAAHTAATLA 227
+GR P L I++ +L G++
Sbjct: 193 ATGRFPYPP-----------ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD----FV 237
Query: 228 LQCLNNEPKLRPRMSEVLA 246
CL +P+ RP E+L
Sbjct: 238 NLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 60/182 (32%), Positives = 90/182 (49%), Gaps = 11/182 (6%)
Query: 1 MVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VA+K++ E Q E EV + Q +HPN+VK + G+ LV ++ GSL
Sbjct: 27 EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86
Query: 60 EN---HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
+ + RG + V KGL +LH + I+RD KA NILL + + K
Sbjct: 87 LDIMKSSYPRGGLDEAIIA--TVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVK 142
Query: 117 LSDFGL-AKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLS 173
++DFG+ A GDRT V +GT + APE + K+D++SFG+ +EL +
Sbjct: 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202
Query: 174 GR 175
G
Sbjct: 203 GA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-21
Identities = 73/262 (27%), Positives = 132/262 (50%), Gaps = 41/262 (15%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K LK G+ +++L+E + +GQ HPN++ L G + +++ EFM G+L+
Sbjct: 35 VAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 61 NHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L + Q + V V + G A G+ +L +E ++RD A NIL+++ K+S
Sbjct: 94 SFLRQNDGQ---FTVIQLVGMLRGIAAGMKYL--SEMNYVHRDLAARNILVNSNLVCKVS 148
Query: 119 DFGLAK--AGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
DFGL++ T D T+ S+ +G + APE +A + T+ SDV+S+G+V+ E++S
Sbjct: 149 DFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
Query: 174 -GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQ 229
G +PY +S++ + I D +L P L L
Sbjct: 207 YGE------------------RPYWDMSNQDVINAIEQDYRLPP--PMDCPTALHQLMLD 246
Query: 230 CLNNEPKLRPRMSEVLAILERL 251
C + RP+ ++++ L+++
Sbjct: 247 CWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 12/181 (6%)
Query: 3 VAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK L+P+ +++L EV L +L PN+ +L+G C ++ E+M G L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 62 HLFRR---------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
L + + LS++ + +A A G+ +L ++RD N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKN 166
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
+ K++DFG+++ + D V + + A E V G+ TTKSDV++FGV L E+L
Sbjct: 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
Query: 173 S 173
+
Sbjct: 227 T 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-21
Identities = 73/258 (28%), Positives = 113/258 (43%), Gaps = 51/258 (19%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL--- 59
VA+KK++ Q + + E+ + HPN+V L G+ +V E+M GSL
Sbjct: 47 VAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI 105
Query: 60 -ENHLFRRGPQPLSWAVRMKVAIGAA------KGLTFLHDAESQVIYRDFKASNILLDAE 112
+ VRM A +GL +LH VI+RD K+ NILL +
Sbjct: 106 ITQN-----------FVRMNEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKD 152
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
+ KL+DFG A A T +++ ++ V GT + APE + K D++S G++ +E+
Sbjct: 153 GSVKLADFGFA-AQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDK--RKLFRIMDTKLGG---QYPQKAAHTAATLA 227
G PYL + R LF I T G + P+K +
Sbjct: 211 EGE------------------PPYLREPPLRALFLI--TTKGIPPLKNPEKWSPEFKDFL 250
Query: 228 LQCLNNEPKLRPRMSEVL 245
+CL +P+ RP E+L
Sbjct: 251 NKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-21
Identities = 71/265 (26%), Positives = 118/265 (44%), Gaps = 35/265 (13%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
++VAVK LK K++ E L L H ++VK G C+EG+ ++V+E+M G L
Sbjct: 36 ILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 61 NHLFRRGPQP-----------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109
L GP L+ + + +A A G+ +L A ++RD N L+
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLV 153
Query: 110 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 169
K+ DFG+++ + D V M + PE + + TT+SDV+S GVVL
Sbjct: 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213
Query: 170 ELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226
E+ + G+ +P+ LS+ + I ++ Q P+ L
Sbjct: 214 EIFTYGK------------------QPWYQLSNNEVIECITQGRV-LQRPRTCPKEVYDL 254
Query: 227 ALQCLNNEPKLRPRMSEVLAILERL 251
L C EP +R + E+ ++L+ L
Sbjct: 255 MLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 73/259 (28%), Positives = 132/259 (50%), Gaps = 37/259 (14%)
Query: 3 VAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K LKP G+ + +++L+E + +GQ H N+++L G + + +++ E+M G+L+
Sbjct: 36 VAIKTLKP-GYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALD 94
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+L R S + + G A G+ +L ++ ++RD A NIL+++ K+SDF
Sbjct: 95 KYL-RDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVHRDLAARNILVNSNLECKVSDF 151
Query: 121 GLAKA---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC 176
GL++ P G T ++ + APE +A + T+ SDV+SFG+V+ E++S G
Sbjct: 152 GLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE- 208
Query: 177 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAAT--LALQCLN 232
+PY +S+ + I D G + P +A L LQC
Sbjct: 209 -----------------RPYWDMSNHEVMKAIND---GFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 233 NEPKLRPRMSEVLAILERL 251
+ RPR +++ +L++L
Sbjct: 249 QDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
M+VAVK LK +++ E L L H ++V+ G C EG L+V+E+M G L
Sbjct: 36 MLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 61 NHLFRRGPQ-------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
L GP L+ + +A A G+ +L A ++RD N
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL--ASLHFVHRDLATRNC 153
Query: 108 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
L+ K+ DFG+++ + D V + M + PE + + TT+SD++SFGVV
Sbjct: 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVV 213
Query: 168 LLELLS 173
L E+ +
Sbjct: 214 LWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-20
Identities = 65/252 (25%), Positives = 120/252 (47%), Gaps = 33/252 (13%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K + EG ++++ E + +L HP LV+L G C + + +V EFM G L N+
Sbjct: 31 VAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L +R + LS + + + +G+ +L + I+RD A N L+ + K+SDFG+
Sbjct: 90 LRQRQGK-LSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGM 146
Query: 123 AKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
R + + + G ++ PE + ++KSDV+SFGV++ E+ +
Sbjct: 147 T-------RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT--- 196
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
+ K+ E+ +S +L+R P+ A+ T + C + +P+
Sbjct: 197 ---EGKMPFEKKSNYEVVEMISRGFRLYR----------PKLASMTVYEVMYSCWHEKPE 243
Query: 237 LRPRMSEVLAIL 248
RP +E+L +
Sbjct: 244 GRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 61/184 (33%), Positives = 93/184 (50%), Gaps = 17/184 (9%)
Query: 2 VVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKG 57
+ A+K +K + LTE + L Q P +VKL Y +G+ L LV E++P G
Sbjct: 20 IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGG 78
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L + L G A I A L +LH + +I+RD K NIL+D+ + KL
Sbjct: 79 DLASLLENVGSLDEDVARIYIAEIVLA--LEYLH--SNGIIHRDLKPDNILIDSNGHLKL 134
Query: 118 SDFGLAKAGPTGDRTHVS------TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLE 170
+DFGL+K G + +++ +++GT Y APE V G+ +K+ D +S G +L E
Sbjct: 135 TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYE 193
Query: 171 LLSG 174
L G
Sbjct: 194 FLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-20
Identities = 57/227 (25%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81
E+ + +L+HP++++++G E + L E+M GS+ + L + G AV +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTE 110
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLA-KAGPTGDRT-HVSTQV 138
+GL++LH+ +Q+I+RD K +N+L+D+ +++DFG A + G Q+
Sbjct: 111 QLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 198
+GT + APE + + DV+S G V++E+ + + + K +L
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--------- 219
Query: 199 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
+F+I P+ + + L+CL +P+ RP E+L
Sbjct: 220 ----IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-20
Identities = 59/180 (32%), Positives = 91/180 (50%), Gaps = 18/180 (10%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LK +G + +L E N + QL HP LV+L + E ++ E+M GSL +
Sbjct: 33 VAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L L+ + +A A+G+ F+ I+RD +A+NIL+ K++DFGL
Sbjct: 91 LKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGL 148
Query: 123 AKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
A R + G + APE + G T KSDV+SFG++L E+++ GR
Sbjct: 149 A-------RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-20
Identities = 69/258 (26%), Positives = 125/258 (48%), Gaps = 35/258 (13%)
Query: 3 VAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K LK G+ + +++L+E + +GQ HPN++ L G + + ++V E+M GSL+
Sbjct: 35 VAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 61 NHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L + Q + V V + G A G+ +L D ++RD A NIL+++ K+S
Sbjct: 94 AFLRKHDGQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVS 148
Query: 119 DFGLAKA---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 174
DFGL++ P T ++ + APE +A + T+ SDV+S+G+V+ E++S G
Sbjct: 149 DFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 206
Query: 175 RCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233
+PY + + + ++ P L L C
Sbjct: 207 E------------------RPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQK 248
Query: 234 EPKLRPRMSEVLAILERL 251
+ RP+ ++++IL++L
Sbjct: 249 DRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-20
Identities = 72/244 (29%), Positives = 116/244 (47%), Gaps = 23/244 (9%)
Query: 3 VAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK K + Q K ++L+E L Q HPN+VKLIG C + + +V E +P G +
Sbjct: 22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L R+ L +K A+ AA G+ +L I+RD A N L+ K+SDFG
Sbjct: 82 FL-RKKKDELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFG 138
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDK 180
+++ G + + + + APE + GR +++SDV+S+G++L E S G C
Sbjct: 139 MSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+ V+ K +R+ PQK + +C + +P+ RP+
Sbjct: 198 MTNQQAREQVE----------KGYRM-------SCPQKCPDDVYKVMQRCWDYKPENRPK 240
Query: 241 MSEV 244
SE+
Sbjct: 241 FSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 8/146 (5%)
Query: 31 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 89
HP L +L C + ++RL V E++ G L H+ R G A I GL F
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQF 111
Query: 90 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149
LH E +IYRD K N+LLD+E + K++DFG+ K G G T ++ GT Y APE
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEI 167
Query: 150 VATGRLTTKSDVYSFGVVLLELLSGR 175
++ D ++ GV+L E+L+G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 75/267 (28%), Positives = 115/267 (43%), Gaps = 40/267 (14%)
Query: 1 MVVAVKKLKPEGFQGHKE--WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK L PE E +L E + + +H N+V+LIG E R ++ E M G
Sbjct: 37 LQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGD 95
Query: 59 LENHLFRRGP---QPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
L++ L P +P S ++ + A AKG +L E+ I+RD A N LL +
Sbjct: 96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKG 153
Query: 114 N---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
AK++DFG+A+ + M + PE G T+K+DV+SFGV+L E
Sbjct: 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE 213
Query: 171 LLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATL 226
+ S G PY + +M+ GG P+ +
Sbjct: 214 IFSLGYM------------------PYPGRTNQ--EVMEFVTGGGRLDPPKGCPGPVYRI 253
Query: 227 ALQCLNNEPKLRPRMSEVLAILERLEA 253
C + P+ RP + ILER++
Sbjct: 254 MTDCWQHTPEDRPNFAT---ILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 72/257 (28%), Positives = 110/257 (42%), Gaps = 37/257 (14%)
Query: 2 VVAVK--KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
++AVK +++ + KE E+ L L HPNLVK G + E + E+ G+L
Sbjct: 27 LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL 86
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
E L + L V + +GL +LH +++RD K +NI LD KL D
Sbjct: 87 EELL--EHGRILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGD 142
Query: 120 FGLAK-AGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTK---SDVYSFGVVLLELLSG 174
FG A Q + GT Y APE + G+ +D++S G V+LE+ +G
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 175 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLAL----- 228
+ W++ D F+IM +G G P +
Sbjct: 203 K--------------RPWSE---LDNE--FQIM-FHVGAGHKPPIPDSLQLSPEGKDFLD 242
Query: 229 QCLNNEPKLRPRMSEVL 245
+CL ++PK RP SE+L
Sbjct: 243 RCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-20
Identities = 69/258 (26%), Positives = 120/258 (46%), Gaps = 31/258 (12%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+V A++K K E Q E+ E++ +L H N+V+L+G C E E ++ E+ G L+
Sbjct: 39 LVKALQKTKDENLQ--SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 61 NHLF-------RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
L + P PLS ++ + A G+ L + ++ ++RD A N L+ ++
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL--SNARFVHRDLAARNCLVSSQR 154
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+S L+K + + ++ + APE V +TKSDV+SFGV++ E+ +
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
Query: 174 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231
+ ++ P+ LSD+ L R+ KL P+ L +C
Sbjct: 214 ------QGEL-----------PFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCW 256
Query: 232 NNEPKLRPRMSEVLAILE 249
PK RP SE+++ L
Sbjct: 257 AVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-20
Identities = 62/260 (23%), Positives = 116/260 (44%), Gaps = 36/260 (13%)
Query: 2 VVAVKKLKP-EGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K LK Q E+ E + + +LHHPN+V L+G + + +++E++ +G L
Sbjct: 36 LVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLH 95
Query: 61 NHLFRRGPQP---------------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 105
L R P L + +AI A G+ +L + +++D A
Sbjct: 96 EFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAAR 153
Query: 106 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 165
NIL+ + + K+SD GL++ + D V + + + PE + G+ ++ SD++SFG
Sbjct: 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG 213
Query: 166 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAA 224
VVL E+ S G++ PY +++ ++ + +
Sbjct: 214 VVLWEIFS---------FGLQ--------PYYGFSNQEVIEMVRKRQLLPCSEDCPPRMY 256
Query: 225 TLALQCLNNEPKLRPRMSEV 244
+L +C P RPR ++
Sbjct: 257 SLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 58/179 (32%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 2 VVAVKKLKP----EGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+VA+KK+K EG K L E+ L +L+HPN++KL+ + LV+EFM
Sbjct: 26 IVAIKKIKLRFESEGIP--KTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DT 82
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L L + + L ++ +GL F H +++RD K N+L++ E KL
Sbjct: 83 DLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKL 139
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
+DFGLA++ + R + T + T Y APE + + +T D++S G + ELLS R
Sbjct: 140 ADFGLARSFGSPVRPY--THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 70/264 (26%), Positives = 105/264 (39%), Gaps = 24/264 (9%)
Query: 1 MVVAVKKLK--PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+VA+KK K + K L EV L QL H N+V L LV+E++ +
Sbjct: 27 EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
LE L P L + + + H +I+RD K NIL+ KL
Sbjct: 87 LE--LLEASPGGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLC 142
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR-- 175
DFG A+A + ++ V T Y APE + K DV++ G ++ ELL G
Sbjct: 143 DFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201
Query: 176 ----CAVDKTKVGIEQSL--VDWAKPYLSDKRKLFRIMDT-------KLGGQYPQKAAHT 222
+D+ + I++ L + + L F + L +YP K +
Sbjct: 202 FPGDSDIDQLYL-IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP 260
Query: 223 AATLALQCLNNEPKLRPRMSEVLA 246
A CL +PK R E+L
Sbjct: 261 ALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 39/239 (16%)
Query: 16 HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA 74
K+ ++E+ L + P ++ G ENR+ + EFM GSL+ ++R+ P+
Sbjct: 43 QKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEFMDGGSLD--VYRKIPEH---- 95
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 134
V ++A+ KGLT+L ++++RD K SN+L++ KL DFG++ T +
Sbjct: 96 VLGRIAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSI 149
Query: 135 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK--------VGIE 186
+ +GT+ Y APE ++ + SDV+S G+ +EL GR + + + +
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 187 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
Q +VD P L GQ+ +K H QC+ +PK RP ++
Sbjct: 210 QCIVDEDPPVLPV-------------GQFSEKFVHFIT----QCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 9/171 (5%)
Query: 6 KKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLF 64
K+LK +G + L E L ++ +V L Y E ++ L LV M G L+ H++
Sbjct: 29 KRLKKR--KGEQMALNEKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIY 85
Query: 65 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124
G A + A GL LH + +++YRD K N+LLD N ++SD GLA
Sbjct: 86 NVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAV 143
Query: 125 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
G + GT GY APE + D ++ G L E+++GR
Sbjct: 144 ELKGGKKIK---GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTE----VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 56
M VAVK LKP +E L +++LG H N+V L+G C G L++ E+
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HENIVNLLGACTIGGPILVITEYCCY 123
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
G L N L R+ L+ + + AKG+ FL A I+RD A N+LL K
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVK 181
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLEL 171
+ DFGLA+ D + S V+ + + APE + T +SDV+S+G++L E+
Sbjct: 182 ICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 172 LS 173
S
Sbjct: 237 FS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 49/153 (32%), Positives = 86/153 (56%), Gaps = 14/153 (9%)
Query: 26 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR----GPQPL-SWAVRMKVA 80
+G L H +V+L+G C G + LV + P GSL +H+ + PQ L +W V++
Sbjct: 63 MGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI--- 118
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 140
AKG+ +L E ++++R+ A NILL ++ +++DFG+A D+ + ++
Sbjct: 119 ---AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ A E + GR T +SDV+S+GV + E++S
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 12/180 (6%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 56
+VA+KK+K + K+ L E+ L +L HPN++ L+ N LV+EFM
Sbjct: 27 IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME- 85
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
LE + + L+ A + +GL +LH + +++RD K +N+L+ ++ K
Sbjct: 86 TDLE-KVIKDKSIVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLK 142
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
L+DFGLA++ + +R ++ QV+ T Y APE + R D++S G + ELL
Sbjct: 143 LADFGLARSFGSPNR-KMTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-19
Identities = 49/183 (26%), Positives = 96/183 (52%), Gaps = 13/183 (7%)
Query: 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VAVK L+ + + ++L E+ + +L +PN+++L+G C+ + ++ E+M G L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 61 NHLFRRGPQP----------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
L +R + +S A + +A+ A G+ +L A ++RD N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVG 163
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
+ K++DFG+++ +GD + + + + A E + G+ TT SDV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 171 LLS 173
+ +
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL------FRRGPQPLSW 73
EVN L +L HPN+V+ ++ N+ L V E+ G L + + + W
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 133
+ ++ + A D + V++RD K +NI LDA N KL DFGLAK G +
Sbjct: 109 RILTQLLL-ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSS 165
Query: 134 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+ +GT Y +PE + KSD++S G ++ EL +
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-19
Identities = 73/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFM 54
VAVK LK + F +E+L E + + HPN++KLIG L + +++ FM
Sbjct: 30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM 89
Query: 55 PKGSLENHLF--RRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
G L L R G +P + ++ ++ I A G+ +L + I+RD A N +L+
Sbjct: 90 KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL--SSKNFIHRDLAARNCMLN 147
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
++DFGL+K +GD + A E +A TT SDV++FGV + E
Sbjct: 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207
Query: 171 LLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229
+++ G+ G+E S + YL +L + P L Q
Sbjct: 208 IMTRGQTPY----AGVENSEI---YNYLIKGNRL----------KQPPDCLEDVYELMCQ 250
Query: 230 CLNNEPKLRPRMSEVLAILERL 251
C + EPK RP + LE +
Sbjct: 251 CWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 63/185 (34%), Positives = 92/185 (49%), Gaps = 28/185 (15%)
Query: 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VAVK LK + E L E N + QL +P +V++IG C E E+ +LV E G L
Sbjct: 24 TVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPL 82
Query: 60 EN------HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
H+ + L V M G+ +L E+ ++RD A N+LL +
Sbjct: 83 NKFLQKNKHVTEKNITELVHQVSM--------GMKYLE--ETNFVHRDLAARNVLLVTQH 132
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 168
AK+SDFGL+KA D + + THG + APE + + ++KSDV+SFGV++
Sbjct: 133 YAKISDFGLSKA-LGADENYYKAK---THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 169 LELLS 173
E S
Sbjct: 189 WEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 77/251 (30%), Positives = 116/251 (46%), Gaps = 29/251 (11%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LKP G + +L E + +L H LV+L E E +V E+M KGSL +
Sbjct: 33 VAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + L + +A A G+ ++ I+RD +++NIL+ K++DFGL
Sbjct: 91 LKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGL 148
Query: 123 AKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
A+ D + + Q G + APE GR T KSDV+SFG++L EL V
Sbjct: 149 ARL--IEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL------VT 198
Query: 180 KTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
K +V PY + R++ ++ PQ + L LQC +P+ R
Sbjct: 199 KGRV-----------PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247
Query: 239 PRMSEVLAILE 249
P + + LE
Sbjct: 248 PTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 75/249 (30%), Positives = 110/249 (44%), Gaps = 25/249 (10%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LKP G + +L E + +L H LV L E E +V EFM KGSL +
Sbjct: 33 VAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDF 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + L + +A A G+ ++ I+RD +A+NIL+ K++DFGL
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGL 148
Query: 123 AKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
A+ D + + Q + APE GR T KSDV+SFG++L EL V K
Sbjct: 149 ARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL------VTKG 200
Query: 182 KVGIEQSLVDWAKPYLSD-KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+V PY R++ ++ PQ + L C +P RP
Sbjct: 201 RV-----------PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPT 249
Query: 241 MSEVLAILE 249
+ + LE
Sbjct: 250 FEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 55/179 (30%), Positives = 85/179 (47%), Gaps = 12/179 (6%)
Query: 2 VVAVKKL----KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
VA+KK+ G + L E+ L HP +VKL+ G +LV E+MP
Sbjct: 27 TVALKKVALRRLEGGIP--NQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-S 83
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L L R +PL A KG+ ++H + +++RD K +N+L+ A+ K+
Sbjct: 84 DLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKI 140
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
+DFGLA+ + S QV T Y APE + R D+++ G + ELL+G
Sbjct: 141 ADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-18
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 50/287 (17%)
Query: 1 MVVAVKKLKPEGFQG-HKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVY---EFMP 55
M A+K LK + H+++ E+ L +L HHPN++ L+G C ENR +Y E+ P
Sbjct: 30 MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC---ENRGYLYIAIEYAP 86
Query: 56 KGSLENHL-----------FRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 101
G+L + L F + L+ ++ A A G+ +L +E Q I+RD
Sbjct: 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL--SEKQFIHRD 144
Query: 102 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKS 159
A N+L+ +K++DFGL++ G+ +V + MG + A E + TTKS
Sbjct: 145 LAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKS 199
Query: 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQK 218
DV+SFGV+L E++S +G PY +L+ + + P+
Sbjct: 200 DVWSFGVLLWEIVS---------LG--------GTPYCGMTCAELYEKLPQGYRMEKPRN 242
Query: 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSE 264
L QC + P RP +++ L R LEA K ++ E
Sbjct: 243 CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFE 289
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-18
Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81
EV+ L L H N+V+ +G CL+ + EF+P GS+ + L R GP P V K
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP--EPVFCKYTK 109
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRTHVSTQ 137
G+ +LH+ + V++RD K +N++L KL DFG A+ G G +++
Sbjct: 110 QILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+ GT + APE + KSD++S G + E+ +G+
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-18
Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77
++L E L Q HPN+V+LIG C + + +V E + G L GP+ L +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELI 97
Query: 78 KVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 136
++ AA G+ +L ES+ I+RD A N L+ + K+SDFG+++ G
Sbjct: 98 QMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154
Query: 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 196
+ APE + GR +++SDV+SFG++L E S +G A PY
Sbjct: 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS---------LG--------AVPY 197
Query: 197 LSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248
+ + R + G + P+ L +C +P RP S V L
Sbjct: 198 ANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-18
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
E L L HPN+++ LE + ++V E+ P G+L ++ +R L +
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQV 138
+ L +H +++RD K NILLD K+ DFG++K ++ T V
Sbjct: 107 FVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-V 161
Query: 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 198
+GT Y +PE KSD+++ G VL EL S + A + + P L
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PAL- 209
Query: 199 DKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246
+ +IM + +Y L L LN +P RP++S+++A
Sbjct: 210 ----VLKIMSGTFAPISDRYSPDLRQ----LILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-18
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E+ L L H +V+ G CL + L ++ E+MP GS+++ L G L+ V K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYT 110
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTGDRTHV 134
+G+ +LH +++RD K +NIL D+ N KL DFG +K + TG ++
Sbjct: 111 RQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-- 166
Query: 135 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 194
V GT + +PE ++ K+DV+S G ++E+L+ K
Sbjct: 167 ---VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-------------------EK 204
Query: 195 PYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
P ++ +F+I Q P + A + K RP E+L
Sbjct: 205 PPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-18
Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVY-EFMPKGSLENHLFRRGP--QPLSWAVRMK 78
E+ L L H N+V+ +G E L ++ E++P GS+ + L G + L +
Sbjct: 58 EIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116
Query: 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138
V +GL +LH +++RD KA N+L+DA+ K+SDFG++K + +
Sbjct: 117 VL----EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 139 MGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 175
G+ + APE + + + K D++S G V+LE+ +GR
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 63/177 (35%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVAVKK+ G Q +++W + EV +L QL HPN ++ G L+ LV E+ GS
Sbjct: 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGS 106
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L +PL + GA +GL +LH +I+RD KA NILL KL+
Sbjct: 107 ASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLA 163
Query: 119 DFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 171
DFG A K+ P + +GT + APE + G+ K DV+S G+ +EL
Sbjct: 164 DFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 4/171 (2%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LKP G + +L E N + L H LV+L + E ++ E+M KGSL +
Sbjct: 33 VAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + + + A+G+ ++ I+RD +A+N+L+ K++DFGL
Sbjct: 92 LKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGL 149
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
A+ + T + APE + G T KSDV+SFG++L E+++
Sbjct: 150 ARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 75/255 (29%), Positives = 115/255 (45%), Gaps = 37/255 (14%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LKP G + +L E + +L H LV+L E E +V E+M KGSL +
Sbjct: 33 VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90
Query: 63 L------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
L + R PQ + A ++ + + + ++H RD +A+NIL+ K
Sbjct: 91 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANILVGENLVCK 142
Query: 117 LSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
++DFGLA+ D + + Q + APE GR T KSDV+SFG++L EL +
Sbjct: 143 VADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-- 198
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSD-KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234
K +V PY R++ ++ P + + L QC E
Sbjct: 199 ----KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243
Query: 235 PKLRPRMSEVLAILE 249
P+ RP + A LE
Sbjct: 244 PEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 3 VAVKKLK---PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFMPKGS 58
VA+K L+ PE + E +L+HPN+V L+ L V+E++P +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNA 115
L L G P R+ + + L H+ +++RD K NI++ +A
Sbjct: 66 LREVLAADGALPAGETGRLMLQV--LDALACAHNQ--GIVHRDLKPQNIMVSQTGVRPHA 121
Query: 116 KLSDFGLAKAGP-TGD----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
K+ DFG+ P D +T+V+GT Y APE + +T SD+Y++G++ LE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 171 LLSGRCAV 178
L+G+ V
Sbjct: 182 CLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 65/184 (35%), Positives = 93/184 (50%), Gaps = 14/184 (7%)
Query: 2 VVAVKKLKPEGFQGHKE--WL-TEVNYLGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPK 56
+ A+K +K E ++ W+ TE + +HP LV L C + E+RL V EF+
Sbjct: 22 IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEFVSG 80
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
G L H+ R+ P A I A L FLH E +IYRD K N+LLDAE + K
Sbjct: 81 GDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLH--ERGIIYRDLKLDNVLLDAEGHIK 136
Query: 117 LSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
L+D+G+ K G GD T + GT Y APE + D ++ GV++ E+++GR
Sbjct: 137 LTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
Query: 176 CAVD 179
D
Sbjct: 194 SPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 29/178 (16%)
Query: 20 LTEVNYLGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 77
E L +L HP ++KL Y + E L V E+ P G L ++ + G S +
Sbjct: 49 KIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKC 103
Query: 78 KVAIGA--AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 135
A L +LH +I+RD K NILLD + + K++DFG AK +
Sbjct: 104 TRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
Query: 136 TQVM------------------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
GT Y +PE + SD+++ G ++ ++L+G+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 51/160 (31%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----QPLSWAV 75
L E L +L+HP LV L + EN LV + + G L HL ++ Q W
Sbjct: 48 LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 135
+ +A L +LH +I+RD K NILLD + + ++DF +A T
Sbjct: 108 EIVLA------LEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--- 156
Query: 136 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
T GT GY APE + + D +S GV E L G+
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 7/174 (4%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VVA+K + E +E + E++ L Q P +VK G + + +V E+ GS+ +
Sbjct: 30 VVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-S 86
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ + + L+ + KGL +LH ++ I+RD KA NILL+ E AKL+DFG
Sbjct: 87 DIMKITNKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFG 144
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+ +G D V+GT + APE + K+D++S G+ +E+ G+
Sbjct: 145 V--SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 74/253 (29%), Positives = 121/253 (47%), Gaps = 33/253 (13%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK +KP G + +L E N + L H LVKL + E ++ EFM KGSL +
Sbjct: 33 VAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDF 90
Query: 63 LFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
L QPL + I A+G+ F+ + I+RD +A+NIL+ A K++DF
Sbjct: 91 LKSDEGSKQPLPKLIDFSAQI--AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADF 146
Query: 121 GLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC 176
GLA+ D + + + G + APE + G T KSDV+SFG++L+E+++ GR
Sbjct: 147 GLARV--IEDNEYTARE--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 202
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
P +S+ ++ R ++ P+ + ++C N P+
Sbjct: 203 PY----------------PGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE 245
Query: 237 LRPRMSEVLAILE 249
RP + ++L+
Sbjct: 246 ERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 6 KKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLF 64
K+LK + G K L E L +++ P +V L Y E + L LV M G L+ H++
Sbjct: 29 KRLKKKS--GEKMALLEKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIY 85
Query: 65 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124
G + L + + G+ LH ++YRD K N+LLD + N +LSD GLA
Sbjct: 86 NVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAV 143
Query: 125 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
G TQ GT+GY APE + + D ++ G + E+++GR
Sbjct: 144 ELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 57/188 (30%), Positives = 95/188 (50%), Gaps = 31/188 (16%)
Query: 2 VVAVKKLKP----EGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+VA+KK++ EG L E++ L +L HPN+VKL+ LV+E+
Sbjct: 26 IVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM- 82
Query: 58 SLENHL-FRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
L+ +L R GP + ++ M + +GL + H ++++RD K NIL++ +
Sbjct: 83 DLKKYLDKRPGPLSPNL-IKSIMYQLL---RGLAYCHSH--RILHRDLKPQNILINRDGV 136
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVV 167
KL+DFGLA+A RT+ T + T Y APE Y +T D++S G +
Sbjct: 137 LKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHY------STAVDIWSVGCI 188
Query: 168 LLELLSGR 175
E+++G+
Sbjct: 189 FAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 11/154 (7%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81
E L + HP LV L G + N LV E++P G L +HL + G P A +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 141
A L +LH + ++YRD K N+LLD++ K++DFG AK RT+ + GT
Sbjct: 111 VLA--LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGT 161
Query: 142 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 174
Y APE + + K+ D ++ G+++ E+L+G
Sbjct: 162 PEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81
E L + +HP +VKL + + ++ E+ G L L RG + R +A
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA- 100
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 141
+LH +IYRD K N+LLD+ KL DFG AK +G +T GT
Sbjct: 101 CVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGT 155
Query: 142 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 201
Y APE + D +S G++L ELL+GR P+ D
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR------------------PPFGEDDE 197
Query: 202 KLFRIMDTKLGG----QYPQKAAHTAATLALQCLNNEPKLR 238
I + L G ++P A L Q L P+ R
Sbjct: 198 DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 30 HHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 88
+HP LV L C + E+RL V E++ G L H+ R+ P A I A L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LN 110
Query: 89 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAP 147
+LH E +IYRD K N+LLD+E + KL+D+G+ K G GD T + GT Y AP
Sbjct: 111 YLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 165
Query: 148 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 207
E + D ++ GV++ E+++GR D VG + P + + LF+++
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLFQVI 217
Query: 208 DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
K + P+ + AA++ LN +PK R
Sbjct: 218 LEK-QIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-17
Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 10/175 (5%)
Query: 3 VAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK E + E + E + QL +P +V++IG C E E +LV E G L
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK 83
Query: 62 HLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
L + + +S V + + + G+ +L ++RD A N+LL + AK+SDF
Sbjct: 84 FLSGKKDEITVSNVVELMHQV--SMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDF 139
Query: 121 GLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
GL+KA D ++ + G + APE + + +++SDV+S+G+ + E S
Sbjct: 140 GLSKA-LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-17
Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 49/273 (17%)
Query: 1 MVVAVKKLKPEGFQG-HKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVY---EFMP 55
M A+K++K + H+++ E+ L +L HHPN++ L+G C E+R +Y E+ P
Sbjct: 23 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAP 79
Query: 56 KGSLENHL-----------FRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 101
G+L + L F LS + A A+G+ +L ++ Q I+RD
Sbjct: 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRD 137
Query: 102 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKS 159
A NIL+ + AK++DFGL++ G +V + MG + A E + TT S
Sbjct: 138 LAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNS 192
Query: 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQK 218
DV+S+GV+L E++S +G PY +L+ + + P
Sbjct: 193 DVWSYGVLLWEIVS---------LG--------GTPYCGMTCAELYEKLPQGYRLEKPLN 235
Query: 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
L QC +P RP +++L L R+
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 43/270 (15%)
Query: 1 MVVAVKKLKPEGFQG-HKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
M A+K++K + H+++ E+ L +L HHPN++ L+G C L E+ P G+
Sbjct: 35 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 94
Query: 59 LENHLFR--------------RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L + L + LS + A A+G+ +L ++ Q I+RD A
Sbjct: 95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAA 152
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG--YAAPEYVATGRLTTKSDVY 162
NIL+ + AK++DFGL++ G +V + MG + A E + TT SDV+
Sbjct: 153 RNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 163 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAH 221
S+GV+L E++S +G PY +L+ + + P
Sbjct: 208 SYGVLLWEIVS---------LG--------GTPYCGMTCAELYEKLPQGYRLEKPLNCDD 250
Query: 222 TAATLALQCLNNEPKLRPRMSEVLAILERL 251
L QC +P RP +++L L R+
Sbjct: 251 EVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-17
Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 41/237 (17%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------PQPLSW 73
+ E+ L ++HPN++ L+G +V E+ P G L + +R P+ W
Sbjct: 47 VNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 133
++ I +GL LH E ++++RD K++NILL A K+ D G++K +
Sbjct: 107 ----RIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNM 157
Query: 134 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 192
TQ+ GT Y APE V GR + KSD++S G +L E+ + +
Sbjct: 158 AKTQI-GTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFA--------------PPF 201
Query: 193 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLA 246
+ D R +++ G+YP + L L +PKLRP ++LA
Sbjct: 202 EARSMQDLR--YKVQ----RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-17
Identities = 69/250 (27%), Positives = 106/250 (42%), Gaps = 26/250 (10%)
Query: 3 VAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK K +E +L E + Q HP++VKLIG E +V E P G L +
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRS 95
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L L A + + + L +L + ++RD A N+L+ + KL DFG
Sbjct: 96 YLQVN-KYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFG 152
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
L++ S + + APE + R T+ SDV+ FGV + E+L
Sbjct: 153 LSRYLEDESYYKASKGKLPIK-WMAPESINFRRFTSASDVWMFGVCMWEILM-------- 203
Query: 182 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRP 239
+G+ KP+ K I + G + P T +L +C +P RP
Sbjct: 204 -LGV--------KPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRP 253
Query: 240 RMSEVLAILE 249
R +E+ A L
Sbjct: 254 RFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-17
Identities = 70/245 (28%), Positives = 108/245 (44%), Gaps = 30/245 (12%)
Query: 17 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGP 68
+++L+E + + HPN+++LIG CL+ +++ FM G L + L R G
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 69 QPLSWAVRMKVAIGA--AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 126
P +M V A G+ +L + I+RD A N +L+ N ++DFGL+K
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
Query: 127 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGI 185
GD + A E +A TTKSDV+SFGV + E+ + G+ G+
Sbjct: 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP----GV 218
Query: 186 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
E S + YL +L + D L G Y +L C PK RP +
Sbjct: 219 ENSEI---YDYLRQGNRLKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLR 265
Query: 246 AILER 250
LE+
Sbjct: 266 CELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 19/183 (10%)
Query: 3 VAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
V VK+L+ +L EV +L+HPN+++ +G C+E LLV EF P G L+N
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 62 HL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+L + Q V ++A A GL +LH A+ I+ D N L A+ +
Sbjct: 85 YLRSNRGMVAQMAQKD---VLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSV 139
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-------TGRLTTKSDVYSFGVVL 168
K+ D+GLA D + APE V T KS+++S GV +
Sbjct: 140 KIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199
Query: 169 LEL 171
EL
Sbjct: 200 WEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 67/245 (27%), Positives = 94/245 (38%), Gaps = 65/245 (26%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81
E+ +L Q P + K G L+G ++ E+ GS L + G +A
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLD-----ETYIAF 102
Query: 82 ---GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138
GL +LH E I+RD KA+NILL E + KL+DFG VS Q+
Sbjct: 103 ILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFG------------VSGQL 148
Query: 139 ----------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 188
+GT + APE + K+D++S G+ +EL G
Sbjct: 149 TSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG-------------- 194
Query: 189 LVDWAKPYLSDK---RKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLRPR 240
+P LSD R LF I P + CLN +PK RP
Sbjct: 195 -----EPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERPS 244
Query: 241 MSEVL 245
E+L
Sbjct: 245 AKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
L E+ L L HPN++ + ++ L+ E+ G+L + + R+ Q + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
++++H A +++RD K NI L KL DFG++K G ++ V+
Sbjct: 107 LFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV 162
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 199
GT Y +PE + KSD+++ G VL EL + +T +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYEL----LTLKRTFDATNPLNLVV------- 211
Query: 200 KRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLA 246
+I+ G P + +++ ++L L +P+ RP EVL
Sbjct: 212 -----KIVQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 71/250 (28%), Positives = 105/250 (42%), Gaps = 35/250 (14%)
Query: 2 VVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VVA+K + E + E + E+ L Q P + + G L+G ++ E++ GS
Sbjct: 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL 90
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ L P PL + KGL +LH I+RD KA+N+LL + + KL+DF
Sbjct: 91 DLL---KPGPLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADF 145
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
G+ AG D +GT + APE + K+D++S G+ +EL G
Sbjct: 146 GV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE----- 198
Query: 181 TKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEP 235
P L R LF I L GQY + CLN +P
Sbjct: 199 -------------PPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA----CLNKDP 241
Query: 236 KLRPRMSEVL 245
+ RP E+L
Sbjct: 242 RFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 21/179 (11%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVKK+ Q + EV + HPN+V++ L G+ +V EF+ G+L +
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD- 105
Query: 63 LFRRGPQPLSWAVRMK------VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNA 115
+ RM V + K L+FLH +Q VI+RD K+ +ILL ++
Sbjct: 106 --------IVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRV 154
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
KLSDFG ++GT + APE ++ T+ D++S G++++E++ G
Sbjct: 155 KLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 51/161 (31%), Positives = 87/161 (54%), Gaps = 14/161 (8%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKV 79
E+ L +L H N+V+ +G L+ ++ + E++P GS+ L G + L VR V
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFV 112
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-----AGPTGDRTHV 134
KGL +LH+ +I+RD K +NIL+D + K+SDFG++K + T
Sbjct: 113 R-QILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA- 168
Query: 135 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+ G+ + APE V T K+D++S G +++E+L+G+
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 31 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RGPQPLSWAVRMKVAIGAAKGLT 88
HP LV L C + E+ + V E+ G L H+ +P + V +G L
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLG----LQ 115
Query: 89 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGYAAP 147
+LH E++++YRD K N+LLD E K++DFGL K G GDRT ST GT + AP
Sbjct: 116 YLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAP 170
Query: 148 EYVATGRLTTKSDVYSFGVVLLELLSGRC 176
E + T D + GV++ E+L G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 60/241 (24%), Positives = 114/241 (47%), Gaps = 34/241 (14%)
Query: 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR----------RG 67
E+L E + + + + ++V+L+G +G+ L++ E M +G L+++L +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 127
P L ++M I A G+ +L+ ++ ++RD A N ++ +F K+ DFG+ +
Sbjct: 115 PPSLKKMIQMAGEI--ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170
Query: 128 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 187
D + + + +PE + G TT SDV+SFGVVL E+
Sbjct: 171 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------A 215
Query: 188 SLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
+L + +PY +S+++ L +M+ L + P L C PK+RP E++
Sbjct: 216 TLAE--QPYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
Query: 246 A 246
+
Sbjct: 273 S 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 36/266 (13%)
Query: 1 MVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
++VAVK L+ + + + ++L E+ + +L PN+++L+ C+ + ++ E+M G L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 60 ENHLFRRGPQP---------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
L R PQ +S++ + +A A G+ +L + ++RD N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVG 164
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
+ K++DFG+++ +GD + + + + + E + G+ TT SDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 171 LLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKR------KLFRIMDTKLGGQYPQKAAHT 222
+L+ C EQ PY LSD++ + FR ++ P +
Sbjct: 225 ILT-LCK--------EQ-------PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDS 268
Query: 223 AATLALQCLNNEPKLRPRMSEVLAIL 248
L L C K RP E+ A L
Sbjct: 269 LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWA 74
+ E L P + + C + +RL V E++ G L H+ + G P + +A
Sbjct: 48 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYA 107
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 134
+ A GL FLH +IYRD K N++LDAE + K++DFG+ K G +T
Sbjct: 108 AEI------AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-- 157
Query: 135 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
+ GT Y APE +A D ++FGV+L E+L+G+ D
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 14/165 (8%)
Query: 18 EWLTEVNYLGQLHHPNLVKLI-GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76
+++ E++ L + HPN+V L Y E + +L+ EF G+L++ + + L+
Sbjct: 48 DFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELE-RGLTEPQI 105
Query: 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVS 135
V + L FLH +VI+RD KA NILL + + KL+DFG+ AK T +
Sbjct: 106 RYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT- 162
Query: 136 TQVMGTHGYAAPEYVATGRLTT-----KSDVYSFGVVLLELLSGR 175
+GT + APE VA K+D++S G+ L+EL
Sbjct: 163 --FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 64/181 (35%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVA+KK+ G Q +++W + EV +L QL HPN ++ G L LV E+ GS
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGS 100
Query: 59 ----LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
LE H ++ Q + A + GA +GL +LH E I+RD KA NILL
Sbjct: 101 ASDILEVH--KKPLQEVEIAA---ICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGT 153
Query: 115 AKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLE 170
KL+DFG A P + +GT + APE + G+ K DV+S G+ +E
Sbjct: 154 VKLADFGSASLVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 171 L 171
L
Sbjct: 207 L 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 31 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 89
+P LV L C + +RL LV E++ G L H+ R+ P A I A L F
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNF 111
Query: 90 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPE 148
LH E +IYRD K N+LLDA+ + KL+D+G+ K G GD T + GT Y APE
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE 166
Query: 149 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 208
+ D ++ GV++ E+++GR D + P ++ + LF+++
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------IITDNPDMNTEDYLFQVIL 216
Query: 209 TKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
K + P+ + A+ + LN +PK R
Sbjct: 217 EK-PIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 10/147 (6%)
Query: 28 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 87
Q P + KL + LV E++ G + + G P WA + G+
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGV 110
Query: 88 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 147
LH +I+RD K N+L+D + KL+DFGL++ G + + +GT Y AP
Sbjct: 111 EDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAP 162
Query: 148 EYVATGRLTTKSDVYSFGVVLLELLSG 174
E + SD +S G V+ E L G
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 64/257 (24%), Positives = 116/257 (45%), Gaps = 31/257 (12%)
Query: 1 MVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VA+ L+ + +L E LGQ H N+V+L G G ++V E+M G+L
Sbjct: 34 LPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
++ L R+ L M + G A G+ +L +E +++ A +L++++ K+S
Sbjct: 94 DSFL-RKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISG 150
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLELLS--G 174
F + D++ M +AAPE + ++ SDV+SFG+V+ E++S
Sbjct: 151 FRRLQE----DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206
Query: 175 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234
R D + + +++ D FR+ P+ + L L C E
Sbjct: 207 RPYWDMSGQDVIKAVEDG-----------FRL-------PAPRNCPNLLHQLMLDCWQKE 248
Query: 235 PKLRPRMSEVLAILERL 251
RPR S++ +IL ++
Sbjct: 249 RGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 73/252 (28%), Positives = 111/252 (44%), Gaps = 39/252 (15%)
Query: 2 VVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VVA+K + E + E + E+ L Q P + K G L+G ++ E++ GS
Sbjct: 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL 90
Query: 61 NHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ L R GP A +K + KGL +LH + I+RD KA+N+LL + + KL+D
Sbjct: 91 D-LLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLAD 144
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FG+ AG D +GT + APE + +K+D++S G+ +EL G
Sbjct: 145 FGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG----- 197
Query: 180 KTKVGIEQSLVDWAKPYLSD---KRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNN 233
+P SD R LF I L G++ + CLN
Sbjct: 198 --------------EPPNSDMHPMRVLFLIPKNNPPTLTGEFSK----PFKEFIDACLNK 239
Query: 234 EPKLRPRMSEVL 245
+P RP E+L
Sbjct: 240 DPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 60/176 (34%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVA+KK+ G Q +++W + EV +L +L HPN ++ G L LV E+ GS
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGS 100
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L +PL V GA +GL +LH +I+RD KA NILL KL
Sbjct: 101 ASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLG 157
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 171
DFG A + +GT + APE + G+ K DV+S G+ +EL
Sbjct: 158 DFGSASI------MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 59/191 (30%), Positives = 91/191 (47%), Gaps = 21/191 (10%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
E L ++ HP +++L + E + R L + E++P G L ++L G S +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
I A L +LH E ++YRD K NILLD E + KL+DFG AK DRT +
Sbjct: 109 EIVCA--LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LC 159
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLS 198
GT Y APE + + D ++ G+++ E+L G D GI + + L+
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LA 212
Query: 199 DKRKLFRIMDT 209
K + R +D
Sbjct: 213 GKLEFPRHLDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 60/177 (33%), Positives = 88/177 (49%), Gaps = 18/177 (10%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVA+KK+ G Q +++W + EV +L ++ HPN ++ G L LV E+ GS
Sbjct: 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGS 110
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L +PL + GA +GL +LH +I+RD KA NILL KL+
Sbjct: 111 ASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLA 167
Query: 119 DFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 171
DFG A A P + +GT + APE + G+ K DV+S G+ +EL
Sbjct: 168 DFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 56/186 (30%), Positives = 77/186 (41%), Gaps = 41/186 (22%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA----V 75
E + L P +VKL Y + E L LV E+MP G L N L R+ P A
Sbjct: 50 AERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108
Query: 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHV 134
+ +A+ + L F+H RD K NIL+DA+ + KL+DFGL K DR +
Sbjct: 109 ELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 135 STQ--------------------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 168
+GT Y APE + + D +S GV+L
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
Query: 169 LELLSG 174
E+L G
Sbjct: 221 YEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 47/178 (26%)
Query: 22 EVNYLGQL-HHPNLVKLIGYCLEGENRL---LVYEFMP--------KGSLEN-H------ 62
E+ +L +L HPN+VKL+ ++ EN LV+E+M LE+ H
Sbjct: 56 EIMFLQELGDHPNIVKLLN-VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY 114
Query: 63 -LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L K L ++H VI+RD K SNILL+++ KL+DFG
Sbjct: 115 QLL--------------------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFG 152
Query: 122 LAKAGPTGDRTH---VSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 175
LA++ + V T + T Y APE + + R T D++S G +L E+L G+
Sbjct: 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 50/275 (18%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL----HHPNLVKLIGYCLEGENRLLVYEFMPK 56
VAVK LK + + K+ V+ + + H N++ L+G C + +V E+
Sbjct: 43 STVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 57 GSLENHLFRRGPQP--------------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 102
G+L + L R P L+ + A A+G+ FL A + I+RD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDL 158
Query: 103 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTT 157
A N+L+ + K++DFGLA+ D H+ T+G + APE + T
Sbjct: 159 AARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213
Query: 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYP 216
+SDV+SFGV+L E+ + +G PY +LF+++ + P
Sbjct: 214 QSDVWSFGVLLWEIFT---------LG--------GSPYPGIPVEELFKLLKEGYRMEKP 256
Query: 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
Q L C + P RP +++ L+R+
Sbjct: 257 QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 56/170 (32%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 22 EVNYLGQLHH---PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRM 77
EV L QL PN+ K G L+G ++ E+ GS+ L + GP +V +
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVII 107
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+ + A L ++H + VI+RD KA+NIL+ N KL DFG+A A + + ST
Sbjct: 108 REVLVA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTF 161
Query: 138 VMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR---CAVDKTKV 183
V GT + APE + G+ TK+D++S G+ + E+ +G VD +
Sbjct: 162 V-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWA 74
+ E L P + + C + +RL V E++ G L H+ + G PQ + +A
Sbjct: 48 MVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA 107
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 134
+ V GL FLH +IYRD K N++LD+E + K++DFG+ K T
Sbjct: 108 AEISV------GLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT-- 157
Query: 135 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
+ GT Y APE +A D +++GV+L E+L+G+ D
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 49/147 (33%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 HPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 88
HP L L +C E+ V E++ G L H+ G + A I GL
Sbjct: 55 HPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI--ICGLQ 110
Query: 89 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148
FLH + +IYRD K N+LLD + + K++DFG+ K G+ ++ GT Y APE
Sbjct: 111 FLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE 166
Query: 149 YVATGRLTTKSDVYSFGVVLLELLSGR 175
+ + D +SFGV+L E+L G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 27/187 (14%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKL----IGYCLEGENRLLVYE 52
+VA+KKLK + KE L E+N L +L HPN+V + +G L + +V E
Sbjct: 32 IVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL--DKIYMVME 86
Query: 53 FMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109
++ K +E QP + + + G+ LHD + +++RD K SN+LL
Sbjct: 87 YVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLL 139
Query: 110 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVL 168
+ K+ DFGLA+ G TQ++ T Y APE + +T D++S G +
Sbjct: 140 NNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197
Query: 169 LELLSGR 175
ELL+ +
Sbjct: 198 AELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-15
Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 29/200 (14%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA---VRM 77
E + L +++HP +VKL Y + E +L L+ +F+ G L F R + + + V+
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKF 102
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+A A L LH +IYRD K NILLD E + KL+DFGL+K ++ S
Sbjct: 103 YLA-ELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 157
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA------------VDKTKVGI 185
GT Y APE V T +D +SFGV++ E+L+G + K K+G+
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
Query: 186 EQSLVDWAKPYLSDKRKLFR 205
Q L A+ L R LF+
Sbjct: 218 PQFLSPEAQSLL---RALFK 234
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 76/264 (28%), Positives = 117/264 (44%), Gaps = 30/264 (11%)
Query: 2 VVAVKKL--KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+VA+KK + K + E+ L QL H NLV LI + LV+EF+ L
Sbjct: 28 IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL 87
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
++ + P L + K +G+ F H +I+RD K NIL+ KL D
Sbjct: 88 DD--LEKYPNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCD 143
Query: 120 FGLAK--AGPTGDRTHVSTQVMGTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR- 175
FG A+ A P G+ V T + T Y APE V + D+++ G ++ E+L+G
Sbjct: 144 FGFARTLAAP-GE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
Query: 176 -----CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM---DTK----LGGQYPQKAAH 221
+D+ I + L + + + K LF M + K L ++P K +
Sbjct: 200 LFPGDSDIDQLY-HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFP-KLSG 257
Query: 222 TAATLALQCLNNEPKLRPRMSEVL 245
LA QCL +P RP S++L
Sbjct: 258 LVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 54/149 (36%), Positives = 77/149 (51%), Gaps = 15/149 (10%)
Query: 32 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTF 89
P LV L Y + + +L L+ +++ G L HL++R S VR+ +A I A L
Sbjct: 65 PFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLA--LDH 120
Query: 90 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAP 147
LH + +IYRD K NILLD+E + L+DFGL+K +R + GT Y AP
Sbjct: 121 LH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175
Query: 148 EYVATGRLTTKS--DVYSFGVVLLELLSG 174
E + G D +S GV+ ELL+G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-15
Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 39/265 (14%)
Query: 2 VVAVKKLKPEGFQGHK---EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVA+KK++ K + L E++ L QL HPN++K + +E +V E G
Sbjct: 29 VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD 88
Query: 59 LENHL--FRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
L + F++ P+ W +++ L +H ++++RD K +N+ + A
Sbjct: 89 LSRMIKHFKKQKRLIPERTIWKYFVQL----CSALEHMH--SKRIMHRDIKPANVFITAT 142
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
KL D GL + +T + ++GT Y +PE + KSD++S G +L E+
Sbjct: 143 GVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY-PQKAAHTAATL---AL 228
+ + P+ DK L+ + Y P A H + L
Sbjct: 201 ALQ------------------SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 229 QCLNNEPKLRPRMSEVLAILERLEA 253
+C+N +P+ RP +S VL + + + A
Sbjct: 243 RCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 56/161 (34%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 20 LTEVNYLGQLH-HPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHL--FRRGPQPLS--W 73
+TE L HP L +L C + +RL V EF+ G L H+ RR + + +
Sbjct: 43 MTEKRILSLARNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY 101
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 133
A + A L FLHD +IYRD K N+LLD E + KL+DFG+ K G +T
Sbjct: 102 AAEITSA------LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT- 152
Query: 134 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
++ GT Y APE + D ++ GV+L E+L G
Sbjct: 153 -TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FR--------RG 67
E+L E + + ++V+L+G +G+ L+V E M G L+++L R R
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 127
P L ++M I A G+ +L+ + ++RD A N ++ +F K+ DFG+ +
Sbjct: 115 PPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170
Query: 128 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 187
D + + + APE + G TT SD++SFGVVL E+
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------T 215
Query: 188 SLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSE 243
SL + +PY LS+++ L +MD GG P L C PK+RP E
Sbjct: 216 SLAE--QPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE 270
Query: 244 VLAILE 249
++ +L+
Sbjct: 271 IVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 68/258 (26%), Positives = 125/258 (48%), Gaps = 37/258 (14%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K L+ + +KE L E + + P + +L+G CL +L V + MP G L +
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLD 97
Query: 62 HLF----RRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
++ R G Q L +W V++ AKG+++L + ++++RD A N+L+ + + K
Sbjct: 98 YVRENKDRIGSQDLLNWCVQI------AKGMSYLEEV--RLVHRDLAARNVLVKSPNHVK 149
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
++DFGLA+ + + + + A E + R T +SDV+S+GV + EL++
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT--- 206
Query: 177 AVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT--LALQCLNN 233
G AKPY R++ +++ G + PQ T + ++C
Sbjct: 207 ------FG--------AKPYDGIPAREIPDLLEK--GERLPQPPICTIDVYMIMVKCWMI 250
Query: 234 EPKLRPRMSEVLAILERL 251
+ + RPR E++ R+
Sbjct: 251 DSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 143
+GL ++H A V++RD K SN+LL+ + K+ DFGLA+ A P D T T+ + T
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 144 YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
Y APE + + TK+ D++S G +L E+LS R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 15/177 (8%)
Query: 3 VAVKKL-KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL-- 59
VA+K L + G + + E++ E + + HP+LV+L+G CL +L V + MP G L
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLD 97
Query: 60 --ENHLFRRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
H G Q L +W V++ AKG+ +L E ++++RD A N+L+ + + K
Sbjct: 98 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVK 149
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
++DFGLA+ ++ + + + A E + + T +SDV+S+GV + EL++
Sbjct: 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 23/132 (17%)
Query: 52 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
E M GSL+ L + G P + + K++I +GLT+L + + ++++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPEN--ILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNS 135
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVSTQVM--------GTHGYAAPEYVATGRLTTKSDVYS 163
KL DFG VS Q++ GT Y +PE + T +SD++S
Sbjct: 136 RGEIKLCDFG------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 164 FGVVLLELLSGR 175
G+ L+E+ GR
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 40/235 (17%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLE--GENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMK 78
E+ L L H +V+ G CL E L ++ E+MP GS+++ L G L+ +V K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRK 110
Query: 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTGDRT 132
+G+++LH + +++RD K +NIL D+ N KL DFG +K TG R+
Sbjct: 111 YTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 133 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 192
V GT + +PE ++ K+DV+S G ++E+L+
Sbjct: 169 -----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT------------------- 204
Query: 193 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA--ATLALQCLNNEPKLRPRMSEVL 245
KP ++ + I PQ +H + A L C+ E + RP E+L
Sbjct: 205 EKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 53/147 (36%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 31 HPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 88
HP L L YC EN V E++ G L H+ L A I GL
Sbjct: 55 HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI--ICGLQ 110
Query: 89 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148
FLH ++YRD K NILLD + + K++DFG+ K GD + GT Y APE
Sbjct: 111 FLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPE 166
Query: 149 YVATGRLTTKSDVYSFGVVLLELLSGR 175
+ + T D +SFGV+L E+L G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 26/235 (11%)
Query: 5 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL 63
+KK K E L E L +++ +V L Y E ++ L LV M G L+ H+
Sbjct: 38 IKKRKGEAMA-----LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI 91
Query: 64 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 123
+ G + A GL LH +++YRD K NILLD + ++SD GLA
Sbjct: 92 YNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLA 149
Query: 124 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 183
P G+ + +V GT GY APE V R T D + G ++ E++ G+ + K
Sbjct: 150 VEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
Query: 184 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
+++ V+ R+ + + +Y +K + A ++ Q L +P R
Sbjct: 207 KVKREEVER------------RVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 57/180 (31%), Positives = 95/180 (52%), Gaps = 14/180 (7%)
Query: 2 VVAVKKLK----PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPK 56
VVA+KK++ EG + E++ L +L+HPN+VKL+ + EN+L LV+EF+ +
Sbjct: 27 VVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ 83
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
L+ + + + +GL F H +V++RD K N+L++ E K
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIK 140
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
L+DFGLA+A RT+ V T Y APE + + +T D++S G + E+++ R
Sbjct: 141 LADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 56/173 (32%), Positives = 91/173 (52%), Gaps = 9/173 (5%)
Query: 3 VAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K++ + Q KE + E+ + + HPN+V + L G+ +V E++ GSL +
Sbjct: 47 VAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 105
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ A + + A L FLH +QVI+RD K+ NILL + + KL+DFG
Sbjct: 106 VVTETCMDEGQIAAVCRECLQA---LEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFG 160
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A T +++ ST V GT + APE V K D++S G++ +E++ G
Sbjct: 161 FC-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 35/258 (13%)
Query: 3 VAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK + +E+ E +L HPN+V L+G + + +++ + L
Sbjct: 38 VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97
Query: 62 HLFRRGPQP--------------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
L R P L A + + A G+ FL + V+++D N+
Sbjct: 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNV 155
Query: 108 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
L+ + N K+SD GL + D + + + +PE + G+ + SD++S+GVV
Sbjct: 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215
Query: 168 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATL 226
L E+ S G++ PY + + ++ + P TL
Sbjct: 216 LWEVFS---------YGLQ--------PYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTL 258
Query: 227 ALQCLNNEPKLRPRMSEV 244
L+C N P RPR ++
Sbjct: 259 MLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 31 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 90
+P L L E+ V EF+ G L H+ +G L A I GL FL
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFL 112
Query: 91 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150
H +IYRD K N++LD + + K++DFG+ K GD ++ GT Y APE +
Sbjct: 113 H--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEIL 168
Query: 151 ATGRLTTKSDVYSFGVVLLELLSGR 175
+ T D +SFGV+L E+L G+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-14
Identities = 52/172 (30%), Positives = 90/172 (52%), Gaps = 7/172 (4%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K++ + + + E+ + +L +PN+V + L G+ +V E++ GSL +
Sbjct: 47 VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV 106
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
+ A + + A L FLH +QVI+RD K+ N+LL + + KL+DFG
Sbjct: 107 VTETCMDEAQIAAVCRECLQA---LEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGF 161
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A T +++ ST V GT + APE V K D++S G++ +E++ G
Sbjct: 162 C-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 57/179 (31%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 2 VVAVKKL--KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
+VA+KK + K L E+ L QL HPNLV LI + +L LV+E+
Sbjct: 28 IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDHTV 86
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L + + P+ + + K+ + + F H + I+RD K NIL+ + KL
Sbjct: 87 L--NELEKNPRGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLC 142
Query: 119 DFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSG 174
DFG A+ GP D T + T Y APE V + DV++ G V ELL+G
Sbjct: 143 DFGFARILTGPGDDY----TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 32 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 91
P +VK GY + + + E M + + L +R P+ + K+ + K L +L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 92 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV- 150
+ + VI+RD K SNILLDA N KL DFG+ +G D + T+ G Y APE +
Sbjct: 132 E-KHGVIHRDVKPSNILLDASGNVKLCDFGI--SGRLVD-SKAKTRSAGCAAYMAPERID 187
Query: 151 ---ATGRLTTKSDVYSFGVVLLELLSGR 175
+ ++DV+S G+ L+EL +G+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 37/289 (12%)
Query: 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L R P + L++ + A A+G+ +L A + I+RD A
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAA 162
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 164
N+L+ + K++DFGLA+ D +T + APE + T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 165 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTA 223
GV+L E+ + +G PY +LF+++ P H
Sbjct: 223 GVLLWEIFT---------LG--------GSPYPGIPVEELFKLLKEGHRMDKPANCTHEL 265
Query: 224 ATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQTGP 271
+ +C + P RP +++ L+R L L S P Q P
Sbjct: 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSP 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 35/267 (13%)
Query: 2 VVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VVA+K + E + E + E+ L Q P + K G L+ ++ E++ GS
Sbjct: 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 90
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ L P PL + KGL +LH + I+RD KA+N+LL KL+DF
Sbjct: 91 DLL---EPGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADF 145
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
G+ AG D +GT + APE + +K+D++S G+ +EL G
Sbjct: 146 GV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE----- 198
Query: 181 TKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEP 235
P+ L + LF I L G Y + CLN EP
Sbjct: 199 -------------PPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA----CLNKEP 241
Query: 236 KLRPRMSEVLAILERLEAPKNSAKLSQ 262
RP E+L + K ++ L++
Sbjct: 242 SFRPTAKELLKHKFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 28/245 (11%)
Query: 14 QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPL 71
+ ++ + E++ L QL+HPN++K + +E +V E G L + F++ + +
Sbjct: 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 131
K + + +H +V++RD K +N+ + A KL D GL + + +
Sbjct: 104 PERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--K 159
Query: 132 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 191
T + ++GT Y +PE + KSD++S G +L E+ QS
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------AALQS--- 204
Query: 192 WAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247
P+ DK LF + YP + + L C+ +P RP + V I
Sbjct: 205 ---PFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
Query: 248 LERLE 252
+++
Sbjct: 262 AKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 31/262 (11%)
Query: 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+ VA+KK++ + + + E++ L QL+HPN++K +E +V E G
Sbjct: 28 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87
Query: 58 SLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
L + F++ + + K + L +H +V++RD K +N+ + A
Sbjct: 88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVV 145
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
KL D GL + + +T + ++GT Y +PE + KSD++S G +L E+ +
Sbjct: 146 KLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-- 201
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCL 231
P+ DK L+ + YP + L C+
Sbjct: 202 ----------------LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245
Query: 232 NNEPKLRPRMSEVLAILERLEA 253
N +P+ RP ++ V + +R+ A
Sbjct: 246 NPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 46/273 (16%)
Query: 3 VAVKKLKPEGFQGH-KEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 61 NHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 106
+L R P + LS+ + A A+G+ +L A + I+RD A N
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 170
Query: 107 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDV 161
+L+ + K++DFGLA+ D H+ T+G + APE + T +SDV
Sbjct: 171 VLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225
Query: 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAA 220
+SFGV+L E+ + +G PY +LF+++ P
Sbjct: 226 WSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDKPSNCT 268
Query: 221 HTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253
+ + C + P RP +++ L+R+ A
Sbjct: 269 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RG-----PQPLSWA 74
EV L ++ HPN+V + RL +V E+ G L + R RG Q LSW
Sbjct: 49 EVILLAKMKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTH 133
V++ + GL +HD ++++RD K+ NI L AKL DFG+A+ D
Sbjct: 108 VQISL------GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 134 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171
++ +GT Y +PE K+D++S G VL EL
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 28/183 (15%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+VA+K +K E + E++ L + HPN+V G L + +V E+ GSL++
Sbjct: 30 LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD 89
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+++ PLS V KGL +LH E+ I+RD K +NILL + + KL+DFG
Sbjct: 90 -IYQVTRGPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFG 146
Query: 122 LAKAGPTGDRTHVSTQV----------MGTHGYAAPEYVA---TGRLTTKSDVYSFGVVL 168
VS Q+ +GT + APE A G K D+++ G+
Sbjct: 147 ------------VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITA 194
Query: 169 LEL 171
+EL
Sbjct: 195 IEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 22/153 (14%)
Query: 31 HPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLF-----RRGPQPLS--WAVRMKVAIG 82
HP L L C + ++RL V E++ G L +F R+ +P S +A + +A
Sbjct: 55 HPFLTALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLA-- 108
Query: 83 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 142
L FLH VIYRD K NILLDAE + KL+DFG+ K G T +T GT
Sbjct: 109 ----LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTP 160
Query: 143 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
Y APE + D ++ GV++ E+++G+
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 36/286 (12%)
Query: 3 VAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK LK + + ++E+ + + H N++ L+G C + ++ E+ KG+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 61 NHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 106
L R P + LS+ + A A+G+ +L + I+RD A N
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRDLAARN 164
Query: 107 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 166
+L+ + K++DFGLA+ D ++ + APE + T +SDV+SFG+
Sbjct: 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224
Query: 167 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 225
++ E+ + +G PY +LF+++ P H
Sbjct: 225 LMWEIFT---------LG--------GSPYPGIPVEELFKLLREGHRMDKPSNCTHELYM 267
Query: 226 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGP 271
L +C + P RP +++ L+++ A + L S P Q P
Sbjct: 268 LMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYSP 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 72/240 (30%), Positives = 100/240 (41%), Gaps = 31/240 (12%)
Query: 4 AVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A+K LK E E LTE L HP L L Y + +RL V E+ G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL 82
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
HL R A I +A L +LH V+YRD K N++LD + + K++D
Sbjct: 83 FFHLSRERVFSEDRARFYGAEIVSA--LGYLH--SCDVVYRDLKLENLMLDKDGHIKITD 138
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGL K G + T GT Y APE + D + GVV+ E++ GR
Sbjct: 139 FGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF- 195
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
Y D KLF I+ ++ ++P+ + A +L L +PK R
Sbjct: 196 ----------------YNQDHEKLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 68/236 (28%), Positives = 104/236 (44%), Gaps = 28/236 (11%)
Query: 5 VKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENH 62
+KK K E K+ L +VN V + Y E ++ L LV M G L+ H
Sbjct: 38 IKKRKGESMALNEKQILEKVN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
++ G + A GL LH + +++YRD K NILLD + ++SD GL
Sbjct: 91 IYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGL 148
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
A P G + +V GT GY APE V R T D ++ G +L E+++G+ + K
Sbjct: 149 AVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
Query: 183 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
I KR+ + ++ +Y +K + A +L L +PK R
Sbjct: 206 KKI--------------KREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 57/188 (30%), Positives = 95/188 (50%), Gaps = 29/188 (15%)
Query: 2 VVAVKKLKPEGFQGHKE-------WLTEVNYLGQLHHPNLVKL----IGYCLEGENRLLV 50
+VA+KK++ + E L E+ L L HPN+V+L +G L+ + LV
Sbjct: 34 IVALKKVRMD-----NERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD--SIFLV 86
Query: 51 YEFMPK--GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
E+ + SL +++ P P S + + + +GL +LH E+ +I+RD K SN+L
Sbjct: 87 MEYCEQDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLL 140
Query: 109 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVV 167
L + K++DFGLA+ G T + T Y APE + T + D+++ G +
Sbjct: 141 LTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI 198
Query: 168 LLELLSGR 175
L ELL+ +
Sbjct: 199 LAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 67/185 (36%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 4 AVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYC-----LEGENRLLVYEFMPKG 57
AVK L P +E E N L L +HPN+VK G L G LV E G
Sbjct: 51 AVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG 109
Query: 58 S---LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
S L L G Q L A+ + GA GL LH+ +++I+RD K +NILL E
Sbjct: 110 SVTELVKGLLICG-QRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGG 166
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-----LTTKSDVYSFGVVLL 169
KL DFG++ A T R +T V GT + APE +A + + DV+S G+ +
Sbjct: 167 VKLVDFGVS-AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224
Query: 170 ELLSG 174
EL G
Sbjct: 225 ELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 25 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVRMKV 79
+L QLH C + +RL V E++ G L + + G P + +A + +
Sbjct: 62 FLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI 112
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
GL FLH +IYRD K N++LD+E + K++DFG+ K T +
Sbjct: 113 ------GLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFC 162
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
GT Y APE +A D ++FGV+L E+L+G+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 60/180 (33%), Positives = 88/180 (48%), Gaps = 20/180 (11%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
AVK L+ + KE + E N L + + HP LV L Y + ++L V +++ G
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGE 82
Query: 59 LENHLFR--RGPQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
L HL R P+P + +A + A+G +LH +IYRD K NILLD++ +
Sbjct: 83 LFFHLQRERSFPEPRARFYAAEIASALG------YLH--SLNIIYRDLKPENILLDSQGH 134
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
L+DFGL K G +T ++ GT Y APE + D + G VL E+L G
Sbjct: 135 VVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 52/177 (29%), Positives = 93/177 (52%), Gaps = 15/177 (8%)
Query: 3 VAVKKLK-PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL-- 59
VA+K+L+ + +KE L E + + +P++ +L+G CL +L + + MP G L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 97
Query: 60 --ENHLFRRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
H G Q L +W V++ AKG+ +L E ++++RD A N+L+ + K
Sbjct: 98 YVREHKDNIGSQYLLNWCVQI------AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVK 149
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
++DFGLAK ++ + + + A E + T +SDV+S+GV + EL++
Sbjct: 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 56/181 (30%), Positives = 95/181 (52%), Gaps = 15/181 (8%)
Query: 2 VVAVKKLK----PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPK 56
+VA+KK++ EG + E++ L +L HPN+V L ++ E+RL L++EF+
Sbjct: 27 IVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLSM 83
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
L+ +L A +K + +G+ F H +V++RD K N+L+D +
Sbjct: 84 -DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVI 140
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSG 174
KL+DFGLA+A G V T + T Y APE + + R +T D++S G + E+ +
Sbjct: 141 KLADFGLARA--FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198
Query: 175 R 175
+
Sbjct: 199 K 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 13/157 (8%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYC-LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 77
E + L +L HP +V + C + ENR+ + EF+ G L HL + G P A
Sbjct: 66 AQEKSILMELSHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY 123
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+ A +LH +IYRD K N+LLD + + K++DFG AK P DRT
Sbjct: 124 HAELVLA--FEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT--- 174
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
+ GT Y APE + + D ++ GV+L E ++G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-13
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 28 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF------RRGPQPLSWAVRMKVAI 81
QL HPN+V+ LE + +V + + L H +R + W + +++ +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 141
L +LH E ++++RD +NI+L + ++DFGLAK T V+GT
Sbjct: 125 A----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGT 176
Query: 142 HGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171
Y+ PE V K+DV++FG +L ++
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-FRRG-----PQPLSWAV 75
EV L + HPN+V+ E N +V ++ G L + +RG Q L W V
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 135
++ +A L +HD ++++RD K+ NI L + KL DFG+A+ ++
Sbjct: 109 QICLA------LKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA 158
Query: 136 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 195
+GT Y +PE KSD+++ G VL E+ + + A + G ++LV
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV----- 210
Query: 196 YLSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVL 245
K+ R G YP ++H + L Q P+ RP ++ +L
Sbjct: 211 -----LKIIR-------GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 28/236 (11%)
Query: 5 VKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENH 62
+KK K E K L +VN V + Y E ++ L LV M G L+ H
Sbjct: 38 IKKRKGEAMALNEKRILEKVN-------SRFVVSLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
++ G + A GL L +++YRD K NILLD + ++SD GL
Sbjct: 91 IYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGL 148
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
A P G+ V +V GT GY APE + + T D + G ++ E++ G+ K K
Sbjct: 149 AVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
Query: 183 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
+++ VD R+ + + +Y +K + A ++ L PK R
Sbjct: 206 ERVKREEVDR------------RVKEDQ--EEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 49/189 (25%), Positives = 91/189 (48%), Gaps = 18/189 (9%)
Query: 1 MVVAVKKLKPEGFQGH-KEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+
Sbjct: 48 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L R P + +++ + A+G+ +L A + I+RD A
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAA 165
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 164
N+L+ K++DFGLA+ D +T + APE + T +SDV+SF
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 165 GVVLLELLS 173
GV++ E+ +
Sbjct: 226 GVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 7/172 (4%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVKK+ Q + EV + HH N+V + L G+ +V EF+ G+L +
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
+ A V + + L++LH+ VI+RD K+ +ILL ++ KLSDFG
Sbjct: 110 VTHTRMNEEQIAT---VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGF 164
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
++GT + APE ++ T+ D++S G++++E++ G
Sbjct: 165 --CAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 72/239 (30%), Positives = 101/239 (42%), Gaps = 28/239 (11%)
Query: 4 AVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A+K LK E E LTE L HP L L Y + +RL V E+ G L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL 82
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
HL R A I +A L +LH +E V+YRD K N++LD + + K++D
Sbjct: 83 FFHLSRERVFSEDRARFYGAEIVSA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITD 139
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGL K G T + GT Y APE + D + GVV+ E++ GR
Sbjct: 140 FGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF- 196
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
Y D KLF ++ + ++P+ + A +L L +PK R
Sbjct: 197 ----------------YNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 12/177 (6%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
++ A K + + + ++++ E++ L HPN+VKL+ N ++ EF G+++
Sbjct: 31 VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ +PL+ V + L +LH E+++I+RD KA NIL + + KL+DF
Sbjct: 91 AVMLEL-ERPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADF 147
Query: 121 GL-AKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGR---LTTKSDVYSFGVVLLEL 171
G+ AK T R +GT + APE V T + K+DV+S G+ L+E+
Sbjct: 148 GVSAKNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
+ E+ L + + P +V G + E M GSL+ L + G P + KV
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKV 108
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
+I KGLT+L + + ++++RD K SNIL+++ KL DFG++ G D ++ +
Sbjct: 109 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
GT Y +PE + + +SD++S G+ L+E+ GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 56/181 (30%), Positives = 96/181 (53%), Gaps = 16/181 (8%)
Query: 2 VVAVKKLKPEGFQGHKEW-----LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
+VA+KK++ E E + E++ L +L+HPN+V+L+ + EN+L LV+EF+
Sbjct: 26 IVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRLLD-VVHSENKLYLVFEFLD 81
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
L+ ++ L + +G+ + H +V++RD K N+L+D E
Sbjct: 82 L-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGAL 138
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSG 174
KL+DFGLA+A RT+ T + T Y APE + R +T D++S G + E+++
Sbjct: 139 KLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196
Query: 175 R 175
R
Sbjct: 197 R 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 27/175 (15%)
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
K+A+ K L +LH ++ VI+RD K SN+L++ KL DFG+ +G D + T
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVD-SVAKTI 162
Query: 138 VMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD 191
G Y APE + KSDV+S G+ ++EL +GR D K +Q +V+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
Query: 192 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246
P L ++ D +CL K RP E+L
Sbjct: 223 EPSPQLPAEKFSPEFQD-----------------FVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 25/179 (13%)
Query: 22 EVNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E+ L ++HPN+VK + GE ++L+ EFM GSLE L+ VA
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQF-LA-----DVA 174
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 139
G+ +LH +++RD K SN+L+++ N K++DFG+++ T D + S +
Sbjct: 175 RQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---V 229
Query: 140 GTHGYAAPEYVAT----GRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 193
GT Y +PE + T G + D++S GV +LE GR + G DWA
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWA 282
|
Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 70/242 (28%), Positives = 100/242 (41%), Gaps = 35/242 (14%)
Query: 4 AVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A+K LK E E LTE L HP L L Y + ++RL V E++ G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL 82
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
HL R + S L +LH +++YRD K N++LD + + K++D
Sbjct: 83 FFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITD 138
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGL K G T T + GT Y APE + D + GVV+ E++ GR
Sbjct: 139 FGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF- 195
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIM---DTKLGGQYPQKAAHTAATLALQCLNNEPK 236
Y D KLF ++ D K +P+ + A +L L +P
Sbjct: 196 ----------------YNQDHEKLFELILMEDIK----FPRTLSADAKSLLSGLLIKDPN 235
Query: 237 LR 238
R
Sbjct: 236 KR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 50/207 (24%)
Query: 2 VVAVKKL----KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-----GENRLLVYE 52
VVA+KK+ + +GF L E+ L +L HPN+V LI +E R VY
Sbjct: 35 VVALKKILMHNEKDGF--PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92
Query: 53 FMP------KGSLENHLFRRGPQPLSWAVRMKVAIGAAK--------GLTFLHDAESQVI 98
P G LEN +K+ K G+ +LH E+ ++
Sbjct: 93 VTPYMDHDLSGLLENP-------------SVKLTESQIKCYMLQLLEGINYLH--ENHIL 137
Query: 99 YRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYAAPEY 149
+RD KA+NIL+D + K++DFGLA+ G G T T ++ T Y PE
Sbjct: 138 HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL 197
Query: 150 VATGR-LTTKSDVYSFGVVLLELLSGR 175
+ R TT D++ G V E+ + R
Sbjct: 198 LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 26 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 85
+ QL H +LVKL G C+ EN ++V E++ G L+ L R +S ++ VA A
Sbjct: 55 MSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLAS 112
Query: 86 GLTFLHDAESQVIYRDFKASNILL----DAEFN---AKLSDFGLAK-AGPTGDRTHVSTQ 137
L +L D ++++ + NIL+ E KLSD G+ +R
Sbjct: 113 ALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 138 VMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 195
+ APE + G+ LT +D +SFG LLE+ S +
Sbjct: 171 I-------APECIRNGQASLTIAADKWSFGTTLLEICS------------------NGEE 205
Query: 196 YLSDK---RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
LS K D + P A L QC +P RP
Sbjct: 206 PLSTLSSSEKERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 65/236 (27%), Positives = 99/236 (41%), Gaps = 28/236 (11%)
Query: 5 VKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENH 62
+KK K E K+ L +VN V + Y E ++ L LV M G L+ H
Sbjct: 38 IKKRKGESMALNEKQILEKVN-------SQFVVNLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
++ G + A GL LH +YRD K NILLD + ++SD GL
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGL 148
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
A P G+ +GT GY APE + R T D + G ++ E++ G+ K
Sbjct: 149 AVKIPEGESIRGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
Query: 183 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
+++ VD R+++T+ Y K + A ++ L +PK R
Sbjct: 206 EKVKREEVDR------------RVLETE--EVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 52/172 (30%), Positives = 89/172 (51%), Gaps = 7/172 (4%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K++ + + + E+ + + +PN+V + L G+ +V E++ GSL +
Sbjct: 47 VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 106
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
+ A + + A L FLH +QVI+RD K+ NILL + + KL+DFG
Sbjct: 107 VTETCMDEGQIAAVCRECLQA---LDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 161
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A T +++ ST V GT + APE V K D++S G++ +E++ G
Sbjct: 162 C-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E N L + HP +V LI Y + +L L+ E++ G L HL R G A
Sbjct: 50 ERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE 108
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVM 139
I A L LH + +IYRD K NILLDA+ + KL+DFGL K G TH
Sbjct: 109 ISLA--LEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FC 161
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAK-- 194
GT Y APE + D +S G ++ ++L+G A ++ K I++ L K
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKILK--GKLN 218
Query: 195 --PYLSD------KRKLFRIMDTKLGG 213
PYL+ K+ L R ++LG
Sbjct: 219 LPPYLTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78
+TE L HP L L Y + +RL V E+ G L HL R A
Sbjct: 43 VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG 101
Query: 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138
I +A L +LH + V+YRD K N++LD + + K++DFGL K G + T +
Sbjct: 102 AEIVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--F 155
Query: 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 198
GT Y APE + D + GVV+ E++ GR Y
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQ 198
Query: 199 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
D +LF ++ + ++P+ + A +L L +PK R
Sbjct: 199 DHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 58/251 (23%), Positives = 108/251 (43%), Gaps = 31/251 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
+A+K++ + + E+ L H N+V+ +G E + E +P GSL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 63 LFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDF 120
L + GP + + +GL +LHD +Q+++RD K N+L++ K+SDF
Sbjct: 96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDF 153
Query: 121 G----LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSG 174
G LA P + GT Y APE + G +D++S G ++E+ +G
Sbjct: 154 GTSKRLAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
Query: 175 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234
+ ++ +P + +F++ K+ + P+ + A L+C +
Sbjct: 208 K-----------PPFIELGEPQAA----MFKVGMFKIHPEIPESLSAEAKNFILRCFEPD 252
Query: 235 PKLRPRMSEVL 245
P R ++L
Sbjct: 253 PDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 9/157 (5%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG-PQPLSWAVRMKV 79
E++ + +L H N+V+L + EN+L LV+E+M K L+ ++ G L
Sbjct: 48 EISLMKELKHENIVRLHD-VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSF 105
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
KG+ F H E++V++RD K N+L++ KL+DFGLA+A T + V
Sbjct: 106 TYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 140 GTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
T Y AP+ + R +T D++S G ++ E+++GR
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 47/127 (37%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
LV ++M G L HL + G R K I A L H + ++YRD K NIL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSED---RAKFYI-AELVLALEHLHKYDIVYRDLKPENIL 128
Query: 109 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVV 167
LDA + L DFGL+KA T ++T + GT Y APE + + TK D +S GV+
Sbjct: 129 LDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 168 LLELLSG 174
+ E+ G
Sbjct: 187 VFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRM 77
+ E+ L + + P +V G + E M GSL+ L +R P+ +
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILG 106
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
KV+I +GL +L + + Q+++RD K SNIL+++ KL DFG++ G D ++
Sbjct: 107 KVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 161
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+GT Y +PE + + +SD++S G+ L+EL GR
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 54/181 (29%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 3 VAVKKLK--PEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMP 55
+AVK+++ PE + KE E+ L L H +V+ G + R L E MP
Sbjct: 30 LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP 89
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
GS+++ L G L+ V K +G+++LH + +++RD K +NIL D+ N
Sbjct: 90 GGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNV 145
Query: 116 KLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
KL DFG +K T + + V GT + +PE ++ K+D++S G ++E+L+
Sbjct: 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTE 205
Query: 175 R 175
+
Sbjct: 206 K 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEG--ENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMK 78
E+ L L H +V+ G CL E +L ++ E+MP GS+++ L G L+ V +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRR 110
Query: 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ- 137
+G+++LH + +++RD K +NIL D+ N KL DFG +K T + +
Sbjct: 111 YTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
V GT + +PE ++ K+DV+S ++E+L+
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEF 53
VA+KK+ F K L E+ L L H N++ + + +R +VYE
Sbjct: 33 VAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYEL 90
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M + H R Q LS +GL ++H A V++RD K SN+LL+A
Sbjct: 91 M---DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANC 145
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 172
+ K+ DFGLA+ T ++ T+ + T Y APE + TT DV+S G + ELL
Sbjct: 146 DLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
Query: 173 SGR 175
GR
Sbjct: 204 -GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFRR-GPQPLSWAVR 76
L E L ++HP+++++ + G +V +P L +L +R P P+ A+
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALI 161
Query: 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 136
++ I +GL +LH ++I+RD K NI ++ + D G A+ P +
Sbjct: 162 IEKQI--LEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG- 215
Query: 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ GT APE +A + +K+D++S G+VL E+L+
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-12
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 32 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPL--SWAVRMKVAIGAAKGL 87
PN+V L Y + ++ LV + G L +H+ F P+ WA M VA+ A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 88 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVSTQVMGTHGYAA 146
LH ++ RD +NILLD + +L+ F ++ + D V Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 147 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 185
PE T D +S G +L ELL+G+ V+ GI
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE-----GENRL-LVYEF 53
+VA+K + +E E N L + +HPN+ G ++ +++L LV E
Sbjct: 32 QLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90
Query: 54 MPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
GS+ + + R+ + L + +GL +LH E++VI+RD K NILL
Sbjct: 91 CGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTK 148
Query: 112 EFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFG 165
KL DFG+ A+ T R + GT + APE +A +SDV+S G
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 166 VVLLELLSG 174
+ +EL G
Sbjct: 206 ITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 26 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLS--WAVRMKVA 80
L + HP LV L Y + +L V +F+ G L HL R P+P + +A + A
Sbjct: 50 LKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA 108
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 140
+G +LH ++YRD K NILLD++ + L+DFGL K G T +T G
Sbjct: 109 LG------YLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCG 158
Query: 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
T Y APE + D + G VL E+L G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
K+A+ K L +L + E ++I+RD K SNILLD N KL DFG+ +G D T+
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSI-AKTR 166
Query: 138 VMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGR 175
G Y APE + +SDV+S G+ L E+ +G+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 60/179 (33%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
AVK L+ + KE + E N L L HP LV L E V +++ G L
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL 83
Query: 60 ENHLFR----RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
HL R P+ +A + AIG +LH +IYRD K NILLD++ +
Sbjct: 84 FFHLQRERCFLEPRARFYAAEVASAIG------YLHSL--NIIYRDLKPENILLDSQGHV 135
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
L+DFGL K G + T ++ GT Y APE + D + G VL E+L G
Sbjct: 136 VLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+VAVKK+ Q + EV + H N+V++ L G+ +V EF+ G+L +
Sbjct: 47 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 106
Query: 62 HLF--RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ R + ++ V + K L+ LH VI+RD K+ +ILL + KLSD
Sbjct: 107 IVTHTRMNEEQIA-----AVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSD 159
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
FG ++GT + APE ++ + D++S G++++E++ G
Sbjct: 160 FGF--CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-11
Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 9/173 (5%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA++++ + + + E+ + + +PN+V + L G+ +V E++ GSL +
Sbjct: 48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
+ A + + A L FLH +QVI+RD K+ NILL + + KL+DFG
Sbjct: 108 VTETCMDEGQIAAVCRECLQA---LEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 123 -AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A+ P + + ++GT + APE V K D++S G++ +E++ G
Sbjct: 163 CAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 56/155 (36%), Positives = 72/155 (46%), Gaps = 6/155 (3%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
L E L Q++ P +V L E LV F+ G L +HL R G LS A
Sbjct: 41 LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA 100
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
+ A L LH + VIYRD K NILLD + + L DFGL K D +
Sbjct: 101 ELLCA--LENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFC 154
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
GT Y APE + T D ++ GV+L E+L+G
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
E L QL HPN+V EGE+ LL V F G L + L + + L ++
Sbjct: 49 EAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
+ A L +LH E +++RD K N+ L K+ D G+A+ ++ +++ ++
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLI 163
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 199
GT Y +PE + KSDV++ G + E+ + + A + + SLV
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLV--------- 211
Query: 200 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
+RI++ KL P+ + L L+ P+ RP + +L
Sbjct: 212 ----YRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 86 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145
GL +H+ V+YRD K +NILLD + ++SD GLA + + H S +GTHGY
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162
Query: 146 APEYVATG-RLTTKSDVYSFGVVLLELLSG 174
APE + G + +D +S G +L +LL G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 35/190 (18%)
Query: 4 AVKKL------KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPK 56
A KKL K +G++G + E L ++H +V L Y + + L LV M
Sbjct: 22 ACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNG 77
Query: 57 GSLENHLFR--------RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
G L H++ P+ + ++ GL LH + ++IYRD K N+L
Sbjct: 78 GDLRYHIYNVDEENPGFPEPRACFYTAQI------ISGLEHLH--QRRIIYRDLKPENVL 129
Query: 109 LDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 165
LD + N ++SD GLA K G + + + GT G+ APE + D ++ G
Sbjct: 130 LDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQGEEYDFSVDYFALG 184
Query: 166 VVLLELLSGR 175
V L E+++ R
Sbjct: 185 VTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 53/185 (28%), Positives = 77/185 (41%), Gaps = 30/185 (16%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNY-------LGQLHHPNLVKLIGYCLEGENRL-LVYEF 53
+VA+K++K L EV + L LVKL+ Y + + L L E+
Sbjct: 28 IVALKRMKKSLLF----KLNEVRHVLTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEY 82
Query: 54 MPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109
+P G L G + M A+ A L ++H RD K N L+
Sbjct: 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH--------RDLKPENFLI 134
Query: 110 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 169
DA + KL+DFGL+K T + V+G+ Y APE + D +S G +L
Sbjct: 135 DASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLY 189
Query: 170 ELLSG 174
E L G
Sbjct: 190 EFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 18/164 (10%)
Query: 17 KEWLTEVNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSW 73
++++ E+ L +HP +VKL+G + +G+ +++ EF P G+++ + RG
Sbjct: 54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQI 112
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRT 132
V + + A L +LH ++I+RD KA N+LL + + KL+DFG+ AK T R
Sbjct: 113 QVICRQMLEA---LQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR- 166
Query: 133 HVSTQVMGTHGYAAPEYVATGRLTT-----KSDVYSFGVVLLEL 171
+GT + APE V + K+D++S G+ L+E+
Sbjct: 167 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 19/181 (10%)
Query: 1 MVVAVKKL-KPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMP 55
VA+KK+ KP F K E+ L L H N++ L + E+ V E +
Sbjct: 36 QNVAIKKIMKP--FSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G+ + L P + I +GL ++H A V++RD K SNIL++ +
Sbjct: 93 -GTDLHRLLTSRPLEKQFIQYFLYQI--LRGLKYVHSA--GVVHRDLKPSNILINENCDL 147
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSG 174
K+ DFGLA+ + T + T Y APE + T + + D++S G + E+L G
Sbjct: 148 KICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 175 R 175
+
Sbjct: 203 K 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCL----EGENRLLVYEFMP 55
VA+KK+ P F K L E+ L H N++ + + ++ +V + M
Sbjct: 33 VAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM- 90
Query: 56 KGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
E+ L QPL+ +GL ++H A VI+RD K SN+L++ +
Sbjct: 91 ----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDC 144
Query: 114 NAKLSDFGLAKAGPTG--DRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLE 170
++ DFG+A+ + + + T+ + T Y APE + + TT D++S G + E
Sbjct: 145 ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
Query: 171 LLSGR 175
+L GR
Sbjct: 205 ML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 8e-11
Identities = 79/277 (28%), Positives = 119/277 (42%), Gaps = 57/277 (20%)
Query: 2 VVAVKKLKPEGFQGHKEW-----LTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMP 55
+VA+KK+K + W L EV L +L HPN+VKL E + V+E+M
Sbjct: 26 LVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+G+L + R +P S +V + +GL +H +RD K N+L+
Sbjct: 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVV 138
Query: 116 KLSDFGLAKAGPTGDR----THVSTQVMGTHGYAAPEYVATGRLTTKS---DVYSFGVVL 168
K++DFGLA+ R +VST+ Y APE + R T+ S D+++ G ++
Sbjct: 139 KIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPEILL--RSTSYSSPVDIWALGCIM 189
Query: 169 LELLS------GRCAVD---KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK- 218
EL + G +D K I L K + KL KLG ++PQ
Sbjct: 190 AELYTLRPLFPGSSEIDQLYK----ICSVLGTPTKQDWPEGYKLAS----KLGFRFPQFA 241
Query: 219 ----------AAHTAATLALQCLNNEPKLRPRMSEVL 245
A+ A L L +PK RP S+ L
Sbjct: 242 PTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 8e-11
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 40/195 (20%)
Query: 3 VAVKKLKPEGFQGH----KEWLTEVNYLGQLHHPNLVKLIG-------------YCLEGE 45
VA+KK+ F K L E+ L L H N++ L+ Y
Sbjct: 28 VAIKKI-SNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY----- 80
Query: 46 NRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDF 102
+V E M E L + + PQPL+ ++ + +GL +LH A VI+RD
Sbjct: 81 ---IVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLKYLHSA--NVIHRDL 129
Query: 103 KASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-D 160
K SNIL+++ + K+ DFGLA+ P D T+ + T Y APE + + TK+ D
Sbjct: 130 KPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAID 189
Query: 161 VYSFGVVLLELLSGR 175
++S G + ELL+ +
Sbjct: 190 IWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 27/206 (13%)
Query: 51 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
Y+ ++N L G + L+ + A+G+ FL A ++RD A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFG 165
K+ DFGLA+ D H S V + APE + TT SDV+S+G
Sbjct: 272 QGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 166 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225
++L E+ SL P + + + + P A
Sbjct: 327 ILLWEIF---------------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYD 371
Query: 226 LALQCLNNEPKLRPRMSEVLAILERL 251
+ ++C N+EP+ RP + I+E L
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 21/167 (12%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHL------FRRGPQPLS 72
L E L L H N++ ++ C+E GE ++Y +M G+L+ L PQ LS
Sbjct: 56 LQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPT--- 128
+ +AI A G+++LH VI++D A N ++D E K++D L++ P
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 129 --GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
GD + + M A E + ++ SDV+SFGV+L EL++
Sbjct: 174 CLGDNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 21/186 (11%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLH-HPNLVKLIGYCLE-----GENRLLVYEF 53
VA+KK+ F K L E+ L H N+ L Y ++ N L +YE
Sbjct: 30 VAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITCL--YDMDIVFPGNFNELYLYEE 86
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
+ + L H R QPL+ A GL ++H A V++RD K N+L++A+
Sbjct: 87 LMEADL--HQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADC 142
Query: 114 NAKLSDFGLAK---AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLL 169
K+ DFGLA+ P + + T+ + T Y APE + + + TK+ DV+S G +L
Sbjct: 143 ELKICDFGLARGFSENPGENAGFM-TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201
Query: 170 ELLSGR 175
ELL +
Sbjct: 202 ELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 30/170 (17%)
Query: 86 GLTFL-------HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138
GL F+ H +I+RD K++NILL + KL DFG +K V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 198
GT Y APE + K+D++S GV+L ELL+ + +P+
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------------------RPF-- 245
Query: 199 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
D + +M L G+Y P + + L+++PK RP S++L
Sbjct: 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 52/246 (21%)
Query: 20 LTEVNYLGQLHHPNLVKLIG-YCLEGENRLLVY---EFMPKGSL-----ENHLFRRGPQP 70
+ E++ L + P +V G + +EG VY E+M GSL P+
Sbjct: 47 IMELDILHKAVSPYIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPED 102
Query: 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 130
V ++ KGL FL + E +I+RD K +N+L++ KL DFG+ +G+
Sbjct: 103 ----VLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGN 152
Query: 131 -RTHVSTQVMGTHGYAAPEYV----ATGRLT--TKSDVYSFGVVLLELLSGRCA----VD 179
++ +G Y APE + T +SDV+S G+ +LE+ GR
Sbjct: 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
++VD P L P + A +CLN P RP
Sbjct: 213 ANIFAQLSAIVDGDPPTL------------------PSGYSDDAQDFVAKCLNKIPNRRP 254
Query: 240 RMSEVL 245
+++L
Sbjct: 255 TYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 49/235 (20%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL----LVYEFMPKGSLENHLFRRGPQPLSWAVRM 77
E+ L ++ N++K+ G+ ++ + L L+ E+ +G L L + LS+ ++
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKL 125
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+AI KGL L+ ++ Y++ + + L+ + K+ GL K + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 138 VMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 195
V Y + + + T K D+YS GVVL E+ +G K+ E
Sbjct: 185 V-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-------KIPFEN-------- 224
Query: 196 YLSDKRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249
++++ ++ K P + C +++ RP + E+L L
Sbjct: 225 --LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 70/239 (29%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 22 EVNYLGQLH-HPNLVKLIGYCLE-----GENRLLVYEFMPKGS---LENHLFRRGPQPLS 72
E N L L HPN+VK G + G+ LV E GS L +RG + +
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-ME 122
Query: 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 132
+ + A GL LH ++ I+RD K +NILL E KL DFG++ A T R
Sbjct: 123 EPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRL 179
Query: 133 HVSTQVMGTHGYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 187
+T V GT + APE +A + + DV+S G+ +EL G +
Sbjct: 180 RRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DP 227
Query: 188 SLVDWAKPYLSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
L D L R LF+I + P+ ++ +CL + + RP +S++L
Sbjct: 228 PLAD-----LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 86 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145
GL +H+ V+YRD K +NILLD + ++SD GLA + + H S +GTHGY
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162
Query: 146 APEYVATGR-LTTKSDVYSFGVVLLELLSG 174
APE + G + +D +S G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 55/261 (21%)
Query: 3 VAVKKLKP-EGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+ V +L P E Q ++E L +L HP +VK LE + ++ E+ L+
Sbjct: 36 IPVGELNPNETVQANQE----AQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 62 HL--FRRG------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
L + Q W +++ + G+ ++H + ++++RD KA NI L
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLL------GVHYMH--QRRILHRDLKAKNIFLKNNL 143
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFG+++ ++T GT Y +PE + +KSD++S G +L E+
Sbjct: 144 -LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM-- 198
Query: 174 GRCAVDKTKVG-----IEQSLVDWAKPYLSDK--RKLFRIMDTKLGGQYPQKAAHTAATL 226
C + G + +V+ P L + R+L IM +
Sbjct: 199 --CCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSM---------------- 240
Query: 227 ALQCLNNEPKLRPRMSEVLAI 247
LN +P LRP +E+L
Sbjct: 241 ----LNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 21 TEVNYLGQLHHPNLVKLI-GYCLEGENRLLVYEFMP--KGSLENHLFRRGPQPLSWAVRM 77
E++ L + H ++ LI Y + V MP K L ++ R GP PL A+ +
Sbjct: 135 REIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+ + A L +LH +I+RD K NI LD NA L DFG A T
Sbjct: 191 QRRLLEA--LAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
GT +PE +A K+D++S G+VL E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK + Q + EV + H N+V++ L GE ++ EF+ G+L +
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 63 L--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ R + ++ V + L +LH VI+RD K+ +ILL + KLSDF
Sbjct: 109 VSQTRLNEEQIA-----TVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDF 161
Query: 121 G----LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
G ++K P ++GT + APE ++ T+ D++S G++++E++ G
Sbjct: 162 GFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 8/111 (7%)
Query: 68 PQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 126
PQPLS + +KV + +GL +LH A +++RD K N+L+++ K+ DFGLA+
Sbjct: 97 PQPLS-SDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153
Query: 127 PTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGR 175
+ H++ +V+ T Y APE + G T+ D++S G + ELL R
Sbjct: 154 EPDESKHMTQEVV-TQYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 57/184 (30%), Positives = 81/184 (44%), Gaps = 19/184 (10%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
V VK+L+ Q ++L E L H NL++ +G C E LLV EF P G L+
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 62 HLFRR------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+L P P ++A A GL LH ++ I+ D N LL A+
Sbjct: 85 YLRSCRKAELMTPDPT---TLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTV 139
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRL-----TTKSDVYSFGVVL 168
K+ D+GL+ D Q+ + APE V G L T +S+V+S GV +
Sbjct: 140 KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199
Query: 169 LELL 172
EL
Sbjct: 200 WELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 58/191 (30%), Positives = 81/191 (42%), Gaps = 63/191 (32%)
Query: 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143
A+G+ FL A + I+RD A NILL K+ DFGLA+
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-----------------DI 223
Query: 144 YAAPEYVATG--RL---------------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 186
Y P+YV G RL TT+SDV+SFGV+L E+ S +G
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG-- 272
Query: 187 QSLVDWAKPYLSDK------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
A PY + R+L T++ P+ A ++ L C +N P+ RP
Sbjct: 273 ------ASPYPGVQIDEEFCRRLKE--GTRMRA--PEYATPEIYSIMLDCWHNNPEDRPT 322
Query: 241 MSEVLAILERL 251
SE++ IL L
Sbjct: 323 FSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK- 78
TE L + + + Y + + +L L+ +++ G L HL +R R K
Sbjct: 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--------ERFKE 104
Query: 79 ----VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 134
+ G L H + +IYRD K NILLD+ + L+DFGL+K D
Sbjct: 105 QEVQIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVER 162
Query: 135 STQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 192
+ GT Y AP+ V G D +S GV++ ELL+G A T G + S +
Sbjct: 163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG--ASPFTVDGEKNSQAEI 220
Query: 193 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
++ RI+ K YPQ+ + A + + L +PK R
Sbjct: 221 SR----------RIL--KSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 21/163 (12%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL-----FRRGPQPL-SWA 74
E++ L ++ H N+V+L + E RL LV+E++ L+ H+ F + P+ + ++
Sbjct: 51 EISLLKEMQHGNIVRLQD-VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTH 133
++ +G+ + H +V++RD K N+L+D NA KL+DFGLA+A RT
Sbjct: 109 YQI------LRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
Query: 134 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 175
T + T Y APE + R +T D++S G + E+++ +
Sbjct: 161 --THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 3 VAVKKLK----PEGFQGHKEWLTEVNYLGQLHHPNLVKL----------IGYCLEGENRL 48
VA+KK++ EGF + E+ L QL+H N+V L + + +
Sbjct: 35 VALKKVRLDNEKEGFP--ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92
Query: 49 LVYEFMPK---GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 105
LV+E+M G LE+ L + MK + +GL + H ++RD K S
Sbjct: 93 LVFEYMDHDLMGLLESGLVHFSEDHI--KSFMKQLL---EGLNYCHK--KNFLHRDIKCS 145
Query: 106 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSF 164
NILL+ + KL+DFGLA+ + + + +V+ T Y PE + R DV+S
Sbjct: 146 NILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 204
Query: 165 GVVLLELLSGR 175
G +L EL + +
Sbjct: 205 GCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 16/182 (8%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE- 60
V VK+LK + E+L + + L HPN+++ +G C+E LLV+E+ G L+
Sbjct: 25 VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS 84
Query: 61 ---NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
+ R L RM I A G+T +H + ++ D N L ++ K+
Sbjct: 85 YLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMH--KHNFLHSDLALRNCFLTSDLTVKV 140
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRL-----TTKSDVYSFGVVLLE 170
D+G+ + D + APE V G L T S+V++ GV L E
Sbjct: 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200
Query: 171 LL 172
L
Sbjct: 201 LF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 31/175 (17%)
Query: 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 140
A+G+ FL A + I+RD A NILL K+ DFGLA+ P R + +
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-- 198
+ APE + TT+SDV+SFGV+L E+ S +G A PY
Sbjct: 242 ---WMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG--------ASPYPGVQ 281
Query: 199 -DKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
++ R+ D T++ + P+ A + L C +PK RP S ++ IL L
Sbjct: 282 INEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 20/180 (11%)
Query: 4 AVKKLKPEGFQGHKE---WLTEVN-YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
AVK L+ + KE ++E N L + HP LV L + + ++L V +++ G
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGE 82
Query: 59 LENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
L HL R P+ +A + A+G +LH ++YRD K NILLD++ +
Sbjct: 83 LFYHLQRERCFLEPRARFYAAEIASALG------YLHSL--NIVYRDLKPENILLDSQGH 134
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
L+DFGL K + T ++ GT Y APE + D + G VL E+L G
Sbjct: 135 IVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 49/203 (24%)
Query: 65 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124
PL ++ + A+G+ FL A I+RD A N+LL AK+ DFGLA+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 125 AGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC-- 176
D + S V+ + + APE + T +SDV+S+G++L E+ S G+
Sbjct: 261 -----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
Query: 177 ---AVDK-----TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228
V+ K G + S D+A P +++ IM
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPP------EIYSIMKM------------------- 350
Query: 229 QCLNNEPKLRPRMSEVLAILERL 251
C N EP RP S++ +++R
Sbjct: 351 -CWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 69/290 (23%), Positives = 106/290 (36%), Gaps = 67/290 (23%)
Query: 2 VVAVKKLKPEGFQGHKEWLT----EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+VAVKK+ + KE L E+ QL HPN++ + + +V M G
Sbjct: 27 LVAVKKINLD--SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 58 S----LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
S L+ H F G L+ A +K L ++H I+R KAS+ILL +
Sbjct: 85 SCEDLLKTH-FPEGLPELAIAFILK---DVLNALDYIH--SKGFIHRSVKASHILLSGDG 138
Query: 114 NAKLSDF----GLAKAG---------PTGDRTHV---STQVM--GTHGYAAPEYVATGRL 155
LS + K G P ++ S +V+ GY
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY----------- 187
Query: 156 TTKSDVYSFGVVLLELLSGRCA----VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--- 208
KSD+YS G+ EL +G + T++ +E+ V P L DK D
Sbjct: 188 NEKSDIYSVGITACELANG-HVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPLYEDSMS 244
Query: 209 ---TKLGGQYPQKAAHTAAT---------LALQCLNNEPKLRPRMSEVLA 246
+ + + T CL +P+ RP S++L
Sbjct: 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 4 AVKKLK-PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLEN 61
A+K+++ P+ ++ E L ++ HPN+V E + L +V E+ G L
Sbjct: 29 AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQ 87
Query: 62 HL-FRRG---PQP--LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+ +RG P+ L W V+M + + H E +V++RD K+ NI L
Sbjct: 88 KIKLQRGKLFPEDTILQWFVQMCLGVQ--------HIHEKRVLHRDIKSKNIFLTQNGKV 139
Query: 116 KLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171
KL DFG A+ P + T V GT Y PE KSD++S G +L EL
Sbjct: 140 KLGDFGSARLLTSPG---AYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 27/187 (14%)
Query: 3 VAVKKL----KPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC---LEGENR-----LLV 50
VA+KK+ + EGF L E+ L L H N+V LI C NR LV
Sbjct: 40 VALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97
Query: 51 YEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
+EF G L N + + ++M + GL ++H +++++RD KA+NI
Sbjct: 98 FEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL-----NGLYYIH--RNKILHRDMKAANI 150
Query: 108 LLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSF 164
L+ + KL+DFGLA+A + + T + T Y PE + R D++
Sbjct: 151 LITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210
Query: 165 GVVLLEL 171
G ++ E+
Sbjct: 211 GCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 18/181 (9%)
Query: 2 VVAVKKLK-PEGFQG-HKEWLTEVNYLGQL---HHPNLVKLIGYC----LEGENRL-LVY 51
VA+KK++ P +G L E+ L QL HPN+V+L+ C + E +L LV+
Sbjct: 26 FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVF 85
Query: 52 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA-AKGLTFLHDAESQVIYRDFKASNILLD 110
E + + L +L + P+P +K + +G+ FLH ++++RD K NIL+
Sbjct: 86 EHVDQ-DLATYL-SKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVT 141
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
++ K++DFGLA+ T V+ T Y APE + T D++S G + E
Sbjct: 142 SDGQVKIADFGLAR---IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198
Query: 171 L 171
L
Sbjct: 199 L 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 55/189 (29%), Positives = 80/189 (42%), Gaps = 40/189 (21%)
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----GPTGDRTHVSTQVMG 140
+ L ++H A V +RD K NIL +A+ K+ DFGLA+ PT T +
Sbjct: 114 RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVA 168
Query: 141 THGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-------- 190
T Y APE + + T D++S G + E+L+G+ V + L+
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228
Query: 191 ---------DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN----EPKL 237
+ A+ YLS RK K + QK + A LAL+ L +PK
Sbjct: 229 PETISRVRNEKARRYLSSMRK-------KQPVPFSQKFPN-ADPLALRLLERLLAFDPKD 280
Query: 238 RPRMSEVLA 246
RP E LA
Sbjct: 281 RPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 26 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSWAVRMKVAIGAA 84
+ QL H +LV G C+ G+ ++V E++ GSL+ +L + +SW +++VA A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLA 110
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH-- 142
L FL D + + + A N+LL E + K + K G V + +
Sbjct: 111 WALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168
Query: 143 GYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 201
+ PE + + L+ +D +SFG L E+ SG D L ++
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQK 213
Query: 202 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
KL + + + Q P A L QC++ EP RP
Sbjct: 214 KL-QFYEDRH--QLPAPKWTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 50/176 (28%), Positives = 93/176 (52%), Gaps = 8/176 (4%)
Query: 2 VVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K+++ E +G + EV+ L L H N+V L ++ LV+E++ K L+
Sbjct: 33 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLK 91
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
++ G V++ + +GL + H +V++RD K N+L++ KL+DF
Sbjct: 92 QYMDDCGNIMSMHNVKIFL-YQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADF 148
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 175
GLA+A +T+ S +V+ T Y P+ + + +T+ D++ G + E+ SGR
Sbjct: 149 GLARAKSVPTKTY-SNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 27/191 (14%)
Query: 2 VVAVKKLKPEGFQGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPK 56
A+KK K + Q + E+ L +L H N+V L+ LE ++ L++++
Sbjct: 29 EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH 88
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
+ F R + +S M ++ G+ +LH + V++RD K +NIL+ E
Sbjct: 89 DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGP 146
Query: 115 A----KLSDFGLA-------KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVY 162
K+ D GLA K D V+ T Y APE + R TK+ D++
Sbjct: 147 ERGVVKIGDLGLARLFNAPLKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIW 200
Query: 163 SFGVVLLELLS 173
+ G + ELL+
Sbjct: 201 AIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
TE N L + + + Y + E +L L+ +++ G + HL++R S ++
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSED-EVRF 109
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
G L H + ++YRD K NILLD+E + L+DFGL+K + ++ +
Sbjct: 110 YSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFC 167
Query: 140 GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 174
GT Y APE + K+ D +S G+++ ELL+G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 45/135 (33%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
+V E+MP G L N L P WA + +A+ A + F+H RD K
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKP 170
Query: 105 SNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKS 159
N+LLD + KL+DFG K G T V GT Y +PE + + G +
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 160 DVYSFGVVLLELLSG 174
D +S GV L E+L G
Sbjct: 229 DWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 23/181 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-------HHPNLVKLIGYCLEGE-NRL-LVYEF 53
A+K +K + F+ L +VN L ++ HPN+++LI + + RL LV+E
Sbjct: 27 YAIKCMK-KHFKS----LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M E L + +PL K L +H + + +RD K NIL+ +
Sbjct: 82 MDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKDD- 136
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELL 172
KL+DFG + T+ + T Y APE + T G K D+++ G V E+L
Sbjct: 137 ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
Query: 173 S 173
S
Sbjct: 194 S 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 16/177 (9%)
Query: 3 VAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VA+K+ + K+ +E L ++HP V L G + LV EF+ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 60 ENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L R R P + ++ L F + ++YRD K N+LLD + K+
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIV------LIFEYLQSLNIVYRDLKPENLLLDKDGFIKM 172
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
+DFG AK T RT+ + GT Y APE + +D ++ G+ + E+L G
Sbjct: 173 TDFGFAKVVDT--RTYT---LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 16/165 (9%)
Query: 20 LTEVNYLGQLH---HPNLVKLIGYCL----EGENRL-LVYEFMPKGSLENHLFRRGPQPL 71
+ EV L L HPN+V+L C + E +L LV+E + + L +L + P+P
Sbjct: 49 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPG 106
Query: 72 SWAVRMK-VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 130
+K + +GL FLH +V++RD K NIL+ + KL+DFGLA+
Sbjct: 107 VPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYS 161
Query: 131 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
T V+ T Y APE + T D++S G + E+ +
Sbjct: 162 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 27/173 (15%)
Query: 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 140
AKG+ FL A + I+RD A NILL K+ DFGLA+ P R + +
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 198
+ APE + T +SDV+SFGV+L E+ S +G A PY +
Sbjct: 246 --KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVK 286
Query: 199 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ R + + P L C + EP RP SE++ L L
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 29/167 (17%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPK----------GSLENHLFRRGP 68
L E+ L +L H N+V+L L + +L LV+E+ + G ++ + +
Sbjct: 47 LREICLLKELKHKNIVRLYD-VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--- 102
Query: 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 128
S+ ++ KGL F H V++RD K N+L++ KL+DFGLA+A
Sbjct: 103 ---SFMFQL------LKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
Query: 129 GDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSG 174
R + S +V+ T Y P+ + +L +T D++S G + EL +
Sbjct: 152 PVRCY-SAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 50/176 (28%), Positives = 93/176 (52%), Gaps = 8/176 (4%)
Query: 2 VVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K+++ E +G + EV+ L L H N+V L ++ LV+E++ K L+
Sbjct: 33 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLK 91
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+L G V++ + +GL + H +V++RD K N+L++ KL+DF
Sbjct: 92 QYLDDCGNSINMHNVKLFL-FQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADF 148
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 175
GLA+A +T+ S +V+ T Y P+ + + +T+ D++ G + E+ +GR
Sbjct: 149 GLARAKSIPTKTY-SNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 36/170 (21%)
Query: 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS----- 72
W+ ++ Y Q + +N LV E+ P G L + L R
Sbjct: 61 PWIPQLQYAFQ--------------DKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQ 105
Query: 73 -WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 131
+ + +AI + + ++H RD K N+L+D + KL+DFG A A T ++
Sbjct: 106 FYLAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA-ARLTANK 156
Query: 132 THVSTQVMGTHGYAAPEYVATGRLTTKS------DVYSFGVVLLELLSGR 175
S +GT Y APE + T K D +S GV+ E++ GR
Sbjct: 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 46/147 (31%), Positives = 65/147 (44%), Gaps = 10/147 (6%)
Query: 32 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 91
P +V+L + + +V E+MP G L N L P WA + A L +H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLA--LDAIH 159
Query: 92 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151
+I+RD K N+LLD + KL+DFG T V GT Y +PE +
Sbjct: 160 SM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLK 216
Query: 152 T----GRLTTKSDVYSFGVVLLELLSG 174
+ G + D +S GV L E+L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 2 VVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K+++ E +G + EV+ L L H N+V L LV+E++ L+
Sbjct: 32 LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLK 90
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+L G V++ +GL++ H + ++++RD K N+L++ + KL+DF
Sbjct: 91 QYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADF 147
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
GLA+A +T+ S +V+ T Y P+ + + +T D++ G +L E+ +GR
Sbjct: 148 GLARAKSVPTKTY-SNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 216
+ V E L+ FR++ T +P
Sbjct: 206 GSTVKEELHLI-------------FRLLGTPTEETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 17/139 (12%)
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
+V E++ G L G P+ A RM A L +LH+ +++RD K N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEYLHN--YGIVHRDLKPDNLL 133
Query: 109 LDAEFNAKLSDFGLAKAG-------------PTGDRTHVSTQVMGTHGYAAPEYVATGRL 155
+ + + KL+DFGL+K G R + QV GT Y APE +
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 156 TTKSDVYSFGVVLLELLSG 174
D ++ G++L E L G
Sbjct: 194 GKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 26 LGQLHHPNLVKLIGYC----LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
L HPN+V+L+ C + E ++ LV+E + + L +L + P L +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVM 139
+GL FLH + +++RD K NIL+ + KL+DFGLA+ ++ T V+
Sbjct: 115 RQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVV 168
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
T Y APE + T D++S G + E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
+E++ L H +VK + LL+ E+ G L + +R + L + +V
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 81 IGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
+ + + L + S+ +++RD K++NI L KL DFG +K V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 199
GT Y APE R + K+D++S GV+L ELL+ +P+
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274
Query: 200 KRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
++ IM L G+Y P + L L+ P LRP ++L
Sbjct: 275 SQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143
AKG++FL A I+RD A NILL K+ DFGLA+ V
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ APE + T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-------------- 48
VAVKK+ Q K L E+ + +L H N+VK+ + L
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
+V E+M + L N L + PLS +GL ++H A V++RD K +N+
Sbjct: 93 IVQEYM-ETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVF 146
Query: 109 LDAE-FNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFG 165
++ E K+ DFGLA+ P ++ + T Y +P + + TK+ D+++ G
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 206
Query: 166 VVLLELLSGR 175
+ E+L+G+
Sbjct: 207 CIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 3 VAVKKL-KPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVYEFM 54
VAVKKL +P Q H K E+ L ++H N++ L+ E ++ LV E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
+ + +S+ + + G+ LH A +I+RD K SNI++ ++
Sbjct: 109 DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCT 161
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
K+ DFGLA+ T + T + T Y APE + D++S G ++ EL+ G
Sbjct: 162 LKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 43/134 (32%), Positives = 59/134 (44%), Gaps = 18/134 (13%)
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
+V E+MP G L N L P WA + +A+ A + F+H RD K
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKP 170
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSD 160
N+LLD + KL+DFG T V GT Y +PE + + G + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 161 VYSFGVVLLELLSG 174
+S GV L E+L G
Sbjct: 230 WWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 51/188 (27%), Positives = 69/188 (36%), Gaps = 39/188 (20%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW----AV 75
LTE L L HP L L LV ++ P G L L +R QP
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGKCLSEEVA 105
Query: 76 RMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 134
R A + A L +LH ++YRD K NILL + LSDF L+K
Sbjct: 106 RFYAAEVLLA--LEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 135 ---------------------------STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
S +GT Y APE ++ + D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 168 LLELLSGR 175
L E+L G
Sbjct: 222 LYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+ A+K +K E + E+ + H N+V G L + + EF GSL++
Sbjct: 36 LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
GP LS + V+ +GL +LH ++RD K +NILL + KL+DFG
Sbjct: 96 IYHVTGP--LSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFG 151
Query: 122 L-AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLEL 171
+ A+ T + +GT + APE A R D+++ G+ +EL
Sbjct: 152 VSAQITATIAK---RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 27/167 (16%)
Query: 15 GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS-- 72
G +W+T ++Y Q + NL ++ Y + G+ L+ +F E+ L P+ ++
Sbjct: 58 GDNQWITTLHYAFQDEN-NLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARF 106
Query: 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 132
+ M +AI + L ++H RD K NIL+D + +L+DFG + D T
Sbjct: 107 YLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGT 157
Query: 133 HVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 174
S+ +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 57/219 (26%)
Query: 2 VVAVKKL-KPEGFQGHKEWLTEV----NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
+ A+KKL K E + KE + V + L + +P +VKL Y + EN L L+ E++P
Sbjct: 28 IYAMKKLRKSEMLE--KEQVAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLP 84
Query: 56 KGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
G + L ++ + + +AI + L ++H RD K N+LLDA
Sbjct: 85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH--------RDIKPDNLLLDA 136
Query: 112 EFNAKLSDFGL----------------AKAGPTGDRTHVSTQ------------------ 137
+ + KLSDFGL + A P+ +S
Sbjct: 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA 196
Query: 138 --VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
+GT Y APE + D +S GV++ E+L G
Sbjct: 197 YSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 53/237 (22%)
Query: 26 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR-RGPQPLSWAVRMKVAIGAA 84
+ Q+ H +L + G C+ G ++V EF+ G L+ L + +G P++W ++ VA A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 85 KGLTFLHDAESQVIYRDFKASNILL--------DAEFNAKLSDFGLAKAGPTGDRTHVST 136
L++L D +++ + A NILL + F KLSD G++ + R
Sbjct: 128 SALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALS--REERVE 182
Query: 137 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLEL-------LSGRCAVDKTKVGIEQS 188
++ + APE V G L+T +D +SFG LLE+ L R +K +
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER------ 232
Query: 189 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
+ K +L P+ + ATL QCL EP RP +L
Sbjct: 233 -------FYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 24/184 (13%)
Query: 3 VAVKKL-KPEGFQG--H-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYE 52
VA+KKL +P FQ H K E+ L + H N++ L+ + LV
Sbjct: 43 VAIKKLSRP--FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100
Query: 53 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
M G+ N++ + Q LS + +GL ++H A +I+RD K SNI ++ +
Sbjct: 101 LM--GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNED 154
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLEL 171
K+ DFGLA+ T D T + T Y APE + ++ D++S G ++ EL
Sbjct: 155 CELKILDFGLAR--HTDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 172 LSGR 175
L+G+
Sbjct: 210 LTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 34/189 (17%)
Query: 3 VAVKKL-KPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYE 52
VA+KKL +P FQ K E+ L + H N++ L+ + LV
Sbjct: 43 VAIKKLYRP--FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100
Query: 53 FMPK--GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
FM G L H + + + V + KGL ++H A +I+RD K N+ ++
Sbjct: 101 FMGTDLGKLMKHE-KLSEDRIQFLVYQML-----KGLKYIHAA--GIIHRDLKPGNLAVN 152
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---THGYAAPEYVATG-RLTTKSDVYSFGV 166
+ K+ DFGLA+ +++ G T Y APE + T D++S G
Sbjct: 153 EDCELKILDFGLAR--------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGC 204
Query: 167 VLLELLSGR 175
++ E+L+G+
Sbjct: 205 IMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144
+GL ++H A+ +I+RD K SN+ ++ + K+ DFGLA+ T D T + T Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 183
Query: 145 AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
APE + ++ D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 53/223 (23%), Positives = 84/223 (37%), Gaps = 62/223 (27%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA----VRM 77
E + L + + +VKL + +N V +++P G + + L R G A +
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAEL 110
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVST 136
AI + + F+H RD K NIL+D + + KL+DFGL TG R TH S
Sbjct: 111 TCAIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSK 158
Query: 137 --------------------------------------------QVMGTHGYAAPEYVAT 152
++GT Y APE +
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 153 GRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAK 194
T D +S GV+L E+L G+ + T + +++W
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 7/176 (3%)
Query: 2 VVAVKKLK-PEGFQGHKEW-LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+VA+KK K E + KE L E+ L L N+V+L LV+E++ K L
Sbjct: 28 IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
E L P + K + + H ++ +++RD K N+L+ KL D
Sbjct: 88 E--LLEEMPNGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCD 143
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
FG A+ G + T+ + T Y +PE + D++S G +L EL G+
Sbjct: 144 FGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 7/172 (4%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81
E + L L H N+V L E V+E+M L ++ + + VR+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMF 110
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 141
+GL ++H +++RD K N+L+ KL+DFGLA+A +T+ S V T
Sbjct: 111 QLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--T 166
Query: 142 HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 192
Y P+ + ++ D++ G + +E+L G+ A EQ W
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 44/207 (21%)
Query: 2 VVAVKKLK----PEGFQGHKEW----------LTEVNYLGQLHHPNLVKLIGYCLEGENR 47
+VA+KK+K ++ L E+ + ++ H N++ L+ +EG+
Sbjct: 36 IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI 95
Query: 48 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA------IGAAKGLTFLHDAESQVIYRD 101
LV + M L+ + R+ +R+ + + GL LH + ++RD
Sbjct: 96 NLVMDIM-ASDLKKVVDRK--------IRLTESQVKCILLQILNGLNVLH--KWYFMHRD 144
Query: 102 FKASNILLDAEFNAKLSDFGLAK-------AGPTGDRTHVS-----TQVMGTHGYAAPEY 149
+NI ++++ K++DFGLA+ + + T + T Y APE
Sbjct: 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL 204
Query: 150 V-ATGRLTTKSDVYSFGVVLLELLSGR 175
+ + D++S G + ELL+G+
Sbjct: 205 LMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 3 VAVKKL-KPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVYEFM 54
VA+KKL +P Q H K E+ + ++H N++ L+ E ++ LV E M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
+ + +S+ + + G+ LH A +I+RD K SNI++ ++
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCT 157
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE---- 170
K+ DFGLA+ T + + T + T Y APE + D++S G ++ E
Sbjct: 158 LKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 171 --LLSGRCAVDKTKVGIEQ 187
L GR +D+ IEQ
Sbjct: 215 KILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+ AVK +K E E+ + + H N+V G L E + E+ GSL++
Sbjct: 36 LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD 95
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
GP LS V +GL +LH ++RD K +NILL + KL+DFG
Sbjct: 96 IYHVTGP--LSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFG 151
Query: 122 L-AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 171
+ AK T + +GT + APE A G D+++ G+ +EL
Sbjct: 152 VAAKITATIAK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 46/178 (25%), Positives = 67/178 (37%), Gaps = 45/178 (25%)
Query: 34 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTF 89
+VK+ + N L+ EF+P G + L ++ + +AI A L F
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 90 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---------------GPTGD---- 130
+H RD K N+LLDA+ + KLSDFGL P D
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 131 --------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
R ++ +GT Y APE D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 38/203 (18%)
Query: 3 VAVKKLKPEGFQG----HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP--K 56
VA+KK++ E K +L E L HP +V + C +G+ VY MP +
Sbjct: 30 VALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIE 85
Query: 57 GSLENHLFR--RGPQPLSWAVRMKVAIGA--------AKGLTFLHDAESQVIYRDFKASN 106
G L + + LS + K ++GA + ++H V++RD K N
Sbjct: 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDN 143
Query: 107 ILLDAEFNAKLSDFGLA-------------KAGPTGDRTHVST---QVMGTHGYAAPEYV 150
ILL + D+G A T +++GT Y APE +
Sbjct: 144 ILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203
Query: 151 ATGRLTTKSDVYSFGVVLLELLS 173
+ +D+Y+ GV+L ++L+
Sbjct: 204 LGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 37/172 (21%)
Query: 15 GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR---RGPQP 70
G + W+T LH Y + EN L LV ++ G L L + R P+
Sbjct: 58 GDRRWIT------NLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED 102
Query: 71 LS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGP 127
++ + M +AI + L ++H RD K N+LLD + +L+DFG +
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLA 154
Query: 128 TGDRTHVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 174
G T S +GT Y +PE + GR + D +S GV + E+L G
Sbjct: 155 DG--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 20/146 (13%)
Query: 40 YCLEGENRL-LVYEFMPKGSLENHLFR---RGPQPLS--WAVRMKVAIGAAKGLTFLHDA 93
Y + EN L LV ++ G L L + R P+ ++ + M +AI + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--- 150
RD K N+LLD + +L+DFG + D T S+ +GT Y +PE +
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 151 --ATGRLTTKSDVYSFGVVLLELLSG 174
G+ + D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 22 EVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74
E+N L + HH N+ G ++ + LV EF GS+ + + L
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-H 133
+ +GL+ LH + +VI+RD K N+LL KL DFG++ DRT
Sbjct: 112 WIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVG 166
Query: 134 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 174
+GT + APE +A KSD++S G+ +E+ G
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 28 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKG 86
Q+ H ++V L G C+ ++V EF+ G L+ LF R L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 87 LTFLHDAESQVIYRDFKASNILL-----DAEFNA--KLSDFGLAKAGPTGDRTHVSTQ-V 138
L++L D + +++ + NILL D E KLSD G+ P T +S Q
Sbjct: 118 LSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PI---TVLSRQEC 168
Query: 139 MGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLEL-LSGRCAV-DKTKVGIEQSLVDWAKP 195
+ + APE V + L+ +D +SFG L E+ +G + DKT
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-------------- 214
Query: 196 YLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRP 239
L++K + + GQ + A L C+N +P RP
Sbjct: 215 -LAEKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 31 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 90
HPN++ G ++ FM GS + L P+ +S A+ + GA +GL +L
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117
Query: 91 HDAESQVIYRDFKASNILLDAEFNAKLSD----FGLAKAGPTG----DRTHVSTQVMGTH 142
H ++ I+R+ KAS+IL+ + LS + L + G D ST V+
Sbjct: 118 H--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-- 173
Query: 143 GYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 175
+ +PE + KSD+YS G+ EL +GR
Sbjct: 174 -WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
TE + L ++HP++++L G + L+ +P+ + + + + ++ + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 140
+ + +LH E+++I+RD KA NI ++ + L DFG A P + G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245
Query: 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
T APE +A D++S G+VL E+ +
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 86 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ G ++ V+ T Y
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV-TRYYR 184
Query: 146 APEYVATGRLTTKSDVYSFGVVLLELLSGR 175
APE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 57/203 (28%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLS--WAVRM 77
E + L + + +VKL + +N V +++P G + + L R P+ L+ + +
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAEL 110
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA------------ 125
+AI + + F+H RD K NIL+D + + KL+DFGL
Sbjct: 111 TLAIESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162
Query: 126 ---------GPT-----------GDRTHVSTQ-------------VMGTHGYAAPEYVAT 152
P+ GDR Q ++GT Y APE +
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 153 GRLTTKSDVYSFGVVLLELLSGR 175
T D +S GV+L E+L G+
Sbjct: 223 KGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 25/184 (13%)
Query: 3 VAVKKL-KPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGY---CLEGENRLLVYEFMP 55
VA+KKL +P FQ K E+ L + H N++ L+ + G+ Y MP
Sbjct: 43 VAIKKLSRP--FQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
++ L + PLS + GL ++H A +I+RD K N+ ++ +
Sbjct: 101 --YMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCEL 156
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMG---THGYAAPEYVATGRLTTKS-DVYSFGVVLLEL 171
K+ DFGLA+ H ++ G T Y APE + ++ D++S G ++ E+
Sbjct: 157 KILDFGLAR--------HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 172 LSGR 175
L+G+
Sbjct: 209 LTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 86 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T + + T + T Y
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 146 APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 187
APE + D++S G ++ E L G +D+ IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 58/221 (26%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLS--WAVRM 77
E + L + + +V+L + +N V +++P G + + L R G P+ L+ + +
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL---------AKAGPT 128
A+ + + F+H RD K NIL+D + + KL+DFGL +K +
Sbjct: 111 TCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 129 GD---------------------------------RTH---VSTQVMGTHGYAAPEYVAT 152
GD R H ++ ++GT Y APE +
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 153 GRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDW 192
T D +S GV+L E+L G+ + +T + + +++W
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 22 EVNYLGQLHHPNLVKL--------IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73
E+ LG+L+H N++K+ Y + + +Y FM + F +PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA-----FDWKDRPLLK 267
Query: 74 AVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 131
R MK + A + ++HD ++I+RD K NI L+ + L DFG A +R
Sbjct: 268 QTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK-ER 321
Query: 132 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+GT +PE +A +D++S G++LL++LS
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143
A G+ FL A ++RD A N+L+ K+ DFGLA+ D S +
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKGST 301
Query: 144 Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ APE + TT SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 41/166 (24%), Positives = 62/166 (37%), Gaps = 45/166 (27%)
Query: 46 NRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 101
N L+ EF+P G + L ++ + + +AI + L F+H RD
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--------RD 126
Query: 102 FKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------------------------- 132
K N+LLD++ + KLSDFGL RT
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 133 ----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
++ +GT Y APE D +S GV++ E+L G
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 7/93 (7%)
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144
+GL + H +V++RD K N+L+ KL+DFGLA+A +T+ S +V+ T Y
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWY 169
Query: 145 AAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 175
P+ V G +T D++ G + E+ +GR
Sbjct: 170 RPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144
+GL ++H A +I+RD K SN+ ++ + ++ DFGLA+ D T + T Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181
Query: 145 AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
APE + ++ D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 6/70 (8%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTE----VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 56
M VAVK LKP +E L ++YLG +H N+V L+G C G L++ E+
Sbjct: 66 MTVAVKMLKPSAHLTEREALMSELKVLSYLG--NHINIVNLLGACTVGGPTLVITEYCCY 123
Query: 57 GSLENHLFRR 66
G L N L R+
Sbjct: 124 GDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 18/166 (10%)
Query: 22 EVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74
E+N L + HH N+ G ++ + LV EF GS+ + + L
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-H 133
+ +GL LH +VI+RD K N+LL KL DFG++ DRT
Sbjct: 122 WIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVG 176
Query: 134 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 174
+GT + APE +A +SD++S G+ +E+ G
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 8/151 (5%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK--GSLENHLFRRGPQPLSWAVRMKV 79
E L +L HP ++ L+ + G LV +PK L +L R +PL A V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGAR-LRPLGLAQVTAV 265
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 139
A + ++H +I+RD K N+L++ + L DFG A T +
Sbjct: 266 ARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
GT APE +A T D++S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 28/94 (29%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 85 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144
+GL+++H + +++RD K N+L+ KL+DFGLA+A T+ S +V+ T Y
Sbjct: 114 RGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWY 169
Query: 145 AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCA 177
P+ + + +T D++ G + +E++ G A
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 20 LTEVNYLGQLHH-PNLVKLIGYCLE------GENRL-LVYEFMP---KGSLENHLFRRGP 68
L E++ L L +V+L+ +E G+ L LV+E++ K ++++ RGP
Sbjct: 48 LREISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN--GRGP 103
Query: 69 -QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG 126
+PL KG+ H + V++RD K N+L+D + K++D GL +A
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
Query: 127 --PTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 174
P TH +++ T Y APE + +T D++S G + E+
Sbjct: 162 SIPVKSYTH---EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL---FRRGPQPLSWAVR 76
EVN + +L H N+V+ I L N+ L + EF G L ++ ++ + A+
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI- 120
Query: 77 MKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLD----------AEFN------- 114
+ + L + H+ + +V++RD K NI L A+ N
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELL 172
AK+ DFGL+K H +GT Y +PE + T KSD+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 173 SGRCAVDK 180
SG+ K
Sbjct: 238 SGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 43/134 (32%), Positives = 60/134 (44%), Gaps = 25/134 (18%)
Query: 2 VVAVKKL-KPEGFQGHKEWLTEV----NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
+ A+K L K E F+ K+ L V + L + P +V L Y + L L+ EF+P
Sbjct: 28 IYAMKTLLKSEMFK--KDQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLP 84
Query: 56 KGSLENHLFRRGPQPLS------WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109
G L L + S + +AI A L F+H RD K NIL+
Sbjct: 85 GGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIH--------RDIKPDNILI 134
Query: 110 DAEFNAKLSDFGLA 123
D + KLSDFGL+
Sbjct: 135 DRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRG------PQPLSW 73
E+ L +L HPN++ L L +R L++++ F R P L
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK----- 124
++ + G+ +LH + V++RD K +NIL+ E K++D G A+
Sbjct: 108 SMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 125 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 173
P D V+ T Y APE + R TK+ D+++ G + ELL+
Sbjct: 166 LKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 30/205 (14%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRG------PQPLSW 73
E+ L +L HPN++ L L +R L++++ F R P L
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK----- 124
+ + G+ +LH + V++RD K +NIL+ E K++D G A+
Sbjct: 108 GMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 125 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKV 183
P D V+ T Y APE + R TK+ D+++ G + ELL+ +
Sbjct: 166 LKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
Query: 184 GIEQSLVDWAKPYLSDK-RKLFRIM 207
I+ S PY D+ ++F +M
Sbjct: 222 DIKTS-----NPYHHDQLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 24/68 (35%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 1 MVVAVKKLKPEGFQGHKEWL-TEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK +E L +E+ L L H N+V L+G C G L++ E+ G
Sbjct: 69 LRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 59 LENHLFRR 66
L N L ++
Sbjct: 129 LLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLEN--HLFRRGPQPLSWAVRM 77
E + L P +V L Y L+ N + LV E++ G +++ H++ + ++ +
Sbjct: 53 AERDALALSKSPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----V 107
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124
K A L +LH +I+RD K N+L+ E + KL+DFGL+K
Sbjct: 108 KYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.003
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 30 HHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 88
+PN +KL Y + +L+ +++ G L + L + G LS A K+ + L
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALN 123
Query: 89 FLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVM--GTHGYA 145
LH +I+ D K N+L D A+ L D+GL K + T GT Y
Sbjct: 124 DLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYF 173
Query: 146 APEYVATGRLTTKSDVYSFGVVLLELLSG 174
+PE + D ++ GV+ ELL+G
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 305 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.19 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.57 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.19 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.41 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.39 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.18 | |
| PLN02236 | 344 | choline kinase | 97.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.88 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.85 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.69 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.55 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.84 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.45 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.38 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.25 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.21 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.55 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.38 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.35 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.7 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-52 Score=339.05 Aligned_cols=229 Identities=26% Similarity=0.398 Sum_probs=194.1
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCC-eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.+|+|++..+.. ...+++.+|++++++.+|||||.+|+.|..++ ...++||||+||+|.+++...+ .+++...-+
T Consensus 105 ~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ 182 (364)
T KOG0581|consen 105 KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGK 182 (364)
T ss_pred eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHH
Confidence 3689999965533 34578999999999999999999999999988 5999999999999999997664 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.++++||.|||.. .+||||||||+|||++..|.|||||||.+....+. .....+||..|||||.+.+..|+.+
T Consensus 183 ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~ 257 (364)
T KOG0581|consen 183 IARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVK 257 (364)
T ss_pred HHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcc
Confidence 999999999999962 55999999999999999999999999999875443 3456789999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH-HHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~ 237 (305)
+||||||++++|+.+|+.||...... ..+.-.+...+........|.+ ++.++++|+..||++||.+
T Consensus 258 sDIWSLGLsllE~a~GrfP~~~~~~~------------~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~ 325 (364)
T KOG0581|consen 258 SDIWSLGLSLLELAIGRFPYPPPNPP------------YLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSE 325 (364)
T ss_pred cceecccHHHHHHhhCCCCCCCcCCC------------CCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCccc
Confidence 99999999999999999999764111 1122234444444455566665 9999999999999999999
Q ss_pred CCCHHHHHHHH
Q 021947 238 RPRMSEVLAIL 248 (305)
Q Consensus 238 Rps~~~~l~~l 248 (305)
|||+.+++++-
T Consensus 326 R~s~~qLl~Hp 336 (364)
T KOG0581|consen 326 RPSAKQLLQHP 336 (364)
T ss_pred CCCHHHHhcCH
Confidence 99999999753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=342.60 Aligned_cols=234 Identities=33% Similarity=0.543 Sum_probs=200.2
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCC-eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++....... .++|.+|+.+|.+++|||||+++|++.+.. .+++||||+++|+|.+++.......++...++.
T Consensus 67 ~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~ 146 (362)
T KOG0192|consen 67 VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLR 146 (362)
T ss_pred eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHH
Confidence 49999998764433 458999999999999999999999999887 789999999999999999774345699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhh--cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~ 155 (305)
++.+|+.|+.|||+++. |||||||++|||++.++ ++||+|||+++...... .......||..|||||++. ...|
T Consensus 147 ~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~ 223 (362)
T KOG0192|consen 147 IALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPY 223 (362)
T ss_pred HHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcC
Confidence 99999999999996443 99999999999999997 99999999998754322 1123367999999999999 5689
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++||||||+++|||+||..||.+... ............+...+..++..+..|+.+||+.||
T Consensus 224 ~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp 287 (362)
T KOG0192|consen 224 TEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDP 287 (362)
T ss_pred CccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987542 233444555666777788899999999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 021947 236 KLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~~~ 254 (305)
..||++.+++..|+.+...
T Consensus 288 ~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 288 SRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CcCCCHHHHHHHHHHHHHh
Confidence 9999999999999887553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=336.45 Aligned_cols=225 Identities=27% Similarity=0.373 Sum_probs=186.1
Q ss_pred CEEEEEecccCCccC-------hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGFQG-------HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
..||||+++...... .....+|+++|++|+|||||+++++|...+..||||||++||+|.+++..++. +.+
T Consensus 198 k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~e 275 (475)
T KOG0615|consen 198 KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LRE 275 (475)
T ss_pred cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--ccc
Confidence 369999998653322 12357999999999999999999999999999999999999999999977654 888
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.....++.|++.|+.|||+. ||+||||||+|||++.+ ..+||+|||+|+..+.. ....+.|||+.|.|||++
T Consensus 276 d~~K~~f~Qll~avkYLH~~--GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl 350 (475)
T KOG0615|consen 276 DLGKLLFKQLLTAVKYLHSQ--GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVL 350 (475)
T ss_pred chhHHHHHHHHHHHHHHHHc--CcccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhhe
Confidence 88899999999999999964 59999999999999876 56999999999987532 335678999999999999
Q ss_pred hcCCCC---CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-c--CCCCChHHHHHHH
Q 021947 151 ATGRLT---TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L--GGQYPQKAAHTAA 224 (305)
Q Consensus 151 ~~~~~~---~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~ 224 (305)
.+.... .++|||||||++|-+++|.+||.+...+. .+.+.+..+ + .......++++..
T Consensus 351 ~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----------------sl~eQI~~G~y~f~p~~w~~Iseea~ 414 (475)
T KOG0615|consen 351 ASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----------------SLKEQILKGRYAFGPLQWDRISEEAL 414 (475)
T ss_pred ecCCeecccchheeeeccceEEEEeccCCCcccccCCc----------------cHHHHHhcCcccccChhhhhhhHHHH
Confidence 877543 37899999999999999999998754321 122222222 1 2344568999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
+||.+||..||+.|||+.|++++-
T Consensus 415 dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 415 DLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred HHHHHhhEeCcccCcCHHHHhcCh
Confidence 999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=346.70 Aligned_cols=222 Identities=30% Similarity=0.448 Sum_probs=192.8
Q ss_pred EEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+||+|++... ....++.+.+|+++.++|+|||||+++++|++.++.|||+|+|..++|..++++++ .+++.++..
T Consensus 45 ~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk--~ltEpEary 122 (592)
T KOG0575|consen 45 VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARY 122 (592)
T ss_pred EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHH
Confidence 6899998764 23456789999999999999999999999999999999999999999999998554 599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|......... ..+.|||+.|.|||++.....+..
T Consensus 123 ~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfE 198 (592)
T KOG0575|consen 123 FLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFE 198 (592)
T ss_pred HHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCc
Confidence 9999999999999754 999999999999999999999999999987644322 456799999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||+||+||.||.|++||+..+. .+.+..+.... ...|...+.++.+||.++|+.||.+|
T Consensus 199 vDiWSlGcvmYtLL~G~PPFetk~v----------------kety~~Ik~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~R 260 (592)
T KOG0575|consen 199 VDIWSLGCVMYTLLVGRPPFETKTV----------------KETYNKIKLNE--YSMPSHLSAEAKDLIRKLLRPNPSER 260 (592)
T ss_pred hhhhhhhhHHHhhhhCCCCcccchH----------------HHHHHHHHhcC--cccccccCHHHHHHHHHHhcCCcccC
Confidence 9999999999999999999987542 12222333332 35566899999999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+++++.+
T Consensus 261 psl~~vL~h 269 (592)
T KOG0575|consen 261 PSLDEVLDH 269 (592)
T ss_pred CCHHHHhcC
Confidence 999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=340.50 Aligned_cols=231 Identities=31% Similarity=0.483 Sum_probs=205.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++.. ....++|.+|+++|++|+|+|||+++++|..++.+||||||++.|+|.+||+...+..+.....+.++.
T Consensus 232 ~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~ 310 (468)
T KOG0197|consen 232 KVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAA 310 (468)
T ss_pred cccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHH
Confidence 5899999886 345578999999999999999999999999988999999999999999999876666799999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|||+|++||++++ +|||||-..||||++++.+||+|||+++...++. ........-+..|.|||.+..+.++.+|||
T Consensus 311 qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDV 387 (468)
T KOG0197|consen 311 QIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDV 387 (468)
T ss_pred HHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccce
Confidence 9999999999755 9999999999999999999999999999554432 222333334678999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||++||||+| |+.||.+.. ...+.+.+..+.+.+.|..++.++.+++..||+.+|++|||
T Consensus 388 WSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 388 WSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred eehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCC
Confidence 999999999999 999988753 45677888999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
++.+...|+.+-.
T Consensus 451 F~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 451 FETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHHhhh
Confidence 9999999887643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=322.13 Aligned_cols=222 Identities=27% Similarity=0.428 Sum_probs=182.2
Q ss_pred CEEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||||.+.... .+..+-+..|+.+|++++|||||.+++++...+.+|||||||.||+|.+|+++++. +++..+..
T Consensus 36 ~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~ 113 (429)
T KOG0595|consen 36 TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR--LPEATARH 113 (429)
T ss_pred ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHH
Confidence 379999998763 34456688999999999999999999999999999999999999999999987764 99999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC------CceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.||+.||++||+ ++||||||||+|||++.. -.+||+|||+++..... ....+.+|++-|||||++..
T Consensus 114 Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~ 188 (429)
T KOG0595|consen 114 FMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMS 188 (429)
T ss_pred HHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHh
Confidence 99999999999995 559999999999999875 35899999999987643 34567899999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh--cccCCCCChHHHHHHHHHHHhh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~ 230 (305)
+.|+.|+|+||+|+|+|++++|+.||+..+... +..... .......+...+..+.+|+...
T Consensus 189 ~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e-----------------L~~~~~k~~~~~~~~~~~~s~~~~~Ll~~l 251 (429)
T KOG0595|consen 189 QQYDAKADLWSIGTILYQCLTGKPPFDAETPKE-----------------LLLYIKKGNEIVPVLPAELSNPLRELLISL 251 (429)
T ss_pred ccccchhhHHHHHHHHHHHHhCCCCccccCHHH-----------------HHHHHhccccccCchhhhccCchhhhhhHH
Confidence 999999999999999999999999998654311 111111 1122233445566677788888
Q ss_pred ccCCCCCCCCHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLA 246 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~ 246 (305)
|..++.+|-+..+...
T Consensus 252 l~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 252 LQRNPKDRISFEDFFD 267 (429)
T ss_pred HhcCccccCchHHhhh
Confidence 8888888877766654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=314.05 Aligned_cols=228 Identities=23% Similarity=0.353 Sum_probs=187.6
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEE-EEEeCCe-eEEEEecCCCCCHHHHhhh--cCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIG-YCLEGEN-RLLVYEFMPKGSLENHLFR--RGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 75 (305)
.||.|.++-+.. ..++++..|+.+|++|+|||||++++ .|.++.. ++||||+|.+|+|..+++. .....+++..
T Consensus 46 l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~ 125 (375)
T KOG0591|consen 46 LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKT 125 (375)
T ss_pred hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHH
Confidence 578888885533 34568999999999999999999999 4555555 8999999999999999954 2345699999
Q ss_pred HHHHHHHHHHHHhhhhcCCC--ceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 76 RMKVAIGAAKGLTFLHDAES--QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
+++++.|++.||..+|++-. -|.||||||.||+++.+|.|||+|||+++...+... .....+|||.||+||.+.+.
T Consensus 126 Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~ 203 (375)
T KOG0591|consen 126 VWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHES 203 (375)
T ss_pred HHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcC
Confidence 99999999999999998433 499999999999999999999999999998755432 34567899999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC-hHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~ 232 (305)
+|+.+||||||||++|||+.-+.||.+.+. ..+.+.+..+.-.+.| .-++..+..||..|+.
T Consensus 204 ~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----------------~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~ 266 (375)
T KOG0591|consen 204 GYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----------------LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIA 266 (375)
T ss_pred CCCcchhHHHHHHHHHHHHhcCCCcccccH-----------------HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHcc
Confidence 999999999999999999999999998632 1233333444444455 6788999999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAIL 248 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l 248 (305)
.||+.||+...++..+
T Consensus 267 vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 267 VDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCcccCCCcchHHHHH
Confidence 9999999855544433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=330.08 Aligned_cols=224 Identities=26% Similarity=0.402 Sum_probs=194.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..||||.+....-...+-+++|+.+|+..+|+|||.+++.|..++.+|+||||++||+|.+.+.... +++.++..++
T Consensus 299 ~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Ic 375 (550)
T KOG0578|consen 299 QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAIC 375 (550)
T ss_pred ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHH
Confidence 3699999887765666778999999999999999999999999999999999999999999996554 9999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||+|||. +||+|||||.+|||++.+|.+||+|||+|..+..... .....+||+.|||||++....|+.++|
T Consensus 376 re~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVD 451 (550)
T KOG0578|consen 376 REILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVD 451 (550)
T ss_pred HHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCcccc
Confidence 999999999995 5699999999999999999999999999987654433 245668999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh-cccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||++++||+.|.+||-..+. ...++.+.. .......+..++..+++|+.+||..|+.+|+
T Consensus 452 IWSLGIMaIEMveGEPPYlnE~P----------------lrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra 515 (550)
T KOG0578|consen 452 IWSLGIMAIEMVEGEPPYLNENP----------------LRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA 515 (550)
T ss_pred chhhhhHHHHHhcCCCCccCCCh----------------HHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCC
Confidence 99999999999999999976432 122333322 2345567789999999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
++.|+|++
T Consensus 516 sA~eLL~H 523 (550)
T KOG0578|consen 516 SAKELLEH 523 (550)
T ss_pred CHHHHhcC
Confidence 99999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=314.66 Aligned_cols=235 Identities=27% Similarity=0.344 Sum_probs=190.3
Q ss_pred EEEEEecccCCccCh-HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||||++.-+.++.. +.+.+|+..|+.++||||++++..|..+..+|+||.||.+|++.+.++..-+..+++..+..++
T Consensus 53 ~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iL 132 (516)
T KOG0582|consen 53 VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATIL 132 (516)
T ss_pred EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHH
Confidence 799999998876655 8899999999999999999999999999999999999999999999988777789999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-ccee-ecccccccccchhhhhc--CCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVS-TQVMGTHGYAAPEYVAT--GRLT 156 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~-~~~~~t~~y~aPE~~~~--~~~~ 156 (305)
+++++||.|||. +|.||||||+.||||+.+|.|||+|||.+-..-..+. .... ...+||++|||||++.. .+|+
T Consensus 133 re~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd 210 (516)
T KOG0582|consen 133 REVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD 210 (516)
T ss_pred HHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCcc
Confidence 999999999994 6699999999999999999999999998765443332 2222 56689999999999655 4799
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhh-hhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.|+||||||++..||.+|+.||........-...- ...|.+. ............+..++.++..||..||
T Consensus 211 fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---------t~~~~~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 211 FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---------TSGLDKDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---------cccCChHHhhhhcHHHHHHHHHHhhcCc
Confidence 99999999999999999999998764321110000 0000000 0011112223566789999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+|||+++++++
T Consensus 282 ~kRptAskLlkh 293 (516)
T KOG0582|consen 282 SKRPTASKLLKH 293 (516)
T ss_pred ccCCCHHHHhcc
Confidence 999999999964
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=311.59 Aligned_cols=222 Identities=29% Similarity=0.398 Sum_probs=186.4
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..|+|++++... .+.+....|..+|.+++||+||+++..|.+.+.+|+|+||+.||.|..+|++.+. +++..+.-
T Consensus 52 iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arf 129 (357)
T KOG0598|consen 52 IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARF 129 (357)
T ss_pred eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHH
Confidence 578888876533 3456788999999999999999999999999999999999999999999987664 99999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.+|+.||.|||++ |||||||||+|||++.+|.++|+|||+++..-..+ ....+.+||+.|||||++.+.+|+.+
T Consensus 130 YlaEi~lAL~~LH~~--gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~ 205 (357)
T KOG0598|consen 130 YLAEIVLALGYLHSK--GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKA 205 (357)
T ss_pred HHHHHHHHHHHHHhC--CeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcc
Confidence 999999999999965 59999999999999999999999999998643332 22456899999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|.||||+++|+|++|.+||.+.+. ..+.+.+........+.-.+.+.++|++++|..||++|
T Consensus 206 vDWWsLGillYeML~G~pPF~~~~~-----------------~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 206 VDWWSLGILLYEMLTGKPPFYAEDV-----------------KKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred cchHhHHHHHHHHhhCCCCCcCccH-----------------HHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHh
Confidence 9999999999999999999987542 22223333332334445588999999999999999999
Q ss_pred C----CHHHHHH
Q 021947 239 P----RMSEVLA 246 (305)
Q Consensus 239 p----s~~~~l~ 246 (305)
. ++.+|.+
T Consensus 269 Lg~~~d~~~ik~ 280 (357)
T KOG0598|consen 269 LGGPGDAEEIKR 280 (357)
T ss_pred cCCCCChHHhhc
Confidence 6 5555553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=324.37 Aligned_cols=225 Identities=27% Similarity=0.372 Sum_probs=190.8
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.+|||++.+... ...+.+..|-++|.+| .||.|++++..|.+...+|+|+||+++|+|.++|.+.+. |++...
T Consensus 99 keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~ca 176 (604)
T KOG0592|consen 99 KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCA 176 (604)
T ss_pred ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHH
Confidence 4688998876522 2335677899999999 799999999999999999999999999999999987764 999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc---------cee--eccccccccc
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---------HVS--TQVMGTHGYA 145 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------~~~--~~~~~t~~y~ 145 (305)
..++.+|+.||+|||+ +|||||||||+|||++.+|+++|+|||.++.+...... ... ..++||..|.
T Consensus 177 R~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV 254 (604)
T KOG0592|consen 177 RFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV 254 (604)
T ss_pred HHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeeccc
Confidence 9999999999999995 56999999999999999999999999999876533221 112 4579999999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
+||++.....+..+|||+||||+|+|+.|.+||.+.++.. .+.+++. +...++.+.++.+.+
T Consensus 255 SPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl----------------iFqkI~~--l~y~fp~~fp~~a~d 316 (604)
T KOG0592|consen 255 SPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL----------------IFQKIQA--LDYEFPEGFPEDARD 316 (604)
T ss_pred CHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----------------HHHHHHH--hcccCCCCCCHHHHH
Confidence 9999999999999999999999999999999999866421 1222222 334678888999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
||+++|..||.+|+|+.+|.++
T Consensus 317 Lv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 317 LIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHccCccccccHHHHhhC
Confidence 9999999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=303.82 Aligned_cols=240 Identities=25% Similarity=0.303 Sum_probs=184.1
Q ss_pred CEEEEEecccCCc-c-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF-Q-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
++||||++..... . -.+-.++|+++|++|+|+|+|.++++|.....++||+|||+. ++.+.+.+.. ..++...+.+
T Consensus 28 qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~ 105 (396)
T KOG0593|consen 28 QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKK 105 (396)
T ss_pred cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHH
Confidence 4799999975432 2 235679999999999999999999999999999999999988 6666665543 4599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 157 (305)
++.|++.|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.... .....+..+.|.||+|||.+.| ..|+.
T Consensus 106 ~l~Q~l~ai~~cHk~--n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~ 181 (396)
T KOG0593|consen 106 YLYQLLKAIHFCHKN--NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGK 181 (396)
T ss_pred HHHHHHHHhhhhhhc--CeecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCC
Confidence 999999999999964 499999999999999999999999999998653 2334566788999999999988 58999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhccchhhhhh-------h-----hc-ccCCCCChHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRI-------M-----DT-KLGGQYPQKAAHTA 223 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-------~-----~~-~~~~~~~~~~~~~~ 223 (305)
++||||+||++.||++|.+.|.+....+.-..+ .-..+.......++.. . .. .+... -++++..+
T Consensus 182 pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k-~p~~s~~~ 260 (396)
T KOG0593|consen 182 PVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERK-YPKISNVL 260 (396)
T ss_pred cccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhh-cccchHHH
Confidence 999999999999999999999886543221110 0000000000000000 0 00 00111 13567789
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+|++.||..||++|++.++++.+
T Consensus 261 ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 261 LDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHHhcCCccccccHHHHhcC
Confidence 999999999999999999999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=315.98 Aligned_cols=250 Identities=58% Similarity=0.969 Sum_probs=209.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC-eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||++.........+|.+|++++.+++|||+++++|+|.+.+ ..+||+||+.+|+|.+++......+++|..+++|
T Consensus 100 ~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kI 179 (361)
T KOG1187|consen 100 TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKI 179 (361)
T ss_pred CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHH
Confidence 379999888765431456999999999999999999999999998 5999999999999999997655336899999999
Q ss_pred HHHHHHHHhhhhcCC-CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc-cccccccchhhhhcCCCCC
Q 021947 80 AIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV-MGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~ 157 (305)
+.++|.||+|||... ..|+|||||+.|||+|++.+.||+|||+++..... ... .... .||.+|++||++..+..+.
T Consensus 180 a~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~ 257 (361)
T KOG1187|consen 180 ALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTE 257 (361)
T ss_pred HHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCc
Confidence 999999999999743 26999999999999999999999999999765431 111 1112 7899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC-CCCCh-HHHHHHHHHHHhhccCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQ-KAAHTAATLALQCLNNEP 235 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~~~p 235 (305)
++||||||+++.|+++|+.+.+.........+..|..+.+.+. .+.++++..+. ..++. .....+..+..+|++.+|
T Consensus 258 KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~ 336 (361)
T KOG1187|consen 258 KSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDP 336 (361)
T ss_pred ccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCC
Confidence 9999999999999999999888765445555888877766655 77778887765 55554 567779999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 021947 236 KLRPRMSEVLAILERLEA 253 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~~ 253 (305)
.+||++.++++.|+.+..
T Consensus 337 ~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 337 KERPTMSQVVKELEGILS 354 (361)
T ss_pred CcCcCHHHHHHHHHhhcc
Confidence 999999999999966544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=337.95 Aligned_cols=235 Identities=32% Similarity=0.534 Sum_probs=205.0
Q ss_pred CEEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC--------C--
Q 021947 1 MVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------Q-- 69 (305)
Q Consensus 1 ~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~-- 69 (305)
+.||||.++.+... .+++|.+|++++..|+|||||+++|+|.+++.+++|+|||..|+|.+||..+++ .
T Consensus 517 ~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~ 596 (774)
T KOG1026|consen 517 QLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDT 596 (774)
T ss_pred eehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCC
Confidence 47999999988665 678999999999999999999999999999999999999999999999965432 2
Q ss_pred --CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccch
Q 021947 70 --PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 147 (305)
Q Consensus 70 --~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 147 (305)
+++..+.+.++.|||.|+.||-++. +|||||-..|+||+++..|||+|||+++..-+.+.........-..+||||
T Consensus 597 ~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp 674 (774)
T KOG1026|consen 597 PPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP 674 (774)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence 3889999999999999999999655 999999999999999999999999999987666655545445568899999
Q ss_pred hhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHH
Q 021947 148 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226 (305)
Q Consensus 148 E~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (305)
|.+..++++++|||||+|+++||+++ |..||.+. .+.+. .+.+..+.....|.+++.+++.|
T Consensus 675 EsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl----------------Sn~EV-Ie~i~~g~lL~~Pe~CP~~vY~L 737 (774)
T KOG1026|consen 675 ESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL----------------SNQEV-IECIRAGQLLSCPENCPTEVYSL 737 (774)
T ss_pred HHhhcCcccchhhhhhhhhhhhhhhccccCccccc----------------chHHH-HHHHHcCCcccCCCCCCHHHHHH
Confidence 99999999999999999999999998 99999873 33333 34444444478899999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 227 ALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
|..||+.+|.+||+++||-..|+.+...
T Consensus 738 M~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 738 MLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 9999999999999999999999887543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=311.42 Aligned_cols=230 Identities=29% Similarity=0.452 Sum_probs=186.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC--eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..|||.+........+.+.+|+++|.+++|||||+++|...... .++++|||+.||+|.+++.+.++ .+++..+..+
T Consensus 44 ~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~y 122 (313)
T KOG0198|consen 44 LMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRY 122 (313)
T ss_pred ceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHH
Confidence 46888776653333567899999999999999999999744444 68999999999999999988776 6999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCC-CCCcceeecccccccccchhhhhcC-CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATG-RLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~-~~~ 156 (305)
..|+++||+|||++ |++|+||||+|||++. ++.+||+|||++..... ...........||+.|||||++.++ ...
T Consensus 123 tr~iL~GL~ylHs~--g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~ 200 (313)
T KOG0198|consen 123 TRQILEGLAYLHSK--GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVAR 200 (313)
T ss_pred HHHHHHHHHHHHhC--CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCC
Confidence 99999999999964 5999999999999999 79999999999986553 1111223356799999999999863 334
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|||||||++.||+||..||.... .....+..+.........|..++.++++|+.+|+..||.
T Consensus 201 ~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~ 265 (313)
T KOG0198|consen 201 RESDIWSLGCTVVEMLTGKPPWSEFF---------------EEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPE 265 (313)
T ss_pred ccchhhhcCCEEEeccCCCCcchhhc---------------chHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcc
Confidence 59999999999999999999998630 111223333333334467788999999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 021947 237 LRPRMSEVLAILE 249 (305)
Q Consensus 237 ~Rps~~~~l~~l~ 249 (305)
+|||+++++++.-
T Consensus 266 ~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 266 KRPTAEELLEHPF 278 (313)
T ss_pred cCcCHHHHhhChh
Confidence 9999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=314.10 Aligned_cols=240 Identities=26% Similarity=0.318 Sum_probs=189.5
Q ss_pred EEEEEecccCCccChHH-HHHHHHHHhccC-CCCcccEEEEEEeCC-eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLH-HPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~-~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++.......+. -+||++.|++++ ||||+++.+++.+.. .+|+|||||+. +|.++++.+ +..|++..+..
T Consensus 37 ~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irn 114 (538)
T KOG0661|consen 37 LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRN 114 (538)
T ss_pred eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHH
Confidence 58999998875443332 368999999998 999999999999888 89999999965 999999888 56799999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 157 (305)
|+.||++||+|+| .+|+.||||||+|||+.....+||+|||+|+...+... .+..+.|.||+|||++.. +.|+.
T Consensus 115 im~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~ 189 (538)
T KOG0661|consen 115 IMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSS 189 (538)
T ss_pred HHHHHHHHHHHHH--hcCcccccCChhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCC
Confidence 9999999999999 46699999999999999888999999999998765443 456788999999998754 57899
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh--hhhhhhhh---hccchhhhhhhhcccCCCC-------ChHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPY---LSDKRKLFRIMDTKLGGQY-------PQKAAHTAAT 225 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 225 (305)
+.|+||+|||++|+.+-++.|.|..+.++-. ..-...|. +.....+...+........ -...+.++.+
T Consensus 190 pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~ 269 (538)
T KOG0661|consen 190 PVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAAS 269 (538)
T ss_pred chHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHH
Confidence 9999999999999999999999987643321 11111111 1111222222222211111 1247889999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l 248 (305)
||.+||.+||.+|||+.+++++.
T Consensus 270 li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 270 LIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhcCCCccCccHHHHhcCc
Confidence 99999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=315.43 Aligned_cols=223 Identities=28% Similarity=0.395 Sum_probs=185.6
Q ss_pred CEEEEEecccC----Cc-cChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPE----GF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++.....+|+|||||.||+|.+++.+.+ .+.+.
T Consensus 43 ~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~ 120 (370)
T KOG0583|consen 43 EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKED 120 (370)
T ss_pred CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChH
Confidence 36999977664 22 23456678999999999 9999999999999999999999999999999998744 48889
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-CceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.|++.|++|+|++ ||+||||||+|||++.+ +++||+|||++.... .........+||+.|+|||++.+.
T Consensus 121 ~ar~~F~Qlisav~y~H~~--gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 121 EARKYFRQLISAVAYCHSR--GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred HHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCC
Confidence 9999999999999999965 59999999999999999 999999999999763 112235567999999999999997
Q ss_pred C-CC-CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHH-HHHHHHHHHhh
Q 021947 154 R-LT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA-AHTAATLALQC 230 (305)
Q Consensus 154 ~-~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~ 230 (305)
. |+ .++||||+|+++|.|++|..||++.+.. .....+. .....+|..+ +.++..|+.+|
T Consensus 197 ~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----------------~l~~ki~--~~~~~~p~~~~S~~~~~Li~~m 258 (370)
T KOG0583|consen 197 GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----------------NLYRKIR--KGEFKIPSYLLSPEARSLIEKM 258 (370)
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----------------HHHHHHh--cCCccCCCCcCCHHHHHHHHHH
Confidence 7 86 6899999999999999999999974321 1111111 2223455556 99999999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~ 247 (305)
|..||.+|+|+.+++++
T Consensus 259 L~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 259 LVPDPSTRITLLEILEH 275 (370)
T ss_pred cCCCcccCCCHHHHhhC
Confidence 99999999999999953
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=318.61 Aligned_cols=223 Identities=28% Similarity=0.422 Sum_probs=190.4
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.+|||++..... .....+.+|+-+|+-+.||||+.+|+++++..++|+|.||++||.|++++.++++ +.+..+.
T Consensus 38 qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa 115 (786)
T KOG0588|consen 38 QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAA 115 (786)
T ss_pred ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC--CCCHHHH
Confidence 4689999976522 2235678999999999999999999999999999999999999999999987764 8999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC-
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT- 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~- 156 (305)
+++.||+.|+.|+|..+ |+||||||+|+|++..+++||+|||+|.....+ ....+-||++.|.+||++.|.+|+
T Consensus 116 ~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG 190 (786)
T KOG0588|consen 116 HFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDG 190 (786)
T ss_pred HHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCCC
Confidence 99999999999999655 999999999999999999999999999864432 235567999999999999999885
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++||||-|+|||.|++|+.||++.+. ..++.-+. .....+|..++.++++||.+||..||.
T Consensus 191 ~~sDVWSCGVILfALLtG~LPFdDdNi-----------------r~LLlKV~-~G~f~MPs~Is~eaQdLLr~ml~VDp~ 252 (786)
T KOG0588|consen 191 RPSDVWSCGVILFALLTGKLPFDDDNI-----------------RVLLLKVQ-RGVFEMPSNISSEAQDLLRRMLDVDPS 252 (786)
T ss_pred CccccchhHHHHHHHHhCCCCCCCccH-----------------HHHHHHHH-cCcccCCCcCCHHHHHHHHHHhccCcc
Confidence 699999999999999999999996432 11222111 123456789999999999999999999
Q ss_pred CCCCHHHHHHHH
Q 021947 237 LRPRMSEVLAIL 248 (305)
Q Consensus 237 ~Rps~~~~l~~l 248 (305)
+|.|.++|+++.
T Consensus 253 ~RiT~~eI~kHP 264 (786)
T KOG0588|consen 253 TRITTEEILKHP 264 (786)
T ss_pred ccccHHHHhhCc
Confidence 999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=304.55 Aligned_cols=227 Identities=20% Similarity=0.316 Sum_probs=185.9
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++...... .+.+.+|+.+|++++||||+++++++.+ ....++||||++||+|.+++.... .+++.
T Consensus 45 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~ 122 (283)
T PHA02988 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFK 122 (283)
T ss_pred EEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChh
Confidence 68999998654333 3667899999999999999999999876 346789999999999999996543 48889
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc--
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-- 152 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-- 152 (305)
....++.+++.||.|||+. .+++||||||+||+++.++.+||+|||+++...... ....++..|+|||++.+
T Consensus 123 ~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 196 (283)
T PHA02988 123 TKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIF 196 (283)
T ss_pred HHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhcc
Confidence 9999999999999999963 358899999999999999999999999998643321 23457899999999976
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
..++.++|||||||++|+|++|..||.+.+.. ...............+..++..+.+|+.+||+
T Consensus 197 ~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 197 SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred ccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 68899999999999999999999999864321 11111112223334455688899999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhc
Q 021947 233 NEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~~~~ 252 (305)
.||.+|||+.++++.|+.+.
T Consensus 261 ~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 261 HDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcccCcCHHHHHHHHHHHH
Confidence 99999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=282.81 Aligned_cols=242 Identities=27% Similarity=0.313 Sum_probs=190.6
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||+++.....+ ....+||++.|+.++|+||+.++++|...+.+.||+||++. +|+..++... ..++...+..
T Consensus 28 ~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~-i~l~pa~iK~ 105 (318)
T KOG0659|consen 28 KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKN-IILSPADIKS 105 (318)
T ss_pred cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccc-cccCHHHHHH
Confidence 369999998764433 24678999999999999999999999999999999999975 9999886554 5699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
++.++++||+|||++. |+||||||+|+|++.+|.+||+|||+++.++...... ...+-|.+|+|||.+.|. .|+.
T Consensus 106 y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~ 181 (318)
T KOG0659|consen 106 YMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGT 181 (318)
T ss_pred HHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccchhcCC
Confidence 9999999999999654 9999999999999999999999999999887655432 233779999999998876 6999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhhc---cchhhhhhhhcc-----cCCCCChHHHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLS---DKRKLFRIMDTK-----LGGQYPQKAAHTAATLA 227 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 227 (305)
.+|+||.|||+.||+.|.+-|.+......- .+.....|... +...+-+++.-. .....-..+++++.+|+
T Consensus 182 ~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl 261 (318)
T KOG0659|consen 182 GVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLL 261 (318)
T ss_pred cchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHH
Confidence 999999999999999998888776543221 22222222222 222222222211 11112235677889999
Q ss_pred HhhccCCCCCCCCHHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l 248 (305)
.+||..||.+|+++.+++++-
T Consensus 262 ~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 262 SKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HhhhccCchhcccHHHHhcch
Confidence 999999999999999999764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=325.39 Aligned_cols=234 Identities=23% Similarity=0.293 Sum_probs=195.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEE-EEEe----C--CeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIG-YCLE----G--ENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~-~~~~----~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
+.+|+|++-..+......+.+|+++|++|+ |+|||.++| .... + -.++|+||||.||.|.+++..+....|+
T Consensus 63 ~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lt 142 (738)
T KOG1989|consen 63 KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLT 142 (738)
T ss_pred ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCC
Confidence 368999887766667788999999999997 999999999 3221 1 2467999999999999999876666699
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-----e--eeccccccccc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-----V--STQVMGTHGYA 145 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----~--~~~~~~t~~y~ 145 (305)
+.++++|+.++++|+++||.....|||||||.+||||+.+|..||||||.++..-...... . .....-|+.|+
T Consensus 143 e~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YR 222 (738)
T KOG1989|consen 143 EDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYR 222 (738)
T ss_pred hHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcccc
Confidence 9999999999999999999998899999999999999999999999999997543222110 0 11224689999
Q ss_pred chhhh---hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHH
Q 021947 146 APEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 222 (305)
Q Consensus 146 aPE~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (305)
+||++ .+.+++.|+|||||||+||.||+...||++.. -..+++..+..+..+.+++.
T Consensus 223 sPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------------~laIlng~Y~~P~~p~ys~~ 282 (738)
T KOG1989|consen 223 SPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------------KLAILNGNYSFPPFPNYSDR 282 (738)
T ss_pred ChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------------ceeEEeccccCCCCccHHHH
Confidence 99976 56789999999999999999999999998752 24566667766666789999
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+.+||+.||..||.+||++-++++.+.++...
T Consensus 283 l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 283 LKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred HHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 99999999999999999999999988876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=304.90 Aligned_cols=242 Identities=25% Similarity=0.264 Sum_probs=187.7
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.+||+|++..+.. ....-..+|+.+|++|+||||+++.++..+. +.+|||+|||++ +|..++... ...|++.++
T Consensus 143 kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qI 220 (560)
T KOG0600|consen 143 KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQI 220 (560)
T ss_pred cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCC-CcccChHHH
Confidence 4799999987753 3345678999999999999999999998876 789999999987 999988544 345999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL 155 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~ 155 (305)
..++.||+.||+|+|+ +||+|||||..||||+++|.+||+|||+|+.+....... .+..+-|.||+|||++.|. .|
T Consensus 221 Kc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Y 297 (560)
T KOG0600|consen 221 KCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSY 297 (560)
T ss_pred HHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCccc
Confidence 9999999999999995 569999999999999999999999999999765544332 4556789999999999886 79
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhhcc--chhhhhhhhcccCCCCC-------hHHHHHHH
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSD--KRKLFRIMDTKLGGQYP-------QKAAHTAA 224 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-------~~~~~~~~ 224 (305)
+.++|+||.||||.||++|++.|++.++.... .+--...|..+. ...+...........+. ...+....
T Consensus 298 g~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l 377 (560)
T KOG0600|consen 298 GTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASAL 377 (560)
T ss_pred ccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHH
Confidence 99999999999999999999999998764322 111111111100 11111100111111111 24566788
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+|+..+|..||.+|.|+.+++..
T Consensus 378 ~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 378 DLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HHHHHHhccCccccccHHHHhcC
Confidence 99999999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=309.22 Aligned_cols=233 Identities=30% Similarity=0.437 Sum_probs=184.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcC-----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRG----------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----------- 67 (305)
.||||+++.... .....+.+|+.++.++ +||||+++++++... +.+++||||+++|+|.+++....
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~ 118 (338)
T cd05102 39 TVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSP 118 (338)
T ss_pred hhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccch
Confidence 589999875432 2345789999999999 899999999988754 45789999999999999986432
Q ss_pred -------------------------------------------------CCCCCHHHHHHHHHHHHHHHhhhhcCCCcee
Q 021947 68 -------------------------------------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98 (305)
Q Consensus 68 -------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 98 (305)
...+++..+..++.|++.||+|||+ +||+
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~iv 196 (338)
T cd05102 119 KQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCI 196 (338)
T ss_pred hhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEE
Confidence 1247788889999999999999996 4599
Q ss_pred eccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCc
Q 021947 99 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 177 (305)
Q Consensus 99 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p 177 (305)
||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 HrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~p 276 (338)
T cd05102 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276 (338)
T ss_pred CCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986533222222223345678999999999999999999999999999997 9999
Q ss_pred cCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 178 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
|.+..... .+...+........+..++..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus 277 f~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 277 YPGVQINE----------------EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CCCCCccH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 97643211 111112222223345567788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=300.53 Aligned_cols=221 Identities=24% Similarity=0.366 Sum_probs=189.1
Q ss_pred CEEEEEecccCCccChH---HHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHK---EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~---~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
|+||||.++.+...+.+ .+.+|+++|..|+||||+.+|++|++.+.+.|||||..+|.|.+|+.+++. +++....
T Consensus 79 R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaR 156 (668)
T KOG0611|consen 79 REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS--LSEREAR 156 (668)
T ss_pred cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHH
Confidence 68999999887665554 568899999999999999999999999999999999999999999987764 9999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~ 156 (305)
.++.||+.|+.|+| +++++|||||.+|||++.++++||+|||++..+.... ...++||++-|.+||++.|.+| +
T Consensus 157 hfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~G 231 (668)
T KOG0611|consen 157 HFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKG 231 (668)
T ss_pred HHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCC
Confidence 99999999999999 5679999999999999999999999999998765432 3567899999999999999887 5
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+.+|.||||+++|.|+.|.+||++.+. +.-+.++-...+ ..+..+..+.-||+.||..||+
T Consensus 232 PEVDsWsLGvLLYtLVyGtMPFDG~Dh----------------k~lvrQIs~GaY---rEP~~PSdA~gLIRwmLmVNP~ 292 (668)
T KOG0611|consen 232 PEVDSWSLGVLLYTLVYGTMPFDGRDH----------------KRLVRQISRGAY---REPETPSDASGLIRWMLMVNPE 292 (668)
T ss_pred CccchhhHHHHHHHHhhcccccCCchH----------------HHHHHHhhcccc---cCCCCCchHHHHHHHHHhcCcc
Confidence 689999999999999999999998653 111222222222 1234456778899999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|.|+.+|..+
T Consensus 293 RRATieDiAsH 303 (668)
T KOG0611|consen 293 RRATIEDIASH 303 (668)
T ss_pred cchhHHHHhhh
Confidence 99999999976
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=306.64 Aligned_cols=225 Identities=26% Similarity=0.384 Sum_probs=196.5
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCe-eEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.+++|++.-....+ +....+|+.+++++.|||||.+.+.|.+++. .+|||+||+||+|.+.|.+..+..++++.+..
T Consensus 31 ~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~ 110 (426)
T KOG0589|consen 31 LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILK 110 (426)
T ss_pred eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHH
Confidence 57899887664433 3568899999999999999999999998888 89999999999999999888777899999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
|+.|++.|+.|||+ ++|+|||||+.||+++.++.|||+|||+++..+.... .....+||+.|+.||++.+.+|+.+
T Consensus 111 ~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~K 186 (426)
T KOG0589|consen 111 WFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEK 186 (426)
T ss_pred HHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCcc
Confidence 99999999999994 5599999999999999999999999999998765531 3456789999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|||||||++|||++-+++|...+. ..+..-+......+.+..++.+++.||+.||..+|..|
T Consensus 187 SDiWsLGC~~yEm~~lk~aF~a~~m-----------------~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~R 249 (426)
T KOG0589|consen 187 SDIWSLGCCLYEMCTLKPAFKASNM-----------------SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHR 249 (426)
T ss_pred CcchhhcchHHHHHhcccccCccch-----------------HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccC
Confidence 9999999999999999999987542 22223333344567788999999999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
|++.+++..
T Consensus 250 Psa~~LL~~ 258 (426)
T KOG0589|consen 250 PSALELLRR 258 (426)
T ss_pred CCHHHHhhC
Confidence 999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=286.03 Aligned_cols=211 Identities=27% Similarity=0.377 Sum_probs=182.1
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
-.|+|+++.... ...+...+|-.+|+.+.||+++++++.+.+.+.+||||||+.||.|..++++.++ +++..+.-
T Consensus 71 yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arF 148 (355)
T KOG0616|consen 71 YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARF 148 (355)
T ss_pred eeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHH
Confidence 368888876532 3345678899999999999999999999999999999999999999999977654 99999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.+|+.||+|||+.+ |++|||||+|||++.+|.+||+|||+|+..... ..+.|||+.|+|||++...+++.+
T Consensus 149 YAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynka 221 (355)
T KOG0616|consen 149 YAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKA 221 (355)
T ss_pred HHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcc
Confidence 9999999999999654 999999999999999999999999999875432 556799999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|.||||+++|||+.|.+||...+. .....+++.. ...+|.-.+.++++|++++|+.|-.+|
T Consensus 222 vDWWalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~~~--~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 222 VDWWALGVLIYEMLAGYPPFYDDNP----------------IQIYEKILEG--KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hhHHHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHHhC--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 9999999999999999999987543 1122233333 346788899999999999999999999
Q ss_pred C
Q 021947 239 P 239 (305)
Q Consensus 239 p 239 (305)
.
T Consensus 284 ~ 284 (355)
T KOG0616|consen 284 F 284 (355)
T ss_pred h
Confidence 3
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=307.83 Aligned_cols=222 Identities=30% Similarity=0.386 Sum_probs=190.3
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.+||+|.+.+....+ .+.+.+|++++++++||||+.++++|+...++|+|+|||.| +|..++...+. ++++.+..
T Consensus 28 ~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~ 104 (808)
T KOG0597|consen 28 QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRA 104 (808)
T ss_pred eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC--CCHHHHHH
Confidence 379999987654433 45689999999999999999999999999999999999987 99999977664 99999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.+++.||.|||+. +|.|||+||.|||+..+|.+|+||||+++.... ++.+.....||+.|||||++.+++|+..
T Consensus 105 ~a~~LVsaL~yLhs~--rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~ 180 (808)
T KOG0597|consen 105 IAYDLVSALYYLHSN--RILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHT 180 (808)
T ss_pred HHHHHHHHHHHHHhc--CcccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccch
Confidence 999999999999964 599999999999999999999999999998654 3455677889999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||||+||+++|++||-.... ..+.+.+ .......|...+..+..|+..+|.+||.+|
T Consensus 181 sDlWslGcilYE~~~G~PPF~a~si-----------------~~Lv~~I-~~d~v~~p~~~S~~f~nfl~gLL~kdP~~R 242 (808)
T KOG0597|consen 181 SDLWSLGCILYELYVGQPPFYARSI-----------------TQLVKSI-LKDPVKPPSTASSSFVNFLQGLLIKDPAQR 242 (808)
T ss_pred hhHHHHHHHHHHHhcCCCCchHHHH-----------------HHHHHHH-hcCCCCCcccccHHHHHHHHHHhhcChhhc
Confidence 9999999999999999999975321 0111111 112345567899999999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
.|+.+++.+
T Consensus 243 ltW~~Ll~H 251 (808)
T KOG0597|consen 243 LTWTDLLGH 251 (808)
T ss_pred ccHHHHhcC
Confidence 999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=286.45 Aligned_cols=242 Identities=24% Similarity=0.275 Sum_probs=188.1
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.+||+|+++.+.... .-.-++|+.+|.+.+|||||.+-.+...+ +.+|+|||||+. +|..++..-+ .++....+
T Consensus 102 eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~ev 179 (419)
T KOG0663|consen 102 EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEV 179 (419)
T ss_pred eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHH
Confidence 379999998764322 24568999999999999999999988754 568999999987 9999986544 67999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL 155 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~ 155 (305)
..+..|+++|++|||. +.|+|||||++|+|+++.|.+||+|||+|+.+++.... .+..+-|.||+|||++.+. .|
T Consensus 180 K~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~ty 255 (419)
T KOG0663|consen 180 KTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTY 255 (419)
T ss_pred HHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCccc
Confidence 9999999999999995 56999999999999999999999999999988765332 4456779999999998886 69
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccch--hhhhhhhhhhhcc-----------chhhhhhhhcccCCCCChH-HHH
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE--QSLVDWAKPYLSD-----------KRKLFRIMDTKLGGQYPQK-AAH 221 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~-~~~ 221 (305)
+++.|+||+|||+.||+++.+.|.+..+..+ ..+.....|.-.. ...........++..++.. .++
T Consensus 256 st~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse 335 (419)
T KOG0663|consen 256 STAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSE 335 (419)
T ss_pred CcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccch
Confidence 9999999999999999999999998765432 2222221111110 0111111111222222222 668
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 222 TAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 222 ~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
...+|+..+|..||.+|.|+++.|++=
T Consensus 336 ~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 336 QGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred hHHHHHHHHhccCccccccHHHhhccc
Confidence 899999999999999999999999753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=309.77 Aligned_cols=219 Identities=29% Similarity=0.475 Sum_probs=187.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
-||||+++.-. ..+++-|++|+|+||+.+.|+|...--++||||||..|-|...|+... .+.......|..
T Consensus 149 tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk 219 (904)
T KOG4721|consen 149 TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSK 219 (904)
T ss_pred eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHH
Confidence 47888876432 247889999999999999999999888999999999999999996544 488889999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+|+.|+.|||.++ |||||||.-||||+.+..|||+|||-++..... .....+.||..|||||++++.+.+.|+||
T Consensus 220 ~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDI 294 (904)
T KOG4721|consen 220 GIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDI 294 (904)
T ss_pred HhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccce
Confidence 9999999999876 999999999999999999999999999865443 22445789999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
||||++||||+||..||.+-+. ...++-.-...+....|..+++-+.-||++||+..|..||++
T Consensus 295 wSfGVVLWEmLT~EiPYkdVds----------------sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSF 358 (904)
T KOG4721|consen 295 WSFGVVLWEMLTGEIPYKDVDS----------------SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSF 358 (904)
T ss_pred ehhHHHHHHHHhcCCCccccch----------------heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccH
Confidence 9999999999999999976432 112222233445567788999999999999999999999999
Q ss_pred HHHHHHHHh
Q 021947 242 SEVLAILER 250 (305)
Q Consensus 242 ~~~l~~l~~ 250 (305)
.+++.+|+-
T Consensus 359 rqil~HldI 367 (904)
T KOG4721|consen 359 RQILLHLDI 367 (904)
T ss_pred HHHHHHHhh
Confidence 999988754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=326.53 Aligned_cols=232 Identities=31% Similarity=0.447 Sum_probs=198.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-----CCCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----PQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~ 75 (305)
.||||.++.... .+..+|++|+.+|++++||||++++|++.+.+..++++|||+||+|..||++.. ...++...
T Consensus 724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~d 803 (1025)
T KOG1095|consen 724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRD 803 (1025)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHH
Confidence 599999987633 445789999999999999999999999999999999999999999999996651 34589999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
.+.++.+||.|+.||++++ +|||||...|+|++....|||+|||+|+.+.....+.......-...|||||.+..+.+
T Consensus 804 Ll~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF 881 (1025)
T KOG1095|consen 804 LLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF 881 (1025)
T ss_pred HHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccc
Confidence 9999999999999999754 99999999999999999999999999996544443333333344678999999999999
Q ss_pred CCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 156 TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
+.++||||||+++||+++ |..||.+.. +..+...+..+.+.+.|..+++.+.++|.+||+.+
T Consensus 882 tskSDvWsFGVllWEifslG~~PY~~~~-----------------n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~ 944 (1025)
T KOG1095|consen 882 TSKSDVWSFGVLLWEIFSLGATPYPSRS-----------------NFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHD 944 (1025)
T ss_pred ccccchhhhHHHHHHHHhCCCCCCCCcc-----------------hHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCC
Confidence 999999999999999999 999998753 22333333333378889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 021947 235 PKLRPRMSEVLAILERLE 252 (305)
Q Consensus 235 p~~Rps~~~~l~~l~~~~ 252 (305)
|++||++..|++.+..+.
T Consensus 945 pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 945 PEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hhhCccHHHHHhhhhhhh
Confidence 999999999999877754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=301.69 Aligned_cols=223 Identities=28% Similarity=0.369 Sum_probs=182.6
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||+++.... .....+.+|++++++++||||+++++++..++..|+||||+.|++|.+++.... .+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 98 (323)
T cd05571 21 KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRAR 98 (323)
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 3689999875422 233567889999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.
T Consensus 99 ~~~~qi~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05571 99 FYGAEIVSALGYLHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred HHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCc
Confidence 9999999999999964 599999999999999999999999999875322211 123457899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||...+... +...+.. ....++..++.++.+||.+||..||++
T Consensus 175 ~~DiwSlG~il~elltg~~Pf~~~~~~~-----------------~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELILM-EEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred cccCcccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999997643211 1111111 122345667889999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|| ++.+++++
T Consensus 237 R~~~~~~~~~~ll~h 251 (323)
T cd05571 237 RLGGGPEDAKEIMEH 251 (323)
T ss_pred cCCCCCCCHHHHHcC
Confidence 99 78898864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=302.26 Aligned_cols=224 Identities=26% Similarity=0.383 Sum_probs=190.2
Q ss_pred CEEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||+|++..+...+ .+++.+|+.+|.+++++||.++|+.+..+..+|++||||.||++.++++... .+.+..+..+
T Consensus 39 k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~i 116 (467)
T KOG0201|consen 39 KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVI 116 (467)
T ss_pred ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC--CCccceeeee
Confidence 479999998775544 4788999999999999999999999999999999999999999999996544 3578888889
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+++.||.|||+++ .+|||||+.|||+..+|.+||+|||.+-........ ...++||+.|||||++.+..|+.++
T Consensus 117 lre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KA 192 (467)
T KOG0201|consen 117 LREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKA 192 (467)
T ss_pred hHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchh
Confidence 999999999999655 999999999999999999999999999765543332 3677999999999999988999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++.+||++|.+|+.+... ....-.+.+.....+...++..+++|+..||+.||+.||
T Consensus 193 DIWSLGITaiEla~GePP~s~~hP-----------------mrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~Rp 255 (467)
T KOG0201|consen 193 DIWSLGITAIELAKGEPPHSKLHP-----------------MRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRP 255 (467)
T ss_pred hhhhhhHHHHHHhcCCCCCcccCc-----------------ceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCc
Confidence 999999999999999999987543 111222233333344457888999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.+++++
T Consensus 256 sA~~LLKh 263 (467)
T KOG0201|consen 256 SAKELLKH 263 (467)
T ss_pred CHHHHhhh
Confidence 99999964
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=304.75 Aligned_cols=231 Identities=25% Similarity=0.406 Sum_probs=189.3
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
-||||+++.+.... .+.|++|+.+|++-+|.||+-+.|++..... .||+-+|+|.+|+.+++-.. ..|.+...+.|
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idI 493 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDI 493 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHH
Confidence 39999999875544 3689999999999999999999999987766 99999999999999996555 34999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC---CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~ 156 (305)
+.|+++|+.|||.++ |||+|||..||++.++++|||+|||++.....-..........|...|||||+++.. +|+
T Consensus 494 AqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS 571 (678)
T KOG0193|consen 494 AQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS 571 (678)
T ss_pred HHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC
Confidence 999999999999755 999999999999999999999999999764433222223445688899999998753 789
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc----CCCCChHHHHHHHHHHHhhcc
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~ 232 (305)
..+||||||+++|||++|..||...+. +++.-.+..++ ......+++.++.+|+..||.
T Consensus 572 ~qSDVYaFGiV~YELltg~lPysi~~~-----------------dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~ 634 (678)
T KOG0193|consen 572 FQSDVYAFGIVWYELLTGELPYSIQNR-----------------DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWK 634 (678)
T ss_pred cccchhhhhHHHHHHHhCcCCcCCCCh-----------------hheEEEecccccCccchhhhccCHHHHHHHHHHHHh
Confidence 999999999999999999999984332 11111122221 112234788899999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcC
Q 021947 233 NEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.++++||.+.+|+..|+.+..
T Consensus 635 ~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 635 FDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCcccCccHHHHHHHHHHhhh
Confidence 999999999999998887755
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=292.99 Aligned_cols=230 Identities=28% Similarity=0.513 Sum_probs=188.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------ 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------ 68 (305)
.||+|.++.... .....+.+|++++.+++||||+++++++...+..+++|||+++++|.+++.....
T Consensus 37 ~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (283)
T cd05048 37 SVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116 (283)
T ss_pred eEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccccccc
Confidence 589998875533 2335689999999999999999999999988899999999999999999965422
Q ss_pred --CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccc
Q 021947 69 --QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 146 (305)
Q Consensus 69 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 146 (305)
..+++..++.++.|++.||+|||+ ++++|+||||+||++++++.++|+|||++................++..|+|
T Consensus 117 ~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05048 117 VKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMP 194 (283)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccC
Confidence 347888999999999999999996 4599999999999999999999999999976543322222334456788999
Q ss_pred hhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 147 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 147 PE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
||.+.+..++.++|+|||||++|+|++ |..||.+... ..+...+........+..++.++.+
T Consensus 195 PE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~ 257 (283)
T cd05048 195 PEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----------------QEVIEMIRSRQLLPCPEDCPARVYA 257 (283)
T ss_pred HHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCcCCCcccCCHHHHH
Confidence 999988899999999999999999998 9999976432 1122222233333456678899999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHh
Q 021947 226 LALQCLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l~~ 250 (305)
|+.+||+.||.+||++.++++.|+.
T Consensus 258 l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 258 LMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHccCChhhCcCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=289.81 Aligned_cols=228 Identities=27% Similarity=0.351 Sum_probs=195.9
Q ss_pred EEEEEecccCCccCh---HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..|+|++..+....+ .++..|-+||..+.||.++.+|..|+.....|+|||||.||+|..+++++....+++..+.-
T Consensus 104 ~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRF 183 (459)
T KOG0610|consen 104 LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARF 183 (459)
T ss_pred eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHH
Confidence 579999987755444 45677999999999999999999999999999999999999999999999888999999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCC-----------------------------
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG----------------------------- 129 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----------------------------- 129 (305)
++.+++.||+|||. .|||+|||||+||||.++|.+.|+||+++......
T Consensus 184 YaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r 261 (459)
T KOG0610|consen 184 YAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPR 261 (459)
T ss_pred HHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccc
Confidence 99999999999995 45999999999999999999999999987532110
Q ss_pred ---CCc----------------------ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCccc
Q 021947 130 ---DRT----------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 184 (305)
Q Consensus 130 ---~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 184 (305)
... ......+||-.|.|||++.|...+.++|.|+||+++|||+.|..||.+.+
T Consensus 262 ~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~-- 339 (459)
T KOG0610|consen 262 CLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN-- 339 (459)
T ss_pred hhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC--
Confidence 000 01223579999999999999999999999999999999999999999854
Q ss_pred chhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC----HHHHHHH
Q 021947 185 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLAI 247 (305)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~ 247 (305)
..+.+.+++......+....++..+++||+++|.+||.+|.. +.||.++
T Consensus 340 --------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 340 --------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred --------------chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 556677777777766666789999999999999999999997 7777653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=287.70 Aligned_cols=242 Identities=27% Similarity=0.298 Sum_probs=185.7
Q ss_pred EEEEEecccC--CccChHHHHHHHHHHhccCCCCcccEEEEEEe-----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPE--GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||++... .....++..+|+++|++++|+||+.+++++.. -+..|+|+|+| +.+|...++.+. .++..
T Consensus 49 ~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~ 125 (359)
T KOG0660|consen 49 KVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDD 125 (359)
T ss_pred EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc--cccHH
Confidence 6999999844 33445788999999999999999999999875 35679999999 559999886554 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-C
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
.+..++.|++.||+|+||.+ ++||||||.|++++.+..+||+|||+|+...........+..+.|.+|.|||++.. .
T Consensus 126 H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~ 203 (359)
T KOG0660|consen 126 HAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSS 203 (359)
T ss_pred HHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccc
Confidence 99999999999999999755 99999999999999999999999999998754322333356678999999997754 5
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhc-------cchhhhhhhhcc---cCCCC---ChHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-------DKRKLFRIMDTK---LGGQY---PQKAA 220 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~---~~~~~---~~~~~ 220 (305)
.|+.+.||||+|||+.||++|++.|.|.+.-..-..+...-+... ........+... ...++ -++.+
T Consensus 204 ~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~ 283 (359)
T KOG0660|consen 204 EYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN 283 (359)
T ss_pred cccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC
Confidence 899999999999999999999999999876433222111111100 000111111111 11111 12677
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
..+.+|+.+||..||.+|+|++|++++.
T Consensus 284 p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 284 PLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 7899999999999999999999999753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=304.69 Aligned_cols=231 Identities=29% Similarity=0.452 Sum_probs=184.8
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||||+++... ....+.+.+|++++..+ +||||+++++++..++..++||||++||+|.+++....
T Consensus 67 ~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~ 146 (375)
T cd05104 67 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHA 146 (375)
T ss_pred eEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchh
Confidence 68999997543 23346788999999999 89999999999999999999999999999999986432
Q ss_pred -------------------------------------------------------------CCCCCHHHHHHHHHHHHHH
Q 021947 68 -------------------------------------------------------------PQPLSWAVRMKVAIGAAKG 86 (305)
Q Consensus 68 -------------------------------------------------------------~~~~~~~~~~~~~~~i~~~ 86 (305)
...+++..+..++.|++.|
T Consensus 147 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~ 226 (375)
T cd05104 147 EAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKG 226 (375)
T ss_pred hhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence 1246788899999999999
Q ss_pred HhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhH
Q 021947 87 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 166 (305)
Q Consensus 87 l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 166 (305)
|.|||+. +++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+
T Consensus 227 l~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~ 304 (375)
T cd05104 227 MSFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 304 (375)
T ss_pred HHHHHHC--CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHH
Confidence 9999964 59999999999999999999999999998654433222222234567899999999999999999999999
Q ss_pred HHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 021947 167 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245 (305)
Q Consensus 167 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 245 (305)
++|+|++ |..||...... ....+.+........+...+.++.+|+.+||+.||++|||+.+++
T Consensus 305 ~l~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 368 (375)
T cd05104 305 LLWEIFSLGSSPYPGMPVD----------------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368 (375)
T ss_pred HHHHHHhcCCCCCCCCCch----------------HHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 9999998 88998764321 111222222222233445577899999999999999999999999
Q ss_pred HHHHh
Q 021947 246 AILER 250 (305)
Q Consensus 246 ~~l~~ 250 (305)
+.|++
T Consensus 369 ~~l~~ 373 (375)
T cd05104 369 QLIEQ 373 (375)
T ss_pred HHHHh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=313.17 Aligned_cols=226 Identities=23% Similarity=0.282 Sum_probs=184.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ 79 (305)
.||+|.+..........+.+|+.+|+.++||||+++++++..++..|+||||++||+|.+++... ...++++..+..+
T Consensus 95 ~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i 174 (478)
T PTZ00267 95 KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174 (478)
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHH
Confidence 57888776554444456788999999999999999999999999999999999999999988542 2345889999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.++
T Consensus 175 ~~qi~~aL~~lH~~--~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 252 (478)
T PTZ00267 175 FYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA 252 (478)
T ss_pred HHHHHHHHHHHHhC--CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHH
Confidence 99999999999964 5999999999999999999999999999875443322234455799999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||||++|+|++|..||.+.... .+...+........+..++..+.+||.+||..||++||
T Consensus 253 Dv~slG~~l~el~tg~~Pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 315 (478)
T PTZ00267 253 DMWSLGVILYELLTLHRPFKGPSQR-----------------EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRP 315 (478)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCc
Confidence 9999999999999999999764321 11111111122234456778899999999999999999
Q ss_pred CHHHHHH
Q 021947 240 RMSEVLA 246 (305)
Q Consensus 240 s~~~~l~ 246 (305)
++.+++.
T Consensus 316 s~~~~l~ 322 (478)
T PTZ00267 316 TTQQLLH 322 (478)
T ss_pred CHHHHHh
Confidence 9999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=304.38 Aligned_cols=232 Identities=29% Similarity=0.456 Sum_probs=185.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||||+++.... .....+.+|+++++.+ +|+||+++++.+..++..++||||+.+|+|.+++....
T Consensus 70 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 149 (374)
T cd05106 70 RVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPE 149 (374)
T ss_pred eeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccc
Confidence 589999976532 2345788999999999 89999999999999999999999999999999985421
Q ss_pred --------------------------------------------------------CCCCCHHHHHHHHHHHHHHHhhhh
Q 021947 68 --------------------------------------------------------PQPLSWAVRMKVAIGAAKGLTFLH 91 (305)
Q Consensus 68 --------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH 91 (305)
...+++..+..++.|++.||.|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH 229 (374)
T cd05106 150 ISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA 229 (374)
T ss_pred cccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 124778889999999999999999
Q ss_pred cCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHH
Q 021947 92 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171 (305)
Q Consensus 92 ~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 171 (305)
+ +|++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|
T Consensus 230 ~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el 307 (374)
T cd05106 230 S--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307 (374)
T ss_pred H--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHH
Confidence 6 45999999999999999999999999999765433222122223356789999999888999999999999999999
Q ss_pred Hh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 021947 172 LS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 172 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 250 (305)
++ |..||...... ...............+..++.++.+++.+||+.||.+|||+.++++.|++
T Consensus 308 lt~G~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 308 FSLGKSPYPGILVN----------------SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HhCCCCCCcccccc----------------HHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 97 99999764321 11122222222333344567889999999999999999999999999987
Q ss_pred h
Q 021947 251 L 251 (305)
Q Consensus 251 ~ 251 (305)
+
T Consensus 372 ~ 372 (374)
T cd05106 372 Q 372 (374)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=294.27 Aligned_cols=228 Identities=27% Similarity=0.352 Sum_probs=182.2
Q ss_pred CEEEEEecccCCc--------------cChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhh
Q 021947 1 MVVAVKKLKPEGF--------------QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLF 64 (305)
Q Consensus 1 ~~VaiK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~ 64 (305)
..||||++..... ...+...+|+.+|+++.|||||+++++..+ ...+|||+|||..|.+..--
T Consensus 123 ~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p- 201 (576)
T KOG0585|consen 123 KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP- 201 (576)
T ss_pred cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-
Confidence 3699999864311 122578899999999999999999999874 46789999999988775422
Q ss_pred hcCCCC-CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC---cceeecccc
Q 021947 65 RRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR---THVSTQVMG 140 (305)
Q Consensus 65 ~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~ 140 (305)
...+ +++.++.+++.+++.||+|||.++ ||||||||+|+|++.+|.|||+|||.+........ .......+|
T Consensus 202 --~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvG 277 (576)
T KOG0585|consen 202 --PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVG 277 (576)
T ss_pred --CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCC
Confidence 2233 899999999999999999999755 99999999999999999999999999986532211 111223689
Q ss_pred cccccchhhhhcCC----CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC
Q 021947 141 THGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 216 (305)
Q Consensus 141 t~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (305)
|+.|+|||.+.++. .+.+.||||+|++||.|+.|+.||.+... .....++++..+..+..
T Consensus 278 TPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----------------~~l~~KIvn~pL~fP~~ 341 (576)
T KOG0585|consen 278 TPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----------------LELFDKIVNDPLEFPEN 341 (576)
T ss_pred CccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----------------HHHHHHHhcCcccCCCc
Confidence 99999999987743 35689999999999999999999987432 22234555555655555
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
+.+...+.+||++||.+||++|.++.+|..+..
T Consensus 342 pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 342 PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 678999999999999999999999999987753
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=292.29 Aligned_cols=234 Identities=28% Similarity=0.475 Sum_probs=190.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-------------
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------- 68 (305)
.|++|.++.......+.+.+|++++++++|+||+++++++..+...++||||+.+++|.+++.....
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (291)
T cd05094 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116 (291)
T ss_pred eeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccC
Confidence 4788888766555557899999999999999999999999999999999999999999999965431
Q ss_pred -CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccch
Q 021947 69 -QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 147 (305)
Q Consensus 69 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 147 (305)
..+++..++.++.+++.||+|||+ ++++||||||+||+++.++.++|+|||++................++..|+||
T Consensus 117 ~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 117 KGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 247889999999999999999995 45999999999999999999999999999765433222222334567889999
Q ss_pred hhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHH
Q 021947 148 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226 (305)
Q Consensus 148 E~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (305)
|++.+..++.++||||||+++|+|++ |..||....... ..+..........+..++..+.++
T Consensus 195 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l 257 (291)
T cd05094 195 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----------------VIECITQGRVLERPRVCPKEVYDI 257 (291)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhCCCCCCCCccCCHHHHHH
Confidence 99999999999999999999999998 999987643210 111112222222344567889999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 227 ALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+.+||+.+|.+|||+.++++.|+++...
T Consensus 258 i~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 258 MLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=292.38 Aligned_cols=228 Identities=26% Similarity=0.376 Sum_probs=183.6
Q ss_pred CEEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||+|++...... ....+.+|++++.+++|+||+++++++.+++..++||||+.+++|.+++.......+++..+.
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05631 26 KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI 105 (285)
T ss_pred ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHH
Confidence 36899988754322 234678999999999999999999999999999999999999999988865554568999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++....... ......|+..|+|||++.+..++.
T Consensus 106 ~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~ 180 (285)
T cd05631 106 FYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTF 180 (285)
T ss_pred HHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCc
Confidence 999999999999996 459999999999999999999999999997653321 123446899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.......... .+...+ ......++..++..+.+|+.+||+.||.+
T Consensus 181 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~ 246 (285)
T cd05631 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-------------EVDRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKE 246 (285)
T ss_pred ccCchhHHHHHHHHHhCCCCCCCCCcchhHH-------------HHHHHh-hcccccCCccCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999998754321110 001111 11122345567889999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
||+ +++++++
T Consensus 247 R~~~~~~~~~~~~~h 261 (285)
T cd05631 247 RLGCRGNGAAGVKQH 261 (285)
T ss_pred hcCCCCCCHHHHhcC
Confidence 997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=294.35 Aligned_cols=222 Identities=25% Similarity=0.387 Sum_probs=193.5
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+||||++.+-..++ ...+++|++-|+-++|||||++|++......+|||+|+-++|+|.+||.+... .+++....++
T Consensus 45 kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kY 123 (864)
T KOG4717|consen 45 KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKY 123 (864)
T ss_pred eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHH
Confidence 69999997664444 35789999999999999999999999999999999999999999999976653 5999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC-
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT- 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~- 157 (305)
+.||+.|+.|+|... +|||||||+|+++.+ -|-|||+|||++..+....+ ....+|+..|-|||++.|..|+.
T Consensus 124 F~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAP 198 (864)
T KOG4717|consen 124 FAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAP 198 (864)
T ss_pred HHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCc
Confidence 999999999999654 999999999988865 47899999999987655433 45678999999999999999875
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+|+|.|++|+.||+..+ +.+.+..+++-++ ..|..++.++++||.+||..||.+
T Consensus 199 AVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkk 260 (864)
T KOG4717|consen 199 AVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKK 260 (864)
T ss_pred chhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchh
Confidence 7899999999999999999999854 4556666666655 567889999999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|.+.++|...
T Consensus 261 RAslEeI~s~ 270 (864)
T KOG4717|consen 261 RASLEEIVST 270 (864)
T ss_pred hccHHHHhcc
Confidence 9999999853
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=302.28 Aligned_cols=234 Identities=32% Similarity=0.445 Sum_probs=199.4
Q ss_pred EEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 3 VAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 3 VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
||||..+.+. .....+|++|+++|++++||||+++||++.....+++|||+|.||+|.+++++.+. .++..+.+.+
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~ 267 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRF 267 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHH
Confidence 8999988643 34457899999999999999999999999999999999999999999999987664 5999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+.+.||+|||+++ ++||||-.+|+|++.++.+||+|||+++...... .......-...|+|||.+..+.++.++
T Consensus 268 ~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kT 343 (474)
T KOG0194|consen 268 CYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKT 343 (474)
T ss_pred HHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCCccee--eccccccCcceecChhhhccCcccccc
Confidence 999999999999654 9999999999999999999999999988643111 111122356899999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++||+++ |..||.+... ......+.....+...+...+..+..++.+||..+|++|
T Consensus 344 DV~sfGV~~~Eif~~g~~Py~g~~~----------------~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R 407 (474)
T KOG0194|consen 344 DVWSFGVLLWEIFENGAEPYPGMKN----------------YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDR 407 (474)
T ss_pred chhheeeeEEeeeccCCCCCCCCCH----------------HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhc
Confidence 99999999999999 8889988542 223334446677788888999999999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCCC
Q 021947 239 PRMSEVLAILERLEAPKNS 257 (305)
Q Consensus 239 ps~~~~l~~l~~~~~~~~~ 257 (305)
||+.++.+.++.+......
T Consensus 408 ~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 408 PTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cCHHHHHHHHHHHHhcccc
Confidence 9999999999988665443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.34 Aligned_cols=220 Identities=25% Similarity=0.345 Sum_probs=180.5
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.... .....+.+|++++++++||||+++++++.+++..|+||||+.|++|.+++.+.+ .+++..+.
T Consensus 44 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 121 (329)
T PTZ00263 44 EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAK 121 (329)
T ss_pred CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHH
Confidence 3689999875422 234568899999999999999999999999999999999999999999997654 48888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.
T Consensus 122 ~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 194 (329)
T PTZ00263 122 FYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGK 194 (329)
T ss_pred HHHHHHHHHHHHHHHC--CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCC
Confidence 9999999999999964 5999999999999999999999999999865332 12346899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.... .....+... ....+..++..+.+||.+||..||.+
T Consensus 195 ~~DiwslG~il~elltg~~pf~~~~~~----------------~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~ 256 (329)
T PTZ00263 195 AVDWWTMGVLLYEFIAGYPPFFDDTPF----------------RIYEKILAG--RLKFPNWFDGRARDLVKGLLQTDHTK 256 (329)
T ss_pred cceeechHHHHHHHHcCCCCCCCCCHH----------------HHHHHHhcC--CcCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999999999999999764321 001111111 12344557788999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
|++ +++++++
T Consensus 257 R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 257 RLGTLKGGVADVKNH 271 (329)
T ss_pred cCCCCCCCHHHHhcC
Confidence 996 6777754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=289.31 Aligned_cols=229 Identities=28% Similarity=0.475 Sum_probs=186.1
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------C
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------P 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~ 68 (305)
.||||+++..... ....+.+|++++++++|+||+++++++..+...++||||+.|++|.+++...+ .
T Consensus 37 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 116 (280)
T cd05049 37 LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116 (280)
T ss_pred eEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccccccc
Confidence 5899998765443 34689999999999999999999999999999999999999999999996543 2
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
..+++..+..++.+++.||.|||+ +|++|+||||+||+++.++.++|+|||++................++..|+|||
T Consensus 117 ~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 117 GELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChh
Confidence 347888999999999999999996 459999999999999999999999999987543322222222334578899999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (305)
++.+..++.++||||||+++|+|++ |..||.+.... ..............+..++..+.+++
T Consensus 195 ~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li 257 (280)
T cd05049 195 SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----------------EVIECITQGRLLQRPRTCPSEVYDIM 257 (280)
T ss_pred hhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 9999999999999999999999998 99998764321 11111112222233456788999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
.+||..||.+||++.++++.|+
T Consensus 258 ~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 258 LGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcCCCcccCCCHHHHHHHhh
Confidence 9999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=293.72 Aligned_cols=236 Identities=27% Similarity=0.481 Sum_probs=181.7
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC------------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------ 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------ 68 (305)
.||+|.+...... ...+|.+|++++.+++||||+++++++.+.+..++||||+.+++|.+++.....
T Consensus 48 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (304)
T cd05096 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127 (304)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccc
Confidence 5899998865332 345789999999999999999999999999999999999999999999854321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccc
Q 021947 69 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143 (305)
Q Consensus 69 -----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 143 (305)
..+++..++.++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++...............++..
T Consensus 128 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~ 205 (304)
T cd05096 128 PAHCLPAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205 (304)
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHHC--CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCcc
Confidence 2367788899999999999999964 599999999999999999999999999976543322222333455788
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHh--CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 221 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (305)
|+|||++.+..++.++||||||+++|+|++ +..||.+..... ..... ...............+..++.
T Consensus 206 y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 275 (304)
T cd05096 206 WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENA-------GEFFRDQGRQVYLFRPPPCPQ 275 (304)
T ss_pred ccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHH-------HHHhhhccccccccCCCCCCH
Confidence 999999988899999999999999999987 567776543211 00000 000000001111123445778
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 222 TAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 222 ~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
.+.+|+.+||..||.+|||+.++.+.|+
T Consensus 276 ~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 276 GLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 8999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=296.04 Aligned_cols=223 Identities=28% Similarity=0.352 Sum_probs=180.7
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||+|+++... ......+.+|++++.+++||||+++++++...+..|+||||+.|++|.+++.+.+ .+++..+.
T Consensus 19 ~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~ 96 (312)
T cd05585 19 RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG--RFDLSRAR 96 (312)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 368999987532 2334567899999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 97 ~~~~qi~~~l~~lH~~--~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 172 (312)
T cd05585 97 FYTAELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTK 172 (312)
T ss_pred HHHHHHHHHHHHHHhC--CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCC
Confidence 9999999999999964 59999999999999999999999999987532221 1133456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.... .....+.. ....++..++..+.+||.+||..||.+
T Consensus 173 ~~DvwslGvil~el~tg~~pf~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 173 AVDWWTLGVLLYEMLTGLPPFYDENVN----------------EMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred ccceechhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHc--CCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence 999999999999999999999764321 00111111 122345667889999999999999999
Q ss_pred CCC---HHHHHHH
Q 021947 238 RPR---MSEVLAI 247 (305)
Q Consensus 238 Rps---~~~~l~~ 247 (305)
||+ +.+++++
T Consensus 235 R~~~~~~~e~l~h 247 (312)
T cd05585 235 RLGYNGAQEIKNH 247 (312)
T ss_pred cCCCCCHHHHHcC
Confidence 985 5666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=285.31 Aligned_cols=229 Identities=27% Similarity=0.435 Sum_probs=188.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|+++.+ ......+.+|+++++.++|+||+++++++...+..+++|||+.+++|.+++.......+++..++.++.
T Consensus 33 ~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ 111 (263)
T cd05052 33 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111 (263)
T ss_pred eEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHH
Confidence 5889988754 234567899999999999999999999999999999999999999999999766555689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||+ ++++||||||+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++|+
T Consensus 112 ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 188 (263)
T cd05052 112 QISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 188 (263)
T ss_pred HHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHH
Confidence 99999999995 56999999999999999999999999999865432211 1112234568999999988899999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.... .....+........+..++..+.+++.+||+.||++|||
T Consensus 189 ~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 189 WAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCC
Confidence 999999999998 99998764321 112222233334455667889999999999999999999
Q ss_pred HHHHHHHHHhh
Q 021947 241 MSEVLAILERL 251 (305)
Q Consensus 241 ~~~~l~~l~~~ 251 (305)
+.++++.|+++
T Consensus 252 ~~~l~~~l~~~ 262 (263)
T cd05052 252 FAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHhh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=289.90 Aligned_cols=228 Identities=36% Similarity=0.597 Sum_probs=182.6
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.|+||.++..... ..+.+.+|++.+++++||||+++++++...+..++||||+.+|+|.+++.......+++..++.++
T Consensus 30 ~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~ 109 (259)
T PF07714_consen 30 PVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIA 109 (259)
T ss_dssp EEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHH
T ss_pred EEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 6899999764332 357899999999999999999999999988889999999999999999988745569999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. +++|+||+++||+++.++.+||+|||++....................|+|||.+.+..++.++|
T Consensus 110 ~~i~~~l~~Lh~~--~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksD 187 (259)
T PF07714_consen 110 IQIAEALSYLHSN--NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSD 187 (259)
T ss_dssp HHHHHHHHHHHHT--TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHH
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999975 49999999999999999999999999998763333322333445678899999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++||+++ |..||.+... ..+...+........+..++..+.+++.+||..||.+||
T Consensus 188 VysfG~~l~ei~~~~~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 188 VYSFGMLLYEILTLGKFPFSDYDN-----------------EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp HHHHHHHHHHHHTTSSGTTTTSCH-----------------HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS-
T ss_pred cccccccccccccccccccccccc-----------------ccccccccccccceeccchhHHHHHHHHHHcCCChhhCc
Confidence 9999999999999 7888876421 122222333333445667889999999999999999999
Q ss_pred CHHHHHHHH
Q 021947 240 RMSEVLAIL 248 (305)
Q Consensus 240 s~~~~l~~l 248 (305)
|+.++++.|
T Consensus 251 s~~~i~~~L 259 (259)
T PF07714_consen 251 SFQEILQEL 259 (259)
T ss_dssp -HHHHHHHH
T ss_pred CHHHHHhcC
Confidence 999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=311.76 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=211.2
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||.++.... ..+.+|+.|+.||-++.||||+++.|+........||+|||++|+|+.||+.+.++ |..-+...+
T Consensus 658 ~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgM 736 (996)
T KOG0196|consen 658 ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGM 736 (996)
T ss_pred eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHH
Confidence 3699999998744 34568999999999999999999999999999999999999999999999877755 999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|+.|++||-+. ++|||||-..|||++.+..+|++|||+++...++..... .....-..+|.|||.+...+++.+
T Consensus 737 LrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA 814 (996)
T KOG0196|consen 737 LRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA 814 (996)
T ss_pred HHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCch
Confidence 99999999999965 599999999999999999999999999998755442221 111223679999999999999999
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
||+||+|++|||.++ |..||.++. ++...+.++.+++.+-|.+++..+.+|+..||++|-.+
T Consensus 815 SDVWSyGIVmWEVmSyGERPYWdmS-----------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~ 877 (996)
T KOG0196|consen 815 SDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNR 877 (996)
T ss_pred hhccccceEEEEecccCCCcccccc-----------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhc
Confidence 999999999999886 999998753 45567778888999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCCCccCCC
Q 021947 238 RPRMSEVLAILERLEAPKNSAKLSQS 263 (305)
Q Consensus 238 Rps~~~~l~~l~~~~~~~~~~~~~~~ 263 (305)
||.+.+|+..|+++...+.+......
T Consensus 878 RP~F~qiV~~lDklIrnP~SLk~~~~ 903 (996)
T KOG0196|consen 878 RPKFAQIVSTLDKLIRNPNSLKTIAP 903 (996)
T ss_pred CCCHHHHHHHHHHHhcCchhhcccCC
Confidence 99999999999998776666544433
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=295.43 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=183.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+..+.. .....+.+|++++++++||||+++++++..++..++||||++|++|.+++.... .+++..+..++
T Consensus 32 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 109 (331)
T cd06649 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVS 109 (331)
T ss_pred EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 588998876532 234678999999999999999999999999999999999999999999996654 48899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+. ++++||||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.++|
T Consensus 110 ~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~D 184 (331)
T cd06649 110 IAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSD 184 (331)
T ss_pred HHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHh
Confidence 9999999999963 359999999999999999999999999987653321 23346899999999999989999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhcc-------------------------------chhhhhhhhc
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-------------------------------KRKLFRIMDT 209 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 209 (305)
||||||++|+|++|+.||...+......... .+.... ...+...+..
T Consensus 185 iwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T cd06649 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVN 262 (331)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHh
Confidence 9999999999999999997543211110000 000000 0000111111
Q ss_pred c-cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 210 K-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 210 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
. ........++.++.+||.+||..||++|||+++++++.
T Consensus 263 ~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 263 EPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1 11111224678899999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=295.83 Aligned_cols=223 Identities=27% Similarity=0.365 Sum_probs=182.1
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||+|++..... .....+.+|+++++.++||||+++++++...+..|+||||+.+++|.+++.... .+++..+.
T Consensus 21 ~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~ 98 (328)
T cd05593 21 KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTR 98 (328)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHH
Confidence 3689999875422 234578899999999999999999999999999999999999999999886543 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 99 ~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 174 (328)
T cd05593 99 FYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGR 174 (328)
T ss_pred HHHHHHHHHHHHHHhC--CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCc
Confidence 9999999999999964 599999999999999999999999999875322111 123456899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+... ....+. .....++..++.++.+||.+||..||.+
T Consensus 175 ~~DiwslGvil~elltG~~Pf~~~~~~~-----------------~~~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELIL-MEDIKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred cCCccccchHHHHHhhCCCCCCCCCHHH-----------------HHHHhc-cCCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 9999999999999999999997643210 111111 1122345667889999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|+ ++.+++++
T Consensus 237 R~~~~~~~~~~il~h 251 (328)
T cd05593 237 RLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCCCCCCHHHHhcC
Confidence 97 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=271.95 Aligned_cols=236 Identities=24% Similarity=0.344 Sum_probs=189.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC-----eeEEEEecCCCCCHHHHhhhcC--CCCCCHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRG--PQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 74 (305)
..|+|++...+.++.+..++|++..++++||||++++++...+. ..||++.|+..|+|.+.+.+.. +..+++.
T Consensus 48 ~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~ 127 (302)
T KOG2345|consen 48 LYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEA 127 (302)
T ss_pred chhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHH
Confidence 46889888777778889999999999999999999988765443 3899999999999999996543 3359999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-------eecccccccccch
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-------STQVMGTHGYAAP 147 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~t~~y~aP 147 (305)
.++.++.++++||++||+....++||||||.|||+++++.+++.|||.++.......... -.....|..|+||
T Consensus 128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP 207 (302)
T KOG2345|consen 128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAP 207 (302)
T ss_pred HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence 999999999999999997666699999999999999999999999999976433221110 0122468899999
Q ss_pred hhhh---cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 148 EYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 148 E~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|.+. +...+.++|||||||++|.|+.|..||+.... .............+..+....+++.+.
T Consensus 208 ELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------------~GgSlaLAv~n~q~s~P~~~~yse~l~ 273 (302)
T KOG2345|consen 208 ELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------------QGGSLALAVQNAQISIPNSSRYSEALH 273 (302)
T ss_pred hheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------------cCCeEEEeeeccccccCCCCCccHHHH
Confidence 9885 44678899999999999999999999975322 111222233344455555556999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+||+.||..||.+||++.+++..++.+
T Consensus 274 ~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 274 QLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999988765
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=296.12 Aligned_cols=222 Identities=27% Similarity=0.344 Sum_probs=181.1
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|+++.... .....+.+|+++++.++||||+++++.+...+..|+||||++|++|..++.... .+++..+..
T Consensus 22 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~ 99 (323)
T cd05595 22 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARF 99 (323)
T ss_pred EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 689999875422 233567889999999999999999999999999999999999999999886554 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||++ |++||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.+
T Consensus 100 ~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (323)
T cd05595 100 YGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA 175 (323)
T ss_pred HHHHHHHHHHHHHHC--CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCch
Confidence 999999999999964 599999999999999999999999999875322211 1234568999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|||||||++|+|++|..||...+... ....+.. .....+..++.++.+||.+||+.||.+|
T Consensus 176 ~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 176 VDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred hchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999999999999997643211 0011111 1123455678899999999999999999
Q ss_pred C-----CHHHHHHH
Q 021947 239 P-----RMSEVLAI 247 (305)
Q Consensus 239 p-----s~~~~l~~ 247 (305)
+ ++.+++++
T Consensus 238 ~~~~~~~~~~~l~h 251 (323)
T cd05595 238 LGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 8 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=287.95 Aligned_cols=233 Identities=28% Similarity=0.488 Sum_probs=187.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-----------CCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----------PQP 70 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~ 70 (305)
.||+|.+..........+.+|++++++++|+||+++++++..++..++||||+.+++|.+++...+ ...
T Consensus 37 ~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (288)
T cd05093 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116 (288)
T ss_pred EEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCC
Confidence 478888876544455679999999999999999999999999999999999999999999996443 124
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
+++..++.++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++................++..|+|||++
T Consensus 117 l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 117 LTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 8999999999999999999996 45999999999999999999999999999865433222222233457789999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.+..++.++|+||||+++|+|++ |..||....... ....+........+..++.++.+|+.+
T Consensus 195 ~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~l~~li~~ 257 (288)
T cd05093 195 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----------------VIECITQGRVLQRPRTCPKEVYDLMLG 257 (288)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 98899999999999999999998 899987643210 111111111122334567789999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhhcC
Q 021947 230 CLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
||+.||.+|||+.++++.|+.+..
T Consensus 258 ~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 258 CWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HccCChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=270.74 Aligned_cols=209 Identities=25% Similarity=0.336 Sum_probs=177.7
Q ss_pred ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 15 GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 15 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
+.+.+.+|+++.+.|+||||+++++.+.+.+..|+|+|+++|++|..-|..+ ..+++..+..++.||+++|.|+|+
T Consensus 53 ~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~-- 128 (355)
T KOG0033|consen 53 DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS-- 128 (355)
T ss_pred cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh--
Confidence 5578889999999999999999999999999999999999999998877655 348999999999999999999995
Q ss_pred CceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHH
Q 021947 95 SQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 171 (305)
++|||||+||+|+++.. ..-+||+|||++...++ ...-...+||+.|||||+++..+|+..+|||+-|+|+|-|
T Consensus 129 n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiL 205 (355)
T KOG0033|consen 129 NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 205 (355)
T ss_pred cCceeccCChhheeeeeccCCCceeecccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHH
Confidence 56999999999999954 34599999999988762 2234567899999999999999999999999999999999
Q ss_pred HhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcc--cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 172 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.|.+||.+.+. ..+++.+ ... ...+..+.++++.++|+++||..||.+|.|+.|.+++
T Consensus 206 L~G~~PF~~~~~-----------------~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 206 LVGYPPFWDEDQ-----------------HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HhCCCCCCCccH-----------------HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 999999987432 1222222 222 3344567899999999999999999999999999854
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=283.95 Aligned_cols=229 Identities=24% Similarity=0.413 Sum_probs=185.2
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+++..... ....+.+|+.++.+++||||+++++++..++..++||||+.+++|.+++.... ..+++..++.++
T Consensus 35 ~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~ 113 (266)
T cd05064 35 PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGML 113 (266)
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence 6899998865332 23578999999999999999999999999999999999999999999996543 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||+|||+ .+++||||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|
T Consensus 114 ~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 190 (266)
T cd05064 114 PGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASD 190 (266)
T ss_pred HHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhH
Confidence 999999999995 4599999999999999999999999998765322211 1111223467899999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|++++ |..||.+.... ...+.+........+..++..+.+++.+||+.+|.+||
T Consensus 191 i~slG~~l~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 191 VWSFGIVMWEVMSYGERPYWDMSGQ-----------------DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCC
Confidence 9999999999775 99999764321 11122222223344566888999999999999999999
Q ss_pred CHHHHHHHHHhh
Q 021947 240 RMSEVLAILERL 251 (305)
Q Consensus 240 s~~~~l~~l~~~ 251 (305)
++.++++.|.++
T Consensus 254 ~~~~i~~~l~~~ 265 (266)
T cd05064 254 RFSQIHSILSKM 265 (266)
T ss_pred CHHHHHHHHHhh
Confidence 999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=295.93 Aligned_cols=219 Identities=23% Similarity=0.297 Sum_probs=180.9
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++.... ......+.+|+++++.++||||+++++++.+++..|+||||+.||+|.+++.+.. .+++..+..
T Consensus 58 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~ 135 (340)
T PTZ00426 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCF 135 (340)
T ss_pred EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 68999886432 2334578899999999999999999999999999999999999999999997654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+. |++||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.+
T Consensus 136 ~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 208 (340)
T PTZ00426 136 YAAQIVLIFEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKA 208 (340)
T ss_pred HHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCcc
Confidence 999999999999964 5999999999999999999999999999865332 223568999999999999889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+|||||++|+|++|..||.+.+... ..+.+.. ....++..++..+.++|++||+.||.+|
T Consensus 209 ~DiwSlGvil~ell~G~~Pf~~~~~~~-----------------~~~~i~~-~~~~~p~~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 209 ADWWTLGIFIYEILVGCPPFYANEPLL-----------------IYQKILE-GIIYFPKFLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred ccccchhhHHHHHhcCCCCCCCCCHHH-----------------HHHHHhc-CCCCCCCCCCHHHHHHHHHHcccCHHHc
Confidence 999999999999999999998643210 1111111 1123455677889999999999999999
Q ss_pred C-----CHHHHHHH
Q 021947 239 P-----RMSEVLAI 247 (305)
Q Consensus 239 p-----s~~~~l~~ 247 (305)
+ ++++++++
T Consensus 271 ~~~~~~~~~~~~~h 284 (340)
T PTZ00426 271 YGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCHHHHHcC
Confidence 5 78888765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=293.17 Aligned_cols=220 Identities=24% Similarity=0.306 Sum_probs=180.6
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||++..... .....+.+|++++++++||||+++++++.+....|+||||+.+++|.+++...+ .+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 104 (291)
T cd05612 27 HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGL 104 (291)
T ss_pred CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 3689999865422 234568899999999999999999999999999999999999999999997654 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. |++||||||+|||++.++.+||+|||++...... .....|++.|+|||++.+..++.
T Consensus 105 ~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 177 (291)
T cd05612 105 FYASEIVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNK 177 (291)
T ss_pred HHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCc
Confidence 9999999999999964 5999999999999999999999999999765332 22346899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+..... ....+... ...++..++..+.+||++||+.||.+
T Consensus 178 ~~DiwSlG~il~~l~~g~~pf~~~~~~~----------------~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~ 239 (291)
T cd05612 178 AVDWWALGILIYEMLVGYPPFFDDNPFG----------------IYEKILAG--KLEFPRHLDLYAKDLIKKLLVVDRTR 239 (291)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC--CcCCCccCCHHHHHHHHHHcCCCHHH
Confidence 9999999999999999999997643211 00111111 12345556788999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
|++ +++++++
T Consensus 240 R~~~~~~~~~~~l~h 254 (291)
T cd05612 240 RLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCccCCHHHHhcC
Confidence 995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=292.90 Aligned_cols=222 Identities=28% Similarity=0.371 Sum_probs=180.5
Q ss_pred EEEEEecccCC----ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG----FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++... ......+.+|+++|+.++||||+++++++..++..|+||||+.|++|.+++.+.+ .+.+..+.
T Consensus 26 ~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 103 (323)
T cd05584 26 IFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTAC 103 (323)
T ss_pred EEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC--CCCHHHHH
Confidence 68999987532 1233567889999999999999999999999999999999999999999997654 47888888
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++....... ......|++.|+|||++.+..++.
T Consensus 104 ~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 179 (323)
T cd05584 104 FYLSEISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGK 179 (323)
T ss_pred HHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCC
Confidence 9999999999999964 599999999999999999999999999875322211 123356899999999999888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|++|..||.+.+.. .....+... ....+..++..+.+||.+||+.||.+
T Consensus 180 ~~DiwslG~il~ell~G~~pf~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 241 (323)
T cd05584 180 AVDWWSLGALMYDMLTGAPPFTAENRK----------------KTIDKILKG--KLNLPPYLTPEARDLLKKLLKRNPSS 241 (323)
T ss_pred cceecccHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccCHhH
Confidence 999999999999999999999864321 011111111 12345567788999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|| ++.+++++
T Consensus 242 R~~~~~~~~~~l~~h 256 (323)
T cd05584 242 RLGAGPGDAAEVQSH 256 (323)
T ss_pred cCCCCCCCHHHHhcC
Confidence 99 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.18 Aligned_cols=227 Identities=27% Similarity=0.333 Sum_probs=179.2
Q ss_pred EEEEEecccCC----ccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEG----FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.||+|++.... ....+.+.+|++++++++ |+||+++++++...+..++||||+.|++|.+++.++. .+++..+
T Consensus 30 ~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~ 107 (332)
T cd05614 30 LYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEV 107 (332)
T ss_pred EEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 68999886432 123356788999999994 9999999999999999999999999999999996654 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RL 155 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~ 155 (305)
..++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+. .+
T Consensus 108 ~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 184 (332)
T cd05614 108 RFYSGEIILALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGH 184 (332)
T ss_pred HHHHHHHHHHHHHHHHC--CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCC
Confidence 99999999999999964 5999999999999999999999999999764332221 12345789999999999765 47
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|||||||++|+|++|..||.......... .+...+. ......+..++..+.+|+.+||+.||
T Consensus 185 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQS-------------EVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred CCccccccchhhhhhhhcCCCCCCCCCCCCCHH-------------HHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence 889999999999999999999997543211110 0111111 11223455678889999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 021947 236 KLRP-----RMSEVLAI 247 (305)
Q Consensus 236 ~~Rp-----s~~~~l~~ 247 (305)
++|| ++++++++
T Consensus 251 ~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 251 KKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9999 67788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.39 Aligned_cols=221 Identities=26% Similarity=0.380 Sum_probs=176.0
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHH---hccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYL---GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++... ....+.+.+|.+++ +.++||||+++++++..++..|+||||+.|++|..++... .+++..
T Consensus 26 ~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~ 102 (324)
T cd05589 26 LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPR 102 (324)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHH
Confidence 68999987542 22335667776665 5668999999999999999999999999999999888542 489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..+
T Consensus 103 ~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 178 (324)
T cd05589 103 AVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSY 178 (324)
T ss_pred HHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCC
Confidence 99999999999999996 4599999999999999999999999999875322211 1234568999999999999999
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|||||||++|+|++|..||.+.+... ....+... ....+..++..+.++|.+||..||
T Consensus 179 ~~~~DiwslG~il~el~~G~~pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP 240 (324)
T cd05589 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEE----------------VFDSIVND--EVRYPRFLSREAISIMRRLLRRNP 240 (324)
T ss_pred CcccchhhHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999998653211 01111111 123455678889999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 021947 236 KLRP-----RMSEVLAI 247 (305)
Q Consensus 236 ~~Rp-----s~~~~l~~ 247 (305)
.+|| ++.+++++
T Consensus 241 ~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 241 ERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hHcCCCCCCCHHHHhhC
Confidence 9999 56676654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.40 Aligned_cols=233 Identities=27% Similarity=0.413 Sum_probs=186.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||||+++.... ...+.+.+|+++|.++. ||||+++++++.+.+..|+|||||++|+|.+++..+.
T Consensus 69 ~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (400)
T cd05105 69 KVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPK 148 (400)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccccc
Confidence 489999976533 23467899999999996 9999999999999999999999999999999885431
Q ss_pred --------------------------------------------------------------------------------
Q 021947 68 -------------------------------------------------------------------------------- 67 (305)
Q Consensus 68 -------------------------------------------------------------------------------- 67 (305)
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 228 (400)
T cd05105 149 KDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSD 228 (400)
T ss_pred ccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHh
Confidence
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|+
T Consensus 229 ~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~ 306 (400)
T cd05105 229 DGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM 306 (400)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceE
Confidence 1236778889999999999999996 459999999999999999999999999998654322222222345678899
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++||||||+++|+|++ |..||...... ......+........+..++..+.
T Consensus 307 aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~ 370 (400)
T cd05105 307 APESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----------------STFYNKIKSGYRMAKPDHATQEVY 370 (400)
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----------------HHHHHHHhcCCCCCCCccCCHHHH
Confidence 9999988899999999999999999997 99998764221 111122222223334556788999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+++.+||+.||++|||+.++.+.|+++.
T Consensus 371 ~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 371 DIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=294.42 Aligned_cols=227 Identities=25% Similarity=0.296 Sum_probs=181.9
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||+++... ......+.+|++++..++||||+++++++..++..|+||||++|++|.+++...+ .+++..+.
T Consensus 27 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~ 104 (333)
T cd05600 27 EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHAR 104 (333)
T ss_pred CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 368999987542 2234578899999999999999999999999999999999999999999996554 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||++..... ......||+.|+|||++.+..++.
T Consensus 105 ~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ 177 (333)
T cd05600 105 FYMAEMFEAVDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDF 177 (333)
T ss_pred HHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCC
Confidence 9999999999999964 599999999999999999999999999976433 123456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++|||||||++|+|++|..||.+.+...... +..+ ...+...........++.++.+||.+||..+|.
T Consensus 178 ~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~ 246 (333)
T cd05600 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-----------KETLQRPVYDDPRFNLSDEAWDLITKLINDPSR 246 (333)
T ss_pred ccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-----------cccccCCCCCccccccCHHHHHHHHHHhhChhh
Confidence 9999999999999999999998654211100 0000 000000000001124678899999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+||++.+++++
T Consensus 247 rr~s~~~ll~h 257 (333)
T cd05600 247 RFGSLEDIKNH 257 (333)
T ss_pred hcCCHHHHHhC
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=267.98 Aligned_cols=224 Identities=27% Similarity=0.379 Sum_probs=192.8
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++-.... ....++.+|+++...|+||||+++|++|.+....||++||..+|+|...+..+....+++.....
T Consensus 49 IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~ 128 (281)
T KOG0580|consen 49 IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAAT 128 (281)
T ss_pred EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhH
Confidence 699998865432 34578999999999999999999999999999999999999999999999877777799999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+..|++.||.|+|. ++++||||||+|+|++..|.+|++|||-+-..... .....+||..|.+||...+...+..
T Consensus 129 Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~ 202 (281)
T KOG0580|consen 129 YIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKF 202 (281)
T ss_pred HHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC----CceeeecccccCCHhhcCCCCccch
Confidence 99999999999995 55999999999999999999999999988765422 2456789999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+|++|++.||++.|.+||..... .+...++. .....+|..++..+++||.+||..+|.+|
T Consensus 203 Vd~w~lgvl~yeflvg~ppFes~~~----------------~etYkrI~--k~~~~~p~~is~~a~dlI~~ll~~~p~~r 264 (281)
T KOG0580|consen 203 VDLWSLGVLCYEFLVGLPPFESQSH----------------SETYKRIR--KVDLKFPSTISGGAADLISRLLVKNPIER 264 (281)
T ss_pred hhHHHHHHHHHHHHhcCCchhhhhh----------------HHHHHHHH--HccccCCcccChhHHHHHHHHhccCcccc
Confidence 9999999999999999999986431 11122222 23345678899999999999999999999
Q ss_pred CCHHHHHHHHH
Q 021947 239 PRMSEVLAILE 249 (305)
Q Consensus 239 ps~~~~l~~l~ 249 (305)
.+..+++++-.
T Consensus 265 ~~l~~v~~hpw 275 (281)
T KOG0580|consen 265 LALTEVMDHPW 275 (281)
T ss_pred ccHHHHhhhHH
Confidence 99999998653
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.53 Aligned_cols=232 Identities=28% Similarity=0.438 Sum_probs=186.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||.++.... ...+.+.+|+++++++ +|+||+++++.+...+..|+||||+.+++|.+++.+.....+++..+..+
T Consensus 67 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i 146 (302)
T cd05055 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146 (302)
T ss_pred EEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHH
Confidence 589998875532 2345788999999999 79999999999999999999999999999999997655445899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++
T Consensus 147 ~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 224 (302)
T cd05055 147 SYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 224 (302)
T ss_pred HHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHh
Confidence 9999999999996 45999999999999999999999999999865433222222233457789999999988999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++|+|++ |..||.+..... ..............+...+..+.+|+.+||+.+|++|
T Consensus 225 DiwslGvil~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 288 (302)
T cd05055 225 DVWSYGILLWEIFSLGSNPYPGMPVDS----------------KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288 (302)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCCCchH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999998 999997643211 1111122222222344567789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021947 239 PRMSEVLAILERL 251 (305)
Q Consensus 239 ps~~~~l~~l~~~ 251 (305)
||+.++++.|+++
T Consensus 289 pt~~ell~~l~~~ 301 (302)
T cd05055 289 PTFKQIVQLIGKQ 301 (302)
T ss_pred cCHHHHHHHHHhh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=281.65 Aligned_cols=229 Identities=29% Similarity=0.467 Sum_probs=190.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++.........++.+|+++++.++|+||+++++++.+....++||||+++++|.+++.......+++..+..++.
T Consensus 32 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 111 (261)
T cd05148 32 RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111 (261)
T ss_pred cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHH
Confidence 58999988776556778999999999999999999999999999999999999999999999776556689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ +|++|+||||+||+++.++.+||+|||++......... .....++..|++||.+.+..++.++|+
T Consensus 112 ~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di 187 (261)
T cd05148 112 QVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDV 187 (261)
T ss_pred HHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhH
Confidence 99999999995 45999999999999999999999999999765432211 123345678999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||..... ...............+..++..+.+++.+||+.||.+|||
T Consensus 188 wslG~~l~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 188 WSFGILLYEMFTYGQVPYPGMNN-----------------HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCH-----------------HHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 999999999998 8999976431 1111112222333445677889999999999999999999
Q ss_pred HHHHHHHHHhh
Q 021947 241 MSEVLAILERL 251 (305)
Q Consensus 241 ~~~~l~~l~~~ 251 (305)
+.++++.|+.+
T Consensus 251 ~~~l~~~L~~~ 261 (261)
T cd05148 251 FKALREELDNI 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=294.46 Aligned_cols=224 Identities=28% Similarity=0.359 Sum_probs=181.8
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||+|+++.... .....+.+|++++..++||||+++++++...+..|+||||+.|++|..++.+.. .+++..+.
T Consensus 21 ~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~ 98 (325)
T cd05594 21 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRAR 98 (325)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 3689999875422 233567889999999999999999999999999999999999999999886544 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. .|++||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.
T Consensus 99 ~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05594 99 FYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGR 175 (325)
T ss_pred HHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCC
Confidence 9999999999999962 4699999999999999999999999999875322211 123356899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+... ...... .....++..++.++.+|+.+||+.||.+
T Consensus 176 ~~DiwslG~il~el~tG~~Pf~~~~~~~-----------------~~~~i~-~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELIL-MEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred ccccccccceeeeeccCCCCCCCCCHHH-----------------HHHHHh-cCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999997643211 111111 1122345567888999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|+ ++.+++++
T Consensus 238 R~~~~~~~~~~il~h 252 (325)
T cd05594 238 RLGGGPDDAKEIMQH 252 (325)
T ss_pred hCCCCCCCHHHHhcC
Confidence 97 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=293.75 Aligned_cols=218 Identities=28% Similarity=0.351 Sum_probs=177.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++..... .....+.+|++++++++||||+++++++..++..|+||||+.+++|.+++.+.. .+++..+..+
T Consensus 26 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~ 103 (318)
T cd05582 26 LYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFY 103 (318)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 689998875432 233567889999999999999999999999999999999999999999996543 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++
T Consensus 104 ~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~ 179 (318)
T cd05582 104 LAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSA 179 (318)
T ss_pred HHHHHHHHHHHHHC--CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCcc
Confidence 99999999999964 599999999999999999999999999876433211 12345689999999999988899999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||||++|+|++|+.||...+.. .....+... ....+..++..+.+||.+||+.||.+||
T Consensus 180 DiwslG~il~el~tg~~p~~~~~~~----------------~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~ 241 (318)
T cd05582 180 DWWSFGVLMFEMLTGSLPFQGKDRK----------------ETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPANRL 241 (318)
T ss_pred ceeccceEeeeeccCCCCCCCCCHH----------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHhHcC
Confidence 9999999999999999999764321 001111111 1234556788899999999999999999
Q ss_pred CHHH
Q 021947 240 RMSE 243 (305)
Q Consensus 240 s~~~ 243 (305)
++.+
T Consensus 242 ~a~~ 245 (318)
T cd05582 242 GAGP 245 (318)
T ss_pred CCCC
Confidence 9544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=275.99 Aligned_cols=242 Identities=26% Similarity=0.286 Sum_probs=184.4
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCC-cccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcCC--C
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGP--Q 69 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~--~ 69 (305)
..||||+++.+... ......+|+.+|++++|+| |+.+++++...+ .+++|+||++. +|..++..... .
T Consensus 37 ~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~ 115 (323)
T KOG0594|consen 37 KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQ 115 (323)
T ss_pred CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhcccccc
Confidence 36999999876543 3356789999999999999 999999998877 78999999965 99999976553 3
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.++...+..++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+...-.... ....++|.+|+|||+
T Consensus 116 g~~~~~ik~~m~Qll~gl~~~H~~--~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEv 191 (323)
T KOG0594|consen 116 GLPPRLIKSFMRQLLRGLAFLHSH--GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEV 191 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHH
Confidence 577789999999999999999965 4999999999999999999999999999975533322 445578999999999
Q ss_pred hhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhhccchhhhhhhhcc--cCCCC-Ch------
Q 021947 150 VATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSDKRKLFRIMDTK--LGGQY-PQ------ 217 (305)
Q Consensus 150 ~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~------ 217 (305)
+.|. .|+...||||+|||++||++++..|.+..+.... .+.....|............+.. ..... +.
T Consensus 192 LlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~ 271 (323)
T KOG0594|consen 192 LLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL 271 (323)
T ss_pred hcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhc
Confidence 9887 7999999999999999999999999887653211 11111111111111111111111 00000 11
Q ss_pred -HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 -KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 -~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.......+++.+||..+|.+|.|+..++++
T Consensus 272 ~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 272 PKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222478999999999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=280.20 Aligned_cols=229 Identities=25% Similarity=0.404 Sum_probs=186.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||+.+++|.+++.+.....+++..+..++.
T Consensus 32 ~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 110 (261)
T cd05072 32 KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110 (261)
T ss_pred eEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHH
Confidence 58899887543 24578899999999999999999999999999999999999999999999766555689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+ .+++|+||||+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++|+
T Consensus 111 ~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di 187 (261)
T cd05072 111 QIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 187 (261)
T ss_pred HHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhh
Confidence 99999999996 45999999999999999999999999999875432211 1222345678999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||....... ....+...........++.++.+++.+||+.+|++|||
T Consensus 188 ~slG~~l~~l~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 250 (261)
T cd05072 188 WSFGILLYEIVTYGKIPYPGMSNSD-----------------VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250 (261)
T ss_pred hhhHHHHHHHHccCCCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence 999999999998 999997643211 11111112222333457788999999999999999999
Q ss_pred HHHHHHHHHhh
Q 021947 241 MSEVLAILERL 251 (305)
Q Consensus 241 ~~~~l~~l~~~ 251 (305)
++++++.|+.+
T Consensus 251 ~~~i~~~l~~~ 261 (261)
T cd05072 251 FDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=284.19 Aligned_cols=229 Identities=25% Similarity=0.417 Sum_probs=181.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC--------CCCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~ 72 (305)
.||||+++.... ....++.+|+.+++.++|+||+++++++.+++..++||||+.+++|.+++.+... ..++
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 117 (277)
T cd05062 38 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117 (277)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCC
Confidence 589998865422 2345688999999999999999999999999999999999999999999865321 2357
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++................++..|+|||++.+
T Consensus 118 ~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05062 118 LKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 195 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc
Confidence 78889999999999999996 4599999999999999999999999999876543322221222345778999999998
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++|+||||+++|+|++ |..||.+.... ..............+..++..+.+++.+||
T Consensus 196 ~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 258 (277)
T cd05062 196 GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCW 258 (277)
T ss_pred CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHc
Confidence 899999999999999999999 78888764321 111111111112334456788999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~ 249 (305)
+.||++|||+.++++.|+
T Consensus 259 ~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 259 QYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCChhhCcCHHHHHHHhh
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=287.21 Aligned_cols=233 Identities=23% Similarity=0.385 Sum_probs=186.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+++.... ....++.+|+.+++.++||||+++++++... ..++++||+.+|+|.+++.... ..++...++.++
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~ 115 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWC 115 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHH
Confidence 489999875532 3346789999999999999999999988764 5789999999999999997654 348888999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|
T Consensus 116 ~qi~~~L~~LH~~--~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D 193 (316)
T cd05108 116 VQIAKGMNYLEER--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD 193 (316)
T ss_pred HHHHHHHHHHHhc--CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhh
Confidence 9999999999964 59999999999999999999999999998765433222222233467899999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+... ..+............+..++..+.+++.+||..+|.+||
T Consensus 194 i~slGv~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 256 (316)
T cd05108 194 VWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP 256 (316)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999999999997 9999976421 111222223333344455677899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 021947 240 RMSEVLAILERLEAPK 255 (305)
Q Consensus 240 s~~~~l~~l~~~~~~~ 255 (305)
++.+++..+..+....
T Consensus 257 s~~~l~~~l~~~~~~~ 272 (316)
T cd05108 257 KFRELIIEFSKMARDP 272 (316)
T ss_pred CHHHHHHHHHHHHcCC
Confidence 9999999998875443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=290.88 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=180.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.... .....+.+|++++++++|+||+++++++.+++..|+||||+.|++|.+++...+ .+++..+..++
T Consensus 32 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 109 (333)
T cd06650 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVS 109 (333)
T ss_pred EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 578888776532 233678999999999999999999999999999999999999999999997654 48889999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+. ++++|+||||+|||++.++.+||+|||++....... .....|+..|+|||++.+..++.++|
T Consensus 110 ~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~D 184 (333)
T cd06650 110 IAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSD 184 (333)
T ss_pred HHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHH
Confidence 9999999999963 359999999999999999999999999987543221 22346899999999999888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhh----hh--------------------hhhhc---cchhhhhhhhcccCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVD----WA--------------------KPYLS---DKRKLFRIMDTKLGG 213 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~--------------------~~~~~---~~~~~~~~~~~~~~~ 213 (305)
+|||||++|+|++|+.||............. .. .+... ....+...+......
T Consensus 185 vwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (333)
T cd06650 185 IWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP 264 (333)
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCc
Confidence 9999999999999999997643221110000 00 00000 000001111111111
Q ss_pred CC-ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 214 QY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 214 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.. ....+.++.+|+.+||..||.+|||+.+++.+
T Consensus 265 ~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 265 KLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 11 12356789999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=290.41 Aligned_cols=225 Identities=24% Similarity=0.293 Sum_probs=182.6
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
++|+|++++...- ..+.++.|-.+|....+|+||++|-.|.+.+.+||||||++||++..+|.+.+ .+++..+..
T Consensus 168 iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arf 245 (550)
T KOG0605|consen 168 IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARF 245 (550)
T ss_pred EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHH
Confidence 6899999876443 34567889999999999999999999999999999999999999999997665 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCC-----------------------CCc---
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-----------------------DRT--- 132 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----------------------~~~--- 132 (305)
++.+++.|+..||. .|+|||||||+|+||+..|++||+|||++.-.... ...
T Consensus 246 YiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (550)
T KOG0605|consen 246 YIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNT 323 (550)
T ss_pred HHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcccccccc
Confidence 99999999999995 45999999999999999999999999998532110 000
Q ss_pred -c------------------eeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 021947 133 -H------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 193 (305)
Q Consensus 133 -~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 193 (305)
. .....+|||.|+|||++.+.+|+..+|.||||||+||||.|.+||.+.+..
T Consensus 324 ~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~--------- 394 (550)
T KOG0605|consen 324 PRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ--------- 394 (550)
T ss_pred ccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---------
Confidence 0 001247999999999999999999999999999999999999999886542
Q ss_pred hhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCCCCCCC---CHHHHHHH
Q 021947 194 KPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRP---RMSEVLAI 247 (305)
Q Consensus 194 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~ 247 (305)
....+++... +..+....++.++++||.+||. ||.+|. .+.||.++
T Consensus 395 -------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 395 -------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred -------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 2222333322 2223334677999999999999 999998 46666653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=279.47 Aligned_cols=228 Identities=27% Similarity=0.407 Sum_probs=181.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+..... .....+.+|++++++++|+||+++++++...+..|+||||+.+++|.+++...+ ..+++..++.++
T Consensus 22 ~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ 100 (252)
T cd05084 22 PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMV 100 (252)
T ss_pred eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence 589998765432 234678999999999999999999999999999999999999999999996543 348899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.................+..|+|||.+.+..++.++|
T Consensus 101 ~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 178 (252)
T cd05084 101 ENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178 (252)
T ss_pred HHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHH
Confidence 999999999995 459999999999999999999999999987543221111111112345799999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++ |..||...... ..............+..++..+.+|+.+||+.+|++||
T Consensus 179 v~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 179 VWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred HHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCc
Confidence 9999999999998 88888653221 11112222223344556778999999999999999999
Q ss_pred CHHHHHHHHH
Q 021947 240 RMSEVLAILE 249 (305)
Q Consensus 240 s~~~~l~~l~ 249 (305)
|+.++++.|+
T Consensus 242 s~~~~~~~l~ 251 (252)
T cd05084 242 SFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=279.42 Aligned_cols=230 Identities=27% Similarity=0.459 Sum_probs=186.5
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++..... ....|.+|+.++++++|+||+++++++..++..+++|||+.+++|.+++..... .+++..+..++
T Consensus 34 ~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~ 112 (266)
T cd05033 34 DVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGML 112 (266)
T ss_pred eEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHH
Confidence 5899998765433 345789999999999999999999999999999999999999999999966443 58999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|
T Consensus 113 ~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~D 190 (266)
T cd05033 113 RGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASD 190 (266)
T ss_pred HHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccc
Confidence 999999999995 569999999999999999999999999998764222221122233467899999999889999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++ |..||...... .+...+........+..++..+.+|+.+||+.+|++||
T Consensus 191 v~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 253 (266)
T cd05033 191 VWSFGIVMWEVMSYGERPYWDMSNQ-----------------DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERP 253 (266)
T ss_pred hHHHHHHHHHHHccCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 9999999999998 99998654311 11111122222233456778899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 021947 240 RMSEVLAILERL 251 (305)
Q Consensus 240 s~~~~l~~l~~~ 251 (305)
++.++++.|+++
T Consensus 254 ~~~ei~~~l~~~ 265 (266)
T cd05033 254 TFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHHhh
Confidence 999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=283.24 Aligned_cols=230 Identities=26% Similarity=0.455 Sum_probs=184.2
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (305)
.||+|.+...... ....+.+|++++++++|+||+++++++..+...|+||||+.+++|.+++..+.
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 115 (283)
T cd05090 36 LVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115 (283)
T ss_pred eEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccccccc
Confidence 5889988754332 23578899999999999999999999999999999999999999999985332
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..++.++.+++.||+|||+ ++++|+||||+||+++.++.+||+|||++................++..|+
T Consensus 116 ~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 193 (283)
T cd05090 116 TVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM 193 (283)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceec
Confidence 1247888899999999999999995 459999999999999999999999999998654332222223334567899
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|+||||+++|+|++ |..||.+... ..+.+.+........+..++..+.
T Consensus 194 aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd05090 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----------------QEVIEMVRKRQLLPCSEDCPPRMY 256 (283)
T ss_pred ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCcCCCCCCCCHHHH
Confidence 9999988889999999999999999998 9999876431 111222222222334456778899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHh
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~ 250 (305)
+++.+||+.||.+||++.++++.|..
T Consensus 257 ~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 257 SLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcccCcccCcCHHHHHHHhhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=285.86 Aligned_cols=241 Identities=22% Similarity=0.235 Sum_probs=178.7
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|+++.... .....+.+|+++++.++|+||+++++++...+..|+||||+.++.+..+.... ..+++..+..+
T Consensus 28 ~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~ 105 (287)
T cd07848 28 IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSY 105 (287)
T ss_pred EEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHH
Confidence 689999875422 23467889999999999999999999999999999999999987665544322 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... ......|+..|+|||++.+..++.++
T Consensus 106 ~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (287)
T cd07848 106 IYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAV 182 (287)
T ss_pred HHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCch
Confidence 9999999999996 45999999999999999999999999999865432211 12234689999999999988999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhcc-------chhhhhhhhcc------cCCCCChHHHHHHHH
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSD-------KRKLFRIMDTK------LGGQYPQKAAHTAAT 225 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~~~~ 225 (305)
|+|||||++|+|++|+.||.+........ ......+.... ........... ........++..+.+
T Consensus 183 DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 262 (287)
T cd07848 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLD 262 (287)
T ss_pred hHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHH
Confidence 99999999999999999998754321110 00000000000 00000000000 000112236778999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
||.+||+.||++|||+++++++
T Consensus 263 ll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 263 LMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHccCCcccCCCHHHHhcC
Confidence 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=283.92 Aligned_cols=231 Identities=28% Similarity=0.451 Sum_probs=185.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc-------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR------------- 66 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------- 66 (305)
.||+|.++.... ....++.+|+++++++ +|+||+++++++..++..+++|||+.+++|.+++..+
T Consensus 44 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 123 (293)
T cd05053 44 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123 (293)
T ss_pred eEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccccccc
Confidence 589998876432 2335688999999999 7999999999999999999999999999999999643
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 67 -GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 67 -~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
....+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...............++..|+
T Consensus 124 ~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 201 (293)
T cd05053 124 PPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWM 201 (293)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCcccc
Confidence 23458889999999999999999995 459999999999999999999999999998654322211122223466799
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|||||||++|+|++ |..||.+.... ...+.+........+..++..+.
T Consensus 202 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 264 (293)
T cd05053 202 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----------------ELFKLLKEGYRMEKPQNCTQELY 264 (293)
T ss_pred CHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHH
Confidence 9999988899999999999999999997 99998764321 11222222223334556778899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+|+.+||..||.+|||+.++++.|+.+
T Consensus 265 ~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 265 HLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=289.96 Aligned_cols=232 Identities=27% Similarity=0.380 Sum_probs=180.7
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||+++.+.. .....+.+|..++.++ +||||+++++++...+..|+||||++|++|.+++.+.+ .+++..+
T Consensus 21 ~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~ 98 (329)
T cd05588 21 RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHA 98 (329)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHH
Confidence 3689999986432 2235678899999998 69999999999999999999999999999999886553 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....... .......||..|+|||++.+..++
T Consensus 99 ~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 99 RFYSAEISLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred HHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCC
Confidence 99999999999999964 59999999999999999999999999987432211 112345789999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|+.||......... .......+.+.+. ......+..++..+.++|.+||+.||.
T Consensus 175 ~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~ 245 (329)
T cd05588 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNP--------DQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKGFLNKDPK 245 (329)
T ss_pred CccceechHHHHHHHHHCCCCcccccccccc--------cccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence 9999999999999999999999743211100 0000011111111 112234566788899999999999999
Q ss_pred CCCC------HHHHHHH
Q 021947 237 LRPR------MSEVLAI 247 (305)
Q Consensus 237 ~Rps------~~~~l~~ 247 (305)
+|+| +.+++++
T Consensus 246 ~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 246 ERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HcCCCCCCCCHHHHhcC
Confidence 9997 5666643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=298.44 Aligned_cols=220 Identities=27% Similarity=0.398 Sum_probs=184.6
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..|||+++++. .++.+..+.|.+++...+ ||.++.++..|...+++|+||||+.||++..+++. ..+++..+.
T Consensus 395 ~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rar 471 (694)
T KOG0694|consen 395 YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRAR 471 (694)
T ss_pred EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHH
Confidence 57999999873 355577889999998885 99999999999999999999999999995554432 249999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
-++.+++.||.|||+ +||||||||.+|||+|.+|.+||+|||+++..-..+ ....+.+||+.|+|||++.+..|+.
T Consensus 472 fyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~ 547 (694)
T KOG0694|consen 472 FYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTR 547 (694)
T ss_pred HHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccc
Confidence 999999999999995 559999999999999999999999999998743222 2466789999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|.||||++||+|+.|..||.+.++.. ....++. ....+|..++.+...+++++|..||++
T Consensus 548 aVDWW~lGVLlyeML~Gq~PF~gddEee----------------~FdsI~~--d~~~yP~~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 548 AVDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDSIVN--DEVRYPRFLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhc--CCCCCCCcccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999865421 1112222 234678889999999999999999999
Q ss_pred CCC-----HHHHHH
Q 021947 238 RPR-----MSEVLA 246 (305)
Q Consensus 238 Rps-----~~~~l~ 246 (305)
|.. +++|..
T Consensus 610 RLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 610 RLGSGERDAEDIKK 623 (694)
T ss_pred ccCCCCCCchhhhh
Confidence 984 455554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=278.78 Aligned_cols=228 Identities=29% Similarity=0.425 Sum_probs=185.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++... ...+.+.+|++++++++|+||+++++++...+..+++|||+.+++|.+++.......+++..+..++.
T Consensus 32 ~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 110 (261)
T cd05068 32 PVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110 (261)
T ss_pred EEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHH
Confidence 58999987653 34567899999999999999999999999999999999999999999999766545689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.+||+ +|++|+||||+||+++.++.++|+|||++......... .......+..|+|||++.+..++.++|+
T Consensus 111 ~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di 187 (261)
T cd05068 111 QVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDV 187 (261)
T ss_pred HHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhH
Confidence 99999999995 46999999999999999999999999999876432111 1111223457999999988899999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |+.||.+.+.. .....+........+..++..+.+++.+||+.+|.+||+
T Consensus 188 ~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 250 (261)
T cd05068 188 WSFGILLTEIVTYGRMPYPGMTNA-----------------EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPT 250 (261)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCC
Confidence 999999999999 99999764321 111122222222344567789999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
+.++++.|+.
T Consensus 251 ~~~l~~~l~~ 260 (261)
T cd05068 251 FETLQWKLED 260 (261)
T ss_pred HHHHHHHHhc
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=282.72 Aligned_cols=229 Identities=26% Similarity=0.446 Sum_probs=184.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-------------
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------- 68 (305)
.||+|.+..........+.+|+++++.++|+||+++++++..+...+++|||+.+++|.+++.....
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (280)
T cd05092 37 LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116 (280)
T ss_pred EEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCc
Confidence 5788888765555567899999999999999999999999999999999999999999999965432
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
..+++..++.++.|++.||+|||+ .|++|+||||+||++++++.+||+|||++................++..|+|||
T Consensus 117 ~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05092 117 GQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194 (280)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHH
Confidence 247889999999999999999995 459999999999999999999999999987553322212122234567899999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (305)
.+.+..++.++|+|||||++|+|++ |..||....... .............+..++..+.+|+
T Consensus 195 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li 257 (280)
T cd05092 195 SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-----------------AIECITQGRELERPRTCPPEVYAIM 257 (280)
T ss_pred HhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----------------HHHHHHcCccCCCCCCCCHHHHHHH
Confidence 9999999999999999999999998 899986533211 1111112222233456778899999
Q ss_pred HhhccCCCCCCCCHHHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
.+||..||.+||++.++++.|+
T Consensus 258 ~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 258 QGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHccCChhhCCCHHHHHHHHh
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=271.30 Aligned_cols=207 Identities=29% Similarity=0.393 Sum_probs=176.1
Q ss_pred HHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCce
Q 021947 19 WLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 97 (305)
Q Consensus 19 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 97 (305)
-.+|+.+|+++ .||||+++.++++.+...|+|+|.|+.|.|.|++...- .++++....++.|+.+|+.|||.. +|
T Consensus 69 T~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~--~I 144 (411)
T KOG0599|consen 69 TRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR--NI 144 (411)
T ss_pred HHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh--hh
Confidence 46799999998 59999999999999999999999999999999996554 499999999999999999999964 59
Q ss_pred eeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc------CCCCCCCceehhhHHHHHH
Q 021947 98 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLEL 171 (305)
Q Consensus 98 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~~l 171 (305)
+||||||+|||++++.++||+|||+++....... ....|||++|+|||.+.- .+|+..+|+||.|+|+|.|
T Consensus 145 VHRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTL 221 (411)
T KOG0599|consen 145 VHRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTL 221 (411)
T ss_pred hhcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHH
Confidence 9999999999999999999999999998765433 456799999999998743 4688899999999999999
Q ss_pred HhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 172 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
+.|.+||...... -.+..++...+ ..+...+++....+||.+||..||.+|.|++|++.+-
T Consensus 222 LaGcpPFwHRkQm----------------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 222 LAGCPPFWHRKQM----------------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HcCCCchhHHHHH----------------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 9999999875321 11222333333 3444568999999999999999999999999999753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=294.80 Aligned_cols=226 Identities=23% Similarity=0.263 Sum_probs=175.4
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||++.... ......+.+|++++++++||||+++++++.+....|+||||++|++|.+++.... .+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~ 104 (377)
T cd05629 27 KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTR 104 (377)
T ss_pred CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 368999886432 1233567889999999999999999999999999999999999999999996554 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------------- 132 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------------------------- 132 (305)
.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus 105 ~~~~ql~~aL~~LH~~--givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (377)
T cd05629 105 FYMAECVLAIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182 (377)
T ss_pred HHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999964 5999999999999999999999999998632110000
Q ss_pred --------------------ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 021947 133 --------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 192 (305)
Q Consensus 133 --------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 192 (305)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------ 256 (377)
T cd05629 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET------ 256 (377)
T ss_pred cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH------
Confidence 000124689999999999999999999999999999999999999976442110
Q ss_pred hhhhhccchhhhhhhhcccCCCCC--hHHHHHHHHHHHhhccCCCCCC---CCHHHHHHH
Q 021947 193 AKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLR---PRMSEVLAI 247 (305)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~~ 247 (305)
...+........++ ..++.++.+||.+||. +|.+| +++.+++.+
T Consensus 257 ----------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 257 ----------YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ----------HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 01111101111112 2467889999999997 77765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=289.54 Aligned_cols=217 Identities=29% Similarity=0.388 Sum_probs=176.0
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||+++... ......+.+|..++..+ +||||+++++++...+.+|+||||++|++|.+++.+.. .+++..+
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~ 98 (320)
T cd05590 21 RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARA 98 (320)
T ss_pred CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC--CCCHHHH
Confidence 368999987542 23345677899998877 69999999999999999999999999999999886554 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++
T Consensus 99 ~~~~~ql~~~L~~lH~~--~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 174 (320)
T cd05590 99 RFYAAEITSALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYG 174 (320)
T ss_pred HHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCC
Confidence 99999999999999964 599999999999999999999999999875322211 12345689999999999988999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|+.||.+.+... +...+.. .....+..++.++.+|+.+||..||.
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~-----------------~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDD-----------------LFEAILN-DEVVYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred CccchhhhHHHHHHHhhCCCCCCCCCHHH-----------------HHHHHhc-CCCCCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999998654211 1111111 11233455778899999999999999
Q ss_pred CCCCH
Q 021947 237 LRPRM 241 (305)
Q Consensus 237 ~Rps~ 241 (305)
+|+++
T Consensus 237 ~R~~~ 241 (320)
T cd05590 237 MRLGS 241 (320)
T ss_pred HCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=288.45 Aligned_cols=233 Identities=31% Similarity=0.442 Sum_probs=183.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCC----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGP---------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---------- 68 (305)
.||+|+++.... ...+.+.+|++++.++ +|+||+++++++... ...+++|||+++++|.+++.....
T Consensus 39 ~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~ 118 (337)
T cd05054 39 TVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKST 118 (337)
T ss_pred eeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccc
Confidence 699999875432 2235688999999999 799999999988654 567899999999999999854321
Q ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHHHhhhhcCCCceee
Q 021947 69 -------------------------------------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 99 (305)
Q Consensus 69 -------------------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 99 (305)
..+++..+..++.|++.||+|||+ +||+|
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH 196 (337)
T cd05054 119 RKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIH 196 (337)
T ss_pred cccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeec
Confidence 257889999999999999999995 46999
Q ss_pred ccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCcc
Q 021947 100 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAV 178 (305)
Q Consensus 100 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf 178 (305)
|||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 197 rDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~ 276 (337)
T cd05054 197 RDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276 (337)
T ss_pred CCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986543222222223345678999999999999999999999999999998 99999
Q ss_pred CCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.+..... .+...+........+...+.++.+++.+||+.+|++||++.+++++|+++.
T Consensus 277 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 277 PGVQIDE----------------EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred CCCCccH----------------HHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7633210 111112222222334456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=282.09 Aligned_cols=231 Identities=26% Similarity=0.363 Sum_probs=181.5
Q ss_pred CEEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||+|++...... ....+..|++++++++||||+++++++..+...|+||||+.|++|.+++.......+++..+.
T Consensus 19 ~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~ 98 (277)
T cd05607 19 KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI 98 (277)
T ss_pred cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHH
Confidence 36899988653221 234566799999999999999999999999999999999999999998876665568999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.
T Consensus 99 ~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 173 (277)
T cd05607 99 HYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSY 173 (277)
T ss_pred HHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCC
Confidence 999999999999996 459999999999999999999999999987654322 123346889999999999888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.......... ........... ......++.++.+|+.+||+.||.+
T Consensus 174 ~~DvwslGv~l~el~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~ 240 (277)
T cd05607 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE------------ELKRRTLEDEV-KFEHQNFTEESKDICRLFLAKKPED 240 (277)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCcchhhHH------------HHHHHhhcccc-ccccccCCHHHHHHHHHHhccCHhh
Confidence 9999999999999999999997643211100 00001111111 1112356788999999999999999
Q ss_pred CCCHHHHHHHHH
Q 021947 238 RPRMSEVLAILE 249 (305)
Q Consensus 238 Rps~~~~l~~l~ 249 (305)
||++.++++.+.
T Consensus 241 R~~~~~~~~~~~ 252 (277)
T cd05607 241 RLGSREKNDDPR 252 (277)
T ss_pred CCCCccchhhhh
Confidence 999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=290.90 Aligned_cols=228 Identities=29% Similarity=0.438 Sum_probs=198.2
Q ss_pred EEEEEecccC-CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
-||||..+.+ ..++.+.|+.|+.+|+.+.||||++++|+|.+ ...|||||++.-|.|.+|++.++. .++......++
T Consensus 420 aVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~ 497 (974)
T KOG4257|consen 420 AVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYC 497 (974)
T ss_pred eeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccc-cchHHHHHHHH
Confidence 4999999985 44556889999999999999999999999975 578999999999999999977664 49999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.||+.+|+||||.+ +|||||-..|||+.....|||+|||++++..+....... ...-..-|||||.+....++.++|
T Consensus 498 ~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASD 574 (974)
T KOG4257|consen 498 YQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASD 574 (974)
T ss_pred HHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhh
Confidence 99999999999866 999999999999999999999999999998765544322 333467899999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+|.||+++||++. |..||.+-. +....-.++.+.+.+.|++|+..+..|+.+||..+|.+||
T Consensus 575 VWMFgVCmWEIl~lGvkPfqgvk-----------------NsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRP 637 (974)
T KOG4257|consen 575 VWMFGVCMWEILSLGVKPFQGVK-----------------NSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRP 637 (974)
T ss_pred HHHHHHHHHHHHHhcCCcccccc-----------------ccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCC
Confidence 9999999999997 999998743 2233444567778899999999999999999999999999
Q ss_pred CHHHHHHHHHhh
Q 021947 240 RMSEVLAILERL 251 (305)
Q Consensus 240 s~~~~l~~l~~~ 251 (305)
++.++...|..+
T Consensus 638 rftei~~~lsdv 649 (974)
T KOG4257|consen 638 RFTEIKAILSDV 649 (974)
T ss_pred cHHHHHHHHHHH
Confidence 999999887654
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=281.92 Aligned_cols=230 Identities=25% Similarity=0.403 Sum_probs=185.2
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (305)
.||||+++..... ....+.+|+.++..++||||+++++++...+..++++||+.+++|.+++....
T Consensus 37 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 116 (283)
T cd05091 37 AVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116 (283)
T ss_pred EEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccc
Confidence 5899999865332 23568899999999999999999999999999999999999999999985321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccc
Q 021947 68 -PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 146 (305)
Q Consensus 68 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 146 (305)
...++...+..++.|++.||.|||+ +|++||||||+||++++++.+||+|||+++...............++..|+|
T Consensus 117 ~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05091 117 VKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194 (283)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccC
Confidence 1247888899999999999999996 4599999999999999999999999999886543322222233445778999
Q ss_pred hhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 147 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 147 PE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
||++.+..++.++|||||||++|+|++ |..||.+... ....+.+........+..++..+.+
T Consensus 195 PE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~ 257 (283)
T cd05091 195 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----------------QDVIEMIRNRQVLPCPDDCPAWVYT 257 (283)
T ss_pred HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 999988889999999999999999998 8888876432 1122222222233445678889999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHh
Q 021947 226 LALQCLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l~~ 250 (305)
|+.+||+.+|.+||++.+++..|+.
T Consensus 258 li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 258 LMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHhCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=277.01 Aligned_cols=229 Identities=32% Similarity=0.482 Sum_probs=189.9
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------CCCCCH
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-------PQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~ 73 (305)
.||+|.++...... ...+.+|++.+..++|+||+++++++..+...++||||+.+++|.+++.... ...+++
T Consensus 25 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 104 (262)
T cd00192 25 EVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL 104 (262)
T ss_pred eEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCH
Confidence 68999988765443 5788999999999999999999999999999999999999999999997641 245899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.+++.||+|||+ ++++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+.
T Consensus 105 ~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 105 KDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred HHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC
Confidence 9999999999999999996 56999999999999999999999999999876543322223344578899999999888
Q ss_pred CCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++|+||||+++|+|++ |..||..... ..+.+.+........+..++.++.+++.+||+
T Consensus 183 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 245 (262)
T cd00192 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----------------EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQ 245 (262)
T ss_pred CcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCChHHHHHHHHHcc
Confidence 89999999999999999999 6999976521 11122222233344566778999999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAILE 249 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~ 249 (305)
.+|.+|||+.++++.|+
T Consensus 246 ~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 246 LDPEDRPTFSELVERLE 262 (262)
T ss_pred CCcccCcCHHHHHHhhC
Confidence 99999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.24 Aligned_cols=222 Identities=27% Similarity=0.346 Sum_probs=179.2
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++.+. ......+..|.+++..+ +||||+++++++...+..|+||||++|++|..++.... .+++..+.
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~ 99 (321)
T cd05591 22 VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSR 99 (321)
T ss_pred EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 68999987542 22335677899999876 79999999999999999999999999999999886554 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.
T Consensus 100 ~~~~qi~~aL~~LH~~--~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (321)
T cd05591 100 FYAAEVTLALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGP 175 (321)
T ss_pred HHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCC
Confidence 9999999999999964 599999999999999999999999999875332221 123456899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|+.||...+... ....+... ....+..++.++.+|+.+||..||++
T Consensus 176 ~~DvwslG~il~el~tg~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 176 SVDWWALGVLMYEMMAGQPPFEADNEDD----------------LFESILHD--DVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred ccceechhHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999999999999998654211 11111111 12234456788999999999999999
Q ss_pred CC-------CHHHHHHH
Q 021947 238 RP-------RMSEVLAI 247 (305)
Q Consensus 238 Rp-------s~~~~l~~ 247 (305)
|+ ++.+++++
T Consensus 238 R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 238 RLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCCCCCCCCCHHHHhcC
Confidence 99 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=277.52 Aligned_cols=229 Identities=28% Similarity=0.419 Sum_probs=185.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||.++.+.. ...+.+.+|++++++++|+||+++++++.. ...++||||+++++|.+++.++....+++..+..++
T Consensus 25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (257)
T cd05040 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA 103 (257)
T ss_pred EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHH
Confidence 589999988766 455789999999999999999999999988 889999999999999999976553458999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++
T Consensus 104 ~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~ 181 (257)
T cd05040 104 VQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHAS 181 (257)
T ss_pred HHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchh
Confidence 999999999995 56999999999999999999999999999876442211 112234567889999999888999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|+||||+++|+|++ |..||....... ..............+...+..+.+++.+||+.+|.+|
T Consensus 182 Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd05040 182 DVWMFGVTLWEMFTYGEEPWAGLSGSQ----------------ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADR 245 (257)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccC
Confidence 99999999999998 999996543211 0001111111222344567889999999999999999
Q ss_pred CCHHHHHHHHH
Q 021947 239 PRMSEVLAILE 249 (305)
Q Consensus 239 ps~~~~l~~l~ 249 (305)
||+.++++.|.
T Consensus 246 ps~~~~~~~l~ 256 (257)
T cd05040 246 PTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHhc
Confidence 99999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=282.65 Aligned_cols=228 Identities=25% Similarity=0.362 Sum_probs=180.4
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~ 76 (305)
.||+|++...... ..+.+..|+++++.++|+||+++++++......|+||||++|++|.+++... ....+++..+
T Consensus 20 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~ 99 (280)
T cd05608 20 LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRA 99 (280)
T ss_pred EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHH
Confidence 6899998754322 2256788999999999999999999999999999999999999999887432 2345899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......... .....|+..|+|||++.+..++
T Consensus 100 ~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~ 175 (280)
T cd05608 100 CFYTAQIISGLEHLHQR--RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYD 175 (280)
T ss_pred HHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCC
Confidence 99999999999999964 5999999999999999999999999999765432211 2334689999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+||||+++|+|++|+.||......... ........ ......+..++..+.+++.+||+.||+
T Consensus 176 ~~~DvwslG~il~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~ 241 (280)
T cd05608 176 FSVDYFALGVTLYEMIAARGPFRARGEKVEN-------------KELKQRIL-NDSVTYPDKFSPASKSFCEALLAKDPE 241 (280)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCcchhH-------------HHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcCCHH
Confidence 9999999999999999999999764321110 00001010 111234556788999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 021947 237 LRP-----RMSEVLAI 247 (305)
Q Consensus 237 ~Rp-----s~~~~l~~ 247 (305)
+|| ++++++++
T Consensus 242 ~R~~~~~~~~~~~l~h 257 (280)
T cd05608 242 KRLGFRDGNCDGLRTH 257 (280)
T ss_pred HhcCCCCCCHHHHhcC
Confidence 999 66777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=292.82 Aligned_cols=223 Identities=25% Similarity=0.338 Sum_probs=174.0
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||++..... .....+.+|+++++.++|+||+++++++..++..++||||+++++|.+.. ...+..+..+
T Consensus 100 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i 173 (353)
T PLN00034 100 RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADV 173 (353)
T ss_pred CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHH
Confidence 3689999865432 22467899999999999999999999999999999999999999986532 2567778889
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-----CC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GR 154 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~ 154 (305)
+.|++.||.|||+. |++||||||+|||++.++.+||+|||++........ ......||..|+|||++.. ..
T Consensus 174 ~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (353)
T PLN00034 174 ARQILSGIAYLHRR--HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAY 249 (353)
T ss_pred HHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcC
Confidence 99999999999964 599999999999999999999999999976533211 1233468999999998743 23
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
.+.++|||||||++|+|++|+.||........ ..+............+..++.++.+||.+||..|
T Consensus 250 ~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 315 (353)
T PLN00034 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--------------ASLMCAICMSQPPEAPATASREFRHFISCCLQRE 315 (353)
T ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--------------HHHHHHHhccCCCCCCCccCHHHHHHHHHHccCC
Confidence 45689999999999999999999974321110 0011111111222334567889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|++|||+.+++++
T Consensus 316 P~~Rpt~~ell~h 328 (353)
T PLN00034 316 PAKRWSAMQLLQH 328 (353)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=296.02 Aligned_cols=229 Identities=27% Similarity=0.412 Sum_probs=203.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
-||||.++.+ ....++|+.|+.+|+.++|||+|+++++|..+-..|||+|||..|+|.+|+++.....++....+.++.
T Consensus 294 TvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAt 372 (1157)
T KOG4278|consen 294 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMAT 372 (1157)
T ss_pred eeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHH
Confidence 3899999876 356689999999999999999999999999999999999999999999999888877788889999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
||..|+.||.. +++|||||-..|+|+.++..||++|||+++.+..+.... .....-...|.|||-+....++.++||
T Consensus 373 QIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDV 449 (1157)
T KOG4278|consen 373 QISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDV 449 (1157)
T ss_pred HHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhh
Confidence 99999999995 559999999999999999999999999999876543322 112223678999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
|+||++|||+.| |..||.+-+ ....+..++++++...|.+|+..+++|++.||+++|.+||+
T Consensus 450 WAFGVLLWEIATYGMsPYPGid-----------------lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPs 512 (1157)
T KOG4278|consen 450 WAFGVLLWEIATYGMSPYPGID-----------------LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPS 512 (1157)
T ss_pred HHHHHHHHHHHhcCCCCCCCcc-----------------HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCcc
Confidence 999999999998 899998743 45677888999999999999999999999999999999999
Q ss_pred HHHHHHHHHhh
Q 021947 241 MSEVLAILERL 251 (305)
Q Consensus 241 ~~~~l~~l~~~ 251 (305)
+.|+-..++.+
T Consensus 513 FaeiHqafEtm 523 (1157)
T KOG4278|consen 513 FAEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHHHH
Confidence 99999888764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=287.89 Aligned_cols=232 Identities=26% Similarity=0.371 Sum_probs=179.8
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.||+|+++.... .....+.+|+.++.++ +||||+++++++...+..|+||||+.+++|..++.... .+++..+
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~ 98 (329)
T cd05618 21 RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHA 98 (329)
T ss_pred CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHH
Confidence 3689999876422 2335677899988877 79999999999999999999999999999999886554 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+..++
T Consensus 99 ~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 99 RFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred HHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCC
Confidence 99999999999999964 599999999999999999999999999875322111 12345789999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|..||......... .......+.+... ......+..++..+.+||.+||+.||.
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~~L~~dP~ 245 (329)
T cd05618 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPK 245 (329)
T ss_pred CccceecccHHHHHHhhCCCCCccCCCcCCc--------ccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHH
Confidence 9999999999999999999999642211000 0000001111111 122345667788999999999999999
Q ss_pred CCCCH------HHHHHH
Q 021947 237 LRPRM------SEVLAI 247 (305)
Q Consensus 237 ~Rps~------~~~l~~ 247 (305)
+||++ .+++++
T Consensus 246 ~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 246 ERLGCHPQTGFADIQGH 262 (329)
T ss_pred HcCCCCCCCCHHHHhcC
Confidence 99984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=284.80 Aligned_cols=241 Identities=23% Similarity=0.297 Sum_probs=178.9
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||+|+++.... .....+.+|++++++++||||+++++++......++||||+.+ +|.+++...+ ..++...+..+
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~ 108 (288)
T cd07871 31 NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIF 108 (288)
T ss_pred CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHH
Confidence 3689999875432 2345678999999999999999999999998999999999975 9999886544 34788999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 158 (305)
+.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++........ .....++..|+|||++.+ ..++.+
T Consensus 109 ~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~ 184 (288)
T cd07871 109 MFQLLRGLSYCHKR--KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTP 184 (288)
T ss_pred HHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcH
Confidence 99999999999964 5999999999999999999999999999764322211 233467899999998865 468899
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhh------hhccchhhhhhhhcccC----CCCChHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKP------YLSDKRKLFRIMDTKLG----GQYPQKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l 226 (305)
+|||||||++|+|++|+.||.+.+...... .... ..+ ................. ......++.++.+|
T Consensus 185 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 264 (288)
T cd07871 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDL 264 (288)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHH
Confidence 999999999999999999998754322111 0000 000 00001111111100000 00112456788999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||..||.+|||+++++++
T Consensus 265 l~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 265 LSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHhcCcCcccCCCHHHHhcC
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.62 Aligned_cols=244 Identities=31% Similarity=0.464 Sum_probs=186.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.++.... .....+.+|++++++++||||+++++++... ...+++|||+.+++|.+++... .+++..+..
T Consensus 35 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~ 111 (283)
T cd05080 35 MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLL 111 (283)
T ss_pred eEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHH
Confidence 589999876533 2346788999999999999999999987653 4578999999999999999654 389999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.
T Consensus 112 i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 189 (283)
T cd05080 112 FAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY 189 (283)
T ss_pred HHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCc
Confidence 99999999999996 45999999999999999999999999999865433221 1112234566799999998888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|++|..||........... ..... ......+.+..........+..++.++.+++.+||+.+|++
T Consensus 190 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 267 (283)
T cd05080 190 ASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQG-QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKF 267 (283)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-ccccc-ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhh
Confidence 99999999999999999999865432211100 00000 00111122222223333345567889999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021947 238 RPRMSEVLAILERLE 252 (305)
Q Consensus 238 Rps~~~~l~~l~~~~ 252 (305)
|||++++++.|+.+.
T Consensus 268 Rps~~~i~~~l~~~~ 282 (283)
T cd05080 268 RPTFRSLIPILKEMH 282 (283)
T ss_pred CCCHHHHHHHHHHhh
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=287.42 Aligned_cols=218 Identities=27% Similarity=0.342 Sum_probs=173.4
Q ss_pred CEEEEEecccCCc---cChHHHHHHHH-HHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.||||++..... .....+++|.. +++.++||||+++++.+...+..|+||||+.|++|.+++.+.. .+++..+
T Consensus 21 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~ 98 (323)
T cd05575 21 KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRA 98 (323)
T ss_pred CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC--CCCHHHH
Confidence 3689999875422 22345556655 4677899999999999999999999999999999999986544 4889999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++
T Consensus 99 ~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (323)
T cd05575 99 RFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYD 174 (323)
T ss_pred HHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCC
Confidence 9999999999999996 459999999999999999999999999987532211 113345689999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|||||||++|+|++|..||...+... ....+... ....+..++..+.++|.+||+.||.
T Consensus 175 ~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNILNK--PLRLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred ccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999997643210 01111111 1223445688899999999999999
Q ss_pred CCCCHH
Q 021947 237 LRPRMS 242 (305)
Q Consensus 237 ~Rps~~ 242 (305)
+||++.
T Consensus 237 ~R~~~~ 242 (323)
T cd05575 237 KRLGAK 242 (323)
T ss_pred hCCCCC
Confidence 999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=281.86 Aligned_cols=232 Identities=29% Similarity=0.448 Sum_probs=186.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (305)
.||+|.++.... ....++.+|+++++.++||||+++++.+...+..++++||+.+++|.+++....
T Consensus 32 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 111 (290)
T cd05045 32 TVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111 (290)
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCcccccccccccc
Confidence 588888875532 234578899999999999999999999999999999999999999999985421
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 68 ---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 68 ---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
...+++..++.++.+++.||.|||+ .+++||||||+||++++++.+||+|||+++..............
T Consensus 112 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 189 (290)
T cd05045 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189 (290)
T ss_pred ccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCC
Confidence 1247888999999999999999995 45999999999999999999999999999764332221112223
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... ..+.+.+........+.
T Consensus 190 ~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~ 252 (290)
T cd05045 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-----------------ERLFNLLKTGYRMERPE 252 (290)
T ss_pred CCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHhCCCCCCCCC
Confidence 45678999999988889999999999999999998 9999976432 11222223333334455
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.++..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 253 ~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 253 NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 67789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=290.67 Aligned_cols=220 Identities=31% Similarity=0.431 Sum_probs=186.5
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+||||+++-.+..+ ..+++.|++.|++++|||++.+-|.|..+...|||||||-| +-.|++.-. .+++.+..+..
T Consensus 53 vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVh-kKplqEvEIAA 130 (948)
T KOG0577|consen 53 VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAA 130 (948)
T ss_pred eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHH-hccchHHHHHH
Confidence 79999997554433 36789999999999999999999999999999999999965 888888433 35699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~ 155 (305)
|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.+..... ...++||+.|||||++. .+.|
T Consensus 131 i~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqY 202 (948)
T KOG0577|consen 131 ITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY 202 (948)
T ss_pred HHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheecccccc
Confidence 9999999999999876 99999999999999999999999999876433 34578999999999874 5789
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+-++||||||+++.+|...++|+..++. ...++.+..+....-..+..+..+..|+..||.+-|
T Consensus 203 dgkvDvWSLGITCIELAERkPPlFnMNA----------------MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKip 266 (948)
T KOG0577|consen 203 DGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 266 (948)
T ss_pred CCccceeeccchhhhhhhcCCCccCchH----------------HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCc
Confidence 9999999999999999999999877542 334444444444334456789999999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+|||.++++.+
T Consensus 267 qeRptse~ll~H 278 (948)
T KOG0577|consen 267 QERPTSEELLKH 278 (948)
T ss_pred ccCCcHHHHhhc
Confidence 999999999854
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=282.94 Aligned_cols=227 Identities=28% Similarity=0.405 Sum_probs=183.2
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++...... ....+.+|+++++.++|+||+++++.+..++..++||||+.|++|.+++.......+++..+..
T Consensus 27 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 106 (285)
T cd05605 27 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106 (285)
T ss_pred eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHH
Confidence 6899998754322 2345788999999999999999999999999999999999999999988665555689999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........ .....|+..|+|||++.+..++.+
T Consensus 107 ~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 181 (285)
T cd05605 107 YAAEITCGLEDLHRE--RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFS 181 (285)
T ss_pred HHHHHHHHHHHHHHC--CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCcc
Confidence 999999999999964 599999999999999999999999999876533221 223468999999999998899999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||+|+++|+|++|..||.+....... ..+...+. .....++..++..+.+|+.+||..||.+|
T Consensus 182 ~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05605 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFR 247 (285)
T ss_pred ccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHHhh-hcccccCcccCHHHHHHHHHHccCCHHHh
Confidence 99999999999999999999865421110 01111111 11223455678889999999999999999
Q ss_pred C-----CHHHHHHH
Q 021947 239 P-----RMSEVLAI 247 (305)
Q Consensus 239 p-----s~~~~l~~ 247 (305)
| ++++++++
T Consensus 248 ~~~~~~~~~~l~~~ 261 (285)
T cd05605 248 LGCRGEGAEEVKAH 261 (285)
T ss_pred cCCCCCCHHHHhcC
Confidence 9 78888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=294.69 Aligned_cols=225 Identities=25% Similarity=0.404 Sum_probs=190.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCC--CHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL--SWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~ 79 (305)
-+|||.+........+-+..|+.+.++|+|.|||+++|.+.+++..-|.||-++||+|.++++..-+ ++ ++.++-.+
T Consensus 602 rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWG-PlKDNEstm~fY 680 (1226)
T KOG4279|consen 602 RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWG-PLKDNESTMNFY 680 (1226)
T ss_pred EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccC-CCccchhHHHHH
Confidence 4789998877666667789999999999999999999999999999999999999999999965543 35 78888899
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC--CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~ 156 (305)
.+||++||.|||+ +.|||||||-+|+|++. .|.+||+|||-++...... ....++.||.-|||||++..+ +|+
T Consensus 681 tkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG 756 (1226)
T KOG4279|consen 681 TKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYG 756 (1226)
T ss_pred HHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhhhChHhhccCCcCCC
Confidence 9999999999995 45999999999999965 6889999999998754332 235677899999999999876 588
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|||||||++.||.||++||-..... ...+++.-..+.-.+.|..++.+++.||.+|+.+||.
T Consensus 757 ~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~ 821 (1226)
T KOG4279|consen 757 KAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPC 821 (1226)
T ss_pred chhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcc
Confidence 8999999999999999999999764322 2223333333444567889999999999999999999
Q ss_pred CCCCHHHHHH
Q 021947 237 LRPRMSEVLA 246 (305)
Q Consensus 237 ~Rps~~~~l~ 246 (305)
+||++.+++.
T Consensus 822 ~R~sA~~LL~ 831 (1226)
T KOG4279|consen 822 DRPSAKDLLQ 831 (1226)
T ss_pred cCccHHHhcc
Confidence 9999999986
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=290.43 Aligned_cols=175 Identities=26% Similarity=0.318 Sum_probs=153.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-C-----CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-H-----PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||||+++..- ....+...|+.+|..|+ | -|+|+++++|...++.|||+|.+. .+|.++++.+...+++..
T Consensus 212 e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~ 289 (586)
T KOG0667|consen 212 EIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLP 289 (586)
T ss_pred cEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHH
Confidence 369999998762 34466778999999997 3 789999999999999999999995 599999999998899999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC--ceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
.+..++.||+.||.+||. .+|||+||||+|||+..-+ .+||+|||.++...... ...+.+..|+|||++.|
T Consensus 290 ~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILG 362 (586)
T KOG0667|consen 290 LVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILG 362 (586)
T ss_pred HHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhcc
Confidence 999999999999999995 5599999999999996643 59999999998754321 24567899999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCccc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 184 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 184 (305)
.+|+.+.||||||||++||++|.+.|.+.++.
T Consensus 363 lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 363 LPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 99999999999999999999999999987764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=279.31 Aligned_cols=229 Identities=27% Similarity=0.410 Sum_probs=182.1
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----CCCCHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~ 75 (305)
.||+|.+...... ....+.+|+.++++++|+||+++++++.+....++||||+.|++|.+++.+... ..+++..
T Consensus 38 ~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~ 117 (277)
T cd05036 38 QVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117 (277)
T ss_pred eEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHH
Confidence 5888988654322 235689999999999999999999999988899999999999999999965432 2488999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC---ceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.++.+++.||.|||+. +++|+||||+||+++.++ .+||+|||+++................+..|+|||++.+
T Consensus 118 ~~~~~~qi~~~l~~LH~~--~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05036 118 LLFCARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195 (277)
T ss_pred HHHHHHHHHHHHHHHHHC--CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence 999999999999999964 599999999999998765 589999999986532221111112233568999999998
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++|||||||++|+|++ |..||.+.... .+...+........+..++..+.+++.+||
T Consensus 196 ~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 258 (277)
T cd05036 196 GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----------------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCW 258 (277)
T ss_pred CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHc
Confidence 899999999999999999997 99999864321 112222222233345567789999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~ 249 (305)
+.+|++|||+.+++++|.
T Consensus 259 ~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 259 QHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCcccCcCHHHHHHHhh
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.72 Aligned_cols=233 Identities=26% Similarity=0.447 Sum_probs=185.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||+|.++.... .....+.+|+++++++ +||||+++++++...+..|++|||+.+++|.+++....
T Consensus 46 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ 125 (314)
T cd05099 46 TVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125 (314)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccC
Confidence 488998875432 3345788999999999 69999999999998889999999999999999996532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||+++...............++..|+
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 203 (314)
T cd05099 126 VPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM 203 (314)
T ss_pred CcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCcccc
Confidence 1347888999999999999999995 469999999999999999999999999998654322111111223456799
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|+||||+++|+|++ |..||.+.... .+...+........+..++.++.
T Consensus 204 aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~ 266 (314)
T cd05099 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-----------------ELFKLLREGHRMDKPSNCTHELY 266 (314)
T ss_pred CHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHH
Confidence 9999988889999999999999999999 88898754321 11122222222334556778899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+++.+||+.+|.+|||+.++++.|.++..
T Consensus 267 ~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 267 MLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=282.85 Aligned_cols=233 Identities=25% Similarity=0.437 Sum_probs=186.9
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||+|.+.... ......+.+|+.+++.+ +||||+++++++......|++|||+.+++|.+++.+...
T Consensus 49 ~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 128 (304)
T cd05101 49 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128 (304)
T ss_pred eEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 58899887543 23346789999999999 799999999999999999999999999999999965421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++...............++..|+
T Consensus 129 ~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~ 206 (304)
T cd05101 129 VPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWM 206 (304)
T ss_pred CCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceee
Confidence 247788899999999999999996 469999999999999999999999999998654332222222234567899
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++||||||+++|+|++ |..||.+... ..+.+.+........+..++..+.
T Consensus 207 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~ 269 (304)
T cd05101 207 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----------------EELFKLLKEGHRMDKPANCTNELY 269 (304)
T ss_pred CchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHcCCcCCCCCCCCHHHH
Confidence 9999988889999999999999999998 7888865431 111122222222334456788999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+|+.+||..+|.+|||+.++++.|.++..
T Consensus 270 ~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 270 MMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=279.76 Aligned_cols=229 Identities=26% Similarity=0.432 Sum_probs=184.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC--------CCCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~ 72 (305)
.||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||||+.+++|.+++..... ..++
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 117 (277)
T cd05032 38 RVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117 (277)
T ss_pred eEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCC
Confidence 589999875532 3345788999999999999999999999999999999999999999999965321 2367
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+
T Consensus 118 ~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05032 118 LQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc
Confidence 88899999999999999995 5699999999999999999999999999876543322212233346788999999988
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++|||||||++|++++ |..||.+.... ...+..........+..++..+.+++.+||
T Consensus 196 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 258 (277)
T cd05032 196 GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----------------EVLKFVIDGGHLDLPENCPDKLLELMRMCW 258 (277)
T ss_pred CCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 889999999999999999998 99998754321 111222222233445566889999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~ 249 (305)
+.+|++|||+.++++.|+
T Consensus 259 ~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 259 QYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCChhhCCCHHHHHHHhc
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=291.47 Aligned_cols=224 Identities=23% Similarity=0.268 Sum_probs=178.7
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|+++... ......+.+|+.+++.++||||+++++++.++...|+||||++||+|.+++... .+++..+..
T Consensus 70 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~ 146 (370)
T cd05596 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARF 146 (370)
T ss_pred EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHH
Confidence 68999986432 123345788999999999999999999999999999999999999999998643 388888999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC----C
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----R 154 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~ 154 (305)
++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+. .
T Consensus 147 ~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~ 223 (370)
T cd05596 147 YTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGY 223 (370)
T ss_pred HHHHHHHHHHHHHHC--CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCC
Confidence 999999999999964 5999999999999999999999999999765432211 12345789999999998653 4
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC--hHHHHHHHHHHHhhcc
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLN 232 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~ 232 (305)
++.++|+|||||++|+|++|..||.+.... .....+........++ ..++.++.+||.+||.
T Consensus 224 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 287 (370)
T cd05596 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLT 287 (370)
T ss_pred CCCceeeeehhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHcc
Confidence 788999999999999999999999865421 1111222211112222 2578899999999999
Q ss_pred CCCCC--CCCHHHHHHH
Q 021947 233 NEPKL--RPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~--Rps~~~~l~~ 247 (305)
.+|.+ |+|+.+++++
T Consensus 288 ~~p~r~~R~s~~ell~h 304 (370)
T cd05596 288 DREVRLGRNGVDEIKSH 304 (370)
T ss_pred ChhhccCCCCHHHHhcC
Confidence 99987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=274.86 Aligned_cols=229 Identities=26% Similarity=0.388 Sum_probs=183.7
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|++...... ..+.+.+|+.++++++|+||+++++++. ....++||||+++++|.+++.... ..+++..++.++
T Consensus 24 ~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 101 (257)
T cd05115 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELM 101 (257)
T ss_pred eEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHH
Confidence 4899998765332 2356899999999999999999999875 457899999999999999986433 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.+++.||+|||+ +|++|+||||+||+++.++.+||+|||++........... .....++..|+|||++.+..++.++
T Consensus 102 ~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (257)
T cd05115 102 HQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179 (257)
T ss_pred HHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchh
Confidence 999999999996 4599999999999999999999999999976543322111 1112235689999999888899999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|+||||+++|++++ |..||.+... ......+........+..++.++.+++.+||..+|++|
T Consensus 180 Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~R 242 (257)
T cd05115 180 DVWSYGITMWEAFSYGQKPYKKMKG-----------------PEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDR 242 (257)
T ss_pred hHHHHHHHHHHHhcCCCCCcCcCCH-----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 99999999999996 9999976432 11222333333445566778999999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021947 239 PRMSEVLAILERL 251 (305)
Q Consensus 239 ps~~~~l~~l~~~ 251 (305)
|++.++.+.|+.+
T Consensus 243 p~~~~i~~~l~~~ 255 (257)
T cd05115 243 PNFAKVEERMRTY 255 (257)
T ss_pred cCHHHHHHHHhhh
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.93 Aligned_cols=221 Identities=27% Similarity=0.402 Sum_probs=177.0
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++.+. ....+.+..|..++... +||||+++++++..++..|+||||+.|++|.+++.... .+++..+.
T Consensus 22 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~ 99 (316)
T cd05592 22 FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARAR 99 (316)
T ss_pred EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 58999987542 22334566777777754 79999999999999999999999999999999986554 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....... .......||..|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (316)
T cd05592 100 FYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNE 175 (316)
T ss_pred HHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCC
Confidence 999999999999996 459999999999999999999999999997543222 1233457899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+.. .+...+. .....++..++.++.+|+.+||..||.+
T Consensus 176 ~~DvwslG~il~ell~G~~Pf~~~~~~-----------------~~~~~i~-~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 176 SVDWWSFGVLLYEMLIGQSPFHGEDED-----------------ELFDSIL-NDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred cccchhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHH-cCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999865321 0111111 1122345567788999999999999999
Q ss_pred CCCHH-HHHH
Q 021947 238 RPRMS-EVLA 246 (305)
Q Consensus 238 Rps~~-~~l~ 246 (305)
||++. ++++
T Consensus 238 R~~~~~~l~~ 247 (316)
T cd05592 238 RLGVDGDIRQ 247 (316)
T ss_pred cCCChHHHHc
Confidence 99875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=293.10 Aligned_cols=226 Identities=27% Similarity=0.324 Sum_probs=182.7
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.... .....+.+|++++..++|+||+++++++.+++..|+||||+.|++|.+++.+. ..+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~ 104 (350)
T cd05573 27 QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETAR 104 (350)
T ss_pred CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHH
Confidence 3699999875422 33457889999999999999999999999999999999999999999999765 348999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCC---------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--------------------------- 130 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------------------------- 130 (305)
.++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++.......
T Consensus 105 ~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (350)
T cd05573 105 FYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182 (350)
T ss_pred HHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccccc
Confidence 999999999999996 459999999999999999999999999997654332
Q ss_pred CcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh--
Q 021947 131 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-- 208 (305)
Q Consensus 131 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 208 (305)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~~ 246 (350)
T cd05573 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE----------------TYNKIINWK 246 (350)
T ss_pred ccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH----------------HHHHHhccC
Confidence 0011233468999999999999999999999999999999999999998754211 0111111
Q ss_pred cccCCCCChHHHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 021947 209 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAI 247 (305)
Q Consensus 209 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~~ 247 (305)
.....+....++..+.+||.+||. ||.+|++ +++++++
T Consensus 247 ~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 247 ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111112222368899999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.47 Aligned_cols=233 Identities=27% Similarity=0.451 Sum_probs=186.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||+|.++.+.. .....+.+|+++++++ +|+||+++++++...+..|+||||+.+++|.+++..+..
T Consensus 52 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 131 (307)
T cd05098 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131 (307)
T ss_pred eEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 489999886532 2345788999999999 799999999999999999999999999999999975432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
..+++..++.++.|++.||+|||+ +|++|+||||+||+++.++.+||+|||++................++..|+
T Consensus 132 ~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~ 209 (307)
T cd05098 132 VPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 209 (307)
T ss_pred CccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCcccee
Confidence 247888999999999999999995 469999999999999999999999999987654322111111223456899
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|+||||+++|+|++ |..||.+... ..+...+........+..++.++.
T Consensus 210 aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~ 272 (307)
T cd05098 210 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELY 272 (307)
T ss_pred ChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----------------HHHHHHHHcCCCCCCCCcCCHHHH
Confidence 9999988889999999999999999998 8888865431 112222222233344556788999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+|+.+||..+|.+|||+.++++.|+++..
T Consensus 273 ~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 273 MMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=285.82 Aligned_cols=221 Identities=28% Similarity=0.403 Sum_probs=177.0
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|+++... ......+..|..++... +||||+++++++.+.+..|+||||+.|++|.+++.... .+++..+.
T Consensus 22 ~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~ 99 (316)
T cd05620 22 YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRAT 99 (316)
T ss_pred EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 68999987542 22345677788888765 89999999999999999999999999999999986653 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+ +|++||||||+||+++.++.++|+|||+++....... ......||..|+|||++.+..++.
T Consensus 100 ~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (316)
T cd05620 100 FYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTF 175 (316)
T ss_pred HHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCc
Confidence 999999999999996 4599999999999999999999999999874322111 133457899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+.. .+.+.+.. .....+..++.++.+||.+||..||.+
T Consensus 176 ~~DiwslGvil~el~~g~~Pf~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 176 SVDWWSFGVLLYEMLIGQSPFHGDDED-----------------ELFESIRV-DTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHh-CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999764321 11111111 112334457788999999999999999
Q ss_pred CCCHH-HHHH
Q 021947 238 RPRMS-EVLA 246 (305)
Q Consensus 238 Rps~~-~~l~ 246 (305)
|+++. ++++
T Consensus 238 R~~~~~~~~~ 247 (316)
T cd05620 238 RLGVVGNIRG 247 (316)
T ss_pred cCCChHHHHc
Confidence 99984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=293.01 Aligned_cols=226 Identities=24% Similarity=0.301 Sum_probs=178.4
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++..... .....+.+|+++++.++|+||+++++++.+++..|+||||+.|++|.+++...+ .+++..+.
T Consensus 27 ~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~ 104 (364)
T cd05599 27 HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETR 104 (364)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHH
Confidence 3699999875421 233567889999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------------------------ 133 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------------------------ 133 (305)
.++.|++.||+|||+. |++||||||+|||++.++.++|+|||++..........
T Consensus 105 ~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (364)
T cd05599 105 FYIAETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182 (364)
T ss_pred HHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccccc
Confidence 9999999999999964 59999999999999999999999999987542211000
Q ss_pred ------------eeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccch
Q 021947 134 ------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 201 (305)
Q Consensus 134 ------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 201 (305)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~--------------- 247 (364)
T cd05599 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET--------------- 247 (364)
T ss_pred ccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH---------------
Confidence 01124689999999999999999999999999999999999999986542110
Q ss_pred hhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 021947 202 KLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 247 (305)
Q Consensus 202 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~ 247 (305)
...+.... ...+....++..+.+||.+||. +|.+|++ +.+++++
T Consensus 248 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 248 -YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred -HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 11111111 1111122467889999999996 9999998 8888864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=275.12 Aligned_cols=225 Identities=25% Similarity=0.418 Sum_probs=181.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||.+.... .....+.+|+.++++++||||+++++++.+....++||||+.+++|.+++..... .+++..++.++.
T Consensus 30 ~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~ 107 (256)
T cd05113 30 DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCK 107 (256)
T ss_pred cEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHH
Confidence 48999887543 3456799999999999999999999999988889999999999999999966443 589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ .|++|+||||+||+++.++.+||+|||.++....... .......++..|++||++.+..++.++|+
T Consensus 108 ~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di 184 (256)
T cd05113 108 DVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184 (256)
T ss_pred HHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHH
Confidence 99999999996 4599999999999999999999999999876533221 11112235678999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||...+.. ..............+...+..+.+++.+||+.+|.+||+
T Consensus 185 ~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 247 (256)
T cd05113 185 WAFGVLMWEVYSLGKMPYERFNNS-----------------ETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPT 247 (256)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 999999999998 99998754321 011111111222233446788999999999999999999
Q ss_pred HHHHHHHH
Q 021947 241 MSEVLAIL 248 (305)
Q Consensus 241 ~~~~l~~l 248 (305)
+.++++.|
T Consensus 248 ~~~ll~~~ 255 (256)
T cd05113 248 FQQLLSSI 255 (256)
T ss_pred HHHHHHhh
Confidence 99999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.35 Aligned_cols=227 Identities=22% Similarity=0.264 Sum_probs=177.3
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++..... .....+.+|++++++++|+||+++++++.+.+.+|+||||++||+|.+++.+.. .+++..+.
T Consensus 27 ~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~ 104 (381)
T cd05626 27 ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLAR 104 (381)
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHH
Confidence 3689999875432 223568899999999999999999999999999999999999999999997654 48888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC--------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-------------------------- 131 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------------------- 131 (305)
.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (381)
T cd05626 105 FYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182 (381)
T ss_pred HHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccc
Confidence 999999999999996 4599999999999999999999999999753211000
Q ss_pred -------------------cceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 021947 132 -------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 192 (305)
Q Consensus 132 -------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 192 (305)
.......+||..|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~------ 256 (381)
T cd05626 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET------ 256 (381)
T ss_pred cccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH------
Confidence 0001234699999999999988999999999999999999999999976442111
Q ss_pred hhhhhccchhhhhhhhc--ccCCCCChHHHHHHHHHHHhh--ccCCCCCCCCHHHHHHH
Q 021947 193 AKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQC--LNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 193 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~--l~~~p~~Rps~~~~l~~ 247 (305)
...+... ....+....++.++.+||.+| +..++..|+++.+++++
T Consensus 257 ----------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 257 ----------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ----------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111111 111222235678899999985 45566679999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=274.79 Aligned_cols=225 Identities=27% Similarity=0.442 Sum_probs=180.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++++|.+++..... .+++..+..++.
T Consensus 30 ~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ 107 (256)
T cd05114 30 KVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQ 107 (256)
T ss_pred eEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHH
Confidence 58899876442 3456789999999999999999999999999999999999999999999865432 488999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+ +|++|+||||+||+++.++.+||+|||.++........ ......++..|+|||++.+..++.++|+
T Consensus 108 ~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di 184 (256)
T cd05114 108 DVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDV 184 (256)
T ss_pred HHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhh
Confidence 99999999995 45999999999999999999999999998764332211 1122234668999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |+.||...+... ....+........+...+..+.+++.+||+.+|.+|||
T Consensus 185 ~s~G~~l~el~~~g~~p~~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps 247 (256)
T cd05114 185 WSFGVLMWEVFTEGKMPFEKKSNYE-----------------VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPT 247 (256)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHH-----------------HHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence 999999999999 899997643211 11111111112223345678999999999999999999
Q ss_pred HHHHHHHH
Q 021947 241 MSEVLAIL 248 (305)
Q Consensus 241 ~~~~l~~l 248 (305)
+.++++.|
T Consensus 248 ~~~l~~~l 255 (256)
T cd05114 248 FAELLRAI 255 (256)
T ss_pred HHHHHHhh
Confidence 99999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=289.18 Aligned_cols=225 Identities=23% Similarity=0.254 Sum_probs=180.0
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|+++.... .....+.+|+.+++.++|+||+++++++.+.+..|+||||++|++|.+++.+.. ..+++..+..
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~ 106 (330)
T cd05601 28 IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQF 106 (330)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHH
Confidence 689999875432 233567889999999999999999999999999999999999999999997653 3589999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh------c
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------T 152 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~ 152 (305)
++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......... ......||..|+|||++. +
T Consensus 107 ~~~qi~~aL~~lH~~--~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~ 183 (330)
T cd05601 107 YLAELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGK 183 (330)
T ss_pred HHHHHHHHHHHHHHC--CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcccccccc
Confidence 999999999999964 5999999999999999999999999999865433221 233456899999999986 4
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 230 (305)
..++.++|||||||++|+|++|..||....... ....+.... ...+....++..+.+|+.+|
T Consensus 184 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~l 247 (330)
T cd05601 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------------TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSL 247 (330)
T ss_pred CCCCCcceeecccceeeeeccCCCCCCCCCHHH----------------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHH
Confidence 567889999999999999999999997643211 111111111 11122235788899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~ 247 (305)
|. +|.+|||+.+++++
T Consensus 248 l~-~p~~R~t~~~l~~h 263 (330)
T cd05601 248 LC-GQKERLGYEGLCCH 263 (330)
T ss_pred cc-ChhhCCCHHHHhCC
Confidence 98 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.09 Aligned_cols=221 Identities=26% Similarity=0.330 Sum_probs=174.1
Q ss_pred EEEEEecccCCc---cChHHHHHHHH-HHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|++..... .....+..|.. +++.++|+||+++++++...+..|+||||+.|++|.+++.... .+.+..+.
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 99 (325)
T cd05602 22 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRAR 99 (325)
T ss_pred EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 589999875321 22234455544 4677899999999999999999999999999999999996544 47888888
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~L~~lH~~--giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05602 100 FYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDR 175 (325)
T ss_pred HHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCC
Confidence 9999999999999964 599999999999999999999999999875322211 133456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+... ....+... ....+..++..+.+++.+||+.||.+
T Consensus 176 ~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred ccccccccHHHHHHhcCCCCCCCCCHHH----------------HHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999999999999997643211 01111111 12234467888999999999999999
Q ss_pred CCCHHHHHH
Q 021947 238 RPRMSEVLA 246 (305)
Q Consensus 238 Rps~~~~l~ 246 (305)
|+++.+.+.
T Consensus 238 R~~~~~~~~ 246 (325)
T cd05602 238 RLGAKDDFM 246 (325)
T ss_pred CCCCCCCHH
Confidence 998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=286.21 Aligned_cols=222 Identities=28% Similarity=0.407 Sum_probs=179.5
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++... ......+.+|.+++..+ +||||+++++++...+..|+||||+.|++|..++.+.. .+++..+.
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~ 99 (318)
T cd05570 22 LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRAR 99 (318)
T ss_pred EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 68999987542 23345678899999888 69999999999999999999999999999999886554 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .....+|+..|+|||++.+..++.
T Consensus 100 ~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~ 175 (318)
T cd05570 100 FYAAEIVLGLQFLHER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGP 175 (318)
T ss_pred HHHHHHHHHHHHHHhC--CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCc
Confidence 9999999999999964 599999999999999999999999999875322111 123346899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+..... ....+.. .....+..++..+.+||.+||..||.+
T Consensus 176 ~~DiwslGvil~~l~~G~~pf~~~~~~~----------------~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 176 AVDWWALGVLLYEMLAGQSPFEGDDEDE----------------LFQSILE--DEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred chhhhhHHHHHHHHhhCCCCCCCCCHHH----------------HHHHHHc--CCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999997643210 0011111 112344567889999999999999999
Q ss_pred CCCH-----HHHHHH
Q 021947 238 RPRM-----SEVLAI 247 (305)
Q Consensus 238 Rps~-----~~~l~~ 247 (305)
|||+ .+++++
T Consensus 238 R~s~~~~~~~~ll~~ 252 (318)
T cd05570 238 RLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCCCCCCHHHHhcC
Confidence 9999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=276.32 Aligned_cols=231 Identities=27% Similarity=0.461 Sum_probs=183.9
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCe------eEEEEecCCCCCHHHHhhhc----CCC
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFRR----GPQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~----~~~ 69 (305)
.||||+++.+.... ...+.+|++.++.++|+||+++++++..... .+++|||+.+++|..++... ...
T Consensus 29 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~ 108 (273)
T cd05035 29 KVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE 108 (273)
T ss_pred eEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcc
Confidence 58999988654332 3578999999999999999999998876554 78999999999999988432 223
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++...............++..|+|||.
T Consensus 109 ~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 186 (273)
T cd05035 109 KLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186 (273)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhh
Confidence 58899999999999999999996 4599999999999999999999999999986543322211222234678999999
Q ss_pred hhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 150 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 150 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
+.+..++.++|||||||++|+|++ |..||.+... ..+.+.+........+..++..+.+++.
T Consensus 187 ~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~ 249 (273)
T cd05035 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----------------HEIYDYLRHGNRLKQPEDCLDELYDLMY 249 (273)
T ss_pred cccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcCCCHHHHHHHH
Confidence 988889999999999999999999 8899865431 1112222222233345567889999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhh
Q 021947 229 QCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+||+.||.+|||+.++++.|+++
T Consensus 250 ~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 250 SCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.77 Aligned_cols=217 Identities=28% Similarity=0.370 Sum_probs=172.4
Q ss_pred EEEEEecccCCc---cChHHHHHHHH-HHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..|+||||++|++|..++.+.. .+++..+.
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 99 (321)
T cd05603 22 FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRAR 99 (321)
T ss_pred EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 689999865421 22344555654 5788999999999999999999999999999999998886543 48888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (321)
T cd05603 100 FYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDR 175 (321)
T ss_pred HHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCC
Confidence 999999999999996 459999999999999999999999999987532211 1123456899999999999889999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+.. .+...+.. .....+...+..+.+++.+||+.||.+
T Consensus 176 ~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 176 TVDWWCLGAVLYEMLYGLPPFYSRDVS-----------------QMYDNILH-KPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred cCcccccchhhhhhhcCCCCCCCCCHH-----------------HHHHHHhc-CCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 999999999999999999999765321 01111111 122345567788999999999999999
Q ss_pred CCCHH
Q 021947 238 RPRMS 242 (305)
Q Consensus 238 Rps~~ 242 (305)
|+++.
T Consensus 238 R~~~~ 242 (321)
T cd05603 238 RLGAK 242 (321)
T ss_pred cCCCC
Confidence 99764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.51 Aligned_cols=222 Identities=26% Similarity=0.327 Sum_probs=190.5
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.+|+|++...... +...+.+|+.+|+++. ||||+.++++|++...+++|||+|+||.|.+.+... . +++..+.
T Consensus 62 ~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~ 138 (382)
T KOG0032|consen 62 EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAA 138 (382)
T ss_pred eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHH
Confidence 5899999766443 3468999999999998 999999999999999999999999999999999776 2 9999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC----CceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.++.|++.++.|||+. |++||||||+|+|+... +.+|++|||++..... .......+||+.|+|||++.+.
T Consensus 139 ~~~~~il~av~~lH~~--gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~ 213 (382)
T KOG0032|consen 139 GIIRQILEAVKYLHSL--GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGR 213 (382)
T ss_pred HHHHHHHHHHHHHHhC--CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCC
Confidence 9999999999999974 59999999999999543 4799999999998665 2335677999999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc--ccCCCCChHHHHHHHHHHHhhc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l 231 (305)
.|+..+|+||+|+++|.|++|..||.+.+.... ...+... .......+.++..+.++|++||
T Consensus 214 ~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----------------~~~i~~~~~~f~~~~w~~is~~akd~i~~ll 277 (382)
T KOG0032|consen 214 PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----------------FLAILRGDFDFTSEPWDDISESAKDFIRKLL 277 (382)
T ss_pred CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----------------HHHHHcCCCCCCCCCccccCHHHHHHHHHhc
Confidence 999999999999999999999999998653221 1122222 2334556688999999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAI 247 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~ 247 (305)
..||..|+|+.+++++
T Consensus 278 ~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 278 EFDPRKRLTAAQALQH 293 (382)
T ss_pred ccCcccCCCHHHHhcC
Confidence 9999999999999986
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=274.33 Aligned_cols=228 Identities=29% Similarity=0.401 Sum_probs=183.3
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|+++..... ..+.+.+|+.+++.+.|+||+++++++. .+..++||||+.+++|.+++.... .+++..+..+
T Consensus 24 ~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 100 (257)
T cd05116 24 TVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK--HVTEKNITEL 100 (257)
T ss_pred EEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 5899998755332 2467899999999999999999999875 456789999999999999996543 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.|++.||.|||+ +|++||||||.||+++.++.+||+|||++........... .....++..|+|||.+.+..++.+
T Consensus 101 ~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (257)
T cd05116 101 VHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178 (257)
T ss_pred HHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCch
Confidence 9999999999996 4599999999999999999999999999986544322111 112234578999999988889999
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+|+||||+++|+|++ |..||...... .+...+........+..++.++.++|.+||+.||.+
T Consensus 179 ~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~ 241 (257)
T cd05116 179 SDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDE 241 (257)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchh
Confidence 999999999999998 99999764321 112222333334455678889999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
||++.+|.+.|++.
T Consensus 242 Rp~~~~i~~~l~~~ 255 (257)
T cd05116 242 RPGFAVVELRLRNY 255 (257)
T ss_pred CcCHHHHHHHHhcc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=273.99 Aligned_cols=224 Identities=29% Similarity=0.456 Sum_probs=182.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEE-eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.+ ...+.+.+|+.++++++|+||+++++++. .++..+++|||+++++|.+++.......+++..++.++
T Consensus 31 ~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 108 (256)
T cd05082 31 KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108 (256)
T ss_pred cEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 5788988654 34567899999999999999999999765 45678999999999999999977665568899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||+|||+ +|++||||||+||+++.++.+||+|||++....... ....++..|+|||++.+..++.++|
T Consensus 109 ~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~D 181 (256)
T cd05082 109 LDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSD 181 (256)
T ss_pred HHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhh
Confidence 999999999996 459999999999999999999999999987543221 1223456899999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+|||||++|+|++ |..||...... .+...+........+..++..+.+++.+||+.+|++||
T Consensus 182 v~slG~i~~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05082 182 VWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRP 244 (256)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence 9999999999997 99998754321 11111222223334556788999999999999999999
Q ss_pred CHHHHHHHHHhh
Q 021947 240 RMSEVLAILERL 251 (305)
Q Consensus 240 s~~~~l~~l~~~ 251 (305)
|+.++++.|+.+
T Consensus 245 t~~~l~~~l~~~ 256 (256)
T cd05082 245 SFLQLREQLEHI 256 (256)
T ss_pred CHHHHHHHHhcC
Confidence 999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=282.78 Aligned_cols=240 Identities=23% Similarity=0.268 Sum_probs=175.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... .....+.+|+++++.++||||+++++++.+....++||||+. ++|.+++.... ..++...+..++
T Consensus 32 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~ 109 (303)
T cd07869 32 LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFL 109 (303)
T ss_pred EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHH
Confidence 689999875432 233567899999999999999999999999999999999996 58888886543 348889999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 159 (305)
.|++.||+|||++ +++||||||+|||++.++.+||+|||++........ ......++..|+|||++.+. .++.++
T Consensus 110 ~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 185 (303)
T cd07869 110 FQLLRGLSYIHQR--YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCL 185 (303)
T ss_pred HHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHH
Confidence 9999999999964 599999999999999999999999999875432211 12334678999999998664 578899
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhh--h-hhhhhhhhc---cchhhhhhhhcccCCCCC---------hHHHHHHH
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQS--L-VDWAKPYLS---DKRKLFRIMDTKLGGQYP---------QKAAHTAA 224 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 224 (305)
|||||||++|+|++|..||.+........ . .....+... .................+ ...+..+.
T Consensus 186 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (303)
T cd07869 186 DMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAE 265 (303)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHH
Confidence 99999999999999999998653221110 0 000000000 000000000000000001 12346788
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+|+.+||+.||.+|||+.+++++
T Consensus 266 dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 266 DLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred HHHHHHhccCchhccCHHHHhcC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=288.77 Aligned_cols=242 Identities=27% Similarity=0.357 Sum_probs=176.2
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
..||||+++.... ....++.+|++++++++||||+++++++... ...|+||||+. ++|.+++.... .+++
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~ 102 (338)
T cd07859 26 EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTP 102 (338)
T ss_pred CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc--cCCH
Confidence 3689999875422 2345688999999999999999999987643 24799999995 59999886554 4899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhc
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 152 (305)
..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++........ .......|+..|+|||++.+
T Consensus 103 ~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 103 EHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc
Confidence 99999999999999999965 5999999999999999999999999999764322211 11234568999999999876
Q ss_pred --CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhh-hhhh-hhhhc--------cchhhhhhhhcccCCCC---Ch
Q 021947 153 --GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWA-KPYLS--------DKRKLFRIMDTKLGGQY---PQ 217 (305)
Q Consensus 153 --~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~-~~~~~--------~~~~~~~~~~~~~~~~~---~~ 217 (305)
..++.++|||||||++|+|++|+.||.+.+....... .... .+... ........+........ ..
T Consensus 181 ~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
T cd07859 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP 260 (338)
T ss_pred cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC
Confidence 5788999999999999999999999977543211100 0000 00000 00000111111111111 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++..+.+++.+||..||++|||+++++++
T Consensus 261 ~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 261 NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=289.79 Aligned_cols=239 Identities=27% Similarity=0.466 Sum_probs=198.9
Q ss_pred CEEEEEecccCCccCh-HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.+||+|+++.+..... .+|.+|+++|.+++||||+.++++|..++.+++++||++.|+|..|+.+........+....+
T Consensus 563 lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi 642 (807)
T KOG1094|consen 563 LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSI 642 (807)
T ss_pred eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHH
Confidence 3799999998866544 899999999999999999999999999999999999999999999997775433466677889
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.||+.|++||.+.+ +|||||.+.|||++.++++||+|||+++-.-...........+-..+|||+|.+..++++.++
T Consensus 643 ~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaS 720 (807)
T KOG1094|consen 643 CTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTAS 720 (807)
T ss_pred HHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchh
Confidence 999999999999876 999999999999999999999999999977666666667777888999999999999999999
Q ss_pred ceehhhHHHHHHHh--CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 160 DVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 160 Di~slG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
|+|+||+++||+++ ...||...+... .++ +...+........-...|.-++..+.++|.+||+.+-.+
T Consensus 721 DvWafgvTlwE~~~~C~e~Py~~lt~e~---vve-------n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~ 790 (807)
T KOG1094|consen 721 DVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVE-------NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQ 790 (807)
T ss_pred hhhhhHHHHHHHHHHHhhCchhhhhHHH---HHH-------hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhc
Confidence 99999999999876 678887654321 111 111111111122223456789999999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
||+++++...|.+.
T Consensus 791 RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 791 RPSFEQLHLFLQED 804 (807)
T ss_pred CCCHHHHHHHHHHh
Confidence 99999999888664
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.56 Aligned_cols=232 Identities=25% Similarity=0.412 Sum_probs=185.3
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||||+++...... ...+.+|+++|.++. ||||+++++.+...+..++||||+.+|+|.+++.+...
T Consensus 69 ~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (401)
T cd05107 69 KVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNR 148 (401)
T ss_pred EEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccc
Confidence 59999998653332 357889999999997 99999999999998999999999999999999965321
Q ss_pred --------------------------------------------------------------------------------
Q 021947 69 -------------------------------------------------------------------------------- 68 (305)
Q Consensus 69 -------------------------------------------------------------------------------- 68 (305)
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (401)
T cd05107 149 DDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDT 228 (401)
T ss_pred ccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhh
Confidence
Q ss_pred -----CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccc
Q 021947 69 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143 (305)
Q Consensus 69 -----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 143 (305)
..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...............++..
T Consensus 229 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~ 306 (401)
T cd05107 229 LINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306 (401)
T ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCc
Confidence 135667788899999999999995 5699999999999999999999999999976433221111223356788
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 222 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (305)
|+|||++.+..++.++|+||||+++|+|++ |..||..... .......+........+..++.+
T Consensus 307 y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~ 370 (401)
T cd05107 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM----------------NEQFYNAIKRGYRMAKPAHASDE 370 (401)
T ss_pred eeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc----------------hHHHHHHHHcCCCCCCCCCCCHH
Confidence 999999988889999999999999999998 8899865321 11112222222333445567889
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+.+|+.+||..+|.+||++.++++.|+++
T Consensus 371 l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 371 IYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=286.63 Aligned_cols=227 Identities=24% Similarity=0.295 Sum_probs=175.9
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.... .....+.+|+.++.+++|+||+++++.+.+...+|+||||++||+|.+++.+.+ .+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~ 104 (363)
T cd05628 27 HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQ 104 (363)
T ss_pred CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 3689999875421 223567889999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------------- 132 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------------------------- 132 (305)
.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus 105 ~~~~qi~~aL~~lH~~--givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (363)
T cd05628 105 FYIAETVLAIDSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182 (363)
T ss_pred HHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccccccc
Confidence 9999999999999964 5999999999999999999999999998754321100
Q ss_pred --------ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhh
Q 021947 133 --------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 204 (305)
Q Consensus 133 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (305)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+... ...
T Consensus 183 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~----------------~~~ 246 (363)
T cd05628 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE----------------TYK 246 (363)
T ss_pred chhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 00123479999999999999999999999999999999999999998654211 011
Q ss_pred hhhhcccCCCCC--hHHHHHHHHHHHhhcc--CCCCCCCCHHHHHHH
Q 021947 205 RIMDTKLGGQYP--QKAAHTAATLALQCLN--NEPKLRPRMSEVLAI 247 (305)
Q Consensus 205 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~--~~p~~Rps~~~~l~~ 247 (305)
.+........++ ..++.++.+||.+++. .++..||++++++++
T Consensus 247 ~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 247 KVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 111111111122 2367788999988664 233356899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=274.57 Aligned_cols=225 Identities=31% Similarity=0.513 Sum_probs=186.1
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||.++.... ..+++.+|+.++++++|+||+++++++.++...++||||+.+++|.+++.......+++..+..++
T Consensus 30 ~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 108 (256)
T cd05039 30 QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA 108 (256)
T ss_pred cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 3689999987643 467899999999999999999999999988899999999999999999977665568999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+ ++++|+||||+||+++.++.++|+|||.++...... .....+..|+|||++.+..++.++|
T Consensus 109 ~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~D 181 (256)
T cd05039 109 LDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSD 181 (256)
T ss_pred HHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHH
Confidence 999999999995 459999999999999999999999999998653221 1223466799999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++ |..||...... .+...+........+..++..+.+++.+||+.+|.+||
T Consensus 182 i~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05039 182 VWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRP 244 (256)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCc
Confidence 9999999999997 99998754321 11111112222233455678999999999999999999
Q ss_pred CHHHHHHHHHh
Q 021947 240 RMSEVLAILER 250 (305)
Q Consensus 240 s~~~~l~~l~~ 250 (305)
|+.++++.|++
T Consensus 245 ~~~~l~~~l~~ 255 (256)
T cd05039 245 TFKQLREQLAL 255 (256)
T ss_pred CHHHHHHHHhc
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=276.33 Aligned_cols=231 Identities=25% Similarity=0.391 Sum_probs=182.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.|++|.+..... ....++..|+..+.++.||||+++++++. +...++++||+.+|+|.+++.... ..+++..+..++
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~ 115 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWC 115 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHH
Confidence 478888764422 22356778888999999999999999875 456789999999999999996544 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|++||.+.+..++.++|
T Consensus 116 ~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D 193 (279)
T cd05111 116 VQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD 193 (279)
T ss_pred HHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhh
Confidence 999999999996 459999999999999999999999999998654332222223345677899999998889999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|++++ |..||.+.... ...+.+........+..++..+.+++.+||..||.+||
T Consensus 194 v~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp 256 (279)
T cd05111 194 VWSYGVTVWEMMSYGAEPYAGMRPH-----------------EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRP 256 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 9999999999998 99999764321 11122222222223334567789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021947 240 RMSEVLAILERLEA 253 (305)
Q Consensus 240 s~~~~l~~l~~~~~ 253 (305)
|+.++++.|..+..
T Consensus 257 s~~el~~~l~~~~~ 270 (279)
T cd05111 257 TFKELANEFTRMAR 270 (279)
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=273.41 Aligned_cols=225 Identities=27% Similarity=0.366 Sum_probs=184.0
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.|++|.+.... ......+.+|++++++++||||+++++.+.+.+..|+||||+.|++|.+++.......+++..++.+
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i 106 (256)
T cd08529 27 VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF 106 (256)
T ss_pred EEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHH
Confidence 58889876542 2344678899999999999999999999999999999999999999999997754456899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+++.||.|||+ .|++|+||||+||+++.++.++|+|||++......... .....++..|+|||++.+..++.++
T Consensus 107 ~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (256)
T cd08529 107 FIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKS 182 (256)
T ss_pred HHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCcc
Confidence 9999999999995 56999999999999999999999999998865433221 2334678899999999998899999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|+||||+++|+|++|..||...... ..............+..++..+.+++.+||+.+|++||
T Consensus 183 Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 245 (256)
T cd08529 183 DVWALGVVLYECCTGKHPFDANNQG-----------------ALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245 (256)
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCc
Confidence 9999999999999999999764311 01111111222233446778899999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
++.++++.
T Consensus 246 ~~~~ll~~ 253 (256)
T cd08529 246 DTFQLLRN 253 (256)
T ss_pred CHHHHhhC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=276.52 Aligned_cols=232 Identities=24% Similarity=0.393 Sum_probs=184.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.... .....+.+|+.++..++|+||+++++++.. ...++++||+++|+|.+++.... ..+++..++.++
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~ 115 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWC 115 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHH
Confidence 589999876533 234678899999999999999999998865 45789999999999999996543 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||+|||+ ++++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|
T Consensus 116 ~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05109 116 VQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSD 193 (279)
T ss_pred HHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhH
Confidence 999999999996 459999999999999999999999999998654322211122223467899999998889999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|+|++ |..||..... ..+...+........+..++..+.+++.+||+.||++||
T Consensus 194 i~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 256 (279)
T cd05109 194 VWSYGVTVWELMTFGAKPYDGIPA-----------------REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRP 256 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCc
Confidence 9999999999998 8999875431 111122222222333455778899999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 021947 240 RMSEVLAILERLEAP 254 (305)
Q Consensus 240 s~~~~l~~l~~~~~~ 254 (305)
++.++++.|..+...
T Consensus 257 ~~~~l~~~l~~~~~~ 271 (279)
T cd05109 257 RFRELVDEFSRMARD 271 (279)
T ss_pred CHHHHHHHHHHhhcC
Confidence 999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=273.08 Aligned_cols=228 Identities=30% Similarity=0.434 Sum_probs=183.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|+++... .....+.+|++++++++|+||+++++.+. ....++||||+.+++|.+++.+.....+++..+..++.
T Consensus 32 ~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (262)
T cd05071 32 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109 (262)
T ss_pred eEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHH
Confidence 58999988643 34567899999999999999999999874 45689999999999999999765444588999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+ ++++|+||||+||++++++.++|+|||.+......... ......++..|+|||+..+..++.++|+
T Consensus 110 ~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 186 (262)
T cd05071 110 QIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186 (262)
T ss_pred HHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhH
Confidence 99999999995 55999999999999999999999999999765432211 1222345678999999988899999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.... ..............+..++..+.+|+.+||+.+|++||+
T Consensus 187 wslG~~l~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~ 249 (262)
T cd05071 187 WSFGILLTELTTKGRVPYPGMVNR-----------------EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 249 (262)
T ss_pred HHHHHHHHHHHcCCCCCCCCCChH-----------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCC
Confidence 999999999999 88888764321 111111112222334567788999999999999999999
Q ss_pred HHHHHHHHHhh
Q 021947 241 MSEVLAILERL 251 (305)
Q Consensus 241 ~~~~l~~l~~~ 251 (305)
+.++++.|+..
T Consensus 250 ~~~~~~~l~~~ 260 (262)
T cd05071 250 FEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHHHh
Confidence 99999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=276.19 Aligned_cols=231 Identities=28% Similarity=0.421 Sum_probs=180.9
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhc----CCC
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRR----GPQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~----~~~ 69 (305)
.||+|.++... ......+.+|+++++.++|+||+++++++... ...+++|||+.+++|.+++... ...
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 58999887542 23346788999999999999999999987532 2468999999999999987422 223
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++................++..|++||+
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 185 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHH
Confidence 47899999999999999999996 4599999999999999999999999999987543322111222345678999999
Q ss_pred hhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 150 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 150 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
+.+..++.++|+||||+++|+|++ |..||.+.... .+...+........+..++..+.+++.
T Consensus 186 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (272)
T cd05075 186 LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----------------EIYDYLRQGNRLKQPPDCLDGLYSLMS 248 (272)
T ss_pred ccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 998899999999999999999999 88999763211 111222222222334567788999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhh
Q 021947 229 QCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+||+.||++|||+.++++.|+++
T Consensus 249 ~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 249 SCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=273.64 Aligned_cols=225 Identities=21% Similarity=0.297 Sum_probs=183.9
Q ss_pred EEEEEecccC-CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.. .....+.+.+|+.+++.++|+||+++++.+..++.+|++|||+++++|.+++.......+++..+..++
T Consensus 27 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 106 (255)
T cd08219 27 KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106 (255)
T ss_pred eEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHH
Confidence 5889988643 233446788999999999999999999999999999999999999999999876555568999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+ +|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||++.+..++.++|
T Consensus 107 ~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~D 182 (255)
T cd08219 107 VQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSD 182 (255)
T ss_pred HHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhh
Confidence 999999999995 4599999999999999999999999999876543221 123346888999999998888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
+||||+++|+|++|..||...+.. .....+........+..++..+.+|+.+||+.||.+|||
T Consensus 183 v~slG~i~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 245 (255)
T cd08219 183 IWSLGCILYELCTLKHPFQANSWK-----------------NLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPS 245 (255)
T ss_pred hhhhchhheehhhccCCCCCCCHH-----------------HHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999764321 111111122222344567788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++..
T Consensus 246 ~~~il~~ 252 (255)
T cd08219 246 ATTILSR 252 (255)
T ss_pred HHHHhhc
Confidence 9999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=284.60 Aligned_cols=224 Identities=28% Similarity=0.373 Sum_probs=177.4
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.||+|+++.... .....+.+|+.++.++ +|+||+.+++++...+.+|+||||++|++|..++...+ .+++..+
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~ 98 (327)
T cd05617 21 QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHA 98 (327)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 3689999986532 2235678899999988 59999999999999999999999999999999886544 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||+|||+. |++||||||+|||++.++.+||+|||++....... ......+||..|+|||++.+..++
T Consensus 99 ~~~~~qi~~al~~lH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 99 RFYAAEICIALNFLHER--GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred HHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCC
Confidence 99999999999999964 59999999999999999999999999987532211 113345789999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|..||......... ........... ......+..++..+.+++.+||+.||.
T Consensus 175 ~~~DiwslGvil~ell~g~~pf~~~~~~~~~----------~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~ 243 (327)
T cd05617 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDM----------NTEDYLFQVIL-EKPIRIPRFLSVKASHVLKGFLNKDPK 243 (327)
T ss_pred chheeehhHHHHHHHHhCCCCCCccCCCccc----------ccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence 9999999999999999999999653221110 01111111111 112335566788899999999999999
Q ss_pred CCCCH
Q 021947 237 LRPRM 241 (305)
Q Consensus 237 ~Rps~ 241 (305)
+|+++
T Consensus 244 ~R~~~ 248 (327)
T cd05617 244 ERLGC 248 (327)
T ss_pred HcCCC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=283.11 Aligned_cols=221 Identities=29% Similarity=0.410 Sum_probs=176.9
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++... ......+..|..++... +||||+++++++.+.+.+|+||||++|++|.+++.... .+++..+.
T Consensus 22 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~ 99 (316)
T cd05619 22 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRAT 99 (316)
T ss_pred EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 68999987642 12345567788888764 89999999999999999999999999999999996543 48888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (316)
T cd05619 100 FYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNT 175 (316)
T ss_pred HHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCc
Confidence 999999999999996 4599999999999999999999999999875322111 123456899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+.. .+.+.+.. ....++..++.++.+|+.+||..||.+
T Consensus 176 ~~DvwslG~il~el~~G~~pf~~~~~~-----------------~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 176 SVDWWSFGVLLYEMLIGQSPFHGHDEE-----------------ELFQSIRM-DNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred hhhhhhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHh-CCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999999999999999764321 11111111 112234456788999999999999999
Q ss_pred CCCHH-HHHH
Q 021947 238 RPRMS-EVLA 246 (305)
Q Consensus 238 Rps~~-~~l~ 246 (305)
||++. +++.
T Consensus 238 R~~~~~~l~~ 247 (316)
T cd05619 238 RLGVKGDIRQ 247 (316)
T ss_pred cCCChHHHHc
Confidence 99997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=273.46 Aligned_cols=225 Identities=28% Similarity=0.435 Sum_probs=181.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.+|+|++.... .....+.+|+++++.++|+||+++++++...+..|+||||++|++|.+++..... .+++..+..++.
T Consensus 30 ~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ 107 (256)
T cd05059 30 DVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCS 107 (256)
T ss_pred cEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHH
Confidence 57899876432 3446788999999999999999999999999999999999999999999965443 589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|+
T Consensus 108 qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di 184 (256)
T cd05059 108 DVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDV 184 (256)
T ss_pred HHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhH
Confidence 99999999996 45999999999999999999999999998765332111 1111223457999999998899999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||...... .....+........+..++.++.+++.+||+.+|++|||
T Consensus 185 ~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 185 WSFGVLMWEVFSEGKMPYERFSNS-----------------EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 999999999999 89999754321 111112222233445567889999999999999999999
Q ss_pred HHHHHHHH
Q 021947 241 MSEVLAIL 248 (305)
Q Consensus 241 ~~~~l~~l 248 (305)
+.++++.|
T Consensus 248 ~~~~l~~l 255 (256)
T cd05059 248 FKKLLSQL 255 (256)
T ss_pred HHHHHHHh
Confidence 99999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=275.33 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=182.6
Q ss_pred CEEEEEecccCCcc-----ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQ-----GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
++||+|.+...... ....+.+|++++++++||||+++++++.++...++|+||+.|++|.+++...+ .++...
T Consensus 28 ~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~ 105 (263)
T cd06625 28 RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETV 105 (263)
T ss_pred cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHH
Confidence 36899987644221 23468889999999999999999999999999999999999999999986654 488899
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGR 154 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~ 154 (305)
+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........... .....++..|+|||++.+..
T Consensus 106 ~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 106 TRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred HHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC
Confidence 99999999999999996 4599999999999999999999999999875432211110 12345788999999999988
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++.++|+||||+++|+|++|+.||...... ...............+..++..+.+++.+||..+
T Consensus 184 ~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (263)
T cd06625 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247 (263)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCccccchH----------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcC
Confidence 999999999999999999999999753211 1111122222233455677889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 248 p~~Rpt~~~ll~~ 260 (263)
T cd06625 248 AKKRPSAEELLRH 260 (263)
T ss_pred cccCCCHHHHhhC
Confidence 9999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=279.76 Aligned_cols=240 Identities=25% Similarity=0.329 Sum_probs=175.7
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhcc---CCCCcccEEEEEEe-----CCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQL---HHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||||+++..... ....+.+|+.+++.+ +||||+++++++.. ....++||||+. ++|.+++.......+
T Consensus 29 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~ 107 (290)
T cd07862 29 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGV 107 (290)
T ss_pred EEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCC
Confidence 5899988754322 234567788777766 69999999998862 356899999996 599999976655568
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||++....... ......|+..|+|||++.
T Consensus 108 ~~~~~~~i~~qi~~aL~~lH~~--~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~ 182 (290)
T cd07862 108 PTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLL 182 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHh
Confidence 9999999999999999999964 59999999999999999999999999997654321 123456899999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhhccchh---hh-hhhhcccCC---CCChHHHHH
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSDKRK---LF-RIMDTKLGG---QYPQKAAHT 222 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~---~~-~~~~~~~~~---~~~~~~~~~ 222 (305)
+..++.++|||||||++|+|++|..||.+....... .+..... +....... +. ......... .....++..
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (290)
T cd07862 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 262 (290)
T ss_pred CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHH
Confidence 889999999999999999999999999875432111 1111000 00000000 00 000000000 011245678
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+|+.+||+.||++|||+.+++++
T Consensus 263 ~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 263 GKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHHHHHhccCchhcCCHHHHhcC
Confidence 8999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=288.03 Aligned_cols=225 Identities=24% Similarity=0.280 Sum_probs=177.1
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||+|++.... ......+.+|+.+++.++||||+++++++.+++..|+||||+.||+|.+++... .+++..+.
T Consensus 69 ~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~ 145 (370)
T cd05621 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAK 145 (370)
T ss_pred CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHH
Confidence 368999886421 123356789999999999999999999999999999999999999999999543 38888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC---
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--- 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--- 154 (305)
.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+..
T Consensus 146 ~~~~qil~aL~~LH~~--~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~ 222 (370)
T cd05621 146 FYTAEVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDG 222 (370)
T ss_pred HHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCC
Confidence 9999999999999964 5999999999999999999999999999865432211 123457999999999987643
Q ss_pred -CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC--hHHHHHHHHHHHhhc
Q 021947 155 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCL 231 (305)
Q Consensus 155 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l 231 (305)
++.++|+|||||++|+|++|..||.+.... .....+.........+ ..++..+.+++.+||
T Consensus 223 ~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L 286 (370)
T cd05621 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLV----------------GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286 (370)
T ss_pred CCCcccCEEeehHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHc
Confidence 778999999999999999999999764321 1111222222112222 356888999999999
Q ss_pred cCCCCC--CCCHHHHHHH
Q 021947 232 NNEPKL--RPRMSEVLAI 247 (305)
Q Consensus 232 ~~~p~~--Rps~~~~l~~ 247 (305)
..++.+ |+++.+++++
T Consensus 287 ~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 287 TDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCchhccCCCCHHHHhcC
Confidence 855543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=272.54 Aligned_cols=227 Identities=30% Similarity=0.462 Sum_probs=183.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++.... ..+.+.+|+.++++++|+||+++++++. ....|++|||+.+++|.+++.......+++..+..++.
T Consensus 32 ~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05070 32 KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109 (260)
T ss_pred eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHH
Confidence 588998876543 4567999999999999999999999875 45689999999999999999765555689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ ++++|+||||+||++++++.++|+|||++......... ......++..|+|||++.+..++.++|+
T Consensus 110 ~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di 186 (260)
T cd05070 110 QVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhh
Confidence 99999999996 45999999999999999999999999999765432211 1112234567999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.+.. .....+........+...+..+.+|+.+||..+|.+|||
T Consensus 187 ~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 249 (260)
T cd05070 187 WSFGILLTELVTKGRVPYPGMNNR-----------------EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249 (260)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcC
Confidence 999999999999 89999764311 111112222233445567788999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
+.++.+.|++
T Consensus 250 ~~~l~~~l~~ 259 (260)
T cd05070 250 FEYLQSFLED 259 (260)
T ss_pred HHHHHHHHhc
Confidence 9999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=272.76 Aligned_cols=229 Identities=33% Similarity=0.505 Sum_probs=184.2
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+...... ..+++.+|+++++.+.|+||+++++++. +...++||||+.+++|.+++.... .+++..+..++
T Consensus 25 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 101 (257)
T cd05060 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELA 101 (257)
T ss_pred eEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHH
Confidence 5889998866443 3467899999999999999999999875 556899999999999999997654 58999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++
T Consensus 102 ~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (257)
T cd05060 102 HQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179 (257)
T ss_pred HHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccc
Confidence 999999999995 4599999999999999999999999999986543322111 1112234679999999888999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|+||||+++|+|++ |..||...+.. .+...+........+..++..+.+++.+||..+|.+|
T Consensus 180 Di~slG~~l~~~~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 242 (257)
T cd05060 180 DVWSYGVTLWEAFSYGAKPYGEMKGA-----------------EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDR 242 (257)
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 99999999999998 99999764321 1111122222234455677899999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 021947 239 PRMSEVLAILERLE 252 (305)
Q Consensus 239 ps~~~~l~~l~~~~ 252 (305)
|++.++++.|+.+.
T Consensus 243 p~~~~l~~~l~~~~ 256 (257)
T cd05060 243 PTFSELESTFRRDP 256 (257)
T ss_pred cCHHHHHHHHHhcc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.60 Aligned_cols=216 Identities=29% Similarity=0.399 Sum_probs=174.8
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCC-CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++.+. ....+.+..|.+++..+.| ++|+.+++++.+.+..|+||||++|++|.+++.... .+++..+.
T Consensus 27 ~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~ 104 (324)
T cd05587 27 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAV 104 (324)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 69999987542 2334678889999999976 568889999999999999999999999999986554 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.
T Consensus 105 ~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 180 (324)
T cd05587 105 FYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGK 180 (324)
T ss_pred HHHHHHHHHHHHHHHC--CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCc
Confidence 9999999999999964 599999999999999999999999999875322211 133457899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|+.||.+..... ....+.. ....++..++.++.+++.+||..||.+
T Consensus 181 ~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~ 242 (324)
T cd05587 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQSIME--HNVSYPKSLSKEAVSICKGLLTKHPAK 242 (324)
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999997643210 0111111 122345567889999999999999999
Q ss_pred CCCH
Q 021947 238 RPRM 241 (305)
Q Consensus 238 Rps~ 241 (305)
|++.
T Consensus 243 R~~~ 246 (324)
T cd05587 243 RLGC 246 (324)
T ss_pred cCCC
Confidence 9976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.33 Aligned_cols=226 Identities=24% Similarity=0.300 Sum_probs=177.5
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++..... .....+.+|+++|++++|+||+++++.+.+++.+|+||||++||+|.+++.+.+ .+++..+.
T Consensus 27 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~ 104 (376)
T cd05598 27 ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLAR 104 (376)
T ss_pred CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 3689999865321 234568899999999999999999999999999999999999999999996654 48888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC--------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-------------------------- 131 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------------------- 131 (305)
.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (376)
T cd05598 105 FYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182 (376)
T ss_pred HHHHHHHHHHHHHHHC--CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence 9999999999999964 599999999999999999999999999753210000
Q ss_pred ---------------cceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 021947 132 ---------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 196 (305)
Q Consensus 132 ---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 196 (305)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--------- 253 (376)
T cd05598 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ--------- 253 (376)
T ss_pred ccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHH---------
Confidence 00011346899999999999999999999999999999999999999875421110
Q ss_pred hccchhhhhhhh--cccCCCCChHHHHHHHHHHHhhccCCCCCCC---CHHHHHHH
Q 021947 197 LSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRP---RMSEVLAI 247 (305)
Q Consensus 197 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~ 247 (305)
..+.. ..........++.++.++|.+|+ .+|.+|+ ++.+++++
T Consensus 254 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 254 -------LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred -------HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 01111 11111222356788899999976 5999999 89999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=273.43 Aligned_cols=232 Identities=22% Similarity=0.351 Sum_probs=184.3
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~ 76 (305)
.||||.++.... .....+.+|+++++.++||||+++++++...+..++++||+++++|.+++... ....++...+
T Consensus 29 ~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 108 (267)
T cd08228 29 PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV 108 (267)
T ss_pred EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHH
Confidence 689998764322 22356889999999999999999999999999999999999999999888532 2234788999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++
T Consensus 109 ~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~ 184 (267)
T cd08228 109 WKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred HHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCC
Confidence 9999999999999996 4599999999999999999999999999886543221 12234578899999999888899
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|+.||........ .+...+.. .........++..+.+++.+||..+|
T Consensus 185 ~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 249 (267)
T cd08228 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLF---------------SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDP 249 (267)
T ss_pred chhhHHHHHHHHHHHhcCCCCCccccccHH---------------HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCc
Confidence 999999999999999999999865432111 11111111 11112234567889999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021947 236 KLRPRMSEVLAILERLE 252 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~ 252 (305)
++||+++++++.++++.
T Consensus 250 ~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 250 DQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ccCcCHHHHHHHHHHhc
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=276.19 Aligned_cols=229 Identities=30% Similarity=0.475 Sum_probs=182.9
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-----CCCCCHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----PQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~ 75 (305)
.||||.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|.+++.... ...+++..
T Consensus 28 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 107 (269)
T cd05044 28 RVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107 (269)
T ss_pred eehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHH
Confidence 47888776542 2345678999999999999999999999998899999999999999999996532 23378899
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-----ceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
++.++.+++.||.|||+ .+++|+||||+||+++.++ .++|+|||++................++..|+|||++
T Consensus 108 ~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (269)
T cd05044 108 LLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESL 185 (269)
T ss_pred HHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHH
Confidence 99999999999999996 4599999999999999877 8999999998765332222222233457789999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.+..++.++||||||+++|+|++ |..||...+.. .....+........+..++..+.+++.+
T Consensus 186 ~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (269)
T cd05044 186 LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----------------EVLQHVTAGGRLQKPENCPDKIYQLMTN 248 (269)
T ss_pred ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----------------HHHHHHhcCCccCCcccchHHHHHHHHH
Confidence 99999999999999999999998 99999754311 1111112222233455678899999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~ 249 (305)
||..+|.+||++.++++.|.
T Consensus 249 ~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 249 CWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HcCCCcccCCCHHHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=274.22 Aligned_cols=230 Identities=25% Similarity=0.461 Sum_probs=183.5
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||.++... .....+|.+|++++++++||||+++++++..+...++||||+.+++|.+++.... ..+++..+..++
T Consensus 34 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~ 112 (269)
T cd05065 34 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGML 112 (269)
T ss_pred eEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHH
Confidence 58999987653 2334689999999999999999999999999999999999999999999986543 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceee-ccc--ccccccchhhhhcCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QVM--GTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~--~t~~y~aPE~~~~~~~~~ 157 (305)
.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++............. ... .+..|+|||.+.+..++.
T Consensus 113 ~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (269)
T cd05065 113 RGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190 (269)
T ss_pred HHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccc
Confidence 999999999996 469999999999999999999999999987654322111111 111 245799999999889999
Q ss_pred CCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++|+||||+++|++++ |..||...... .....+........+..++..+.+++.+||..+|.
T Consensus 191 ~~DvwslG~~l~e~l~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 253 (269)
T cd05065 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------------DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRN 253 (269)
T ss_pred hhhhhhhHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChh
Confidence 9999999999999886 99999764321 11111112222333456778899999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 021947 237 LRPRMSEVLAILERL 251 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~ 251 (305)
+||++.+++..|+++
T Consensus 254 ~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 254 ARPKFGQIVSTLDKM 268 (269)
T ss_pred hCcCHHHHHHHHHhh
Confidence 999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=268.23 Aligned_cols=217 Identities=24% Similarity=0.259 Sum_probs=175.1
Q ss_pred ChHHHHHHHHHHhcc-CCCCcccEEEEEEeC----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhh
Q 021947 15 GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 89 (305)
Q Consensus 15 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 89 (305)
+....++|+++.-.. .|||||.++++|.+. .-+.+|||+++||.|++.++.++...+++..+..+..||+.|+.|
T Consensus 97 Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~ 176 (400)
T KOG0604|consen 97 DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRY 176 (400)
T ss_pred cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHH
Confidence 345677899987666 599999999998743 335789999999999999999999999999999999999999999
Q ss_pred hhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhH
Q 021947 90 LHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 166 (305)
Q Consensus 90 lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 166 (305)
||+.+ |.||||||+|+|.+. +..+||+|||+++...... .....+-|+.|.|||++....|+..+|+||||+
T Consensus 177 lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgV 251 (400)
T KOG0604|consen 177 LHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_pred HHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhH
Confidence 99765 999999999999965 4468999999998754322 244567899999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCCCCCCCHHHH
Q 021947 167 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 244 (305)
Q Consensus 167 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 244 (305)
++|-|++|.+||........ ....-.++....+ ..+-...+++...++|+.+|+.+|.+|.|+.++
T Consensus 252 imYIlLCGyPPFYS~hg~ai------------spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 252 IMYILLCGYPPFYSNHGLAI------------SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred HHHHhhcCCCcccccCCccC------------ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 99999999999976543100 0000111222222 223345889999999999999999999999999
Q ss_pred HHHH
Q 021947 245 LAIL 248 (305)
Q Consensus 245 l~~l 248 (305)
+++-
T Consensus 320 m~hp 323 (400)
T KOG0604|consen 320 MDHP 323 (400)
T ss_pred hcCc
Confidence 8753
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=271.49 Aligned_cols=228 Identities=30% Similarity=0.443 Sum_probs=183.7
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+++..... ....+.+|++++++++|+||+++++++......++||||+.|++|.+++.... ..++...+..++
T Consensus 21 ~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~ 99 (251)
T cd05041 21 EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMS 99 (251)
T ss_pred cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 5899988765443 45678999999999999999999999999999999999999999999996543 358899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.+|.|||+ ++++||||||+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|
T Consensus 100 ~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 177 (251)
T cd05041 100 LDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177 (251)
T ss_pred HHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchh
Confidence 999999999995 569999999999999999999999999997654221111111223356799999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++ |..||....... ....+........+...+..+.+++.+||..+|.+||
T Consensus 178 i~slG~i~~~l~t~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 178 VWSYGILLWETFSLGDTPYPGMSNQQ-----------------TRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred HHHHHHHHHHHHhccCCCCccCCHHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCc
Confidence 9999999999999 888887643211 1111112222334556778999999999999999999
Q ss_pred CHHHHHHHHH
Q 021947 240 RMSEVLAILE 249 (305)
Q Consensus 240 s~~~~l~~l~ 249 (305)
|+.++++.|+
T Consensus 241 ~~~ell~~l~ 250 (251)
T cd05041 241 SFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHhh
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=285.94 Aligned_cols=226 Identities=24% Similarity=0.347 Sum_probs=180.1
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.+|+|++.... .....-|.+|+..|.+|+ |.+|++++||-..++.+||||||=+ .+|..+|.+.......+ .+..
T Consensus 387 iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ 464 (677)
T KOG0596|consen 387 IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDW-FLKF 464 (677)
T ss_pred chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchH-HHHH
Confidence 35666655432 233467899999999996 9999999999999999999999974 49999998776554444 6778
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-----
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----- 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----- 153 (305)
+..|++.++.++|.++ |||.||||.|+|+ -.|.+||+|||+|..+..+.........+||..||+||.+...
T Consensus 465 ywkqML~aV~~IH~~g--IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~ 541 (677)
T KOG0596|consen 465 YWKQMLLAVKTIHQHG--IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRE 541 (677)
T ss_pred HHHHHHHHHHHHHHhc--eeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccccc
Confidence 8999999999999654 9999999999999 4568999999999998877777777788999999999988542
Q ss_pred ------CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHH-HHHHHH
Q 021947 154 ------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA-HTAATL 226 (305)
Q Consensus 154 ------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 226 (305)
..+.++||||||||||+|+.|+.||..-. +....+..+.+.....+++.--. .++.++
T Consensus 542 ~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~ 606 (677)
T KOG0596|consen 542 NGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------------NQIAKLHAITDPNHEIEFPDIPENDELIDV 606 (677)
T ss_pred CCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------------HHHHHHHhhcCCCccccccCCCCchHHHHH
Confidence 25678999999999999999999997521 12233444445444444443222 239999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
++.||..||++|||+.++|++
T Consensus 607 mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 607 MKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhcCcccCCCcHHHhcC
Confidence 999999999999999999964
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.81 Aligned_cols=228 Identities=25% Similarity=0.296 Sum_probs=182.6
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC--------eeEEEEecCCCCCHHHHhhhcC--C
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--------NRLLVYEFMPKGSLENHLFRRG--P 68 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~--~ 68 (305)
+.||||++...... ....+.+|+..+..++|+||+++++.+.... .+++||||+.+|+|.+++..+. .
T Consensus 58 ~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~ 137 (496)
T PTZ00283 58 EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN 137 (496)
T ss_pred CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccC
Confidence 36999998765432 3356789999999999999999988775332 3679999999999999986432 3
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...............||+.|+|||
T Consensus 138 ~~l~e~~~~~i~~qll~aL~~lH~~--~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE 215 (496)
T PTZ00283 138 RTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215 (496)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHH
Confidence 4589999999999999999999964 59999999999999999999999999998654332222334567899999999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
++.+..++.++|||||||++|+|++|..||.+.+.. .+............+..++.++.+|+.
T Consensus 216 ~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~ 278 (496)
T PTZ00283 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----------------EVMHKTLAGRYDPLPPSISPEMQEIVT 278 (496)
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999764321 111111112222345677889999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||+.||.+||++.+++++
T Consensus 279 ~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 279 ALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHcccChhhCcCHHHHHhC
Confidence 9999999999999999864
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.89 Aligned_cols=234 Identities=26% Similarity=0.438 Sum_probs=186.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||+|.++.... ....++.+|+++++++ +|+||+++++++...+..+++|||+.+++|.+++.+..
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 125 (334)
T cd05100 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125 (334)
T ss_pred eEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 478998875432 2346789999999999 79999999999999999999999999999999996542
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++...............++..|+
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 203 (334)
T cd05100 126 LPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM 203 (334)
T ss_pred CccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEc
Confidence 1237788899999999999999995 569999999999999999999999999997654322111122223456799
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++||||||+++|+|++ |..||.+... ......+........+..++..+.
T Consensus 204 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~ 266 (334)
T cd05100 204 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----------------EELFKLLKEGHRMDKPANCTHELY 266 (334)
T ss_pred CHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHH
Confidence 9999999899999999999999999998 8888876432 111122222223334456778899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+|+.+||+.+|.+|||+.++++.|+++...
T Consensus 267 ~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 267 MIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=278.12 Aligned_cols=236 Identities=27% Similarity=0.461 Sum_probs=183.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC---------CCCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---------PQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~ 71 (305)
+||+|.+..... .....+.+|++++.+++|+||+++++++..++..+++||++.+++|.+++.+.. ...+
T Consensus 48 ~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (296)
T cd05051 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127 (296)
T ss_pred eEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCC
Confidence 589999886533 334678899999999999999999999999999999999999999999996543 1258
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++...............++..|+|||++.
T Consensus 128 ~~~~~~~~~~~i~~al~~LH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (296)
T cd05051 128 SFSTLLYMATQIASGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHHc--CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence 8999999999999999999964 59999999999999999999999999987644332222233445677899999998
Q ss_pred cCCCCCCCceehhhHHHHHHHh--CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 152 TGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
+..++.++||||||+++|+|++ |..||....... ..... ...............+..++.++.+++.+
T Consensus 206 ~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (296)
T cd05051 206 LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VIENA-------GHFFRDDGRQIYLPRPPNCPKDIYELMLE 275 (296)
T ss_pred cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HHHHH-------HhccccccccccCCCccCCCHHHHHHHHH
Confidence 8889999999999999999998 677876543211 00000 00000001111112234566889999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~ 249 (305)
||..||.+|||+.++++.|+
T Consensus 276 cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 276 CWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HhccChhcCCCHHHHHHHhc
Confidence 99999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=283.40 Aligned_cols=220 Identities=29% Similarity=0.343 Sum_probs=173.9
Q ss_pred EEEEEecccCCc---cChHHHHHHHH-HHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|++..... .....+.+|.. +++.++||||+++++++...+..|+||||+.|++|..++.... .+++..+.
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 99 (325)
T cd05604 22 CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRAR 99 (325)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 689999865421 22345566655 4677899999999999999999999999999999999886544 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||++........ ......|+..|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~lH~~--givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05604 100 FYAAEIASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDN 175 (325)
T ss_pred HHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCC
Confidence 9999999999999964 599999999999999999999999999875322211 133456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||...+... ........ ....+...+..+.+++.+||..+|.+
T Consensus 176 ~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAE----------------MYDNILHK--PLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred cCccccccceehhhhcCCCCCCCCCHHH----------------HHHHHHcC--CccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999999999999997643210 01111111 11223457788999999999999999
Q ss_pred CCCHHHHH
Q 021947 238 RPRMSEVL 245 (305)
Q Consensus 238 Rps~~~~l 245 (305)
||++.+.+
T Consensus 238 R~~~~~~~ 245 (325)
T cd05604 238 RLGAKEDF 245 (325)
T ss_pred cCCCCCCH
Confidence 99876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.30 Aligned_cols=225 Identities=23% Similarity=0.286 Sum_probs=176.0
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++..... .....+.+|++++++++|+||+++++.+.+++..|+||||++||+|.+++.+.+ .+++..+..
T Consensus 28 ~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~ 105 (382)
T cd05625 28 LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARF 105 (382)
T ss_pred EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 689999875422 223568899999999999999999999999999999999999999999996654 488899999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC---------------------------
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--------------------------- 131 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------------------------- 131 (305)
++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||++........
T Consensus 106 ~~~qi~~al~~lH~~--~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (382)
T cd05625 106 YIAELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183 (382)
T ss_pred HHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccc
Confidence 999999999999964 599999999999999999999999999753210000
Q ss_pred ------------------cceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 021947 132 ------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 193 (305)
Q Consensus 132 ------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 193 (305)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------- 255 (382)
T cd05625 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE-------- 255 (382)
T ss_pred cccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH--------
Confidence 000123468999999999999999999999999999999999999998654211
Q ss_pred hhhhccchhhhhhhhc--ccCCCCChHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 021947 194 KPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 247 (305)
Q Consensus 194 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~ 247 (305)
....+... ....+....++.++.++|.+|+ .+|.+|++ +.+++++
T Consensus 256 --------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 256 --------TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred --------HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 11111111 1111222356788999998876 59999997 8887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=270.99 Aligned_cols=227 Identities=30% Similarity=0.435 Sum_probs=182.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+.... ...+.+.+|++++++++|+||+++++++. .+..+++|||+.+++|.+++.......+++..+..++.
T Consensus 32 ~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05069 32 KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109 (260)
T ss_pred eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Confidence 47899887543 34567899999999999999999999875 45689999999999999999765555689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ .|++|+||||+||+++.++.++|+|||++......... ......++..|+|||...+..++.++|+
T Consensus 110 ~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di 186 (260)
T cd05069 110 QIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHH
Confidence 99999999995 45999999999999999999999999999765332211 1122345678999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.... ..............+...+..+.+++.+||+.||.+||+
T Consensus 187 ~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05069 187 WSFGILLTELVTKGRVPYPGMVNR-----------------EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPT 249 (260)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcC
Confidence 999999999999 89999764321 011111122222344567889999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
++++++.|++
T Consensus 250 ~~~i~~~l~~ 259 (260)
T cd05069 250 FEYIQSFLED 259 (260)
T ss_pred HHHHHHHHhc
Confidence 9999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=284.47 Aligned_cols=222 Identities=27% Similarity=0.352 Sum_probs=172.4
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhcc---CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQL---HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||||++..... .....+..|..++... .||||+++++++......|+||||+.+++|.+++.+.+ .+++.
T Consensus 19 ~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~ 96 (330)
T cd05586 19 RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSED 96 (330)
T ss_pred CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC--CCCHH
Confidence 3689999864322 1223456677777665 69999999999999999999999999999999986554 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG- 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 153 (305)
.+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++........ .....+||..|+|||++.+.
T Consensus 97 ~~~~~~~qil~al~~LH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 172 (330)
T cd05586 97 RAKFYIAELVLALEHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEK 172 (330)
T ss_pred HHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCC
Confidence 9999999999999999964 599999999999999999999999999875432221 12345689999999998765
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC-hHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~ 232 (305)
.++.++|||||||++|+|++|..||.+.+... +...+.... ...+ ..++..+.+|+.+||+
T Consensus 173 ~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----------------~~~~i~~~~-~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----------------MYRNIAFGK-VRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCCCccceeccccEEEEeccCCCCCCCCCHHH-----------------HHHHHHcCC-CCCCCccCCHHHHHHHHHHcC
Confidence 57899999999999999999999997643211 111111110 1111 2467889999999999
Q ss_pred CCCCCCC----CHHHHHH
Q 021947 233 NEPKLRP----RMSEVLA 246 (305)
Q Consensus 233 ~~p~~Rp----s~~~~l~ 246 (305)
.||.+|| ++.++++
T Consensus 235 ~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 235 RNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHCCCCCCCHHHHhc
Confidence 9999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=276.35 Aligned_cols=236 Identities=25% Similarity=0.458 Sum_probs=181.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC---------CCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------QPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~ 71 (305)
.||+|+++.... ....++.+|++++++++|+||+++++++..++..++||||+.+++|.+++..... ..+
T Consensus 48 ~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (296)
T cd05095 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127 (296)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccccc
Confidence 589999876532 2346789999999999999999999999999999999999999999999965432 236
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.+++.||+|||+. |++|+||||+||+++.++.++|+|||++................++..|++||+..
T Consensus 128 ~~~~~~~~~~~i~~al~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 128 SYSTLIFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 6778999999999999999964 59999999999999999999999999987653322211122234467899999988
Q ss_pred cCCCCCCCceehhhHHHHHHHh--CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 152 TGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
++.++.++|+|||||++|+|++ |..||....... . ... ................+..++..+.+|+.+
T Consensus 206 ~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~--~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 275 (296)
T cd05095 206 LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ--V-IEN-------TGEFFRDQGRQVYLPKPALCPDSLYKLMLS 275 (296)
T ss_pred cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--H-HHH-------HHHHHhhccccccCCCCCCCCHHHHHHHHH
Confidence 8889999999999999999998 778886543211 0 000 000000000111112234567889999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~ 249 (305)
||..||.+||++.++.+.|+
T Consensus 276 cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 276 CWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HcCCCcccCCCHHHHHHHHh
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=272.22 Aligned_cols=232 Identities=23% Similarity=0.371 Sum_probs=185.0
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~ 76 (305)
.||||.+..... ....++.+|+++++.++|+||+++++++..++..+++|||+.|++|.+++... ....+++..+
T Consensus 29 ~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 108 (267)
T cd08229 29 PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV 108 (267)
T ss_pred eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHH
Confidence 688998765322 23357889999999999999999999999999999999999999999988632 2235899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
+.++.+++.||.|||+ +|++|+||||+||+++.++.++|+|||++......... .....++..|+|||++.+..++
T Consensus 109 ~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~ 184 (267)
T cd08229 109 WKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred HHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCcc
Confidence 9999999999999995 45999999999999999999999999998765432211 2234678899999999888899
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|..||.+....... ..+.+.. ......+..++..+.+++.+||+.||
T Consensus 185 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 249 (267)
T cd08229 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---------------LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 249 (267)
T ss_pred chhhHHHHHHHHHHHHhCCCCcccccchHHH---------------HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCc
Confidence 9999999999999999999999754321110 1111111 11111223577899999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021947 236 KLRPRMSEVLAILERLE 252 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~ 252 (305)
.+|||+.++++.++++.
T Consensus 250 ~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 250 EKRPDITYVYDVAKRMH 266 (267)
T ss_pred ccCCCHHHHHHHHhhhc
Confidence 99999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.50 Aligned_cols=227 Identities=29% Similarity=0.448 Sum_probs=184.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+.... ....++.+|+.++++++|+||+++++++. .+..+++|||+.+++|.+++.......+++..+..++.
T Consensus 32 ~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ 109 (260)
T cd05067 32 KVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109 (260)
T ss_pred eEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence 68999987653 34568899999999999999999999874 45789999999999999998766556689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+ .|++|+||||+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++|+
T Consensus 110 ~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di 186 (260)
T cd05067 110 QIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 186 (260)
T ss_pred HHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccch
Confidence 99999999995 45999999999999999999999999999765422211 1222345678999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|++++ |..||.+.+.. .....+........+...+.++.+++.+||+.+|++|||
T Consensus 187 ~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05067 187 WSFGILLTEIVTYGRIPYPGMTNP-----------------EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT 249 (260)
T ss_pred HHHHHHHHHHHhCCCCCCCCCChH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 999999999999 99999764321 111112222223344556788999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
++++++.|+.
T Consensus 250 ~~~l~~~l~~ 259 (260)
T cd05067 250 FEYLRSVLED 259 (260)
T ss_pred HHHHHHHhhc
Confidence 9999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=276.56 Aligned_cols=230 Identities=29% Similarity=0.462 Sum_probs=181.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------ 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------ 68 (305)
.||+|.+..... ....++.+|+.++++++||||+++++++..+...+++|||+.+++|.+++.....
T Consensus 37 ~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (288)
T cd05050 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116 (288)
T ss_pred eEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccc
Confidence 589999876533 2345788999999999999999999999999999999999999999999964321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccc
Q 021947 69 --------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 140 (305)
Q Consensus 69 --------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 140 (305)
..+++..++.++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++.................
T Consensus 117 ~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 194 (288)
T cd05050 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI 194 (288)
T ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHhheEecCCCceEECccccceecccCccccccCCCcc
Confidence 236788889999999999999995 5699999999999999999999999999875433221111222234
Q ss_pred cccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHH
Q 021947 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 219 (305)
Q Consensus 141 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (305)
+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.... .....+........+..+
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~ 257 (288)
T cd05050 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-----------------EVIYYVRDGNVLSCPDNC 257 (288)
T ss_pred ChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCC
Confidence 667999999988899999999999999999997 88888654321 111111111112234456
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~ 250 (305)
+.++.+|+.+||+.+|.+|||+.|+++.|++
T Consensus 258 ~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 258 PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=288.72 Aligned_cols=234 Identities=20% Similarity=0.242 Sum_probs=173.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||... ...+.+|++++++++||||+++++++..+...++|+|++. ++|..++.... .+++..++.++.
T Consensus 119 ~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~ 189 (391)
T PHA03212 119 HVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR--NIAICDILAIER 189 (391)
T ss_pred EEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHH
Confidence 57888643 2356799999999999999999999999999999999995 58988886544 488999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||++ ||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||
T Consensus 190 qi~~aL~ylH~~--~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 266 (391)
T PHA03212 190 SVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDI 266 (391)
T ss_pred HHHHHHHHHHhC--CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHH
Confidence 999999999964 599999999999999999999999999975322211 11234578999999999999899999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccc-----hhh---hhhhhhh----hhcc-chhhhhhh----hcccC--CCC-----Ch
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGI-----EQS---LVDWAKP----YLSD-KRKLFRIM----DTKLG--GQY-----PQ 217 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~-----~~~---~~~~~~~----~~~~-~~~~~~~~----~~~~~--~~~-----~~ 217 (305)
|||||++|+|++|..||....... ... +...... +... ...+.... ..... ... ..
T Consensus 267 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (391)
T PHA03212 267 WSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY 346 (391)
T ss_pred HHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHh
Confidence 999999999999998875432110 000 0000000 0000 00000000 00000 000 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.++.+||.+||..||.+|||+.+++++
T Consensus 347 ~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 347 ELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 456789999999999999999999999964
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=277.58 Aligned_cols=236 Identities=24% Similarity=0.427 Sum_probs=180.7
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC----------CC
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------QP 70 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~ 70 (305)
.||+|.++..... ....+.+|++++++++|+||+++++++...+..++||||+.+++|.+++..... ..
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 125 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence 4899999865332 345789999999999999999999999999999999999999999999854321 13
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.+||+|||++................++..|+|||++
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 203 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence 6788899999999999999996 45999999999999999999999999999764332222222233456789999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHh--CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
.+..++.++|+||||+++|+|++ |..||....... ..... ...............+...+..+.+|+.
T Consensus 204 ~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (295)
T cd05097 204 LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIENT--------GEFFRNQGRQIYLSQTPLCPSPVFKLMM 273 (295)
T ss_pred ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--HHHHH--------HHhhhhccccccCCCCCCCCHHHHHHHH
Confidence 88899999999999999999998 667776533211 00000 0000000011111223346788999999
Q ss_pred hhccCCCCCCCCHHHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~ 249 (305)
+||..||.+|||+.++++.|.
T Consensus 274 ~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 274 RCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHcCCCchhCcCHHHHHHHHh
Confidence 999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=270.06 Aligned_cols=232 Identities=24% Similarity=0.386 Sum_probs=185.8
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~ 76 (305)
.||+|.++... ......+.+|++++++++|+||+++++.+...+..++||||+++++|.+++... ....+++..+
T Consensus 29 ~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 108 (267)
T cd08224 29 VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108 (267)
T ss_pred EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHH
Confidence 68999886432 223467899999999999999999999999999999999999999999998542 2344889999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
+.++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++
T Consensus 109 ~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~ 184 (267)
T cd08224 109 WKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred HHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCC
Confidence 9999999999999996 45999999999999999999999999998765432211 2234578899999999888899
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh-HHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|..||......... +.+..........+. .++..+.++|.+||..+|
T Consensus 185 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p 249 (267)
T cd08224 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---------------LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDP 249 (267)
T ss_pred chhcHHHHHHHHHHHHHCCCCcccCCccHHH---------------HHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCc
Confidence 9999999999999999999999654321110 111111111222333 677789999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021947 236 KLRPRMSEVLAILERLE 252 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~ 252 (305)
++|||+.++++.|+.+.
T Consensus 250 ~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 250 EKRPDISYVLQVAKEMH 266 (267)
T ss_pred ccCCCHHHHHHHHHHhc
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.57 Aligned_cols=223 Identities=25% Similarity=0.366 Sum_probs=182.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+..........+.+|+.+++.++|+||+++++.+..+...|+||||+.|++|.+++... .+++..+..++.
T Consensus 47 ~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ 123 (296)
T cd06654 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCR 123 (296)
T ss_pred EEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHH
Confidence 68999888765556678899999999999999999999999999999999999999999998543 378899999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+
T Consensus 124 ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 199 (296)
T cd06654 124 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 199 (296)
T ss_pred HHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchH
Confidence 99999999996 45999999999999999999999999998754322111 223467889999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
|||||++|+|++|..||........ ..... ........+..++..+.+++.+||..+|++|||
T Consensus 200 ~s~Gvil~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 263 (296)
T cd06654 200 WSLGIMAIEMIEGEPPYLNENPLRA----------------LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263 (296)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHh----------------HHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC
Confidence 9999999999999999976432110 00000 111112234567788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.++++.
T Consensus 264 ~~eil~~ 270 (296)
T cd06654 264 AKELLQH 270 (296)
T ss_pred HHHHhhC
Confidence 9999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=269.27 Aligned_cols=227 Identities=30% Similarity=0.452 Sum_probs=182.0
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++..... ....+.+|++++++++|+||+++++++...+..++||||+.+++|.+++.... ..+++..+..++
T Consensus 21 ~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ 99 (250)
T cd05085 21 PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFA 99 (250)
T ss_pred EEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 5899988765432 23468899999999999999999999999999999999999999999986543 348899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.+|.|+|+ +|++|+||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++|
T Consensus 100 ~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~D 176 (250)
T cd05085 100 LDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESD 176 (250)
T ss_pred HHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhH
Confidence 999999999995 45999999999999999999999999998754322111 111223456799999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|++++ |..||.+..... ....+........+..++..+.+++.+||+.+|.+||
T Consensus 177 i~slG~ll~~~~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (250)
T cd05085 177 VWSYGILLWETFSLGVCPYPGMTNQQ-----------------AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239 (250)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence 9999999999998 999997643211 1111112222233455778999999999999999999
Q ss_pred CHHHHHHHHH
Q 021947 240 RMSEVLAILE 249 (305)
Q Consensus 240 s~~~~l~~l~ 249 (305)
++.++++.|.
T Consensus 240 ~~~~l~~~l~ 249 (250)
T cd05085 240 KFSELQKELA 249 (250)
T ss_pred CHHHHHHHhc
Confidence 9999998774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=276.90 Aligned_cols=228 Identities=29% Similarity=0.397 Sum_probs=182.5
Q ss_pred CEEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
++||+|.+....... ...+.+|+.++++++|+||+.+++.+.+.+..++||||+.|++|.+++.......+++..+.
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~ 105 (285)
T cd05630 26 KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAV 105 (285)
T ss_pred ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHH
Confidence 368999887543222 24577899999999999999999999999999999999999999999866555568999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.
T Consensus 106 ~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~ 180 (285)
T cd05630 106 FYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF 180 (285)
T ss_pred HHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCC
Confidence 999999999999996 4599999999999999999999999999876433221 12346899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+||||+++|+|++|..||........... ..... .......+..++..+.+|+.+||+.||.+
T Consensus 181 ~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-------------~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (285)
T cd05630 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-------------VERLV-KEVQEEYSEKFSPDARSLCKMLLCKDPKE 246 (285)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCCccchHHH-------------HHhhh-hhhhhhcCccCCHHHHHHHHHHhhcCHHH
Confidence 99999999999999999999986432211100 00000 11111234456778999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
||| +.+++++
T Consensus 247 R~s~~~~~~~~~~~h 261 (285)
T cd05630 247 RLGCQGGGAREVKEH 261 (285)
T ss_pred ccCCCCCchHHHHcC
Confidence 999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.96 Aligned_cols=228 Identities=25% Similarity=0.414 Sum_probs=197.8
Q ss_pred CEEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||.++.+... ...+|++|+.+|.+|+|+|++++||++.+ ....+|||++++|+|.+.|.+.....|.....-.+
T Consensus 139 V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdy 217 (1039)
T KOG0199|consen 139 VNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDY 217 (1039)
T ss_pred EeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHH
Confidence 36999999988665 55789999999999999999999999987 67889999999999999998755566888889999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.||+.|+.||.+++ +|||||-..|+|+.....|||+|||+.+..+....... .....-...|+|||.++...++.+
T Consensus 218 a~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha 295 (1039)
T KOG0199|consen 218 AMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA 295 (1039)
T ss_pred HHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc
Confidence 999999999999755 99999999999999888999999999998765443322 223334668999999999999999
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+|+|++|+++|||++ |..||-+.. ...+++.++.+.+...|..+++.+++++++||..+|.+
T Consensus 296 SDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paD 358 (1039)
T KOG0199|consen 296 SDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPAD 358 (1039)
T ss_pred chhhhhhhhHHhhhccCCCCCCCCC-----------------HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccc
Confidence 999999999999998 899998753 33456667777788889999999999999999999999
Q ss_pred CCCHHHHHHHH
Q 021947 238 RPRMSEVLAIL 248 (305)
Q Consensus 238 Rps~~~~l~~l 248 (305)
|||+.+|.+.+
T Consensus 359 RptFsair~~~ 369 (1039)
T KOG0199|consen 359 RPTFSAIREDL 369 (1039)
T ss_pred cccHHHHHHhH
Confidence 99999998543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=271.54 Aligned_cols=228 Identities=31% Similarity=0.475 Sum_probs=185.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||.++... ....++.+|++++++++|+||+++++++......++||||+++++|.+++.......+++..+..++.
T Consensus 32 ~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 110 (261)
T cd05034 32 KVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110 (261)
T ss_pred eEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHH
Confidence 58999987643 34578999999999999999999999999888999999999999999999776555689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ ++++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+
T Consensus 111 ~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di 187 (261)
T cd05034 111 QIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDV 187 (261)
T ss_pred HHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHH
Confidence 99999999995 46999999999999999999999999998765432111 1112234568999999998889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|++++ |+.||.+.... ..............+...+..+.+++.+||..+|.+||+
T Consensus 188 ~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 250 (261)
T cd05034 188 WSFGILLTEIVTYGRVPYPGMTNR-----------------EVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPT 250 (261)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 999999999998 99999764311 111112222223334456788999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
++++.+.|+.
T Consensus 251 ~~~l~~~l~~ 260 (261)
T cd05034 251 FEYLQSFLED 260 (261)
T ss_pred HHHHHHHHhc
Confidence 9999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.64 Aligned_cols=231 Identities=29% Similarity=0.453 Sum_probs=181.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||+|.++.... .....+.+|++++.++ +|+||+++++++..++.+|+||||+++++|.+++.+..
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (303)
T cd05088 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115 (303)
T ss_pred eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 467777764322 2335788999999999 89999999999999999999999999999999996543
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..++.++.|++.||+|||+ +|++||||||+|||++.++.+||+|||++........ .....++..|+
T Consensus 116 ~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~ 190 (303)
T cd05088 116 STASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWM 190 (303)
T ss_pred cccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCCCcEEeCccccCcccchhhh---cccCCCccccc
Confidence 1247889999999999999999995 5699999999999999999999999999864221110 11122356799
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++||||||+++|+|++ |..||...+.. ...+..........+..++..+.
T Consensus 191 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 253 (303)
T cd05088 191 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVY 253 (303)
T ss_pred CHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----------------HHHHHHhcCCcCCCCCCCCHHHH
Confidence 9999988889999999999999999998 99999754321 11111112222223445677899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+|+.+||+.+|++||++.+++..|.++...
T Consensus 254 ~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 254 DLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=275.59 Aligned_cols=232 Identities=25% Similarity=0.392 Sum_probs=182.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--------CCCCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~ 72 (305)
.||+|.++.... .....+.+|+.+++.++|+||+++++++......++||||+.+|+|.+++.+.. ...+.
T Consensus 38 ~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 117 (288)
T cd05061 38 RVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117 (288)
T ss_pred EEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCC
Confidence 589998875532 233568899999999999999999999999999999999999999999996532 12356
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
...+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+
T Consensus 118 ~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 195 (288)
T cd05061 118 LQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence 67888999999999999996 4599999999999999999999999999876433222221222345678999999988
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++|+|||||++|+|++ |..||.+.... ...+.+........+..++..+.+++.+||
T Consensus 196 ~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 258 (288)
T cd05061 196 GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----------------QVLKFVMDGGYLDQPDNCPERVTDLMRMCW 258 (288)
T ss_pred CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 899999999999999999998 78888753321 111111111122234456788999999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhc
Q 021947 232 NNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+.||++|||+.++++.|+...
T Consensus 259 ~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 259 QFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCChhHCcCHHHHHHHHHhhc
Confidence 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=271.91 Aligned_cols=219 Identities=25% Similarity=0.401 Sum_probs=174.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.|++|.+..........+.+|+.+++.++||||+++++++......++||||+++++|..++.+.. ..+++..++.++.
T Consensus 34 ~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~ 112 (262)
T cd05077 34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAK 112 (262)
T ss_pred eEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHH
Confidence 588998877655555678899999999999999999999999889999999999999998886543 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCc-------eeeccccccccCCCCCCcceeecccccccccchhhhh-cC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TG 153 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~ 153 (305)
|++.||+|||+ ++++||||||+|||++.++. ++++|||++...... ....++..|+|||++. +.
T Consensus 113 qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~ 184 (262)
T cd05077 113 QLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSK 184 (262)
T ss_pred HHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCC
Confidence 99999999996 45999999999999987654 899999998654321 2235788899999886 45
Q ss_pred CCCCCCceehhhHHHHHHH-hCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++||||||+++|+|+ .|..||......... ....... ......+.++.+||.+||+
T Consensus 185 ~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~~~li~~cl~ 245 (262)
T cd05077 185 NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----------------RFYEGQC--MLVTPSCKELADLMTHCMN 245 (262)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----------------HHHhcCc--cCCCCChHHHHHHHHHHcC
Confidence 7889999999999999998 588888654321110 0001111 1112235678999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAIL 248 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l 248 (305)
.||.+||++.+|+..+
T Consensus 246 ~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 246 YDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChhhCcCHHHHHHhc
Confidence 9999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.77 Aligned_cols=245 Identities=29% Similarity=0.404 Sum_probs=184.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.++.... .....+.+|+++++.++|+||+++++++... ...++||||++|++|.+++.+.. ..+++..++.
T Consensus 35 ~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~ 113 (284)
T cd05079 35 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLK 113 (284)
T ss_pred eEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHH
Confidence 589999876532 3346789999999999999999999998765 56789999999999999986543 3489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.+++.||+|||+ +|++||||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.
T Consensus 114 i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 191 (284)
T cd05079 114 YAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI 191 (284)
T ss_pred HHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCc
Confidence 99999999999995 56999999999999999999999999999875433221 1122345677899999998888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|+++..|+............... ...........+........+..++..+.+|+.+||+.+|.+
T Consensus 192 ~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 269 (284)
T cd05079 192 ASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH--GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269 (284)
T ss_pred cccchhhhhhhhhhhcCCCCCccccchhhhhccccc--ccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCccc
Confidence 999999999999999987665332111000000000 000001111122222223344567889999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
|||+.++++.|+.+
T Consensus 270 Rpt~~~il~~l~~~ 283 (284)
T cd05079 270 RTTFQNLIEGFEAI 283 (284)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=271.94 Aligned_cols=228 Identities=29% Similarity=0.457 Sum_probs=180.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||+|.++.... .....+.+|++++.++ +||||+++++++...+..|+||||+.+++|.+++..+.
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 368888775432 3346788999999999 79999999999999999999999999999999996542
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..+..++.+++.||+|||+ +|++|+||||+||+++.++.+||+|||++....... .......+..|+
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~ 178 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWM 178 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccC
Confidence 1247889999999999999999996 469999999999999999999999999986322111 011122356799
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|+||||+++|+|++ |..||.+.... .....+........+..++.++.
T Consensus 179 apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 241 (270)
T cd05047 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVY 241 (270)
T ss_pred ChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----------------HHHHHHhCCCCCCCCCcCCHHHH
Confidence 9999988889999999999999999997 99999764321 11111112222233445677899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+|+.+||..||.+|||+.+++..|.++
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 242 DLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=273.48 Aligned_cols=228 Identities=25% Similarity=0.281 Sum_probs=178.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++..........+.+|+.++++++|+||+++++++...+..|+||||+.+++|.+++.+.+ .+++..+..++.
T Consensus 36 ~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ 113 (267)
T cd06646 36 LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCR 113 (267)
T ss_pred EEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHH
Confidence 589999876544455678899999999999999999999999999999999999999999986544 489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTK 158 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~ 158 (305)
|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .....++..|+|||.+. ...++.+
T Consensus 114 qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~ 189 (267)
T cd06646 114 ETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQL 189 (267)
T ss_pred HHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcch
Confidence 99999999996 45999999999999999999999999999865322111 22346788999999874 3457789
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||......... .. +...............++..+.+|+.+||..+|++|
T Consensus 190 ~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 256 (267)
T cd06646 190 CDIWAVGITAIELAELQPPMFDLHPMRAL--FL-----------MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256 (267)
T ss_pred hhHHHHHHHHHHHHhCCCCccccchhhhh--ee-----------eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhC
Confidence 99999999999999999998653211000 00 000000000011123456789999999999999999
Q ss_pred CCHHHHHHHH
Q 021947 239 PRMSEVLAIL 248 (305)
Q Consensus 239 ps~~~~l~~l 248 (305)
||++++++.|
T Consensus 257 p~~~~il~~l 266 (267)
T cd06646 257 PTAERLLTHL 266 (267)
T ss_pred cCHHHHhcCC
Confidence 9999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=281.24 Aligned_cols=216 Identities=26% Similarity=0.377 Sum_probs=174.8
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++.... .....+..|..++..+ .|++|+++++++...+..|+||||+.+|+|.+++...+ .+++..+.
T Consensus 27 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~ 104 (323)
T cd05616 27 LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAV 104 (323)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 689999875432 2234567788888877 58999999999999999999999999999999986554 48899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||++ |++||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.
T Consensus 105 ~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 180 (323)
T cd05616 105 FYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGK 180 (323)
T ss_pred HHHHHHHHHHHHHHHC--CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCC
Confidence 9999999999999964 599999999999999999999999999875332211 123456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+... ....+.. ....++..++.++.+|+.+||+.||.+
T Consensus 181 ~~DiwSlGvil~elltg~~Pf~~~~~~~----------------~~~~i~~--~~~~~p~~~s~~~~~li~~~l~~~p~~ 242 (323)
T cd05616 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------LFQSIME--HNVAYPKSMSKEAVAICKGLMTKHPGK 242 (323)
T ss_pred ccchhchhHHHHHHHhCCCCCCCCCHHH----------------HHHHHHh--CCCCCCCcCCHHHHHHHHHHcccCHHh
Confidence 9999999999999999999998643210 0111111 122345667889999999999999999
Q ss_pred CCCH
Q 021947 238 RPRM 241 (305)
Q Consensus 238 Rps~ 241 (305)
|++.
T Consensus 243 R~~~ 246 (323)
T cd05616 243 RLGC 246 (323)
T ss_pred cCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=274.37 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=184.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++.........+.+|++++++++||||+++++++... ...++||||+.+++|.+++.+.. ..+++..+..+
T Consensus 35 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~ 113 (284)
T cd05081 35 VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLY 113 (284)
T ss_pred EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHH
Confidence 6899998876555567889999999999999999999987543 46789999999999999996543 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-eeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.+++.||+|||+ +|++||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.+
T Consensus 114 ~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 191 (284)
T cd05081 114 ASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA 191 (284)
T ss_pred HHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChH
Confidence 9999999999995 459999999999999999999999999998654332211 1111223456999999988889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..++.............. .........+.+.+........+..++..+.+|+.+||..+|++|
T Consensus 192 ~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05081 192 SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270 (284)
T ss_pred HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999999998777644321110000000 000000011122233333334455677899999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021947 239 PRMSEVLAILERL 251 (305)
Q Consensus 239 ps~~~~l~~l~~~ 251 (305)
||+.++++.|+.+
T Consensus 271 pt~~ei~~~l~~~ 283 (284)
T cd05081 271 PSFSELALQVEAI 283 (284)
T ss_pred CCHHHHHHHHHhc
Confidence 9999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=271.33 Aligned_cols=230 Identities=27% Similarity=0.467 Sum_probs=184.4
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+++... ....+.+.+|++++++++|+||+++++++...+..|+||||+.+++|.+++.... ..+++..+..++
T Consensus 35 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ 113 (268)
T cd05063 35 AVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGML 113 (268)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 58999887653 2334678999999999999999999999999999999999999999999986543 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCccee-ecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.+++.||.|||+ .|++|+||||+||+++.++.+||+|||++............ .....+..|+|||++.+..++.++
T Consensus 114 ~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 191 (268)
T cd05063 114 RGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191 (268)
T ss_pred HHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHh
Confidence 999999999996 45999999999999999999999999998765432221111 111234579999999888899999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|+||||+++|+|++ |..||..... ......+........+..++..+.+++.+||..+|.+|
T Consensus 192 Dv~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 254 (268)
T cd05063 192 DVWSFGIVMWEVMSFGERPYWDMSN-----------------HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARR 254 (268)
T ss_pred HHHHHHHHHHHHHhCCCCCCCcCCH-----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 99999999999997 9999975431 11112222222333344577889999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021947 239 PRMSEVLAILERL 251 (305)
Q Consensus 239 ps~~~~l~~l~~~ 251 (305)
|++.++++.|+++
T Consensus 255 p~~~~i~~~l~~~ 267 (268)
T cd05063 255 PRFVDIVNLLDKL 267 (268)
T ss_pred cCHHHHHHHHHhh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=270.77 Aligned_cols=230 Identities=27% Similarity=0.463 Sum_probs=184.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.... .....+.+|+.++++++||||+++++++..++..|+||||++|++|.+++.+.. ..++...+..++
T Consensus 34 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~ 112 (267)
T cd05066 34 PVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGML 112 (267)
T ss_pred EEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 588998875432 234678999999999999999999999999999999999999999999996554 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce-eecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.+++.||.|||+. +++|+||||+||+++.++.++|+|||++........... .....++..|++||.+.+..++.++
T Consensus 113 ~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~ 190 (267)
T cd05066 113 RGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190 (267)
T ss_pred HHHHHHHHHHHHC--CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchh
Confidence 9999999999964 599999999999999999999999999986543322111 1112235689999999988999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|+||||+++|++++ |..||.+..... ....+......+.+..++..+.+++.+||+.+|.+|
T Consensus 191 Dv~slG~~l~ell~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (267)
T cd05066 191 DVWSYGIVMWEVMSYGERPYWEMSNQD-----------------VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNER 253 (267)
T ss_pred hhHHHHHHHHHHhcCCCCCcccCCHHH-----------------HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhC
Confidence 99999999999886 999997643210 111111122223344567889999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021947 239 PRMSEVLAILERL 251 (305)
Q Consensus 239 ps~~~~l~~l~~~ 251 (305)
|++.++++.|+++
T Consensus 254 p~~~~i~~~l~~~ 266 (267)
T cd05066 254 PKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHHhh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.62 Aligned_cols=232 Identities=25% Similarity=0.351 Sum_probs=184.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhcCC------CCCCH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGP------QPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~ 73 (305)
.|++|+++.... .....+.+|+.++++++|+||+++++++.. +...++++||+.+++|.+++..... ..+++
T Consensus 37 ~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~ 116 (280)
T cd05043 37 EVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116 (280)
T ss_pred EEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCH
Confidence 588898875422 234668899999999999999999998776 4678999999999999999865322 35889
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..++.++.+++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|+|||++.+.
T Consensus 117 ~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 194 (280)
T cd05043 117 QQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194 (280)
T ss_pred HHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence 9999999999999999995 45999999999999999999999999999765332221112223456789999999888
Q ss_pred CCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++||||||+++|++++ |+.||...+.. .+...+........+..++..+.+++.+||.
T Consensus 195 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (280)
T cd05043 195 EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----------------EMAAYLKDGYRLAQPINCPDELFAVMACCWA 257 (280)
T ss_pred CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcC
Confidence 89999999999999999999 99999764321 1111222222223344567889999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhc
Q 021947 233 NEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~~~~ 252 (305)
.||++|||+.++++.|..+.
T Consensus 258 ~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 258 LDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CChhhCCCHHHHHHHHHHHH
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=275.82 Aligned_cols=230 Identities=28% Similarity=0.435 Sum_probs=181.8
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.|++|.++... ....+.+.+|++++.++ +||||+++++++...+..|+||||+++++|.+++.....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 36788777432 22345788999999999 799999999999998999999999999999999965321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++........ ......+..|+
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~ 185 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWM 185 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCcccc
Confidence 247888999999999999999996 4599999999999999999999999999864321111 11112345799
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|||||||++|+|++ |..||.+.... ..............+..++..+.
T Consensus 186 aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T cd05089 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRMEKPRNCDDEVY 248 (297)
T ss_pred CchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCCCCHHHH
Confidence 9999988889999999999999999997 99999764321 11111222223334456778899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+|+.+||..+|.+|||++++++.|..+..
T Consensus 249 ~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 249 ELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=268.16 Aligned_cols=224 Identities=28% Similarity=0.381 Sum_probs=189.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.+||||.+..+ .+.+++..|+.+|.+.+.++||++||.+..+..+|+|||||..|++.+.++.+. +++++..+..++
T Consensus 59 ~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL 135 (502)
T KOG0574|consen 59 HVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVL 135 (502)
T ss_pred cEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHH
Confidence 37999998876 577899999999999999999999999999999999999999999999886554 569999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
...++||.|||... -+|||||..|||++.+|..||+|||.+-...+..- ......||+-|||||++..-.|+.++|
T Consensus 136 ~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~AD 211 (502)
T KOG0574|consen 136 RDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKAD 211 (502)
T ss_pred HHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccHHHHHHhccchhhh
Confidence 99999999999765 79999999999999999999999999875543221 234568999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||++..||..|++||.+-.. .+.++-+. ........|...++++.+|+++||-++|++|-
T Consensus 212 IWSLGITaIEMAEG~PPYsDIHP----------------MRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~ 275 (502)
T KOG0574|consen 212 IWSLGITAIEMAEGRPPYSDIHP----------------MRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK 275 (502)
T ss_pred HhhhcchhhhhhcCCCCcccccc----------------cceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH
Confidence 99999999999999999986432 11111111 11122345678889999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+..++++
T Consensus 276 TA~~L~~H 283 (502)
T KOG0574|consen 276 TALRLCEH 283 (502)
T ss_pred HHHHHhhh
Confidence 99998865
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=269.02 Aligned_cols=225 Identities=24% Similarity=0.359 Sum_probs=183.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.|++|.+..... ....++.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++.+.....+++..+..+
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08221 27 LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106 (256)
T ss_pred EEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHH
Confidence 578898765432 334678899999999999999999999999999999999999999999997764556899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+++.+|.|||+. +++|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++
T Consensus 107 ~~~l~~~l~~lh~~--~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~ 182 (256)
T cd08221 107 LFQIVSAVSYIHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKS 182 (256)
T ss_pred HHHHHHHHHHHHhC--CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcc
Confidence 99999999999964 599999999999999999999999999976543221 12345688999999999888889999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|+||||+++|+|++|..||...... .....+. .......+..++.++.+++.+||..+|.+||
T Consensus 183 Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 245 (256)
T cd08221 183 DIWALGCVLYELLTLKRTFDATNPL----------------NLVVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245 (256)
T ss_pred hhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHH-cCCCCCCccccCHHHHHHHHHHcccCcccCC
Confidence 9999999999999999999764321 0111111 1111223356778899999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
++.+++++
T Consensus 246 s~~~ll~~ 253 (256)
T cd08221 246 TADEVLDQ 253 (256)
T ss_pred CHHHHhhC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=271.49 Aligned_cols=229 Identities=28% Similarity=0.367 Sum_probs=183.8
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||...... ....+.+.+|+.++++++|+||+++++++.+ +..|+||||+++++|.+++.... ..+++..+..++
T Consensus 36 ~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 113 (270)
T cd05056 36 AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYS 113 (270)
T ss_pred ceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence 58899887664 2345679999999999999999999998865 56789999999999999996544 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||+|||+ .+++|+||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|
T Consensus 114 ~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~D 190 (270)
T cd05056 114 YQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASD 190 (270)
T ss_pred HHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhh
Confidence 999999999995 45999999999999999999999999999765433211 111223456799999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|++++ |..||.+..... ....+........+..++..+.+++.+||..+|.+||
T Consensus 191 i~slG~il~el~~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 253 (270)
T cd05056 191 VWMFGVCMWEILMLGVKPFQGVKNND-----------------VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRP 253 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999999996 999997653211 0111112222234556788999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|+++.
T Consensus 254 t~~~~~~~l~~~~ 266 (270)
T cd05056 254 RFTELKAQLSDIL 266 (270)
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=271.08 Aligned_cols=231 Identities=24% Similarity=0.392 Sum_probs=186.3
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+...... ....+.+|+.++.+++|+||+++++++.. ...++||||+.+++|.+++..... .+++..+..++
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~ 115 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWC 115 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHH
Confidence 5889988766432 34678899999999999999999999876 788999999999999999976543 48999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|
T Consensus 116 ~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05057 116 VQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193 (279)
T ss_pred HHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhh
Confidence 999999999996 569999999999999999999999999998754332221111222356899999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|++++ |..||.+... ..+...+........+..++..+.+++.+||..+|.+||
T Consensus 194 i~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp 256 (279)
T cd05057 194 VWSYGVTVWELMTFGAKPYEGIPA-----------------VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRP 256 (279)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCCH-----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999999999998 9999976432 111222222223344455677899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021947 240 RMSEVLAILERLEA 253 (305)
Q Consensus 240 s~~~~l~~l~~~~~ 253 (305)
++.++++.|.++..
T Consensus 257 ~~~~l~~~l~~~~~ 270 (279)
T cd05057 257 TFKELINEFSKMAR 270 (279)
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=270.25 Aligned_cols=231 Identities=27% Similarity=0.409 Sum_probs=178.5
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEE-eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||.+.... ......+.+|+.+++.++||||+++++++. .++..+++|||+.+++|.+++.+... ..++..+..+
T Consensus 25 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~ 103 (262)
T cd05058 25 HCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGF 103 (262)
T ss_pred EEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHH
Confidence 58999886432 233467889999999999999999999775 45567899999999999999965432 3677788899
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhcCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
+.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++........ .......++..|+|||.+.+..++.
T Consensus 104 ~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (262)
T cd05058 104 GLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTT 181 (262)
T ss_pred HHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccch
Confidence 9999999999995 46999999999999999999999999999754322111 1111234567899999998889999
Q ss_pred CCceehhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++||||||+++|+|++| ..||...... .+...+........+..++..+.+++.+||..+|+
T Consensus 182 ~~Di~slG~~l~el~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 244 (262)
T cd05058 182 KSDVWSFGVLLWELMTRGAPPYPDVDSF-----------------DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPE 244 (262)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 99999999999999995 5666543211 11111222222223345677899999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 021947 237 LRPRMSEVLAILERLE 252 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~ 252 (305)
+||++.++++.|+++.
T Consensus 245 ~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 245 MRPTFSELVSRIEQIF 260 (262)
T ss_pred hCCCHHHHHHHHHHHh
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=268.26 Aligned_cols=221 Identities=33% Similarity=0.514 Sum_probs=180.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++.+. ....+.+|+.++++++|+||+++++++... ..+++|||+.+++|.+++.......+++..++.++.
T Consensus 31 ~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 107 (254)
T cd05083 31 KVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107 (254)
T ss_pred ceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHH
Confidence 58999887542 446789999999999999999999998654 579999999999999999766555689999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+ +|++||||||+||+++.++.++|+|||++....... .....+..|+|||.+.+..++.++|+
T Consensus 108 qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv 180 (254)
T cd05083 108 DVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDV 180 (254)
T ss_pred HHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhH
Confidence 99999999995 569999999999999999999999999987543211 11234567999999988899999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||...... ..............+..++..+.+++.+||+.+|.+||+
T Consensus 181 ~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 243 (254)
T cd05083 181 WSYGVLLWEVFSYGRAPYPKMSLK-----------------EVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPS 243 (254)
T ss_pred HHHHHHHHHHHhCCCCCCccCCHH-----------------HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcC
Confidence 999999999997 99999764321 111222222333344567788999999999999999999
Q ss_pred HHHHHHHHH
Q 021947 241 MSEVLAILE 249 (305)
Q Consensus 241 ~~~~l~~l~ 249 (305)
+.++++.|+
T Consensus 244 ~~~l~~~l~ 252 (254)
T cd05083 244 FHKLREKLE 252 (254)
T ss_pred HHHHHHHHc
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=268.57 Aligned_cols=227 Identities=33% Similarity=0.519 Sum_probs=185.2
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+++..... ....+.+|++.++.++|+||+++++++.+.+..+++|||+++++|.+++.......+++..+..++
T Consensus 30 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 109 (258)
T smart00219 30 EVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFA 109 (258)
T ss_pred eEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHH
Confidence 5899999766443 457899999999999999999999999999999999999999999999976544338999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||++||+ .+++|+||||+||+++.++.++|+|||++............ ...++..|+|||.+.+..++.++|
T Consensus 110 ~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~D 186 (258)
T smart00219 110 LQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSD 186 (258)
T ss_pred HHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchh
Confidence 999999999996 45999999999999999999999999999865443222111 223678999999998888999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++ |..||..... ..+.+..........+..++..+.+++.+||+.||.+||
T Consensus 187 i~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 187 VWSFGVLLWEIFTLGESPYPGMSN-----------------EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCc
Confidence 9999999999998 7888875321 111122222223344455788999999999999999999
Q ss_pred CHHHHHHHH
Q 021947 240 RMSEVLAIL 248 (305)
Q Consensus 240 s~~~~l~~l 248 (305)
|+.++++.|
T Consensus 250 t~~~ll~~l 258 (258)
T smart00219 250 TFSELVEIL 258 (258)
T ss_pred CHHHHHhhC
Confidence 999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.91 Aligned_cols=226 Identities=23% Similarity=0.252 Sum_probs=176.5
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..|+||||++|++|.+++... .++...+.
T Consensus 69 ~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~ 145 (371)
T cd05622 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWAR 145 (371)
T ss_pred cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHH
Confidence 368999886421 123345788999999999999999999999999999999999999999998654 38888899
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC---
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--- 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--- 154 (305)
.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..
T Consensus 146 ~~~~qi~~aL~~LH~~--~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ 222 (371)
T cd05622 146 FYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222 (371)
T ss_pred HHHHHHHHHHHHHHHC--CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCc
Confidence 9999999999999964 599999999999999999999999999986543221 1123457899999999987643
Q ss_pred -CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhc
Q 021947 155 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 155 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 231 (305)
++.++|||||||++|+|++|..||.+.+.. .....+.... ...+....++..+.+||.+||
T Consensus 223 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (371)
T cd05622 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286 (371)
T ss_pred cCCCccceeehhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHc
Confidence 788999999999999999999999865421 1111122111 111223357889999999999
Q ss_pred cCCCCC--CCCHHHHHHHH
Q 021947 232 NNEPKL--RPRMSEVLAIL 248 (305)
Q Consensus 232 ~~~p~~--Rps~~~~l~~l 248 (305)
..++.+ |+++++++++.
T Consensus 287 ~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 287 TDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CChhhhcCCCCHHHHhcCc
Confidence 844433 77999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=271.12 Aligned_cols=225 Identities=24% Similarity=0.314 Sum_probs=178.5
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..||+|.++.........+.+|+.+++.++||||+++++.+...+..|+||||+++++|.+++...+ .+++..+..++
T Consensus 35 ~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~ 112 (267)
T cd06645 35 ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVS 112 (267)
T ss_pred cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 3689999876654455678899999999999999999999999999999999999999999986554 48999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTT 157 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~ 157 (305)
.+++.||.|||+. |++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++. ...++.
T Consensus 113 ~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 188 (267)
T cd06645 113 RETLQGLYYLHSK--GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQ 188 (267)
T ss_pred HHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCc
Confidence 9999999999964 599999999999999999999999999875432211 123446889999999874 456888
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC---CCCChHHHHHHHHHHHhhccCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++|+|||||++|+|++|..||......... ......... ......++..+.+++.+||..+
T Consensus 189 ~~DvwSlG~il~~l~~~~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06645 189 LCDIWAVGITAIELAELQPPMFDLHPMRAL----------------FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKN 252 (267)
T ss_pred hhhhHHHHHHHHHHhcCCCCcccccchhhH----------------HhhhccCCCCCcccccCCCCHHHHHHHHHHccCC
Confidence 999999999999999999998654321100 000000000 0011235667899999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|++|||+++++++
T Consensus 253 P~~R~~~~~ll~~ 265 (267)
T cd06645 253 PKKRPTAEKLLQH 265 (267)
T ss_pred chhCcCHHHHhcC
Confidence 9999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=279.19 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=177.6
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||++..+... ....+.+|+++++.++||||+++++++..++..|+||||+++++|.+++.......+++..+..+
T Consensus 27 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i 106 (327)
T cd08227 27 YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106 (327)
T ss_pred EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHH
Confidence 6899998765332 23467789999999999999999999999999999999999999999997654445899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-----ceeecccccccccchhhhhc--
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVAT-- 152 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~-- 152 (305)
+.|++.||+|||++ +++||||||+||+++.++.++++||+........... .......++..|+|||++.+
T Consensus 107 ~~qi~~~L~~LH~~--~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (327)
T cd08227 107 LQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNL 184 (327)
T ss_pred HHHHHHHHHHHHHC--CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhccc
Confidence 99999999999964 5999999999999999999999999865432211110 01122346778999999876
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhccc-----hhh----------------------h
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDK-----RKL----------------------F 204 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~-----~~~----------------------~ 204 (305)
..++.++|||||||++|+|++|..||.......... ......+...+. ..+ .
T Consensus 185 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (327)
T cd08227 185 QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPR 264 (327)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcC
Confidence 468899999999999999999999997543211000 000000000000 000 0
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 205 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..............++..+.+|+.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 265 PSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000000011223456789999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=268.39 Aligned_cols=227 Identities=29% Similarity=0.471 Sum_probs=182.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++... .....+.+|++++++++|+||+++++.+.+ ...+++|||+.+++|.+++.......+++..+..++.
T Consensus 32 ~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05073 32 KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109 (260)
T ss_pred cEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHH
Confidence 47889887542 234678999999999999999999999887 7789999999999999999765555688889999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ .|++|+||||+||+++.++.+||+|||.+......... ......++..|+|||++.+..++.++|+
T Consensus 110 ~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di 186 (260)
T cd05073 110 QIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccc
Confidence 99999999995 56999999999999999999999999999765432211 1222335677999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|++++ |..||.+..... +...+........+...+.++.+++.+||+.+|++||+
T Consensus 187 ~slG~~l~~l~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 249 (260)
T cd05073 187 WSFGILLMEIVTYGRIPYPGMSNPE-----------------VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249 (260)
T ss_pred hHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcC
Confidence 999999999998 999997643211 11111122222334567788999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
+.++++.|+.
T Consensus 250 ~~~l~~~L~~ 259 (260)
T cd05073 250 FEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHhc
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=276.06 Aligned_cols=240 Identities=23% Similarity=0.342 Sum_probs=181.4
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.+... ...++.+|++++++++||||+++++.+..++..++||||++|++|.+++.+.+ .+++..+..++
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~ 105 (308)
T cd06615 28 IMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKIS 105 (308)
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 5788888755322 23568899999999999999999999999999999999999999999996653 48899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|
T Consensus 106 ~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~D 180 (308)
T cd06615 106 IAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSD 180 (308)
T ss_pred HHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccch
Confidence 9999999999962 469999999999999999999999999987543221 23346789999999998888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhcc-------------------chhhhhhhhcccCCCCC-hHHH
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-------------------KRKLFRIMDTKLGGQYP-QKAA 220 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~-~~~~ 220 (305)
+||||+++|+|++|..||...+................. .....+..........+ ..++
T Consensus 181 iwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (308)
T cd06615 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS 260 (308)
T ss_pred HHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccC
Confidence 999999999999999999754422111111000000000 00000001011111111 1356
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
.++.+|+.+||..+|++|||+.+++++.
T Consensus 261 ~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 261 DEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 7899999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=270.31 Aligned_cols=224 Identities=25% Similarity=0.432 Sum_probs=180.5
Q ss_pred EEEEEecccCCccC---------hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 2 VVAVKKLKPEGFQG---------HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
.||+|.+....... .+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++...+ .++
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~ 104 (267)
T cd06628 27 LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFE 104 (267)
T ss_pred EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc--Ccc
Confidence 58899886543322 1457889999999999999999999999999999999999999999996653 488
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc----ceeecccccccccchh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----HVSTQVMGTHGYAAPE 148 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~t~~y~aPE 148 (305)
...+..++.+++.||.|||+ +|++||||+|+||+++.++.++|+|||+++........ .......++..|+|||
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe 182 (267)
T cd06628 105 ETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChh
Confidence 88999999999999999996 45999999999999999999999999998865422111 0112235788999999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
.+.+..++.++|+||||+++|+|++|..||.+.+.. ....... .......+..++..+.++|.
T Consensus 183 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06628 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------------QAIFKIG-ENASPEIPSNISSEAIDFLE 245 (267)
T ss_pred HhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------------HHHHHHh-ccCCCcCCcccCHHHHHHHH
Confidence 998888999999999999999999999999764321 1111111 12223345567889999999
Q ss_pred hhccCCCCCCCCHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~ 246 (305)
+||+.||.+||++.++++
T Consensus 246 ~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 246 KTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHccCCchhCcCHHHHhh
Confidence 999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.25 Aligned_cols=238 Identities=24% Similarity=0.270 Sum_probs=178.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+... ..+.+|+++|++++|+||+++++++......|+|||++. ++|.+++... ..+++..++.++.
T Consensus 121 ~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ 192 (392)
T PHA03207 121 KVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQR 192 (392)
T ss_pred eEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHH
Confidence 5788877643 235689999999999999999999999999999999996 5899988433 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+. ||+||||||+|||++.++.++|+|||+++...............||..|+|||++.+..++.++||
T Consensus 193 ql~~aL~~LH~~--givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 270 (392)
T PHA03207 193 RLLEALAYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270 (392)
T ss_pred HHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhH
Confidence 999999999964 599999999999999999999999999976544333222334578999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-------hhhc-cchhhhh---hhhcccCCCC--C-----hHHHHH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-------PYLS-DKRKLFR---IMDTKLGGQY--P-----QKAAHT 222 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-------~~~~-~~~~~~~---~~~~~~~~~~--~-----~~~~~~ 222 (305)
|||||++|+|++|+.||.+....... .+..... .+.. ....+.. .........+ + ...+.+
T Consensus 271 wslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (392)
T PHA03207 271 WSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD 350 (392)
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchh
Confidence 99999999999999999775432111 0000000 0000 0000000 0000011111 1 134567
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
+.++|.+||..||++|||+.+++.+-.
T Consensus 351 ~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 351 VEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCch
Confidence 889999999999999999999998643
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=268.84 Aligned_cols=224 Identities=28% Similarity=0.367 Sum_probs=182.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.+|+|++........+.+.+|++++++++||||+++++.+.++...|++|||+.+++|.+++.... ..+++..+..++.
T Consensus 30 ~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ 108 (262)
T cd06613 30 LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCR 108 (262)
T ss_pred EEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHH
Confidence 588999887655566789999999999999999999999999999999999999999999886542 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC---CCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTK 158 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~ 158 (305)
|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.+
T Consensus 109 ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~ 184 (262)
T cd06613 109 ETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGK 184 (262)
T ss_pred HHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCch
Confidence 99999999996 4599999999999999999999999999876543211 12234678899999998776 78899
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc---ccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+|+||||+++|+|++|..||.+...... ....... .........++.++.+++.+||..+|
T Consensus 185 ~Di~slG~~l~~~~tg~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 248 (262)
T cd06613 185 CDIWALGITAIELAELQPPMFDLHPMRA----------------LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDP 248 (262)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCCh
Confidence 9999999999999999999976432110 0000000 01112244567889999999999999
Q ss_pred CCCCCHHHHHH
Q 021947 236 KLRPRMSEVLA 246 (305)
Q Consensus 236 ~~Rps~~~~l~ 246 (305)
.+|||+.+++.
T Consensus 249 ~~Rpt~~~il~ 259 (262)
T cd06613 249 KKRPTATKLLQ 259 (262)
T ss_pred hhCCCHHHHhc
Confidence 99999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=271.75 Aligned_cols=225 Identities=24% Similarity=0.375 Sum_probs=179.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+..........+.+|+++++.++|+||+++++.+...+..|+|+||+.+++|..++.+.. ..+++..+..++.
T Consensus 32 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ 110 (282)
T cd06643 32 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCK 110 (282)
T ss_pred EEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence 578888876554556778999999999999999999999999999999999999999998875432 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLT 156 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~ 156 (305)
|++.||.|||+. |++||||||+||+++.++.++|+|||++........ ......++..|+|||++. +..++
T Consensus 111 qi~~~L~~LH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 186 (282)
T cd06643 111 QTLEALNYLHEN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYD 186 (282)
T ss_pred HHHHHHHHHHHC--CeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCC
Confidence 999999999964 599999999999999999999999999876432211 123346789999999874 34577
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|+|||||++|+|++|..||...... ......... ......+..++.++.+||.+||+.||
T Consensus 187 ~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (282)
T cd06643 187 YKADVWSLGITLIEMAQIEPPHHELNPM----------------RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNV 250 (282)
T ss_pred ccchhhhHHHHHHHHccCCCCccccCHH----------------HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 8999999999999999999999754311 001111110 11122344577889999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+||++.+++++
T Consensus 251 ~~Rp~~~~il~~ 262 (282)
T cd06643 251 DARWTTTQLLQH 262 (282)
T ss_pred hhCcCHHHHhcC
Confidence 999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.43 Aligned_cols=227 Identities=21% Similarity=0.195 Sum_probs=174.9
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||+|++... .....+.+.+|..++..++|+||+++++++.+++..|+||||+.|++|.+++.+.. ..+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~ 105 (331)
T cd05597 27 QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMAR 105 (331)
T ss_pred CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHH
Confidence 36899998642 12234568899999999999999999999999999999999999999999996533 348999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-----
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----- 152 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----- 152 (305)
.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+
T Consensus 106 ~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05597 106 FYLAEMVLAIDSVHQL--GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGK 182 (331)
T ss_pred HHHHHHHHHHHHHHhC--CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccc
Confidence 9999999999999964 5999999999999999999999999998764432211 1223468999999999863
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC---CCChHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~ 229 (305)
..++.++|||||||++|+|++|+.||.+...... ...+....... .....++..+.+||.+
T Consensus 183 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (331)
T cd05597 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------------YGKIMNHKEHFQFPPDVTDVSEEAKDLIRR 246 (331)
T ss_pred cCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----------------HHHHHcCCCcccCCCccCCCCHHHHHHHHH
Confidence 3577899999999999999999999976432110 01111111111 1122467889999999
Q ss_pred hccCCCC--CCCCHHHHHHH
Q 021947 230 CLNNEPK--LRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~--~Rps~~~~l~~ 247 (305)
||..++. .|+++.+++++
T Consensus 247 ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 247 LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HccCcccccCCCCHHHHhcC
Confidence 8865443 37899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=274.37 Aligned_cols=223 Identities=25% Similarity=0.370 Sum_probs=182.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||.+........+.+.+|+.+++.++|+||+++++++..+...|+|+||+.+++|.+++... .+++..+..++.
T Consensus 46 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~ 122 (296)
T cd06655 46 EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCR 122 (296)
T ss_pred EEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHH
Confidence 68999887665555678899999999999999999999999999999999999999999988543 389999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+. |++|+||||+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+
T Consensus 123 ~l~~al~~LH~~--~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 198 (296)
T cd06655 123 ECLQALEFLHAN--QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 198 (296)
T ss_pred HHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhH
Confidence 999999999964 5999999999999999999999999998764332211 223467889999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||......... .... ........+..++..+.+||.+||..||.+|||
T Consensus 199 ~slGvil~~lltg~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 262 (296)
T cd06655 199 WSLGIMAIEMVEGEPPYLNENPLRAL----------------YLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262 (296)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC
Confidence 99999999999999999765421110 0000 001111234457788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++++
T Consensus 263 ~~~il~~ 269 (296)
T cd06655 263 AKELLQH 269 (296)
T ss_pred HHHHhhC
Confidence 9999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=271.20 Aligned_cols=227 Identities=27% Similarity=0.373 Sum_probs=181.2
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.+...... ....+.+|+++++.++|+||+.+++.+..++..+++|||+.+++|.+++...+...+++..+..
T Consensus 27 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 106 (285)
T cd05632 27 MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF 106 (285)
T ss_pred EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHH
Confidence 6899988754322 2345788999999999999999999999999999999999999999988765555699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.+
T Consensus 107 ~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~ 181 (285)
T cd05632 107 YAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLS 181 (285)
T ss_pred HHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcc
Confidence 99999999999996 4599999999999999999999999999876432211 223468999999999988899999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||.+........ .+...+. .....++..++..+.+|+.+||+.||.+|
T Consensus 182 ~Di~slG~~l~~l~~g~~P~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKRE-------------EVDRRVL-ETEEVYSAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHHhhh-ccccccCccCCHHHHHHHHHHccCCHhHc
Confidence 999999999999999999998643211100 0111111 11122345577789999999999999999
Q ss_pred CC-----HHHHHHH
Q 021947 239 PR-----MSEVLAI 247 (305)
Q Consensus 239 ps-----~~~~l~~ 247 (305)
|+ +.+++.+
T Consensus 248 ~~~~~~~~~~l~~~ 261 (285)
T cd05632 248 LGCQEEGAGEVKRH 261 (285)
T ss_pred CCCcccChHHHHcC
Confidence 99 6677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=271.98 Aligned_cols=219 Identities=28% Similarity=0.425 Sum_probs=173.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++..........+.+|+++++.++||||+++++++.++...++||||+++++|..++.+.. ..+++..+..++.
T Consensus 46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~ 124 (274)
T cd05076 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQ 124 (274)
T ss_pred eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence 589999876544445678899999999999999999999999999999999999999999886533 3488999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCC-------ceeeccccccccCCCCCCcceeecccccccccchhhhhc-C
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
|++.||+|||+ .+++||||||+||+++..+ .+|++|||++...... ....++..|+|||.+.+ .
T Consensus 125 qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 125 QLASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHHHc--CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCC
Confidence 99999999996 4599999999999997643 3799999987643221 12346788999998865 5
Q ss_pred CCCCCCceehhhHHHHHHH-hCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++|+||||+++|+++ +|..||......... ...... ...+......+.++|.+||+
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~~li~~cl~ 257 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-----------------RFYEKK--HRLPEPSCKELATLISQCLT 257 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-----------------HHHHhc--cCCCCCCChHHHHHHHHHcc
Confidence 6889999999999999995 699998764321110 011111 11222334578999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAIL 248 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l 248 (305)
.+|++|||+.++++.|
T Consensus 258 ~~p~~Rps~~~il~~L 273 (274)
T cd05076 258 YEPTQRPSFRTILRDL 273 (274)
T ss_pred cChhhCcCHHHHHHhh
Confidence 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=279.33 Aligned_cols=233 Identities=30% Similarity=0.416 Sum_probs=180.1
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhcc-CCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCC----------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGP---------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---------- 68 (305)
.||||+++..... ....+.+|+.++.++ +|+||+++++++... ...+++|||+++|+|.+++.....
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~ 118 (343)
T cd05103 39 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDA 118 (343)
T ss_pred eEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccccccc
Confidence 6899999765322 335688999999999 689999999987654 457899999999999999864321
Q ss_pred -------------------------------------------------------CCCCHHHHHHHHHHHHHHHhhhhcC
Q 021947 69 -------------------------------------------------------QPLSWAVRMKVAIGAAKGLTFLHDA 93 (305)
Q Consensus 69 -------------------------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~ 93 (305)
..+++..+..++.|++.||+|||+.
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 198 (343)
T cd05103 119 RFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR 198 (343)
T ss_pred ccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2367778889999999999999964
Q ss_pred CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHh
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 173 (305)
+++||||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 199 --~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 276 (343)
T cd05103 199 --KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276 (343)
T ss_pred --CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 599999999999999999999999999976533222111222345678999999988899999999999999999997
Q ss_pred -CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 174 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 174 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
|..||....... .....+........+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 277 ~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 277 LGASPYPGVKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCCCCCccccH----------------HHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999987542210 111111122222233345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=285.26 Aligned_cols=225 Identities=25% Similarity=0.316 Sum_probs=175.7
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++... ......+.+|+.++..++|+||+++++.+.+.+..|+||||++|++|.+++.+.. .+++..+..
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~ 105 (360)
T cd05627 28 IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQF 105 (360)
T ss_pred EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHH
Confidence 68999987532 2234567889999999999999999999999999999999999999999996554 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--------------------------
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------------------- 132 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------------------------- 132 (305)
++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.........
T Consensus 106 ~~~qi~~~L~~lH~~--givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (360)
T cd05627 106 YIAETVLAIDAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183 (360)
T ss_pred HHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccc
Confidence 999999999999964 5999999999999999999999999998754221100
Q ss_pred -------ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhh
Q 021947 133 -------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 205 (305)
Q Consensus 133 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (305)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.... ...
T Consensus 184 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~----------------~~~ 247 (360)
T cd05627 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET----------------YRK 247 (360)
T ss_pred cccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHH----------------HHH
Confidence 001134689999999999999999999999999999999999999986542111 111
Q ss_pred hhhcccCCCCC--hHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 021947 206 IMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 247 (305)
Q Consensus 206 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~ 247 (305)
+........++ ..++.++.+||.+|+ .||.+|++ +.+++++
T Consensus 248 i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 248 VMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 11111111122 236778999999977 49999985 6676654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=268.05 Aligned_cols=225 Identities=23% Similarity=0.309 Sum_probs=181.3
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++..+.. ...+.+.+|++++++++|+|++++++.+.. ....|++|||+++++|.+++.......+++..+..
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~ 106 (257)
T cd08223 27 QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106 (257)
T ss_pred EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHH
Confidence 689999875432 234568899999999999999999998764 44679999999999999999765555689999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.+++.||.+||+ +|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||++.+..++.+
T Consensus 107 ~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (257)
T cd08223 107 WFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYK 182 (257)
T ss_pred HHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCch
Confidence 99999999999995 4699999999999999999999999999976533221 2234467899999999999899999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|+.||...+... .............+..++..+.+++.+||+.||.+|
T Consensus 183 ~Dv~slG~il~~l~~g~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd08223 183 SDVWALGCCVYEMATLKHAFNAKDMNS-----------------LVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKR 245 (257)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCHHH-----------------HHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccC
Confidence 999999999999999999997543110 011111111223445678899999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 246 p~~~~~l~~ 254 (257)
T cd08223 246 PSVKSILRQ 254 (257)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=277.78 Aligned_cols=217 Identities=26% Similarity=0.372 Sum_probs=174.9
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||+++.+. ....+.+..|..++..+. |++|+++++++...+..|+||||++|++|.+++.+.+ .+++..+
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~ 103 (323)
T cd05615 26 ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQA 103 (323)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHH
Confidence 369999987542 223356788999998886 5788889999999999999999999999999986554 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++
T Consensus 104 ~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 104 VFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred HHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCC
Confidence 9999999999999996 4599999999999999999999999999875432211 12345689999999999988999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|..||.+..... ....+.. ....++..++.++.+++.+||..+|.
T Consensus 180 ~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~~--~~~~~p~~~~~~~~~li~~~l~~~p~ 241 (323)
T cd05615 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDE----------------LFQSIME--HNVSYPKSLSKEAVSICKGLMTKHPS 241 (323)
T ss_pred CccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHh--CCCCCCccCCHHHHHHHHHHcccCHh
Confidence 99999999999999999999998653210 1111111 12234556778899999999999999
Q ss_pred CCCCH
Q 021947 237 LRPRM 241 (305)
Q Consensus 237 ~Rps~ 241 (305)
+|++.
T Consensus 242 ~R~~~ 246 (323)
T cd05615 242 KRLGC 246 (323)
T ss_pred hCCCC
Confidence 99975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=298.95 Aligned_cols=225 Identities=24% Similarity=0.340 Sum_probs=174.9
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcC--CCCCCHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRG--PQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 75 (305)
.||+|.+...... ....|..|+.+|.+++||||++++++|... ..+||||||+.+++|.++|.... ...+++..
T Consensus 40 ~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~ 119 (1021)
T PTZ00266 40 FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119 (1021)
T ss_pred EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHH
Confidence 5889988754332 346789999999999999999999988643 56899999999999999996431 23589999
Q ss_pred HHHHHHHHHHHHhhhhcCC-----CceeeccCCCCceEeCCC-----------------CceeeccccccccCCCCCCcc
Q 021947 76 RMKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLDAE-----------------FNAKLSDFGLAKAGPTGDRTH 133 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~-----~~ivH~dlkp~Nil~~~~-----------------~~~kl~Dfg~~~~~~~~~~~~ 133 (305)
++.++.||+.||.|||+.+ .+|+|+||||+|||++.+ +.+||+|||++.......
T Consensus 120 Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--- 196 (1021)
T PTZ00266 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--- 196 (1021)
T ss_pred HHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---
Confidence 9999999999999999743 459999999999999642 348999999998654322
Q ss_pred eeecccccccccchhhhhc--CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc
Q 021947 134 VSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 211 (305)
Q Consensus 134 ~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (305)
......||+.|+|||++.+ ..++.++||||||||+|+|++|..||...... ..+...+....
T Consensus 197 ~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~----------------~qli~~lk~~p 260 (1021)
T PTZ00266 197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF----------------SQLISELKRGP 260 (1021)
T ss_pred cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH----------------HHHHHHHhcCC
Confidence 1234578999999999865 35788999999999999999999999754321 11111111111
Q ss_pred CCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 212 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
... ....+.++.+||.+||..+|.+||++.+++.
T Consensus 261 ~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 261 DLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 1245778999999999999999999999995
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=268.27 Aligned_cols=236 Identities=25% Similarity=0.317 Sum_probs=175.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC---e--eEEEEecCCCCCHHHHhhhc--CCCCCCHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE---N--RLLVYEFMPKGSLENHLFRR--GPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~--~~lv~e~~~~~~L~~~l~~~--~~~~~~~~ 74 (305)
.||||+.-++.. .--+|+++|+++.|||||++..+|.... . ..+||||++. +|...++.. .+..++..
T Consensus 51 ~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~ 125 (364)
T KOG0658|consen 51 EVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLL 125 (364)
T ss_pred eeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCcee
Confidence 699998765522 1137999999999999999988877432 2 3489999975 999998642 23347888
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-CceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+.-+..||.+||+|||++ ||+||||||+|+|++.+ |.+||||||.|+....... ......|..|+|||.+.|.
T Consensus 126 ~iKLYt~Qlfrgl~yLh~~--~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---niSYicSRyYRaPELifga 200 (364)
T KOG0658|consen 126 EIKLYTYQLFRGLAYLHSH--GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA 200 (364)
T ss_pred eeHHHHHHHHHHHHHHHhc--CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---ceeEEEeccccCHHHHcCc
Confidence 8899999999999999974 59999999999999987 8899999999998655433 2344678999999998876
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhhhc------c---chhhhhhhhcccCCCCChHHHH
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLS------D---KRKLFRIMDTKLGGQYPQKAAH 221 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~------~---~~~~~~~~~~~~~~~~~~~~~~ 221 (305)
.|+.+.||||.||++.||+-|++.|.+......-. +.. +..|... . .....++........+....+.
T Consensus 201 ~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~ 280 (364)
T KOG0658|consen 201 TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPP 280 (364)
T ss_pred cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCH
Confidence 79999999999999999999999999855432211 111 1111000 0 0001111111111124456788
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 222 TAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 222 ~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++.+|+.++|..+|.+|.++.+++.+
T Consensus 281 d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 281 DALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHHHHHHhccChhhcCCHHHHhcc
Confidence 99999999999999999999999964
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=271.86 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=188.2
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++..... ....|.+|+++++.++|+||+++++++.. ....+++|||+++++|.+++..... .+++..+..
T Consensus 35 ~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~ 113 (284)
T cd05038 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLL 113 (284)
T ss_pred EEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHH
Confidence 5899999866443 45689999999999999999999999877 5578999999999999999966543 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-eeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.+++.||+|||+ +|++|+||||+||+++.++.++|+|||.+.......... ......++..|++||.+.+..++.
T Consensus 114 ~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 191 (284)
T cd05038 114 FSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSS 191 (284)
T ss_pred HHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCc
Confidence 99999999999996 459999999999999999999999999998765322211 111223456799999998889999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+||||+++|+|++|..||............. .........+...+........+..++.++.+|+.+||+.+|.+
T Consensus 192 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05038 192 ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQD 269 (284)
T ss_pred ccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhh
Confidence 9999999999999999999986543211100000 00000111222233333333445567788999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
|||+.++++.|+++
T Consensus 270 Rpt~~ei~~~l~~i 283 (284)
T cd05038 270 RPSFADLILIVDRL 283 (284)
T ss_pred CCCHHHHHHHHhhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=273.18 Aligned_cols=232 Identities=24% Similarity=0.395 Sum_probs=182.6
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+....... ...+.+|+.+++.++|+||+++++++... ..++++||+.+|+|.+++.... ..+++..++.++
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~ 115 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWC 115 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHH
Confidence 57899887653322 34688999999999999999999988654 5679999999999999986543 248899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|
T Consensus 116 ~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (303)
T cd05110 116 VQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193 (303)
T ss_pred HHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHH
Confidence 999999999995 459999999999999999999999999998654332221122234567899999998889999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+..... ....+........+..++..+.+++.+||..+|++||
T Consensus 194 iwslG~~l~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp 256 (303)
T cd05110 194 VWSYGVTIWELMTFGGKPYDGIPTRE-----------------IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRP 256 (303)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999999997 899997643111 1111122222223344667899999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 021947 240 RMSEVLAILERLEAP 254 (305)
Q Consensus 240 s~~~~l~~l~~~~~~ 254 (305)
++.++++.|..+...
T Consensus 257 ~~~~l~~~l~~~~~~ 271 (303)
T cd05110 257 KFKELAAEFSRMARD 271 (303)
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=268.32 Aligned_cols=233 Identities=26% Similarity=0.313 Sum_probs=174.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC---CCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 77 (305)
.||+|.++.... .....+.+|+.++++++||||+++++.+.+....++||||+++++|.+++.... ....++..+.
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 103 (269)
T cd05087 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ 103 (269)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHH
Confidence 478898876543 233578899999999999999999999998888999999999999999996532 1235677888
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC----
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---- 153 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---- 153 (305)
.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++................++..|+|||++.+.
T Consensus 104 ~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (269)
T cd05087 104 RMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181 (269)
T ss_pred HHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccc
Confidence 899999999999996 45999999999999999999999999998754332222222234567889999988642
Q ss_pred ---CCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 154 ---RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 154 ---~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.++.++|+||||+++|+|++ |..||............ .................+..+.+++.+
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~~ 249 (269)
T cd05087 182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT------------VREQQLKLPKPRLKLPLSDRWYEVMQF 249 (269)
T ss_pred cccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH------------hhcccCCCCCCccCCCCChHHHHHHHH
Confidence 35789999999999999996 99999764321110000 000000000111122456778899999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~ 249 (305)
|| .+|++|||+++|+..|.
T Consensus 250 c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 250 CW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred Hh-cCcccCCCHHHHHHHhc
Confidence 99 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=274.20 Aligned_cols=229 Identities=27% Similarity=0.324 Sum_probs=182.8
Q ss_pred CEEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||.+...... ....+.+|+++++.++|+||+++++.+..+...|+||||+.|++|.+++.+.....+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~ 106 (316)
T cd05574 27 KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR 106 (316)
T ss_pred cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHH
Confidence 36899998765433 345688999999999999999999999999999999999999999999976555568999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-------------------------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------------- 132 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------------------------- 132 (305)
.++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus 107 ~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (316)
T cd05574 107 FYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184 (316)
T ss_pred HHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhccc
Confidence 999999999999995 56999999999999999999999999998754321110
Q ss_pred --ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc
Q 021947 133 --HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 210 (305)
Q Consensus 133 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (305)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+.. ..+.......
T Consensus 185 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----------------~~~~~~~~~~ 248 (316)
T cd05574 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD----------------ETFSNILKKE 248 (316)
T ss_pred ccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH----------------HHHHHHhcCC
Confidence 0111235788999999999888999999999999999999999999765421 1111222222
Q ss_pred cCCCCChHHHHHHHHHHHhhccCCCCCCCC----HHHHHHH
Q 021947 211 LGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLAI 247 (305)
Q Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~ 247 (305)
.........+..+.+++.+||..||++||| +++++.+
T Consensus 249 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 249 VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 222222337889999999999999999999 7777653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=268.94 Aligned_cols=228 Identities=29% Similarity=0.371 Sum_probs=172.9
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC---CCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 77 (305)
.||+|.+...... ....+.+|+++++.++|+||+++++.+......|+||||+.+++|.+++..... ...++....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 103 (269)
T cd05042 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ 103 (269)
T ss_pred EEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHH
Confidence 5788877654322 235688999999999999999999999999999999999999999999965432 224677888
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-----
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----- 152 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----- 152 (305)
.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++................++..|+|||++..
T Consensus 104 ~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (269)
T cd05042 104 RMACEVASGLLWLHQA--DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181 (269)
T ss_pred HHHHHHHHHHHHHHhc--CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccc
Confidence 9999999999999964 599999999999999999999999999875432221111222345678999998753
Q ss_pred --CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc----ccCCCCChHHHHHHHH
Q 021947 153 --GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT----KLGGQYPQKAAHTAAT 225 (305)
Q Consensus 153 --~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 225 (305)
..++.++|||||||++|+|++ |..||....... .+...... ......+..++..+.+
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (269)
T cd05042 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----------------VLKQVVREQDIKLPKPQLDLKYSDRWYE 245 (269)
T ss_pred cccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----------------HHHHHhhccCccCCCCcccccCCHHHHH
Confidence 356779999999999999999 788887543210 01111110 0111223456778888
Q ss_pred HHHhhccCCCCCCCCHHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l 248 (305)
++..|| .||++|||++++++.|
T Consensus 246 ~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 246 VMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHh-cCcccccCHHHHHHHh
Confidence 999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.57 Aligned_cols=223 Identities=25% Similarity=0.361 Sum_probs=182.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...|+||||++|++|.+++.+. .+++..+..++.
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ 122 (297)
T cd06656 46 EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCR 122 (297)
T ss_pred EEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHH
Confidence 68999987665555677889999999999999999999999999999999999999999998543 378899999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.+|.|||+. +++|+||||+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+
T Consensus 123 ~l~~~L~~LH~~--~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di 198 (297)
T cd06656 123 ECLQALDFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 198 (297)
T ss_pred HHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHH
Confidence 999999999964 5999999999999999999999999998764332211 223457889999999998889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||...+.... ..... ........+..++..+.+|+.+||..+|.+||+
T Consensus 199 ~slGvil~~l~tg~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 199 WSLGIMAIEMVEGEPPYLNENPLRA----------------LYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcchh----------------eeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999976432100 00000 011112234557788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++++
T Consensus 263 ~~~il~~ 269 (297)
T cd06656 263 AKELLQH 269 (297)
T ss_pred HHHHhcC
Confidence 9999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=268.94 Aligned_cols=226 Identities=25% Similarity=0.346 Sum_probs=177.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
++||+|.+.... .....+.+|+.+++++ +|+||+++++++... ...|++|||+.+++|.+++.......+++
T Consensus 32 ~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~ 110 (272)
T cd06637 32 QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110 (272)
T ss_pred cEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCH
Confidence 368999886542 4456788999999998 699999999998753 45799999999999999997655556899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh--
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-- 151 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-- 151 (305)
..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.
T Consensus 111 ~~~~~~~~qi~~~l~~LH~~--~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 186 (272)
T cd06637 111 EWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACD 186 (272)
T ss_pred HHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccc
Confidence 99999999999999999964 599999999999999999999999999876432211 123346889999999986
Q ss_pred ---cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 152 ---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 152 ---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
+..++.++|+|||||++|+|++|..||........ ................++..+.+|+.
T Consensus 187 ~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (272)
T cd06637 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----------------LFLIPRNPAPRLKSKKWSKKFQSFIE 250 (272)
T ss_pred cCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----------------HHHHhcCCCCCCCCCCcCHHHHHHHH
Confidence 33578899999999999999999999965332110 00111111112223356778999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..+|.+|||+.+++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 251 SCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHcCCChhhCCCHHHHhhC
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=269.84 Aligned_cols=229 Identities=28% Similarity=0.404 Sum_probs=182.1
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-------CCCCH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-------QPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~ 73 (305)
.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..|+||||+++++|.+++..... ..+++
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~ 116 (275)
T cd05046 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116 (275)
T ss_pred eEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCH
Confidence 5888887654333 346789999999999999999999999988899999999999999999965541 25899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.+|+|||+ ++++|+||||+||+++.++.++++|||++........ .......++..|+|||.+.+.
T Consensus 117 ~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~ 193 (275)
T cd05046 117 KQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED 193 (275)
T ss_pred HHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccC
Confidence 9999999999999999995 4599999999999999999999999999875432211 112233567789999999888
Q ss_pred CCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++||||||+++|+|++ |..||...... ...............+..++..+.+++.+||.
T Consensus 194 ~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 257 (275)
T cd05046 194 DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----------------EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWA 257 (275)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccccchH----------------HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcC
Confidence 88999999999999999998 88888653211 01111111112223344677899999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAILE 249 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~ 249 (305)
.+|.+|||+.++++.|.
T Consensus 258 ~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 258 VNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcccCCCHHHHHHHhc
Confidence 99999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.09 Aligned_cols=227 Identities=20% Similarity=0.226 Sum_probs=175.6
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||+|++.... ......+.+|..++..++|+||+++++++.+.+..|+||||+.||+|.+++.+.. ..+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~ 105 (331)
T cd05624 27 RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMAR 105 (331)
T ss_pred CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHH
Confidence 368999886421 1233457889999999999999999999999999999999999999999997533 348899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-----
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----- 152 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----- 152 (305)
.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......... ......|++.|+|||++.+
T Consensus 106 ~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05624 106 FYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGM 182 (331)
T ss_pred HHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCC
Confidence 999999999999996 45999999999999999999999999999765432221 1233568999999999876
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC---hHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ 229 (305)
+.++.++|+||||+++|+|++|+.||...... .....+........++ ..++.++.+|+.+
T Consensus 183 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ 246 (331)
T cd05624 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR 246 (331)
T ss_pred CCCCCcccEEeeehhhhhhhhCCCCccCCCHH----------------HHHHHHHcCCCcccCCCccccCCHHHHHHHHH
Confidence 46788999999999999999999999764321 0111111111111122 2467889999999
Q ss_pred hccCCCCC--CCCHHHHHHH
Q 021947 230 CLNNEPKL--RPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~--Rps~~~~l~~ 247 (305)
||..++.+ |+++++++++
T Consensus 247 ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 247 LICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HccCchhhcCCCCHHHHhcC
Confidence 99876544 4588888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=282.86 Aligned_cols=223 Identities=24% Similarity=0.392 Sum_probs=183.3
Q ss_pred EEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHH
Q 021947 4 AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 83 (305)
Q Consensus 4 aiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i 83 (305)
|-|++........++|+=|+++|....||+|+++++.|...+.+|++.|||.||-....+..-+. .+.+..+..+++++
T Consensus 61 AaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ 139 (1187)
T KOG0579|consen 61 AAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQV 139 (1187)
T ss_pred hhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHH
Confidence 44666555556668899999999999999999999999999999999999999999888766553 59999999999999
Q ss_pred HHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cCCCCCC
Q 021947 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTK 158 (305)
Q Consensus 84 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~ 158 (305)
++||.|||+.+ |||||||..|||++-+|.++|+|||.+-...... .....++||+.|||||+.. ..+|+++
T Consensus 140 ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk 215 (1187)
T KOG0579|consen 140 LDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYK 215 (1187)
T ss_pred HHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHH--hhhccccCCcccccchheeeccccCCCchhh
Confidence 99999999755 9999999999999999999999999886532221 1234678999999999874 4589999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc-CCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+||||||+++.+|..+.+|-...+ ....+.++..... ..-.|...+..+.+|+++||..||..
T Consensus 216 aDiWSlGITLIEMAqiEPPHheln----------------pMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~ 279 (1187)
T KOG0579|consen 216 ADIWSLGITLIEMAQIEPPHHELN----------------PMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRN 279 (1187)
T ss_pred hhHHhhhhHHHHHhccCCCccccc----------------hHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCcc
Confidence 999999999999999999876532 2333333333222 22345678889999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
||++.+++++
T Consensus 280 Rp~aaqll~H 289 (1187)
T KOG0579|consen 280 RPPAAQLLKH 289 (1187)
T ss_pred CCCHHHHhhC
Confidence 9999999964
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=270.65 Aligned_cols=219 Identities=26% Similarity=0.377 Sum_probs=173.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+.+|+|.+++..++. .+++..++.++.
T Consensus 29 ~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~ 107 (258)
T cd05078 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAK 107 (258)
T ss_pred hhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHH
Confidence 3677776554434456788999999999999999999999998999999999999999999976543 488999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCc--------eeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
|++.||+|||+ .+++||||||+||+++.++. ++++|||++..... .....++..|+|||++.+.
T Consensus 108 qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 108 QLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENP 179 (258)
T ss_pred HHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCC
Confidence 99999999996 45999999999999987765 69999998865432 1234578889999998764
Q ss_pred -CCCCCCceehhhHHHHHHHhCC-CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
.++.++|+||||+++|+|++|. .||........ ..... .....+...+.++.+|+.+||
T Consensus 180 ~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----------------~~~~~--~~~~~~~~~~~~~~~li~~~l 240 (258)
T cd05078 180 QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----------------LQFYE--DRHQLPAPKWTELANLINQCM 240 (258)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----------------HHHHH--ccccCCCCCcHHHHHHHHHHh
Confidence 5788999999999999999984 56554321110 00111 112344456678999999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l 248 (305)
+.||++|||++++++.|
T Consensus 241 ~~~p~~Rps~~~il~~l 257 (258)
T cd05078 241 DYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ccChhhCCCHHHHHHhc
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=273.96 Aligned_cols=240 Identities=24% Similarity=0.322 Sum_probs=178.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||+.+ +|.+++...+ ..++...+..++
T Consensus 33 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~ 110 (309)
T cd07872 33 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFL 110 (309)
T ss_pred eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHH
Confidence 689999875532 2335678999999999999999999999999999999999975 8888886544 347889999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 159 (305)
.|++.||+|||+ +|++||||||+||+++.++.+||+|||++......... .....++..|+|||++.+ ..++.++
T Consensus 111 ~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~ 186 (309)
T cd07872 111 YQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQI 186 (309)
T ss_pred HHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHH
Confidence 999999999996 45999999999999999999999999998764332211 223457889999998865 4678899
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhh------hccchhhhhhhhcccC----CCCChHHHHHHHHHH
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY------LSDKRKLFRIMDTKLG----GQYPQKAAHTAATLA 227 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li 227 (305)
||||||+++|+|++|+.||.+.+...... ... ...+. ................ ......++.++.+||
T Consensus 187 DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 266 (309)
T cd07872 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELL 266 (309)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHH
Confidence 99999999999999999998765322111 000 00000 0000000000000000 001124677899999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||..||.+|||+.+++++
T Consensus 267 ~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 267 TKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHhccCChhhCCCHHHHhcC
Confidence 99999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=270.28 Aligned_cols=225 Identities=27% Similarity=0.391 Sum_probs=181.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++.......+.+.+|++++++++|+||+++++++......|+||||+++++|.+++.... ..+++..+..++.
T Consensus 32 ~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ 110 (280)
T cd06611 32 FAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCR 110 (280)
T ss_pred EEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHH
Confidence 689999876655556789999999999999999999999999999999999999999999986543 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-----CCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLT 156 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~ 156 (305)
|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......++..|++||++.. ..++
T Consensus 111 ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~ 186 (280)
T cd06611 111 QMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYD 186 (280)
T ss_pred HHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCC
Confidence 99999999996 4599999999999999999999999998875433221 1233467899999998753 3567
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|..||....... ......... .....+..++..+.+++.+||..+|
T Consensus 187 ~~sDi~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (280)
T cd06611 187 YKADIWSLGITLIELAQMEPPHHELNPMR----------------VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDP 250 (280)
T ss_pred ccccHHHHHHHHHHHHhCCCCcccCCHHH----------------HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccCh
Confidence 79999999999999999999997643210 011111110 1112244567889999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+||++.+++++
T Consensus 251 ~~Rps~~~il~~ 262 (280)
T cd06611 251 DDRPTAAELLKH 262 (280)
T ss_pred hhCcCHHHHhcC
Confidence 999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=274.01 Aligned_cols=226 Identities=20% Similarity=0.214 Sum_probs=174.9
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++.... ......+.+|+.++..++|+||+++++.+.+.+..|+||||+.||+|.+++.+.. ..+++..+..
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~ 106 (332)
T cd05623 28 VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARF 106 (332)
T ss_pred EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHH
Confidence 68999886421 1223457889999999999999999999999999999999999999999996543 3489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TG 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~ 153 (305)
++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........ .......||+.|+|||++. ..
T Consensus 107 ~~~qi~~al~~lH~~--~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 183 (332)
T cd05623 107 YLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKG 183 (332)
T ss_pred HHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCC
Confidence 999999999999964 599999999999999999999999999875432221 1123356899999999986 34
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC---ChHHHHHHHHHHHhh
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQC 230 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 230 (305)
.++.++|+|||||++|+|++|+.||....... ....+......... ...++.++.+|+.+|
T Consensus 184 ~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~l 247 (332)
T cd05623 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRL 247 (332)
T ss_pred CCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH----------------HHHHHhCCCccccCCCccccCCHHHHHHHHHH
Confidence 67889999999999999999999997643211 11111111111112 235688999999999
Q ss_pred ccCCCCC--CCCHHHHHHH
Q 021947 231 LNNEPKL--RPRMSEVLAI 247 (305)
Q Consensus 231 l~~~p~~--Rps~~~~l~~ 247 (305)
|..++.+ |+++.+++++
T Consensus 248 l~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 248 ICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccChhhhcCCCCHHHHhCC
Confidence 9665444 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=279.46 Aligned_cols=237 Identities=24% Similarity=0.281 Sum_probs=173.2
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||+++.... .....+.+|+.+++.++||||+++++++.... ..|+||||+.+ +|.+.+.. .++.
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~ 122 (359)
T cd07876 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDH 122 (359)
T ss_pred eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCH
Confidence 689999875422 33467889999999999999999999986443 46999999975 67776632 3788
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++....... ......+|..|+|||++.+.
T Consensus 123 ~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~ 197 (359)
T cd07876 123 ERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGM 197 (359)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCC
Confidence 89999999999999999964 59999999999999999999999999997543221 12334679999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hh-hhhhhhh---ccch-hhhhhhhcc-----------------
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LV-DWAKPYL---SDKR-KLFRIMDTK----------------- 210 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~~~~~~~---~~~~-~~~~~~~~~----------------- 210 (305)
.++.++|||||||++|+|++|+.||.+.+...... .. ....+.. .... .........
T Consensus 198 ~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
T cd07876 198 GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF 277 (359)
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccc
Confidence 99999999999999999999999998764321100 00 0000000 0000 000000000
Q ss_pred -cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 211 -LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 211 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
.........+..+.+||.+||..||++|||+.+++++-
T Consensus 278 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 278 PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00011122456789999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=284.71 Aligned_cols=236 Identities=23% Similarity=0.269 Sum_probs=172.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||... ...+.+|+++|++++|+||+++++++..++..++|||++. ++|.+++.... ..+++..++.++.
T Consensus 196 ~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~ 267 (461)
T PHA03211 196 RVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVAR 267 (461)
T ss_pred EEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHH
Confidence 57888532 2346789999999999999999999999999999999995 58988886543 3599999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++||
T Consensus 268 qi~~aL~yLH~~--gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDv 345 (461)
T PHA03211 268 QLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345 (461)
T ss_pred HHHHHHHHHHHC--CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHH
Confidence 999999999964 599999999999999999999999999986543322222234568999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccc-----hhhhhhhhhh---hhcc-----chhhhhhhh----cccCCCCC-------h
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGI-----EQSLVDWAKP---YLSD-----KRKLFRIMD----TKLGGQYP-------Q 217 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~---~~~~-----~~~~~~~~~----~~~~~~~~-------~ 217 (305)
|||||++|+|++|..++....... ...+...... .... ...+..... ........ .
T Consensus 346 wSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (461)
T PHA03211 346 WSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYY 425 (461)
T ss_pred HHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhc
Confidence 999999999999876654322110 0111100000 0000 000000000 00000000 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..+..+.+||.+||..||.+|||+.|++++
T Consensus 426 ~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 426 KLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 344578999999999999999999999975
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=270.36 Aligned_cols=225 Identities=23% Similarity=0.369 Sum_probs=178.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+..........+.+|+++++.++|+||+++++.+..++..|+||||++|++|..++.+.. ..+++..+..++.
T Consensus 39 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ 117 (292)
T cd06644 39 LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICR 117 (292)
T ss_pred eEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHH
Confidence 688999887655556788999999999999999999999999999999999999999988875443 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLT 156 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~ 156 (305)
|++.+|.|||+ .+++||||||+||+++.++.++|+|||++........ ......++..|+|||++. ...++
T Consensus 118 ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 193 (292)
T cd06644 118 QMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYD 193 (292)
T ss_pred HHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCC
Confidence 99999999995 4699999999999999999999999998875332211 123345788999999885 34567
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|..||...... . ........ ......+..++.++.+++.+||..+|
T Consensus 194 ~~~Dv~slG~il~el~~g~~p~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 257 (292)
T cd06644 194 YKADIWSLGITLIEMAQIEPPHHELNPM--R--------------VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHP 257 (292)
T ss_pred chhhhHhHHHHHHHHhcCCCCCccccHH--H--------------HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCc
Confidence 8999999999999999999999764311 0 00111100 01112234567789999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
++||++++++++
T Consensus 258 ~~Rp~~~~il~~ 269 (292)
T cd06644 258 ETRPSAAQLLEH 269 (292)
T ss_pred ccCcCHHHHhcC
Confidence 999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=273.67 Aligned_cols=224 Identities=25% Similarity=0.352 Sum_probs=180.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||.+........+.+.+|+.++++++|+||+++++.+..++..|+||||+++++|.+++... .+++..+..++.
T Consensus 49 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~ 125 (292)
T cd06658 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCL 125 (292)
T ss_pred EEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHH
Confidence 68999887654455567899999999999999999999999999999999999999999988543 388999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+. +++||||||+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+
T Consensus 126 qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 201 (292)
T cd06658 126 SVLRALSYLHNQ--GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDI 201 (292)
T ss_pred HHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhH
Confidence 999999999965 5999999999999999999999999998754332211 223467899999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
||||+++|+|++|..||........ . ..+..... ........++..+.+++.+||..||.+|||+
T Consensus 202 ~slGvil~el~~g~~p~~~~~~~~~--~-----------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 266 (292)
T cd06658 202 WSLGIMVIEMIDGEPPYFNEPPLQA--M-----------RRIRDNLP--PRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH--H-----------HHHHhcCC--CccccccccCHHHHHHHHHHccCChhHCcCH
Confidence 9999999999999999975432100 0 00000000 0111223467789999999999999999999
Q ss_pred HHHHHH
Q 021947 242 SEVLAI 247 (305)
Q Consensus 242 ~~~l~~ 247 (305)
++++++
T Consensus 267 ~~il~~ 272 (292)
T cd06658 267 QELLQH 272 (292)
T ss_pred HHHhhC
Confidence 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=265.14 Aligned_cols=222 Identities=27% Similarity=0.382 Sum_probs=180.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.|++|.++.... .+++.+|++++++++|+||+++++.+......|+++||+.+++|.+++.... ..+++..+..++.
T Consensus 30 ~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~ 106 (256)
T cd06612 30 VVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILY 106 (256)
T ss_pred EEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHH
Confidence 688998875532 6789999999999999999999999999999999999999999999986543 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+
T Consensus 107 ~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di 182 (256)
T cd06612 107 QTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADI 182 (256)
T ss_pred HHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhH
Confidence 99999999995 4599999999999999999999999999886543221 1223457889999999998899999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh-cccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||......... ..... .......+..++..+.+++.+||+.||++|||
T Consensus 183 ~s~G~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 246 (256)
T cd06612 183 WSLGITAIEMAEGKPPYSDIHPMRAI----------------FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS 246 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCcchhhhh----------------hhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC
Confidence 99999999999999999764321100 00000 01111223456778999999999999999999
Q ss_pred HHHHHH
Q 021947 241 MSEVLA 246 (305)
Q Consensus 241 ~~~~l~ 246 (305)
+.++++
T Consensus 247 ~~~il~ 252 (256)
T cd06612 247 AIQLLQ 252 (256)
T ss_pred HHHHhc
Confidence 999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=270.09 Aligned_cols=240 Identities=25% Similarity=0.305 Sum_probs=174.2
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhcc---CCCCcccEEEEEEe-----CCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQL---HHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ....+++|||+.+ +|.+++.......+
T Consensus 27 ~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 105 (288)
T cd07863 27 FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL 105 (288)
T ss_pred EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCC
Confidence 6899988754322 234566788877765 69999999998864 2457899999975 89998876555568
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ .....++..|+|||++.
T Consensus 106 ~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~ 180 (288)
T cd07863 106 PAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLL 180 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhh
Confidence 9999999999999999999964 599999999999999999999999999986543221 22346789999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhhccchhhhh----hhhccc---CCCCChHHHHH
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSDKRKLFR----IMDTKL---GGQYPQKAAHT 222 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~ 222 (305)
+..++.++|||||||++|+|++|..||.+....... ....... +.......... ...... .......++..
T Consensus 181 ~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (288)
T cd07863 181 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEES 260 (288)
T ss_pred CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHH
Confidence 889999999999999999999999999765432111 0110000 00000000000 000000 00111246678
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+|+.+||..||.+|||+.+++.+
T Consensus 261 ~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 261 GAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcC
Confidence 8999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=265.62 Aligned_cols=225 Identities=22% Similarity=0.326 Sum_probs=182.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.+..... ....++.+|++++++++|+||+++++++.+.+..|+||||+.+++|.+++.......+++..++.+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08218 27 QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106 (256)
T ss_pred EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 588998864322 334578999999999999999999999999999999999999999999997655455889999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++
T Consensus 107 ~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~ 182 (256)
T cd08218 107 FVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKS 182 (256)
T ss_pred HHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCcc
Confidence 9999999999996 4599999999999999999999999999976543221 12234578889999999888899999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|+||||+++|+|++|..||...+.. ...... ........+..++..+.++|.+||+.+|.+||
T Consensus 183 Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 245 (256)
T cd08218 183 DIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRP 245 (256)
T ss_pred chhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHH-hcCCCCCCcccCCHHHHHHHHHHhhCChhhCc
Confidence 9999999999999999999753211 011111 11122234556788899999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
++.+++++
T Consensus 246 ~~~~vl~~ 253 (256)
T cd08218 246 SVNSILEK 253 (256)
T ss_pred CHHHHhhC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=263.88 Aligned_cols=225 Identities=27% Similarity=0.464 Sum_probs=180.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.+|+|.++... .....+.+|++++++++||||+++++++......++||||+.+++|.+++.... ..+++..+..++.
T Consensus 30 ~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 107 (256)
T cd05112 30 KVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCL 107 (256)
T ss_pred eEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHH
Confidence 57899887543 334678999999999999999999999999999999999999999999986543 3488999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.+|++||+. +++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++|+
T Consensus 108 ~l~~~l~~lH~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv 184 (256)
T cd05112 108 DVCEGMAYLESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184 (256)
T ss_pred HHHHHHHHHHHC--CccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHH
Confidence 999999999964 599999999999999999999999999876533211 11122234678999999988889999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||...... .+.+.+........+...+..+.+|+.+||+.+|++|||
T Consensus 185 ~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 247 (256)
T cd05112 185 WSFGVLMWEVFSEGKTPYENRSNS-----------------EVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPS 247 (256)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCC
Confidence 999999999998 99999764321 111111111122223345688999999999999999999
Q ss_pred HHHHHHHH
Q 021947 241 MSEVLAIL 248 (305)
Q Consensus 241 ~~~~l~~l 248 (305)
+.++++.|
T Consensus 248 ~~~~l~~l 255 (256)
T cd05112 248 FSLLLHQL 255 (256)
T ss_pred HHHHHHhh
Confidence 99999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=266.84 Aligned_cols=223 Identities=26% Similarity=0.371 Sum_probs=182.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||||.+..... .....+.+|+++++++.|+||+++++.+.++...|+||||++|++|.+++... .++...+..++
T Consensus 31 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~ 107 (277)
T cd06640 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATML 107 (277)
T ss_pred EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHH
Confidence 689998875432 33467889999999999999999999999999999999999999999998543 48888999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||+|||+ ++++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|
T Consensus 108 ~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~D 183 (277)
T cd06640 108 KEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKAD 183 (277)
T ss_pred HHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHH
Confidence 999999999996 4599999999999999999999999999976543221 122345788899999998888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
+||||+++|+|++|..||....... .............+..++..+.+++.+||+.+|.+||+
T Consensus 184 v~slG~il~el~tg~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06640 184 IWSLGITAIELAKGEPPNSDMHPMR-----------------VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPT 246 (277)
T ss_pred HHHHHHHHHHHHHCCCCCCCcChHh-----------------HhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcC
Confidence 9999999999999999997643210 01111112223345567889999999999999999999
Q ss_pred HHHHHHHH
Q 021947 241 MSEVLAIL 248 (305)
Q Consensus 241 ~~~~l~~l 248 (305)
+.+++.+-
T Consensus 247 ~~~il~~~ 254 (277)
T cd06640 247 AKELLKHK 254 (277)
T ss_pred HHHHHhCh
Confidence 99998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=269.16 Aligned_cols=222 Identities=26% Similarity=0.386 Sum_probs=179.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||+|.+..... .....+.+|++++++++|+||+++++.+..+...|+||||+.+++|.+++... .+++..+..++
T Consensus 31 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~ 107 (277)
T cd06642 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATIL 107 (277)
T ss_pred EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHH
Confidence 689998875432 23357889999999999999999999999999999999999999999988542 48899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|
T Consensus 108 ~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 183 (277)
T cd06642 108 REILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKAD 183 (277)
T ss_pred HHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhh
Confidence 999999999995 5699999999999999999999999999876543221 122345788999999998888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
+||||+++|+|++|..||....... ....+...........++..+.+++.+||..+|.+||+
T Consensus 184 v~slG~il~el~tg~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06642 184 IWSLGITAIELAKGEPPNSDLHPMR-----------------VLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPT 246 (277)
T ss_pred HHHHHHHHHHHHhCCCCCcccchhh-----------------HHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcC
Confidence 9999999999999999987543210 00111111122233456788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++++
T Consensus 247 ~~~il~~ 253 (277)
T cd06642 247 AKELLKH 253 (277)
T ss_pred HHHHHHh
Confidence 9999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.86 Aligned_cols=205 Identities=22% Similarity=0.401 Sum_probs=173.2
Q ss_pred hHHHHHHHHHHhccCCCCcccEEEEEEeCCe--eEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcC
Q 021947 16 HKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN--RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 93 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 93 (305)
.++|..|+.+|+.|+|+||+++|+++.+... ..+|+|.+..|+|..|+++.+. ++...+..|++||++||.|||++
T Consensus 85 leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~ 162 (632)
T KOG0584|consen 85 LERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ 162 (632)
T ss_pred HHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC
Confidence 4789999999999999999999999987655 7799999999999999987764 88999999999999999999999
Q ss_pred CCceeeccCCCCceEeCCC-CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHH
Q 021947 94 ESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 172 (305)
...|||||||.+||+|+.+ |.|||+|+|+|....... ....+|||.|||||++. ..|+..+||||||++++||+
T Consensus 163 ~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv 237 (632)
T KOG0584|consen 163 DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV 237 (632)
T ss_pred CCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence 9999999999999999765 889999999998765432 33468999999999986 88999999999999999999
Q ss_pred hCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHH----HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA----AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 173 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
|+..||..-. +..++++-+..+ ..|... ..++++||.+||.. ..+|+|+.|+|+.
T Consensus 238 T~eYPYsEC~----------------n~AQIYKKV~SG---iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 238 TSEYPYSECT----------------NPAQIYKKVTSG---IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hccCChhhhC----------------CHHHHHHHHHcC---CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 9999997643 222333333322 223222 35799999999999 9999999999963
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.10 Aligned_cols=226 Identities=24% Similarity=0.373 Sum_probs=179.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCC--CHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL--SWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~ 79 (305)
.||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+.+++|.+++.... ..+ +...+..+
T Consensus 35 ~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 113 (268)
T cd06624 35 RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFY 113 (268)
T ss_pred EEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHH
Confidence 689998877655566789999999999999999999999999999999999999999999996542 224 78888899
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC--CC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~ 156 (305)
+.|++.||+|||+ ++++|+||||+||+++. ++.++|+|||++......... .....++..|+|||++.+.. ++
T Consensus 114 ~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~ 189 (268)
T cd06624 114 TKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYG 189 (268)
T ss_pred HHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCC
Confidence 9999999999995 46999999999999976 678999999998765332211 22335788999999986643 78
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+||||+++|+|++|..||........ ..............+..++.++.+|+.+||..+|.
T Consensus 190 ~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 254 (268)
T cd06624 190 APADIWSLGCTIVEMATGKPPFIELGEPQA---------------AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPD 254 (268)
T ss_pred chhhhHHHHHHHHHHHhCCCCCccccChhh---------------hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCch
Confidence 899999999999999999999975322110 00111111122234556778899999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++.+
T Consensus 255 ~Rpt~~~ll~~ 265 (268)
T cd06624 255 KRASAHDLLQD 265 (268)
T ss_pred hCCCHHHHHhC
Confidence 99999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=296.17 Aligned_cols=235 Identities=20% Similarity=0.276 Sum_probs=180.7
Q ss_pred CEEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC---------C
Q 021947 1 MVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---------P 68 (305)
Q Consensus 1 ~~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~ 68 (305)
+.||||+++.+... ..+++.+|++++++++||||+++++++.+++..|+||||++|++|.+++.... .
T Consensus 28 ~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~ 107 (932)
T PRK13184 28 RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA 107 (932)
T ss_pred cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhh
Confidence 36899998764322 23578999999999999999999999999999999999999999999885421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC----------------c
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----------------T 132 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------------~ 132 (305)
...+...++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||++........ .
T Consensus 108 ~~lsv~~iL~I~~QIa~AL~yLHs~--GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~ 185 (932)
T PRK13184 108 EKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185 (932)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHC--CccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccccccc
Confidence 2355677889999999999999964 599999999999999999999999999976521100 0
Q ss_pred ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC
Q 021947 133 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 212 (305)
Q Consensus 133 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (305)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..........
T Consensus 186 t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~---------------~~~~i~~P~~ 250 (932)
T PRK13184 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS---------------YRDVILSPIE 250 (932)
T ss_pred ccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh---------------hhhhccChhh
Confidence 0112346899999999999999999999999999999999999999764321000 0000000000
Q ss_pred CCCChHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhc
Q 021947 213 GQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE 252 (305)
Q Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~ 252 (305)
......++..+.+++.+||..||++|+ +++++++.|+...
T Consensus 251 ~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 251 VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111235677899999999999999997 6777777777653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=281.48 Aligned_cols=242 Identities=25% Similarity=0.297 Sum_probs=177.9
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCC-----eeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
..||||++..... ....++.+|+++++.++|+||+++++++.... ..|+||||+. ++|.+++.... .++.
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~ 102 (372)
T cd07853 26 KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSS 102 (372)
T ss_pred CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC--CCCH
Confidence 3689999865422 23467889999999999999999999998766 7899999996 48888885443 4899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+.
T Consensus 103 ~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 103 DHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCC
Confidence 99999999999999999964 5999999999999999999999999999864332211 12234578899999998775
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhh-hhh-hhhhhccc----hhhhhhhhc-ccCC-------CCChH
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLSDK----RKLFRIMDT-KLGG-------QYPQK 218 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~----~~~~~~~~~-~~~~-------~~~~~ 218 (305)
.++.++|||||||++|+|++|+.||.+.+....... ... ..+..... ......+.. .... .....
T Consensus 180 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (372)
T cd07853 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQ 259 (372)
T ss_pred CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCC
Confidence 478899999999999999999999987653211110 000 00000000 000000000 0000 11223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
.+.++.+||.+||+.||.+|||+.+++++-
T Consensus 260 ~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 260 ATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred CCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 467899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=271.52 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=170.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhc-------CCCCCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR-------GPQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~ 72 (305)
.||+|.+.... ....+.+|++++++++||||+++++++.. +...|++|||+.+ +|.+++... ....++
T Consensus 30 ~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~ 106 (317)
T cd07868 30 DYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP 106 (317)
T ss_pred eEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCC
Confidence 58999887542 33567899999999999999999998864 4567899999964 888887432 123488
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEe----CCCCceeeccccccccCCCCCCc-ceeecccccccccch
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAP 147 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aP 147 (305)
+..+..++.|++.||.|||+. |++||||||+|||+ +.++.+||+|||+++........ .......+|..|+||
T Consensus 107 ~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07868 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCC
Confidence 899999999999999999964 59999999999999 45578999999999865432211 112345689999999
Q ss_pred hhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-------hhh---h-hhhhhhccch---------hhhhh
Q 021947 148 EYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLV---D-WAKPYLSDKR---------KLFRI 206 (305)
Q Consensus 148 E~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~---~-~~~~~~~~~~---------~~~~~ 206 (305)
|++.+. .++.++|||||||++|+|++|+.||......... .+. . ...+...... .....
T Consensus 185 E~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (317)
T cd07868 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD 264 (317)
T ss_pred HHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhh
Confidence 998774 5889999999999999999999999765432110 000 0 0000000000 00000
Q ss_pred hhcccC---------CCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 207 MDTKLG---------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 207 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
...... .......+..+.+||.+||..||.+|||+++++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 265 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00001123568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=286.73 Aligned_cols=237 Identities=24% Similarity=0.326 Sum_probs=169.9
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC--------CeeEEEEecCCCCCHHHHhhh--cCCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--------ENRLLVYEFMPKGSLENHLFR--RGPQP 70 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~--~~~~~ 70 (305)
+.||||++..+. ....+|+.+|+.++|+||+++++++... ..+++||||+.+ +|.+++.. .....
T Consensus 92 ~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~ 166 (440)
T PTZ00036 92 EKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHA 166 (440)
T ss_pred CEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCC
Confidence 368999885432 2345799999999999999999886532 246799999975 78777643 22345
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++....... .....||+.|+|||+
T Consensus 167 l~~~~~~~~~~qi~~gL~yLH~~--~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~ 241 (440)
T PTZ00036 167 LPLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPEL 241 (440)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC--CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHH
Confidence 89999999999999999999964 599999999999998665 699999999986543221 223467999999999
Q ss_pred hhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhh-hhhhhhccchh----hh-----hhhhcccCCCCCh
Q 021947 150 VATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLSDKRK----LF-----RIMDTKLGGQYPQ 217 (305)
Q Consensus 150 ~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~-~~~~~~~~~~~----~~-----~~~~~~~~~~~~~ 217 (305)
+.+. .++.++|||||||++|+|++|.+||.+....... .... ...+....... .. ..........++.
T Consensus 242 ~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~ 321 (440)
T PTZ00036 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPK 321 (440)
T ss_pred hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhcc
Confidence 8764 6899999999999999999999999875432110 0000 00000000000 00 0000001111233
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..+.++.+||.+||..||.+|||+.+++++
T Consensus 322 ~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 322 GTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 456789999999999999999999999965
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=269.79 Aligned_cols=241 Identities=24% Similarity=0.275 Sum_probs=177.4
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-CCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 78 (305)
.||||+++..... ....+.+|+.++++++||||+++++++.+++..|+||||+. ++|.+++..... ..+++..+..
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 105 (285)
T cd07861 27 IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKS 105 (285)
T ss_pred EEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHH
Confidence 6899988754322 23678899999999999999999999999999999999997 589888865332 4589999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.
T Consensus 106 ~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (285)
T cd07861 106 YLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYST 181 (285)
T ss_pred HHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCc
Confidence 99999999999996 4599999999999999999999999999976533221 12233568899999988664 5788
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhh---hhccchhh---hhhhhc---ccCCCCChHHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKP---YLSDKRKL---FRIMDT---KLGGQYPQKAAHTAATL 226 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~---~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~l 226 (305)
++|+||||+++|+|++|+.||.+....... .+..+..+ .+.....+ ...... .........++.++.+|
T Consensus 182 ~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (285)
T cd07861 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDL 261 (285)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHH
Confidence 999999999999999999999865432110 00000000 00000000 000000 00001122467888999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||+.||.+|||+.+++++
T Consensus 262 i~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 262 LEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhcCChhhCCCHHHHhcC
Confidence 999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=271.76 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=182.8
Q ss_pred CEEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||||+++... ......+.+|+++++.++|+||+++++++.+.+..+++|||+.+++|.+++.......+++..+..
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 105 (314)
T cd08216 26 TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF 105 (314)
T ss_pred CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHH
Confidence 369999987652 234467899999999999999999999999999999999999999999999765555689999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-----cceeecccccccccchhhhhcC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||.+........ ........++..|+|||++.+.
T Consensus 106 ~~~~l~~~L~~LH~~--~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 106 ILKDVLNALDYIHSK--GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred HHHHHHHHHHHHHHC--CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCC
Confidence 999999999999964 599999999999999999999999998865432111 0111233467789999998763
Q ss_pred --CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhh-hc------cchhh--------hhhhhcccCCCC
Q 021947 154 --RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPY-LS------DKRKL--------FRIMDTKLGGQY 215 (305)
Q Consensus 154 --~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~-~~------~~~~~--------~~~~~~~~~~~~ 215 (305)
.++.++|+||||+++|+|++|..||.......... ......+. .. ..... ............
T Consensus 184 ~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (314)
T cd08216 184 LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263 (314)
T ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcch
Confidence 58889999999999999999999998643221100 00000000 00 00000 000011112223
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
...++.++.+|+.+||..||++|||+++++++
T Consensus 264 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 44667889999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=271.17 Aligned_cols=223 Identities=25% Similarity=0.338 Sum_probs=180.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+........+.+.+|+.+++.++||||+++++.+..++..|++|||+++++|.+++... .+++..+..++.
T Consensus 48 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ 124 (297)
T cd06659 48 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCE 124 (297)
T ss_pred EEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHH
Confidence 68999987655555677899999999999999999999999999999999999999999987543 389999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+
T Consensus 125 qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 200 (297)
T cd06659 125 SVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDI 200 (297)
T ss_pred HHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhH
Confidence 99999999995 4599999999999999999999999999875433221 1223468899999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||........ . ...... .........++..+.+++.+||+.+|.+||+
T Consensus 201 ~slG~il~el~~g~~p~~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps 264 (297)
T cd06659 201 WSLGIMVIEMVDGEPPYFSDSPVQA--M--------------KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH--H--------------HHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC
Confidence 9999999999999999975432110 0 000000 0011122346678999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+++++++
T Consensus 265 ~~~ll~~ 271 (297)
T cd06659 265 AQELLDH 271 (297)
T ss_pred HHHHhhC
Confidence 9999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.17 Aligned_cols=224 Identities=24% Similarity=0.356 Sum_probs=176.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|++..+.. .....+.+|++++++++||||+++++.+...+..++||||+++++|..+. .+++..+..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~ 101 (279)
T cd06619 28 ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIA 101 (279)
T ss_pred EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHH
Confidence 689998875532 23357889999999999999999999999999999999999999987653 37888889999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|
T Consensus 102 ~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~D 175 (279)
T cd06619 102 VAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSD 175 (279)
T ss_pred HHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcch
Confidence 999999999996 459999999999999999999999999997653321 23346899999999999889999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC-CChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++|..||.......... ................ .....+.++.+++.+||..+|.+||
T Consensus 176 vwslG~~l~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 245 (279)
T cd06619 176 VWSLGISFMELALGRFPYPQIQKNQGSL----------MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP 245 (279)
T ss_pred HHHHHHHHHHHHhCCCCchhhccccccc----------chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCC
Confidence 9999999999999999997532211100 0000011111111111 1234567899999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
++++++++
T Consensus 246 ~~~eil~~ 253 (279)
T cd06619 246 APENLMDH 253 (279)
T ss_pred CHHHHhcC
Confidence 99999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=262.80 Aligned_cols=224 Identities=26% Similarity=0.397 Sum_probs=182.3
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||.+..... .....+.+|+++++.++|+||+++++.+..++..++||||++|++|.+++.......+++..+..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08220 27 LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106 (256)
T ss_pred EEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHH
Confidence 588998875532 234678899999999999999999999999999999999999999999997765556899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.+++.+|+|||+ +|++|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+..++.+
T Consensus 107 ~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 181 (256)
T cd08220 107 FVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQK 181 (256)
T ss_pred HHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcc
Confidence 9999999999996 4599999999999998654 579999999986543321 223467889999999988888999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||...+... .............+..++..+.+++.+||..+|.+|
T Consensus 182 ~Dv~slG~~l~~l~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (256)
T cd08220 182 SDIWALGCVLYELASLKRAFEAANLPA-----------------LVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244 (256)
T ss_pred cchHHHHHHHHHHHhCCCCcccCchHH-----------------HHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhC
Confidence 999999999999999999997643211 111111112223345578889999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++.+
T Consensus 245 pt~~~ll~~ 253 (256)
T cd08220 245 PQLSQIMAQ 253 (256)
T ss_pred CCHHHHhhC
Confidence 999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.11 Aligned_cols=222 Identities=26% Similarity=0.366 Sum_probs=180.9
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+..+. ......+.+|++++++++|+||+++++.+.++...|+|+||+.+++|.+++... .+++..+..++
T Consensus 28 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~ 104 (274)
T cd06609 28 VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFIL 104 (274)
T ss_pred EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHH
Confidence 68999887653 233457889999999999999999999999999999999999999999999654 58999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|
T Consensus 105 ~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sD 180 (274)
T cd06609 105 REVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKAD 180 (274)
T ss_pred HHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhh
Confidence 999999999996 4599999999999999999999999999987643321 123346788999999999888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH-HHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++|..||...+... ....+........+.. ++..+.+++.+||..+|++||
T Consensus 181 v~slG~il~~l~tg~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rp 243 (274)
T cd06609 181 IWSLGITAIELAKGEPPLSDLHPMR-----------------VLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP 243 (274)
T ss_pred HHHHHHHHHHHHhCCCCcccCchHH-----------------HHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCc
Confidence 9999999999999999997543110 0011111111122222 677899999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+++++++
T Consensus 244 t~~~il~~ 251 (274)
T cd06609 244 SAKELLKH 251 (274)
T ss_pred CHHHHhhC
Confidence 99999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.35 Aligned_cols=227 Identities=25% Similarity=0.388 Sum_probs=179.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-CCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (305)
.||+|.++.... .....+.+|++++++++|+||+++++.+...+..|+||||++|++|..++.... ...+++..+..+
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 107 (286)
T cd06622 28 TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRI 107 (286)
T ss_pred EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHH
Confidence 689998875422 223678899999999999999999999999999999999999999999886531 235899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-----
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----- 154 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----- 154 (305)
+.+++.||.|||+. .+++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+..
T Consensus 108 ~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (286)
T cd06622 108 TYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNP 182 (286)
T ss_pred HHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccC
Confidence 99999999999962 469999999999999999999999999987543221 22345788999999985543
Q ss_pred -CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 155 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 155 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
++.++|+|||||++|+|++|..||......... ..+..+. .......+..++.++.+||.+||..
T Consensus 183 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 248 (286)
T cd06622 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNK 248 (286)
T ss_pred CCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HHHHHHh-hcCCCCCCcccCHHHHHHHHHHccc
Confidence 478999999999999999999999754221100 0011111 1122334556888999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
+|++||++.+++..
T Consensus 249 ~p~~Rp~~~~l~~~ 262 (286)
T cd06622 249 IPNRRPTYAQLLEH 262 (286)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.01 Aligned_cols=225 Identities=28% Similarity=0.430 Sum_probs=179.5
Q ss_pred EEEEEecccCCcc------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++++||+.|++|.+++.+.+ .+++..
T Consensus 26 ~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 103 (265)
T cd06631 26 LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPV 103 (265)
T ss_pred eEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHH
Confidence 5899988754221 12458899999999999999999999999999999999999999999997654 478999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCC----Ccceeecccccccccchhhhh
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD----RTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~ 151 (305)
+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .........++..|+|||++.
T Consensus 104 ~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 181 (265)
T cd06631 104 FCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181 (265)
T ss_pred HHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhc
Confidence 99999999999999995 459999999999999999999999999987542211 111122345788999999998
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhh
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 230 (305)
+..++.++|+||||+++|+|++|..||...+.... ....... ......+..++.++.++|.+|
T Consensus 182 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 245 (265)
T cd06631 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----------------MFYIGAHRGLMPRLPDSFSAAAIDFVTSC 245 (265)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----------------HHHhhhccCCCCCCCCCCCHHHHHHHHHH
Confidence 88899999999999999999999999975432110 0011111 112234456788899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLA 246 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~ 246 (305)
|..+|.+||++.++++
T Consensus 246 l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 246 LTRDQHERPSALQLLR 261 (265)
T ss_pred hcCCcccCCCHHHHhc
Confidence 9999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.50 Aligned_cols=236 Identities=22% Similarity=0.265 Sum_probs=173.6
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++..... .....+.+|+.+++.++||||+++++++... ...|+||||+.+ +|.+++.. .++.
T Consensus 51 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~ 125 (364)
T cd07875 51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDH 125 (364)
T ss_pred EEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh----cCCH
Confidence 589999875432 3346788999999999999999999987643 357999999965 78887743 2788
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...... ......+|..|+|||++.+.
T Consensus 126 ~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~ 200 (364)
T cd07875 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 200 (364)
T ss_pred HHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCC
Confidence 8999999999999999996 459999999999999999999999999998653321 12334689999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhhhc---cch-hhhhhhhc------------------
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLS---DKR-KLFRIMDT------------------ 209 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~---~~~-~~~~~~~~------------------ 209 (305)
.++.++|||||||++|+|++|+.||.+.+...... ... ...+... ... ........
T Consensus 201 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (364)
T cd07875 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF 280 (364)
T ss_pred CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccc
Confidence 99999999999999999999999998754321110 000 0000000 000 00000000
Q ss_pred ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 210 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..........+..+.+||.+||..||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 281 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00001112235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=263.87 Aligned_cols=232 Identities=23% Similarity=0.314 Sum_probs=171.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC--CCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~ 78 (305)
.+++|.++.... .....+.+|+.+++.++||||+++++.+......|+||||+.+++|.+++.+... ...+...+..
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (268)
T cd05086 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103 (268)
T ss_pred eEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH
Confidence 356777665432 3456899999999999999999999999998899999999999999999965432 2356677888
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc------
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------ 152 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------ 152 (305)
++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++................++..|+|||++..
T Consensus 104 ~~~~i~~al~~lH~~--~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (268)
T cd05086 104 MACEIAAGVTHMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181 (268)
T ss_pred HHHHHHHHHHHHHHC--CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccc
Confidence 999999999999964 599999999999999999999999999864322211111234467889999998753
Q ss_pred -CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhh
Q 021947 153 -GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 153 -~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (305)
..++.++||||||+++|+|++ |..||....... ..... +...............++..+.+++..|
T Consensus 182 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~~c 249 (268)
T cd05086 182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHV----------IKDQQVKLFKPQLELPYSERWYEVLQFC 249 (268)
T ss_pred cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----------HhhcccccCCCccCCCCcHHHHHHHHHH
Confidence 235778999999999999997 577886533210 00000 0000000111222334677889999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~l 248 (305)
| .+|++||+++++++.|
T Consensus 250 ~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 250 W-LSPEKRATAEEVHRLL 266 (268)
T ss_pred h-hCcccCCCHHHHHHHh
Confidence 9 6899999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=263.59 Aligned_cols=217 Identities=27% Similarity=0.409 Sum_probs=173.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.|++|.+...... ...+.+|+.++++++|+||+++++++.. ...++||||+.+++|.+++..... .++...+..++.
T Consensus 32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~ 108 (259)
T cd05037 32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAK 108 (259)
T ss_pred eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHH
Confidence 4778877655433 6788999999999999999999999887 778999999999999999976543 589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCC-------ceeeccccccccCCCCCCcceeecccccccccchhhhhcC-
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG- 153 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 153 (305)
|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++..... .....++..|+|||++.+.
T Consensus 109 ~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~ 180 (259)
T cd05037 109 QLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQ 180 (259)
T ss_pred HHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCC
Confidence 99999999995 4599999999999999887 799999999886433 1223467789999998876
Q ss_pred -CCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 154 -RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
.++.++|+||||+++|+|++ |..||.......... ..... ...+......+.+++.+||
T Consensus 181 ~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-----------------~~~~~--~~~~~~~~~~~~~li~~~l 241 (259)
T cd05037 181 ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-----------------FYQDQ--HRLPMPDCAELANLINQCW 241 (259)
T ss_pred CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-----------------HHhcC--CCCCCCCchHHHHHHHHHh
Confidence 78899999999999999999 577776543111000 00000 0111112278899999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l 248 (305)
..+|.+|||+.++++.|
T Consensus 242 ~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 242 TYDPTKRPSFRAILRDL 258 (259)
T ss_pred ccChhhCCCHHHHHHhc
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=277.12 Aligned_cols=236 Identities=22% Similarity=0.262 Sum_probs=173.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++..... .....+.+|+.+++.++||||+++++++... ...|+||||+++ +|.+++.. .++.
T Consensus 44 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~ 118 (355)
T cd07874 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDH 118 (355)
T ss_pred eEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCH
Confidence 589999875432 2335788999999999999999999988643 346999999975 77777643 3788
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||+++...... ......+|..|+|||++.+.
T Consensus 119 ~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~ 193 (355)
T cd07874 119 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 193 (355)
T ss_pred HHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCC
Confidence 8999999999999999996 459999999999999999999999999998654321 12334689999999999998
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhh---cc-chhhhhhhhcc-----------------
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYL---SD-KRKLFRIMDTK----------------- 210 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~---~~-~~~~~~~~~~~----------------- 210 (305)
.++.++|||||||++|+|++|+.||.+.+..... .......+.. .. ...........
T Consensus 194 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (355)
T cd07874 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 273 (355)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccc
Confidence 9999999999999999999999999875432110 0000000000 00 00000000000
Q ss_pred -cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 211 -LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 211 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.........+..+.+||.+||..||++|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred ccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0001122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=263.82 Aligned_cols=225 Identities=26% Similarity=0.385 Sum_probs=175.6
Q ss_pred EEEEEecccCCc-----cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGF-----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||+|++..... .....+.+|+.++++++|+||+++++++.+. ...++++||+.+++|.+++.... .+++.
T Consensus 29 ~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~ 106 (266)
T cd06651 29 ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTES 106 (266)
T ss_pred EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHH
Confidence 688998764422 1234688899999999999999999988753 56789999999999999996554 38889
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-cceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ ........++..|+|||++.+.
T Consensus 107 ~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (266)
T cd06651 107 VTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184 (266)
T ss_pred HHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC
Confidence 999999999999999995 4599999999999999999999999999875432111 1111234578899999999988
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|+|||||++|+|++|+.||...... ...............+..++..+.+++ +||..
T Consensus 185 ~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~ 247 (266)
T cd06651 185 GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----------------AAIFKIATQPTNPQLPSHISEHARDFL-GCIFV 247 (266)
T ss_pred CCCchhhhHHHHHHHHHHHHCCCCccccchH----------------HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcC
Confidence 8999999999999999999999999754211 111111111222334556777888888 68889
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
+|++||++++++++
T Consensus 248 ~p~~Rp~~~eil~h 261 (266)
T cd06651 248 EARHRPSAEELLRH 261 (266)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=263.45 Aligned_cols=231 Identities=29% Similarity=0.446 Sum_probs=179.2
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhc----CCC
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRR----GPQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~----~~~ 69 (305)
.||||.++.+... ..+++.+|++++++++||||+++++++.... ..++++||+.+++|.+++... ...
T Consensus 29 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 108 (273)
T cd05074 29 KVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108 (273)
T ss_pred EEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCC
Confidence 5899988765322 3457889999999999999999999886532 237899999999998887432 122
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.++...+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...............++..|++||.
T Consensus 109 ~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 186 (273)
T cd05074 109 TLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186 (273)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhH
Confidence 47888999999999999999996 4599999999999999999999999999886543222211223345678999999
Q ss_pred hhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 150 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 150 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
+.+..++.++||||||+++|+|++ |..||.+.+... +............+...+..+.+++.
T Consensus 187 ~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (273)
T cd05074 187 LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-----------------IYNYLIKGNRLKQPPDCLEDVYELMC 249 (273)
T ss_pred HhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-----------------HHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 988889999999999999999999 889887543211 11111111112223456778999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhh
Q 021947 229 QCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+||+.+|++|||+.+++..|+++
T Consensus 250 ~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 250 QCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=264.28 Aligned_cols=229 Identities=25% Similarity=0.424 Sum_probs=182.3
Q ss_pred EEEEEecccCCcc------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||+|+++..... ....+.+|++++++++|+||+++++++.+++..++|+||+.|++|.+++.+.+ .+++..
T Consensus 27 ~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~ 104 (268)
T cd06630 27 LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAV 104 (268)
T ss_pred EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHH
Confidence 5899988754321 23578899999999999999999999999999999999999999999996544 488999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCC--cceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++........ ........++..|+|||.+.+
T Consensus 105 ~~~~~~ql~~al~~LH~~--~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 182 (268)
T cd06630 105 IINYTEQLLRGLSYLHEN--QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182 (268)
T ss_pred HHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc
Confidence 999999999999999964 599999999999998775 599999999876543211 111223467889999999988
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
..++.++|+||||+++|+|++|..||......... ...............+...+..+.+++.+||.
T Consensus 183 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 249 (268)
T cd06630 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-------------ALIFKIASATTAPSIPEHLSPGLRDVTLRCLE 249 (268)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-------------HHHHHHhccCCCCCCchhhCHHHHHHHHHHcC
Confidence 88999999999999999999999999754321100 11111112222344566788899999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.+|.+|||+.+++++
T Consensus 250 ~~p~~R~~~~~ll~~ 264 (268)
T cd06630 250 LQPEDRPPSRELLKH 264 (268)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=265.80 Aligned_cols=223 Identities=26% Similarity=0.366 Sum_probs=180.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.|++|++........+.+.+|+.+++.++|+||+++++++..++..++++||+.|++|.+++.. ..++...+..++.
T Consensus 46 ~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ 122 (285)
T cd06648 46 QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCL 122 (285)
T ss_pred EEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHH
Confidence 5899988755445556789999999999999999999999999999999999999999999865 2488999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+. |++||||+|+||+++.++.++|+|||.+......... .....|+..|+|||.+.+..++.++|+
T Consensus 123 ql~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 198 (285)
T cd06648 123 AVLKALSFLHAQ--GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDI 198 (285)
T ss_pred HHHHHHHHHHhC--CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccH
Confidence 999999999964 5999999999999999999999999988754332211 223468899999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||...+.... ....... ......+..++..+.+++.+||..+|++|||
T Consensus 199 ~slGv~l~ell~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 262 (285)
T cd06648 199 WSLGIMVIEMVDGEPPYFNEPPLQA----------------MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT 262 (285)
T ss_pred HHHHHHHHHHHhCCCCCcCCCHHHH----------------HHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC
Confidence 9999999999999999976432100 0000000 0011122346788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++++
T Consensus 263 ~~~il~~ 269 (285)
T cd06648 263 AAELLNH 269 (285)
T ss_pred HHHHccC
Confidence 9999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=265.69 Aligned_cols=237 Identities=26% Similarity=0.393 Sum_probs=182.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|++..... .....+.+|+++++.++||||+++++.+.....+++||||+++++|.+++...+ .+++..+..++
T Consensus 32 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~ 109 (284)
T cd06620 32 VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIA 109 (284)
T ss_pred EEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHH
Confidence 688998765432 334678999999999999999999999999999999999999999999986543 48999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.+|.|||+. .+++|+||+|+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|
T Consensus 110 ~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~D 184 (284)
T cd06620 110 VAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSD 184 (284)
T ss_pred HHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccch
Confidence 9999999999962 459999999999999999999999999986542211 22346899999999998888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC-hHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+|||||++|+|++|..||.......+.... ...................+ ..++..+.+|+.+||+.||.+||
T Consensus 185 i~slG~~l~~l~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 258 (284)
T cd06620 185 VWSLGISIIELALGKFPFAFSNIDDDGQDD------PMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258 (284)
T ss_pred HHHHHHHHHHHHhCCCCCcccchhhhhhhh------hhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCc
Confidence 999999999999999999864432110000 00000000111111111112 23677899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 021947 240 RMSEVLAILERL 251 (305)
Q Consensus 240 s~~~~l~~l~~~ 251 (305)
|+.+++++..-+
T Consensus 259 t~~e~~~~~~~~ 270 (284)
T cd06620 259 TPQQLCAMPPFI 270 (284)
T ss_pred CHHHHhcCcccc
Confidence 999999865433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=265.38 Aligned_cols=226 Identities=29% Similarity=0.401 Sum_probs=180.1
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++++|.+++.+.....+++..+..
T Consensus 20 ~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 99 (277)
T cd05577 20 MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF 99 (277)
T ss_pred EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHH
Confidence 68899886432 123456788999999999999999999999999999999999999999999776655689999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++....... ......++..|+|||++.+..++.+
T Consensus 100 ~~~ql~~~l~~lH~~--~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~ 174 (277)
T cd05577 100 YAAQIICGLEHLHQR--RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174 (277)
T ss_pred HHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCch
Confidence 999999999999964 59999999999999999999999999987643311 1223457789999999988889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|+.||......... ..+.... .......+..++..+.++|.+||+.||.+|
T Consensus 175 ~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------EELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred hhhHHHHHHHHHHhhCCCCCCCCcccccH-------------HHHHhcc-ccccccCCccCCHHHHHHHHHHccCChhHc
Confidence 99999999999999999999765431110 0011110 111223445678889999999999999999
Q ss_pred C-----CHHHHHH
Q 021947 239 P-----RMSEVLA 246 (305)
Q Consensus 239 p-----s~~~~l~ 246 (305)
| ++.+++.
T Consensus 241 ~~~~~~~~~~ll~ 253 (277)
T cd05577 241 LGCRGGSADEVRE 253 (277)
T ss_pred cCCCcccHHHHHh
Confidence 9 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=262.75 Aligned_cols=224 Identities=26% Similarity=0.350 Sum_probs=182.7
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++..... ...+.+.+|+++++.++|+||+++++.+.++...+++|||+++++|.+++.+.. .++...+..
T Consensus 20 ~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~ 97 (262)
T cd05572 20 TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARF 97 (262)
T ss_pred EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC--CCCHHHHHH
Confidence 689998875432 233678999999999999999999999999999999999999999999996653 388999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.+..++.+
T Consensus 98 ~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~ 172 (262)
T cd05572 98 YIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFS 172 (262)
T ss_pred HHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCCh
Confidence 99999999999996 459999999999999999999999999998654432 1223467889999999988889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||........ ...............+...+..+.++|.+||..+|.+|
T Consensus 173 ~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 173 VDYWSLGILLYELLTGRPPFGEDDEDPM--------------EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred hhhhhhHHHHHHHHhCCCCcCCCCCCHH--------------HHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999986542110 11111121223334555568899999999999999999
Q ss_pred CC-----HHHHHH
Q 021947 239 PR-----MSEVLA 246 (305)
Q Consensus 239 ps-----~~~~l~ 246 (305)
|+ ++++++
T Consensus 239 ~~~~~~~~~~l~~ 251 (262)
T cd05572 239 LGNLKGGIKDIKK 251 (262)
T ss_pred cCCcccCHHHHhc
Confidence 99 778776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=276.41 Aligned_cols=235 Identities=24% Similarity=0.275 Sum_probs=171.6
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++..... .....+.+|++++++++|+||+++++++... ...|+++|++ +++|.+++... .+++
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~ 117 (343)
T cd07878 42 KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSD 117 (343)
T ss_pred EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCH
Confidence 689999875432 2335678999999999999999999987543 3468999998 67998887533 4899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++...... .....||..|+|||++.+
T Consensus 118 ~~~~~i~~qi~~aL~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~ 190 (343)
T cd07878 118 EHVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNW 190 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCC
Confidence 99999999999999999964 5999999999999999999999999999865432 223468999999999877
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhhcc-----chhhhhhhhcccCCC------CChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSD-----KRKLFRIMDTKLGGQ------YPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~------~~~~~ 219 (305)
..++.++|||||||++|+|++|..||.+.+..... ....... +.... ............... .....
T Consensus 191 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (343)
T cd07878 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGA 270 (343)
T ss_pred ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCC
Confidence 46889999999999999999999999765422110 0000000 00000 000000000000000 00123
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+|+.+||..||.+|||+.+++++
T Consensus 271 ~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 271 NPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=267.31 Aligned_cols=220 Identities=26% Similarity=0.365 Sum_probs=180.2
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||+|+++.... .....+.+|++++++++||||+++++++.++...|+||||+.+++|.+++.... .++...+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~ 104 (290)
T cd05580 27 KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVAR 104 (290)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHH
Confidence 3689998865422 234678899999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ .|++|+||+|.||+++.++.+||+|||++...... .....++..|+|||.+.+...+.
T Consensus 105 ~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~ 177 (290)
T cd05580 105 FYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGK 177 (290)
T ss_pred HHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCc
Confidence 999999999999996 55999999999999999999999999999865433 22346789999999998888899
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+||||+++|+|++|..||....... ....+. ......+...+..+.+++.+||..||.+
T Consensus 178 ~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~ 239 (290)
T cd05580 178 AVDWWALGILIYEMLAGYPPFFDDNPIQ----------------IYEKIL--EGKVRFPSFFSPDAKDLIRNLLQVDLTK 239 (290)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHh--cCCccCCccCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999997643110 001111 1122344556788999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|+ ++++++++
T Consensus 240 R~~~~~~~~~~l~~~ 254 (290)
T cd05580 240 RLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCcccCCHHHHHcC
Confidence 99 67777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=268.38 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=176.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.++.... .....+.+|+.++++++|+||+++++++...+..++||||+.+ +|.+++.... ..+++..+..++
T Consensus 33 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~ 110 (301)
T cd07873 33 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKLFL 110 (301)
T ss_pred EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcC-CCCCHHHHHHHH
Confidence 689998875432 3345678999999999999999999999999999999999974 9999886543 348899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 159 (305)
.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++
T Consensus 111 ~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~ 186 (301)
T cd07873 111 FQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQI 186 (301)
T ss_pred HHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHH
Confidence 999999999996 45999999999999999999999999999754322211 2233568899999988664 578899
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhhhccchhh------hhhhhcccC----CCCChHHHHHHHHHH
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKL------FRIMDTKLG----GQYPQKAAHTAATLA 227 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~~~li 227 (305)
||||||+++|+|++|+.||...+...... ..... .+.......+ ......... ......++..+.+||
T Consensus 187 Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 266 (301)
T cd07873 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELL 266 (301)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHH
Confidence 99999999999999999998754321110 00000 0000000000 000000000 011124577889999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||+.||.+|||+.+++++
T Consensus 267 ~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 267 SKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred HHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=266.36 Aligned_cols=224 Identities=25% Similarity=0.338 Sum_probs=175.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEe------CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||+|++.... ....++..|+.+++++ +|+||+++++++.. ....|++|||+.+++|.+++.......+++.
T Consensus 43 ~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~ 121 (282)
T cd06636 43 LAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121 (282)
T ss_pred EEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHH
Confidence 58899875542 3445788899999998 69999999999853 4578999999999999999976555568888
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--- 151 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--- 151 (305)
.+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.
T Consensus 122 ~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~ 197 (282)
T cd06636 122 WIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDE 197 (282)
T ss_pred HHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCccc
Confidence 8999999999999999964 599999999999999999999999999875432211 123346888999999875
Q ss_pred --cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 152 --TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 152 --~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
+..++.++|+||||+++|+|++|..||...... ..................++.++.+||.+
T Consensus 198 ~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (282)
T cd06636 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----------------RALFLIPRNPPPKLKSKKWSKKFIDFIEG 261 (282)
T ss_pred CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----------------hhhhhHhhCCCCCCcccccCHHHHHHHHH
Confidence 346788999999999999999999999653211 01111111111112233577889999999
Q ss_pred hccCCCCCCCCHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~ 246 (305)
||..||.+|||+.++++
T Consensus 262 cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 262 CLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhCCChhhCcCHHHHhc
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=263.42 Aligned_cols=226 Identities=25% Similarity=0.396 Sum_probs=176.7
Q ss_pred EEEEEecccCCc---c-------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGF---Q-------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||||.++.... . ..+.+.+|++++++++|+||+++++++...+..++||||+.|++|.+++.+.+ .+
T Consensus 28 ~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l 105 (272)
T cd06629 28 MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RF 105 (272)
T ss_pred eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CC
Confidence 589998753211 0 12357789999999999999999999999999999999999999999997653 48
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
+...+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++................++..|+|||.+.
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (272)
T cd06629 106 EEQLVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183 (272)
T ss_pred CHHHHHHHHHHHHHHHHHHhhC--CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhc
Confidence 8899999999999999999964 59999999999999999999999999997654322111123345788999999987
Q ss_pred cCC--CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc----CCCCChHHHHHHHH
Q 021947 152 TGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYPQKAAHTAAT 225 (305)
Q Consensus 152 ~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 225 (305)
... ++.++|+||||+++|++++|..||....... ...+...... .......++..+.+
T Consensus 184 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (272)
T cd06629 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----------------AMFKLGNKRSAPPIPPDVSMNLSPVALD 247 (272)
T ss_pred cccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----------------HHHHhhccccCCcCCccccccCCHHHHH
Confidence 654 7889999999999999999999996532210 0011111111 11122346789999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++.+||..+|.+|||+++++++
T Consensus 248 li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 248 FLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHhcCChhhCCCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=276.66 Aligned_cols=221 Identities=26% Similarity=0.371 Sum_probs=186.9
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||.+.+...+. ...+.+|+++|+.++|||||+++.+......+|+||||+.+|.+++++.+.+. ..+..+..+
T Consensus 83 ~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~ 160 (596)
T KOG0586|consen 83 EVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAK 160 (596)
T ss_pred eEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhh
Confidence 59999998764433 35688999999999999999999999999999999999999999999988775 666888999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~ 158 (305)
+.|++.+++|||++. |+|||||.+|||++.+.++||+|||++..+... ......+|++.|.|||++.+..| +..
T Consensus 161 F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe 235 (596)
T KOG0586|consen 161 FRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPE 235 (596)
T ss_pred hHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcc
Confidence 999999999999754 999999999999999999999999999876532 33567799999999999999876 468
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|.|+.|..||++.+...-+ ...+... ...+.-++.++.+||+++|..+|.+|
T Consensus 236 ~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------------~rvl~gk--~rIp~~ms~dce~lLrk~lvl~Pskr 297 (596)
T KOG0586|consen 236 VDIWSLGVVLYALVEGSLPFDGQNLKELR----------------PRVLRGK--YRIPFYMSCDCEDLLRKFLVLNPSKR 297 (596)
T ss_pred eehhhhhhhheeeeecccccCCccccccc----------------chheeee--ecccceeechhHHHHHHhhccCcccc
Confidence 99999999999999999999986532111 1111222 23445578889999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
++++++.+.
T Consensus 298 ~~~dqim~~ 306 (596)
T KOG0586|consen 298 GPCDQIMKD 306 (596)
T ss_pred CCHHHhhhh
Confidence 999999864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=305.20 Aligned_cols=225 Identities=28% Similarity=0.381 Sum_probs=185.5
Q ss_pred EEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 3 VAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 3 VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.|+|-++-.. ......+.+|+.++..++|||+|++||+=...+..+|.||||+||+|.+++.... ..++.....+.
T Consensus 1263 lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt 1340 (1509)
T KOG4645|consen 1263 LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYT 1340 (1509)
T ss_pred hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHH
Confidence 4666555332 2233567899999999999999999999998899999999999999999996543 37777778899
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc--eeecccccccccchhhhhcC---CC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVATG---RL 155 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~ 155 (305)
.|++.|++|||++ |||||||||+||+++.+|.+|++|||.|.......... ......||+.|||||++.+. +.
T Consensus 1341 ~qll~gla~LH~~--gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~ 1418 (1509)
T KOG4645|consen 1341 KQLLEGLAYLHEH--GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGH 1418 (1509)
T ss_pred HHHHHHHHHHHhc--CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCC
Confidence 9999999999965 59999999999999999999999999998765432111 12245799999999999764 45
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.-++|||||||++.||+||+.||... ++.-.+.--+..+.....|..++.+.++||.+||..||
T Consensus 1419 ~~A~DiWslGCVVlEM~tGkrPW~~~----------------dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP 1482 (1509)
T KOG4645|consen 1419 GGAADIWSLGCVVLEMATGKRPWAEL----------------DNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDP 1482 (1509)
T ss_pred CcchhhhcccceEEEeecCCCchhhc----------------cchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCc
Confidence 66999999999999999999999763 33444555566667778888999999999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
++|.++.+++++
T Consensus 1483 ~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1483 KMRWTASQLLEH 1494 (1509)
T ss_pred hhhhHHHHHHHh
Confidence 999999998875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=261.59 Aligned_cols=226 Identities=26% Similarity=0.353 Sum_probs=176.3
Q ss_pred CEEEEEecccCCc-----cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGF-----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
..||||.+..+.. .....+.+|++++++++|+||+++++.+.+. ..++++|||++|++|.+++.+.. .+++
T Consensus 28 ~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~ 105 (265)
T cd06652 28 RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTE 105 (265)
T ss_pred cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCH
Confidence 3689998764321 1234678899999999999999999988763 46789999999999999987554 3788
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhc
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 152 (305)
.....++.+++.+|.|||+. +++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 106 NVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC
Confidence 88999999999999999964 5999999999999999999999999998754321111 11223457889999999988
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
..++.++|+||||+++|+|++|+.||...... ....+..........+...+..+.+++.+||.
T Consensus 184 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06652 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------------AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV 247 (265)
T ss_pred CCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence 88999999999999999999999999753211 11111111222233456778889999999995
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
+|.+||++++++++
T Consensus 248 -~p~~Rp~~~~il~~ 261 (265)
T cd06652 248 -EAKLRPSADELLRH 261 (265)
T ss_pred -ChhhCCCHHHHhcC
Confidence 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.51 Aligned_cols=231 Identities=29% Similarity=0.391 Sum_probs=182.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-CCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~ 79 (305)
.||+|++..... .....+.+|+++++.++|+||+++++.+...+..|+|||++.|++|.+++..... ..+++..+..+
T Consensus 28 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 107 (267)
T cd06610 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107 (267)
T ss_pred EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHH
Confidence 688999875432 3456789999999999999999999999999999999999999999999976433 45899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhcC-CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-RLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~ 156 (305)
+.|++.||+|||+ .|++|+||+|+||++++++.++|+|||++......... .......++..|++||++... .++
T Consensus 108 ~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~ 185 (267)
T cd06610 108 LKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185 (267)
T ss_pred HHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcC
Confidence 9999999999995 45999999999999999999999999998765443222 122344688999999998777 788
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC-CCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|..||....... .+..... ........ .....++..+.+++.+||..||
T Consensus 186 ~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 252 (267)
T cd06610 186 FKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ-----------NDPPSLETGADYKKYSKSFRKMISLCLQKDP 252 (267)
T ss_pred cccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc-----------CCCCCcCCccccccccHHHHHHHHHHcCCCh
Confidence 99999999999999999999997643211 0000000 00000000 0123567889999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
++|||+.+++++
T Consensus 253 ~~Rp~~~~ll~~ 264 (267)
T cd06610 253 SKRPTAEELLKH 264 (267)
T ss_pred hhCcCHHHHhhC
Confidence 999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=263.07 Aligned_cols=228 Identities=28% Similarity=0.415 Sum_probs=181.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+..... ....++.+|++++++++||||+++++.+..+..+++++||+.+++|.+++.... ..++...+..++
T Consensus 28 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ 106 (265)
T cd06605 28 IMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIA 106 (265)
T ss_pred EEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHH
Confidence 689998876543 334678999999999999999999999999999999999999999999996543 458999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.+|+|||+ ..+++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|
T Consensus 107 ~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~D 181 (265)
T cd06605 107 VAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSD 181 (265)
T ss_pred HHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhh
Confidence 999999999996 1569999999999999999999999999987543221 11256788999999998889999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH-HHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++|..||.......... ....+..........+.. ++.++.++|.+||..||++||
T Consensus 182 v~slG~~l~~l~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 249 (265)
T cd06605 182 IWSLGLSLIELATGRFPYPPENDPPDGI------------FELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249 (265)
T ss_pred HHHHHHHHHHHHhCCCCCCccccccccH------------HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCc
Confidence 9999999999999999997643211100 001111111111222233 778899999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.+++.+
T Consensus 250 t~~~ll~~ 257 (265)
T cd06605 250 SYKELLEH 257 (265)
T ss_pred CHHHHhhC
Confidence 99999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=262.96 Aligned_cols=225 Identities=27% Similarity=0.366 Sum_probs=175.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcC--CCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRG--PQPL 71 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~--~~~~ 71 (305)
+.|++|++.... ....++.+|+.+++++ +|+||+++++++.... .+|+||||+++++|.+++.... ...+
T Consensus 32 ~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 110 (275)
T cd06608 32 QLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110 (275)
T ss_pred cEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCC
Confidence 368899887653 2346789999999999 6999999999997644 4899999999999999986533 3468
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.
T Consensus 111 ~~~~~~~~~~ql~~al~~lH~~--~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 186 (275)
T cd06608 111 KEEWIAYILRETLRGLAYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIA 186 (275)
T ss_pred CHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhc
Confidence 9999999999999999999964 599999999999999999999999999876433221 123345788999999875
Q ss_pred c-----CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc-CCCCChHHHHHHHH
Q 021947 152 T-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAAT 225 (305)
Q Consensus 152 ~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 225 (305)
. ..++.++|+||||+++|+|++|..||....... .+..+..... ....+..++..+.+
T Consensus 187 ~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (275)
T cd06608 187 CDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----------------ALFKIPRNPPPTLKSPENWSKKFND 250 (275)
T ss_pred ccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH----------------HHHHhhccCCCCCCchhhcCHHHHH
Confidence 4 346778999999999999999999997532110 1111111111 11223346788999
Q ss_pred HHHhhccCCCCCCCCHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~ 246 (305)
|+.+||..||.+|||+.++++
T Consensus 251 li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 251 FISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHhhcChhhCcCHHHHhc
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=260.99 Aligned_cols=223 Identities=30% Similarity=0.445 Sum_probs=180.1
Q ss_pred EEEEEecccCCc-----cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEGF-----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.|++|.+..... ...+.+.+|+++++.++|+||+++++++..+..+++++||+++++|.+++.+.. .+++..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~ 104 (258)
T cd06632 27 FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVI 104 (258)
T ss_pred EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHH
Confidence 688998765432 133578899999999999999999999999999999999999999999996554 4889999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-C
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-L 155 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~ 155 (305)
..++.+++.||+|||+. |++|+||+|+||+++.++.+||+|||++....... ......++..|++||.+.... +
T Consensus 105 ~~~~~~i~~~l~~lH~~--~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~ 179 (258)
T cd06632 105 RLYTRQILLGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGY 179 (258)
T ss_pred HHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCC
Confidence 99999999999999964 59999999999999999999999999987654322 123446788999999987766 8
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|+||||+++|+|++|..||...... ...............+..++..+.+++.+||..+|
T Consensus 180 ~~~~D~~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 243 (258)
T cd06632 180 GLAADIWSLGCTVLEMATGKPPWSQLEGV----------------AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243 (258)
T ss_pred CchhhhHHHHHHHHHHHhCCCCcccCcHH----------------HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCc
Confidence 89999999999999999999999764310 00111111111223445677889999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+||++.+++.+
T Consensus 244 ~~Rp~~~~~l~~ 255 (258)
T cd06632 244 SLRPTAAELLEH 255 (258)
T ss_pred ccCcCHHHHhcC
Confidence 999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=258.87 Aligned_cols=240 Identities=25% Similarity=0.294 Sum_probs=186.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..|||++.+.-...+.+.++|++++.+.+ |+||++++++|+++...|||||.+.||+|..+|.++. .+++..+..+.
T Consensus 105 EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vv 182 (463)
T KOG0607|consen 105 EYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVV 182 (463)
T ss_pred hhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHH
Confidence 36899988776677889999999999995 9999999999999999999999999999999997665 49999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc---eeeccccccccCCCCC-----Ccceeecccccccccchhhhhc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD-----RTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
.+|+.||.|||. +||.||||||+|||...-.. +|||||.+..-+.... ........+|+..|||||+..-
T Consensus 183 kdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~ 260 (463)
T KOG0607|consen 183 KDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDV 260 (463)
T ss_pred HHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhh
Confidence 999999999995 56999999999999966543 8999999876432211 1111335678999999997642
Q ss_pred -----CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccC--CCCChHHHHHHH
Q 021947 153 -----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLG--GQYPQKAAHTAA 224 (305)
Q Consensus 153 -----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~ 224 (305)
..|+.++|.||||+|+|-|+.|.+||.+.... +.-++-..+.-.....+++-+ +..+. ..-...++.+..
T Consensus 261 fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~--dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eak 338 (463)
T KOG0607|consen 261 FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA--DCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAK 338 (463)
T ss_pred hccccccccccccHHHHHHHHHHHHhCCCCccCccCC--cCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHH
Confidence 35899999999999999999999999886542 111111111112223333332 33332 122347899999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+|+..+|..++.+|.++..++.+
T Consensus 339 dlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 339 DLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHhccHHhhhhhhhccCC
Confidence 99999999999999999998873
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=261.17 Aligned_cols=228 Identities=22% Similarity=0.371 Sum_probs=179.4
Q ss_pred EEEEEecccCC----------ccChHHHHHHHHHHhc-cCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhh--cCC
Q 021947 2 VVAVKKLKPEG----------FQGHKEWLTEVNYLGQ-LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGP 68 (305)
Q Consensus 2 ~VaiK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~ 68 (305)
.||+|.+.... .....++.+|+.++.+ ++|+||+++++++.+++..+++|||+.|++|.+++.. ...
T Consensus 28 ~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~ 107 (269)
T cd08528 28 LLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK 107 (269)
T ss_pred eeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhcc
Confidence 58889875321 1223457789998875 7999999999999999999999999999999998743 223
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
..+++..++.++.+++.+|.|||+. .+++|+||+|+||+++.++.++|+|||.+....... ......++..|++||
T Consensus 108 ~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe 183 (269)
T cd08528 108 QRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPE 183 (269)
T ss_pred CCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChh
Confidence 4589999999999999999999962 469999999999999999999999999998654332 223456788999999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
.+.+..++.++|+||||+++|+|++|..||........ ................++..+.+++.
T Consensus 184 ~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~ 247 (269)
T cd08528 184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----------------ATKIVEAVYEPLPEGMYSEDVTDVIT 247 (269)
T ss_pred hhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----------------HHHHhhccCCcCCcccCCHHHHHHHH
Confidence 99988899999999999999999999999975432110 00111111111112246678999999
Q ss_pred hhccCCCCCCCCHHHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~ 249 (305)
+||..||++||++.++.++++
T Consensus 248 ~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 248 SCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHCCCCCccCCCHHHHHHHhc
Confidence 999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=265.58 Aligned_cols=223 Identities=26% Similarity=0.370 Sum_probs=180.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.+........+.+.+|+.++++++||||+++++.+..++..|+|+||+++++|.+++.+. .+++..+..++.
T Consensus 46 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~ 122 (293)
T cd06647 46 EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCR 122 (293)
T ss_pred EEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHH
Confidence 58999887655455677899999999999999999999999999999999999999999998654 378889999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......... .....++..|++||.+.+..++.++|+
T Consensus 123 ~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv 198 (293)
T cd06647 123 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 198 (293)
T ss_pred HHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhH
Confidence 99999999996 45999999999999999999999999988754432211 223457889999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|++++|..||...+.... +.... ........+..++..+.+++.+||..+|.+||+
T Consensus 199 ~slG~ll~~ll~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~ 262 (293)
T cd06647 199 WSLGIMAIEMVEGEPPYLNENPLRA----------------LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 262 (293)
T ss_pred HHHHHHHHHHHhCCCCCCCCChhhh----------------eeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999976432110 00000 001111223456778999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++.+
T Consensus 263 ~~~il~h 269 (293)
T cd06647 263 AKELLQH 269 (293)
T ss_pred HHHHhcC
Confidence 9999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=271.89 Aligned_cols=233 Identities=22% Similarity=0.331 Sum_probs=168.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|+.... ....|+.++++++|+||+++++++..+...++|||++. ++|.+++.... ..+++..+..++.
T Consensus 93 ~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~ 164 (357)
T PHA03209 93 PVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEK 164 (357)
T ss_pred eEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHH
Confidence 5788875432 23579999999999999999999999999999999996 58888886543 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ......||..|+|||++.+..++.++||
T Consensus 165 qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di 239 (357)
T PHA03209 165 QILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADI 239 (357)
T ss_pred HHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhH
Confidence 999999999964 59999999999999999999999999997533221 1223468999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCcc-CCCcccchh-------hhhhhhhh-------hh--ccchhhhhhhhcc--cCCCC-------
Q 021947 162 YSFGVVLLELLSGRCAV-DKTKVGIEQ-------SLVDWAKP-------YL--SDKRKLFRIMDTK--LGGQY------- 215 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf-~~~~~~~~~-------~~~~~~~~-------~~--~~~~~~~~~~~~~--~~~~~------- 215 (305)
|||||++|+|+++..++ ......... .+...... .. ............. .....
T Consensus 240 wSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (357)
T PHA03209 240 WSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQ 319 (357)
T ss_pred HHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHh
Confidence 99999999999865544 432221110 00000000 00 0000000000000 00000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
...++..+.+||.+||+.||.+|||+.+++++
T Consensus 320 ~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 320 RVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 11345577889999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.85 Aligned_cols=226 Identities=29% Similarity=0.422 Sum_probs=179.9
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||+|.++..... ....+.+|++++++++|+||+++++.+...+..++|+||+++++|.+++.... .+++..+..
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 103 (264)
T cd06626 26 ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRV 103 (264)
T ss_pred cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHH
Confidence 36899998766443 45678999999999999999999999999999999999999999999996543 378889999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcce--eecccccccccchhhhhcCC--
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV--STQVMGTHGYAAPEYVATGR-- 154 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-- 154 (305)
++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........... .....++..|+|||++.+..
T Consensus 104 i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 181 (264)
T cd06626 104 YTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181 (264)
T ss_pred HHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCC
Confidence 99999999999996 4599999999999999999999999999987544322111 11245788999999998766
Q ss_pred -CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh--HHHHHHHHHHHhhc
Q 021947 155 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ--KAAHTAATLALQCL 231 (305)
Q Consensus 155 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l 231 (305)
++.++|+||||+++|++++|..||........ .............+. .++..+.+++.+||
T Consensus 182 ~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (264)
T cd06626 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----------------IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCL 245 (264)
T ss_pred CCCcccchHHHHHHHHHHHhCCCCccCCcchHH----------------HHHHHhcCCCCCCCcccccCHHHHHHHHHHc
Confidence 78899999999999999999999975421100 000011111112222 34788899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 021947 232 NNEPKLRPRMSEVLA 246 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~ 246 (305)
+.+|.+|||+.+++.
T Consensus 246 ~~~p~~R~~~~~i~~ 260 (264)
T cd06626 246 ESDPKKRPTASELLQ 260 (264)
T ss_pred cCCcccCCCHHHHhc
Confidence 999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=261.99 Aligned_cols=224 Identities=27% Similarity=0.392 Sum_probs=181.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.|++|++..... ....+.+|++.++.++|+||+++++.+......|+++||++|++|.+++.... ..++...+..++.
T Consensus 46 ~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ 123 (286)
T cd06614 46 EVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCR 123 (286)
T ss_pred EEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHH
Confidence 588998876543 46778999999999999999999999999999999999999999999997654 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+
T Consensus 124 ~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 199 (286)
T cd06614 124 EVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDI 199 (286)
T ss_pred HHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCcccc
Confidence 99999999996 5699999999999999999999999998875433211 1223357789999999988889999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc-CCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||........ ......... ....+..++..+.++|.+||+.+|.+|||
T Consensus 200 ~slGvil~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 263 (286)
T cd06614 200 WSLGIMCIEMAEGEPPYLREPPLRA----------------LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263 (286)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC
Confidence 9999999999999999975432100 011111111 11122346788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.++++.
T Consensus 264 ~~~il~~ 270 (286)
T cd06614 264 AEELLQH 270 (286)
T ss_pred HHHHhhC
Confidence 9999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=267.30 Aligned_cols=228 Identities=21% Similarity=0.289 Sum_probs=176.6
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||.+..... .....+.+|+++++.++||||+++++.+..++..++||||++|++|.+++...+ .+++..+..
T Consensus 28 ~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~ 105 (305)
T cd05609 28 RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARM 105 (305)
T ss_pred EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 689998875532 233567899999999999999999999999999999999999999999996654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-------------cceeeccccccccc
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-------------THVSTQVMGTHGYA 145 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~t~~y~ 145 (305)
++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||+++....... ........++..|+
T Consensus 106 ~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 183 (305)
T cd05609 106 YFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183 (305)
T ss_pred HHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCcccc
Confidence 99999999999996 4599999999999999999999999998864211100 00111235688899
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC-CCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (305)
|||.+.+..++.++|+||||+++|+|++|..||.+..... ........... ......++..+.
T Consensus 184 aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~ 247 (305)
T cd05609 184 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----------------LFGQVISDDIEWPEGDEALPADAQ 247 (305)
T ss_pred CchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhcccCCCCccccCCHHHH
Confidence 9999988889999999999999999999999997643110 00111111111 111224678899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
++|.+||+.||++||+..++.+.|+
T Consensus 248 ~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 248 DLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHHHHhccChhhccCccCHHHHHh
Confidence 9999999999999998655555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.87 Aligned_cols=227 Identities=26% Similarity=0.379 Sum_probs=185.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++..... .....+.+|++.+.+++|+||+++++++...+..++||||+++++|.+++... ..+++..++.++
T Consensus 28 ~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~ 105 (264)
T cd06623 28 IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIA 105 (264)
T ss_pred EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHH
Confidence 689998877644 34578999999999999999999999999999999999999999999999765 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.+|.|||+. .+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|
T Consensus 106 ~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~D 182 (264)
T cd06623 106 RQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAAD 182 (264)
T ss_pred HHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhh
Confidence 9999999999951 55999999999999999999999999999865433221 12345788999999998888999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH-HHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rp 239 (305)
+||||+++|+|++|..||........ ......+........+.. ++..+.++|.+||..+|++||
T Consensus 183 v~slG~il~~l~tg~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 183 IWSLGLTLLECALGKFPFLPPGQPSF--------------FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred HHHHHHHHHHHHhCCCCCccccccCH--------------HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCC
Confidence 99999999999999999976542100 011111112222233344 788999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.+++++
T Consensus 249 ~~~~ll~~ 256 (264)
T cd06623 249 SAAELLQH 256 (264)
T ss_pred CHHHHHhC
Confidence 99999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=263.64 Aligned_cols=240 Identities=25% Similarity=0.280 Sum_probs=176.5
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++..... ...+.+.+|++++++++|+||+++++++......++||||++++.|..++.... .+++..+..+
T Consensus 28 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~ 105 (286)
T cd07847 28 IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKI 105 (286)
T ss_pred EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHH
Confidence 689998865422 233567899999999999999999999999999999999999988877764433 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 158 (305)
+.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||++......... .....++..|+|||++.+ ..++.+
T Consensus 106 ~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~ 181 (286)
T cd07847 106 IWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPP 181 (286)
T ss_pred HHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCch
Confidence 9999999999996 45999999999999999999999999999875443211 223457889999999876 457889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhccchh------hhhh-hhcccCC-----CCChHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRK------LFRI-MDTKLGG-----QYPQKAAHTAAT 225 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~-~~~~~~~-----~~~~~~~~~~~~ 225 (305)
+|+||||+++|+|++|..||.+....... ............... .... ....... .....++..+.+
T Consensus 182 ~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (286)
T cd07847 182 VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALS 261 (286)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHH
Confidence 99999999999999999999865432110 000000000000000 0000 0000000 001245678999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
|+.+||+.+|++|||+.+++.+
T Consensus 262 li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 262 FLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHHhcCCccccCCHHHHhcC
Confidence 9999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.86 Aligned_cols=241 Identities=22% Similarity=0.267 Sum_probs=170.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhc-------CCCCCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR-------GPQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~ 72 (305)
.||+|.++... ....+.+|++++++++||||+++++++.. +...|+||||+.+ +|.+++... ....++
T Consensus 30 ~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~ 106 (317)
T cd07867 30 EYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLP 106 (317)
T ss_pred eEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCC
Confidence 58999887542 33567899999999999999999998854 4567999999965 888877422 123478
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEe----CCCCceeeccccccccCCCCCCc-ceeecccccccccch
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAP 147 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aP 147 (305)
+..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+++........ .......+|..|+||
T Consensus 107 ~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07867 107 RSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCc
Confidence 889999999999999999964 59999999999999 45678999999999865433211 112334679999999
Q ss_pred hhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-------hhhhhhh----hhhccchh---------hhhh
Q 021947 148 EYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLVDWAK----PYLSDKRK---------LFRI 206 (305)
Q Consensus 148 E~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~----~~~~~~~~---------~~~~ 206 (305)
|++.+. .++.++|||||||++|+|++|..||......... ....... +....... ....
T Consensus 185 E~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (317)
T cd07867 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKD 264 (317)
T ss_pred HHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhh
Confidence 998764 5788999999999999999999999765432111 0000000 00000000 0000
Q ss_pred hhcc---------cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 207 MDTK---------LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 207 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.... ............+.+|+.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 265 FRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0000011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.48 Aligned_cols=227 Identities=24% Similarity=0.347 Sum_probs=182.5
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 75 (305)
.||+|.+..... ...+++.+|++++++++|+||+++++++.. +...|++|||+++++|.+++... ....+++..
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~ 106 (265)
T cd08217 27 ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF 106 (265)
T ss_pred EEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHH
Confidence 588998875433 234578899999999999999999998764 45679999999999999998653 234589999
Q ss_pred HHHHHHHHHHHHhhhhcC---CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDA---ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.++.+++.||.|||.. ..+++|+||+|+||+++.++.+||+|||++......... .....++..|+|||.+.+
T Consensus 107 ~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred HHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcC
Confidence 999999999999999933 356999999999999999999999999999876543221 223468899999999988
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
..++.++|+||||+++|+|++|..||...... .+.+..........+...+..+.+++.+||.
T Consensus 185 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 247 (265)
T cd08217 185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----------------QLASKIKEGKFRRIPYRYSSELNEVIKSMLN 247 (265)
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----------------HHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 88999999999999999999999999865311 1112222222234455678899999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.+|.+||++.+++++
T Consensus 248 ~~p~~Rp~~~~il~~ 262 (265)
T cd08217 248 VDPDKRPSTEELLQL 262 (265)
T ss_pred CCcccCCCHHHHhhC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=260.97 Aligned_cols=229 Identities=29% Similarity=0.471 Sum_probs=178.3
Q ss_pred EEEEEecccCCccChH--HHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHK--EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~--~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++......... ...+|+.++++++|+||+++++++......++|||++.+++|.+++.... .++...+..+
T Consensus 26 ~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~ 103 (260)
T PF00069_consen 26 KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKI 103 (260)
T ss_dssp EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHH
T ss_pred EEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccc--cccccccccc
Confidence 5899999876443332 34569999999999999999999999999999999999999999997333 3899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-cCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~ 158 (305)
+.|+++||++||+. +++|+||||+||+++.++.++|+|||.+..... .........++..|+|||++. +..++.+
T Consensus 104 ~~qi~~~L~~Lh~~--~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (260)
T PF00069_consen 104 AYQILEALAYLHSK--GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRK 179 (260)
T ss_dssp HHHHHHHHHHHHHT--TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTH
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence 99999999999975 599999999999999999999999999975411 112234456899999999998 7889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||.............. ......... ..........+.+++.+||+.||++|
T Consensus 180 ~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~---------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R 248 (260)
T PF00069_consen 180 SDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK---------ILKRPLPSS--SQQSREKSEELRDLIKKMLSKDPEQR 248 (260)
T ss_dssp HHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH---------HHHTHHHHH--TTSHTTSHHHHHHHHHHHSSSSGGGS
T ss_pred ccccccccccccccccccccccccchhhhhhhhh---------ccccccccc--ccccchhHHHHHHHHHHHccCChhHC
Confidence 9999999999999999999987521111110000 000000000 00011123889999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 249 ~~~~~l~~~ 257 (260)
T PF00069_consen 249 PSAEELLKH 257 (260)
T ss_dssp TTHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.33 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=178.3
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++.+.....+++..+..
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 105 (328)
T cd08226 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN 105 (328)
T ss_pred cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHH
Confidence 36899998754322 2367889999999999999999999999999999999999999999999776555689999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-----eeecccccccccchhhhhcC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~ 153 (305)
++.|++.||+|||+ +|++||||||+||+++.++.++++||+.+.......... ......++..|+|||++.+.
T Consensus 106 ~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 106 ILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred HHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCC
Confidence 99999999999995 469999999999999999999999998654321111000 01112345679999998764
Q ss_pred --CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhh--hh----hccchh----------------h-h---
Q 021947 154 --RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK--PY----LSDKRK----------------L-F--- 204 (305)
Q Consensus 154 --~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~--~~----~~~~~~----------------~-~--- 204 (305)
.++.++|+|||||++|+|++|..||.......... ...... +. ...... . .
T Consensus 184 ~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (328)
T cd08226 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGM 263 (328)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccc
Confidence 47889999999999999999999997653221100 000000 00 000000 0 0
Q ss_pred --hhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 205 --RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 205 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..............++..+.+|+.+||..||++|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 264 TQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000011122234577889999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=265.12 Aligned_cols=240 Identities=23% Similarity=0.256 Sum_probs=174.7
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.++..... ....+.+|++++++++|+||+++++++.+....++++||+.+ +|.+++.... ..+++..+..+
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~ 104 (284)
T cd07839 27 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN-GDIDPEIVKSF 104 (284)
T ss_pred EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHH
Confidence 5889988754322 235678899999999999999999999999999999999975 8888876543 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.+
T Consensus 105 ~~qi~~al~~LH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~ 180 (284)
T cd07839 105 MFQLLKGLAFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTS 180 (284)
T ss_pred HHHHHHHHHHHHHC--CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcH
Confidence 99999999999964 5999999999999999999999999999765332211 2234568899999998775 46889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh--hhhhh-hhhhhccchhhhhhhhcccC---------CCCChHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDW-AKPYLSDKRKLFRIMDTKLG---------GQYPQKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l 226 (305)
+|||||||++|+|++|..||......... ..... ..+.......+......... ......++.++.+|
T Consensus 181 ~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (284)
T cd07839 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDL 260 (284)
T ss_pred HHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHH
Confidence 99999999999999999886543321111 00000 00000000000000000000 01123467889999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||+.||.+|||+++++++
T Consensus 261 i~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 261 LQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHhcCChhhcCCHHHHhcC
Confidence 999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=251.46 Aligned_cols=225 Identities=26% Similarity=0.422 Sum_probs=178.3
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.|||.+...++. +-++++..++++.+-+ +|+||+.+|+|..+...++.||.|. ..++.++++ -.+++++..+-++
T Consensus 119 iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~ 196 (391)
T KOG0983|consen 119 IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKM 196 (391)
T ss_pred EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhh
Confidence 5799988765443 3467888888876654 8999999999999999999999994 356666544 4456999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc---CCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~ 156 (305)
...++.||.||-.+ ++|+|||+||+|||++..|++||||||++-...+.. ......|-+.|||||.+.- ..|+
T Consensus 197 tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYD 272 (391)
T KOG0983|consen 197 TVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYD 272 (391)
T ss_pred HHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccc
Confidence 99999999999874 679999999999999999999999999986543321 2334468899999998864 3688
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc-CCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++||||||++++||.||+.||.+.+.. .+.+..+++... ..+....++..+.+|+..||.+|+
T Consensus 273 iRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~ 337 (391)
T KOG0983|consen 273 IRADVWSLGITLVELATGQYPYKGCKTD---------------FEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDH 337 (391)
T ss_pred hhhhhhhhccchhhhhcccCCCCCCCcc---------------HHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCc
Confidence 9999999999999999999999885432 222333333221 112223488999999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+||.+.+++++
T Consensus 338 r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 338 RKRPKYNKLLEH 349 (391)
T ss_pred ccCcchHHHhcC
Confidence 999999999975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=280.17 Aligned_cols=236 Identities=18% Similarity=0.261 Sum_probs=167.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCC------CCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHH------PNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++... .....+..|++++++++| .+++.+++++... ..+|+|||++ |++|.+++.+.+ .+++.
T Consensus 156 ~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~ 231 (467)
T PTZ00284 156 YCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHR 231 (467)
T ss_pred EEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHH
Confidence 68999986432 223445667777777654 4588888888754 5688999998 679999886654 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----------------ceeeccccccccCCCCCCcceeecc
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------------NAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
.+..++.|++.||.|||++ .||+||||||+|||++.++ .+||+|||.+...... ....
T Consensus 232 ~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~ 305 (467)
T PTZ00284 232 HLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAI 305 (467)
T ss_pred HHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccc
Confidence 9999999999999999963 3699999999999998765 4999999987643221 2345
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-h--------hhhhhh-ccchhhhhhhh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D--------WAKPYL-SDKRKLFRIMD 208 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~--------~~~~~~-~~~~~~~~~~~ 208 (305)
+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+........ . |..... .....+.....
T Consensus 306 ~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 385 (467)
T PTZ00284 306 VSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAG 385 (467)
T ss_pred cCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcc
Confidence 7899999999999999999999999999999999999999875532111110 0 000000 00000000000
Q ss_pred cccCC-------------CC-ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 209 TKLGG-------------QY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 209 ~~~~~-------------~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..... .. .......+.+||.+||..||.+|||+++++++
T Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 386 QLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred cccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 00000 00 00124567899999999999999999999975
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=260.65 Aligned_cols=223 Identities=26% Similarity=0.336 Sum_probs=182.1
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.+..... ...+.+.+|++++++++||||+++++.+.++...++|+||+.|++|.+++... ..+++..+..
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~ 104 (258)
T cd05578 27 MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKF 104 (258)
T ss_pred EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHH
Confidence 689998875533 23467899999999999999999999999999999999999999999999665 3589999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.+
T Consensus 105 ~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~ 179 (258)
T cd05578 105 WICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVA 179 (258)
T ss_pred HHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCc
Confidence 99999999999995 459999999999999999999999999998654332 1233457889999999988889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||.......... +...... .....+...+..+.++|.+||..||.+|
T Consensus 180 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (258)
T cd05578 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQ--------------IRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKR 244 (258)
T ss_pred ccchhhHHHHHHHHhCCCCCCCCCccHHHH--------------HHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHc
Confidence 999999999999999999998654321111 1111111 2234455677899999999999999999
Q ss_pred CCH--HHHHH
Q 021947 239 PRM--SEVLA 246 (305)
Q Consensus 239 ps~--~~~l~ 246 (305)
|++ .++++
T Consensus 245 ~~~~~~~l~~ 254 (258)
T cd05578 245 LGDNLKDLKN 254 (258)
T ss_pred CCccHHHHhc
Confidence 999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=260.86 Aligned_cols=224 Identities=26% Similarity=0.332 Sum_probs=173.4
Q ss_pred CEEEEEecccCCcc---ChHHHHHHHHHHhc---cCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQ---GHKEWLTEVNYLGQ---LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~---~~~~~~~E~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||+|.+...... ....+.+|..+++. ..|+||+.+++++..++..++||||+.|++|.+++..++ .+++.
T Consensus 20 ~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~l~~~ 97 (279)
T cd05633 20 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEK 97 (279)
T ss_pred cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC--CCCHH
Confidence 36899988654322 12334455544443 479999999999999999999999999999999986554 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-C
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
.+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+ .
T Consensus 98 ~~~~i~~qi~~al~~lH~~--~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 171 (279)
T cd05633 98 EMRFYATEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGT 171 (279)
T ss_pred HHHHHHHHHHHHHHHHHHC--CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCC
Confidence 9999999999999999964 59999999999999999999999999987543321 223468999999998864 5
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|+|||||++|+|++|..||.......... + ...........+..++.++.++|.+||+.
T Consensus 172 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------I-DRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------------H-HHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 68899999999999999999999997643211110 0 00111122334566788999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 021947 234 EPKLRP-----RMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rp-----s~~~~l~~ 247 (305)
||.+|+ |+.+++++
T Consensus 237 ~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHhcCCCCCCHHHHHhC
Confidence 999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=256.43 Aligned_cols=226 Identities=24% Similarity=0.370 Sum_probs=185.9
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--CCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 76 (305)
.+||+|++..... .....+.+|+++++.++|+|++++++.+..+...++|+||+++++|.+++.+.. ...++...+
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (258)
T cd08215 26 KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105 (258)
T ss_pred cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHH
Confidence 3689999876544 345678999999999999999999999999999999999999999999997643 356999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.+++.||.+||+. |++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++
T Consensus 106 ~~i~~~i~~~l~~lh~~--~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~ 181 (258)
T cd08215 106 LDWFVQLCLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYN 181 (258)
T ss_pred HHHHHHHHHHHHHHHhC--CEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCC
Confidence 99999999999999964 69999999999999999999999999998654432 123344688899999999888899
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+||||+++|+|++|..||...... .+............+..++..+.+++.+||+.+|+
T Consensus 182 ~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 244 (258)
T cd08215 182 YKSDIWSLGCVLYELCTLKHPFEGENLL-----------------ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPE 244 (258)
T ss_pred ccccHHHHHHHHHHHHcCCCCCCCCcHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999999764311 11111112222334446778999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 245 ~Rp~~~~ll~~ 255 (258)
T cd08215 245 ERPSIAQILQS 255 (258)
T ss_pred hCcCHHHHhcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=258.40 Aligned_cols=225 Identities=23% Similarity=0.353 Sum_probs=180.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.+..... ...+.+.+|++++++++|+||+++++.+..++..++|+||+.+++|.+++.+.....+++..+..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (257)
T cd08225 27 HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106 (257)
T ss_pred eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 478998865422 334578899999999999999999999999999999999999999999997665556899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc-eeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.+++.||.|||+ .+++|+||||+||++++++. ++|+|||.+........ ......|+..|+|||++.+..++.+
T Consensus 107 ~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~ 182 (257)
T cd08225 107 FVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNK 182 (257)
T ss_pred HHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCch
Confidence 9999999999996 45999999999999988864 69999999876543221 1223457889999999988889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|+|++|..||...+... ....... ..........+..+.+++.+||..+|++|
T Consensus 183 ~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 245 (257)
T cd08225 183 TDIWSLGCVLYELCTLKHPFEGNNLHQ----------------LVLKICQ-GYFAPISPNFSRDLRSLISQLFKVSPRDR 245 (257)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHhc-ccCCCCCCCCCHHHHHHHHHHhccChhhC
Confidence 999999999999999999997543210 0111111 11122334567789999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 246 pt~~~ll~~ 254 (257)
T cd08225 246 PSITSILKR 254 (257)
T ss_pred cCHHHHhhC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=254.70 Aligned_cols=224 Identities=30% Similarity=0.451 Sum_probs=182.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.|++|++..........+.+|++.+++++|+||+++++++......++++||+.|++|.+++.... ..+++..+..++.
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ 105 (253)
T cd05122 27 EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCK 105 (253)
T ss_pred EEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHH
Confidence 588999887655566789999999999999999999999999999999999999999999986653 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.+|.+||+ .|++|+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+..++.++|+
T Consensus 106 ~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv 180 (253)
T cd05122 106 ELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADI 180 (253)
T ss_pred HHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccH
Confidence 99999999995 5699999999999999999999999999976544321 234467889999999988888999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++|..||........ ........ ........++..+.+++.+||..||++|||
T Consensus 181 ~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t 244 (253)
T cd05122 181 WSLGITAIELAEGKPPYSELPPMKA----------------LFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244 (253)
T ss_pred HHHHHHHHHHHhCCCCCCCCchHHH----------------HHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC
Confidence 9999999999999999976431100 00000000 011112223778999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++++
T Consensus 245 ~~~~l~~ 251 (253)
T cd05122 245 AEQLLKH 251 (253)
T ss_pred HHHHhcC
Confidence 9999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.03 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=179.1
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++..... .....+.+|+.++++++|+||+++++++..+...++||||+ +++|.+++.... ..+++..+..+
T Consensus 27 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~ 104 (286)
T cd07832 27 TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSY 104 (286)
T ss_pred eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHH
Confidence 689999876542 23467899999999999999999999999999999999999 999999986544 45899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.|++.+|+|||+. +++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.+
T Consensus 105 ~~~i~~~l~~lH~~--~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~ 181 (286)
T cd07832 105 MRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPG 181 (286)
T ss_pred HHHHHHHHHHHHHC--CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCch
Confidence 99999999999965 599999999999999999999999999987644322 112234688999999988654 46889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhh------ccchhhhhhhhccc-C---CCCChHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYL------SDKRKLFRIMDTKL-G---GQYPQKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~------~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~l 226 (305)
+||||||+++|+|++|..+|.+....... .......+.. .............. . .......+..+.+|
T Consensus 182 ~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (286)
T cd07832 182 VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDL 261 (286)
T ss_pred hHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHH
Confidence 99999999999999998888664421110 0000000000 00000000000000 0 00112456889999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||..+|.+|||+++++.+
T Consensus 262 i~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 262 LKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=261.00 Aligned_cols=226 Identities=28% Similarity=0.367 Sum_probs=173.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEE-----eCCeeEEEEecCCCCCHHHHhhhc--CCCCCCH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRR--GPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 73 (305)
.||+|+++... .....+.+|+.+++++ +|+||+++++++. .++..++||||++|++|.+++... ....+++
T Consensus 45 ~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 123 (286)
T cd06638 45 KAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123 (286)
T ss_pred eeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccH
Confidence 57889876532 2345688899999999 6999999999874 345689999999999999987532 2235888
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.+++.||.|||+. +++||||||+||+++.++.++|+|||++........ ......|+..|+|||++..
T Consensus 124 ~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 199 (286)
T cd06638 124 PIIAYILHEALMGLQHLHVN--KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACE 199 (286)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchh
Confidence 89999999999999999964 599999999999999999999999999876533211 1223468899999998753
Q ss_pred ----CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHH
Q 021947 153 ----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 153 ----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 227 (305)
..++.++|+|||||++|+|++|..||....... .+...... ......+..++..+.+|+
T Consensus 200 ~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li 263 (286)
T cd06638 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----------------ALFKIPRNPPPTLHQPELWSNEFNDFI 263 (286)
T ss_pred hhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----------------HHhhccccCCCcccCCCCcCHHHHHHH
Confidence 457889999999999999999999997643210 00000000 011112334567899999
Q ss_pred HhhccCCCCCCCCHHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l 248 (305)
.+||+.||++|||+.++++++
T Consensus 264 ~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 264 RKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHccCCcccCCCHHHHhhcc
Confidence 999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.11 Aligned_cols=222 Identities=26% Similarity=0.375 Sum_probs=179.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||||.+..... .....+.+|++++++++|+||+++++.+..+...|+||||+.+++|.+++... .+++..+..++
T Consensus 31 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~ 107 (277)
T cd06641 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATIL 107 (277)
T ss_pred EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHH
Confidence 689998764432 23357889999999999999999999999999999999999999999998543 48899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|
T Consensus 108 ~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~D 183 (277)
T cd06641 108 REILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKAD 183 (277)
T ss_pred HHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhh
Confidence 999999999995 5699999999999999999999999999876533211 122345788999999998888899999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
+||||+++|+|++|..||....... ....+........+..++.++.+++.+||..+|.+||+
T Consensus 184 v~slG~~l~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (277)
T cd06641 184 IWSLGITAIELAKGEPPHSELHPMK-----------------VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246 (277)
T ss_pred HHHHHHHHHHHHcCCCCCCccchHH-----------------HHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999997533110 01111111122334457788999999999999999999
Q ss_pred HHHHHHH
Q 021947 241 MSEVLAI 247 (305)
Q Consensus 241 ~~~~l~~ 247 (305)
+.+++.+
T Consensus 247 ~~~~l~~ 253 (277)
T cd06641 247 AKELLKH 253 (277)
T ss_pred HHHHHhC
Confidence 9999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.61 Aligned_cols=241 Identities=26% Similarity=0.286 Sum_probs=178.3
Q ss_pred CEEEEEecccCCcc-----ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQ-----GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
..||||++...... ....+.+|++++++++|+||+++++++.++...++||||+ +++|.+++.... ..+++..
T Consensus 26 ~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~ 103 (298)
T cd07841 26 RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPAD 103 (298)
T ss_pred cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHH
Confidence 36899998765433 2345778999999999999999999999999999999999 889999996554 3589999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GR 154 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~ 154 (305)
+..++.|+++||.|||++ |++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..
T Consensus 104 ~~~~~~qi~~al~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 179 (298)
T cd07841 104 IKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARH 179 (298)
T ss_pred HHHHHHHHHHHHHHHHhC--CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCC
Confidence 999999999999999964 5999999999999999999999999999875443211 222345788999998865 45
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhhcc---chhhhhhhhcccCC-----CCChHHHHHHH
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSD---KRKLFRIMDTKLGG-----QYPQKAAHTAA 224 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~~~ 224 (305)
++.++|+|||||++|+|++|..+|.+....... .......+.... .............. ......+..+.
T Consensus 180 ~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T cd07841 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDAL 259 (298)
T ss_pred CCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHH
Confidence 788999999999999999998888764432110 100000000000 00000000000000 01134567899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++|.+||..+|++|||+.+++++
T Consensus 260 ~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 260 DLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.84 Aligned_cols=240 Identities=27% Similarity=0.322 Sum_probs=177.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|+++.... .....+.+|++++++++|+||+++++++..++..+++|||+.++.+..+..+. ..++...+..+
T Consensus 28 ~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~ 105 (288)
T cd07833 28 IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSY 105 (288)
T ss_pred EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHH
Confidence 689998875432 23467899999999999999999999999999999999999986666555433 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.+++.||.|||+ ++++|+||+|+||+++.++.+||+|||++......... ......++..|+|||++.+. .++.+
T Consensus 106 ~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~ 182 (288)
T cd07833 106 IWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKP 182 (288)
T ss_pred HHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCch
Confidence 9999999999996 45999999999999999999999999998875543321 12334678899999999888 78899
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhh-------hccchhhh-----hhh-hcccCCCCChHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPY-------LSDKRKLF-----RIM-DTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~-------~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~ 224 (305)
+|+||||+++|+|++|..||.+........ ........ ........ ... .......++..++.++.
T Consensus 183 ~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (288)
T cd07833 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262 (288)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHH
Confidence 999999999999999999997653221100 00000000 00000000 000 00000112334578899
Q ss_pred HHHHhhccCCCCCCCCHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~ 246 (305)
+||++||..+|++|||++++++
T Consensus 263 ~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 263 DFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHhccCchhcccHHHHhc
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=258.05 Aligned_cols=222 Identities=26% Similarity=0.379 Sum_probs=176.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|.++.... ....++.+|++++++++ |+||+++++++..+...++||||+.|++|.+++... .+++..+.
T Consensus 28 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~ 104 (277)
T cd06917 28 VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYIS 104 (277)
T ss_pred EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHH
Confidence 589998875432 34467889999999996 999999999999999999999999999999998543 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~ 156 (305)
.++.+++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++......... .....|+..|+|||.+.++ .++
T Consensus 105 ~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 180 (277)
T cd06917 105 VIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYD 180 (277)
T ss_pred HHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccc
Confidence 999999999999995 45999999999999999999999999999765443211 2234688899999988654 568
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh-HHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p 235 (305)
.++|+||||+++|+|++|..||.+....... ...........+. .++.++.+++.+||+.||
T Consensus 181 ~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 243 (277)
T cd06917 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAM-----------------MLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243 (277)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChhhhh-----------------hccccCCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence 8999999999999999999999764321100 0000000011111 266789999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
++||++.+++++
T Consensus 244 ~~R~~~~~il~~ 255 (277)
T cd06917 244 KERLSAEELLKS 255 (277)
T ss_pred ccCcCHHHHhhC
Confidence 999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=261.95 Aligned_cols=225 Identities=29% Similarity=0.427 Sum_probs=177.7
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++...... ....+.+|++++++++|+|++++++++.++...|+||||+.| +|.+++.... ..+++..+..
T Consensus 52 ~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~ 129 (317)
T cd06635 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAA 129 (317)
T ss_pred EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc-CCCCHHHHHH
Confidence 6899988754322 235788999999999999999999999999999999999975 8888775433 3489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~ 155 (305)
++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..... .....++..|+|||++. ++.+
T Consensus 130 i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (317)
T cd06635 130 ITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQY 201 (317)
T ss_pred HHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCC
Confidence 99999999999995 4599999999999999999999999998875432 12345788999999874 4568
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|+||||+++|+|++|..||...... ..................++..+.+|+.+||+.+|
T Consensus 202 ~~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 265 (317)
T cd06635 202 DGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265 (317)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCc
Confidence 88999999999999999999998754211 11111111111122233567789999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021947 236 KLRPRMSEVLAILERLE 252 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~ 252 (305)
.+||++.++++++..+.
T Consensus 266 ~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 266 QDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccCcCHHHHHhChhhhc
Confidence 99999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=263.15 Aligned_cols=241 Identities=24% Similarity=0.302 Sum_probs=176.7
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++.+... ....+.+|++++++++||||+++++++.+++..++||||+. ++|.+++.......+++..+..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~ 105 (284)
T cd07860 27 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSY 105 (284)
T ss_pred EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHH
Confidence 6899988754322 23578899999999999999999999999999999999996 58999886655556899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-CCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~ 158 (305)
+.+++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......... .....++..|+|||++.+.. ++.+
T Consensus 106 ~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~ 181 (284)
T cd07860 106 LFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTA 181 (284)
T ss_pred HHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcH
Confidence 9999999999996 45999999999999999999999999998765432211 22234678899999886654 5889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhh-------hccchhhhhhhhcccC---CCCChHHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPY-------LSDKRKLFRIMDTKLG---GQYPQKAAHTAATLA 227 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li 227 (305)
+|+||||+++|+|++|..||.+....... ......... ................ ......++.++.++|
T Consensus 182 ~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (284)
T cd07860 182 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLL 261 (284)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHH
Confidence 99999999999999999999765421110 000000000 0000000000000000 001123567789999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||+.||.+|||+++++++
T Consensus 262 ~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 262 SQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhcCCCcccCCCHHHHhcC
Confidence 99999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=260.91 Aligned_cols=224 Identities=24% Similarity=0.319 Sum_probs=178.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||++..........+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++... .+++..+..++.
T Consensus 47 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ 123 (292)
T cd06657 47 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCL 123 (292)
T ss_pred EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHH
Confidence 58999886554445567899999999999999999999999999999999999999999987543 388999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.+|+|||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+
T Consensus 124 ql~~~l~~lH~~--givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 199 (292)
T cd06657 124 AVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDI 199 (292)
T ss_pred HHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhH
Confidence 999999999964 599999999999999999999999998875533221 1223457889999999988888999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
||||+++|+|++|..||.+......... +..... ........++..+.+++.+||..+|.+||++
T Consensus 200 ~slGvil~el~tg~~p~~~~~~~~~~~~-------------~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~ 264 (292)
T cd06657 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLP--PKLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhhCC--cccCCcccCCHHHHHHHHHHHhCCcccCcCH
Confidence 9999999999999999976432111000 000000 0111123466788999999999999999999
Q ss_pred HHHHHH
Q 021947 242 SEVLAI 247 (305)
Q Consensus 242 ~~~l~~ 247 (305)
.+++++
T Consensus 265 ~~ll~~ 270 (292)
T cd06657 265 AELLKH 270 (292)
T ss_pred HHHhcC
Confidence 999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=260.11 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=173.9
Q ss_pred CEEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||.+...... ....+.+|+++++.++|+||+++++++.++...++||||+.+ +|.+++.+... .+++..+..+
T Consensus 31 ~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~ 108 (291)
T cd07844 31 QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLF 108 (291)
T ss_pred cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHH
Confidence 36899998754322 234577899999999999999999999999999999999975 99998865543 5899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 158 (305)
+.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........ .....++..|+|||++.+ ..++.+
T Consensus 109 ~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~ 184 (291)
T cd07844 109 LFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTS 184 (291)
T ss_pred HHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcH
Confidence 9999999999995 45999999999999999999999999998754322111 122346788999998876 457889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhh--hhhh-hhhh---hccchhhhhhhhcccCC-------CCChHHH--HHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDW-AKPY---LSDKRKLFRIMDTKLGG-------QYPQKAA--HTA 223 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~-~~~~---~~~~~~~~~~~~~~~~~-------~~~~~~~--~~~ 223 (305)
+|+||||+++|+|++|..||.+........ .... ..+. ................. ....... ..+
T Consensus 185 ~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (291)
T cd07844 185 LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHG 264 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhH
Confidence 999999999999999999997654211110 0000 0000 00000000000000000 0001122 678
Q ss_pred HHHHHhhccCCCCCCCCHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
.+++.+||+.+|.+|||+.+++.
T Consensus 265 ~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 265 EELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHhccCcccccCHHHHhc
Confidence 89999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.89 Aligned_cols=225 Identities=28% Similarity=0.386 Sum_probs=179.0
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+||+|.+..... .....+.+|++++++++|+||+++++.+..+...|++|||+.+++|.+++.+.+ .+++..+..
T Consensus 20 ~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 97 (265)
T cd05579 20 IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARI 97 (265)
T ss_pred EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 689999876543 334678899999999999999999999999999999999999999999997654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC------cceeecccccccccchhhhhc
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------THVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ........++..|++||...+
T Consensus 98 i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 175 (265)
T cd05579 98 YIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175 (265)
T ss_pred HHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC
Confidence 99999999999995 5599999999999999999999999999876433211 112233457889999999988
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH--HHHHHHHHHHhh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--AAHTAATLALQC 230 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~ 230 (305)
...+.++|+||||+++|++++|..||....... ....... .....+.. .+..+.+++.+|
T Consensus 176 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----------------IFQNILN-GKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHhc-CCcCCCccccCCHHHHHHHHHH
Confidence 888999999999999999999999997643210 1111111 01112222 378899999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~l 248 (305)
|+.+|.+|||+.++.+.|
T Consensus 238 l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred hcCCHhhcCCCccHHHHh
Confidence 999999999995544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=255.79 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=180.6
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhc---CCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRR---GPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~ 75 (305)
.+|||+++.+... -.....+|+.+++.++|+||+.+..+|.. ....|+++||.+. +|...|+-. ....++...
T Consensus 55 ~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~m 133 (438)
T KOG0666|consen 55 EYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSM 133 (438)
T ss_pred hhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHH
Confidence 4688888765332 23567899999999999999999999887 6789999999987 999988432 124588899
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC----CceeeccccccccCCCCCCcc-eeecccccccccchhhh
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~ 150 (305)
+..++.||+.|+.|||+.. |+||||||.|||+..+ |.|||+|||+++.+.+.-... .....+-|.+|+|||.+
T Consensus 134 vKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL 211 (438)
T KOG0666|consen 134 VKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL 211 (438)
T ss_pred HHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHh
Confidence 9999999999999999765 9999999999999887 899999999999876544332 23445679999999999
Q ss_pred hcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-------hh----hhhhhhhccchhhhh---------hhhc
Q 021947 151 ATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-------LV----DWAKPYLSDKRKLFR---------IMDT 209 (305)
Q Consensus 151 ~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~----~~~~~~~~~~~~~~~---------~~~~ 209 (305)
.|. .|+.+.|+||+|||+.||++-.+.|.+........ +. -...|...+...+.+ ....
T Consensus 212 LGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~ 291 (438)
T KOG0666|consen 212 LGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRR 291 (438)
T ss_pred cccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHH
Confidence 886 68999999999999999999999998876543221 00 000011111100000 0000
Q ss_pred ccCCCC--------ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 210 KLGGQY--------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 210 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
...... ...-++...+|+.++|..||.+|.|+++.+++.-
T Consensus 292 ~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 292 HYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred hhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 000000 0012234789999999999999999999998653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.51 Aligned_cols=221 Identities=30% Similarity=0.417 Sum_probs=174.3
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++...... ....+.+|+++++.++||||+++++++......|+||||+.| ++.+++.... ..+++..+..
T Consensus 42 ~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~ 119 (307)
T cd06607 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHK-KPLQEVEIAA 119 (307)
T ss_pred EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcc-cCCCHHHHHH
Confidence 6899988644322 225688999999999999999999999999999999999975 7877775433 3489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~ 155 (305)
++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... ....++..|+|||++. ...+
T Consensus 120 ~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~ 191 (307)
T cd06607 120 ICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQY 191 (307)
T ss_pred HHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCC
Confidence 99999999999996 45999999999999999999999999998754322 2345788999999874 3567
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|+||||+++|+|++|..||.+.+.... ................++..+.+++.+||..+|
T Consensus 192 ~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 255 (307)
T cd06607 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIP 255 (307)
T ss_pred CcccchHHHHHHHHHHHcCCCCCCCccHHHH----------------HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCCh
Confidence 8899999999999999999999976432110 011111111111233467789999999999999
Q ss_pred CCCCCHHHHHHHH
Q 021947 236 KLRPRMSEVLAIL 248 (305)
Q Consensus 236 ~~Rps~~~~l~~l 248 (305)
++||++.+++.+.
T Consensus 256 ~~Rp~~~~il~~~ 268 (307)
T cd06607 256 QDRPSSEELLKHR 268 (307)
T ss_pred hhCcCHHHHhcCh
Confidence 9999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=254.58 Aligned_cols=227 Identities=27% Similarity=0.411 Sum_probs=185.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++++||+.+++|.+++.+.. .+++..+.
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 104 (260)
T cd06606 27 LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIR 104 (260)
T ss_pred EEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHH
Confidence 688998876543 3356789999999999999999999999988 88999999999999999997654 58999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.+++.+|+|||+ .+++|+||+|+||+++.++.++|+|||.+................++..|++||.+.+...+.
T Consensus 105 ~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 182 (260)
T cd06606 105 KYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182 (260)
T ss_pred HHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCc
Confidence 999999999999996 569999999999999999999999999998765443211123346788999999998888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+||||+++|+|++|..||...... ................+...+..+.+++.+||..+|.+
T Consensus 183 ~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 247 (260)
T cd06606 183 AADIWSLGCTVIEMATGKPPWSELGNP---------------MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKK 247 (260)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhh
Confidence 999999999999999999999765411 01111111122333455567889999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
||++.+++.+
T Consensus 248 Rp~~~~ll~~ 257 (260)
T cd06606 248 RPTADELLQH 257 (260)
T ss_pred CCCHHHHhhC
Confidence 9999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=260.09 Aligned_cols=240 Identities=25% Similarity=0.304 Sum_probs=177.2
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+||+|.++...... ...+.+|++++++++||||+++++++... ...|+||||+.+ +|.+++..... .+++..+.
T Consensus 32 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~l~~~~~~ 109 (293)
T cd07843 32 IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ-PFLQSEVK 109 (293)
T ss_pred EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC-CCCHHHHH
Confidence 68999887553322 24577899999999999999999998877 889999999975 99998865443 58999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~ 156 (305)
.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......... .....++..|+|||.+.+. .++
T Consensus 110 ~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~ 185 (293)
T cd07843 110 CLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYS 185 (293)
T ss_pred HHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCcccc
Confidence 9999999999999964 5999999999999999999999999999865443211 2234568889999988765 468
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhh--hhhhhhhhhccc-----------hhhhhhhhcccCCCCChH-HHHH
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDK-----------RKLFRIMDTKLGGQYPQK-AAHT 222 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~-~~~~ 222 (305)
.++|+||||+++|+|++|..||.......... ...+..+..... ..............++.. ++..
T Consensus 186 ~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (293)
T cd07843 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDN 265 (293)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChH
Confidence 89999999999999999999998654321110 000000000000 000000001111222222 5788
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.++|.+||+.+|++|||+.+++++
T Consensus 266 ~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 266 GFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHHHHhccCccccCCHHHHhcC
Confidence 9999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=257.42 Aligned_cols=230 Identities=27% Similarity=0.353 Sum_probs=176.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhh--cCCCCCCHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~ 76 (305)
.||+|.+..... ....++.+|++++++++|+||+++++++.+. +.+|+||||++|++|.+++.. .....++...+
T Consensus 28 ~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 107 (287)
T cd06621 28 IFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL 107 (287)
T ss_pred EEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHH
Confidence 689998875433 2346789999999999999999999988654 468999999999999988743 22345888999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .....++..|++||.+.+..++
T Consensus 108 ~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~ 181 (287)
T cd06621 108 GKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYS 181 (287)
T ss_pred HHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCC
Confidence 9999999999999996 459999999999999999999999999987543221 1233568899999999888999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccc--hhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhhcc
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGI--EQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~ 232 (305)
.++|+||||+++|+|++|..||....... ......+.. ........ .......+..+.+++.+||.
T Consensus 182 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (287)
T cd06621 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----------NMPNPELKDEPGNGIKWSEEFKDFIKQCLE 251 (287)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----------cCCchhhccCCCCCCchHHHHHHHHHHHcC
Confidence 99999999999999999999998653210 000000000 00000000 01112356789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.+|.+|||+.+++++
T Consensus 252 ~~p~~Rpt~~eil~~ 266 (287)
T cd06621 252 KDPTRRPTPWDMLEH 266 (287)
T ss_pred CCcccCCCHHHHHhC
Confidence 999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.65 Aligned_cols=225 Identities=30% Similarity=0.390 Sum_probs=173.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhc--CCCCCCH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRR--GPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 73 (305)
.||+|.+.... .....+.+|+.+++++ +|+||+++++++... +..|+||||+.|++|.+++... ....+++
T Consensus 49 ~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~ 127 (291)
T cd06639 49 LAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127 (291)
T ss_pred EEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCH
Confidence 58899886532 2345678899999999 799999999998753 3579999999999999988532 2345899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++......... .....++..|+|||++...
T Consensus 128 ~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 203 (291)
T cd06639 128 AMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACE 203 (291)
T ss_pred HHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCC
Confidence 99999999999999999964 5999999999999999999999999998765432211 2234578899999987643
Q ss_pred -----CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHH
Q 021947 154 -----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLA 227 (305)
Q Consensus 154 -----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 227 (305)
.++.++|+||||+++|+|++|+.||...... .. +....... .....+......+.+||
T Consensus 204 ~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li 267 (291)
T cd06639 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KT--------------LFKIPRNPPPTLLHPEKWCRSFNHFI 267 (291)
T ss_pred CCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HH--------------HHHHhcCCCCCCCcccccCHHHHHHH
Confidence 3678999999999999999999999764321 00 11111000 01122344667899999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||+.+|++||++.+++++
T Consensus 268 ~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 268 SQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHhhcChhhCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=260.37 Aligned_cols=227 Identities=25% Similarity=0.387 Sum_probs=175.0
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHh---hhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL---FRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~ 75 (305)
..||+|.+..... .....+.+|+.++.++. |+||+++++++...+..+++|||+.+ ++.++. .......+++..
T Consensus 30 ~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~ 108 (288)
T cd06616 30 TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEI 108 (288)
T ss_pred CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHH
Confidence 3689998875432 33457889999999996 99999999999988899999999864 665543 222334589999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC--
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-- 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-- 153 (305)
+..++.+++.||+|||+. .+++||||||+||+++.++.++|+|||++........ .....++..|+|||++.+.
T Consensus 109 ~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd06616 109 LGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSAR 184 (288)
T ss_pred HHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccc
Confidence 999999999999999963 3699999999999999999999999999875433221 1233578899999998776
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh---cccCCCCChHHHHHHHHHHHh
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD---TKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~ 229 (305)
.++.++|+||||+++|+|++|..||........ .+.+... .......+..++.++.+|+.+
T Consensus 185 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 249 (288)
T cd06616 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD---------------QLTQVVKGDPPILSNSEEREFSPSFVNFINL 249 (288)
T ss_pred cCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH---------------HHhhhcCCCCCcCCCcCCCccCHHHHHHHHH
Confidence 688999999999999999999999976431000 0011000 011112223578889999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||..+|.+|||+++++++
T Consensus 250 ~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 250 CLIKDESKRPKYKELLEH 267 (288)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.01 Aligned_cols=222 Identities=30% Similarity=0.496 Sum_probs=182.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.+..... .....+.+|++++++++|+|++++++++.+++..+++|||+.+++|.+++.... .+++..+..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~ 104 (254)
T cd06627 27 FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVY 104 (254)
T ss_pred EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHH
Confidence 689999877654 344678999999999999999999999999999999999999999999997653 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+++.+|.+||+ .|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||...+..++.++
T Consensus 105 ~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~ 180 (254)
T cd06627 105 VYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTAS 180 (254)
T ss_pred HHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcch
Confidence 9999999999995 45999999999999999999999999999876543321 2234578899999999888888999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|+|+||+++|+|++|..||...... ....... .......+..++..+.+++.+||..+|++||
T Consensus 181 Dv~~lG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 243 (254)
T cd06627 181 DIWSLGCTVIELLTGNPPYYDLNPM----------------AALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRP 243 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCc
Confidence 9999999999999999999754311 0011111 1122234556788999999999999999999
Q ss_pred CHHHHHH
Q 021947 240 RMSEVLA 246 (305)
Q Consensus 240 s~~~~l~ 246 (305)
|+.+++.
T Consensus 244 ~~~~~l~ 250 (254)
T cd06627 244 TAKQLLK 250 (254)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=257.11 Aligned_cols=226 Identities=26% Similarity=0.379 Sum_probs=172.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHH-HhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNY-LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 77 (305)
.||||.++.... ....++..|+.+ ++.++|+||+++++++..++..|++|||++ ++|.+++... ....+++..++
T Consensus 28 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ 106 (283)
T cd06617 28 IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILG 106 (283)
T ss_pred EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHH
Confidence 689998876532 233566677776 556689999999999999999999999997 5888887542 22458999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc----C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----G 153 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~ 153 (305)
.++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++....... ......++..|+|||++.+ .
T Consensus 107 ~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 182 (283)
T cd06617 107 KIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQK 182 (283)
T ss_pred HHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCccccc
Confidence 9999999999999963 269999999999999999999999999987653321 1222457889999998865 4
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|+||||+++|+|++|..||........ .+...............++.++.++|.+||..
T Consensus 183 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 247 (283)
T cd06617 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---------------QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKK 247 (283)
T ss_pred ccCccccchhhHHHHHHHHhCCCCCCccccCHH---------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccC
Confidence 568899999999999999999999965322110 11111111111111234678899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
+|.+||++.+++++
T Consensus 248 ~p~~Rp~~~~il~~ 261 (283)
T cd06617 248 NYKERPNYPELLQH 261 (283)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=261.17 Aligned_cols=207 Identities=27% Similarity=0.372 Sum_probs=177.2
Q ss_pred hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 021947 16 HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 95 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 95 (305)
....++|-++|.+++.+.||.+--.|+..+.+++||..|.||+|.-+|.+.+...+++..+.-++.+|+.||.+||. .
T Consensus 229 e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~--~ 306 (591)
T KOG0986|consen 229 ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR--R 306 (591)
T ss_pred hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh--c
Confidence 34578999999999999999998889999999999999999999999988887789999999999999999999995 4
Q ss_pred ceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCC
Q 021947 96 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 175 (305)
+||+|||||+|||+|+.|+++|+|+|+|..+..... ....+||.+|||||++.++.|+...|.|||||++|+|+.|+
T Consensus 307 ~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~ 383 (591)
T KOG0986|consen 307 RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGH 383 (591)
T ss_pred ceeeccCChhheeeccCCCeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHccc
Confidence 599999999999999999999999999998755432 33448999999999999999999999999999999999999
Q ss_pred CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 176 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
.||.......... -.+.........++...++++++|++.+|..||.+|...
T Consensus 384 sPFr~~KeKvk~e--------------Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 384 SPFRQRKEKVKRE--------------EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred CchhhhhhhhhHH--------------HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 9998754422211 111112223446778999999999999999999999743
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=253.27 Aligned_cols=225 Identities=25% Similarity=0.340 Sum_probs=178.1
Q ss_pred EEEEEecccCC-----ccChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEG-----FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||+|.+..+. ......+.+|++++++++|+||+++++.+.+. ..+++++||+.+++|.+++...+ .+++.
T Consensus 29 ~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~ 106 (264)
T cd06653 29 ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTEN 106 (264)
T ss_pred EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHH
Confidence 58999875321 12335788999999999999999999998764 45789999999999999986554 37888
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-cceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
....++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....... ........++..|+|||++.+.
T Consensus 107 ~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (264)
T cd06653 107 VTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184 (264)
T ss_pred HHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCC
Confidence 999999999999999995 4599999999999999999999999999986432111 1112234578899999999888
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|+||||+++|+|++|+.||..... .....+..........+..++..+.+++.+||.
T Consensus 185 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~- 247 (264)
T cd06653 185 GYGRKADVWSVACTVVEMLTEKPPWAEYEA----------------MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV- 247 (264)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCccCH----------------HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-
Confidence 899999999999999999999999975321 111222222223344577788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
+|..||++.+++.+
T Consensus 248 ~~~~r~~~~~~~~~ 261 (264)
T cd06653 248 EEKRRPTAEFLLRH 261 (264)
T ss_pred CcccCccHHHHhcC
Confidence 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=258.50 Aligned_cols=241 Identities=22% Similarity=0.246 Sum_probs=175.4
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++..... .....+.+|++++++++|+||+++++++..+...|+||||+. ++|.+++.......+++..+..+
T Consensus 29 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 107 (294)
T PLN00009 29 TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTY 107 (294)
T ss_pred EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHH
Confidence 689998865432 223568899999999999999999999999999999999996 48888886655555788888999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
+.|++.||+|||+ ++++|+||+|+||+++. ++.+||+|||++......... .....++..|+|||++.+. .++.
T Consensus 108 ~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~ 183 (294)
T PLN00009 108 LYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYST 183 (294)
T ss_pred HHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCc
Confidence 9999999999996 45999999999999985 457999999999765432111 1233568899999988764 5788
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhh---hccchhhhhhhhccc--CC----CCChHHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPY---LSDKRKLFRIMDTKL--GG----QYPQKAAHTAATL 226 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~l 226 (305)
++|+||||+++|+|++|..||......... .+..+..+. +.....+........ .. .....++..+.++
T Consensus 184 ~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (294)
T PLN00009 184 PVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDL 263 (294)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHH
Confidence 999999999999999999999765432110 000000000 000000000000000 00 0123456789999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||+.+|.+||++.+++++
T Consensus 264 i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 264 LSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999863
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=261.50 Aligned_cols=241 Identities=26% Similarity=0.341 Sum_probs=177.0
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||+|++...... ..+.+.+|+++++.++|+||+++++++..++..|+||||+++++|..+..... .+++..++.
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~ 104 (286)
T cd07846 27 QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRK 104 (286)
T ss_pred CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC--CCCHHHHHH
Confidence 36899987654332 24568899999999999999999999999999999999999988888765433 389999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.
T Consensus 105 ~~~~i~~~l~~LH~~--~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 180 (286)
T cd07846 105 YLFQILRGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGR 180 (286)
T ss_pred HHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCc
Confidence 999999999999964 599999999999999999999999999876533221 12234578899999988753 5678
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhccchhhhh---hhhcc----c-----CCCCChHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFR---IMDTK----L-----GGQYPQKAAHTAA 224 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~----~-----~~~~~~~~~~~~~ 224 (305)
++|+||||+++|+|++|..||......... .................. ..... . .......++..+.
T Consensus 181 ~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (286)
T cd07846 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVL 260 (286)
T ss_pred hHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHH
Confidence 999999999999999999999754321100 000000000000000000 00000 0 0001234678899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+|+.+||..+|.+||++.+++++
T Consensus 261 ~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 261 DLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHHHhcCCcccchhHHHHhcC
Confidence 99999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.50 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=176.4
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcC---CCCCC
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRG---PQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~---~~~~~ 72 (305)
..||||.+.... ......+.+|+.++++++||||+++++++.+. ...|+||||+.+ +|.+++.... ...++
T Consensus 28 ~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 106 (316)
T cd07842 28 KEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIP 106 (316)
T ss_pred CeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcC
Confidence 368999988743 33446788999999999999999999999988 789999999975 7777764322 23588
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC----CCceeeccccccccCCCCCC-cceeecccccccccch
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAP 147 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aP 147 (305)
+..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+|||++........ ........++..|+||
T Consensus 107 ~~~~~~i~~qi~~~l~~lH~~--~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 184 (316)
T cd07842 107 PSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCH
Confidence 999999999999999999964 5999999999999999 89999999999986543322 1112234578899999
Q ss_pred hhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-------hhhhhhh----hh------hccchhhhhhhhc
Q 021947 148 EYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLVDWAK----PY------LSDKRKLFRIMDT 209 (305)
Q Consensus 148 E~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~----~~------~~~~~~~~~~~~~ 209 (305)
|++.+. .++.++|+||||+++|+|++|+.||.+....... ....... +. .............
T Consensus 185 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (316)
T cd07842 185 ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD 264 (316)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhh
Confidence 988764 5788999999999999999999999876543200 0000000 00 0000000000000
Q ss_pred ccCCCCC-----------hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 210 KLGGQYP-----------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 210 ~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....++ ...+..+.+++.+||..||++|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 265 FKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred ccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0001111 1345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=253.30 Aligned_cols=223 Identities=25% Similarity=0.376 Sum_probs=182.4
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--CCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 77 (305)
.+|+|.+..... .....+.+|++++++++|+||+++++++..+...|+||||+.+++|.+++.+.. ...+++..++
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08530 27 FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106 (256)
T ss_pred EEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHH
Confidence 578998875432 234577899999999999999999999999999999999999999999986522 2458999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.+++.||+|||+ .|++|+||+|+||+++.++.+||+|||++....... .....++..|++||.+.+..++.
T Consensus 107 ~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~ 180 (256)
T cd08530 107 RIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSY 180 (256)
T ss_pred HHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCc
Confidence 999999999999996 459999999999999999999999999998754431 22345788999999998888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+||||+++|+|++|+.||...+.. .+............+...+.++.+++.+||..+|.+
T Consensus 181 ~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 243 (256)
T cd08530 181 KSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKL 243 (256)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCccc
Confidence 999999999999999999999764321 111111222222344567888999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+.+++++
T Consensus 244 Rp~~~~~l~~ 253 (256)
T cd08530 244 RPNCDKILAS 253 (256)
T ss_pred CCCHHHHhcC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=254.47 Aligned_cols=224 Identities=26% Similarity=0.333 Sum_probs=173.7
Q ss_pred CEEEEEecccCCccC---hHHHHHHHH---HHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQG---HKEWLTEVN---YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~---~~~~~~E~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||+|.+....... ...+..|.. .++...||||+.+++.+...+..++||||+.|++|.+++...+ .+++.
T Consensus 20 ~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~ 97 (278)
T cd05606 20 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEA 97 (278)
T ss_pred CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHH
Confidence 368999887543221 123444443 3444579999999999999999999999999999999886543 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG- 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 153 (305)
.+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .....|+..|+|||++.++
T Consensus 98 ~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 171 (278)
T cd05606 98 EMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV 171 (278)
T ss_pred HHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCC
Confidence 999999999999999996 459999999999999999999999999987543221 2234689999999998754
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++||||+|+++|+|++|..||.......... .... ........+..++..+.+++.+||..
T Consensus 172 ~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~-~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRM-TLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--------------HHHH-hhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 68899999999999999999999997653211110 0000 11112334555688999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 021947 234 EPKLRP-----RMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rp-----s~~~~l~~ 247 (305)
+|.+|| ++.+++++
T Consensus 237 ~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CHHhccCCCCCCHHHHHhC
Confidence 999999 89998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=253.61 Aligned_cols=220 Identities=24% Similarity=0.253 Sum_probs=170.0
Q ss_pred CEEEEEecccCCccC---hHHHHHHHHHH-hccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGFQG---HKEWLTEVNYL-GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~---~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||+|.+....... ...+..|..++ ...+|+||+++++++..++..|+|+||+.|++|.+++...+ .+++..+
T Consensus 22 ~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 99 (260)
T cd05611 22 DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWA 99 (260)
T ss_pred CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHH
Confidence 368999987543222 22344555544 44589999999999999999999999999999999996554 4889999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..... .....++..|++||.+.+..++
T Consensus 100 ~~i~~qi~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~ 171 (260)
T cd05611 100 KQYIAEVVLGVEDLHQR--GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDD 171 (260)
T ss_pred HHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCc
Confidence 99999999999999964 599999999999999999999999999875432 2234578899999999888889
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
.++|+||||+++|+|++|..||...+..... ....... ........++..+.+++.+||..+
T Consensus 172 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVF----------------DNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred chhhhHHHHHHHHHHHHCCCCCCCCCHHHHH----------------HHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 9999999999999999999999764321100 0000001 111222356788999999999999
Q ss_pred CCCCCCHHHHHH
Q 021947 235 PKLRPRMSEVLA 246 (305)
Q Consensus 235 p~~Rps~~~~l~ 246 (305)
|++||++..+.+
T Consensus 236 p~~R~~~~~~~~ 247 (260)
T cd05611 236 PAKRLGANGYQE 247 (260)
T ss_pred HHHccCCCcHHH
Confidence 999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=262.91 Aligned_cols=236 Identities=23% Similarity=0.280 Sum_probs=173.6
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||.+.... ......+.+|+.++++++|+||+++++++... ...|+||||+.+ +|.+++... ++.
T Consensus 43 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----l~~ 117 (353)
T cd07850 43 NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDH 117 (353)
T ss_pred EEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc----CCH
Confidence 68999986532 22345678999999999999999999988643 356999999965 888887432 888
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++........ .....++..|+|||++.+.
T Consensus 118 ~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 192 (353)
T cd07850 118 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM 192 (353)
T ss_pred HHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCC
Confidence 8999999999999999996 4599999999999999999999999999986543221 2234578899999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhh-hhhhh---hcc-----------c-----hhhhhhhhc---
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPY---LSD-----------K-----RKLFRIMDT--- 209 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~-~~~~~---~~~-----------~-----~~~~~~~~~--- 209 (305)
.++.++|+|||||++|+|++|+.||...+..... .... ...+. ... . ..+.+....
T Consensus 193 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
T cd07850 193 GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLF 272 (353)
T ss_pred CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccccc
Confidence 9999999999999999999999999765431110 0000 00000 000 0 000000000
Q ss_pred -ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 210 -KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 210 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
......+...+..+.+||.+||..||++|||+.+++.+
T Consensus 273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000122456778999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=258.01 Aligned_cols=241 Identities=24% Similarity=0.262 Sum_probs=177.5
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++..+... ....+.+|++++++++|+||+++++++.+++..|++|||+. ++|.+++.......+++..+..+
T Consensus 26 ~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 104 (283)
T cd07835 26 IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSY 104 (283)
T ss_pred EEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHH
Confidence 6899988755322 23568899999999999999999999999999999999995 59999987665445899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.+
T Consensus 105 ~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~ 180 (283)
T cd07835 105 LYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTP 180 (283)
T ss_pred HHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcH
Confidence 9999999999996 45999999999999999999999999999764332111 1223468889999987664 56889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhc----cchhhhhh---hhcc---cCCCCChHHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLS----DKRKLFRI---MDTK---LGGQYPQKAAHTAATLA 227 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~---~~~~---~~~~~~~~~~~~~~~li 227 (305)
+|+||||+++|+|++|..||......... ........... ....+... .... ........++..+.++|
T Consensus 181 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 260 (283)
T cd07835 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLL 260 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHH
Confidence 99999999999999999999765421110 00000000000 00000000 0000 00011234567899999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||+.+|.+|||+++++++
T Consensus 261 ~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 261 SKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=255.52 Aligned_cols=240 Identities=24% Similarity=0.265 Sum_probs=172.8
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+....... ...+.+|+++++.++|+||+++++++..+...|+||||+. ++|.+++.... ..+....+..++
T Consensus 32 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~ 109 (291)
T cd07870 32 LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFM 109 (291)
T ss_pred EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHH
Confidence 68999987553322 3467899999999999999999999999999999999996 58877775433 347888888999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 159 (305)
.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++........ .....++..|+|||++.+. .++.++
T Consensus 110 ~qi~~~L~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~ 185 (291)
T cd07870 110 FQLLRGLAYIHGQ--HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSAL 185 (291)
T ss_pred HHHHHHHHHHHhC--CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHH
Confidence 9999999999964 5999999999999999999999999998754332211 2233568899999988764 578899
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhh---hhhhc------cchhhhhh-hhcccCCCC-----ChHHHHHHH
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA---KPYLS------DKRKLFRI-MDTKLGGQY-----PQKAAHTAA 224 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~------~~~~~~~~-~~~~~~~~~-----~~~~~~~~~ 224 (305)
|+||||+++|+|++|..||.+.....+.....+. .+... ........ ......... ....+..+.
T Consensus 186 Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (291)
T cd07870 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAE 265 (291)
T ss_pred HHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHH
Confidence 9999999999999999999765432111100000 00000 00000000 000000000 001256788
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+++.+||..||.+|||+.+++.+
T Consensus 266 ~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 266 DLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HHHHHHhCcCcccCcCHHHHhcC
Confidence 99999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.66 Aligned_cols=232 Identities=28% Similarity=0.452 Sum_probs=196.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------C-----
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------P----- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~----- 68 (305)
.||||.++.... .+.+.+..|+++|+.+ +|+||+.+++.+...+..++|+||+..|+|.++++... .
T Consensus 330 ~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~ 409 (609)
T KOG0200|consen 330 TVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFP 409 (609)
T ss_pred EEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCc
Confidence 599999986643 3457899999999999 59999999999999899999999999999999997654 0
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc-cccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV-MGTHGY 144 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~~t~~y 144 (305)
..++....+.++.||+.|++||++.. ++||||-..|||++.+..+||+|||+++.............. .-...|
T Consensus 410 ~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kW 487 (609)
T KOG0200|consen 410 NERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKW 487 (609)
T ss_pred cccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceee
Confidence 13888999999999999999999755 999999999999999999999999999965444333211111 124569
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
||||.+....|+.++||||+|+++||+++ |..||.+.. ....+.+.+..+.+...|..++.++
T Consensus 488 mApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----------------~~~~l~~~l~~G~r~~~P~~c~~ei 551 (609)
T KOG0200|consen 488 MAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----------------PTEELLEFLKEGNRMEQPEHCSDEI 551 (609)
T ss_pred cCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----------------cHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 99999999999999999999999999999 899987621 1233456778888889999999999
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
.++++.||+.+|++||++.++.+.++..
T Consensus 552 Y~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 552 YDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 9999999999999999999999999884
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=256.39 Aligned_cols=223 Identities=30% Similarity=0.404 Sum_probs=175.0
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.+..... ....++.+|+++++.++|+|++++++++......|+||||+. +++.+++.... ..+++..+..
T Consensus 42 ~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~ 119 (308)
T cd06634 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAA 119 (308)
T ss_pred EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHH
Confidence 588998864322 223568899999999999999999999999999999999996 58888775433 3489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~ 155 (305)
++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...+
T Consensus 120 ~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~ 191 (308)
T cd06634 120 VTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQY 191 (308)
T ss_pred HHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCC
Confidence 99999999999995 4599999999999999999999999999875432 12345788999999874 3467
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++||||||+++|+|++|..||...+... .................++..+.+||.+||..+|
T Consensus 192 ~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P 255 (308)
T cd06634 192 DGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255 (308)
T ss_pred CcccchHHHHHHHHHHHcCCCCCccccHHH----------------HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCc
Confidence 889999999999999999999986532110 0111111111111234577889999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 021947 236 KLRPRMSEVLAILER 250 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~ 250 (305)
.+||++.+++++...
T Consensus 256 ~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 256 QDRPTSEVLLKHRFV 270 (308)
T ss_pred ccCCCHHHHhhCccc
Confidence 999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=257.29 Aligned_cols=220 Identities=31% Similarity=0.440 Sum_probs=173.3
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++...... ....+.+|+++++.++|+|++++++++.+....|+||||+.| ++.+++.... ..+++..+..
T Consensus 48 ~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~ 125 (313)
T cd06633 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAA 125 (313)
T ss_pred EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC-CCCCHHHHHH
Confidence 6899988654332 225688999999999999999999999999999999999964 8888775443 3589999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~ 155 (305)
++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++..... .....|+..|+|||++. +..+
T Consensus 126 ~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~ 197 (313)
T cd06633 126 ITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQY 197 (313)
T ss_pred HHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCC
Confidence 99999999999996 4599999999999999999999999998864322 22346788999999874 3568
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|+||||+++|+|++|..||...+.... ................++..+.+|+.+||+.+|
T Consensus 198 ~~~sDv~slGvil~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 261 (313)
T cd06633 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIP 261 (313)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChHHH----------------HHHHHhcCCCCCCccccCHHHHHHHHHHccCCh
Confidence 8899999999999999999999976432110 111111111111223456679999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+||++.+++.+
T Consensus 262 ~~Rp~~~~~l~~ 273 (313)
T cd06633 262 QERPASAELLRH 273 (313)
T ss_pred hhCcCHHHHhcC
Confidence 999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=255.16 Aligned_cols=240 Identities=24% Similarity=0.315 Sum_probs=176.9
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-CCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (305)
.||||+++..... ....+.+|++++++++|+||+++++.+.+.+..++||||+.+ +|.+++.... ...+++..+..+
T Consensus 27 ~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 105 (284)
T cd07836 27 IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSF 105 (284)
T ss_pred EEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHH
Confidence 5899988765332 346678999999999999999999999999999999999985 8988886543 235899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.|++.||.|||+. |++|+||||+||++++++.++|+|||++........ ......++..|++||++.+. .++.+
T Consensus 106 ~~qi~~~l~~lH~~--~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~ 181 (284)
T cd07836 106 TYQLLKGIAFCHEN--RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTS 181 (284)
T ss_pred HHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcH
Confidence 99999999999964 599999999999999999999999999975433211 12233568899999988664 56889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhh-hh-hhhhhhhccchhhhh--hhhccc-------CCCCChHHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LV-DWAKPYLSDKRKLFR--IMDTKL-------GGQYPQKAAHTAATLA 227 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~~li 227 (305)
+|+||||+++|+|++|..||.+.+...... .. .+..+.......+.. ...... .......++..+.+++
T Consensus 182 ~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 261 (284)
T cd07836 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLL 261 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHH
Confidence 999999999999999999998754321110 00 000000000000000 000000 0001124567889999
Q ss_pred HhhccCCCCCCCCHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~ 246 (305)
.+||+.||.+||++.++++
T Consensus 262 ~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 262 HRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCCcccCCCHHHHhc
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=252.74 Aligned_cols=235 Identities=24% Similarity=0.279 Sum_probs=172.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccC-CCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|+++.... .......+|+.++.++. |+||+++++++.++ +..++||||+.+ +|.+++.... ..+++..+.
T Consensus 26 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~ 103 (282)
T cd07831 26 YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK-RPLPEKRVK 103 (282)
T ss_pred EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhcc-CCCCHHHHH
Confidence 589998876432 22334568999999985 99999999999987 889999999975 8888886543 358999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~ 156 (305)
.++.|++.||.|||+ .+++|+||+|+||+++. +.+||+|||++........ .....++..|+|||++.. ..++
T Consensus 104 ~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 177 (282)
T cd07831 104 SYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYG 177 (282)
T ss_pred HHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCC
Confidence 999999999999996 45999999999999999 9999999999986543222 122357889999997654 4578
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhccchhhhhhhhcc--cCCC-----------CChHHHHH
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTK--LGGQ-----------YPQKAAHT 222 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----------~~~~~~~~ 222 (305)
.++|+|||||++|+|++|..||.+.+..... ....... .....+....... .... ....++..
T Consensus 178 ~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (282)
T cd07831 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG---TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAE 254 (282)
T ss_pred cchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcC---CCCHHHHHhhcccccccccCcccccccHHHHcccccHH
Confidence 8999999999999999999999775432110 0000000 0000000000000 0000 01246789
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||.+||..+|.+|||+.+++.+
T Consensus 255 ~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 255 GLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHHHHhccCcccccCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=268.71 Aligned_cols=213 Identities=26% Similarity=0.322 Sum_probs=172.9
Q ss_pred EEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.++|++.... .+-.+|+.++... +||||+++++++.++.+.|+|||.+.|+-+.+.+.... .....+..|+.
T Consensus 350 ~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~ 422 (612)
T KOG0603|consen 350 PAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAA 422 (612)
T ss_pred hhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHH
Confidence 3566665441 1223677666665 69999999999999999999999999999988886554 33367778999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEe-CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
+|+.++.|||+ .|++||||||+|||+ +..++++|+|||.++..... ....+-|..|.|||++....|+.++|
T Consensus 423 ~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD 495 (612)
T KOG0603|consen 423 ELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACD 495 (612)
T ss_pred HHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchh
Confidence 99999999996 459999999999999 68899999999999876543 22345688999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
+||||++||+|++|+.||.....+ .++.......++...++..+++|+.+||+.||.+|++
T Consensus 496 ~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~ 556 (612)
T KOG0603|consen 496 WWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLG 556 (612)
T ss_pred hHHHHHHHHHHHhCCCccccCCch-------------------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcC
Confidence 999999999999999999875432 2222233333444789999999999999999999999
Q ss_pred HHHHHHHH
Q 021947 241 MSEVLAIL 248 (305)
Q Consensus 241 ~~~~l~~l 248 (305)
+.+++.+-
T Consensus 557 ~~~i~~h~ 564 (612)
T KOG0603|consen 557 ADEIGAHP 564 (612)
T ss_pred hhhhccCc
Confidence 99998653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=272.53 Aligned_cols=227 Identities=21% Similarity=0.263 Sum_probs=164.3
Q ss_pred HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC---CCCCCHHHHHHHHHHHHHHHhhhhcC
Q 021947 17 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDA 93 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~ 93 (305)
..+.+|+++|++++|+||+++++++...+..|+|+|++. ++|.+++.... ........+..++.|++.||.|||++
T Consensus 208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 467899999999999999999999999999999999995 48888774432 11234556778999999999999964
Q ss_pred CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHh
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 173 (305)
||+||||||+|||++.++.+||+|||++......... ......||..|+|||++.+..++.++|||||||++|+|++
T Consensus 287 --gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~ 363 (501)
T PHA03210 287 --KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363 (501)
T ss_pred --CeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 5999999999999999999999999999865432221 1234578999999999999999999999999999999999
Q ss_pred CCCc-cCCCcccchhhhhhhhh-------hhhccchhhhhhhhcccCC----CC-----ChHHHHHHHHHHHhhccCCCC
Q 021947 174 GRCA-VDKTKVGIEQSLVDWAK-------PYLSDKRKLFRIMDTKLGG----QY-----PQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 174 g~~p-f~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~li~~~l~~~p~ 236 (305)
|..+ |..........+..... .+......+.+.+...... .. ....+..+.++|.+||..||.
T Consensus 364 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~ 443 (501)
T PHA03210 364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH 443 (501)
T ss_pred CCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence 8754 43332221111111000 0011111112221111000 00 012445678899999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.|++++
T Consensus 444 ~Rpsa~elL~h 454 (501)
T PHA03210 444 LRPGAAELLAL 454 (501)
T ss_pred cCcCHHHHhhC
Confidence 99999999975
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=251.33 Aligned_cols=216 Identities=23% Similarity=0.305 Sum_probs=168.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.+|+|.+........ |+.....+ +|+||+++++.+...+..|+||||++|++|.+++.... .+++..+..++
T Consensus 43 ~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~ 115 (267)
T PHA03390 43 LFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKII 115 (267)
T ss_pred EEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence 577888765432221 23222223 69999999999999999999999999999999997654 58999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||.|||+. |++||||||+||+++.++ .++|+|||++...... ....++..|+|||++.+..++.++
T Consensus 116 ~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~ 187 (267)
T PHA03390 116 RQLVEALNDLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSF 187 (267)
T ss_pred HHHHHHHHHHHhC--CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchh
Confidence 9999999999964 599999999999999988 9999999998765432 123578899999999988999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|+||||+++|+|++|..||........ .. ..+.... ......+...+..+.+||.+||+.+|.+||
T Consensus 188 DvwslG~il~~l~~g~~p~~~~~~~~~-~~-----------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (267)
T PHA03390 188 DWWAVGVLTYELLTGKHPFKEDEDEEL-DL-----------ESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRL 253 (267)
T ss_pred hHHHHHHHHHHHHHCCCCCCCCCcchh-hH-----------HHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCC
Confidence 999999999999999999985432110 00 0011111 111233446888999999999999999999
Q ss_pred C-HHHHHH
Q 021947 240 R-MSEVLA 246 (305)
Q Consensus 240 s-~~~~l~ 246 (305)
+ ++++++
T Consensus 254 ~~~~~~l~ 261 (267)
T PHA03390 254 TNYNEIIK 261 (267)
T ss_pred chHHHHhc
Confidence 5 698875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=256.96 Aligned_cols=240 Identities=25% Similarity=0.283 Sum_probs=173.5
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|+++.+.... ...+.+|+.++++++|+||+++++++... +..++||||+.+ +|.+++.... ..+++..+.
T Consensus 34 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~ 111 (309)
T cd07845 34 IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVK 111 (309)
T ss_pred EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHH
Confidence 68999987553322 23567899999999999999999998755 568999999975 8988886543 458999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~ 156 (305)
.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++......... .....++..|+|||++.+ ..++
T Consensus 112 ~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 187 (309)
T cd07845 112 CLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYT 187 (309)
T ss_pred HHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcC
Confidence 9999999999999964 5999999999999999999999999999875433211 122245778999998865 4578
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhccc----hhh---hhhhhcccCC----CCChHHHHHHH
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDK----RKL---FRIMDTKLGG----QYPQKAAHTAA 224 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~----~~~---~~~~~~~~~~----~~~~~~~~~~~ 224 (305)
.++|+||||+++|+|++|..||...+...... ............ ... .......... ......+..+.
T Consensus 188 ~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T cd07845 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGL 267 (309)
T ss_pred chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHH
Confidence 99999999999999999999998654321111 111000000000 000 0000000000 00112467789
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+||.+||..||++|||+.+++.+
T Consensus 268 ~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 268 RLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.69 Aligned_cols=241 Identities=22% Similarity=0.241 Sum_probs=172.6
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccC-CCCcccEEEEEEeCCe-----eEEEEecCCCCCHHHHhhhcC---CCC
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGEN-----RLLVYEFMPKGSLENHLFRRG---PQP 70 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~---~~~ 70 (305)
+||||+++..... ....+.+|+.+++.+. |+||+++++++..... .|+||||+++ +|.+++.... ...
T Consensus 28 ~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 106 (295)
T cd07837 28 LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRP 106 (295)
T ss_pred EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCC
Confidence 6899987654322 3357889999999995 6999999999887655 7999999986 8988885433 235
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
+++..+..++.|++.||.|||+. +++||||+|+||+++. ++.+||+|||++......... .....++..|+|||+
T Consensus 107 ~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~ 182 (295)
T cd07837 107 LPAKTIKSFMYQLLKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEV 182 (295)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHH
Confidence 89999999999999999999964 5999999999999998 889999999998764332111 122346788999998
Q ss_pred hhc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhh-hhh---hccchhhhhhhhccc-C----CCCChH
Q 021947 150 VAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPY---LSDKRKLFRIMDTKL-G----GQYPQK 218 (305)
Q Consensus 150 ~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~---~~~~~~~~~~~~~~~-~----~~~~~~ 218 (305)
+.+ ..++.++|+||||+++|+|++|..||.+....... .+.... .+. ............... . ......
T Consensus 183 ~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (295)
T cd07837 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD 262 (295)
T ss_pred hhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccc
Confidence 865 45788999999999999999999999765422111 000000 000 000000000000000 0 001124
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++..+.+||.+||..||.+||++.+++.+
T Consensus 263 ~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 263 LSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 67789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=249.27 Aligned_cols=222 Identities=28% Similarity=0.376 Sum_probs=185.2
Q ss_pred CEEEEEecccCCccChH---HHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHK---EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~---~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+..|+|+++++..-... .-+.|-++|+..+||.+..+.-.|.....+++||||..||.|.-++.+.. .+++....
T Consensus 194 k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtR 271 (516)
T KOG0690|consen 194 KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTR 271 (516)
T ss_pred ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh--cccchhhh
Confidence 35789999887544433 34679999999999999999888999999999999999999999886543 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
-+-.+|+.||.|||+. +||+||||.+|+|++.+|.+||+|||+++..-..+ ......+||+.|+|||++....|+.
T Consensus 272 FYGaEIvsAL~YLHs~--~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgr 347 (516)
T KOG0690|consen 272 FYGAEIVSALGYLHSR--NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGR 347 (516)
T ss_pred hhhHHHHHHhhhhhhC--CeeeeechhhhheeccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccccccc
Confidence 9999999999999974 59999999999999999999999999998643332 3356789999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|.|.+|+++|||++|+.||...+. ..++..+.. ....+|...++++..|+.-+|.+||.+
T Consensus 348 aVDWWG~GVVMYEMmCGRLPFyn~dh-----------------~kLFeLIl~-ed~kFPr~ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 348 AVDWWGVGVVMYEMMCGRLPFYNKDH-----------------EKLFELILM-EDLKFPRTLSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred eeehhhhhHHHHHHHhccCcccccch-----------------hHHHHHHHh-hhccCCccCCHHHHHHHHHHhhcChHh
Confidence 99999999999999999999987542 223332221 234678899999999999999999999
Q ss_pred CC-----CHHHHHH
Q 021947 238 RP-----RMSEVLA 246 (305)
Q Consensus 238 Rp-----s~~~~l~ 246 (305)
|. .+.||..
T Consensus 410 RLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 410 RLGGGPDDAKEIMR 423 (516)
T ss_pred hcCCCchhHHHHHh
Confidence 96 4555554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=250.13 Aligned_cols=204 Identities=25% Similarity=0.281 Sum_probs=164.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++... .+.+|...+....||||+++++++.+....|++|||+.|++|.+++.+.. .+++..+..++.
T Consensus 20 ~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~ 92 (237)
T cd05576 20 TFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAA 92 (237)
T ss_pred EEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHHHH
Confidence 58999887543 23345555666679999999999999999999999999999999986654 389999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|+|||.+.+..++.++|+
T Consensus 93 ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv 165 (237)
T cd05576 93 EMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDW 165 (237)
T ss_pred HHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCchhhH
Confidence 99999999995 459999999999999999999999999876543321 12345678999999988888999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
||+|+++|+|++|..||...... .........+..++..+.++|.+||+.||++|+++
T Consensus 166 wslG~il~el~~g~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 166 WSLGAILFELLTGKTLVECHPSG----------------------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHHHHCcchhhcCchh----------------------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99999999999999887542110 00011112345577889999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=251.30 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=185.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhc--cCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||||++... +.+.|.+|-+++.. ++|+||+++++.-..+. .+|||+||.+.|+|.+|++.+- .+|.
T Consensus 234 ~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~ 307 (534)
T KOG3653|consen 234 RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWN 307 (534)
T ss_pred ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc---ccHH
Confidence 47999999754 56778888888776 47999999999877655 7899999999999999997664 9999
Q ss_pred HHHHHHHHHHHHHhhhhcC-------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccch
Q 021947 75 VRMKVAIGAAKGLTFLHDA-------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 147 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~-------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 147 (305)
...+++..+++||+|||+. +..|+|||||..|||+.+++++.|+|||+|..+.......-....+||.+||||
T Consensus 308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAP 387 (534)
T KOG3653|consen 308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAP 387 (534)
T ss_pred HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCH
Confidence 9999999999999999953 457999999999999999999999999999876544333334457899999999
Q ss_pred hhhhcCC-CC-----CCCceehhhHHHHHHHhCCCccC-CCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCCh--
Q 021947 148 EYVATGR-LT-----TKSDVYSFGVVLLELLSGRCAVD-KTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQ-- 217 (305)
Q Consensus 148 E~~~~~~-~~-----~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-- 217 (305)
|++.+.- +. .+.||||+|.++|||++.-.-++ +......-.+-.-..... ..+.+...+ ..+.+..++.
T Consensus 388 EvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP-t~e~mq~~VV~kK~RP~~p~~W 466 (534)
T KOG3653|consen 388 EVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP-TLEEMQELVVRKKQRPKIPDAW 466 (534)
T ss_pred HHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC-CHHHHHHHHHhhccCCCChhhh
Confidence 9998752 22 37999999999999998543332 111111111110000001 112222332 3333344443
Q ss_pred ---HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 021947 218 ---KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 257 (305)
Q Consensus 218 ---~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 257 (305)
.-...+.+.+..||+.|++.|.|+.=+.+.+.++......
T Consensus 467 ~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 467 RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 2345688999999999999999999999999888765543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.77 Aligned_cols=241 Identities=23% Similarity=0.297 Sum_probs=175.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||+|+++.... .....+.+|+.++++++|+||+++++++.. ....|+||||+. ++|.+++.... .+++..
T Consensus 32 ~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~ 108 (334)
T cd07855 32 KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEH 108 (334)
T ss_pred EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHH
Confidence 689999876532 334677889999999999999999998763 356799999996 58999886544 389999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhc-
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~- 152 (305)
+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+
T Consensus 109 ~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (334)
T cd07855 109 IRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186 (334)
T ss_pred HHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCC
Confidence 99999999999999996 45999999999999999999999999999764332211 11223468889999998866
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhh--hhhhhc-----cchhhhhhhhc-ccCCCC-----ChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLS-----DKRKLFRIMDT-KLGGQY-----PQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~-~~~~~~-----~~~~ 219 (305)
..++.++|+||||+++|+|++|+.||.+.+.......... ..+... ....+...... ...... ....
T Consensus 187 ~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (334)
T cd07855 187 PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA 266 (334)
T ss_pred cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccC
Confidence 4688999999999999999999999976543211100000 000000 00000000000 000011 1345
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.++|.+||+.+|.+|||+++++.+
T Consensus 267 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 267 SPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 7889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.33 Aligned_cols=243 Identities=25% Similarity=0.291 Sum_probs=171.6
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC--------eeEEEEecCCCCCHHHHhhhcCCCC
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--------NRLLVYEFMPKGSLENHLFRRGPQP 70 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (305)
..||||.+...... ....+.+|++++++++||||+++++++...+ ..++||||+.+ +|.+++.... ..
T Consensus 38 ~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~ 115 (310)
T cd07865 38 QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VK 115 (310)
T ss_pred cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcc-cC
Confidence 36899988654322 2345678999999999999999999887543 45999999965 8888885543 35
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPE 148 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE 148 (305)
+++..+..++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++......... .......++..|+|||
T Consensus 116 ~~~~~~~~i~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 116 FTLSEIKKVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193 (310)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcH
Confidence 89999999999999999999964 5999999999999999999999999999765432211 1122345688899999
Q ss_pred hhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhh-----hhhccch--hhhhhhh--cccCCCC---
Q 021947 149 YVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK-----PYLSDKR--KLFRIMD--TKLGGQY--- 215 (305)
Q Consensus 149 ~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~--~~~~~~~--- 215 (305)
.+.+. .++.++|+||||+++|+|++|..||.+.+............ ....... ....... .......
T Consensus 194 ~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (310)
T cd07865 194 LLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKER 273 (310)
T ss_pred HhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHh
Confidence 88665 46889999999999999999999997654322111110000 0000000 0000000 0000000
Q ss_pred --ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 216 --PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 216 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+...+..+.+||.+||..||.+|||+++++++
T Consensus 274 l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 274 LKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 01124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=253.42 Aligned_cols=229 Identities=27% Similarity=0.324 Sum_probs=177.7
Q ss_pred EEEEEecccCC----ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEG----FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.||||.++... ......+.+|++++.++ +|+||+++++.+..+...++||||+.+++|.+++.... .+++..+
T Consensus 30 ~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~ 107 (288)
T cd05583 30 LYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEV 107 (288)
T ss_pred EEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHH
Confidence 58899886432 12335688999999999 59999999999999999999999999999999986543 4889999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC--
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-- 154 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-- 154 (305)
..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||+++........ ......++..|++||.+.+..
T Consensus 108 ~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 184 (288)
T cd05583 108 RVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGG 184 (288)
T ss_pred HHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCC
Confidence 9999999999999996 45999999999999999999999999998765432211 122345788999999987654
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
.+.++|+||||+++|+|++|..||......... ..+.+.... .....+..++..+.+++.+||+.|
T Consensus 185 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~ 250 (288)
T cd05583 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-------------SEISRRILK-SKPPFPKTMSAEARDFIQKLLEKD 250 (288)
T ss_pred CcchhhhHHHHHHHHHHHhCCCCcccCcccchH-------------HHHHHHHHc-cCCCCCcccCHHHHHHHHHHhcCC
Confidence 788999999999999999999999643211100 001111111 112344557788999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 021947 235 PKLRPRMSEVLAILE 249 (305)
Q Consensus 235 p~~Rps~~~~l~~l~ 249 (305)
|++|||+.++.+.|.
T Consensus 251 p~~R~t~~~~~~~l~ 265 (288)
T cd05583 251 PKKRLGANGADEIKN 265 (288)
T ss_pred HhhccCcchHHHHhc
Confidence 999999887766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=260.16 Aligned_cols=239 Identities=27% Similarity=0.313 Sum_probs=175.3
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||.++... ......+.+|+.+++.++|+||+++++++... ...|+|+||+. ++|.+++...+ .+++.
T Consensus 32 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~ 108 (337)
T cd07858 32 KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDD 108 (337)
T ss_pred eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHH
Confidence 68999887542 23345678899999999999999999987644 34799999996 58999886543 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-C
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
.+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+ .
T Consensus 109 ~~~~i~~qi~~aL~~LH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 184 (337)
T cd07858 109 HCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCS 184 (337)
T ss_pred HHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCC
Confidence 9999999999999999964 59999999999999999999999999998654322 11223457889999998865 4
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhhhh-hhc-----cchhhhhhhh---cccCC---CCChHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKP-YLS-----DKRKLFRIMD---TKLGG---QYPQKAA 220 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~-~~~-----~~~~~~~~~~---~~~~~---~~~~~~~ 220 (305)
.++.++|+||||+++|+|++|+.||.+.+........ ..... ... ........+. ..... .....++
T Consensus 185 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (337)
T cd07858 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHAN 264 (337)
T ss_pred CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCC
Confidence 6889999999999999999999999765422111000 00000 000 0000000110 00000 1123567
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..+.+||.+||+.+|.+|||+++++++
T Consensus 265 ~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 265 PLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=253.26 Aligned_cols=240 Identities=29% Similarity=0.320 Sum_probs=179.2
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.++..... ....+.+|++++++++|+||+++++++..+...++|+||+.+ +|.+++.... ..+++..+..+
T Consensus 26 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~ 103 (283)
T cd05118 26 IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSY 103 (283)
T ss_pred EEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHH
Confidence 5889988765333 346788999999999999999999999999999999999975 8888886543 45899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.+++.||.|||+. +++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.+
T Consensus 104 ~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~ 179 (283)
T cd05118 104 LYQLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTP 179 (283)
T ss_pred HHHHHHHHHHHHHC--CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCch
Confidence 99999999999964 599999999999999999999999999976644321 12224577889999998776 78899
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhh--hhhhhhhhccchhhhh---h----hhcccC---CCCChHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSL--VDWAKPYLSDKRKLFR---I----MDTKLG---GQYPQKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~----~~~~~~---~~~~~~~~~~~~~l 226 (305)
+|+||||+++|+|++|+.||...+....... .....+.......... . ...... ......++.++.++
T Consensus 180 ~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (283)
T cd05118 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDL 259 (283)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHH
Confidence 9999999999999999999976543111000 0000000000000000 0 000000 01123567889999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||+.||.+||++.+++.+
T Consensus 260 i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 260 LSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHhccCcccCcCHHHHhhC
Confidence 999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=261.85 Aligned_cols=221 Identities=24% Similarity=0.328 Sum_probs=188.0
Q ss_pred EEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 4 AVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 4 aiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
|+|++++. +....+.+..|-.+|.+.+.|.||++|-.|.++...|++||-|-||.|+..++.++. |+..+..-++
T Consensus 449 AlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~ 526 (732)
T KOG0614|consen 449 ALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYV 526 (732)
T ss_pred HHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhH
Confidence 44555433 334456788999999999999999999999999999999999999999999977764 8999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
..+++|++|||+++ ||+|||||+|++++.+|-+||.|||+++..+.... ..+++||+.|.|||++.+...+.++|
T Consensus 527 acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avD 601 (732)
T KOG0614|consen 527 ACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVD 601 (732)
T ss_pred HHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhH
Confidence 99999999999754 99999999999999999999999999998876554 45679999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhh-hhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
.||||+++|||++|.+||++.+.. ..++. +.......+|..++....+||+++...+|.+|.
T Consensus 602 yWaLGIli~ELL~G~pPFs~~dpm-----------------ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 602 YWALGILIYELLTGSPPFSGVDPM-----------------KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred HHHHHHHHHHHHcCCCCCCCCchH-----------------HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhh
Confidence 999999999999999999986532 22222 233334567888999999999999999999997
Q ss_pred C-----HHHHHHHH
Q 021947 240 R-----MSEVLAIL 248 (305)
Q Consensus 240 s-----~~~~l~~l 248 (305)
. +.+|.++-
T Consensus 665 G~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 665 GYQKGGINDIKKHR 678 (732)
T ss_pred ccccCChHHHHhhh
Confidence 4 66777653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=248.12 Aligned_cols=221 Identities=32% Similarity=0.403 Sum_probs=179.7
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|.+...... ....+.+|++++++++|+||+++++.+..+...+++|||+.+++|.+++.... .+++.....
T Consensus 20 ~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~ 97 (250)
T cd05123 20 LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARF 97 (250)
T ss_pred EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 5889988765332 33578899999999999999999999999999999999999999999996654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ ......++..|++||...+...+.+
T Consensus 98 ~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~ 173 (250)
T cd05123 98 YAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKA 173 (250)
T ss_pred HHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCch
Confidence 99999999999996 5599999999999999999999999999876543211 1233457889999999988888999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||||+++|++++|..||...... .....+.. .....+...+..+.+++.+||..||++|
T Consensus 174 ~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 174 VDWWSLGVLLYEMLTGKPPFYAEDRK-----------------EIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCCHH-----------------HHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999999999999999764320 11111111 2234555668899999999999999999
Q ss_pred CCH---HHHHH
Q 021947 239 PRM---SEVLA 246 (305)
Q Consensus 239 ps~---~~~l~ 246 (305)
|++ +++++
T Consensus 236 ~~~~~~~~l~~ 246 (250)
T cd05123 236 LGSGGAEEIKA 246 (250)
T ss_pred CCcccHHHHHh
Confidence 999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.53 Aligned_cols=240 Identities=28% Similarity=0.377 Sum_probs=173.7
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.||+|++.... ......+.+|+.++.++ +|+||+++++++... ...|+||||+.+ +|.+++... .+++...
T Consensus 34 ~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~ 109 (337)
T cd07852 34 VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN---ILEDVHK 109 (337)
T ss_pred EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC---CCCHHHH
Confidence 68999886432 23345677899999999 999999999988643 467999999975 999988654 4888899
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc---ceeecccccccccchhhhhc-
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~- 152 (305)
..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+
T Consensus 110 ~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 110 RYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred HHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence 9999999999999996 45999999999999999999999999999865433221 12233467899999998755
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhh-hhhcc--------chhhhhhhhcccC---CCCChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSD--------KRKLFRIMDTKLG---GQYPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~~~~~--------~~~~~~~~~~~~~---~~~~~~~ 219 (305)
..++.++|+||||+++|+|++|+.||.+........ ...... +.... ...+......... ......+
T Consensus 188 ~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (337)
T cd07852 188 TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA 267 (337)
T ss_pred ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCC
Confidence 457889999999999999999999997643221110 000000 00000 0000000000000 0111236
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.++.++|.+||+.||.+|||+.+++++
T Consensus 268 ~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 268 SDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 7889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=260.42 Aligned_cols=240 Identities=25% Similarity=0.314 Sum_probs=172.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.... .....+.+|+.++++++|+||+++++++... ...|+|+||+.+ +|.+++... .+++..
T Consensus 32 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~l~~~~ 107 (336)
T cd07849 32 KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ---HLSNDH 107 (336)
T ss_pred eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC---CCCHHH
Confidence 689999875322 2345688999999999999999999987644 357999999965 888887443 489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhc-C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+ .
T Consensus 108 ~~~i~~ql~~aL~~LH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (336)
T cd07849 108 IQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK 185 (336)
T ss_pred HHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCC
Confidence 999999999999999964 5999999999999999999999999998765332211 11223467899999998755 4
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhhhccchh--------hhhhhhcccCCC---CChHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRK--------LFRIMDTKLGGQ---YPQKAA 220 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~--------~~~~~~~~~~~~---~~~~~~ 220 (305)
.++.++|+||||+++|+|++|+.||.+.+...... ..... .+....... ............ .....+
T Consensus 186 ~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (336)
T cd07849 186 GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNAD 265 (336)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccC
Confidence 68889999999999999999999997654321100 00000 000000000 000000000000 012346
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.+|+.+||+.+|.+|||+.+++++
T Consensus 266 ~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 266 PKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=224.80 Aligned_cols=240 Identities=25% Similarity=0.295 Sum_probs=185.0
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.++.++.++ ....++|+-+|+.++|.||++++++...+..+-+|+|||+ .+|..+...-. ..++.+.+..+
T Consensus 29 ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsln-g~~d~~~~rsf 106 (292)
T KOG0662|consen 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLN-GDLDPEIVRSF 106 (292)
T ss_pred eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcC-CcCCHHHHHHH
Confidence 69999988664433 3678999999999999999999999999999999999995 59999886544 35999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.|++.||.|+|+++ +.||||||+|.|++.+|++|++|||+++.++-.. ......+-|.+|.+|.++.|. -|++.
T Consensus 107 mlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~ts 182 (292)
T KOG0662|consen 107 MLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTS 182 (292)
T ss_pred HHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccc
Confidence 999999999999866 9999999999999999999999999999876432 223445679999999998886 58899
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchh--hhhhhhhhhhccchhhhhhhhcccCCCCC---------hHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQ--SLVDWAKPYLSDKRKLFRIMDTKLGGQYP---------QKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l 226 (305)
.|+||.|||+.|+.. |++.|.+.+..... .+.....+.-+....+.+.-+...-..++ +.....-++|
T Consensus 183 idmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdl 262 (292)
T KOG0662|consen 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDL 262 (292)
T ss_pred hHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHH
Confidence 999999999999987 77778877654322 22211112111112222222222111222 2445567899
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.++|.-+|.+|.++++.+++
T Consensus 263 lqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 263 LQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHhccCcccccCHHHHhcC
Confidence 999999999999999998764
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=251.85 Aligned_cols=227 Identities=27% Similarity=0.324 Sum_probs=176.0
Q ss_pred EEEEEecccCCc----cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.||+|+++.... ...+.+.+|+++++++ +|+||+++++.+..+...|+||||+++++|.+++.... .+++..+
T Consensus 30 ~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~ 107 (290)
T cd05613 30 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEV 107 (290)
T ss_pred eEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHH
Confidence 589998875322 2335678899999999 59999999999999899999999999999999997654 4888899
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC--C
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--R 154 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~ 154 (305)
..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||++......... ......|+..|+|||.+.+. .
T Consensus 108 ~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 184 (290)
T cd05613 108 QIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGG 184 (290)
T ss_pred HHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCC
Confidence 9999999999999995 55999999999999999999999999999765432211 12234678899999998653 4
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++.++|+||||+++|+|++|..||........ ...+...... .....+..++..+.+++.+||..|
T Consensus 185 ~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------------~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~ 250 (290)
T cd05613 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------------QAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKD 250 (290)
T ss_pred CCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------------HHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCC
Confidence 67899999999999999999999964321100 0011111111 112345567788999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 021947 235 PKLRP-----RMSEVLAI 247 (305)
Q Consensus 235 p~~Rp-----s~~~~l~~ 247 (305)
|.+|| ++.+++++
T Consensus 251 p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 251 PKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHhcCCCCCCHHHHHcC
Confidence 99997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=257.32 Aligned_cols=241 Identities=24% Similarity=0.276 Sum_probs=174.1
Q ss_pred EEEEEecccCCccC--------------hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC
Q 021947 2 VVAVKKLKPEGFQG--------------HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
.||||+++...... ...+.+|++++++++|+||+++++++..++..++||||+. ++|.+++....
T Consensus 36 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~ 114 (335)
T PTZ00024 36 IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI 114 (335)
T ss_pred eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC
Confidence 68999886543222 1257899999999999999999999999999999999997 59999986543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC------------ccee
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------------THVS 135 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~ 135 (305)
.++......++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 115 --~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (335)
T PTZ00024 115 --RLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190 (335)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccc
Confidence 48899999999999999999996 4599999999999999999999999999976541110 0011
Q ss_pred ecccccccccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhh---ccchhhhhhh--
Q 021947 136 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYL---SDKRKLFRIM-- 207 (305)
Q Consensus 136 ~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~---~~~~~~~~~~-- 207 (305)
....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..... .+..... +.. ..........
T Consensus 191 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
T PTZ00024 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF 270 (335)
T ss_pred cccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc
Confidence 123467889999998764 4688999999999999999999999865432110 0000000 000 0000000000
Q ss_pred hc---ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 208 DT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 208 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.. ..........+..+.++|.+||+.+|++|||+++++.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 271 TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 00 00000112346788999999999999999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=253.58 Aligned_cols=223 Identities=27% Similarity=0.391 Sum_probs=180.7
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|++..... .....+.+|+++++++. |+||+++++++..++..++|||++.+++|.+++.+.+ .+++..++
T Consensus 28 ~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~ 105 (280)
T cd05581 28 EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTR 105 (280)
T ss_pred EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 689998875322 22356889999999998 9999999999999999999999999999999997654 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc------------------ceeeccc
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------HVSTQVM 139 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------------------~~~~~~~ 139 (305)
.++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||++......... .......
T Consensus 106 ~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (280)
T cd05581 106 FYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183 (280)
T ss_pred HHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccccccccc
Confidence 999999999999996 45999999999999999999999999998765432211 1122345
Q ss_pred ccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHH
Q 021947 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 219 (305)
Q Consensus 140 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (305)
++..|+|||+..+..++.++|+||||+++|++++|..||....... ...... ......+..+
T Consensus 184 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~--~~~~~~~~~~ 245 (280)
T cd05581 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----------------TFQKIL--KLEYSFPPNF 245 (280)
T ss_pred CCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH--hcCCCCCCcc
Confidence 7889999999988889999999999999999999999998654210 011111 1223445566
Q ss_pred HHHHHHHHHhhccCCCCCCCCH----HHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRM----SEVLA 246 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~----~~~l~ 246 (305)
+..+.+|+.+||+.+|.+|||+ +++++
T Consensus 246 ~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 246 PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 8889999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=286.76 Aligned_cols=236 Identities=33% Similarity=0.510 Sum_probs=178.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++...... ...|++.+++++||||+++++++.+....|+||||+++|+|.+++. .+++..+..++
T Consensus 716 ~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~ 786 (968)
T PLN00113 716 MQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIA 786 (968)
T ss_pred cEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHH
Confidence 36899988654321 2356889999999999999999999999999999999999999994 27889999999
Q ss_pred HHHHHHHhhhhcC-CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.+++.||+|||.. ..+++||||||+||+++.++..++. ||....... .....++..|+|||++.+..++.++
T Consensus 787 ~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~s 859 (968)
T PLN00113 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKS 859 (968)
T ss_pred HHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCccc
Confidence 9999999999954 4579999999999999988887765 555433211 1123578999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
|||||||++|||++|+.||+..... ......|........ .....++... ....+.....++.+++.+||+.||++
T Consensus 860 Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~ 937 (968)
T PLN00113 860 DIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937 (968)
T ss_pred chhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchh
Confidence 9999999999999999999543221 222333322211111 1111111111 11233456667889999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 021947 238 RPRMSEVLAILERLEAP 254 (305)
Q Consensus 238 Rps~~~~l~~l~~~~~~ 254 (305)
|||+.++++.|+++...
T Consensus 938 RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 938 RPCANDVLKTLESASRS 954 (968)
T ss_pred CcCHHHHHHHHHHhhcc
Confidence 99999999999987553
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.64 Aligned_cols=239 Identities=25% Similarity=0.305 Sum_probs=174.9
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhcc---CCCCcccEEEEEEeCCe-----eEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQL---HHPNLVKLIGYCLEGEN-----RLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||+|+++...... ...+.+|+.+++++ +|+||+++++++..... .+++|||+.+ +|.+++.......+
T Consensus 26 ~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l 104 (287)
T cd07838 26 FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGL 104 (287)
T ss_pred EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCC
Confidence 68999987543222 34566788877666 59999999999987776 8999999975 89998876554468
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .....++..|+|||++.
T Consensus 105 ~~~~~~~~~~~i~~al~~LH~~--~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~ 179 (287)
T cd07838 105 PPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLL 179 (287)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhc
Confidence 9999999999999999999964 599999999999999999999999999876543321 12234688899999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhh-hh----hccchhhhhhhhcccC---CCCChHHHHH
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PY----LSDKRKLFRIMDTKLG---GQYPQKAAHT 222 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~ 222 (305)
+..++.++|+||||+++|+|++|..||.+........ +..... +. ................ .......+..
T Consensus 180 ~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (287)
T cd07838 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEE 259 (287)
T ss_pred cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHH
Confidence 9899999999999999999999999998654321100 000000 00 0000000000000000 1111245678
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
+.++|.+||+.||.+||++.+++.
T Consensus 260 ~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 260 GLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHHhccCCccCCCHHHHhc
Confidence 899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=250.94 Aligned_cols=237 Identities=20% Similarity=0.221 Sum_probs=178.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-C-----CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-H-----PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||||+++.-. .-++..+-|+++|.++. + --++.+.++|...++.+||+|.+ |-++.+++..++-.+++..
T Consensus 115 ~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~ 192 (415)
T KOG0671|consen 115 EHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPID 192 (415)
T ss_pred ceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchH
Confidence 368999988652 34456778999999994 2 23688888999999999999999 6699999999888899999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC--------------------CCceeeccccccccCCCCCCcce
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--------------------EFNAKLSDFGLAKAGPTGDRTHV 134 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~ 134 (305)
.+..++.|++++++|||+. +++|.||||+|||+.. +..++|+|||.|+.....
T Consensus 193 ~ir~m~~QL~~sv~fLh~~--kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----- 265 (415)
T KOG0671|consen 193 HIRHMGYQLLESVAFLHDL--KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----- 265 (415)
T ss_pred HHHHHHHHHHHHHHHHHhc--ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----
Confidence 9999999999999999964 5999999999999932 234899999999875433
Q ss_pred eecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccch-----hhhhhhhhhhhccchhhhhhhhc
Q 021947 135 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-----QSLVDWAKPYLSDKRKLFRIMDT 209 (305)
Q Consensus 135 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 209 (305)
....+.|..|.|||++.+-+++.++||||+||||+|+++|...|++.+.... ..+.... ...-....-.++...
T Consensus 266 hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P-~~mi~r~~~~Kyf~~ 344 (415)
T KOG0671|consen 266 HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIP-SRMIKKTRKEKYFRR 344 (415)
T ss_pred cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCc-HHHhhhhhhHhhhhc
Confidence 2456789999999999999999999999999999999999999988763211 1110000 000000000000000
Q ss_pred c----------------cC--------CCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 210 K----------------LG--------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 210 ~----------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+ .. ....+....++.+|+++||..||.+|+|+.|++.+
T Consensus 345 ~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 345 GRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred ccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 0 00 01112455579999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.55 Aligned_cols=226 Identities=28% Similarity=0.440 Sum_probs=172.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||.++.... .....+.+|+.++.+.. |+||+++++++.+....|++|||+. +++.+++.... ..+++..+..+
T Consensus 42 ~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i 119 (296)
T cd06618 42 VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKM 119 (296)
T ss_pred EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHH
Confidence 689999875433 23356777888777765 9999999999999999999999995 47877775533 35899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC----C
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----L 155 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~ 155 (305)
+.+++.||.|||+. .+++||||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. +
T Consensus 120 ~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (296)
T cd06618 120 TVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKY 195 (296)
T ss_pred HHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCcccc
Confidence 99999999999963 4699999999999999999999999999876433221 12234678899999987553 7
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhccCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
+.++|+||||+++|+|++|..||....... ..+....... ........++.++.+|+.+||..|
T Consensus 196 ~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 260 (296)
T cd06618 196 DIRADVWSLGISLVELATGQFPYKNCKTEF---------------EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKD 260 (296)
T ss_pred ccchhHHHHHHHHHHHHhCCCCCCcchhHH---------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 889999999999999999999997532110 0011111111 011111246778999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021947 235 PKLRPRMSEVLAIL 248 (305)
Q Consensus 235 p~~Rps~~~~l~~l 248 (305)
|.+||++.+++.+.
T Consensus 261 p~~Rp~~~~il~~~ 274 (296)
T cd06618 261 HRKRPKYRELLQHP 274 (296)
T ss_pred hhhCCCHHHHhcCh
Confidence 99999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.24 Aligned_cols=241 Identities=25% Similarity=0.270 Sum_probs=172.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCC----------eeEEEEecCCCCCHHHHhhhcCCC
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE----------NRLLVYEFMPKGSLENHLFRRGPQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~ 69 (305)
.||+|+++.... .....+.+|++++++++||||+++++++.+.. ..++|+||+++ ++.+++... ..
T Consensus 34 ~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~ 111 (302)
T cd07864 34 LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LV 111 (302)
T ss_pred EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CC
Confidence 589999875432 23356788999999999999999999987654 78999999976 787777554 23
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.+++..+..++.|++.||+|||+ +|++|+||||+||++++++.+||+|||++......... ......++..|+|||.
T Consensus 112 ~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~ 188 (302)
T cd07864 112 HFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPEL 188 (302)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHH
Confidence 58999999999999999999995 46999999999999999999999999999865433211 1122345778999998
Q ss_pred hhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhh-hhhhccchhhhhh-----hhcc-----cCCCCC
Q 021947 150 VATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA-KPYLSDKRKLFRI-----MDTK-----LGGQYP 216 (305)
Q Consensus 150 ~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~-----~~~~-----~~~~~~ 216 (305)
+.+. .++.++|||||||++|+|++|+.||............ ... .+.......+... .... ......
T Consensus 189 ~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd07864 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF 268 (302)
T ss_pred hcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc
Confidence 8654 5788999999999999999999999764422111000 000 0000000000000 0000 000011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..++..+.+++.+||..||.+|||+++++++
T Consensus 269 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 269 SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2357789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=258.15 Aligned_cols=245 Identities=27% Similarity=0.330 Sum_probs=181.9
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCC-----eeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||++.... ....+.+.+|+++++.++|+||+++++++.... ..|++|||+.+ +|.+++.+.. .+++.
T Consensus 27 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~l~~~ 103 (330)
T cd07834 27 KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDD 103 (330)
T ss_pred EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCC--CCCHH
Confidence 68999887654 334467899999999999999999999988765 78999999974 8999886544 58999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.+++.||+|||+. |++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+.
T Consensus 104 ~~~~i~~~l~~~l~~LH~~--gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 104 HIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred HHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecc
Confidence 9999999999999999964 5999999999999999999999999999875443210 112234578899999999887
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhh-----ccchhhhhhhhccc---C---CCCChHH
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYL-----SDKRKLFRIMDTKL---G---GQYPQKA 219 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~-----~~~~~~~~~~~~~~---~---~~~~~~~ 219 (305)
.++.++|+||||+++|+|++|..||.+.+..... ....... +.. .........+.... . ......+
T Consensus 182 ~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (330)
T cd07834 182 SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA 261 (330)
T ss_pred cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccC
Confidence 7899999999999999999999999876532111 0000000 000 00001111111000 0 0011236
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhh
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI--LERL 251 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~--l~~~ 251 (305)
+..+.++|.+||+.+|.+|||+++++.+ ++.+
T Consensus 262 ~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 262 SPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 7789999999999999999999999974 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=248.80 Aligned_cols=241 Identities=24% Similarity=0.294 Sum_probs=176.8
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||+|++.... ......+.+|++++++++|+|++++++++... +..++||||+++ +|.+++.+.. ..+++..++
T Consensus 26 ~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~ 103 (287)
T cd07840 26 LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIK 103 (287)
T ss_pred EEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC-CCCCHHHHH
Confidence 58999988663 23345788999999999999999999999987 789999999975 8999886543 358999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~ 156 (305)
.++.+++.||+|||+ .|++|+||+|+||++++++.++|+|||++......... ......++..|+|||.+.+ ..++
T Consensus 104 ~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~ 180 (287)
T cd07840 104 CYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYG 180 (287)
T ss_pred HHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCC
Confidence 999999999999996 45999999999999999999999999999866443211 1223356788999997765 4578
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhhhccchhhhh---hhhcccCC--------CCChHHHHHH
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLFR---IMDTKLGG--------QYPQKAAHTA 223 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~---~~~~~~~~--------~~~~~~~~~~ 223 (305)
.++||||||+++|+|++|..||...+...... ..... .+.......... ........ .....++..+
T Consensus 181 ~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (287)
T cd07840 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSA 260 (287)
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHH
Confidence 89999999999999999999998755321110 00000 000000000000 00000000 0111137789
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+++.+||..+|.+||+++++++.
T Consensus 261 ~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 261 LDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhC
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=253.12 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=171.5
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhcc-CCCCcccEEEEEEeC----CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||+|++...... ..+.+.+|+++++++ +|+||+++++.+... ...|+++|++. ++|.+++.... .+++.
T Consensus 29 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~ 105 (332)
T cd07857 29 TVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ--PLTDA 105 (332)
T ss_pred eEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC--CCCHH
Confidence 5899988754322 246788999999999 599999999875432 45789999996 58999886443 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhc
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~ 152 (305)
.+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++......... .......|+..|+|||++.+
T Consensus 106 ~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 106 HFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred HHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC
Confidence 999999999999999995 45999999999999999999999999999765432211 11223468899999998765
Q ss_pred -CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhc------cc--hhhhhhhhcccCCC---CChH
Q 021947 153 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLS------DK--RKLFRIMDTKLGGQ---YPQK 218 (305)
Q Consensus 153 -~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-~~~~~~------~~--~~~~~~~~~~~~~~---~~~~ 218 (305)
..++.++|+||||+++|+|++|..||...+..... ..... ..+... .. .............. ....
T Consensus 184 ~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (332)
T cd07857 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPN 263 (332)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCC
Confidence 46889999999999999999999999765421100 00000 000000 00 00000000000000 1122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++..+.+|+.+||+.||.+|||+.+++..
T Consensus 264 ~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 264 ANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 46789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=264.05 Aligned_cols=225 Identities=27% Similarity=0.390 Sum_probs=185.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEE-----eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.+|+|+...+. +..+++..|.++|+.. .|||++.++++|. .++++|||||||.||+..|+++...+..+.+..
T Consensus 46 ~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~ 124 (953)
T KOG0587|consen 46 LAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEW 124 (953)
T ss_pred eeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHH
Confidence 57888887664 3345677889999988 5999999999987 457899999999999999999887777899999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc---
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--- 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--- 152 (305)
+..|++.++.||.+|| ++.++|||+|=.|||++.++.|||+|||.+....... ....+.+||+.|||||++..
T Consensus 125 IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~ 200 (953)
T KOG0587|consen 125 IAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDES 200 (953)
T ss_pred HHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccC
Confidence 9999999999999999 4569999999999999999999999999987654322 12445689999999999864
Q ss_pred --CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHh
Q 021947 153 --GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 153 --~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 229 (305)
..|+..+|+||||++..||..|.+|+-+... ...++.+.... .....+...+.++.++|..
T Consensus 201 ~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----------------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~ 264 (953)
T KOG0587|consen 201 PDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----------------MRALFLIPRNPPPKLKRPKKWSKKFNDFIST 264 (953)
T ss_pred CCCCcccccchhhccceeehhcCCCCCccCcch----------------hhhhccCCCCCCccccchhhHHHHHHHHHHH
Confidence 3577899999999999999999999977532 23333333322 2233467889999999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||.+|..+||+..+++++
T Consensus 265 cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 265 CLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHhhccccCcchhhhccC
Confidence 999999999999999854
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.85 Aligned_cols=240 Identities=26% Similarity=0.341 Sum_probs=177.8
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++||||+.+ +|.+++.+.. ..+++..+..+
T Consensus 26 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~-~~~~~~~~~~~ 103 (282)
T cd07829 26 IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRP-GPLSPNLIKSI 103 (282)
T ss_pred EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhc-cCCCHHHHHHH
Confidence 68999887653 23346788999999999999999999999999999999999975 9999997653 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
+.+++.||.|||+. +++|+||+|+||++++++.++|+|||++......... .....++..|+|||.+.+. .++.+
T Consensus 104 ~~~i~~~l~~LH~~--~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~ 179 (282)
T cd07829 104 MYQLLRGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTA 179 (282)
T ss_pred HHHHHHHHHHHHHC--CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCcc
Confidence 99999999999964 5999999999999999999999999999765433211 2223457789999998776 78899
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh-hhhhhh-hhh------hccc---hhhhhhhhcccCCCCChHHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPY------LSDK---RKLFRIMDTKLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (305)
+|+||||+++|++++|..||...+..... ...... .+. .... ................+..+..+.+++
T Consensus 180 ~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 259 (282)
T cd07829 180 VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLL 259 (282)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHH
Confidence 99999999999999999999775432110 000000 000 0000 000000000000001123467899999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||..||.+||++++++.+
T Consensus 260 ~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 260 SKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHhhccCcccCCCHHHHhhC
Confidence 99999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=255.04 Aligned_cols=240 Identities=24% Similarity=0.297 Sum_probs=171.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC--------------CeeEEEEecCCCCCHHHHhhhcC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--------------ENRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
.||+|++........+.+.+|++++++++||||+++++++... ...|+||||+.+ +|.+++...
T Consensus 32 ~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~- 109 (342)
T cd07854 32 RVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG- 109 (342)
T ss_pred EEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHcC-
Confidence 6899998776556667889999999999999999999876543 357899999974 898888543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCc-ceeeccccccccc
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYA 145 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~ 145 (305)
.+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++......... .......++..|+
T Consensus 110 --~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 185 (342)
T cd07854 110 --PLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185 (342)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccccccccc
Confidence 38899999999999999999996 45999999999999975 456899999998764322111 1112235788999
Q ss_pred chhhhhc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh--hccchhhh----hhhh-cccCCC---
Q 021947 146 APEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLF----RIMD-TKLGGQ--- 214 (305)
Q Consensus 146 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~----~~~~-~~~~~~--- 214 (305)
|||.+.+ ..++.++|||||||++|+|++|+.||.+.+............+. ........ .... ......
T Consensus 186 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (342)
T cd07854 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL 265 (342)
T ss_pred CHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCH
Confidence 9998754 46788999999999999999999999765432111100000000 00000000 0000 000000
Q ss_pred --CChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 215 --YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 215 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....+.++.+|+.+||..||.+|||+.+++.+
T Consensus 266 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 266 RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=246.49 Aligned_cols=240 Identities=27% Similarity=0.351 Sum_probs=175.8
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||.+...... ......+|+..+++++ |+||+++++++..++..++||||+ +++|.+++.......+++..+..+
T Consensus 26 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~ 104 (283)
T cd07830 26 LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSI 104 (283)
T ss_pred EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHH
Confidence 6899988765332 2334567999999999 999999999999999999999999 779999887665456899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 158 (305)
+.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........ .....++..|+|||++.+ ..++.+
T Consensus 105 ~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~ 179 (283)
T cd07830 105 IYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSP 179 (283)
T ss_pred HHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCc
Confidence 9999999999996 4599999999999999999999999999976543221 123457889999998754 457889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhc----cchhhhhhhhcccC-------CCCChHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLS----DKRKLFRIMDTKLG-------GQYPQKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l 226 (305)
+|+||||+++|+|++|..||......... ........... ....+......... .......+..+.++
T Consensus 180 ~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (283)
T cd07830 180 VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDL 259 (283)
T ss_pred cchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHH
Confidence 99999999999999999999765432110 00000000000 00000000000000 00011225779999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||..+|.+|||+++++.+
T Consensus 260 i~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 260 IKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcccCcccCCCHHHHhhC
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=244.11 Aligned_cols=209 Identities=24% Similarity=0.342 Sum_probs=168.8
Q ss_pred HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhh--cCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 17 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
.++.+|+.++++++||||+++++.+.+....++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-- 124 (260)
T cd08222 47 VQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124 (260)
T ss_pred HHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--
Confidence 4577899999999999999999999988899999999999999998854 223458999999999999999999996
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhC
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 174 (305)
.|++|+||+|+||+++. +.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 125 ~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 125 RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201 (260)
T ss_pred cCccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 45999999999999975 5699999999876533221 12334578899999999888889999999999999999999
Q ss_pred CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 175 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 175 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..||...... ..............+..++.++.++|.+||..+|++||++.+++++
T Consensus 202 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 202 AHAFEGQNFL-----------------SVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCccHH-----------------HHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9999653210 0001111122223456778899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=238.68 Aligned_cols=222 Identities=32% Similarity=0.447 Sum_probs=182.0
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+.+++|.+++..... ++...+..++
T Consensus 16 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 93 (244)
T smart00220 16 LVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYA 93 (244)
T ss_pred EEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHH
Confidence 68999998765555 67899999999999999999999999998999999999999999999965543 8899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|
T Consensus 94 ~~l~~~l~~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~D 168 (244)
T smart00220 94 RQILSALEYLHSN--GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVD 168 (244)
T ss_pred HHHHHHHHHHHHc--CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhh
Confidence 9999999999964 59999999999999999999999999998754432 123345788999999998888899999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH--HHHHHHHHHHhhccCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--AAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R 238 (305)
+|+||+++|++++|..||..... .....+.+........... ++..+.+++.+||..+|++|
T Consensus 169 i~slG~~l~~l~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 169 VWSLGVILYELLTGKPPFPGDDQ----------------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCc----------------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 99999999999999999976311 1111121211111111111 67889999999999999999
Q ss_pred CCHHHHHH
Q 021947 239 PRMSEVLA 246 (305)
Q Consensus 239 ps~~~~l~ 246 (305)
|++.++++
T Consensus 233 p~~~~~~~ 240 (244)
T smart00220 233 LTAEEALQ 240 (244)
T ss_pred cCHHHHhh
Confidence 99999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=252.47 Aligned_cols=235 Identities=25% Similarity=0.283 Sum_probs=170.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||+|+++.... .....+.+|++++++++|+||+++++++... ...|++++++ |++|.+++... .+++
T Consensus 44 ~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~ 119 (345)
T cd07877 44 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTD 119 (345)
T ss_pred EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCH
Confidence 689999875422 2245688999999999999999999988643 3467888887 77998888543 3899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+
T Consensus 120 ~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 192 (345)
T cd07877 120 DHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 192 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCc
Confidence 99999999999999999964 5999999999999999999999999998764322 223467889999998866
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh---h----hhcc--chhhhhhhhcccCCC---CChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK---P----YLSD--KRKLFRIMDTKLGGQ---YPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~---~----~~~~--~~~~~~~~~~~~~~~---~~~~~ 219 (305)
..++.++|+|||||++|+|++|..||...+..... ....... + .... .......+....... .....
T Consensus 193 ~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (345)
T cd07877 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 272 (345)
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCC
Confidence 46788999999999999999999999764421110 0000000 0 0000 000000000000000 01134
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+||.+||+.||.+||++.+++.+
T Consensus 273 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 273 NPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 6678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=252.52 Aligned_cols=234 Identities=23% Similarity=0.267 Sum_probs=171.2
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++...... ....+.+|++++++++|+||+++++++.... ..++||||+ |++|.+++... .+++
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~ 117 (343)
T cd07880 42 KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSE 117 (343)
T ss_pred EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCH
Confidence 6899988654222 2356889999999999999999999987543 358999999 67998888542 4899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++...... .....++..|++||.+.+
T Consensus 118 ~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 190 (343)
T cd07880 118 DRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNW 190 (343)
T ss_pred HHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCC
Confidence 9999999999999999996 45999999999999999999999999999764332 123356889999998876
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhh---------ccchhhhhhhhcccC---CCCChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYL---------SDKRKLFRIMDTKLG---GQYPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~ 219 (305)
..++.++|+||||+++|++++|..||.+.+..... .......... .........+..... ......+
T Consensus 191 ~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (343)
T cd07880 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNA 270 (343)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCC
Confidence 45788999999999999999999999865431110 0000000000 000000000000000 0011245
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
+..+.++|.+||+.||.+|||+.+++.
T Consensus 271 ~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 271 NPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred ChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 667999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=254.26 Aligned_cols=225 Identities=23% Similarity=0.260 Sum_probs=185.1
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+-||||++.+..+. ...++++|+.+|.++.||.||.+..-|+..+..|.|||.+.| ++.++|-......+++.....
T Consensus 590 rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkF 668 (888)
T KOG4236|consen 590 RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKF 668 (888)
T ss_pred ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHH
Confidence 46999999877553 346799999999999999999999999999999999999965 777777555556699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.||+.||.|||.+ +|+|+||||+|||+... -.+||||||+++.++... .....+||+.|+|||++++..|
T Consensus 669 lvtQIL~ALr~LH~k--nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGy 743 (888)
T KOG4236|consen 669 LVTQILVALRYLHFK--NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGY 743 (888)
T ss_pred HHHHHHHHHHHhhhc--ceeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccc
Confidence 999999999999964 59999999999999654 359999999999886543 2456789999999999999999
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
...-|+||.|+|+|--+.|..||.......++. +.....+...-...++..+.+||..+|+..-
T Consensus 744 NrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI----------------QNAaFMyPp~PW~eis~~AidlIn~LLqVkm 807 (888)
T KOG4236|consen 744 NRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI----------------QNAAFMYPPNPWSEISPEAIDLINNLLQVKM 807 (888)
T ss_pred cccccceeeeEEEEEEecccccCCCccchhHHh----------------hccccccCCCchhhcCHHHHHHHHHHHHHHH
Confidence 999999999999999999999998754322221 1111112223345788899999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+|.|....+++
T Consensus 808 ~kRysvdk~lsh 819 (888)
T KOG4236|consen 808 RKRYSVDKSLSH 819 (888)
T ss_pred HHhcchHhhccc
Confidence 999999887754
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=249.58 Aligned_cols=242 Identities=26% Similarity=0.321 Sum_probs=170.4
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCC--------eeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--------NRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||||++......+ ...+.+|++++++++|+||+++++++.+.. ..++||||+.+ +|...+.... ..+
T Consensus 35 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~-~~~ 112 (311)
T cd07866 35 VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-VKL 112 (311)
T ss_pred EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccc-cCC
Confidence 58899886543322 346789999999999999999999875433 46999999965 7877775433 359
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc---------eeecccccc
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---------VSTQVMGTH 142 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~t~ 142 (305)
++..+..++.|+++||.|||+. |++|+||||+||+++.++.++|+|||++.......... ......++.
T Consensus 113 ~~~~~~~i~~~l~~al~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (311)
T cd07866 113 TESQIKCYMLQLLEGINYLHEN--HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190 (311)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceecc
Confidence 9999999999999999999964 59999999999999999999999999997643322111 112235678
Q ss_pred cccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhh-hhhh-hhhhc---cchhhhhhhhcccCCCCC
Q 021947 143 GYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWA-KPYLS---DKRKLFRIMDTKLGGQYP 216 (305)
Q Consensus 143 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~-~~~~~---~~~~~~~~~~~~~~~~~~ 216 (305)
.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+....... .... .+... ....+............+
T Consensus 191 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (311)
T cd07866 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP 270 (311)
T ss_pred CcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCC
Confidence 89999987654 578899999999999999999999976554221110 0000 00000 000000000000000001
Q ss_pred -------hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 217 -------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 217 -------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
......+.+++.+||..||.+|||+.+++.+
T Consensus 271 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 271 RTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred ccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1233678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.56 Aligned_cols=233 Identities=24% Similarity=0.373 Sum_probs=201.2
Q ss_pred CEEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
++||||++.... .+...++++|+-+|.++.|||++++++++..+. +.||++|+++|+|.+|++... ..+.....+.|
T Consensus 726 ipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw 803 (1177)
T KOG1025|consen 726 IPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNW 803 (1177)
T ss_pred ceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHH
Confidence 589999987653 345578999999999999999999999997654 889999999999999997654 45888999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
..||++|+.|||. ..++||||-..|+|+..-..+|+.|||+++...............-.+.|||-|.+....++.++
T Consensus 804 ~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqS 881 (1177)
T KOG1025|consen 804 CYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQS 881 (1177)
T ss_pred HHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchh
Confidence 9999999999995 45999999999999999999999999999987665554434444457789999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++||++| |..||++.. .+.+.+.+..+.+...|+.++-+++.++.+||..|+..|
T Consensus 882 DVWsfGVtiWElmTFGa~Py~gi~-----------------~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 882 DVWSFGVTIWELMTFGAKPYDGIP-----------------AEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred hhhhhhhhHHHHHhcCCCccCCCC-----------------HHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccC
Confidence 99999999999998 999998753 344566677777788899999999999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 021947 239 PRMSEVLAILERLEAP 254 (305)
Q Consensus 239 ps~~~~l~~l~~~~~~ 254 (305)
|+++++...+.++...
T Consensus 945 p~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 945 PTFKELAEEFSRMARD 960 (1177)
T ss_pred ccHHHHHHHHHHHhcC
Confidence 9999999988876543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.55 Aligned_cols=176 Identities=30% Similarity=0.415 Sum_probs=149.2
Q ss_pred CEEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcC-CCCCC
Q 021947 1 MVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRG-PQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 72 (305)
+.||||.++... ....+.+.+|+++|++|+|+|||+++++=+... ...+|||||.||+|...+.+-. ..+++
T Consensus 39 ~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLp 118 (732)
T KOG4250|consen 39 RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLP 118 (732)
T ss_pred cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCC
Confidence 469999998764 345678899999999999999999999755433 4579999999999999996532 23599
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC--C--ceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--F--NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~--~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
+..++.++.+++.||.|||+ +||+||||||.||++-.+ | ..||+|||.|+...... .....+||..|.+||
T Consensus 119 E~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPe 193 (732)
T KOG4250|consen 119 ESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPE 193 (732)
T ss_pred HHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChH
Confidence 99999999999999999994 569999999999999433 3 37999999999876543 355678999999999
Q ss_pred hhhc-CCCCCCCceehhhHHHHHHHhCCCccCCC
Q 021947 149 YVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKT 181 (305)
Q Consensus 149 ~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 181 (305)
++.. +.|+..+|.|||||++|+.+||..||-..
T Consensus 194 l~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 194 LYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred HHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9984 88999999999999999999999999653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=272.76 Aligned_cols=225 Identities=23% Similarity=0.250 Sum_probs=184.2
Q ss_pred EEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
++|+|++++- ...+..-|+.|-++|..-+.+-|+.++-.|.+..++|+||||+.||+|..++.+.. .+++..+..
T Consensus 102 VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArF 179 (1317)
T KOG0612|consen 102 VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARF 179 (1317)
T ss_pred chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHH
Confidence 5677777652 22344568889999998899999999999999999999999999999999997665 599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-----C
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----G 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~ 153 (305)
++..|+.||..||+. |+|||||||+|||++..|++||+|||.|-.+..++.. .....+|||.|.+||++.. +
T Consensus 180 Y~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g 256 (1317)
T KOG0612|consen 180 YTAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKG 256 (1317)
T ss_pred HHHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCcc
Confidence 999999999999965 5999999999999999999999999999887655443 3556789999999999853 5
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC--hHHHHHHHHHHHhhc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCL 231 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l 231 (305)
.|+..+|.||+|+++|||+.|..||.... -.....++++-.....+| ..++.++.+||.+.+
T Consensus 257 ~yG~ecDwWSlGV~~YEMlyG~TPFYads----------------lveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll 320 (1317)
T KOG0612|consen 257 EYGRECDWWSLGVFMYEMLYGETPFYADS----------------LVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL 320 (1317)
T ss_pred ccCCccchhhhHHHHHHHHcCCCcchHHH----------------HHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh
Confidence 68999999999999999999999997532 123333444443334444 569999999999887
Q ss_pred cCCCCCCCC---HHHHHHHH
Q 021947 232 NNEPKLRPR---MSEVLAIL 248 (305)
Q Consensus 232 ~~~p~~Rps---~~~~l~~l 248 (305)
. +|+.|.. ++++..+.
T Consensus 321 ~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 321 C-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred c-ChhhhcccccHHHHHhCc
Confidence 5 6788886 88888653
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=253.34 Aligned_cols=234 Identities=23% Similarity=0.299 Sum_probs=168.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||+++.... .....+.+|+++++.++|+||+++++++... ..+|+|+||+.+ +|..++. ..+++
T Consensus 42 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~ 116 (342)
T cd07879 42 KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSE 116 (342)
T ss_pred EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc----CCCCH
Confidence 689998875422 2235688999999999999999999998754 346899999964 7776652 24889
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+
T Consensus 117 ~~~~~~~~qi~~aL~~LH~~--~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 189 (342)
T cd07879 117 DKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNW 189 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCc
Confidence 99999999999999999964 5999999999999999999999999998764322 123356889999999876
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhh---hhhcc---chhhhhhhhc---ccCC---CCChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK---PYLSD---KRKLFRIMDT---KLGG---QYPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~---~~~~~---~~~~~~~~~~---~~~~---~~~~~~ 219 (305)
..++.++|+||||+++|+|++|+.||.+.+...... ...... +.... .......... .... ......
T Consensus 190 ~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (342)
T cd07879 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKA 269 (342)
T ss_pred cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCC
Confidence 468889999999999999999999998754321110 000000 00000 0000000000 0000 001235
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+||.+||+.||.+||++.+++.+
T Consensus 270 ~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 270 SPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=250.11 Aligned_cols=233 Identities=27% Similarity=0.346 Sum_probs=171.5
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++..... ...+.+.+|++++++++||||+++++++.. +...++++||+ +++|.+++... .++...+..
T Consensus 37 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~ 112 (328)
T cd07856 37 NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQY 112 (328)
T ss_pred EEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHH
Confidence 589998765322 234678899999999999999999999875 56789999999 56898888533 378888889
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 157 (305)
++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.
T Consensus 113 ~~~ql~~aL~~LH~~--~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~ 185 (328)
T cd07856 113 FLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDV 185 (328)
T ss_pred HHHHHHHHHHHHHhC--CcccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCc
Confidence 999999999999964 5999999999999999999999999998754321 122356888999998765 56889
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhh--------hhc-cchhhhhhhhcccCCCCC-----hHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKP--------YLS-DKRKLFRIMDTKLGGQYP-----QKAAHT 222 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (305)
++|+||||+++|+|++|..||.......... ..+.... ... ....+...+. .....+ ..++..
T Consensus 186 ~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 263 (328)
T cd07856 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPS 263 (328)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHH
Confidence 9999999999999999999997654311100 0000000 000 0000000000 011111 235678
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.++|.+||..+|.+|||+.+++.+
T Consensus 264 ~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 264 AIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=254.36 Aligned_cols=235 Identities=25% Similarity=0.300 Sum_probs=172.4
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCe------eEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||+|++..... .....+.+|+.++++++|+||+++++++...+. .++|+||+ +++|.+++.. ..+++
T Consensus 42 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~ 117 (343)
T cd07851 42 KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSD 117 (343)
T ss_pred EEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCH
Confidence 689998875422 233567889999999999999999988765544 89999999 6699998864 24899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.+++.||.|||+ .|++|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+.
T Consensus 118 ~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 190 (343)
T cd07851 118 DHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 190 (343)
T ss_pred HHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCC
Confidence 9999999999999999996 45999999999999999999999999999865332 2233578899999988653
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-h--hhc---cchhhhhhhh---cccCCCC---ChHH
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-P--YLS---DKRKLFRIMD---TKLGGQY---PQKA 219 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-~--~~~---~~~~~~~~~~---~~~~~~~---~~~~ 219 (305)
.++.++|+||||+++|+|++|+.||.+....... .+..... + ... ........+. ......+ ....
T Consensus 191 ~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (343)
T cd07851 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA 270 (343)
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccC
Confidence 6788999999999999999999999765432110 0000000 0 000 0000000000 0000011 1134
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+||.+||+.+|.+|||+.+++++
T Consensus 271 s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 271 NPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 7789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=239.25 Aligned_cols=227 Identities=24% Similarity=0.343 Sum_probs=175.6
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhh---hcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF---RRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~ 75 (305)
++.|||.++.... .+.++++.|.+...+- +.||||++||....++..|+.||+|+ .+|..+-+ ......+++..
T Consensus 90 ~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~I 168 (361)
T KOG1006|consen 90 KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENI 168 (361)
T ss_pred cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhh
Confidence 4689999987655 4557899999976665 69999999999999999999999995 47755432 22233488888
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc--C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--G 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~ 153 (305)
.-.+....+.||.||-.. ..|||||+||+|||++..|.+||||||++-....+- ..+...|-..|||||.+.. .
T Consensus 169 lg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~ 244 (361)
T KOG1006|consen 169 LGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDK 244 (361)
T ss_pred hhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccC
Confidence 889999999999999753 459999999999999999999999999986543221 1233467889999998864 3
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC-CC---ChHHHHHHHHHHHh
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG-QY---PQKAAHTAATLALQ 229 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~li~~ 229 (305)
+|+.+||+||||+++||+.||..||.+++...++ +...+...... .. -..++..+..+|.-
T Consensus 245 gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq---------------l~~Vv~gdpp~l~~~~~~~~~s~~~~~fint 309 (361)
T KOG1006|consen 245 GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ---------------LCQVVIGDPPILLFDKECVHYSFSMVRFINT 309 (361)
T ss_pred CcchhhhhhhhcceEeeeecCCCCcchHHHHHHH---------------HHHHHcCCCCeecCcccccccCHHHHHHHHH
Confidence 6899999999999999999999999986543222 11111111110 01 12477889999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||.+|-.+||.+.++++.
T Consensus 310 Cl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 310 CLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HhhcccccCcchhhhhcC
Confidence 999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=234.18 Aligned_cols=246 Identities=25% Similarity=0.300 Sum_probs=180.6
Q ss_pred EEEEEecccC--CccChHHHHHHHHHHhccCCCCcccEEEEEEe--------CCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPE--GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--------GENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||+|++-.+ ........++|+++|..++|+|++.++++|.. ...+|+|+++|+. +|..++.... ..+
T Consensus 44 kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~ 121 (376)
T KOG0669|consen 44 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK-VRF 121 (376)
T ss_pred hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcc-ccc
Confidence 4677765432 22334677899999999999999999887752 2457999999987 9999885443 458
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~ 149 (305)
+...+.+++.++..||.|+|+.+ |+|||+|++|+||+.+|.+||+|||+++.+....+. ...+..+-|.+|++||.
T Consensus 122 sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEl 199 (376)
T KOG0669|consen 122 SLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPEL 199 (376)
T ss_pred cHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHH
Confidence 99999999999999999999654 999999999999999999999999999875433322 22345567999999998
Q ss_pred hhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhh-----hhhhhcc--chhhhhhhhcc-c----CCC--
Q 021947 150 VATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW-----AKPYLSD--KRKLFRIMDTK-L----GGQ-- 214 (305)
Q Consensus 150 ~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~-~----~~~-- 214 (305)
+.|. .|+.+.|||+.|||+.+|+++.+-+++.+....-.+++. .+..+.+ +-.+++.+... . ...
T Consensus 200 lLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~ 279 (376)
T KOG0669|consen 200 LLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVK 279 (376)
T ss_pred hhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhh
Confidence 8775 789999999999999999999999998876644333221 1111111 11112211111 0 000
Q ss_pred ---CChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 215 ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
.+-.-.++..+|+.++|..||.+|+++.+++.+---.
T Consensus 280 n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 280 NRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred hhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 0111234788999999999999999999999775444
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=246.47 Aligned_cols=215 Identities=29% Similarity=0.417 Sum_probs=178.0
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.|||+++.+.. ++.+--+.|-++|.-. +-|.+++++..|..-+.+|+||||+.||+|.-.+++.+. +.+..+.
T Consensus 376 LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~Av 453 (683)
T KOG0696|consen 376 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAV 453 (683)
T ss_pred hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhh
Confidence 468898887632 2223335677777766 578999999999999999999999999999999987765 7777888
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
-++.+|+-||-|||+ +||++||||.+||+++.+|.+||+|||+++..-.... ...+.+||+.|+|||++...+|+.
T Consensus 454 FYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgk 529 (683)
T KOG0696|consen 454 FYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGK 529 (683)
T ss_pred hhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeecccccccccCCc--ceeeecCCCcccccceEEeccccc
Confidence 899999999999996 4599999999999999999999999999986433332 356789999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|.||+|+++|||+.|++||++.++. .+.+.+. .....+|...+.++.++++..|.+.|.+
T Consensus 530 svDWWa~GVLLyEmlaGQpPFdGeDE~-----------------elF~aI~-ehnvsyPKslSkEAv~ickg~ltK~P~k 591 (683)
T KOG0696|consen 530 SVDWWAFGVLLYEMLAGQPPFDGEDED-----------------ELFQAIM-EHNVSYPKSLSKEAVAICKGLLTKHPGK 591 (683)
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHH-HccCcCcccccHHHHHHHHHHhhcCCcc
Confidence 999999999999999999999986542 1222111 1234678899999999999999999999
Q ss_pred CCC
Q 021947 238 RPR 240 (305)
Q Consensus 238 Rps 240 (305)
|..
T Consensus 592 RLG 594 (683)
T KOG0696|consen 592 RLG 594 (683)
T ss_pred ccC
Confidence 963
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=241.68 Aligned_cols=232 Identities=24% Similarity=0.344 Sum_probs=180.2
Q ss_pred CEEEEEecccCC-ccC------hHHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEG-FQG------HKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~-~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
|-||+|+-.... +.+ .+...+|.++.+.|.||.||++|++|.- ....|-|+|||+|.+|.-|++.+. .++
T Consensus 489 RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmS 566 (775)
T KOG1151|consen 489 RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMS 566 (775)
T ss_pred heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhh
Confidence 358888765331 111 1456889999999999999999999974 466789999999999999997665 489
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCc-----ceeecccccccc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGY 144 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y 144 (305)
+..+..|+.||+.||.||......|||-||||.|||+.++ |.+||+|||+++.+.+.... .......||.||
T Consensus 567 EKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWY 646 (775)
T KOG1151|consen 567 EKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWY 646 (775)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeee
Confidence 9999999999999999999988999999999999999554 67999999999987654332 123455799999
Q ss_pred cchhhhhcC----CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHH
Q 021947 145 AAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 220 (305)
Q Consensus 145 ~aPE~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (305)
++||++--+ .++.++||||+|+|+|..+.|+-||+......+ + +.. ..+.+ ......+..+.++
T Consensus 647 LPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--I-------Lqe-NTIlk--AtEVqFP~KPvVs 714 (775)
T KOG1151|consen 647 LPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--I-------LQE-NTILK--ATEVQFPPKPVVS 714 (775)
T ss_pred cCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--H-------Hhh-hchhc--ceeccCCCCCccC
Confidence 999987533 578899999999999999999999987543211 0 000 00111 1112233345789
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
.++.+||++||.+.-++|....++..
T Consensus 715 seAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 715 SEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 99999999999999999998888764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=242.14 Aligned_cols=213 Identities=14% Similarity=0.116 Sum_probs=156.4
Q ss_pred HHHHHHhccCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 21 TEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 21 ~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
.+...+..+.|+||+.+++.+.... ..++++|++. .++.+.+.... ..++..+..++.|++.||.|||+. +
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~ 146 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH--G 146 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence 3444566778999999998765443 3468888874 47777765432 257788899999999999999964 5
Q ss_pred eeeccCCCCceEeCCCCceeeccccccccCCCCCCc-----ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHH
Q 021947 97 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 171 (305)
++||||||+|||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 147 iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 147 ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW 226 (294)
T ss_pred eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999999999765322111 112234689999999999999999999999999999999
Q ss_pred HhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 172 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
++|..||.+.......... ........+... ......++..+.+++..||..+|.+||++.++++.+
T Consensus 227 ~~g~~P~~~~~~~~~~~~~--------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 227 AGIKLPWKGFGHNGNLIHA--------AKCDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhCCCCCCccccchHHHHH--------hHHHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999999875321110000 000011111110 011234578899999999999999999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=265.28 Aligned_cols=224 Identities=28% Similarity=0.385 Sum_probs=170.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC--CCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~ 77 (305)
|.||||.+-.+. ..-+.+|++.|+.- .||||+++|+.-.+.+..||+.|.|. .+|.+++..... ........+
T Consensus 534 R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~ 609 (903)
T KOG1027|consen 534 REVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPI 609 (903)
T ss_pred ceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHH
Confidence 578999887653 23456999999988 59999999998888899999999996 599999976311 111113446
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC---C--CceeeccccccccCCCCCCc-ceeecccccccccchhhhh
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---E--FNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~--~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~ 151 (305)
.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++........ .......||.+|+|||++.
T Consensus 610 ~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 610 SVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred HHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHh
Confidence 78999999999999866 999999999999976 3 46899999999987654432 2244567999999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhh
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (305)
....+.++|||||||++|+.++| ..||++.-....+.+ .+...+... ... ..+ ++.+||.+|
T Consensus 688 ~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------~~~~~L~~L------~~~-~d~--eA~dLI~~m 750 (903)
T KOG1027|consen 688 EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------TGNYTLVHL------EPL-PDC--EAKDLISRM 750 (903)
T ss_pred ccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------cCccceeee------ccC-chH--HHHHHHHHh
Confidence 99889999999999999999995 999987533211110 011111000 011 112 899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~ 247 (305)
++++|..||++.+++.+
T Consensus 751 l~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 751 LNPDPQLRPSATDVLNH 767 (903)
T ss_pred cCCCcccCCCHHHHhCC
Confidence 99999999999999954
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=241.10 Aligned_cols=234 Identities=24% Similarity=0.363 Sum_probs=176.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc--CCCCcccEEEEEEeC----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL--HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
-||||++... +...+.+|.+++... +|+||+.+++....+ .++|||++|.+.|+|.|||.++ .++.+.
T Consensus 236 ~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ 309 (513)
T KOG2052|consen 236 DVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEG 309 (513)
T ss_pred ceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHH
Confidence 4899999864 566788999999874 899999999876533 3679999999999999999764 399999
Q ss_pred HHHHHHHHHHHHhhhhcC------CCceeeccCCCCceEeCCCCceeeccccccccCCCCC-C-cceeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-R-THVSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~-~~~~~~~~~t~~y~aP 147 (305)
.++++..++.||++||.. +..|.|||||..|||+..+|.+.|+|+|+|-...... . .......+||.+||||
T Consensus 310 ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAP 389 (513)
T KOG2052|consen 310 MLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAP 389 (513)
T ss_pred HHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccCh
Confidence 999999999999999942 4569999999999999999999999999996543321 1 1223456899999999
Q ss_pred hhhhcCC----C--CCCCceehhhHHHHHHHhC----------CCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-c
Q 021947 148 EYVATGR----L--TTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-K 210 (305)
Q Consensus 148 E~~~~~~----~--~~~~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 210 (305)
|++...- + -..+||||||+++||++.. +.||.+.... ....+.+.+.+-. .
T Consensus 390 EvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~------------DPs~eeMrkVVCv~~ 457 (513)
T KOG2052|consen 390 EVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS------------DPSFEEMRKVVCVQK 457 (513)
T ss_pred HHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC------------CCCHHHHhcceeecc
Confidence 9997642 2 2379999999999999862 3444332211 1112222222211 1
Q ss_pred cCCCCC-----hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 211 LGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 211 ~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.+...| ..+-..+.+|++.||..||.-|.|+--+.+.|.++..
T Consensus 458 ~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 458 LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222222 3555678899999999999999999999999988753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=264.17 Aligned_cols=120 Identities=29% Similarity=0.368 Sum_probs=106.2
Q ss_pred CEEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++...... ...+.+|+.++..++|+||+++++++......|+||||+.|++|.+++...+ .+++..++
T Consensus 30 ~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~ 107 (669)
T cd05610 30 KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAV 107 (669)
T ss_pred cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHH
Confidence 369999987643322 3578899999999999999999999999999999999999999999996544 48889999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~i~~qil~aL~yLH~~--gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 108 KYISEVALALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHhC--CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999964 59999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.32 Aligned_cols=238 Identities=22% Similarity=0.293 Sum_probs=178.0
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
++||+|++..... ...++..+|+.++..++|+||++++.+|.-. ...|+|||+++. +|...+.. .++
T Consensus 42 ~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~----elD 116 (369)
T KOG0665|consen 42 RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM----ELD 116 (369)
T ss_pred CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH----hcc
Confidence 4789998876532 3346788999999999999999999998733 345899999965 99998862 388
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
.+++..++.|++.|+.|||+ .||+||||||+||++..++.+||.|||+++..+.. ...+..+.|..|.|||++.+
T Consensus 117 H~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 117 HETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred hHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheec
Confidence 88999999999999999996 45999999999999999999999999999865433 23445677899999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh------------hhhhhhh----hhccchh-----hhhhhhc--
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS------------LVDWAKP----YLSDKRK-----LFRIMDT-- 209 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------~~~~~~~----~~~~~~~-----~~~~~~~-- 209 (305)
..+...+||||+||++.||++|...|.+.+...... +.+-..+ +...... ..+.+..
T Consensus 192 ~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~ 271 (369)
T KOG0665|consen 192 MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSL 271 (369)
T ss_pred cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccc
Confidence 889999999999999999999999999765432110 0000000 0000000 0000000
Q ss_pred -ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 210 -KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 210 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
......+..-...+++++.+||..||++|.|+.++|.+-
T Consensus 272 f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 272 FPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred ccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000111123445789999999999999999999999753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=229.94 Aligned_cols=223 Identities=28% Similarity=0.402 Sum_probs=178.9
Q ss_pred CEEEEEecccCCccCh---HHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGFQGH---KEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~---~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+..|+|+++++-..+. .-...|-.+...- +||.+|-++..|..++.+|+|.||+.||+|.-+++++.. ++++.+
T Consensus 276 qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk--lpeeha 353 (593)
T KOG0695|consen 276 QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHA 353 (593)
T ss_pred eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc--CcHHHh
Confidence 3678898887644333 3455677777766 699999999999999999999999999999888866543 999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..+..+|+.||.|||+ +||++||||.+|+|++..|.+||+|+|+++..... .....+.+||+.|.|||++++..|+
T Consensus 354 rfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeyg 429 (593)
T KOG0695|consen 354 RFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYG 429 (593)
T ss_pred hhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccC
Confidence 9999999999999995 56999999999999999999999999999864333 2346678999999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
..+|.|+||++++||+.|+.||+--..+. +..+...-+++++ -......|...+-....+++..|++||.
T Consensus 430 fsvdwwalgvlmfemmagrspfdivgm~n---------~d~ntedylfqvi-lekqiriprslsvkas~vlkgflnkdp~ 499 (593)
T KOG0695|consen 430 FSVDWWALGVLMFEMMAGRSPFDIVGMDN---------PDMNTEDYLFQVI-LEKQIRIPRSLSVKASHVLKGFLNKDPK 499 (593)
T ss_pred ceehHHHHHHHHHHHHcCCCCcceecCCC---------cccchhHHHHHHH-hhhcccccceeehhhHHHHHHhhcCCcH
Confidence 99999999999999999999997543221 1111222222222 2223456677788888999999999999
Q ss_pred CCC
Q 021947 237 LRP 239 (305)
Q Consensus 237 ~Rp 239 (305)
+|.
T Consensus 500 erl 502 (593)
T KOG0695|consen 500 ERL 502 (593)
T ss_pred Hhc
Confidence 995
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.33 Aligned_cols=178 Identities=26% Similarity=0.399 Sum_probs=131.4
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccC
Q 021947 47 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 47 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
+||-||||+..++.+++.++... -.....+.++.+|++||+|+|+ .|+|||||||.||+++.++.|||+|||+++..
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 47899999986677766555421 1467889999999999999996 45999999999999999999999999999861
Q ss_pred C------C----------CCCcceeecccccccccchhhhhcCC---CCCCCceehhhHHHHHHHhCCCccCCCcccchh
Q 021947 127 P------T----------GDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 187 (305)
Q Consensus 127 ~------~----------~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 187 (305)
. . .......+..+||.-|+|||++.+.. |+.|+|+||||+|++||+. ||+..-+.
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--- 821 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--- 821 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH---
Confidence 1 0 01111244568999999999997754 9999999999999999996 46543211
Q ss_pred hhhhhhhhhhccchhhhhhhhcc-cCC--CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 188 SLVDWAKPYLSDKRKLFRIMDTK-LGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
.. ....+..+ +.. .+.......-..+|..||+.||.+|||+.++|.
T Consensus 822 ------------a~-iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 822 ------------AS-ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ------------HH-HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11 11111111 111 123344456678999999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=242.57 Aligned_cols=203 Identities=25% Similarity=0.284 Sum_probs=160.5
Q ss_pred HHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCce
Q 021947 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 97 (305)
Q Consensus 18 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 97 (305)
....|-+||..-..+-||++|-.|.+.+.+|+||||+.||++..+|.+.+ .|.+..+..++.++..|+++.| +.|+
T Consensus 675 HVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH--kmGF 750 (1034)
T KOG0608|consen 675 HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH--KMGF 750 (1034)
T ss_pred hhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH--hccc
Confidence 35668899999999999999999999999999999999999999997765 4899999999999999999999 5669
Q ss_pred eeccCCCCceEeCCCCceeeccccccccCCCCCCc----------------------------------------ceeec
Q 021947 98 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------------------------------------HVSTQ 137 (305)
Q Consensus 98 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------------------------------------~~~~~ 137 (305)
|||||||+|||||.+|.+||+|||+|.-+...... .....
T Consensus 751 IHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahs 830 (1034)
T KOG0608|consen 751 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHS 830 (1034)
T ss_pred eecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhh
Confidence 99999999999999999999999999632111000 00113
Q ss_pred ccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 138 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.+||+.|+|||++....++..+|.||.|+|||+|+.|+.||-..+....+.-+. .....+...+..
T Consensus 831 lvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~--------------nw~~~l~~~~~~ 896 (1034)
T KOG0608|consen 831 LVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVI--------------NWRNFLHIPYQG 896 (1034)
T ss_pred hcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeee--------------ehhhcccccccc
Confidence 479999999999999999999999999999999999999998765443322110 011122233445
Q ss_pred HHHHHHHHHHHhhccCCCCCCC
Q 021947 218 KAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+.+.++.+||.++. -+++.|.
T Consensus 897 ~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 897 NLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred ccCHHHHHHHHHHh-cChhhhh
Confidence 67778888877644 3566675
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=212.37 Aligned_cols=177 Identities=27% Similarity=0.379 Sum_probs=145.7
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhh--cCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~ 77 (305)
+.|+|.+...- .+..+++++|+++.++- .+|++|.+||....++..|+.||.|+. +|..+-.+ ..+...++..+-
T Consensus 73 imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlG 151 (282)
T KOG0984|consen 73 IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLG 151 (282)
T ss_pred EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhh
Confidence 67999887653 34456788999987665 699999999999999999999999964 88776532 123458999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc----C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----G 153 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~ 153 (305)
+++..+++||.|||++ -.++|||+||+|||++.+|.||+||||++-+..++.- .+...|...|||||.+.. .
T Consensus 152 kIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~ 227 (282)
T KOG0984|consen 152 KIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQK 227 (282)
T ss_pred HhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcc
Confidence 9999999999999985 5699999999999999999999999999976544321 222457788999998754 3
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKV 183 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 183 (305)
.|+.++||||||+++.||.+++.||+.+..
T Consensus 228 gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 228 GYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred cceeehhhhhhhhhhhhhhhccccccccCC
Confidence 789999999999999999999999987543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=234.55 Aligned_cols=238 Identities=19% Similarity=0.243 Sum_probs=160.3
Q ss_pred EEEEEecccCCccChHHH--------------HHHHHHHhccCCCCc-----ccEEEEEEe--------CCeeEEEEecC
Q 021947 2 VVAVKKLKPEGFQGHKEW--------------LTEVNYLGQLHHPNL-----VKLIGYCLE--------GENRLLVYEFM 54 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~--------------~~E~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~ 54 (305)
.||||++........++| ..|+..+.+++|.++ ++++++|.. .+..||||||+
T Consensus 188 ~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~ 267 (507)
T PLN03224 188 RVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFE 267 (507)
T ss_pred eEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcC
Confidence 699999876533323333 346677777766554 566666643 35679999999
Q ss_pred CCCCHHHHhhhcCC----------------------CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC
Q 021947 55 PKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112 (305)
Q Consensus 55 ~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~ 112 (305)
.+++|.+++..... ..+++..+..++.+++.+|.|||+. +++||||||+||+++.+
T Consensus 268 ~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~--~ivHrDLKp~NILl~~~ 345 (507)
T PLN03224 268 SDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI--GIVHRDIKPENLLVTVD 345 (507)
T ss_pred CCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCchHhEEECCC
Confidence 99999998854211 1245677888999999999999964 59999999999999999
Q ss_pred CceeeccccccccCCCCCCcceeecccccccccchhhhhcCC--------------------CC--CCCceehhhHHHHH
Q 021947 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--------------------LT--TKSDVYSFGVVLLE 170 (305)
Q Consensus 113 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--------------------~~--~~~Di~slG~il~~ 170 (305)
+.+||+|||++.......... .....+++.|+|||.+.... ++ .+.|+||+||++|+
T Consensus 346 ~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~e 424 (507)
T PLN03224 346 GQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQ 424 (507)
T ss_pred CcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHH
Confidence 999999999997543322111 11223478999999875432 11 24799999999999
Q ss_pred HHhCCC-ccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC---CCCCCHHHHHH
Q 021947 171 LLSGRC-AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP---KLRPRMSEVLA 246 (305)
Q Consensus 171 l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~~~l~ 246 (305)
|++|.. ||.+...... .. ..+..+...+.............+..++..++|+.+||..+| .+|+|+.++++
T Consensus 425 m~~~~l~p~~~~~~f~~-~~----~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 425 MCVPELRPVANIRLFNT-EL----RQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHhCCCCCccchhhhhh-HH----hhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 999875 6654221100 00 000001111111111222223345678899999999999866 68999999987
Q ss_pred H
Q 021947 247 I 247 (305)
Q Consensus 247 ~ 247 (305)
+
T Consensus 500 H 500 (507)
T PLN03224 500 H 500 (507)
T ss_pred C
Confidence 5
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=216.55 Aligned_cols=216 Identities=24% Similarity=0.322 Sum_probs=183.0
Q ss_pred HHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhc------CCCCCCHHHHHHHHHHHHHHHhh
Q 021947 17 KEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRR------GPQPLSWAVRMKVAIGAAKGLTF 89 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~i~~~l~~ 89 (305)
..++.|...+..+.|||+.++.+++.+ ....+.++.+..-|+|..|+... ....++..+...++.|++.|++|
T Consensus 332 ~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~h 411 (563)
T KOG1024|consen 332 NLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEH 411 (563)
T ss_pred HHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHH
Confidence 457889999999999999999998765 46678999999889999999621 22346667788899999999999
Q ss_pred hhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHH
Q 021947 90 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 169 (305)
Q Consensus 90 lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 169 (305)
||.+ ++||.||-..|++|++...|||+|=.+++..-..+.......-.....||++|.+.+..|+.++|+||||+++|
T Consensus 412 lh~~--~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW 489 (563)
T KOG1024|consen 412 LHNH--GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW 489 (563)
T ss_pred HHhc--CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence 9964 59999999999999999999999999998654333333333444577899999999999999999999999999
Q ss_pred HHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 170 ELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 170 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
||+| |+.||..- +...+...+..+++...|.++++++..++.-||...|++||+++++..-|
T Consensus 490 ELmtlg~~PyaeI-----------------DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 490 ELMTLGKLPYAEI-----------------DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred HHHhcCCCCcccc-----------------CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 9999 89998764 34456777888888899999999999999999999999999999999988
Q ss_pred Hhh
Q 021947 249 ERL 251 (305)
Q Consensus 249 ~~~ 251 (305)
.++
T Consensus 553 seF 555 (563)
T KOG1024|consen 553 SEF 555 (563)
T ss_pred HHH
Confidence 765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=241.52 Aligned_cols=199 Identities=17% Similarity=0.194 Sum_probs=131.7
Q ss_pred EeCCeeEEEEecCCCCCHHHHhhhcCCC------------------CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCC
Q 021947 42 LEGENRLLVYEFMPKGSLENHLFRRGPQ------------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 103 (305)
Q Consensus 42 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlk 103 (305)
..+...++|+||+.+++|.+++...... ......+..++.|++.||.|||+. +|+|||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--gIiHRDLK 282 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--GIVHRDVK 282 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--CEEeCcCC
Confidence 3456789999999999999998654311 012234567999999999999964 59999999
Q ss_pred CCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC----------------------CCCCCCc
Q 021947 104 ASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----------------------RLTTKSD 160 (305)
Q Consensus 104 p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~D 160 (305)
|+|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57899999999976533221 123345789999999976432 2344679
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC------CCChHHHHHHHHHHHhhccCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG------QYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~ 234 (305)
||||||++|+|+++..+++.........+... ..+...+.......... ...+......++||.+||..|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN----DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhc----CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999998766543211111111000 00001111111111000 001112335668999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=203.66 Aligned_cols=233 Identities=20% Similarity=0.279 Sum_probs=173.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.++||++++. ..+.+.+|+++|..|. ||||++++++..+. ..+.|++||+.+.+...+- ..++...+..
T Consensus 65 K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIry 136 (338)
T KOG0668|consen 65 KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRY 136 (338)
T ss_pred eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHH
Confidence 5788999876 4567889999999997 99999999998754 4568999999887766544 2377788899
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLT 156 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~ 156 (305)
++.+++.||.|+||.+ |.|||+||.|++++... .++|+|||+|......... .-.+.+..|--||.+-. ..|+
T Consensus 137 Y~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YD 211 (338)
T KOG0668|consen 137 YIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYD 211 (338)
T ss_pred HHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhcc
Confidence 9999999999999755 99999999999998764 5999999999876554332 23356778899998755 4689
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhh-----------hhhhhhhhh-ccchhhhhhhhcccCC--------CCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-----------LVDWAKPYL-SDKRKLFRIMDTKLGG--------QYP 216 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~~~--------~~~ 216 (305)
..-|+|||||++..|+..+.||..+....++- +..+...+. .-......++....+. ...
T Consensus 212 YSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~ 291 (338)
T KOG0668|consen 212 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQ 291 (338)
T ss_pred ccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccc
Confidence 99999999999999999999997765543331 111111110 1111111222211111 112
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.-+++++.+|+.++|..|-.+|+|+.|.+.+
T Consensus 292 hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 292 HLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 2356789999999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-33 Score=217.89 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=177.6
Q ss_pred CEEEEEecccC--CccChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPE--GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
+.||+|++..- +..+.+++.+|+++|..++|.||+..+++..-. +.+|.++|.+.. +|...|. .+..++.
T Consensus 79 rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIV--SPQ~Ls~ 155 (449)
T KOG0664|consen 79 KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIV--SPQALTP 155 (449)
T ss_pred cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheec--cCCCCCc
Confidence 35777877544 234557899999999999999999998876532 345789999965 8888774 4456888
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+.-++.||+.||+|||+.+ |.||||||.|.|++.+..+||||||+++......... .+..+-|..|.|||++.|.
T Consensus 156 DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGa 232 (449)
T KOG0664|consen 156 DHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGA 232 (449)
T ss_pred chhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcc
Confidence 899999999999999999754 9999999999999999999999999999865444333 3344568999999999886
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-h-hhhhhhccch-----hhhhhhhcccCC---------CCC
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D-WAKPYLSDKR-----KLFRIMDTKLGG---------QYP 216 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~-~~~~~~~~~~-----~~~~~~~~~~~~---------~~~ 216 (305)
.|+.+.||||.|||+.|++..+..|+.........++ + ...|...... .-..++...... ..+
T Consensus 233 RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~ 312 (449)
T KOG0664|consen 233 RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASP 312 (449)
T ss_pred hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCC
Confidence 6899999999999999999999999876543222211 1 1111111110 011111111111 111
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
..-..+...++.++|..||++|.+.++.+.++.
T Consensus 313 ~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 313 DDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 233446778899999999999999999887653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=253.56 Aligned_cols=200 Identities=19% Similarity=0.197 Sum_probs=141.2
Q ss_pred HHhccCC-CCcccEEEEEE-------eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 25 YLGQLHH-PNLVKLIGYCL-------EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 25 ~l~~l~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
..+.++| +||..++++|. ....+++++|++ +++|.+++... ...++...++.++.||+.||.|||+ +|
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~g 100 (793)
T PLN00181 25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS--QG 100 (793)
T ss_pred ccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh--CC
Confidence 3455667 78888888872 334567889988 55999999643 2459999999999999999999996 45
Q ss_pred eeeccCCCCceEeCCC-------------------CceeeccccccccCCCCCC--------------cceeeccccccc
Q 021947 97 VIYRDFKASNILLDAE-------------------FNAKLSDFGLAKAGPTGDR--------------THVSTQVMGTHG 143 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~ 143 (305)
|+||||||+|||++.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999653 4456666666653211000 000112357889
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
|+|||++.+..++.++|||||||++|||++|..|+........ ........ ..........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~------------------~~~~~~~~-~~~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS------------------SLRHRVLP-PQILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH------------------HHHHhhcC-hhhhhcCHHH
Confidence 9999999999999999999999999999999888653211000 00000000 0001123345
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..++.+||..+|.+||++.+++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 688999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=227.08 Aligned_cols=238 Identities=21% Similarity=0.208 Sum_probs=177.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC------CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-CCCCHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH------HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~ 74 (305)
-||||+|...... .+.=+.|+++|++|+ --|++.++-.|...+++|||+|.+. .+|.+.+++.+. ..+...
T Consensus 459 ~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ik 536 (752)
T KOG0670|consen 459 EVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIK 536 (752)
T ss_pred eeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeeh
Confidence 4999999865221 134468999999995 3689999999999999999999995 599999976553 358888
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.|+..||..|-. .||+|.||||+|||++++. .+||||||.|........+ -..-+..|.|||++.|.
T Consensus 537 aVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~ 610 (752)
T KOG0670|consen 537 AVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGL 610 (752)
T ss_pred HHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecC
Confidence 999999999999999995 4599999999999998764 5799999999876543321 12235679999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhh-----------------------------------
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYL----------------------------------- 197 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~----------------------------------- 197 (305)
+|+...|+||.||+||||.||+..|.+.+..... .+.+...++.
T Consensus 611 ~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~ 690 (752)
T KOG0670|consen 611 PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRT 690 (752)
T ss_pred cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEE
Confidence 9999999999999999999999999987643211 0110000000
Q ss_pred -----ccchhhhhhhhccc-CCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 198 -----SDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 198 -----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....+...+.... ...-.......+.+|+.+||..||++|.|+.++|.+
T Consensus 691 vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 691 VMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred EecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 00011111111111 111123566789999999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=217.64 Aligned_cols=237 Identities=21% Similarity=0.320 Sum_probs=175.5
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC--------CCCcccEEEEEE----eCCeeEEEEecCCCCCHHHHhhhcCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH--------HPNLVKLIGYCL----EGENRLLVYEFMPKGSLENHLFRRGP 68 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~ 68 (305)
+-||+|+.+... .-.+..+.|+++|++++ ..+||++++.|. .+.+++||+|++ |.+|..+|....-
T Consensus 104 r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y 181 (590)
T KOG1290|consen 104 RYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY 181 (590)
T ss_pred eEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC
Confidence 469999988652 22356789999999984 257999999997 457889999999 7799999988777
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC------------------------------------
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------------------------------------ 112 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~------------------------------------ 112 (305)
..++...+..|++|++.||.|||.. -||||.||||+|||+...
T Consensus 182 rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~ 260 (590)
T KOG1290|consen 182 RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRM 260 (590)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchh
Confidence 7799999999999999999999984 789999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 021947 113 -------------------------------------------------------------------------------- 112 (305)
Q Consensus 113 -------------------------------------------------------------------------------- 112 (305)
T Consensus 261 ~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e 340 (590)
T KOG1290|consen 261 AAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPE 340 (590)
T ss_pred hccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCcc
Confidence
Q ss_pred --------------------------------------------------CceeeccccccccCCCCCCcceeecccccc
Q 021947 113 --------------------------------------------------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 142 (305)
Q Consensus 113 --------------------------------------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~ 142 (305)
..|||+|||.|++.... .+..+.|.
T Consensus 341 ~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTR 415 (590)
T KOG1290|consen 341 NFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTR 415 (590)
T ss_pred ccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhh
Confidence 01455555555553322 22335688
Q ss_pred cccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCccc----chhhh---h--------------hhhhhhhccch
Q 021947 143 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG----IEQSL---V--------------DWAKPYLSDKR 201 (305)
Q Consensus 143 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~---~--------------~~~~~~~~~~~ 201 (305)
-|+|||++.|..|++.+||||++|++|||+||...|+..... .+..+ + .+.+.+++...
T Consensus 416 QYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G 495 (590)
T KOG1290|consen 416 QYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRG 495 (590)
T ss_pred hccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhcccc
Confidence 899999999999999999999999999999999999653321 11110 0 11111222211
Q ss_pred hhh-----------hhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 202 KLF-----------RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 202 ~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+. +.+..+ ..++.....++.+|+.-||+.+|++|||+.+++++
T Consensus 496 ~LrhI~~LK~WpL~~VL~eK--Y~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 496 ELRHIRRLKPWPLYEVLIEK--YEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred ceecccccCCCcHHHHHHHH--hCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 111 111111 23455777899999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=202.38 Aligned_cols=192 Identities=35% Similarity=0.528 Sum_probs=164.8
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.+++|++...... ....+.+|++.++.++|++|+++++++......++++|++.|++|.+++.... ..++...+..++
T Consensus 20 ~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ 98 (215)
T cd00180 20 KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRIL 98 (215)
T ss_pred EEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHH
Confidence 5789998876433 34678999999999999999999999999899999999999899999996542 348899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 158 (305)
.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+... ..+.+
T Consensus 99 ~~l~~~l~~lh~~--~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~ 174 (215)
T cd00180 99 LQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEK 174 (215)
T ss_pred HHHHHHHHHHHhC--CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCch
Confidence 9999999999965 5999999999999999 89999999999986543321 12234567889999998877 78889
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|+|+||++++++ ..+.+++.+|+..+|.+|
T Consensus 175 ~D~~~lg~~~~~l-------------------------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 175 SDIWSLGVILYEL-------------------------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred hhhHHHHHHHHHH-------------------------------------------------HHHHHHHHHHhhCCcccC
Confidence 9999999999998 457789999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
|++.++++.
T Consensus 206 ~~~~~l~~~ 214 (215)
T cd00180 206 PSAKEILEH 214 (215)
T ss_pred cCHHHHhhC
Confidence 999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=200.86 Aligned_cols=165 Identities=25% Similarity=0.241 Sum_probs=125.8
Q ss_pred CCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceee
Q 021947 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 136 (305)
Q Consensus 57 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 136 (305)
|+|.+++..++ ..+++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------
Confidence 58999997543 35999999999999999999999642 999999999999999 9998765332
Q ss_pred cccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCC
Q 021947 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQ 214 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 214 (305)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .... +....... ....
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~ 130 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEI-----------LLNGMPADDPRDRS 130 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHH-----------HHHHhccCCccccc
Confidence 12578999999999999999999999999999999999999975432110 0000 00000000 0001
Q ss_pred CChHHHH--HHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 215 YPQKAAH--TAATLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 215 ~~~~~~~--~~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
.+..+.. .+.+++.+||+.+|.+||++.++++++..+
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2234444 699999999999999999999999988765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=199.59 Aligned_cols=224 Identities=21% Similarity=0.328 Sum_probs=163.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEE-EEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGY-CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.++||-+... .....+|.+|+..--.|. |.||+.-|++ |...+.+++++||++.|+|.+-+... ++.+.....+
T Consensus 51 ~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v 126 (378)
T KOG1345|consen 51 RIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKV 126 (378)
T ss_pred EEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc---cccHHHHHHH
Confidence 4667766554 245678999998877775 9999998886 45567788999999999999887543 4889999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC--CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC----
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---- 153 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---- 153 (305)
+.|++.|+.|||+++ +||||||.+||||-. ..++||||||..+..+..- .....+..|.+||+....
T Consensus 127 ~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~ 199 (378)
T KOG1345|consen 127 FAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEK 199 (378)
T ss_pred HHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccc
Confidence 999999999999865 999999999999943 3479999999998654432 222346789999977532
Q ss_pred -CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 -RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
...+.+|+|.||+++|..++|..||+.. ...++....|.. +..-..... ...-...++.+..+.++-|.
T Consensus 200 ~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~--------w~~rk~~~~-P~~F~~fs~~a~r~Fkk~lt 269 (378)
T KOG1345|consen 200 LVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQ--------WLKRKNPAL-PKKFNPFSEKALRLFKKSLT 269 (378)
T ss_pred eEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHH--------HhcccCccC-chhhcccCHHHHHHHHHhcC
Confidence 2466899999999999999999999843 333333333321 111111111 11123467788899999999
Q ss_pred CCCCCCC---CHHHHHH
Q 021947 233 NEPKLRP---RMSEVLA 246 (305)
Q Consensus 233 ~~p~~Rp---s~~~~l~ 246 (305)
.++++|- ++.....
T Consensus 270 ~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 270 PRFKDRCKIWTAKKMRK 286 (378)
T ss_pred CcccccchhHHHHHHHH
Confidence 9999993 4444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=220.83 Aligned_cols=170 Identities=23% Similarity=0.322 Sum_probs=144.6
Q ss_pred EEEEEecccCCccCh--------HHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecC-CCCCHHHHhhhcCCC
Q 021947 2 VVAVKKLKPEGFQGH--------KEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFM-PKGSLENHLFRRGPQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~ 69 (305)
.|+||.+.++..-.. -..-.|+++|..++ |+||++++++|++++.+||+||.. +|.+|.++|.....
T Consensus 588 eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~- 666 (772)
T KOG1152|consen 588 EVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR- 666 (772)
T ss_pred EEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc-
Confidence 588998876532111 12335999999997 999999999999999999999986 46689999976553
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
+++.....++.|++.|+++||+. ||||||||-+|+.++.+|.+||+|||.+.+..+.. ...++||..|.|||+
T Consensus 667 -m~E~eAk~IFkQV~agi~hlh~~--~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapev 739 (772)
T KOG1152|consen 667 -MDEPEAKLIFKQVVAGIKHLHDQ--GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEV 739 (772)
T ss_pred -cchHHHHHHHHHHHhcccccccc--CceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhh
Confidence 99999999999999999999965 49999999999999999999999999998754432 445789999999999
Q ss_pred hhcCCC-CCCCceehhhHHHHHHHhCCCccC
Q 021947 150 VATGRL-TTKSDVYSFGVVLLELLSGRCAVD 179 (305)
Q Consensus 150 ~~~~~~-~~~~Di~slG~il~~l~~g~~pf~ 179 (305)
+.|..| +..-|||+||+++|.++....||.
T Consensus 740 l~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 740 LGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999877 567899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=224.38 Aligned_cols=223 Identities=26% Similarity=0.335 Sum_probs=178.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
+.|+|+++.+-.++..-+..|+-+++..+|+||+.+++.+.....+|++||||.||+|.+.-. ...++++.++..+++
T Consensus 42 laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~--~TgplselqiayvcR 119 (829)
T KOG0576|consen 42 LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCR 119 (829)
T ss_pred hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee--ecccchhHHHHHHHh
Confidence 468999887766666777889999999999999999999999999999999999999998553 344699999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh---hcCCCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV---ATGRLTTK 158 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~ 158 (305)
+.+.||+|||+.+ =+|||||-.||++++.|.+|+.|||.+-.++..... ...+.||+.|||||+. +.+.|...
T Consensus 120 etl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~K--rksfiGtpywmapEvaaverkggynql 195 (829)
T KOG0576|consen 120 ETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQL 195 (829)
T ss_pred hhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhhh--hhcccCCccccchhHHHHHhccccccc
Confidence 9999999999654 899999999999999999999999998665433222 3456899999999976 45678999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc---ccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+|||++|++..|+-.-++|....... +.++-.... ......+...+..+.+|++.+|.++|
T Consensus 196 cdiwa~gitAiel~eLqpplfdlhpm----------------r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknp 259 (829)
T KOG0576|consen 196 CDIWALGITAIELGELQPPLFDLHPM----------------RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNP 259 (829)
T ss_pred ccccccccchhhhhhcCCcccccchH----------------HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCC
Confidence 99999999999999888775432211 001100011 11122234677889999999999999
Q ss_pred CCCCCHHHHHH
Q 021947 236 KLRPRMSEVLA 246 (305)
Q Consensus 236 ~~Rps~~~~l~ 246 (305)
++||+++.++.
T Consensus 260 KkRptaeklL~ 270 (829)
T KOG0576|consen 260 KKRPTAEKLLQ 270 (829)
T ss_pred ccCCChhhhee
Confidence 99999988763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=193.41 Aligned_cols=175 Identities=35% Similarity=0.454 Sum_probs=150.0
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|.+...... ..+.+.+|++.+++++|+|++++++.+......++++|++.+++|.+++...... +++.....++
T Consensus 26 ~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~ 104 (225)
T smart00221 26 LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYL 104 (225)
T ss_pred EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHH
Confidence 5899998876544 5678899999999999999999999999888999999999999999999655422 7889999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh-hcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-ATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~ 159 (305)
.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+......... ......++..|++||.+ ....++.++
T Consensus 105 ~~l~~~l~~lh~~--~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~ 181 (225)
T smart00221 105 RQILEALEYLHSL--GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAV 181 (225)
T ss_pred HHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchh
Confidence 9999999999964 6999999999999999999999999999876443200 12334577889999998 666778899
Q ss_pred ceehhhHHHHHHHhCCCccCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDK 180 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~ 180 (305)
|+|+||+++++|++|+.||..
T Consensus 182 Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 182 DIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred hHHHHHHHHHHHHHCCCCccc
Confidence 999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=199.54 Aligned_cols=238 Identities=26% Similarity=0.327 Sum_probs=173.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||+|.+..-+ ...++.+|++.|..+. +.||+++.+.+..+++..+|+||+++....++... ++...+..+
T Consensus 65 ~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Y 137 (418)
T KOG1167|consen 65 RYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWY 137 (418)
T ss_pred ceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHH
Confidence 368999987653 4567889999999995 99999999999999999999999999888888732 678889999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-CceeeccccccccCCCCC--------------C-------------
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGD--------------R------------- 131 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~--------------~------------- 131 (305)
+..++.||+++|. +|||||||||.|+|.+.. +.-.|+|||++....... .
T Consensus 138 l~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~ 215 (418)
T KOG1167|consen 138 LRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVAT 215 (418)
T ss_pred HHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccccc
Confidence 9999999999994 669999999999999875 568999999997211000 0
Q ss_pred ---------------cceeecccccccccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhh--
Q 021947 132 ---------------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD-- 191 (305)
Q Consensus 132 ---------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-- 191 (305)
........||++|.|||++... ..++++||||.|+|+..+++++.||.....+.+. .+..
T Consensus 216 ~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tif 295 (418)
T KOG1167|consen 216 ASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIF 295 (418)
T ss_pred ccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHh
Confidence 0001123699999999998765 5688999999999999999999999765543221 0000
Q ss_pred -----------------hhhh---hhccchhhhhhh--hcccC--------CCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 192 -----------------WAKP---YLSDKRKLFRIM--DTKLG--------GQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 192 -----------------~~~~---~~~~~~~~~~~~--~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
|.+. .......-++.+ ..... .......+..+.+|+.+||..||.+|.|+
T Consensus 296 G~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitA 375 (418)
T KOG1167|consen 296 GSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITA 375 (418)
T ss_pred ChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccH
Confidence 0000 000000000001 00011 11122344589999999999999999999
Q ss_pred HHHHHH
Q 021947 242 SEVLAI 247 (305)
Q Consensus 242 ~~~l~~ 247 (305)
++.|++
T Consensus 376 EeALkH 381 (418)
T KOG1167|consen 376 EDALKH 381 (418)
T ss_pred HHHhcC
Confidence 999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=185.54 Aligned_cols=224 Identities=21% Similarity=0.381 Sum_probs=181.4
Q ss_pred EEEecccCCccCh--HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 4 AVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 4 aiK~~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
+.|+++......+ .+|..|+-.|+-+.||||+.+++.|....++.++..|++.|+|+..+........+..++.+++.
T Consensus 217 vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~fal 296 (448)
T KOG0195|consen 217 VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFAL 296 (448)
T ss_pred hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHH
Confidence 3466655444333 57889999999999999999999999998999999999999999999887776778889999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeec--cccccccCCCCCCcceeecccccccccchhhhhcCCCC---
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT--- 156 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--- 156 (305)
+++.|++|||+...-|.---|....++++++.+.+|. |--++.. .......+.|++||.+...+-+
T Consensus 297 diargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~ 367 (448)
T KOG0195|consen 297 DIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNI 367 (448)
T ss_pred HHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcch
Confidence 9999999999987656666788999999999876664 2221111 1122457899999999876544
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||++++||+.|...||.+.. ..+--.++...+++...|++++..+..|+.-|++.||.
T Consensus 368 raadmwsfaillwel~trevpfadls----------------pmecgmkialeglrv~ippgis~hm~klm~icmnedpg 431 (448)
T KOG0195|consen 368 RAADMWSFAILLWELNTREVPFADLS----------------PMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPG 431 (448)
T ss_pred hhhhHHHHHHHHHHhhccccccccCC----------------chhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCC
Confidence 37999999999999999999998632 22333455566778888999999999999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 021947 237 LRPRMSEVLAILERLE 252 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~ 252 (305)
+||.+..++-.|+++.
T Consensus 432 krpkfdmivpilekm~ 447 (448)
T KOG0195|consen 432 KRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCcceehhhHHHhc
Confidence 9999999998888753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=212.83 Aligned_cols=214 Identities=20% Similarity=0.236 Sum_probs=166.6
Q ss_pred HHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCcee
Q 021947 19 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98 (305)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 98 (305)
+..|+.+-..|+|+|++..+..+.+....+-.||||++ +|..++.+.+. +....+-.++.|++.|+.|+|+. |+.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~--Gia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSM--GLA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhc--Cce
Confidence 45577777788999998888777776666666999999 99999976633 78888899999999999999965 499
Q ss_pred eccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhcCCCCC-CCceehhhHHHHHHHhCC
Q 021947 99 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT-KSDVYSFGVVLLELLSGR 175 (305)
Q Consensus 99 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~ 175 (305)
|||+|++|+++..+|.+||+|||.+......... ......+|+..|+|||++.+..|+. ..||||.|++++.|++|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 9999999999999999999999999876544433 4566778999999999999999987 689999999999999999
Q ss_pred CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 176 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
.||........+... .......-............+...+.+|.+||+.||.+|.|+++|++
T Consensus 523 ~~Wk~a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKT---------NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Cccccccccccchhh---------hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 999765433221100 00000000000011122357778899999999999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-23 Score=175.90 Aligned_cols=236 Identities=21% Similarity=0.172 Sum_probs=177.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC----CCCcccEEEEE-EeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH----HPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
.+|+|............+..|..++..+. ..++..+++.+ ..+...|+||+.+ |.+|.++........++..+.
T Consensus 46 ~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~ 124 (322)
T KOG1164|consen 46 EYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTV 124 (322)
T ss_pred eEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHH
Confidence 46778776653333337788999999986 36999999998 4777889999999 789999886666567999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-----Cceeeccccccc--cCCCCCCc-----ce-eeccccccc
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-----FNAKLSDFGLAK--AGPTGDRT-----HV-STQVMGTHG 143 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~~~--~~~~~~~~-----~~-~~~~~~t~~ 143 (305)
+.++.|++.+|.+||+. |++||||||+|+++... ..+.|.|||+++ ........ .. .....||..
T Consensus 125 l~ia~q~l~~l~~lH~~--G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~r 202 (322)
T KOG1164|consen 125 LRIAIQNLNALEDLHSK--GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLR 202 (322)
T ss_pred HHHHHHHHHHHHHHHhc--CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccc
Confidence 99999999999999964 59999999999999765 359999999998 32222111 11 223459999
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
|+++.+..+...+.+.|+||++.++.+++.|..||.+....... ..+.+..............+.++
T Consensus 203 y~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~ 269 (322)
T KOG1164|consen 203 YASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-------------SKFEKDPRKLLTDRFGDLKPEEF 269 (322)
T ss_pred cccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-------------HHHHHHhhhhccccccCCChHHH
Confidence 99999999999999999999999999999999999765432111 01111111111111233455677
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.++...+-..+...+|....+...+.....
T Consensus 270 ~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 270 AKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 777777777999999999999998876544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=166.48 Aligned_cols=231 Identities=19% Similarity=0.213 Sum_probs=179.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.+||||.-... .+..++..|.+..+.|. .++|..+|-+..++.+-.||||++ |.+|+|++.-.+. .|+.+++.-+
T Consensus 54 e~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~mi 129 (449)
T KOG1165|consen 54 EPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMI 129 (449)
T ss_pred ceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHH
Confidence 37999975443 35568889999999985 799999998888888889999999 7899998754443 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-----ceeeccccccccCCCCCCc-----ceeecccccccccchhh
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~ 149 (305)
+.|++.-++++|+++ +|+|||||+|+||..-+ .+.++|||+++.+.+.... .......||.+||+--.
T Consensus 130 A~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINT 207 (449)
T KOG1165|consen 130 AKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINT 207 (449)
T ss_pred HHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeec
Confidence 999999999999765 99999999999997644 4899999999876554322 23445679999999999
Q ss_pred hhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC---hHHHHHHHHH
Q 021947 150 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATL 226 (305)
Q Consensus 150 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 226 (305)
..|...+.+-|+-|||-++++++.|..||++..... .++...++-+++...... .+++.++..-
T Consensus 208 HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-------------nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Y 274 (449)
T KOG1165|consen 208 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-------------NKEKYEKIGETKRSTPIEVLCEGFPEEFATY 274 (449)
T ss_pred cccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-------------hHHHHHHhccccccCCHHHHHhcCHHHHHHH
Confidence 999999999999999999999999999999865432 223333333333222211 3567788888
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHh
Q 021947 227 ALQCLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~l~~ 250 (305)
+.-.-+.+-.+-|..+-+...+..
T Consensus 275 l~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 275 LRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHHHHhcCcccCCCHHHHHHHHHH
Confidence 877777777888888877765544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-22 Score=172.44 Aligned_cols=231 Identities=32% Similarity=0.447 Sum_probs=176.7
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCC-CcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-CCCCHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHP-NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~ 76 (305)
.+++|.+...... ....+.+|+.++..+.|+ +|+++++.+......+++++++.++++.+++..... ..+.....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 103 (384)
T COG0515 24 LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA 103 (384)
T ss_pred EEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHH
Confidence 5788988766443 357899999999999988 799999999777778999999999999977754432 15888999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcc----eeecccccccccchhhhh
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTH----VSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~----~~~~~~~t~~y~aPE~~~ 151 (305)
..+..+++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.......... ......|+..|++||.+.
T Consensus 104 ~~~~~~~~~~l~~~H~~--~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~ 181 (384)
T COG0515 104 LFILAQILSALEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181 (384)
T ss_pred HHHHHHHHHHHHHHHhC--CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhc
Confidence 99999999999999965 499999999999999988 69999999998544332211 235567999999999998
Q ss_pred c---CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc----CCCCC----hHHH
Q 021947 152 T---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYP----QKAA 220 (305)
Q Consensus 152 ~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~ 220 (305)
+ ...+...|+|++|++++++++|..||....... ........+.... ..... ....
T Consensus 182 ~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (384)
T COG0515 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-------------ATSQTLKIILELPTPSLASPLSPSNPELIS 248 (384)
T ss_pred CCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-------------cHHHHHHHHHhcCCcccccccCccccchhh
Confidence 7 578889999999999999999999977654210 0000011111100 00111 2234
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..+.+++.+|+..+|..|.+..+....
T Consensus 249 ~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 249 KAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 678999999999999999988877754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=174.44 Aligned_cols=217 Identities=24% Similarity=0.386 Sum_probs=162.0
Q ss_pred HhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCC
Q 021947 26 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 105 (305)
Q Consensus 26 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~ 105 (305)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...+.++++.||.|+|+.. ...|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence 4678999999999999999999999999999999999965 3345888888999999999999999643 2399999999
Q ss_pred ceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-------CCCCCceehhhHHHHHHHhCCCcc
Q 021947 106 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-------LTTKSDVYSFGVVLLELLSGRCAV 178 (305)
Q Consensus 106 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~g~~pf 178 (305)
|++++....+||+|||+....................-|.|||.+++.. .+.++|+||+|++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987653211111122223456799999997741 466799999999999999999999
Q ss_pred CCCcccchh-hhhhhhhhhhccchhhhhhhhcccCCCCC--hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 179 DKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 179 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
......... .++.... +......+.... ....+++..++.+||..+|.+||+++.+...++.+-..
T Consensus 159 ~~~~~~~~~~eii~~~~----------~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVK----------KGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHH----------hcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 875543221 1111100 000000111111 13445789999999999999999999999888776543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-23 Score=189.46 Aligned_cols=224 Identities=23% Similarity=0.286 Sum_probs=158.5
Q ss_pred EEEEEecccCCc----cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.|+||++-.... ....+.+.|++ ...+++||++++.-+......-|||-+|..+ +|.|.+..+.. +...+..
T Consensus 48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF--L~~iEKk 123 (1431)
T KOG1240|consen 48 LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF--LVLIEKK 123 (1431)
T ss_pred eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchH--HHHHHHH
Confidence 477888754432 22244455555 5556899999998887777778999999976 99999965543 6777888
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccccccc--CCCCCCcce---eecccccccccchhhhhc
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHV---STQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~--~~~~~~~~~---~~~~~~t~~y~aPE~~~~ 152 (305)
.++.|++.||..+|. .||+|||||.+|||++.-+.+.|+||...+- ...++.... ..+...-.+|.|||.+-.
T Consensus 124 WiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 124 WIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred HHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence 899999999999995 5599999999999999999999999987642 222222221 112233457999997643
Q ss_pred C----------C-CCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHH
Q 021947 153 G----------R-LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 220 (305)
Q Consensus 153 ~----------~-~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (305)
. . .+++-||||+||++.|+++ |+++|.-. ++..|......+.+...+.+ ..
T Consensus 202 ~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le~I-----------ed 264 (1431)
T KOG1240|consen 202 ALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLEKI-----------ED 264 (1431)
T ss_pred cccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccCccCHHHHHHhC-----------cC
Confidence 1 1 5678999999999999998 78888632 12222211111112222111 12
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
..++.||..|++.||.+|.++++.|+.-
T Consensus 265 ~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 265 VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 2588999999999999999999999763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=169.82 Aligned_cols=138 Identities=17% Similarity=0.074 Sum_probs=102.4
Q ss_pred EEEEEecccCC-----ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 2 VVAVKKLKPEG-----FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+||||++.... ......|.+|+++|++++|+||+..+.. .+..|+||||++|++|.. +. . .. .
T Consensus 46 ~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~--~---~~---~ 113 (365)
T PRK09188 46 ARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-AR--P---HG---D 113 (365)
T ss_pred EEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-hC--c---cc---h
Confidence 57999875331 1124568999999999999999853322 246899999999999963 21 1 11 1
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccC-CCCceEeCCCCceeeccccccccCCCCCCcce------eecccccccccchhh
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRTHV------STQVMGTHGYAAPEY 149 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~t~~y~aPE~ 149 (305)
..++.+++.+|.|||+ .||+|||| ||+|||++.++.+||+|||+++.......... -....++..|++||.
T Consensus 114 ~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~ 191 (365)
T PRK09188 114 PAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA 191 (365)
T ss_pred HHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence 4678899999999996 45999999 99999999999999999999987654321111 124567888999998
Q ss_pred hhcC
Q 021947 150 VATG 153 (305)
Q Consensus 150 ~~~~ 153 (305)
+...
T Consensus 192 ~~~~ 195 (365)
T PRK09188 192 LTPR 195 (365)
T ss_pred CChh
Confidence 8653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=154.08 Aligned_cols=230 Identities=20% Similarity=0.202 Sum_probs=174.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+-+.. ....++..|.++.+.|+ ...|..+..++.+...-.+|||.+ |.+|++++.-... .++..+++-++
T Consensus 42 ~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLa 117 (341)
T KOG1163|consen 42 EVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLA 117 (341)
T ss_pred eEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHH
Confidence 5899987654 34467889999999997 477777777888888889999999 8899998854433 49999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCC-----Ccceeecccccccccchhhhhc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD-----RTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
.|++.-++|+|. ++++||||||+|+|..-+ ..+.|+|||+++.+.+.. .........||.+|.+--...+
T Consensus 118 DQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g 195 (341)
T KOG1163|consen 118 DQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG 195 (341)
T ss_pred HHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh
Confidence 999999999995 559999999999999644 458999999998754432 1223445679999999888888
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC---hHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ 229 (305)
...+.+-|+-|+|.++.++..|..||++...... .++...+.+.+...... .+.+.++.-.+.-
T Consensus 196 ~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-------------~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y 262 (341)
T KOG1163|consen 196 IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-------------KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNY 262 (341)
T ss_pred hhhhhhhhhhhhcceeeeeecCCCcccccchhhH-------------HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHH
Confidence 8888999999999999999999999998654322 22233333333322222 2456677778888
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q 021947 230 CLNNEPKLRPRMSEVLAILER 250 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~~ 250 (305)
|-..--++-|...-+...+.-
T Consensus 263 ~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 263 CRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HhhcCCCCCCcHHHHHHHHHH
Confidence 877777788887776665443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=162.38 Aligned_cols=196 Identities=21% Similarity=0.284 Sum_probs=141.4
Q ss_pred CCCCcccEEEEEEe---------------------------CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHH
Q 021947 30 HHPNLVKLIGYCLE---------------------------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 82 (305)
Q Consensus 30 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 82 (305)
+|||||.+++.|.+ +..+|+||..++. +|.+++-.+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999888763 3456999999965 9999996554 566677778999
Q ss_pred HHHHHhhhhcCCCceeeccCCCCceEeC--CCC--ceeeccccccccCCCCCC----cceeecccccccccchhhhhcCC
Q 021947 83 AAKGLTFLHDAESQVIYRDFKASNILLD--AEF--NAKLSDFGLAKAGPTGDR----THVSTQVMGTHGYAAPEYVATGR 154 (305)
Q Consensus 83 i~~~l~~lH~~~~~ivH~dlkp~Nil~~--~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~ 154 (305)
+++|+.|||.+ |+.|||||.+|||+. +++ .++|+|||.+-.....+- ....-...|.-.-||||+....+
T Consensus 350 lLEav~hL~~h--gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLHKH--GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHc--cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999965 599999999999993 333 379999998753222111 01111234667789999886432
Q ss_pred -----C-CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 155 -----L-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 155 -----~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
. -.++|.|+.|.+.||++....||.+..+..- + ... .........+..++..+++|+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------~-~r~----Yqe~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------D-TRT----YQESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------c-hhh----hhhhhCCCCcccCChHHHHHHH
Confidence 1 2389999999999999999999987432110 0 000 1112234567788999999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
.+|+.||++|++..-....
T Consensus 492 ~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHhcCCccccCCccHHHhH
Confidence 9999999999986554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=172.76 Aligned_cols=173 Identities=27% Similarity=0.380 Sum_probs=128.3
Q ss_pred eeEEEEecCCCCCHHHHhhhc-CCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 46 NRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 46 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
.+|+.|++|+..+|.+|+.++ .....++...+.++.|++.++.| ++.+|+|+||.||+...+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence 468999999999999999643 33457788899999999999999 349999999999999999999999999998
Q ss_pred cCCCCC----CcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhcc
Q 021947 125 AGPTGD----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 199 (305)
Q Consensus 125 ~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 199 (305)
...... .........||.+||+||.+.+..|+.++||||||+|++|++. -...|...
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------------ 466 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------------ 466 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------------
Confidence 765544 1222445679999999999999999999999999999999998 33333211
Q ss_pred chhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHH
Q 021947 200 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 243 (305)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 243 (305)
..+..+-+..+...+..+. ..-.+|+.+++.+.|.+||++.+
T Consensus 467 -~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 -ATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 0111111111110111111 23457999999999999994433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=170.38 Aligned_cols=190 Identities=29% Similarity=0.347 Sum_probs=159.0
Q ss_pred HHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 18 EWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 18 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
....|..++...+ ||.+++++-.+......++++++..||.|...+.... .+.......+...++.+++++|+ .+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~--l~ 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK--LG 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch--hH
Confidence 4456888888886 9999999999999999999999999999988885543 37777788889999999999995 56
Q ss_pred eeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCC
Q 021947 97 VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 176 (305)
++|+|+|++||+++.+|.+++.|||+++..-... ..+||..|||||++. ....++|.||||+++++|++|..
T Consensus 118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~ 189 (612)
T KOG0603|consen 118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTL 189 (612)
T ss_pred HHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCC
Confidence 9999999999999999999999999998654322 128999999999997 66779999999999999999999
Q ss_pred ccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 177 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
||.+. ....++. .....|...+..+.+++.+++..+|..|.-.
T Consensus 190 pf~~~--------------------~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 190 PFGGD--------------------TMKRILK--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchH--------------------HHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 99861 1112222 2235688899999999999999999999744
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=155.71 Aligned_cols=145 Identities=12% Similarity=0.145 Sum_probs=109.1
Q ss_pred EEEEEecccCCccChHH---------HHHHHHHHhccCCCCcccEEEEEEeC--------CeeEEEEecCCCCCHHHHhh
Q 021947 2 VVAVKKLKPEGFQGHKE---------WLTEVNYLGQLHHPNLVKLIGYCLEG--------ENRLLVYEFMPKGSLENHLF 64 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~---------~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~ 64 (305)
.+|||.+.++....... +.+|++.+.++.|++|..+.+++... +..+++|||++|.+|.++..
T Consensus 56 ~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~ 135 (232)
T PRK10359 56 KYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE 135 (232)
T ss_pred cEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh
Confidence 48999998764433322 67899999999999999999886633 35789999999999988741
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 65 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
++. ....+++.+|..+|+ .|++|||+||+||+++++| ++|+|||.......... +
T Consensus 136 ------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a-------~----- 190 (232)
T PRK10359 136 ------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA-------K----- 190 (232)
T ss_pred ------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh-------H-----
Confidence 333 245688999999995 5699999999999999988 99999998764321110 0
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHh
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLS 173 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~ 173 (305)
-.+.....++.++|+|+||+++..+..
T Consensus 191 --d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 191 --DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred --HHHHHHhHhcccccccceeEeehHHHH
Confidence 013344456679999999998776543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-20 Score=143.04 Aligned_cols=151 Identities=19% Similarity=0.169 Sum_probs=113.3
Q ss_pred HHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 18 EWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 18 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
.+.+|+++|++|. |++|++++++ +..+++|||+.|.+|...+.. ....++.+++.+|.++|++ |
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~--G 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC--G 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC--c
Confidence 4789999999995 5889999886 346999999999888654311 1135778999999999964 5
Q ss_pred eeeccC-CCCceEeCCCCceeeccccccccCCCCCCc----c-------eeecccccccccchhhhhcC-CCC-CCCcee
Q 021947 97 VIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRT----H-------VSTQVMGTHGYAAPEYVATG-RLT-TKSDVY 162 (305)
Q Consensus 97 ivH~dl-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~-------~~~~~~~t~~y~aPE~~~~~-~~~-~~~Di~ 162 (305)
|+|||| ||+|||++.++.++|+|||++......... . .......++.|+.|+...-- ..+ .+.+.+
T Consensus 112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 999999 799999999999999999999854432210 0 01122357778888754332 333 467889
Q ss_pred hhhHHHHHHHhCCCccCCCcc
Q 021947 163 SFGVVLLELLSGRCAVDKTKV 183 (305)
Q Consensus 163 slG~il~~l~~g~~pf~~~~~ 183 (305)
+.|+-+|.++|++.++.+.++
T Consensus 192 ~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HhcchHHHHHhccCCccccCC
Confidence 999999999999988766543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=142.97 Aligned_cols=100 Identities=17% Similarity=0.208 Sum_probs=78.7
Q ss_pred HHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhh-hcCCCcee
Q 021947 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL-HDAESQVI 98 (305)
Q Consensus 20 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~iv 98 (305)
.+|++++.++.++++.....+.. ...++||||++|+++...+... ..++...+..++.|++.+|.++ |+ .|++
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~--~gii 140 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD--CRLV 140 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCcc
Confidence 34999999998887744333322 2338999999987776553322 3488999999999999999999 65 4599
Q ss_pred eccCCCCceEeCCCCceeeccccccccC
Q 021947 99 YRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 99 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
||||||+||+++ ++.++|+|||++...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-20 Score=151.95 Aligned_cols=161 Identities=20% Similarity=0.257 Sum_probs=106.5
Q ss_pred EEEEecCCCCCHHHHhh---hcCC--CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccc
Q 021947 48 LLVYEFMPKGSLENHLF---RRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122 (305)
Q Consensus 48 ~lv~e~~~~~~L~~~l~---~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 122 (305)
+++|.-+.+ +|.+++. .... ..+.....+.+..|+++.+++||+. |++|+||+|+|++++.+|.+.|+||+.
T Consensus 115 ~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~--GlVHgdi~~~nfll~~~G~v~Lg~F~~ 191 (288)
T PF14531_consen 115 FLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY--GLVHGDIKPENFLLDQDGGVFLGDFSS 191 (288)
T ss_dssp EEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TEEEST-SGGGEEE-TTS-EEE--GGG
T ss_pred hhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--ceEecccceeeEEEcCCCCEEEcChHH
Confidence 678888854 8888763 2221 1244455677789999999999965 499999999999999999999999998
Q ss_pred cccCCCCCCcceeecccccccccchhhhhcC--------CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 021947 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 194 (305)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 194 (305)
....+... .. ...+..|.+||..... .++.+.|.|+||+++|.|++|..||+.........
T Consensus 192 ~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~------ 260 (288)
T PF14531_consen 192 LVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE------ 260 (288)
T ss_dssp EEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG------
T ss_pred HeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc------
Confidence 87644321 11 2345789999977442 46778999999999999999999998654221100
Q ss_pred hhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 195 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
. .-.... ++++.++.||..+|+.||.+|
T Consensus 261 ------~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 ------W---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------G---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ------c---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 0 011233 789999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.9e-19 Score=139.05 Aligned_cols=113 Identities=19% Similarity=0.189 Sum_probs=88.6
Q ss_pred EEEecccCCccChHHHHHHHHHHhcc-----CCCCcccEEEEEEeCC---eeE-EEEec--CCCCCHHHHhhhcCCCCCC
Q 021947 4 AVKKLKPEGFQGHKEWLTEVNYLGQL-----HHPNLVKLIGYCLEGE---NRL-LVYEF--MPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 4 aiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~ 72 (305)
+||++........+.+.+|+++++++ .||||+++++++.++. ..+ +|+|| +.+++|.+++.+.. ++
T Consensus 28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~---~~ 104 (210)
T PRK10345 28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR---YE 104 (210)
T ss_pred EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc---cc
Confidence 68888765555667899999999999 5799999999998763 333 78999 55789999996532 55
Q ss_pred HHHHHHHHHHHHHHH-hhhhcCCCceeeccCCCCceEeCCC----Cceeecccccc
Q 021947 73 WAVRMKVAIGAAKGL-TFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLA 123 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l-~~lH~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~ 123 (305)
+. ..++.+++.++ +|||++ +|+||||||+|||++.. +.++|+||+.+
T Consensus 105 e~--~~~~~~~L~~l~~yLh~~--~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 105 ED--VAQLRQLLKKLKRYLLDN--RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred Hh--HHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 55 35677888777 899964 59999999999999743 37999995433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=136.01 Aligned_cols=103 Identities=17% Similarity=0.118 Sum_probs=81.3
Q ss_pred HHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCcee
Q 021947 19 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98 (305)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 98 (305)
+.+|++.+.++.|++|.....+... ..|+||||++|+++....... ..++......++.+++.++.++|+. .|++
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~-~giv 140 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQE-AGLV 140 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHh-CCEe
Confidence 3579999999999988555444333 348999999987554432222 2377888999999999999999961 4699
Q ss_pred eccCCCCceEeCCCCceeeccccccccCC
Q 021947 99 YRDFKASNILLDAEFNAKLSDFGLAKAGP 127 (305)
Q Consensus 99 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 127 (305)
||||||+||+++ ++.++|+|||++....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999998 7899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=159.41 Aligned_cols=169 Identities=20% Similarity=0.190 Sum_probs=131.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
++||||+-++....+.. ==.+++.+|+ -+-|..+...+...+..+||+||.+-|+|.+++. ..+.+++..+.
T Consensus 723 ~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~ 797 (974)
T KOG1166|consen 723 KLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVM 797 (974)
T ss_pred cEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhh
Confidence 47999998876543321 1122333333 3445555555556677789999999999999996 44569999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-------CceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.+..+++..++.||.++ ||||||||+|+||... ..++|+|||.+..+.--.........++|..|--+|..
T Consensus 798 ~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~ 875 (974)
T KOG1166|consen 798 FFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR 875 (974)
T ss_pred HHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh
Confidence 99999999999999655 9999999999999532 34899999998765433333345667889999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCC
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRC 176 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~ 176 (305)
.|..|++.+|.|.|+.+++-||.|+.
T Consensus 876 ~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 876 EGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999999999973
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=158.62 Aligned_cols=230 Identities=25% Similarity=0.276 Sum_probs=174.3
Q ss_pred EEEEecccCC--ccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 3 VAVKKLKPEG--FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 3 VaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+|.|.+.... .........|..+-..+. |.|++.+++...+.+..++++++..|+++.+.+........+......+
T Consensus 49 ~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~ 128 (601)
T KOG0590|consen 49 SATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRY 128 (601)
T ss_pred eeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhh
Confidence 4555554432 122234455888888887 9999999999999999999999999999999883222223666677889
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCC-CCCcceeecccc-cccccchhhhhcC-CC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPT-GDRTHVSTQVMG-THGYAAPEYVATG-RL 155 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~~~~~-t~~y~aPE~~~~~-~~ 155 (305)
+.|+..++.|+|. +.++.|+|+||+|.+++..+ ..++.|||++..... .+........+| +..|+|||...+. ..
T Consensus 129 ~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~ 207 (601)
T KOG0590|consen 129 LPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYR 207 (601)
T ss_pred hhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhc
Confidence 9999999999994 35699999999999999999 999999999988766 444444556678 9999999998884 45
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
....|+||.|+++..+++|..|+........ ....|.. ..................+++.+++..+|
T Consensus 208 ~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 208 GPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKS------------NKGRFTQLPWNSISDQAHDLLHKILKENP 274 (601)
T ss_pred CCCcccccccccccccccCCCCccccccccc-cceeecc------------cccccccCccccCChhhhhcccccccCCc
Confidence 6789999999999999999999976543221 0011100 00111223345677888899999999999
Q ss_pred CCCCCHHHHHH
Q 021947 236 KLRPRMSEVLA 246 (305)
Q Consensus 236 ~~Rps~~~~l~ 246 (305)
..|.+.+++..
T Consensus 275 ~~r~s~~~~~~ 285 (601)
T KOG0590|consen 275 SNRLSIEELKL 285 (601)
T ss_pred hhccccccccc
Confidence 99999988764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-18 Score=156.43 Aligned_cols=138 Identities=26% Similarity=0.319 Sum_probs=105.4
Q ss_pred HHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-------------ceeecccccccccchhhh
Q 021947 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-------------HVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 84 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~~t~~y~aPE~~ 150 (305)
+.+++|+|+ .||+|||+||+|.+|+.-|.+|++|||+++........ ......+||+.|.|||++
T Consensus 153 vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 788999995 55999999999999999999999999998753322111 112345899999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccc-hhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
....|+..+|.|++|+|+|+.+.|..||.+.+... ...++.... ....-....+.+++++|.+
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----------------~wpE~dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----------------EWPEEDEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc----------------cccccCcCCCHHHHHHHHH
Confidence 99999999999999999999999999999864321 111111000 0011123467789999999
Q ss_pred hccCCCCCCC
Q 021947 230 CLNNEPKLRP 239 (305)
Q Consensus 230 ~l~~~p~~Rp 239 (305)
+|..+|..|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=127.15 Aligned_cols=115 Identities=21% Similarity=0.302 Sum_probs=94.5
Q ss_pred EEEEEecccCCccC--------hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGFQG--------HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.|++|+........ ...+.+|++++..+.|++|.....++......+++|||++|++|.+++.... .
T Consensus 21 ~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~ 95 (211)
T PRK14879 21 KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M 95 (211)
T ss_pred ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H
Confidence 57888766543221 1357889999999999998877777777788899999999999999985432 1
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
....++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 96 -~~~~i~~~i~~~l~~lH~~--~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 -EELELSREIGRLVGKLHSA--GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred -HHHHHHHHHHHHHHHHHhC--CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7788999999999999964 599999999999998 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=124.60 Aligned_cols=112 Identities=19% Similarity=0.307 Sum_probs=88.9
Q ss_pred EEEEEecccCCccC--------hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGFQG--------HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.|++|......... ..++.+|++++..+.|+++.....++......++||||++|++|.+++.... .
T Consensus 19 ~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~-- 93 (199)
T TIGR03724 19 KAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D-- 93 (199)
T ss_pred cEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H--
Confidence 57888865432211 2457789999999998876655555566677899999999999999874322 1
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
.++.+++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus 94 ----~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ----ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ----HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 788999999999996 4599999999999998 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=126.97 Aligned_cols=99 Identities=16% Similarity=0.142 Sum_probs=77.8
Q ss_pred HHHHHHHHhccCCCC--cccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 19 WLTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 19 ~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
+.+|++++.++.+.+ +.++++. ...++||||+.|.+|..+..... .+.......++.+++.+|.+||+ .|
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~g 168 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYK--EG 168 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHh--cC
Confidence 568999999997533 3444432 23589999999988876553222 35666678899999999999995 56
Q ss_pred -eeeccCCCCceEeCCCCceeeccccccccC
Q 021947 97 -VIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 97 -ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
++|+||||+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999998 788999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-15 Score=122.84 Aligned_cols=101 Identities=25% Similarity=0.204 Sum_probs=79.5
Q ss_pred hHHHHHHHHHHhccCCCCc--ccEEEEEEeC-Ce---eEEEEecCCC-CCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHh
Q 021947 16 HKEWLTEVNYLGQLHHPNL--VKLIGYCLEG-EN---RLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 88 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 88 (305)
...+.+|++++.++.|++| +..+++.... .. .++|||+++| .+|.+++... .++... +.+++.+|.
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~ 156 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIA 156 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHH
Confidence 3568899999999998775 6666664432 22 2599999997 6898888542 245443 568899999
Q ss_pred hhhcCCCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 89 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 89 ~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
+||+ .||+|+||||+|||++.++.++|+|||.+..
T Consensus 157 ~lH~--~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 157 RFHD--AGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHH--CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 9995 5599999999999999988999999998875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-15 Score=130.07 Aligned_cols=161 Identities=19% Similarity=0.217 Sum_probs=122.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
+|.|...+...........+.++.|+.++||||+++++.++..+..|||+|.+. .|..++.+.+ ...+-.-+.
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v~~Gl~ 111 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEVCLGLF 111 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHHHHHHH
Confidence 466666665433334567889999999999999999999999999999999984 6888886543 455566788
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
||+.||.|||. +.+++|++|+-+.|+++..|..||++|.++........ .......-..|..|+.+.... ...|.
T Consensus 112 qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~ 186 (690)
T KOG1243|consen 112 QILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDS 186 (690)
T ss_pred HHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhh
Confidence 99999999986 35699999999999999999999999999875433221 011112233466666543222 45799
Q ss_pred ehhhHHHHHHHhC
Q 021947 162 YSFGVVLLELLSG 174 (305)
Q Consensus 162 ~slG~il~~l~~g 174 (305)
|.|||++++++.|
T Consensus 187 ~~Lg~li~el~ng 199 (690)
T KOG1243|consen 187 WGLGCLIEELFNG 199 (690)
T ss_pred hhHHHHHHHHhCc
Confidence 9999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.2e-16 Score=125.83 Aligned_cols=206 Identities=23% Similarity=0.311 Sum_probs=141.3
Q ss_pred HHHHHhccCCCCcccEEEEEEeCC-----eeEEEEecCCCCCHHHHhhhcC--CCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 22 EVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 22 E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
-+..|-.+-|.||++++.++.+.. ...+++||+..|++..+|++.. ...+......+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 345566677999999999987543 3578999999999999996543 345778888899999999999999999
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccccCCCCC--CcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHH
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 172 (305)
..++|+++..+.|++..+|-+|+.--.-...-.... .........+-++|.+||.-.....+.++|||++|+...+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999999877775422111100000 000111223567899999766667778999999999999999
Q ss_pred hCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 173 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.|..--........ .+.....+...+. ..--+.++.+|++..|..||++++++-+
T Consensus 277 ilEiq~tnseS~~~-------------~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE-------------VEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceee-------------hhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 87643222111000 0000000000110 1112458899999999999999998854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.2e-15 Score=136.47 Aligned_cols=96 Identities=20% Similarity=0.280 Sum_probs=84.8
Q ss_pred HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 17 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
+++.+|+++++.++|++|+....++......++||||++|++|.+++. ....++.+++.+|.+||+ .+
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~--~g 448 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK--AG 448 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh--CC
Confidence 467899999999999999888777777778899999999999999884 346789999999999996 45
Q ss_pred eeeccCCCCceEeCCCCceeecccccccc
Q 021947 97 VIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
++||||||+||++ .++.++|+|||+++.
T Consensus 449 iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 449 IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999 677899999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=110.40 Aligned_cols=113 Identities=19% Similarity=0.119 Sum_probs=94.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCC--CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHH--PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.+++|....... ...+.+|+.+++.+++ .++.++++++...+..+++|||+.|+.+..+ +......+
T Consensus 23 ~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~ 91 (155)
T cd05120 23 DYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDI 91 (155)
T ss_pred eEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHH
Confidence 478888766533 5678899999999976 5899999888877889999999998777553 44566778
Q ss_pred HHHHHHHHhhhhcCC-CceeeccCCCCceEeCCCCceeecccccccc
Q 021947 80 AIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
+.+++.+|+++|... .+++|+|++|+||+++..+.++++|||.+..
T Consensus 92 ~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 92 AEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 899999999999642 4699999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=116.20 Aligned_cols=96 Identities=17% Similarity=0.072 Sum_probs=76.4
Q ss_pred HHHHHHHHHhccCCC--CcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 021947 18 EWLTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 95 (305)
Q Consensus 18 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 95 (305)
.+.+|+.++.++.|. .+...++ ....++||||++|++|..+... .....++.+++.++.++|+ .
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~--~ 144 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK--H 144 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH--C
Confidence 367799999999877 4444443 2456899999999998765421 2345688899999999996 4
Q ss_pred ceeeccCCCCceEeCCCCceeeccccccccCC
Q 021947 96 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 127 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 127 (305)
|++|+||||+||+++.++.++|+|||.+....
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 59999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-14 Score=127.89 Aligned_cols=208 Identities=23% Similarity=0.252 Sum_probs=156.6
Q ss_pred HHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHH----HHhhhh
Q 021947 17 KEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK----GLTFLH 91 (305)
Q Consensus 17 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~----~l~~lH 91 (305)
..=++|+...+++. |+|.++.+..+..++..|+-+|+|. .+|.++...... -++....+..+.+... ||..+|
T Consensus 162 ~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h 239 (524)
T KOG0601|consen 162 KRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH 239 (524)
T ss_pred ccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC
Confidence 34457888888885 9999999999999999999999994 699998865543 2777888888888888 999999
Q ss_pred cCCCceeeccCCCCceEeCCC-CceeeccccccccCCCCCCcce---eecccccccccchhhhhcCCCCCCCceehhhHH
Q 021947 92 DAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHV---STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167 (305)
Q Consensus 92 ~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 167 (305)
+. +++|-|+||.||+...+ ..++++|||+...++...-... .....|...|++||.. ++-++...|+|+||.+
T Consensus 240 s~--~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev 316 (524)
T KOG0601|consen 240 SN--NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEV 316 (524)
T ss_pred CC--cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhh
Confidence 64 59999999999999999 8899999999988765542221 2222567889999986 5567889999999999
Q ss_pred HHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 168 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 168 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
+.+..+|......+.. ..+.++-...+...+-...+..+...+..|++.+|..|+++..++.
T Consensus 317 ~l~~~l~~~~~~~g~~-----------------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 317 ILEAILGSHLPSVGKN-----------------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHhhHhhcccccCCCC-----------------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 9999998766654311 0011111111122222344556666999999999999999988875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.4e-13 Score=104.54 Aligned_cols=97 Identities=20% Similarity=0.140 Sum_probs=69.3
Q ss_pred HHHHHHHhccCCCC--cccEEEEEEeCCeeEEEEecCCCCCHHHH-hhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 20 LTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGSLENH-LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 20 ~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
..|.+.+.++.+.. +.+.++. ...++||||+.|+.+... +.... .. .....++.+++.++.++|+. .+
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~-~~ 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE-AG 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc-cC
Confidence 35677777765433 4444443 246899999998543221 11111 11 56778999999999999961 46
Q ss_pred eeeccCCCCceEeCCCCceeeccccccccC
Q 021947 97 VIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
++|+||||+||+++ ++.++|+|||.+...
T Consensus 136 ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 136 LVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.7e-12 Score=98.27 Aligned_cols=110 Identities=21% Similarity=0.084 Sum_probs=78.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCc-ccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.|+||....... ....+.+|+++++.+.+.++ .+++.+. ....++||||++|.++.+.- .. ....+
T Consensus 23 ~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~-------~~---~~~~~ 89 (170)
T cd05151 23 KYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED-------FS---DPENL 89 (170)
T ss_pred EEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc-------cc---CHHHH
Confidence 478898765532 23456789999999875554 4455443 33458999999998876430 11 12356
Q ss_pred HHHHHHHhhhhcCC---CceeeccCCCCceEeCCCCceeecccccccc
Q 021947 81 IGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 81 ~~i~~~l~~lH~~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
.+++.+|+.||+.+ .+++|+|++|.||+++ ++.++++|||.+..
T Consensus 90 ~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 90 EKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 78999999999653 1369999999999998 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=97.07 Aligned_cols=96 Identities=13% Similarity=0.137 Sum_probs=71.5
Q ss_pred HHHHHHhccC--CCCcccEEEEEEeCCeeEEEEecCCCCCHHH-HhhhcCCCCCCHHHHHHHHHHHHHHHhhh-hcCCCc
Q 021947 21 TEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLEN-HLFRRGPQPLSWAVRMKVAIGAAKGLTFL-HDAESQ 96 (305)
Q Consensus 21 ~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ 96 (305)
+|++.|+++. .-++...+++ ..-++||||+.+..+.. .+.. ..++......+..+++.+|..| |. .|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~--~g 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE--CN 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh--CC
Confidence 7999999995 3566666654 45689999997643322 2221 1255556677889999999988 74 56
Q ss_pred eeeccCCCCceEeCCCCceeeccccccccC
Q 021947 97 VIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
++||||++.||+++ ++.++|+|||.+-..
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999996 467999999977643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.9e-12 Score=112.15 Aligned_cols=103 Identities=17% Similarity=0.107 Sum_probs=69.2
Q ss_pred HHHHHHHHhccC----CCCcccEEEEE-EeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHH-HHhhhhc
Q 021947 19 WLTEVNYLGQLH----HPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK-GLTFLHD 92 (305)
Q Consensus 19 ~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~-~l~~lH~ 92 (305)
|.+|++.+.++. |.+-+.+-.++ ...+..+|||||++|++|.++...... ..+ ...++..++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh
Confidence 556777666663 22222222222 223457899999999999887643211 122 2334555554 4677884
Q ss_pred CCCceeeccCCCCceEeCCCCceeeccccccccCC
Q 021947 93 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 127 (305)
Q Consensus 93 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 127 (305)
.|++|+|+||.||+++.++.++++|||++....
T Consensus 276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 569999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.5e-10 Score=95.29 Aligned_cols=199 Identities=16% Similarity=0.174 Sum_probs=132.0
Q ss_pred eEEEEecCCCCCH-HHHh----hhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccc
Q 021947 47 RLLVYEFMPKGSL-ENHL----FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121 (305)
Q Consensus 47 ~~lv~e~~~~~~L-~~~l----~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 121 (305)
..++|..+.|..- .++. +++.....+|.-.+..+..++.+.+.||.+ |.+-||+.++|+|+++++.|+|.|-+
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--CCcccccCccceeeecCceEEEEccc
Confidence 5688888876422 2222 223333478889999999999999999965 48889999999999999999999865
Q ss_pred ccccCCCCCCcceeecccccccccchhhhh-----cCCCCCCCceehhhHHHHHHHhC-CCccCCCcccchh------hh
Q 021947 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQ------SL 189 (305)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~------~~ 189 (305)
...... +.....-.+|...|++||... +...+...|.|.||+++++++.| +.||.+-...... .+
T Consensus 163 sfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 163 SFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 544331 122233457899999999765 34567789999999999999986 9999885433211 00
Q ss_pred hhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC--CCCCCCCHHHHHHHHHhhcC
Q 021947 190 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN--EPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~~~l~~l~~~~~ 253 (305)
.....-+..+ . ..-........-....+..+..|..+|+.. ++.-|||++..+..|..+..
T Consensus 240 a~g~f~ya~~--~-~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 240 AHGRFAYASD--Q-RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hcceeeechh--c-cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0000000000 0 000000000111135667889999999865 46789999999998887653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-11 Score=92.84 Aligned_cols=96 Identities=23% Similarity=0.308 Sum_probs=75.7
Q ss_pred HHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCce
Q 021947 18 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 97 (305)
Q Consensus 18 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 97 (305)
+-.+|++++.++.--.|..-.=++.+.....|+|||++|..|.+++... ...++..+-.-+.-|| .+||
T Consensus 45 Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~gi 113 (204)
T COG3642 45 RTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGI 113 (204)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCe
Confidence 4567999999987555544444445566777999999999999888544 2456777888888999 5679
Q ss_pred eeccCCCCceEeCCCCceeecccccccc
Q 021947 98 IYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 98 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
+|+||.++||+++.++ +.++|||++..
T Consensus 114 vHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 114 VHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999997764 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2e-12 Score=119.94 Aligned_cols=193 Identities=23% Similarity=0.279 Sum_probs=141.2
Q ss_pred CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEe
Q 021947 30 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109 (305)
Q Consensus 30 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~ 109 (305)
.+|.++...-.+......+|+++|+.|++|...++.-+ ..+.+.....+..+..++++||+.. +.|+|++|.|++.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLI 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhh
Confidence 34555544444445567899999999999999886554 3566666677888899999999654 8999999999999
Q ss_pred CCCCceeeccccccccCCCC---------------------C--------CcceeecccccccccchhhhhcCCCCCCCc
Q 021947 110 DAEFNAKLSDFGLAKAGPTG---------------------D--------RTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 110 ~~~~~~kl~Dfg~~~~~~~~---------------------~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
..++..++.|||.....+.. . .........+|+.|.+||.+.+......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 99999999999843221100 0 001123456899999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC-CCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
+|++|+++++.++|..||........ ...++..... ..-+...+....+++.+.+..+|.+|.
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhcc
Confidence 99999999999999999987543211 1111111111 122346777899999999999999998
Q ss_pred CHH
Q 021947 240 RMS 242 (305)
Q Consensus 240 s~~ 242 (305)
.+.
T Consensus 1082 ~a~ 1084 (1205)
T KOG0606|consen 1082 GAK 1084 (1205)
T ss_pred Ccc
Confidence 766
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.6e-12 Score=110.85 Aligned_cols=200 Identities=21% Similarity=0.156 Sum_probs=143.8
Q ss_pred HHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCcee
Q 021947 20 LTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98 (305)
Q Consensus 20 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 98 (305)
+.|+.+...+ .|.+++.++..+....+.|+-.|||+++++...+. -...+++...+.+..+++.++.++|+.. ++
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~ 388 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL--FV 388 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh--hh
Confidence 4566666666 48999998888888888889999999998876662 2234788889999999999999999654 99
Q ss_pred eccCCCCceEeCCC-CceeeccccccccCCCCCCcceeeccccccccc--chhhhhcCCCCCCCceehhhHHHHHHHhCC
Q 021947 99 YRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA--APEYVATGRLTTKSDVYSFGVVLLELLSGR 175 (305)
Q Consensus 99 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 175 (305)
|+|+||.||++.++ +..++.|||......... .......++. +++......+..+.|+|+||..+.+.++|.
T Consensus 389 ~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 389 HLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred cccccccceeeccchhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCc
Confidence 99999999999886 778999999886422211 1112333444 445555567788999999999999999876
Q ss_pred CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 176 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
..-... .....+..+. .........++..+.+.++..++..||.+.++..+.+
T Consensus 464 ~ls~~~--------------------~~~~~i~~~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 464 PLSESG--------------------VQSLTIRSGD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccCccc--------------------ccceeeeccc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 322111 1111111111 1223344488889999999999999999988875543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-10 Score=88.40 Aligned_cols=107 Identities=21% Similarity=0.220 Sum_probs=82.0
Q ss_pred HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCC-CCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 021947 17 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 95 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 95 (305)
.+..+|+++|.++.--.|.--.-++.+...-.|.|||++| .++.+++...............++..+-+.+.-||. +
T Consensus 55 ~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~--n 132 (229)
T KOG3087|consen 55 KRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD--N 132 (229)
T ss_pred HHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh--C
Confidence 4567899999998754554444455566667799999977 478888866654444444557889999999999994 5
Q ss_pred ceeeccCCCCceEeCCCCc---eeecccccccc
Q 021947 96 QVIYRDFKASNILLDAEFN---AKLSDFGLAKA 125 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~ 125 (305)
+++||||..+||++..++. +.++|||++..
T Consensus 133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 6999999999999976653 58999999865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-10 Score=95.24 Aligned_cols=105 Identities=15% Similarity=0.149 Sum_probs=80.0
Q ss_pred HHHHHHHHHhccCCCCc--ccEEEEEEe-----CCeeEEEEecCCCC-CHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhh
Q 021947 18 EWLTEVNYLGQLHHPNL--VKLIGYCLE-----GENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 89 (305)
Q Consensus 18 ~~~~E~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 89 (305)
.+.+|...+.++..-+| ...+++++. ...-+||||++++. +|.+++........+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47899999988853333 344455543 23468999999886 79998854323345667778899999999999
Q ss_pred hhcCCCceeeccCCCCceEeCC-------CCceeeccccccc
Q 021947 90 LHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAK 124 (305)
Q Consensus 90 lH~~~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~~~ 124 (305)
||. .|++|+||++.|||++. ++.+.|+||+.+.
T Consensus 154 LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 995 56999999999999975 4679999999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-11 Score=109.82 Aligned_cols=160 Identities=20% Similarity=0.283 Sum_probs=111.7
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-----c--eeecccccccc
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----H--VSTQVMGTHGY 144 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~--~~~~~~~t~~y 144 (305)
..+....=+.+++.|+.|+|.. .++||++|.|++|.++..+.+||+.|+++-........ . ...-......|
T Consensus 97 aTe~~f~nl~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f 175 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF 175 (700)
T ss_pred cccHhhhhhhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence 3334445556677999999974 67999999999999999999999999988643331110 0 01111245679
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHH-hCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
.|||++.+...+.++|+||||+++|.+. .|+.-+..........+ ...........+...++.++
T Consensus 176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el 241 (700)
T KOG2137|consen 176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSEL 241 (700)
T ss_pred ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHH
Confidence 9999999888889999999999999999 45555544322211111 11111112223346788999
Q ss_pred HHHHHhhccCCCCCCCCHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
++=+.+++..+...||++..+..
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhhc
Confidence 99999999999999997776653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.2e-10 Score=97.68 Aligned_cols=200 Identities=16% Similarity=0.201 Sum_probs=137.1
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEE----eCCeeEEEEecCCC-CCHHHHhhhcC----------
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL----EGENRLLVYEFMPK-GSLENHLFRRG---------- 67 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~~---------- 67 (305)
+++|+++.+..........-++.++++.|.|||++.++|. ....+.+|++|+++ ++|.++-....
T Consensus 304 YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~ 383 (655)
T KOG3741|consen 304 YVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFY 383 (655)
T ss_pred eeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccccccc
Confidence 5778885443333333445688999999999999999887 34567899999875 46666542211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 68 ---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 68 ---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
+...+++.+|.++.|+..||.++|+. |+..+-|.+.+|+++.+.+++|...|+......+..
T Consensus 384 ~~~~~~~~e~~lW~y~~QLtaaL~sIHss--GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~------------- 448 (655)
T KOG3741|consen 384 PSQNLKAPEEVLWSYISQLTAALYSIHSS--GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT------------- 448 (655)
T ss_pred ccCCCCchHHHHHHHHHHHHHHHHHHHhc--CceeecccHhHeEeeCcceEEEecccceeeecCCCC-------------
Confidence 22377899999999999999999965 499999999999999998999998888766543320
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|-+.+ -.+-|.=.||.++..|.||..=-...+.. ... ........++.+++
T Consensus 449 ---~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~---------------~~s--------~~~~I~~~yS~D~r 499 (655)
T KOG3741|consen 449 ---EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST---------------QSS--------HLTRITTTYSTDLR 499 (655)
T ss_pred ---cchhH---HhhhhHHHHHHHHHHHhhcccccccccch---------------HHH--------HHHHhhhhhhHHHH
Confidence 00111 12457889999999999985211000000 000 00112345777888
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+++.-....++++ -++.+++.+
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHH
Confidence 8888888888876 667777644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-11 Score=109.27 Aligned_cols=101 Identities=14% Similarity=0.097 Sum_probs=64.8
Q ss_pred HHHHHHHHhccC----CCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHh--hhcCC--CCCCHHHHHHHHHHHHHHHhh
Q 021947 19 WLTEVNYLGQLH----HPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHL--FRRGP--QPLSWAVRMKVAIGAAKGLTF 89 (305)
Q Consensus 19 ~~~E~~~l~~l~----h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~--~~~~~~~~~~~~~~i~~~l~~ 89 (305)
+.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.+.++- ...+. ..+....+..++.|+.
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 455666666553 3333443343332 45678999999999998742 22220 0123333333444443
Q ss_pred hhcCCCceeeccCCCCceEeCCCC----ceeeccccccccCCC
Q 021947 90 LHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPT 128 (305)
Q Consensus 90 lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 128 (305)
..|++|+|+||.||+++.+| .++++|||++.....
T Consensus 278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 24599999999999999888 899999999876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.8e-10 Score=89.32 Aligned_cols=121 Identities=21% Similarity=0.288 Sum_probs=88.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCC--CCcccEEEEEEeC---CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHH--PNLVKLIGYCLEG---ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.+++|....... ....++.+|++++..+.+ .++.+++.+.... +..++||||++|.++.+.+.. ..++...
T Consensus 24 ~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~ 100 (223)
T cd05154 24 RLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEE 100 (223)
T ss_pred ceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHH
Confidence 467888765432 234578899999999975 4467777776653 256899999999888775531 1356666
Q ss_pred HHHHHHHHHHHHhhhhcC------------------------------------------------------CCceeecc
Q 021947 76 RMKVAIGAAKGLTFLHDA------------------------------------------------------ESQVIYRD 101 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------------------------------------------------------~~~ivH~d 101 (305)
...++.+++..|..||+. ...++|+|
T Consensus 101 ~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD 180 (223)
T cd05154 101 RRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGD 180 (223)
T ss_pred HHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECC
Confidence 667777777777777732 23579999
Q ss_pred CCCCceEeCC--CCceeecccccccc
Q 021947 102 FKASNILLDA--EFNAKLSDFGLAKA 125 (305)
Q Consensus 102 lkp~Nil~~~--~~~~kl~Dfg~~~~ 125 (305)
+++.||+++. ++.+.|+||+.+..
T Consensus 181 ~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 181 YRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CCcccEEEcCCCCcEEEEEecccccc
Confidence 9999999988 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.4e-09 Score=83.63 Aligned_cols=106 Identities=22% Similarity=0.212 Sum_probs=82.5
Q ss_pred hHHHHHHHHHHhccCC--CCcccEEEEEEeC----CeeEEEEecCCCC-CHHHHhhhcCCCCCCHHHHHHHHHHHHHHHh
Q 021947 16 HKEWLTEVNYLGQLHH--PNLVKLIGYCLEG----ENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 88 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~ 88 (305)
...+.+|...+..|.. =.+.+.+++.... ...+||+|+++|. +|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3567889998888853 3345556665542 2348999999884 79998865332 566677889999999999
Q ss_pred hhhcCCCceeeccCCCCceEeCCCC---ceeecccccccc
Q 021947 89 FLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA 125 (305)
Q Consensus 89 ~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~ 125 (305)
-||. .|++|+|+++.|||++.++ .+.++||+-++.
T Consensus 133 ~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9995 5699999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.3e-09 Score=83.72 Aligned_cols=98 Identities=21% Similarity=0.213 Sum_probs=62.3
Q ss_pred HHHHHHHHHhccCCC--CcccEEEEEEeCCeeEEEEecCC--CCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhh-hhc
Q 021947 18 EWLTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF-LHD 92 (305)
Q Consensus 18 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~-lH~ 92 (305)
...+|++.|.++..- ++.+.+++. ...|||||++ |..+..+. ... ++......++.+++..+.. +|.
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~ 125 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHK 125 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHh
Confidence 356899999999755 566666542 3469999998 65554433 221 1123345566677774444 564
Q ss_pred CCCceeeccCCCCceEeCCCCceeeccccccccC
Q 021947 93 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 93 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
.|++||||.+.||+++++ .+.++|||.+...
T Consensus 126 --~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 126 --AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp --TTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred --cCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 569999999999999877 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-07 Score=74.89 Aligned_cols=108 Identities=19% Similarity=0.175 Sum_probs=81.4
Q ss_pred ChHHHHHHHHHHhccCCCC--cccEEEEEE---eC--CeeEEEEecCCC-CCHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 021947 15 GHKEWLTEVNYLGQLHHPN--LVKLIGYCL---EG--ENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKG 86 (305)
Q Consensus 15 ~~~~~~~E~~~l~~l~h~~--i~~~~~~~~---~~--~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~ 86 (305)
....|.+|+..|.+|..-+ +.+.. ++. .+ -.-+||+|-+.| .+|.+++....-...+......++.+++..
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 4568999999999996322 44443 222 11 124799998754 488888866544456778888999999999
Q ss_pred HhhhhcCCCceeeccCCCCceEeCCCCc--eeecccccccc
Q 021947 87 LTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKA 125 (305)
Q Consensus 87 l~~lH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 125 (305)
++-||+ .|+.|+|+-+.||+++.+|. ++++||.-++.
T Consensus 141 ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999996 45999999999999986666 99999986654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.2e-07 Score=76.55 Aligned_cols=95 Identities=15% Similarity=0.095 Sum_probs=65.5
Q ss_pred HHHHHHHHHHhccCCC--CcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 17 KEWLTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
....+|+++|.+|... .|.+.+++ +.-.+|||+++|..|...-- +....-.++..|++-+.-+- .
T Consensus 154 l~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~--~ 220 (304)
T COG0478 154 LAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY--R 220 (304)
T ss_pred HHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH--H
Confidence 3467899999999754 77777664 45679999999976655331 12222223333333333333 2
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
.|+||||+.+-||+++++|.+.++||--+.
T Consensus 221 ~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 221 RGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cCccccCCchheEEEecCCCEEEEeCcccc
Confidence 459999999999999999999999996554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-06 Score=70.63 Aligned_cols=120 Identities=12% Similarity=0.111 Sum_probs=70.1
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccCCCC--cccEEEEEEeCCeeEEEEecCCCCC-HHHHh----------------
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGS-LENHL---------------- 63 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l---------------- 63 (305)
+++|...... ......+|+++++.+..-. +.+.+++...++..++|||+++|.+ +...+
T Consensus 25 ~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~ 102 (226)
T TIGR02172 25 WMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAE 102 (226)
T ss_pred EEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHH
Confidence 3456665432 3456789999999986433 4777888877788889999999863 21111
Q ss_pred -----hhcCCCCCCHHHHHH-HHH----------HHHH-HHhhh--hcCCCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 64 -----FRRGPQPLSWAVRMK-VAI----------GAAK-GLTFL--HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 64 -----~~~~~~~~~~~~~~~-~~~----------~i~~-~l~~l--H~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
+.............. +.. .+.. ...+| +.....++|+|+.|.||++++++ +.++||+.+.
T Consensus 103 ~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 103 MAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 000000111111000 000 0000 01111 12234589999999999999888 9999999875
Q ss_pred c
Q 021947 125 A 125 (305)
Q Consensus 125 ~ 125 (305)
.
T Consensus 182 ~ 182 (226)
T TIGR02172 182 Y 182 (226)
T ss_pred c
Confidence 3
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.1e-06 Score=66.39 Aligned_cols=99 Identities=25% Similarity=0.286 Sum_probs=78.3
Q ss_pred HHHHHHhccCC-CCcccEEEEEEeCCeeEEEEecCCCCCHHHH---hhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC-C
Q 021947 21 TEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENH---LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE-S 95 (305)
Q Consensus 21 ~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ 95 (305)
+|.-+++.+.+ +++.+++|+| ..++|.||...+++... +.+. ...+|..+.+++.++++.+.+++... .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888898875 7999999998 34689999986655421 1111 13789999999999999999998521 2
Q ss_pred ceeeccCCCCceEeCCCCceeecccccccc
Q 021947 96 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
.+.-.|++++|+-++++|++|++|.+.+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 388889999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.9e-07 Score=71.07 Aligned_cols=67 Identities=15% Similarity=0.141 Sum_probs=51.0
Q ss_pred CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 45 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 45 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
...+++|||++|..|.+... +++ .+...+.+++.-+|.. |++|||..|.|+++++++ ++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~--G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH--GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc--CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 34568999999988876531 222 2445667789999965 599999999999998654 9999997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.7e-08 Score=87.27 Aligned_cols=153 Identities=18% Similarity=0.158 Sum_probs=112.9
Q ss_pred HHHHHHHHHHhccCCCC-cccEEEEEEeCCeeEEEEecCCCC-CHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 17 KEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
....-++++|.+++||| .+..++-+..+...+++++++.++ +-..... .....+........+..-+++++++|+..
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~ 356 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY 356 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc
Confidence 34456899999999999 677777777777889999999876 2222111 11112444455566777788999999643
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhC
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 174 (305)
=+|+| ||+.++ +..+..||+......... ......+++.++|||+..+..+....|.|++|.-..++.-|
T Consensus 357 --~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 357 --KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred --ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 47888 887755 578999999887654432 24456789999999999999999999999999877788878
Q ss_pred CCccCC
Q 021947 175 RCAVDK 180 (305)
Q Consensus 175 ~~pf~~ 180 (305)
-+|-..
T Consensus 427 ~pPr~~ 432 (829)
T KOG0576|consen 427 LPPRSS 432 (829)
T ss_pred CCCCCC
Confidence 777654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.8e-06 Score=71.14 Aligned_cols=119 Identities=17% Similarity=0.083 Sum_probs=71.0
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhh-----------------
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF----------------- 64 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----------------- 64 (305)
+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.++.....
T Consensus 25 ~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~ 101 (244)
T cd05150 25 LYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRR 101 (244)
T ss_pred EEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHH
Confidence 4566655432 345678999998884 4446677777776667899999999987764321
Q ss_pred --hcC--CCCCCHH--HHHHH-----------------------HHHHHHHHhhhh--cCCCceeeccCCCCceEeCCCC
Q 021947 65 --RRG--PQPLSWA--VRMKV-----------------------AIGAAKGLTFLH--DAESQVIYRDFKASNILLDAEF 113 (305)
Q Consensus 65 --~~~--~~~~~~~--~~~~~-----------------------~~~i~~~l~~lH--~~~~~ivH~dlkp~Nil~~~~~ 113 (305)
... ..++... ..... ..++...|.... .....++|+|+.|.|||+++++
T Consensus 102 lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~ 181 (244)
T cd05150 102 LHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGK 181 (244)
T ss_pred HhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCc
Confidence 000 0011100 00000 111111111100 1134599999999999999887
Q ss_pred ceeeccccccc
Q 021947 114 NAKLSDFGLAK 124 (305)
Q Consensus 114 ~~kl~Dfg~~~ 124 (305)
.+.|+||+.+.
T Consensus 182 ~~~iIDwe~a~ 192 (244)
T cd05150 182 FSGFIDLGRLG 192 (244)
T ss_pred EEEEEEccccc
Confidence 78899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.9e-06 Score=65.60 Aligned_cols=108 Identities=21% Similarity=0.312 Sum_probs=75.8
Q ss_pred EEEEecccCC----------------ccChHHHHHHHHHHhccC------CCCcccEEEEEEeCCeeEEEEecCCC----
Q 021947 3 VAVKKLKPEG----------------FQGHKEWLTEVNYLGQLH------HPNLVKLIGYCLEGENRLLVYEFMPK---- 56 (305)
Q Consensus 3 VaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~---- 56 (305)
.+||+..... .....+..+|+.....+. +.+|.+++|+.+.+....+|+|.+.+
T Consensus 26 ~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~ 105 (199)
T PF10707_consen 26 LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGN 105 (199)
T ss_pred eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCC
Confidence 3578877665 123456777887777666 89999999999999889999998753
Q ss_pred --CCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----ceeecc
Q 021947 57 --GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSD 119 (305)
Q Consensus 57 --~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~D 119 (305)
.+|.+++.+.. ++. .....+.++.+ +|-+ ++|+.+||+|+||++.... .+.|+|
T Consensus 106 ~s~TL~~~l~~~~---~~~-~~~~~L~~f~~---~l~~--~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 106 ISPTLEDYLKEGG---LTE-ELRQALDEFKR---YLLD--HHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cCccHHHHHHcCC---ccH-HHHHHHHHHHH---HHHH--cCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 36888885443 555 44445555544 4432 2399999999999995532 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6e-06 Score=78.96 Aligned_cols=196 Identities=21% Similarity=0.221 Sum_probs=132.5
Q ss_pred HHHHHHHHhccCCCCcccEEEEEEeCCe----eEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 19 WLTEVNYLGQLHHPNLVKLIGYCLEGEN----RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
...|+..+.+..|+|++.++.+..+... ..+..|+|...++...+...+. .+......+..++.+||+++|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3457777888899999999998765432 2356788888888888865553 777888889999999999999753
Q ss_pred CceeeccCCCC---ceEeCCCCceeec--cccccccCCCCCCcceeecccccccccchhhhhcCCCCC--CCceehhhHH
Q 021947 95 SQVIYRDFKAS---NILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT--KSDVYSFGVV 167 (305)
Q Consensus 95 ~~ivH~dlkp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Di~slG~i 167 (305)
+.|.-|... +--.+.++.+... ||+.......... ......+..+.++|.......+. ..|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 444444433 3333445556666 8887765544322 22223456678888776665544 4799999999
Q ss_pred HHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 168 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 168 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
...+..|..+-... ......+ +........++..+|+..+.++|+++.+++.+
T Consensus 382 ~~~~~~~~~i~~~~-------------------~~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKS-------------------AVPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccc-------------------cchhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999876432110 0011111 11112267889999999999999999999876
Q ss_pred H
Q 021947 248 L 248 (305)
Q Consensus 248 l 248 (305)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.7e-06 Score=74.48 Aligned_cols=105 Identities=14% Similarity=0.131 Sum_probs=67.5
Q ss_pred HHHHHHHHhccC-----CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcC
Q 021947 19 WLTEVNYLGQLH-----HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 93 (305)
Q Consensus 19 ~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 93 (305)
+.+|+..+.++. .++|.--.=++...+...|+|||++|..+.+...-.. ...+...+.....++.----+-
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~--- 283 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR--- 283 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh---
Confidence 456777777763 3443222222333566789999999999988742222 2356444433333322111122
Q ss_pred CCceeeccCCCCceEeCCCCceeeccccccccCCC
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 128 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 128 (305)
.|+.|.|.+|.||+++.+|.+.+.|||+......
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3499999999999999999999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.4e-06 Score=65.45 Aligned_cols=98 Identities=20% Similarity=0.194 Sum_probs=64.9
Q ss_pred HHHHHHHhccC--CCCcccEEEEEEeCCeeEEEEecCCCCCH-HHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCc
Q 021947 20 LTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSL-ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 96 (305)
Q Consensus 20 ~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 96 (305)
.+|+..|+++. +=.+.+-+++. .-.|||||+..... .-.|. ..++.......+..++++.+.-|-. ..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~-~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYK-EAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHH-hcC
Confidence 46899999885 44445555543 34699999954311 01111 1112333566667777777776654 256
Q ss_pred eeeccCCCCceEeCCCCceeeccccccccC
Q 021947 97 VIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 97 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
+||+||..-|||+. ++.+.++|||-+...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999998 778999999977643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-05 Score=65.98 Aligned_cols=31 Identities=19% Similarity=0.243 Sum_probs=26.1
Q ss_pred CceeeccCCCCceEeCCCCceeecccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
.+++|+|+.+.||++++++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4599999999999998766567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=4e-05 Score=74.02 Aligned_cols=57 Identities=18% Similarity=0.315 Sum_probs=39.3
Q ss_pred EEEEecccCC-ccChHHHHHHHHHHhccC-CCCc--ccEEEEEEeC---CeeEEEEecCCCCCH
Q 021947 3 VAVKKLKPEG-FQGHKEWLTEVNYLGQLH-HPNL--VKLIGYCLEG---ENRLLVYEFMPKGSL 59 (305)
Q Consensus 3 VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 59 (305)
+++|+..... ......+.+|+++|+.+. |.+| .+++.++.+. +..|+||||++|..+
T Consensus 68 ~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 68 YVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred EEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 4556544322 123457889999999995 6665 7777777654 467999999998643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.8e-05 Score=64.49 Aligned_cols=121 Identities=19% Similarity=0.181 Sum_probs=64.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCC--CcccEEEEEE---eCCeeEEEEecCCCCCHHH---------------
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP--NLVKLIGYCL---EGENRLLVYEFMPKGSLEN--------------- 61 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~~~L~~--------------- 61 (305)
.+++|..... .....+.+|+.+++.+... .+.+++.... .....+++|++++|..+..
T Consensus 22 ~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~ 99 (239)
T PF01636_consen 22 RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLG 99 (239)
T ss_dssp EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHH
T ss_pred EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccch
Confidence 4677776544 3456788999999888533 3556666443 3345689999999987777
Q ss_pred -Hhh---hc--CCCCCCHHH---------HHHH------------HHHHHH-HHhhhhc-----CCCceeeccCCCCceE
Q 021947 62 -HLF---RR--GPQPLSWAV---------RMKV------------AIGAAK-GLTFLHD-----AESQVIYRDFKASNIL 108 (305)
Q Consensus 62 -~l~---~~--~~~~~~~~~---------~~~~------------~~~i~~-~l~~lH~-----~~~~ivH~dlkp~Nil 108 (305)
.+. +. ....+.... .... ...+.. .+..+++ ....++|+|+.+.||+
T Consensus 100 ~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil 179 (239)
T PF01636_consen 100 RALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNIL 179 (239)
T ss_dssp HHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEE
T ss_pred hhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccce
Confidence 110 11 001111100 0000 011111 2222321 2456999999999999
Q ss_pred eC-CCCceeeccccccc
Q 021947 109 LD-AEFNAKLSDFGLAK 124 (305)
Q Consensus 109 ~~-~~~~~kl~Dfg~~~ 124 (305)
++ .++.+.|+||+.+.
T Consensus 180 ~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 180 VDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EESSTTEEEE--GTT-E
T ss_pred eeeccceeEEEecccce
Confidence 99 55666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.6e-05 Score=61.59 Aligned_cols=29 Identities=24% Similarity=0.274 Sum_probs=25.7
Q ss_pred ceeeccCCCCceEeCCCCceeecccccccc
Q 021947 96 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999998876 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.1e-05 Score=68.34 Aligned_cols=102 Identities=18% Similarity=0.180 Sum_probs=64.7
Q ss_pred HHHHHHHHHhcc----CCCC------cccEEEEEEeCCeeEEEEecCCCCCHHHH--hhhcCCCCCCHHHHHHHHHHHHH
Q 021947 18 EWLTEVNYLGQL----HHPN------LVKLIGYCLEGENRLLVYEFMPKGSLENH--LFRRGPQPLSWAVRMKVAIGAAK 85 (305)
Q Consensus 18 ~~~~E~~~l~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~~i~~ 85 (305)
+|.+|++...++ .|-+ |.++|-.+ .....|+||||+|..+.+. +.+.+ ++...+...+.+...
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL 314 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH
Confidence 356677766655 3444 44443322 3466899999999876654 33333 555544433333332
Q ss_pred HHhhhhcCCCceeeccCCCCceEeCC----CCceeeccccccccCCC
Q 021947 86 GLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPT 128 (305)
Q Consensus 86 ~l~~lH~~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~ 128 (305)
-.-+- .|++|+|=+|.||+++. ++.+.+.|||+......
T Consensus 315 ~qIf~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFK----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHh----cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22222 34999999999999983 66799999999876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00027 Score=57.73 Aligned_cols=30 Identities=20% Similarity=0.285 Sum_probs=26.5
Q ss_pred CceeeccCCCCceEeCC-CCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDA-EFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 124 (305)
.+++|+|+.+.|||++. ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46999999999999997 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=3.2e-06 Score=82.81 Aligned_cols=158 Identities=13% Similarity=0.029 Sum_probs=114.1
Q ss_pred HHHHHHHhccCCCCcccEEEEEE--eCCeeEEEEecCCCCCHHHHhhhcCC--CCCCHHHHHHHHHHHHHHHhhhhcC--
Q 021947 20 LTEVNYLGQLHHPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDA-- 93 (305)
Q Consensus 20 ~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-- 93 (305)
+.|.+.+++..|+++...+.-.. ++...|.+++++.+|.+.+.|.+... .+++..-+...-.+.+....-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 44555556678888877665443 23456899999999999998865432 2344444444444446666666654
Q ss_pred -CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHH
Q 021947 94 -ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172 (305)
Q Consensus 94 -~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 172 (305)
++-.+|++||+-|.++..+..++++++|+.+.... .....+...+++.|+.+++...-.++.++|+|..|+.+|...
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23478999999999999999999999999983222 112233456788899999988888888899999999999999
Q ss_pred hCCCccC
Q 021947 173 SGRCAVD 179 (305)
Q Consensus 173 ~g~~pf~ 179 (305)
.|..+|-
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8887663
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00015 Score=61.52 Aligned_cols=120 Identities=18% Similarity=0.180 Sum_probs=66.8
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccCCCC--cccEEEE------EEeCCeeEEEEecCCCCCHHH----Hh-------
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIGY------CLEGENRLLVYEFMPKGSLEN----HL------- 63 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~~~~~L~~----~l------- 63 (305)
+++|+... .....+..|++++..+.+.+ +.+++.. ...++..++|+++++|..+.. ..
T Consensus 40 ~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~L 116 (296)
T cd05153 40 YVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEAL 116 (296)
T ss_pred EEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHH
Confidence 45677654 23456777888888885322 4444331 233456789999999876432 01
Q ss_pred ---hhc--C-CC------CCCHHHHH----------HHHHHHHHHHhhhhc-----CCCceeeccCCCCceEeCCCCcee
Q 021947 64 ---FRR--G-PQ------PLSWAVRM----------KVAIGAAKGLTFLHD-----AESQVIYRDFKASNILLDAEFNAK 116 (305)
Q Consensus 64 ---~~~--~-~~------~~~~~~~~----------~~~~~i~~~l~~lH~-----~~~~ivH~dlkp~Nil~~~~~~~k 116 (305)
+.. + .. ...+.... .....+...+.++.. ...+++|+|+.|.||++++++.+.
T Consensus 117 a~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~ 196 (296)
T cd05153 117 ARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSG 196 (296)
T ss_pred HHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEE
Confidence 000 0 00 00110000 001112223333331 234699999999999999877778
Q ss_pred ecccccccc
Q 021947 117 LSDFGLAKA 125 (305)
Q Consensus 117 l~Dfg~~~~ 125 (305)
|+||+.+..
T Consensus 197 iIDfe~a~~ 205 (296)
T cd05153 197 VIDFYFACT 205 (296)
T ss_pred EeehhhhcC
Confidence 999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00067 Score=57.52 Aligned_cols=44 Identities=16% Similarity=0.055 Sum_probs=34.3
Q ss_pred hHHHHHHHHHHhccCC---CCcccEEEEEEeC---CeeEEEEecCCCCCH
Q 021947 16 HKEWLTEVNYLGQLHH---PNLVKLIGYCLEG---ENRLLVYEFMPKGSL 59 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~e~~~~~~L 59 (305)
...+.+|++.|+.+.. -.|.++++++..+ +..+||||+++|.++
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 3578899999998853 4678888877543 568999999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00054 Score=52.29 Aligned_cols=107 Identities=13% Similarity=0.084 Sum_probs=71.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCccc-EEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVK-LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+-..+ ..+..+..|+++|..+...++.+ ++.+. ..++.|||++|..|.++... .+...+
T Consensus 47 ~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~-----~~rk~l---- 111 (201)
T COG2112 47 EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIG-----GDRKHL---- 111 (201)
T ss_pred eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhc-----ccHHHH----
Confidence 5788887765 45678899999999998777644 44443 33566999999888876531 122232
Q ss_pred HHHHHHHhhhhcCCCceeeccCC-CCceEeCCCCceeecccccccc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFK-ASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlk-p~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..+++.-.-|. ..||-|+.|. |..+++.+++.+.|+||..|+.
T Consensus 112 ~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 112 LRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred HHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 33334422333 2458888887 5555555666899999998874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00052 Score=58.41 Aligned_cols=31 Identities=29% Similarity=0.259 Sum_probs=27.1
Q ss_pred CCceeeccCCCCceEeCCC----Cceeeccccccc
Q 021947 94 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAK 124 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~ 124 (305)
...++|+|+.+.||+++.+ +.++++||.++.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3469999999999999875 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00056 Score=57.88 Aligned_cols=103 Identities=20% Similarity=0.252 Sum_probs=65.7
Q ss_pred hHHHHHHHHHHhccCC--CCcccEEEEEEeCC--eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH-HHHHHHHhhh
Q 021947 16 HKEWLTEVNYLGQLHH--PNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFL 90 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~-~~i~~~l~~l 90 (305)
.....+|+.+++.+.- --+...++.|.++. ..|.||+|++|..+.+..... ... -.++ ..+++.|+.|
T Consensus 65 ~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-----~~~--~~~~~~~l~~~La~L 137 (321)
T COG3173 65 AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-----SLG--RQFALDALADFLAEL 137 (321)
T ss_pred hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-----cch--HHHHHHHHHHHHHHH
Confidence 3456678888888753 33344456666555 669999999985443322110 000 0111 2444444444
Q ss_pred hcC--------------------------------------------------------CCceeeccCCCCceEeCCCCc
Q 021947 91 HDA--------------------------------------------------------ESQVIYRDFKASNILLDAEFN 114 (305)
Q Consensus 91 H~~--------------------------------------------------------~~~ivH~dlkp~Nil~~~~~~ 114 (305)
|+. ...++|||+.+.|+++++++.
T Consensus 138 H~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~ 217 (321)
T COG3173 138 HSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP 217 (321)
T ss_pred hCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe
Confidence 421 136999999999999999988
Q ss_pred eeecccccccc
Q 021947 115 AKLSDFGLAKA 125 (305)
Q Consensus 115 ~kl~Dfg~~~~ 125 (305)
+-|+||+.+..
T Consensus 218 ~gVlDwe~~~l 228 (321)
T COG3173 218 TGVLDWELATL 228 (321)
T ss_pred eEEEecccccc
Confidence 99999999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00048 Score=61.09 Aligned_cols=166 Identities=25% Similarity=0.306 Sum_probs=94.1
Q ss_pred hHHHHHHHHHHhccCCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 16 HKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
..+++..++.++.+.|+|...++++.... ....+|||++ +.+|++.+..+.... .. + + -|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~---~s-------~---~--~~--- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD---ES-------L---L--AH--- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch---hh-------h---c--cc---
Confidence 35677889999999999999999887643 4467999999 569999886554111 11 0 0 12
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhC
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 174 (305)
++.|- || .+.+| -+.... .. ...+++|||++|.++.++.-|
T Consensus 87 -~~~~~-----~~-------~~~td-~~~t~~---------~~----------------~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 -GVLHL-----NI-------IYITD-HFLTKY---------PS----------------PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -cccee-----hh-------hhccc-cccccC---------CC----------------CCCcchhhhhHHHHHHHHHHh
Confidence 23332 22 22333 111000 00 111399999999999999999
Q ss_pred CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 021947 175 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245 (305)
Q Consensus 175 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 245 (305)
...+........- .....+.............. ...-.+.....++.++|+-..|..||...++.
T Consensus 128 ~~l~~~~~~s~~l---~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 128 ISLEAELTESEYL---EILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hHHHHHHHHHHHH---HHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 8766543321110 00011111111111111100 11224566778899999999999998666554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.001 Score=52.75 Aligned_cols=99 Identities=16% Similarity=0.139 Sum_probs=64.7
Q ss_pred EEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHH
Q 021947 5 VKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 83 (305)
Q Consensus 5 iK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i 83 (305)
+|++...... ...-|.++.+++.++. .|+++..- .+-.+.++.|+|-.... .. ..++..=
T Consensus 90 lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~ag 150 (308)
T PF07387_consen 90 LKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFITAG 150 (308)
T ss_pred hhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHHHh
Confidence 5555544333 3455678888888764 35555421 22345689999854211 11 1112222
Q ss_pred HHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccc
Q 021947 84 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122 (305)
Q Consensus 84 ~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 122 (305)
+..|.-.|+...+.+|||..|+||+-+..|-+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 456778898788899999999999999999999999653
|
The function of this family is unknown. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0044 Score=53.14 Aligned_cols=32 Identities=25% Similarity=0.293 Sum_probs=26.8
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..+++|+|+.+.||+++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 35799999999999998665568999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0029 Score=54.86 Aligned_cols=31 Identities=19% Similarity=0.268 Sum_probs=26.4
Q ss_pred CceeeccCCCCceEeCC-CCceeecccccccc
Q 021947 95 SQVIYRDFKASNILLDA-EFNAKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 125 (305)
..++|+|+++.||++++ ++.++++||.++..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 35999999999999976 46799999988753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.002 Score=51.65 Aligned_cols=30 Identities=30% Similarity=0.381 Sum_probs=21.2
Q ss_pred CceeeccCCCCceEe-CCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILL-DAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~-~~~~~~kl~Dfg~~~ 124 (305)
..++|+|+.+.||++ +.++.++++||.++.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358999999999999 888899999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0077 Score=52.94 Aligned_cols=31 Identities=19% Similarity=0.278 Sum_probs=26.0
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
...++|||+.+.||++..+ .++++||.++.+
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 3469999999999999776 589999987754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0047 Score=51.75 Aligned_cols=31 Identities=26% Similarity=0.419 Sum_probs=25.8
Q ss_pred CceeeccCCCCceEeCCCCc-eeecccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFN-AKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~ 125 (305)
..++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999987555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.025 Score=45.39 Aligned_cols=44 Identities=25% Similarity=0.408 Sum_probs=34.6
Q ss_pred HHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecCCCCCHH
Q 021947 17 KEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60 (305)
Q Consensus 17 ~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 60 (305)
..|..|+.-|+.|. .-.|.+++.+..+..+.|+||||++-+.+.
T Consensus 53 ~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 53 SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 56777888777774 356788888888889999999999876554
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0023 Score=53.79 Aligned_cols=93 Identities=17% Similarity=0.136 Sum_probs=62.2
Q ss_pred HHHHHHHHHhccC-C-CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 021947 18 EWLTEVNYLGQLH-H-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 95 (305)
Q Consensus 18 ~~~~E~~~l~~l~-h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 95 (305)
...+|+..|+.|. | =-|.+.++ .+.-++|||++.|..|...-. ..+...+..-+..+ +.-|. ++
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~---Iv~la--~~ 221 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGL---IVRLA--NH 221 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHH---HHHHH--Hc
Confidence 4567999999885 3 22334443 345679999999987765431 12333333333333 33444 45
Q ss_pred ceeeccCCCCceEeCCCCceeeccccccc
Q 021947 96 QVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
|+||+|..-=||++.+++.++++||--.-
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhh
Confidence 69999999999999999999999997554
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0087 Score=51.61 Aligned_cols=30 Identities=20% Similarity=0.257 Sum_probs=25.7
Q ss_pred ceeeccCCCCceEeCC-CCceeecccccccc
Q 021947 96 QVIYRDFKASNILLDA-EFNAKLSDFGLAKA 125 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 125 (305)
-++|+|+.+.||++++ ++.++++||.++-.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3899999999999975 46899999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0092 Score=51.07 Aligned_cols=72 Identities=19% Similarity=0.156 Sum_probs=55.3
Q ss_pred CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 45 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 45 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
...|++|++. |+++. .+. .-..++...++.+.+..++-+.. +-.+-|||+.-.||||+ +|.+.|+||-+++
T Consensus 299 ~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeee
Confidence 3457888876 54553 231 14567888888888887777765 45689999999999998 8999999999998
Q ss_pred c
Q 021947 125 A 125 (305)
Q Consensus 125 ~ 125 (305)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 5
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.016 Score=48.33 Aligned_cols=47 Identities=17% Similarity=0.109 Sum_probs=35.6
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
.+..+-..+.-.+....-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 44455555555553213599999999999999989999999988753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.0069 Score=47.20 Aligned_cols=29 Identities=24% Similarity=0.251 Sum_probs=25.6
Q ss_pred ceeeccCCCCceEeCCCCceeecccccccc
Q 021947 96 QVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 96 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998877 89999998853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.039 Score=46.46 Aligned_cols=52 Identities=23% Similarity=0.257 Sum_probs=31.8
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecCCCC
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKG 57 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 57 (305)
+.||+-. ......|..|++-|+.|. .-.+.+++++....+..||||||++.+
T Consensus 43 ~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 43 YFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4566544 123456788999888883 456778888888777789999999865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.018 Score=49.12 Aligned_cols=31 Identities=29% Similarity=0.331 Sum_probs=27.3
Q ss_pred CCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3579999999999999988767899998875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.05 Score=47.83 Aligned_cols=29 Identities=24% Similarity=0.170 Sum_probs=24.2
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
..++|.|+-+.||+.+++ .++++||.+|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 358999999999998654 59999998774
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.023 Score=48.02 Aligned_cols=53 Identities=19% Similarity=0.125 Sum_probs=33.7
Q ss_pred HHHHHHHHHHHHHhhh-hcC-CCceeeccCCCCceEeCCCC------------------ceeeccccccccCC
Q 021947 75 VRMKVAIGAAKGLTFL-HDA-ESQVIYRDFKASNILLDAEF------------------NAKLSDFGLAKAGP 127 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~l-H~~-~~~ivH~dlkp~Nil~~~~~------------------~~kl~Dfg~~~~~~ 127 (305)
-+..++.|++.-.-.+ .-. -.+.+|-||||+|||+-+.. .++|.||++++..+
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 352 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVAN 352 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHcc
Confidence 3445666776443222 111 13599999999999995432 26788888887644
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.038 Score=47.16 Aligned_cols=31 Identities=23% Similarity=0.268 Sum_probs=26.2
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..+++|||+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 357999999999999987 5689999987653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.053 Score=46.17 Aligned_cols=51 Identities=20% Similarity=0.316 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHHhhhh--cC--CCceeeccCCCCceEeCCC------------------CceeeccccccccCCC
Q 021947 76 RMKVAIGAAKGLTFLH--DA--ESQVIYRDFKASNILLDAE------------------FNAKLSDFGLAKAGPT 128 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH--~~--~~~ivH~dlkp~Nil~~~~------------------~~~kl~Dfg~~~~~~~ 128 (305)
+.-++.|++ |-|+- .. -.+.+|-||||+|||+-+. -.++|.||++++..+-
T Consensus 277 vkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i 349 (434)
T PF05445_consen 277 VKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANI 349 (434)
T ss_pred HHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhccc
Confidence 344566665 33421 10 2359999999999999443 2378889998886543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.19 Score=44.42 Aligned_cols=31 Identities=10% Similarity=0.216 Sum_probs=25.2
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
...++||||.+.||+++.++ .+++|..++.+
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~ 259 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY 259 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence 35699999999999998875 88888766543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.056 Score=46.15 Aligned_cols=32 Identities=16% Similarity=0.198 Sum_probs=28.6
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..+++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.03 Score=44.31 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=25.8
Q ss_pred CceeeccCCCCceEeCCCC-----ceeecccccccc
Q 021947 95 SQVIYRDFKASNILLDAEF-----NAKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~ 125 (305)
+.++|||+.+.||++..++ .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4699999999999997543 589999987763
|
subfamily of choline kinases |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.12 Score=44.58 Aligned_cols=100 Identities=16% Similarity=0.120 Sum_probs=61.6
Q ss_pred HHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCcee
Q 021947 19 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98 (305)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 98 (305)
...|++.|.+++...|.----+.. ..-.|||+|+.+ +=+-.= .-....++...+..+-.+++.-+.-|-. ..++|
T Consensus 213 AEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LV 287 (520)
T KOG2270|consen 213 AEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGR-DGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLV 287 (520)
T ss_pred HHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccC-CCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHH-Hhcee
Confidence 346888999987655432221211 133699999953 211110 0112236655566666666666655543 24599
Q ss_pred eccCCCCceEeCCCCceeeccccccc
Q 021947 99 YRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 99 H~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
|.||.--|+|+ .+|.+.++|.+-+-
T Consensus 288 HADLSEfN~Ly-hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 288 HADLSEFNLLY-HDGKLYIIDVSQSV 312 (520)
T ss_pred ccchhhhhheE-ECCEEEEEEccccc
Confidence 99999999999 55689999987654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.28 Score=44.06 Aligned_cols=29 Identities=21% Similarity=0.280 Sum_probs=24.3
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
..++|.|+.+.|||.+.+ .++|+||.+|.
T Consensus 284 ~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCC-CEEEEeecccc
Confidence 358999999999998655 49999998774
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.094 Score=45.13 Aligned_cols=30 Identities=20% Similarity=0.252 Sum_probs=24.9
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..+++|+|+.+.|||++ + .+.|+||+.+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 35699999999999995 4 578999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 305 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-164
Identities = 97/257 (37%), Positives = 154/257 (59%), Gaps = 11/257 (4%)
Query: 2 VVAVKKLK----PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
VAVKKL + +++ E+ + + H NLV+L+G+ +G++ LVY +MP G
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 58 SLENHLF-RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
SL + L G PLSW +R K+A GAA G+ FLH E+ I+RD K++NILLD F AK
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAK 173
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
+SDFGLA+A +T ++++++GT Y APE + G +T KSD+YSFGVVLLE+++G
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 232
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
AVD+ + Q L+D + +++ + +D K+ + ++A QCL+ +
Sbjct: 233 AVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289
Query: 237 LRPRMSEVLAILERLEA 253
RP + +V +L+ + A
Sbjct: 290 KRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-155
Identities = 104/260 (40%), Positives = 151/260 (58%), Gaps = 5/260 (1%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K+ PE QG +E+ TE+ L HP+LV LIG+C E +L+Y++M G+L+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 61 NHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
HL+ +SW R+++ IGAA+GL +LH +I+RD K+ NILLD F K++
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKIT 181
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFG++K G D+TH+ST V GT GY PEY GRLT KSDVYSFGVVL E+L R A+
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
++ +L +WA + +L +I+D L + ++ A++CL + R
Sbjct: 242 VQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 239 PRMSEVLAILERLEAPKNSA 258
P M +VL LE + S
Sbjct: 301 PSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 382 bits (984), Expect = e-134
Identities = 111/273 (40%), Positives = 166/273 (60%), Gaps = 8/273 (2%)
Query: 2 VVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VAVK+LK E QG + ++ TEV + H NL++L G+C+ RLLVY +M GS+
Sbjct: 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 61 NHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKL 117
+ L R PL W R ++A+G+A+GL +LH + ++I+RD KA+NILLD EF A +
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
DFGLAK D THV+T V GT G+ APEY++TG+ + K+DV+ +GV+LLEL++G+ A
Sbjct: 176 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 178 VDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235
D ++ + L+DW K L +K+ L ++D L G Y + +AL C + P
Sbjct: 235 FDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 236 KLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 268
RP+MSEV+ +LE + + + E RQ
Sbjct: 294 MERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-73
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 30/274 (10%)
Query: 3 VAVKKLKPEGFQGHKEWL--TEVNYLGQLHHPNLVKLIGYCLEGEN----RLLVYEFMPK 56
VAVK + Q W EV L + H N+++ IG G + L+ F K
Sbjct: 50 VAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ--------VIYRDFKASNIL 108
GSL + L +SW +A A+GL +LH+ + +RD K+ N+L
Sbjct: 107 GSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163
Query: 109 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYS 163
L A ++DFGLA G + +GT Y APE + + D+Y+
Sbjct: 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 164 FGVVLLELLSGRCAVDKTKVGIEQSLVD--WAKPYLSDKRKL--FRIMDTKLGGQYPQKA 219
G+VL EL S A D + P L D +++ + L + + A
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA 283
Query: 220 AHTA-ATLALQCLNNEPKLRPRMSEVLAILERLE 252
+C +++ + R V + +++
Sbjct: 284 GMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-59
Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 31/270 (11%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK L + F E+L EV + +L HPN+V +G + N +V E++ +GSL
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 61 NHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
L + G + L R+ +A AKG+ +LH+ +++R+ K+ N+L+D ++ K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGL++ + + S GT + APE + KSDVYSFGV+L EL + +
Sbjct: 183 FGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ---- 236
Query: 180 KTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
+P+ L+ + + + + P+ A + C NEP
Sbjct: 237 --------------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWK 282
Query: 238 RPRMSEVLAILERLEAPKNSAKLSQSEPHR 267
RP + ++ +L L K + P+R
Sbjct: 283 RPSFATIMDLLRPL------IKSAVPPPNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-58
Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K+++ E + K ++ E+ L +++HPN+VKL G CL LV E+ GSL N
Sbjct: 34 VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 89
Query: 63 LFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFN-AKLSD 119
L P P + A M + ++G+ +LH + + +I+RD K N+LL A K+ D
Sbjct: 90 LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FG A D T G+ + APE + K DV+S+G++L E+++ R
Sbjct: 150 FGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR---- 200
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL---QCLNNEPK 236
KP+ FRIM G P + + +C + +P
Sbjct: 201 --------------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPS 246
Query: 237 LRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGP 271
RP M E++ I+ L A P + + P
Sbjct: 247 QRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-57
Identities = 56/259 (21%), Positives = 106/259 (40%), Gaps = 34/259 (13%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGS 58
+ VK LK + +++ E L HPN++ ++G C + L+ +MP GS
Sbjct: 36 IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L N L + + +K A+ A+G+ FLH E + + ++++D + A++S
Sbjct: 96 LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGR 175
+ + S M + APE +D++SF V+L EL++
Sbjct: 156 MADVK-------FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233
P+ LS+ ++ L P + + L C+N
Sbjct: 209 ------------------VPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNE 250
Query: 234 EPKLRPRMSEVLAILERLE 252
+P RP+ ++ ILE+++
Sbjct: 251 DPAKRPKFDMIVPILEKMQ 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-57
Identities = 58/283 (20%), Positives = 107/283 (37%), Gaps = 30/283 (10%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
V+ +K+L + + +L EV + L HPN++K IG + + + E++ G+L
Sbjct: 37 VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ + W+ R+ A A G+ +LH +I+RD + N L+ N ++DFG
Sbjct: 97 II-KSMDSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 122 LAK------------AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 169
LA+ V+G + APE + K DV+SFG+VL
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 170 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229
E++ A +D+ + P + + ++
Sbjct: 214 EIIGRVNADP----DYLPRTMDFGLNVRGFLDRYC-----------PPNCPPSFFPITVR 258
Query: 230 CLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPV 272
C + +P+ RP ++ LE L + +
Sbjct: 259 CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGF 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-55
Identities = 64/264 (24%), Positives = 113/264 (42%), Gaps = 38/264 (14%)
Query: 3 VAVKKLKPEGFQGH-------KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP 55
VA+K L +G +E+ EV + L+HPN+VKL G +V EF+P
Sbjct: 47 VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD----- 110
G L + L P+ W+V++++ + A G+ ++ + +++RD ++ NI L
Sbjct: 105 CGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN 163
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVV 167
A AK++DFGL++ H + ++G + APE T K+D YSF ++
Sbjct: 164 APVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMI 217
Query: 168 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227
L +L+G D + + + + P+ +
Sbjct: 218 LYTILTGEGPFD----EYSYGKIKFINMIREEGLRP----------TIPEDCPPRLRNVI 263
Query: 228 LQCLNNEPKLRPRMSEVLAILERL 251
C + +PK RP S ++ L L
Sbjct: 264 ELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-55
Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 33/260 (12%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK L + + EV L + H N++ +GY +V ++ SL
Sbjct: 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLY 107
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+HL + + +A A+G+ +LH +I+RD K++NI L + K+ DF
Sbjct: 108 HHLHASETK-FEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCA 177
GLA +H Q+ G+ + APE + + +SDVY+FG+VL EL++G+
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL- 223
Query: 178 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQCL 231
PY ++++ ++ ++ + L +CL
Sbjct: 224 -----------------PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266
Query: 232 NNEPKLRPRMSEVLAILERL 251
+ RP +LA +E L
Sbjct: 267 KKKRDERPSFPRILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-55
Identities = 56/300 (18%), Positives = 99/300 (33%), Gaps = 43/300 (14%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVN--YLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMP 55
VAVK Q ++ E N + + H N+ + I LLV E+ P
Sbjct: 39 VAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-------VIYRDFKASNIL 108
GSL +L W ++A +GL +LH + + +RD + N+L
Sbjct: 96 NGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 109 LDAEFNAKLSDFGLAK------AGPTGDRTHVSTQVMGTHGYAAPEY-------VATGRL 155
+ + +SDFGL+ G+ + + +GT Y APE
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK-----PYLSDKRKLFRIMDTK 210
+ D+Y+ G++ E+ RC + + + + P D + L +
Sbjct: 213 LKQVDMYALGLIYWEIFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271
Query: 211 L----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 266
+ A + C + + + R + L K H
Sbjct: 272 PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-55
Identities = 72/264 (27%), Positives = 112/264 (42%), Gaps = 40/264 (15%)
Query: 3 VAVKKLKPEGFQGH----KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VAVK + + + + E L HPN++ L G CL+ N LV EF G
Sbjct: 33 VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP 92
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEF---- 113
L L + + + + A+ A+G+ +LHD A +I+RD K+SNIL+ +
Sbjct: 93 LNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149
Query: 114 ----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 169
K++DFGLA+ RT + G + + APE + + SDV+S+GV+L
Sbjct: 150 LSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205
Query: 170 ELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227
ELL+G P+ + + + KL P A L
Sbjct: 206 ELLTGEV------------------PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247
Query: 228 LQCLNNEPKLRPRMSEVLAILERL 251
C N +P RP + +L L +
Sbjct: 248 EDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-53
Identities = 56/278 (20%), Positives = 103/278 (37%), Gaps = 44/278 (15%)
Query: 3 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA++ + E K + EV Q H N+V +G C+ + ++ +L
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ + R L ++A KG+ +LH ++++D K+ N+ D ++DF
Sbjct: 118 SVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDF 173
Query: 121 GLAK---AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---------TTKSDVYSFGVVL 168
GL G R G + APE + + SDV++ G +
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233
Query: 169 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA----A 224
EL + P+ + I+ G P + +
Sbjct: 234 YELHAREW------------------PF--KTQPAEAIIWQMGTGMKPNLSQIGMGKEIS 273
Query: 225 TLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ 262
+ L C E + RP ++++ +LE+L PK + +LS
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKL--PKRNRRLSH 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-49
Identities = 60/285 (21%), Positives = 100/285 (35%), Gaps = 44/285 (15%)
Query: 3 VAVKKLKPEGFQGHKEWL--TEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPK 56
VAVK W TE+ + H N++ I ++G L+ ++
Sbjct: 63 VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLD 110
GSL ++L L +K+A + GL LH + +RD K+ NIL+
Sbjct: 120 GSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176
Query: 111 AEFNAKLSDFGLA--KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-------TTKSDV 161
++D GLA T + +GT Y PE V L +D+
Sbjct: 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADM 235
Query: 162 YSFGVVLLELLSGRCAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 211
YSFG++L E+ RC V + S D + K + +
Sbjct: 236 YSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP-SFPNRWS 293
Query: 212 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 256
+ ++ L +C + P R V L ++ ++
Sbjct: 294 SDECLRQMGK----LMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-49
Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 42/280 (15%)
Query: 3 VAVKKLKPEGFQGHKEWL--TEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPK 56
VAVK + K W TE+ L H N++ I + + L+ +
Sbjct: 34 VAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLD 110
GSL ++L L +++ + A GL LH + +RD K+ NIL+
Sbjct: 91 GSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 111 AEFNAKLSDFGLA--KAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVY 162
++D GLA + T + +GT Y APE V + D++
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 163 SFGVVLLELLSGRCAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG 212
+FG+VL E+ R + V + S D K D+++ I +
Sbjct: 208 AFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFS 265
Query: 213 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252
A L +C P R + L +++
Sbjct: 266 DPTLTSLAK----LMKECWYQNPSARLTALRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 58/279 (20%), Positives = 99/279 (35%), Gaps = 32/279 (11%)
Query: 3 VAVKKLKPEGFQGHKEWLTE--VNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPK 56
VAVK + + W E + L H N++ I + LV ++
Sbjct: 68 VAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLD 110
GSL ++L R ++ +K+A+ A GL LH + +RD K+ NIL+
Sbjct: 125 GSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181
Query: 111 AEFNAKLSDFGLA--KAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVY 162
++D GLA T +GT Y APE + ++D+Y
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241
Query: 163 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-----GGQYPQ 217
+ G+V E+ RC++ + D S + + + KL
Sbjct: 242 AMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 300
Query: 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 256
+A A + +C R + L +L +
Sbjct: 301 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-44
Identities = 70/265 (26%), Positives = 108/265 (40%), Gaps = 41/265 (15%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK + ++L E L Q HPN+V+LIG C + + +V E + G
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L R L +++ AA G+ +L I+RD A N L+ + K+SDFG
Sbjct: 202 FL-RTEGARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFG 258
Query: 122 LAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
+++ G G APE + GR +++SDV+SFG++L E S G
Sbjct: 259 MSREEADGVYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231
PY LS+++ + GG P+ L QC
Sbjct: 314 S------------------PYPNLSNQQTREFVEK---GGRLPCPELCPDAVFRLMEQCW 352
Query: 232 NNEPKLRPRMSEVLAILERL-EAPK 255
EP RP S + L+ + + +
Sbjct: 353 AYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-41
Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 21/261 (8%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKG 57
VAVK LKPE G + E+ L L+H N+VK G C E L+ EF+P G
Sbjct: 51 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 110
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
SL+ +L + ++ ++K A+ KG+ +L Q ++RD A N+L+++E K+
Sbjct: 111 SLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKI 167
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELL 172
DFGL KA T + + APE + + SDV+SFGV L ELL
Sbjct: 168 GDFGLTKAIETDKEYYTVKD----DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQC 230
+ C D + + + ++ ++ R + + + G + P L +C
Sbjct: 224 T-YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE---GKRLPCPPNCPDEVYQLMRKC 279
Query: 231 LNNEPKLRPRMSEVLAILERL 251
+P R ++ E L
Sbjct: 280 WEFQPSNRTSFQNLIEGFEAL 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-41
Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 23/262 (8%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGS 58
VVAVKKL+ + +++ E+ L L H N+VK G C R L+ E++P GS
Sbjct: 40 EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L ++L + + + ++ KG+ +L + I+RD NIL++ E K+
Sbjct: 100 LRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIG 156
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
DFGL K P + G + APE + + + SDV+SFGVVL EL +
Sbjct: 157 DFGLTKVLPQDKEFFKVKE----PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
Query: 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY----PQKAAHTAATLALQ 229
+ + + +F +++ L P + +
Sbjct: 213 YIEKSKSPPAEFMRMI--GNDKQ--GQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTE 267
Query: 230 CLNNEPKLRPRMSEVLAILERL 251
C NN RP ++ ++++
Sbjct: 268 CWNNNVNQRPSFRDLALRVDQI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-41
Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 20/286 (6%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGS 58
+VAVK+L+ G +++ E+ L LH +VK G ++ LV E++P G
Sbjct: 53 ALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L + L R + L + + + KG+ +L + ++RD A NIL+++E + K++
Sbjct: 113 LRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIA 169
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
DFGLAK P V+ G + APE ++ + +SDV+SFGVVL EL +
Sbjct: 170 DFGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
Query: 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TLALQCL 231
C + ++ + + R L + + G + P A A L C
Sbjct: 226 -YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE---GQRLPAPPACPAEVHELMKLCW 281
Query: 232 NNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKS 277
P+ RP S + L+ L + + H + ++ S
Sbjct: 282 APSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 21/261 (8%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGS 58
VVAVKKL+ + +++ E+ L L H N+VK G C R L+ E++P GS
Sbjct: 71 EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L ++L + + + ++ KG+ +L + I+RD NIL++ E K+
Sbjct: 131 LRDYLQKHKER-IDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIG 187
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
DFGL K P + G + APE + + + SDV+SFGVVL EL +
Sbjct: 188 DFGLTKVLPQDKEYYKVK----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
Query: 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQC 230
+ + + + + + + + P + +C
Sbjct: 244 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----NGRLPRPDGCPDEIYMIMTEC 299
Query: 231 LNNEPKLRPRMSEVLAILERL 251
NN RP ++ ++++
Sbjct: 300 WNNNVNQRPSFRDLALRVDQI 320
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LK E +E+L E + ++ HPNLV+L+G C ++ EFM G+L ++
Sbjct: 248 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L Q +S V + +A + + +L + I+R+ A N L+ K++DFGL
Sbjct: 307 LRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGL 364
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC---AV 178
++ TGD + APE +A + + KSDV++FGV+L E+ + G +
Sbjct: 365 SRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
D ++V L ++ R P+ L C P R
Sbjct: 424 DLSQV----------YELLEKDYRMER----------PEGCPEKVYELMRACWQWNPSDR 463
Query: 239 PRMSEVLAILERL-EAPKNSAKLSQSEPHRQT 269
P +E+ E + + S ++ + R T
Sbjct: 464 PSFAEIHQAFETMFQESSISDEVEKELGKRGT 495
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 54/270 (20%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
V +K L + + + + +L H +LV G C+ G+ +LV EF+ GSL+ +
Sbjct: 43 VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-------- 114
L ++ ++ +++VA A + FL E+ +I+ + A NILL E +
Sbjct: 103 L-KKNKNCINILWKLEVAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGY------AAPEYVATGRL-TTKSDVYSFGVV 167
KLSD G++ V+ PE + + +D +SFG
Sbjct: 160 IKLSDPGISIT------------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTT 207
Query: 168 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA 224
L E+ S G KP L +RKL D Q P A A
Sbjct: 208 LWEICSGGD------------------KPLSALDSQRKLQFYED---RHQLPAPKAAELA 246
Query: 225 TLALQCLNNEPKLRPRMSEVLAILERLEAP 254
L C++ EP RP ++ L L P
Sbjct: 247 NLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 45/280 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LK E +E+L E + ++ HPNLV+L+G C ++ EFM G+L ++
Sbjct: 41 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L Q +S V + +A + + +L + I+RD A N L+ K++DFGL
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 123 AKAGPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-G 174
++ ++ H A APE +A + + KSDV++FGV+L E+ + G
Sbjct: 158 SRL--------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209
Query: 175 RCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQC 230
PY + + + + P+ L C
Sbjct: 210 MS------------------PYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRAC 248
Query: 231 LNNEPKLRPRMSEVLAILERL-EAPKNSAKLSQSEPHRQT 269
P RP +E+ E + + S ++ + R T
Sbjct: 249 WQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 48/261 (18%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLEN 61
VAVK +K + + +L E + + QL H NLV+L+G +E + L +V E+M KGSL +
Sbjct: 219 VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L RG L +K ++ + + +L + ++RD A N+L+ + AK+SDFG
Sbjct: 277 YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFG 334
Query: 122 LAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 177
L K S+ + APE + + +TKSDV+SFG++L E+ S GR
Sbjct: 335 LTK--------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV- 385
Query: 178 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQC 230
PY + K + R+ MD P + C
Sbjct: 386 -----------------PYPRIPLKDVVPRVEKGYKMDA------PDGCPPAVYDVMKNC 422
Query: 231 LNNEPKLRPRMSEVLAILERL 251
+ + RP ++ LE +
Sbjct: 423 WHLDAATRPTFLQLREQLEHI 443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 73/257 (28%), Positives = 111/257 (43%), Gaps = 37/257 (14%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LK G + +L E + +L H LV+L E E +V E+M KGSL +
Sbjct: 211 VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 268
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + L + +A A G+ ++ ++RD +A+NIL+ K++DFGL
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGL 326
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKT 181
A+ + T + APE GR T KSDV+SFG++L EL + GR
Sbjct: 327 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------ 379
Query: 182 KVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNE 234
PY + ++ L ++ M P + + L QC E
Sbjct: 380 ------------VPYPGMVNREVLDQVERGYRMPC------PPECPESLHDLMCQCWRKE 421
Query: 235 PKLRPRMSEVLAILERL 251
P+ RP + A LE
Sbjct: 422 PEERPTFEYLQAFLEDY 438
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 59/259 (22%), Positives = 111/259 (42%), Gaps = 39/259 (15%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K+L+ + +KE L E + + +P++ +L+G CL L+ + MP G L +
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD 105
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
++ R + + + AKG+ +L + ++++RD A N+L+ + K++DFG
Sbjct: 106 YV-REHKDNIGSQYLLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
LAK ++ + G + A E + T +SDV+S+GV + EL++ G
Sbjct: 163 LAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLN 232
KPY D I G+ P + +C
Sbjct: 218 ------------------KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWM 257
Query: 233 NEPKLRPRMSEVLAILERL 251
+ RP+ E++ ++
Sbjct: 258 IDADSRPKFRELIIEFSKM 276
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 72/290 (24%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 1 MVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VA+K LK + +++L E + +GQ HPN+++L G + + ++V E+M GSL
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
++ L + Q + + + G A G+ +L ++ ++RD A NIL+++ K+SD
Sbjct: 134 DSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSD 190
Query: 120 FGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
FGL + +T+ G + +PE +A + T+ SDV+S+G+VL E++S G
Sbjct: 191 FGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLAL 228
+PY +S++ + + + G + P A + L L
Sbjct: 249 ------------------RPYWEMSNQDVIKAVDE---GYRLPPPMDCPAALY---QLML 284
Query: 229 QCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 278
C + RP+ ++++IL++L S K+ S R + + + +
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNV 334
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 77/262 (29%), Positives = 118/262 (45%), Gaps = 25/262 (9%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKG 57
+VAVK LK + G Q W E++ L L+H +++K G C + + LV E++P G
Sbjct: 61 EMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
SL ++L R L+ + A +G+ +LH I+RD A N+LLD + K+
Sbjct: 121 SLRDYL-PRHSIGLAQLLLF--AQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKI 175
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELL 172
DFGLAKA P G + G + APE + + SDV+SFGV L ELL
Sbjct: 176 GDFGLAKAVPEGH----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQ 229
+ C D ++ + L + + R+ + G+ P K L
Sbjct: 232 T-HC--DSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKN 286
Query: 230 CLNNEPKLRPRMSEVLAILERL 251
C E RP ++ IL+ +
Sbjct: 287 CWETEASFRPTFENLIPILKTV 308
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-38
Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 43/260 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK +K EG E+ E + +L HP LVK G C + +V E++ G L N+
Sbjct: 35 VAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L G L + +++ +G+ FL Q I+RD A N L+D + K+SDFG+
Sbjct: 94 LRSHGKG-LEPSQLLEMCYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
Query: 123 AKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
R + Q + + G ++APE + ++KSDV++FG+++ E+ S G+
Sbjct: 151 T-------RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231
PY ++ + ++ G P A+ T + C
Sbjct: 204 ------------------MPYDLYTNSEVVLKVSQ---GHRLYRPHLASDTIYQIMYSCW 242
Query: 232 NNEPKLRPRMSEVLAILERL 251
+ P+ RP ++L+ +E L
Sbjct: 243 HELPEKRPTFQQLLSSIEPL 262
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 41/281 (14%)
Query: 3 VAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK + ++L E +GQ H N+++L G + + +++ E+M G+L+
Sbjct: 76 VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L R S + + G A G+ +L A ++RD A NIL+++ K+SDFG
Sbjct: 136 FL-REKDGEFSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 122 LAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 177
L++ +T G + APE ++ + T+ SDV+SFG+V+ E+++ G
Sbjct: 193 LSRVLEDDPEATYTTS--GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-- 248
Query: 178 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQC 230
+PY LS+ + I D G + P A + L +QC
Sbjct: 249 ----------------RPYWELSNHEVMKAIND---GFRLPTPMDCPSAIY---QLMMQC 286
Query: 231 LNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGP 271
E RP+ +++++IL++L +S K R +
Sbjct: 287 WQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIR 327
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-38
Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 43/260 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K ++ EG ++++ E + +L HP LV+L G CLE LV EFM G L ++
Sbjct: 35 VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L R + + + + +G+ +L E+ VI+RD A N L+ K+SDFG+
Sbjct: 94 L-RTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAARNCLVGENQVIKVSDFGM 150
Query: 123 AKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
R + Q + G +A+PE + R ++KSDV+SFGV++ E+ S G+
Sbjct: 151 T-------RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231
PY S+ + I G P+ A+ + C
Sbjct: 204 ------------------IPYENRSNSEVVEDIST---GFRLYKPRLASTHVYQIMNHCW 242
Query: 232 NNEPKLRPRMSEVLAILERL 251
P+ RP S +L L +
Sbjct: 243 RERPEDRPAFSRLLRQLAEI 262
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 70/276 (25%), Positives = 110/276 (39%), Gaps = 38/276 (13%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK +E + E + QL +P +V+LIG C E +LV E G L
Sbjct: 40 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK 98
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L + + + + ++ + G+ +L E ++RD A N+LL AK+SDFG
Sbjct: 99 FLVGKREE-IPVSNVAELLHQVSMGMKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
L+KA D + + G + APE + + +++SDV+S+GV + E LS G+
Sbjct: 156 LSKALGADDSYYTARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLN 232
KPY K K +M G+ P + L C
Sbjct: 212 ------------------KPY--KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWI 251
Query: 233 NEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 268
+ + RP V + S H
Sbjct: 252 YKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHHH 287
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-37
Identities = 73/254 (28%), Positives = 111/254 (43%), Gaps = 31/254 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LK G + +L E + +L H LV+L E E +V E+M KGSL +
Sbjct: 294 VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 351
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + L + +A A G+ ++ ++RD +A+NIL+ K++DFGL
Sbjct: 352 LKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGL 409
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKT 181
A+ + T + APE GR T KSDV+SFG++L EL + GR
Sbjct: 410 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------ 462
Query: 182 KVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKL 237
PY + ++ L ++ G P + + L QC EP+
Sbjct: 463 ------------VPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRKEPEE 507
Query: 238 RPRMSEVLAILERL 251
RP + A LE
Sbjct: 508 RPTFEYLQAFLEDY 521
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-37
Identities = 74/262 (28%), Positives = 119/262 (45%), Gaps = 50/262 (19%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLEN 61
VAVK +K + + +L E + + QL H NLV+L+G +E + L +V E+M KGSL +
Sbjct: 47 VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 104
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L RG L +K ++ + + +L + ++RD A N+L+ + AK+SDFG
Sbjct: 105 YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFG 162
Query: 122 LAKAGPTGDRTHVSTQVMG------THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 174
L + STQ G T APE + + +TKSDV+SFG++L E+ S G
Sbjct: 163 LT-------KEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFG 211
Query: 175 RCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQ 229
R PY + K + R+ G P +
Sbjct: 212 RV------------------PYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYEVMKN 249
Query: 230 CLNNEPKLRPRMSEVLAILERL 251
C + + +RP ++ LE +
Sbjct: 250 CWHLDAAMRPSFLQLREQLEHI 271
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 59/260 (22%), Positives = 109/260 (41%), Gaps = 43/260 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K +K EG E++ E + L H LV+L G C + ++ E+M G L N+
Sbjct: 51 VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L R +++ + + +L Q ++RD A N L++ + K+SDFGL
Sbjct: 110 L-REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
Query: 123 AKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
+ R + + + G ++ PE + + ++KSD+++FGV++ E+ S G+
Sbjct: 167 S-------RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231
PY ++ I G P A+ T+ C
Sbjct: 220 ------------------MPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCW 258
Query: 232 NNEPKLRPRMSEVLAILERL 251
+ + RP +L+ + +
Sbjct: 259 HEKADERPTFKILLSNILDV 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 43/260 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK +K G + +L E N + L H LVKL + E ++ EFM KGSL +
Sbjct: 215 VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 272
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + + A+G+ F+ + I+RD +A+NIL+ A K++DFGL
Sbjct: 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 123 AKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAV 178
A+ + T G + APE + G T KSDV+SFG++L+E+++ GR
Sbjct: 331 ARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-- 384
Query: 179 DKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCL 231
PY +S+ + + M P+ + ++C
Sbjct: 385 ----------------PYPGMSNPEVIRALERGYRMPR------PENCPEELYNIMMRCW 422
Query: 232 NNEPKLRPRMSEVLAILERL 251
N P+ RP + ++L+
Sbjct: 423 KNRPEERPTFEYIQSVLDDF 442
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 70/263 (26%), Positives = 111/263 (42%), Gaps = 43/263 (16%)
Query: 3 VAVKKLKPEGFQGHK---EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VAVK LKP+ + +++ EVN + L H NL++L G L +V E P GSL
Sbjct: 49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSL 107
Query: 60 ENHLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L + L R A+ A+G+ +L + I+RD A N+LL K+
Sbjct: 108 LDRLRKHQGHFLLGTLSRY--AVQVAEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIG 163
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
DFGL +A P D +V + H + APE + T + SD + FGV L E+ +
Sbjct: 164 DFGLMRALPQNDDHYVMQE----HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
Query: 174 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAA--TLAL 228
G+ +P+ +I+ K G + P+ + +
Sbjct: 220 YGQ------------------EPW--IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 259
Query: 229 QCLNNEPKLRPRMSEVLAILERL 251
QC ++P+ RP + L
Sbjct: 260 QCWAHKPEDRPTFVALRDFLLEA 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 70/263 (26%), Positives = 126/263 (47%), Gaps = 45/263 (17%)
Query: 3 VAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK + +++L+E + +GQ HPN+++L G G ++V E+M GSL+
Sbjct: 80 VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L R + + + G G+ +L ++ ++RD A N+L+D+ K+SDFG
Sbjct: 140 FL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
L++ +T G + APE +A ++ SDV+SFGVV+ E+L+ G
Sbjct: 197 LSRVLEDDPDAAYTTT----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLAL 228
+PY ++++ + + + G + P A H L L
Sbjct: 253 ------------------RPYWNMTNRDVISSVEE---GYRLPAPMGCPHALH---QLML 288
Query: 229 QCLNNEPKLRPRMSEVLAILERL 251
C + + RPR S+++++L+ L
Sbjct: 289 DCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 65/298 (21%), Positives = 127/298 (42%), Gaps = 39/298 (13%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
V +K ++ + G Q + + +G L H ++V+L+G C + LV +++P GSL +
Sbjct: 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLD 103
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
H+ R+ L + + + AKG+ +L E +++R+ A N+LL + +++DFG
Sbjct: 104 HV-RQHRGALGPQLLLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFG 160
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
+A P D Q++ + + A E + G+ T +SDV+S+GV + EL++ G
Sbjct: 161 VADLLPPDD-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLN 232
+PY +L + D G+ PQ + ++C
Sbjct: 216 ------------------EPY--AGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWM 255
Query: 233 NEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTP 290
+ +RP E+ R+ + + E P ++ + + P
Sbjct: 256 IDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 59/178 (33%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 3 VAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK LK E E L E N + QL +P +V++IG C E+ +LV E G L
Sbjct: 47 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLN 105
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+L + + + + G+ +L ES ++RD A N+LL + AK+SDF
Sbjct: 106 KYLQQNRHVKDKNIIEL--VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDF 161
Query: 121 GLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
GL+KA + + + HG + APE + + ++KSDV+SFGV++ E S
Sbjct: 162 GLSKALRADENYYKAQT----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 45/261 (17%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VAVK LK +G +L E N + QL H LV+L + E ++ E+M GSL +
Sbjct: 40 VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L L+ + +A A+G+ F+ E I+RD +A+NIL+ + K++DFGL
Sbjct: 98 LKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 123 AKAGPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-G 174
A+ + A APE + G T KSDV+SFG++L E+++ G
Sbjct: 156 AR--------LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 175 RCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQC 230
R PY +++ + + G + P L C
Sbjct: 208 RI------------------PYPGMTNPEVIQNLER---GYRMVRPDNCPEELYQLMRLC 246
Query: 231 LNNEPKLRPRMSEVLAILERL 251
P+ RP + ++LE
Sbjct: 247 WKERPEDRPTFDYLRSVLEDF 267
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 58/259 (22%), Positives = 111/259 (42%), Gaps = 39/259 (15%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K+L+ + +KE L E + + +P++ +L+G CL L+ + MP G L +
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD 105
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
++ + + + AKG+ +L + ++++RD A N+L+ + K++DFG
Sbjct: 106 YVREHKDN-IGSQYLLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
LAK ++ + G + A E + T +SDV+S+GV + EL++ G
Sbjct: 163 LAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLN 232
KPY D I G+ P + ++C
Sbjct: 218 ------------------KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 257
Query: 233 NEPKLRPRMSEVLAILERL 251
+ RP+ E++ ++
Sbjct: 258 IDADSRPKFRELIIEFSKM 276
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 69/266 (25%), Positives = 115/266 (43%), Gaps = 45/266 (16%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGS 58
+ AVK L ++LTE + HPN++ L+G CL E L+V +M G
Sbjct: 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 113
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L N + + + + AKG+ +L A + ++RD A N +LD +F K++
Sbjct: 114 LRNFIRNETHN-PTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVA 170
Query: 119 DFGLAKAGPTGD--RTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
DFGLA+ + H T M A E + T + TTKSDV+SFGV+L E
Sbjct: 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWM------ALESLQTQKFTTKSDVWSFGVLLWE 224
Query: 171 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAAT 225
L++ G PY ++ ++ G P+
Sbjct: 225 LMTRGA------------------PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYE 263
Query: 226 LALQCLNNEPKLRPRMSEVLAILERL 251
+ L+C + + ++RP SE+++ + +
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 73/275 (26%), Positives = 113/275 (41%), Gaps = 53/275 (19%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
M+VAVK LK +++ E L L H ++V+ G C EG L+V+E+M G L
Sbjct: 72 MLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 61 NHLFRRGP-------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
L GP PL + VA A G+ +L A ++RD N
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNC 189
Query: 108 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDV 161
L+ K+ DFG+++ + D V + M PE + + TT+SDV
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYRKFTTESDV 243
Query: 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYP 216
+SFGVVL E+ + G+ +P+ LS+ + I G + P
Sbjct: 244 WSFGVVLWEIFTYGK------------------QPWYQLSNTEAIDCITQ---GRELERP 282
Query: 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ + C EP+ R + +V A L+ L
Sbjct: 283 RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 72/276 (26%), Positives = 113/276 (40%), Gaps = 54/276 (19%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
M+VAVK LK K++ E L L H ++VK G C +G+ ++V+E+M G L
Sbjct: 46 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 61 NHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 106
L GP L + + +A A G+ +L A ++RD N
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRN 163
Query: 107 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSD 160
L+ A K+ DFG+++ + D V M PE + + TT+SD
Sbjct: 164 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTESD 217
Query: 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QY 215
V+SFGV+L E+ + G+ P+ LS+ + I G +
Sbjct: 218 VWSFGVILWEIFTYGKQ------------------PWFQLSNTEVIECITQ---GRVLER 256
Query: 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
P+ + L C EP+ R + E+ IL L
Sbjct: 257 PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 70/292 (23%), Positives = 127/292 (43%), Gaps = 50/292 (17%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VA+K + + E+L E + + + + ++V+L+G +G+ L++ E M +G L
Sbjct: 56 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 60 ENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
+++L P P S + +++A A G+ +L ++ ++RD A N ++
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAE 173
Query: 112 EFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFG 165
+F K+ DFG+ + D R + M +PE + G TT SDV+SFG
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFG 227
Query: 166 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAA 220
VVL E+ + +PY LS+++ L +M+ GG P
Sbjct: 228 VVLWEIATLAE------------------QPYQGLSNEQVLRFVME---GGLLDKPDNCP 266
Query: 221 HTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQTGP 271
L C PK+RP E+++ ++ +E SE ++ P
Sbjct: 267 DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEP 318
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 45/270 (16%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK K + +++++E + L HP++VKLIG E E ++ E P G L +
Sbjct: 43 VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH 101
Query: 62 HLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+L R + V ++ K + +L ++RD NIL+ + KL DF
Sbjct: 102 YLERNKNSLKVLTLVLY--SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDF 157
Query: 121 GLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-G 174
GL++ D + + +PE + R TT SDV+ F V + E+LS G
Sbjct: 158 GLSRY--IEDEDYYKAS----VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 175 RCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQC 230
+ +P+ L +K + + G P TL +C
Sbjct: 212 K------------------QPFFWLENKDVIGVLEK---GDRLPKPDLCPPVLYTLMTRC 250
Query: 231 LNNEPKLRPRMSEVLAILERL-EAPKNSAK 259
+ +P RPR +E++ L + + K+ A
Sbjct: 251 WDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 51/273 (18%)
Query: 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR-----LLVYEF 53
+ VAVK +K + + +E+L+E + HPN+++L+G C+E ++ +++ F
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 54 MPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109
M G L +L GP+ + +K + A G+ +L + ++RD A N +L
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML 180
Query: 110 DAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYS 163
+ ++DFGL+K +GD R ++ + A E +A T+KSDV++
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWA 234
Query: 164 FGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQK 218
FGV + E+ + G PY + + ++ G + P+
Sbjct: 235 FGVTMWEIATRGM------------------TPYPGVQNHEMYDYLLH---GHRLKQPED 273
Query: 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ C +P RP S + LE+L
Sbjct: 274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-35
Identities = 69/260 (26%), Positives = 108/260 (41%), Gaps = 42/260 (16%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K K +++L E + Q HP++VKLIG E ++ E G L +
Sbjct: 46 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 104
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L R L A + A + L +L + ++RD A N+L+ + KL DFG
Sbjct: 105 FLQVRKYS-LDLASLILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFG 161
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
L++ ST + G + APE + R T+ SDV+ FGV + E+L G
Sbjct: 162 LSRY------MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231
KP+ + + + RI + G P T +L +C
Sbjct: 216 ------------------KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCW 254
Query: 232 NNEPKLRPRMSEVLAILERL 251
+P RPR +E+ A L +
Sbjct: 255 AYDPSRRPRFTELKAQLSTI 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 52/286 (18%)
Query: 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYE 52
+ VAVK LK + +E+L E + + HP++ KL+G L + +++
Sbjct: 52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 53 FMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
FM G L L L ++ + A G+ +L + I+RD A N +
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCM 169
Query: 109 LDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVY 162
L + ++DFGL++ +GD R ++++ + A E +A T SDV+
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL------ALESLADNLYTVHSDVW 223
Query: 163 SFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQ 217
+FGV + E+++ G+ PY + + ++ G + P
Sbjct: 224 AFGVTMWEIMTRGQ------------------TPYAGIENAEIYNYLIG---GNRLKQPP 262
Query: 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQS 263
+ L QC + +PK RP + + LE + + SQ
Sbjct: 263 ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 45/266 (16%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFMPKGS 58
+ A+K L Q + +L E + L+HPN++ LIG L E + +M G
Sbjct: 50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD 109
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L + + + + A+G+ +L AE + ++RD A N +LD F K++
Sbjct: 110 LLQFIRSPQRN-PTVKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVA 166
Query: 119 DFGLAK----AGPTGDRTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
DFGLA+ + H ++ A E + T R TTKSDV+SFGV+L E
Sbjct: 167 DFGLARDILDREYYSVQQHRHARLPVKWT------ALESLQTYRFTTKSDVWSFGVLLWE 220
Query: 171 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAAT 225
LL+ G PY + + G P+ +
Sbjct: 221 LLTRGA------------------PPYRHIDPFDLTHFLAQ---GRRLPQPEYCPDSLYQ 259
Query: 226 LALQCLNNEPKLRPRMSEVLAILERL 251
+ QC +P +RP ++ +E++
Sbjct: 260 VMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 43/265 (16%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGS 58
+ AVK L ++LTE + HPN++ L+G CL E L+V +M G
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 177
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L N + + + + AKG+ FL A + ++RD A N +LD +F K++
Sbjct: 178 LRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVA 234
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLEL 171
DFGLA+ D + A A E + T + TTKSDV+SFGV+L EL
Sbjct: 235 DFGLAR-----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 172 LS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATL 226
++ G PY ++ ++ G P+ +
Sbjct: 290 MTRGA------------------PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEV 328
Query: 227 ALQCLNNEPKLRPRMSEVLAILERL 251
L+C + + ++RP SE+++ + +
Sbjct: 329 MLKCWHPKAEMRPSFSELVSRISAI 353
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K LK +E + E + QL +P +V+LIG C E +LV E G L
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK 424
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L + + + + ++ + G+ +L E ++R+ A N+LL AK+SDFG
Sbjct: 425 FLVGKREE-IPVSNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
L+KA D + + G + APE + + +++SDV+S+GV + E LS
Sbjct: 482 LSKALGADDSYYTARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 68/260 (26%), Positives = 108/260 (41%), Gaps = 42/260 (16%)
Query: 3 VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K K +++L E + Q HP++VKLIG E ++ E G L +
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 479
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L + L A + A + L +L + ++RD A N+L+ + KL DFG
Sbjct: 480 FL-QVRKFSLDLASLILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 122 LAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GR 175
L++ ST + G + APE + R T+ SDV+ FGV + E+L G
Sbjct: 537 LSRY------MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231
KP+ + + + RI + G P T +L +C
Sbjct: 591 ------------------KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCW 629
Query: 232 NNEPKLRPRMSEVLAILERL 251
+P RPR +E+ A L +
Sbjct: 630 AYDPSRRPRFTELKAQLSTI 649
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 59/314 (18%), Positives = 118/314 (37%), Gaps = 36/314 (11%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+K++ KE EV L + HPN+V+ E + +V ++ G
Sbjct: 51 QYVIKEINISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L + + + + L +HD ++++RD K+ NI L + +L
Sbjct: 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLG 167
Query: 119 DFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
DFG+A+ T + + GT Y +PE KSD+++ G VL EL + + A
Sbjct: 168 DFGIARVLNSTVELAR--ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNE 234
+ + ++LV +I+ G + ++ +L Q
Sbjct: 225 FEAGSM---KNLV-------------LKIIS----GSFPPVSLHYSYDLRSLVSQLFKRN 264
Query: 235 PKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPT 291
P+ RP ++ +L I +R+E + +++ + + P ++ S N
Sbjct: 265 PRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISV 324
Query: 292 ASPLPSHRQSPRVR 305
+ + +
Sbjct: 325 MPAQKITKPAAKYG 338
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 49/287 (17%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VAVK L Q ++L E + + +H N+V+ IG L+ R ++ E M G L
Sbjct: 61 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 60 ENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-- 112
++ L P L+ + VA A G +L E+ I+RD A N LL
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGP 178
Query: 113 -FNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFG 165
AK+ DFG+A+ R + M PE G T+K+D +SFG
Sbjct: 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM------PPEAFMEGIFTSKTDTWSFG 232
Query: 166 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAA 220
V+L E+ S G PY S++ L + GG P+
Sbjct: 233 VLLWEIFSLGY------------------MPYPSKSNQEVLEFVTS---GGRMDPPKNCP 271
Query: 221 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 267
+ QC ++P+ RP + +L +E + + +
Sbjct: 272 GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 318
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 70/286 (24%), Positives = 110/286 (38%), Gaps = 47/286 (16%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VAVK L Q ++L E + + +H N+V+ IG L+ R ++ E M G L
Sbjct: 102 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 60 ENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-- 112
++ L P L+ + VA A G +L E+ I+RD A N LL
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGP 219
Query: 113 -FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFGV 166
AK+ DFG+A+ G PE G T+K+D +SFGV
Sbjct: 220 GRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274
Query: 167 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAH 221
+L E+ S G PY S++ L + GG P+
Sbjct: 275 LLWEIFSLGY------------------MPYPSKSNQEVLEFVTS---GGRMDPPKNCPG 313
Query: 222 TAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 267
+ QC ++P+ RP + +L +E + + +
Sbjct: 314 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 64/274 (23%), Positives = 113/274 (41%), Gaps = 32/274 (11%)
Query: 2 VVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VA+KK++ K + E++ L QL+HPN++K +E +V E G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118
Query: 59 LENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
L + F++ + + K + L +H +V++RD K +N+ + A K
Sbjct: 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVK 176
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
L D GL + + T + V GT Y +PE + KSD++S G +L E+ + +
Sbjct: 177 LGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ- 233
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLN 232
P+ DK L+ + YP + L C+N
Sbjct: 234 -----------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 276
Query: 233 NEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 266
+P+ RP ++ V + +R+ A ++ L H
Sbjct: 277 PDPEKRPDVTYVYDVAKRMHACT-ASSLEHHHHH 309
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 55/275 (20%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VA+K LK + +E+ E +L HPN+V L+G + + +++ + G L
Sbjct: 40 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 60 ENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 105
L R P L + + A G+ +L + V+++D
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATR 157
Query: 106 NILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKS 159
N+L+ + N K+SD GL + D + ++ + M APE + G+ + S
Sbjct: 158 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDS 211
Query: 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 214
D++S+GVVL E+ S G +PY S++ + I +
Sbjct: 212 DIWSYGVVLWEVFSYGL------------------QPYCGYSNQDVVEMIRN---RQVLP 250
Query: 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249
P L ++C N P RPR ++ + L
Sbjct: 251 CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 58/293 (19%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
M A+K++K H+++ E+ L +L HHPN++ L+G C L E+ P G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 59 LENHLFRRGPQ--------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L + L + LS + A A+G+ +L ++ Q I+RD A
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAA 170
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKS 159
NIL+ + AK++DFGL++ V T G + A E + TT S
Sbjct: 171 RNILVGENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 214
DV+S+GV+L E++S G PY ++ ++ G +
Sbjct: 223 DVWSYGVLLWEIVSLGG------------------TPYCGMTCAELYEKLPQ---GYRLE 261
Query: 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPH 266
P L QC +P RP +++L L R LE K + E
Sbjct: 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 56/253 (22%), Positives = 96/253 (37%), Gaps = 35/253 (13%)
Query: 3 VAVK--KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL---EGENRLLVY-EFMPK 56
VA + + + + E L L HPN+V+ +G+ +++ E M
Sbjct: 54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS 113
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 115
G+L+ +L R + V KGL FLH +I+RD K NI + +
Sbjct: 114 GTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
K+ D GLA R + V+GT + APE DVY+FG+ +LE+ +
Sbjct: 172 KIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAAT-LALQCLN 232
PY + +++R + + + K A + C+
Sbjct: 227 Y------------------PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 233 NEPKLRPRMSEVL 245
R + ++L
Sbjct: 269 QNKDERYSIKDLL 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 53/276 (19%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + ++E+ + L H N+V L+G C G L++ E+ G
Sbjct: 77 LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 59 LENHLFRRGP------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 106
L N L R+ S + + A+G+ FL A I+RD A N
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 194
Query: 107 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDV 161
+LL AK+ DFGLA+ D + S ++ + + APE + T +SDV
Sbjct: 195 VLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQ--Y 215
+S+G++L E+ S G PY L + + + D G Q
Sbjct: 250 WSYGILLWEIFSLGLN------------------PYPGILVNSKFYKLVKD---GYQMAQ 288
Query: 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
P A ++ C EP RP ++ + L+
Sbjct: 289 PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 63/285 (22%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+VAVK LK E ++ E + + +PN+VKL+G C G+ L++E+M G L
Sbjct: 78 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 60 ENHLFRRGPQPLSWAVR----------------------MKVAIGAAKGLTFLHDAESQV 97
L P + + +A A G+ +L +E +
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKF 195
Query: 98 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVA 151
++RD N L+ K++DFGL++ + D + + + M PE +
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIF 249
Query: 152 TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMD 208
R TT+SDV+++GVVL E+ S G PY ++ + ++ + D
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFSYGLQ------------------PYYGMAHEEVIYYVRD 291
Query: 209 TKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
G P+ L C + P RP + IL+R+
Sbjct: 292 ---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 49/261 (18%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL------------- 48
+K++K +++ EV L +L H N+V G +
Sbjct: 38 TYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK 93
Query: 49 ---LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 105
+ EF KG+LE + +R + L + +++ KG+ ++H ++I RD K S
Sbjct: 94 CLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPS 151
Query: 106 NILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 164
NI L K+ DFGL + G RT GT Y +PE +++ + D+Y+
Sbjct: 152 NIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSK-GTLRYMSPEQISSQDYGKEVDLYAL 207
Query: 165 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224
G++L ELL + + D + + +K
Sbjct: 208 GLILAELLHV------------------CDTAFETSKFFTDLRDGIISDIFDKKEKT--- 246
Query: 225 TLALQCLNNEPKLRPRMSEVL 245
L + L+ +P+ RP SE+L
Sbjct: 247 -LLQKLLSKKPEDRPNTSEIL 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 55/295 (18%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+
Sbjct: 68 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 127
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L R P + +++ + A+G+ +L A + I+RD A
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAA 185
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKS 159
N+L+ K++DFGLA+ D ++ T+G + APE + T +S
Sbjct: 186 RNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 214
DV+SFGV++ E+ + G PY + + + + G
Sbjct: 241 DVWSFGVLMWEIFTLGGS------------------PYPGIPVEELFKLLKE---GHRMD 279
Query: 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQ 268
P + + C + P RP +++ L+R L N L S+P Q
Sbjct: 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQ 334
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 60/249 (24%), Positives = 88/249 (35%), Gaps = 32/249 (12%)
Query: 2 VVAVKKLKPEGFQGHKE---WLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+ AVK+ F+G K+ L EV ++ HP V+L EG L E
Sbjct: 84 LYAVKRSMSP-FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
SL+ H G L A L LH +++ D K +NI L KL
Sbjct: 142 SLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKL 198
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
DFGL T Q G Y APE + G T +DV+S G+ +LE+
Sbjct: 199 GDFGLLVELGTAGAGE--VQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACN--- 251
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
++ L ++ + ++ + L +PKL
Sbjct: 252 ----------------MELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295
Query: 238 RPRMSEVLA 246
R +LA
Sbjct: 296 RATAEALLA 304
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 62/323 (19%), Positives = 115/323 (35%), Gaps = 45/323 (13%)
Query: 2 VVAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKG 57
+ A+K + E + E+ YL +L + ++L Y + + +V E
Sbjct: 35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L + L ++ + + + +H +++ D K +N L+ + KL
Sbjct: 94 DLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKL 148
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGV 166
DFG+A + V +GT Y PE + +++ KSDV+S G
Sbjct: 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208
Query: 167 VLLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTA 223
+L + G+ P+ ++ KL I+D ++P
Sbjct: 209 ILYYMTYGKT------------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 250
Query: 224 ATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMR 280
+ CL +PK R + E+LA + + AK + E G + SP
Sbjct: 251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 310
Query: 281 QQRSPLNMTPTASPLPSHRQSPR 303
++ + S SH S
Sbjct: 311 ILKAAKTLYEHYSGGESHNSSSS 333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 61/284 (21%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VAVK LK ++ L+E N L Q++HP+++KL G C + LL+ E+ GSL
Sbjct: 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 60 ENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQV 97
L + L+ + A ++G+ +L AE ++
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKL 171
Query: 98 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVAT 152
++RD A NIL+ K+SDFGL++ D + V + G + A E +
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSR-----DVYEEDSYVKRSQGRIPVKWMAIESLFD 226
Query: 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT 209
TT+SDV+SFGV+L E+++ G PY + +R +
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGN------------------PYPGIPPERLFNLLKT- 267
Query: 210 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
G + P + L LQC EP RP +++ LE++
Sbjct: 268 --GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 54/277 (19%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+
Sbjct: 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L R P + +++ + A+G+ +L A + I+RD A
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAA 231
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKS 159
N+L+ K++DFGLA+ D ++ T+G + APE + T +S
Sbjct: 232 RNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286
Query: 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 214
DV+SFGV++ E+ + G PY + + + + G
Sbjct: 287 DVWSFGVLMWEIFTLGGS------------------PYPGIPVEELFKLLKE---GHRMD 325
Query: 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
P + + C + P RP +++ L+R+
Sbjct: 326 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 3 VAVKKLKPEGFQGHKEWLT----EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VA+K + + +E L EV+ QL H N+V +I E + LV E++ +
Sbjct: 39 VAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L ++ GP + A+ G+ HD ++++RD K NIL+D+ K+
Sbjct: 98 LSEYIESHGPLSVDTAIN--FTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIF 153
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
DFG+AKA T + V+GT Y +PE +D+YS G+VL E+L G
Sbjct: 154 DFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 73/286 (25%), Positives = 111/286 (38%), Gaps = 69/286 (24%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
M VAVK LKP + ++E+ L L +H N+V L+G C G L++ E+ G
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 59 LENHLFRRGP----------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 102
L N L R+ L + + AKG+ FL A I+RD
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 171
Query: 103 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA------------APEYV 150
A NILL K+ DFGLA+ + Y APE +
Sbjct: 172 AARNILLTHGRITKICDFGLAR------------DIKNDSNYVVKGNARLPVKWMAPESI 219
Query: 151 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM 207
T +SDV+S+G+ L EL S G PY + K ++++
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSS------------------PYPGMPVDSKFYKMI 261
Query: 208 DTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
K G P+ A + C + +P RP +++ ++E+
Sbjct: 262 --KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 51/262 (19%), Positives = 97/262 (37%), Gaps = 42/262 (16%)
Query: 2 VVAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKG 57
+ A+K + E + E+ YL +L + ++L Y + + +V E
Sbjct: 54 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 112
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L + L ++ + + + +H +++ D K +N L+ + KL
Sbjct: 113 DLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKL 167
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGV 166
DFG+A + V +GT Y PE + +++ KSDV+S G
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227
Query: 167 VLLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTA 223
+L + G+ P+ ++ KL I+D ++P
Sbjct: 228 ILYYMTYGKT------------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 224 ATLALQCLNNEPKLRPRMSEVL 245
+ CL +PK R + E+L
Sbjct: 270 QDVLKCCLKRDPKQRISIPELL 291
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 54/294 (18%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L R P + LS + A A+G+ +L A + I+RD A
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAA 219
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKS 159
N+L+ + K++DFGLA+ D H+ T+G + APE + T +S
Sbjct: 220 RNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 214
DV+SFGV+L E+ + G PY + + + + G
Sbjct: 275 DVWSFGVLLWEIFTLGGS------------------PYPGVPVEELFKLLKE---GHRMD 313
Query: 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 268
P + + C + P RP +++ L+R+ A ++ ++ H
Sbjct: 314 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHH 367
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 65/284 (22%), Positives = 109/284 (38%), Gaps = 60/284 (21%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + + ++E+ + QL H N+V L+G C L++E+ G
Sbjct: 76 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 59 LENHLFRRGPQPLSWAVR---------------------MKVAIGAAKGLTFLHDAESQV 97
L N+L + + + + A AKG+ FL
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSC 193
Query: 98 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVAT 152
++RD A N+L+ K+ DFGLA+ D S V+ + + APE +
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLAR-----DIMSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT 209
G T KSDV+S+G++L E+ S G PY + ++++
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVN------------------PYPGIPVDANFYKLI-- 288
Query: 210 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ G P A + C + + RP + + L
Sbjct: 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 48/178 (26%), Positives = 73/178 (41%), Gaps = 10/178 (5%)
Query: 2 VVAVKKLKPEGFQGHKEWLT----EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+VA+K + + T E G+L P++V + + + +
Sbjct: 61 IVALKLMSET-LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L L R+GP AV + L H A +RD K NIL+ A+ A L
Sbjct: 120 DLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYL 175
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
DFG+A A T + +GT Y APE + T ++D+Y+ VL E L+G
Sbjct: 176 VDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 62/323 (19%), Positives = 116/323 (35%), Gaps = 45/323 (13%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKG 57
+ A+K + E Q + E+ YL +L + ++L Y + + +V E
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 140
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L + L ++ + + + +H + +++ D K +N L+ + KL
Sbjct: 141 DLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKL 195
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGV 166
DFG+A + V +G Y PE + +++ KSDV+S G
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255
Query: 167 VLLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTA 223
+L + G+ P+ ++ KL I+D ++P
Sbjct: 256 ILYYMTYGK------------------TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297
Query: 224 ATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMR 280
+ CL +PK R + E+LA + + AK + E G + SP
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357
Query: 281 QQRSPLNMTPTASPLPSHRQSPR 303
++ + S SH S
Sbjct: 358 ILKAAKTLYEHYSGGESHNSSSS 380
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 76/278 (27%), Positives = 111/278 (39%), Gaps = 54/278 (19%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL-EGENRLLVYEFMPKG 57
VAVK LK H+ ++E+ L + HH N+V L+G C G +++ EF G
Sbjct: 58 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 58 SLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 103
+L +L + L+ + + AKG+ FL A + I+RD
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLA 175
Query: 104 ASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTK 158
A NILL + K+ DFGLA+ D V + APE + T +
Sbjct: 176 ARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230
Query: 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG-- 213
SDV+SFGV+L E+ S G PY + + R + K G
Sbjct: 231 SDVWSFGVLLWEIFSLGAS------------------PYPGVKIDEEFCRRL--KEGTRM 270
Query: 214 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ P L C + EP RP SE++ L L
Sbjct: 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 31/165 (18%), Positives = 64/165 (38%), Gaps = 17/165 (10%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E+ + + + + G + + + ++YE+M S+ ++ + +
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 81 IGA------AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 134
+ +++H E + +RD K SNIL+D KLSDFG ++
Sbjct: 152 VIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-- 208
Query: 135 STQVMGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSGRC 176
GT+ + PE + + K D++S G+ L +
Sbjct: 209 -G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 51/274 (18%), Positives = 99/274 (36%), Gaps = 54/274 (19%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL------------- 48
A+KK++ + L+EV L L+H +V+ LE N +
Sbjct: 33 YYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
+ E+ G+L + + ++ + L+++H +I+RD K NI
Sbjct: 92 IQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIF 148
Query: 109 LDAEFNAKLSDFGLAK-------------AGPTGDRTHVSTQVMGTHGYAAPEYVA-TGR 154
+D N K+ DFGLAK G ++++ + GT Y A E + TG
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGH 207
Query: 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM---DTKL 211
K D+YS G++ E++ ++ + + + +
Sbjct: 208 YNEKIDMYSLGIIFFEMIYPF-------------------STGMERVNILKKLRSVSIEF 248
Query: 212 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 245
+ + ++++P RP +L
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 59/269 (21%), Positives = 102/269 (37%), Gaps = 33/269 (12%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKG 57
A+K++ Q +E E + +HPN+++L+ YCL L+ F +G
Sbjct: 56 FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 58 SLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+L N + + L+ + + +G +GL +H +RD K +NILL E
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQP 173
Query: 116 KLSDFGLAKA---GPTGDRTHVSTQVM----GTHGYAAPEYVATGR---LTTKSDVYSFG 165
L D G G R ++ Q T Y APE + + ++DV+S G
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 166 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225
VL ++ G D + S + + ++
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGD-----------SVALAVQNQLSIPQSPRHSSALWQ---- 278
Query: 226 LALQCLNNEPKLRPRMSEVLAILERLEAP 254
L + +P RP + +L+ LE L+ P
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 58/291 (19%), Positives = 110/291 (37%), Gaps = 53/291 (18%)
Query: 2 VVAVKKLK-PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN---------RLLVY 51
A+K+++ P ++ + EV L +L HP +V+ LE ++ +Y
Sbjct: 32 NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91
Query: 52 ---EFMPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
+ K +L++ + R + +V + + + A+ + FLH +++RD K SNI
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNI 149
Query: 108 LLDAEFNAKLSDFGLAKA----------GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157
+ K+ DFGL A T +GT Y +PE + +
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217
K D++S G++L ELL +E+ L + + ++P
Sbjct: 210 KVDIFSLGLILFELLYPFST------QMERVRT------------LTDVRN----LKFPP 247
Query: 218 KAAH---TAATLALQCLNNEPKLRPRMSEVLA--ILERLEAPKNSAKLSQS 263
+ L+ P RP ++ + E L+ P + +S
Sbjct: 248 LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 34/245 (13%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
AVKK++ E F+ E+ L P +V L G EG + E + GSL
Sbjct: 85 QCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDF 120
+ + G L + A +GL +LH ++++ D KA N+LL ++ A L DF
Sbjct: 140 LIKQMG--CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 121 GLAK--AGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
G A ++ ++ + GT + APE V K D++S ++L +L+G
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC-- 253
Query: 178 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNE 234
P+ +I + + P A A + L E
Sbjct: 254 ----------------HPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKE 297
Query: 235 PKLRP 239
P R
Sbjct: 298 PVHRA 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 56/253 (22%), Positives = 106/253 (41%), Gaps = 33/253 (13%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+A+K++ + + E+ L H N+V+ +G E + E +P GSL
Sbjct: 49 RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108
Query: 62 HLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSD 119
L + GP + +GL +LHD +Q+++RD K N+L++ K+SD
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISD 166
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRC 176
FG +K + GT Y APE + G +D++S G ++E+ +G+
Sbjct: 167 FGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK- 222
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRK----LFRIMDTKLGGQYPQKAAHTAATLALQCLN 232
P+ + + +F++ K+ + P+ + A L+C
Sbjct: 223 -----------------PPF-YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 233 NEPKLRPRMSEVL 245
+P R +++L
Sbjct: 265 PDPDKRACANDLL 277
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 3 VAVKKLKPEGFQGHKEWLT----EVNYLGQLHHPNLVKL--IGYCLEGENRL--LVYEFM 54
VAVK L+ + + E L+HP +V + G L +V E++
Sbjct: 40 VAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
+L + + GP A+ V A + L F H +I+RD K +NI++ A
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIE--VIADACQALNFSHQN--GIIHRDVKPANIMISATNA 154
Query: 115 AKLSDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFG+A+A + T V+GT Y +PE + +SDVYS G VL E+L+
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 174 GR 175
G
Sbjct: 215 GE 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 69/246 (28%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A KKL+ + + K L E L +++ +V L Y E ++ L LV M G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL 271
Query: 60 ENHLFRRGPQPLSWAVRMKV-AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ H++ G A R A GL LH +++YRD K NILLD + ++S
Sbjct: 272 KFHIYHMGQAGFPEA-RAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRIS 328
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
D GLA P G +V GT GY APE V R T D ++ G +L E+++G+
Sbjct: 329 DLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS-- 383
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKL------FRIMDTKLGGQYPQKAAHTAATLALQCLN 232
P+ K+K+ + + +Y ++ + A +L Q L
Sbjct: 384 ----------------PFQQRKKKIKREEVERLVKEVPE--EYSERFSPQARSLCSQLLC 425
Query: 233 NEPKLR 238
+P R
Sbjct: 426 KDPAER 431
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 64/265 (24%), Positives = 103/265 (38%), Gaps = 33/265 (12%)
Query: 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPK 56
++ K+L + ++EVN L +L HPN+V+ ++ N L V E+
Sbjct: 32 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91
Query: 57 GSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHD---AESQVIYRDFKASNILLDA 111
G L + + + Q L ++V L H V++RD K +N+ LD
Sbjct: 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151
Query: 112 EFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
+ N KL DFGLA+ T V GT Y +PE + KSD++S G +L E
Sbjct: 152 KQNVKLGDFGLARILNHDTSFAK--TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 171 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230
L + A K+ ++ +Y + + +
Sbjct: 209 LCALMPPFT-------------AFSQKELAGKIREGKFRRIPYRYSDELNE----IITRM 251
Query: 231 LNNEPKLRPRMSEVLA---ILERLE 252
LN + RP + E+L ILE
Sbjct: 252 LNLKDYHRPSVEEILENPLILEHHH 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 57/257 (22%), Positives = 96/257 (37%), Gaps = 37/257 (14%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK++ PE F EV L + HPN+++ + + + + E +L+
Sbjct: 51 VAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE 106
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAK 116
++ ++ L + GL LH +++RD K NIL+ + A
Sbjct: 107 YVEQKDFAHLGLEPI-TLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAM 163
Query: 117 LSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELL 172
+SDFGL K G + + V GT G+ APE + T D++S G V ++
Sbjct: 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQ 229
S P+ ++ I+ H A L +
Sbjct: 224 SEGSH-----------------PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEK 266
Query: 230 CLNNEPKLRPRMSEVLA 246
+ +P+ RP VL
Sbjct: 267 MIAMDPQKRPSAKHVLK 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 17/180 (9%)
Query: 2 VVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
++A+K +L+ EG + E+ L HPN++++ Y R+ L+ EF P
Sbjct: 41 IMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAP 97
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+G L L + G + + A L + H E +VI+RD K N+L+ +
Sbjct: 98 RGELYKELQKHGRFDEQRSATFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGEL 153
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
K++DFG + P R GT Y PE + K D++ GV+ E L G
Sbjct: 154 KIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 61/308 (19%), Positives = 109/308 (35%), Gaps = 51/308 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR-------LLVYEFM 54
A+K+L + ++ + EV ++ +L HPN+V+ G+ L+ +
Sbjct: 56 YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL 115
Query: 55 PKGSLENHLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
KG L L + + PLS +K+ + + +H + +I+RD K N+LL +
Sbjct: 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175
Query: 114 NAKLSDFGLAKA---GPTGDRTHVSTQVM-------GTHGYAAPEYVATGR---LTTKSD 160
KL DFG A P + ++ T Y PE + + K D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 161 VYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDW--AKPYLSDKRKLFRIMDTKLGGQYPQ 217
+++ G +L L + D K+ I + L R M
Sbjct: 236 IWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAM---------- 285
Query: 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKS 277
L P+ R ++EV+ L+ + A +N ++ P +
Sbjct: 286 -------------LQVNPEERLSIAEVVHQLQEIAAARN---VNPKSPITELLEQNGGYG 329
Query: 278 PMRQQRSP 285
R P
Sbjct: 330 SATLSRGP 337
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 22/181 (12%)
Query: 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-----LVYEFMP 55
V +K L G + + E +L ++ HP++V++ + + +V E++
Sbjct: 108 PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
SL+ P++ A+ + L++LH ++Y D K NI+L E
Sbjct: 168 GQSLKRSK--GQKLPVAEAIA--YLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QL 220
Query: 116 KLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
KL D G G + GT G+ APE + T +D+Y+ G L L
Sbjct: 221 KLIDLGAVSRINSFG-------YLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLD 272
Query: 175 R 175
Sbjct: 273 L 273
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 37/247 (14%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A KKL + + K + + E L ++H +V L Y E + L LV M G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGA--AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
H++ + + A GL LH + +IYRD K N+LLD + N ++
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRI 330
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
SD GLA G GT G+ APE + D ++ GV L E+++ R
Sbjct: 331 SDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG- 387
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRK-----LFR-IMDTKLGGQYPQKAAHTAATLALQCL 231
P+ + K L + +++ + YP K + + L
Sbjct: 388 -----------------PFRARGEKVENKELKQRVLEQAV--TYPDKFSPASKDFCEALL 428
Query: 232 NNEPKLR 238
+P+ R
Sbjct: 429 QKDPEKR 435
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 32/190 (16%), Positives = 59/190 (31%), Gaps = 18/190 (9%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+K KP + L +K L +LV E G+L
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 61 NHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-------- 109
N + + + + + A+ + +HD E +I+ D K N +L
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQD 213
Query: 110 ---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFG 165
D L D G + + + T T G+ E + + + + D +
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVA 272
Query: 166 VVLLELLSGR 175
+ +L G
Sbjct: 273 ATVYCMLFGT 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 17/180 (9%)
Query: 2 VVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
++A+K +L+ G + EV L HPN+++L GY R+ L+ E+ P
Sbjct: 36 ILALKVLFKAQLEKAGVEHQLR--REVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAP 92
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G++ L + + A L++ H +VI+RD K N+LL +
Sbjct: 93 LGTVYRELQKLSKFDEQRTATYITEL--ANALSYCH--SKRVIHRDIKPENLLLGSAGEL 148
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
K++DFG + P+ RT + GT Y PE + K D++S GV+ E L G+
Sbjct: 149 KIADFGWSVHAPSSRRT---D-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 16/186 (8%)
Query: 1 MVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLI------GYCLEGENRLLVYEF 53
VA+K+ + E ++E W E+ + +L+HPN+V + LL E+
Sbjct: 40 EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 54 MPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
G L +L + L + + L +LH E+++I+RD K NI+L
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPG 157
Query: 113 FNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 169
K+ D G AK G + T+ +GT Y APE + + T D +SFG +
Sbjct: 158 PQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 170 ELLSGR 175
E ++G
Sbjct: 215 ECITGF 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 65/249 (26%), Positives = 98/249 (39%), Gaps = 44/249 (17%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQLH---HPNLVKLIGYCLEGENRL-LVYEFMPK 56
A+K L + + + L E L + P +V + Y ++L + + M
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNG 276
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAK---GLTFLHDAESQVIYRDFKASNILLDAEF 113
G L HL + G + AA+ GL +H V+YRD K +NILLD
Sbjct: 277 GDLHYHLSQHGVFSEADMR-----FYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHG 329
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELL 172
+ ++SD GLA + H V GTHGY APE + G S D +S G +L +LL
Sbjct: 330 HVRISDLGLACDFS-KKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 173 SGRC--AVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQ 229
G KTK DK ++ R + + + P + +L
Sbjct: 386 RGHSPFRQHKTK----------------DKHEIDRMTLTMAV--ELPDSFSPELRSLLEG 427
Query: 230 CLNNEPKLR 238
L + R
Sbjct: 428 LLQRDVNRR 436
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 77/244 (31%), Positives = 118/244 (48%), Gaps = 29/244 (11%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
A+K +K E ++ TE + Q +HP LV L C + E+RL V E++ G
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 96
Query: 59 LENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L H+ R+ P A R A I A L +LH E +IYRD K N+LLD+E + KL
Sbjct: 97 LMFHMQRQRKLPEEHA-RFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKL 151
Query: 118 SDFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
+D+G+ K G T T GT Y APE + G S D ++ GV++ E+++GR
Sbjct: 152 TDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
D P + + LF+ I++ ++ + P+ + AA++ LN +
Sbjct: 208 SPFDIVGSS--------DNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKD 257
Query: 235 PKLR 238
PK R
Sbjct: 258 PKER 261
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 70/244 (28%), Positives = 104/244 (42%), Gaps = 40/244 (16%)
Query: 4 AVKKLKPEGFQGHKEW--LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLE 60
A+K LK + E + L +++HP +VKL Y + E +L L+ +F+ G L
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLF 114
Query: 61 NHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
L + + +A + A L LH +IYRD K NILLD E + KL+D
Sbjct: 115 TRLSKEVMFTEEDV-KFYLAELALA--LDHLH--SLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 120 FGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCA 177
FGL+K ++ GT Y APE V R T+S D +SFGV++ E+L+G
Sbjct: 170 FGLSKESIDHEKK---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT-- 223
Query: 178 VDKTKVGIEQSLVDWAKP--YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
D+++ I+ KL PQ + A +L
Sbjct: 224 -----------------LPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRN 264
Query: 235 PKLR 238
P R
Sbjct: 265 PANR 268
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/281 (18%), Positives = 90/281 (32%), Gaps = 39/281 (13%)
Query: 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
V V+++ E E++ +HPN+V + +V FM GS
Sbjct: 54 YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA 113
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
++ + ++ + G K L ++H ++R KAS+IL+ + LS
Sbjct: 114 KDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSG 171
Query: 120 FG-LAKAGPTGDRTHV----STQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELL 172
G R V + + +PE + KSD+YS G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 173 SGR---CAVDKTKV------GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223
+G + T++ G L+D + + G +
Sbjct: 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 224 ATLAL-------------------QCLNNEPKLRPRMSEVL 245
+ QCL P RP S +L
Sbjct: 292 PSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 71/243 (29%), Positives = 104/243 (42%), Gaps = 37/243 (15%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A+K L+ E E +TE L HP L L Y + +RL V E+ G L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL 92
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
HL R A I +A L +LH V+YRD K N++LD + + K++D
Sbjct: 93 FFHLSRERVFTEERARFYGAEIVSA--LEYLH--SRDVVYRDIKLENLMLDKDGHIKITD 148
Query: 120 FGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCA 177
FGL K G + T + GT Y APE V ++ D + GVV+ E++ GR
Sbjct: 149 FGLCKEGISDGAT---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL- 203
Query: 178 VDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEP 235
P Y D +LF I+ ++ ++P+ + A +L L +P
Sbjct: 204 -----------------PFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDP 244
Query: 236 KLR 238
K R
Sbjct: 245 KQR 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 48/190 (25%), Positives = 73/190 (38%), Gaps = 21/190 (11%)
Query: 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGS 58
+ A+K F + + E L +L+H N+VKL E R L+ EF P GS
Sbjct: 36 LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95
Query: 59 LENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEF 113
L L L + + V G+ L E+ +++R+ K NI+ D +
Sbjct: 96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQS 153
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT--------KSDVYSFG 165
KL+DFG A+ D + GT Y P+ L D++S G
Sbjct: 154 VYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210
Query: 166 VVLLELLSGR 175
V +G
Sbjct: 211 VTFYHAATGS 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-24
Identities = 76/244 (31%), Positives = 118/244 (48%), Gaps = 29/244 (11%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
A++ +K E ++ TE + Q +HP LV L C + E+RL V E++ G
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 139
Query: 59 LENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L H+ R+ P A R A I A L +LH E +IYRD K N+LLD+E + KL
Sbjct: 140 LMFHMQRQRKLPEEHA-RFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKL 194
Query: 118 SDFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
+D+G+ K G T T GT Y APE + G S D ++ GV++ E+++GR
Sbjct: 195 TDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
Query: 176 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
D P + + LF+ I++ ++ + P+ + AA++ LN +
Sbjct: 251 SPFDIVGSS--------DNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKD 300
Query: 235 PKLR 238
PK R
Sbjct: 301 PKER 304
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-24
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 24/183 (13%)
Query: 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
V+A K + E + + E+ L + + P +V G + E M GSL+
Sbjct: 60 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ + + KV+I KGLT+L + + ++++RD K SNIL+++ KL DF
Sbjct: 120 Q--VLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 121 GLAKAGPTGDRTHVSTQ--------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
G VS Q +GT Y +PE + + +SD++S G+ L+E+
Sbjct: 177 G------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 173 SGR 175
GR
Sbjct: 225 VGR 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-24
Identities = 48/189 (25%), Positives = 72/189 (38%), Gaps = 21/189 (11%)
Query: 3 VAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGSL 59
A+K F + + E L +L+H N+VKL E R L+ EF P GSL
Sbjct: 37 FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96
Query: 60 ENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFN 114
L L + + V G+ L E+ +++R+ K NI+ D +
Sbjct: 97 YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT--------KSDVYSFGV 166
KL+DFG A+ D + GT Y P+ L D++S GV
Sbjct: 155 YKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 167 VLLELLSGR 175
+G
Sbjct: 212 TFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-24
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 2 VVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
V A K L + E++ L H ++V G+ E + + +V E
Sbjct: 42 VFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCR 98
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+ SL RR A I G +LH ++VI+RD K N+ L+ +
Sbjct: 99 RRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEV 154
Query: 116 KLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLS 173
K+ DFGLA K G+R V GT Y APE V + + + + DV+S G ++ LL
Sbjct: 155 KIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLV 210
Query: 174 GR 175
G+
Sbjct: 211 GK 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 46/244 (18%), Positives = 87/244 (35%), Gaps = 38/244 (15%)
Query: 16 HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWA 74
++ + N V + + + K +L++ + RR +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--------- 125
V + + I A+ + FLH +++RD K SNI + K+ DFGL A
Sbjct: 165 VCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 126 -GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 184
T +GT Y +PE + + K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------Q 276
Query: 185 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEPKLRPRM 241
+E+ + ++D R ++P + L+ P RP
Sbjct: 277 MERVRI------ITDVRN----------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320
Query: 242 SEVL 245
++++
Sbjct: 321 TDII 324
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 74/243 (30%), Positives = 102/243 (41%), Gaps = 36/243 (14%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A+K LK E E LTE L HP L L Y + +RL V E+ G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL 235
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
HL R A I L +LH +E V+YRD K N++LD + + K++D
Sbjct: 236 FFHLSRERVFSEDRARFYGAEI--VSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITD 292
Query: 120 FGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCA 177
FGL K G T + GT Y APE V ++ D + GVV+ E++ GR
Sbjct: 293 FGLCKEGIKDGAT---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL- 347
Query: 178 VDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEP 235
P Y D KLF I+ ++ ++P+ A +L L +P
Sbjct: 348 -----------------PFYNQDHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDP 388
Query: 236 KLR 238
K R
Sbjct: 389 KQR 391
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 2 VVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMP 55
V A K L + E++ L H ++V G+ E + + +V E
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCR 124
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
+ SL RR A I G +LH ++VI+RD K N+ L+ +
Sbjct: 125 RRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEV 180
Query: 116 KLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLS 173
K+ DFGLA K G+R V GT Y APE V + + + + DV+S G ++ LL
Sbjct: 181 KIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLV 236
Query: 174 GR 175
G+
Sbjct: 237 GK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 22 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLS-WAVRMKV 79
EV QL HP++++L Y E N + LV E G + +L R +P S R +
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFM 118
Query: 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQV 138
G+ +LH +++RD SN+LL N K++DFGLA + ++ +
Sbjct: 119 H-QIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-- 173
Query: 139 MGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
GT Y +PE +AT +SDV+S G + LL GR
Sbjct: 174 -GTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 7/173 (4%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA++++ + + + E+ + + +PN+V + L G+ +V E++ GSL +
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ + V + L FLH +QVI+RD K+ NILL + + KL+DFG
Sbjct: 107 VV---TETCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A T +++ ST V GT + APE V K D++S G++ +E++ G
Sbjct: 162 FC-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 61/226 (26%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78
E N L ++ HP +V LI Y + +L L+ E++ G L L R G A
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFY 126
Query: 79 VA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+A I A L LH + +IYRD K NI+L+ + + KL+DFGL K T
Sbjct: 127 LAEISMA--LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---TH 179
Query: 138 VM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 195
GT Y APE + ++ D +S G ++ ++L+G P
Sbjct: 180 TFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA-------------------P 219
Query: 196 --YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
+++K I+ KL P A L + L R
Sbjct: 220 PFTGENRKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-23
Identities = 42/269 (15%), Positives = 89/269 (33%), Gaps = 53/269 (19%)
Query: 2 VVAVKK--LKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ A+K+ G + L EV L H ++V+ E ++ L+ E+ GS
Sbjct: 38 IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGS 97
Query: 59 LENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD------ 110
L + + R A + + +GL ++H +++ D K SNI +
Sbjct: 98 LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPN 155
Query: 111 -------------AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLT 156
+ K+ D G + + G + A E +
Sbjct: 156 AASEEGDEDDWASNKVMFKIGDLGHVTR-----ISSPQVEE-GDSRFLANEVLQENYTHL 209
Query: 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 216
K+D+++ + ++ +P + + I +L + P
Sbjct: 210 PKADIFALALTVVCAAGA-------------------EPLPRNGDQWHEIRQGRL-PRIP 249
Query: 217 QKAAHTAATLALQCLNNEPKLRPRMSEVL 245
Q + L ++ +P+ RP ++
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLSWAVR 76
E+ + L HP LV L Y + E + +V + + G L HL + + V+
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVK 118
Query: 77 MKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 135
+ + + A L +L ++I+RD K NILLD + ++DF +A P +
Sbjct: 119 LFICELVMA--LDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--- 171
Query: 136 TQVMGTHGYAAPEYVATGRLT--TKS-DVYSFGVVLLELLSGR 175
T + GT Y APE ++ + + + D +S GV ELL GR
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 70/252 (27%), Positives = 107/252 (42%), Gaps = 39/252 (15%)
Query: 2 VVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VVA+K + E + E + E+ L Q P + K G L+ ++ E++ GS
Sbjct: 49 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA- 107
Query: 61 NHLFRRGPQPLSW-AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
L GP + A ++ KGL +LH + I+RD KA+N+LL KL+D
Sbjct: 108 LDLLEPGPLDETQIATILR---EILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLAD 162
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FG+A T + +T +GT + APE + +K+D++S G+ +EL G
Sbjct: 163 FGVA-GQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG----- 215
Query: 180 KTKVGIEQSLVDWAKPYLSDK---RKLFRIMDT---KLGGQYPQKAAHTAATLALQCLNN 233
+P S+ + LF I L G Y + CLN
Sbjct: 216 --------------EPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE----ACLNK 257
Query: 234 EPKLRPRMSEVL 245
EP RP E+L
Sbjct: 258 EPSFRPTAKELL 269
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 70/244 (28%), Positives = 100/244 (40%), Gaps = 38/244 (15%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
A+K LK + + + E L HP L + + + L V E++ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L H+ LS A I GL FLH ++YRD K NILLD + + K++
Sbjct: 105 LMYHIQSCHKFDLSRATFYAAEI--ILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIA 160
Query: 119 DFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 176
DFG+ K GD T GT Y APE + G+ S D +SFGV+L E+L G+
Sbjct: 161 DFGMCKENMLGDAK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
Query: 177 AVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
P + D+ +LF I YP+ A L ++ E
Sbjct: 217 ------------------PFHGQDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVRE 256
Query: 235 PKLR 238
P+ R
Sbjct: 257 PEKR 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 9e-23
Identities = 24/183 (13%), Positives = 58/183 (31%), Gaps = 25/183 (13%)
Query: 10 PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC--LEGENRLLVYEFM--PKGSLENHLFR 65
+ + H ++ + + ++++ + +R +Y M + L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 66 RGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 123
L R+++ + + L LH +++ + +I+LD L+ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 124 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELL 172
R + G+ PE A +T D ++ G+V+ +
Sbjct: 254 V------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 173 SGR 175
Sbjct: 308 CAD 310
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 70/244 (28%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
AVK LK + + +TE L +HP L +L C + +RL V EF+ G
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGD 110
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L H+ + + A I +A L FLH + +IYRD K N+LLD E + KL+
Sbjct: 111 LMFHIQKSRRFDEARARFYAAEIISA--LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLA 166
Query: 119 DFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 176
DFG+ K G T T GT Y APE + L + D ++ GV+L E+L G
Sbjct: 167 DFGMCKEGICNGVT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
Query: 177 AVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
P ++ LF I++ ++ YP A + +
Sbjct: 223 ------------------PFEAENEDDLFEAILNDEV--VYPTWLHEDATGILKSFMTKN 262
Query: 235 PKLR 238
P +R
Sbjct: 263 PTMR 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 7/174 (4%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K++ E +E + E++ + Q P++VK G + + +V E+ GS+
Sbjct: 55 QIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ + R + L+ + KGL +LH + I+RD KA NILL+ E +AKL+DF
Sbjct: 113 D-IIRLRNKTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADF 169
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
G+A T +T + GT + APE + +D++S G+ +E+ G
Sbjct: 170 GVA-GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 38/244 (15%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
AVK LK + + + E L P L +L C + +RL V E++ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 107
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L H+ + G AV I L FL +IYRD K N++LD+E + K++
Sbjct: 108 LMYHIQQVGRFKEPHAVFYAAEIAIG--LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIA 163
Query: 119 DFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 176
DFG+ K T T+ GT Y APE + + KS D ++FGV+L E+L+G+
Sbjct: 164 DFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
Query: 177 AVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
P D+ +LF+ IM+ + YP+ + A + +
Sbjct: 220 ------------------PFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKH 259
Query: 235 PKLR 238
P R
Sbjct: 260 PGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 69/245 (28%), Positives = 105/245 (42%), Gaps = 40/245 (16%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
AVK L+ + KE ++E N L + + HP LV L + + ++L V +++ G
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125
Query: 59 LENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L HL R A R A I +A L +LH ++YRD K NILLD++ + L
Sbjct: 126 LFYHLQRERCFLEPRA-RFYAAEIASA--LGYLH--SLNIVYRDLKPENILLDSQGHIVL 180
Query: 118 SDFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
+DFGL K + T T GT Y APE V + ++ D + G VL E+L G
Sbjct: 181 TDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
Query: 176 CAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNN 233
P Y + +++ I++ L Q ++A L L
Sbjct: 237 P------------------PFYSRNTAEMYDNILNKPL--QLKPNITNSARHLLEGLLQK 276
Query: 234 EPKLR 238
+ R
Sbjct: 277 DRTKR 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 7/173 (4%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK + Q + EV + H N+V++ L GE ++ EF+ G+L +
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ + L+ V + L +LH VI+RD K+ +ILL + KLSDFG
Sbjct: 132 -IVSQVR--LNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFG 186
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
A + D + V GT + APE ++ T+ D++S G++++E++ G
Sbjct: 187 FC-AQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 13/178 (7%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSL 59
A+K L+ + E + + +L HP VKL + + + +L + G L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL 117
Query: 60 ENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
++ + G + R A I +A L +LH +I+RD K NILL+ + + +++
Sbjct: 118 LKYIRKIGSFDETCT-RFYTAEIVSA--LEYLH--GKGIIHRDLKPENILLNEDMHIQIT 172
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
DFG AK + + +GT Y +PE + T + KS D+++ G ++ +L++G
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 57/278 (20%), Positives = 99/278 (35%), Gaps = 58/278 (20%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSL-- 59
VAVK++ + E+ L + HPN+++ + E +L
Sbjct: 42 VAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD 97
Query: 60 ---ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---- 112
++ + + + A G+ LH ++I+RD K NIL+
Sbjct: 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFT 155
Query: 113 ---------FNAKLSDFGLAK---AGPTGDRTHVSTQVMGTHGYAAPE-------YVATG 153
+SDFGL K +G + RT+++ GT G+ APE
Sbjct: 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKR 214
Query: 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD----- 208
RLT D++S G V +LS G P+ + I+
Sbjct: 215 RLTRSIDIFSMGCVFYYILSK---------GKH--------PFGDKYSRESNIIRGIFSL 257
Query: 209 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246
++ + + A L Q ++++P RP +VL
Sbjct: 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-22
Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+ A K ++ + + ++++ E+ L HP +VKL+G ++ EF P G+++
Sbjct: 46 LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA 105
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ + L+ V + L FLH ++I+RD KA N+L+ E + +L+DFG
Sbjct: 106 -IMLELDRGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFG 162
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-----TKSDVYSFGVVLLELLSG 174
++ A + + GT + APE V + K+D++S G+ L+E+
Sbjct: 163 VS-AKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-22
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 13/182 (7%)
Query: 2 VVAVKKLKPEG-FQGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
++AVK+++ Q K L +++ + + P V G + + E M SL
Sbjct: 34 IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSL 92
Query: 60 ENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
+ Q + + K+A+ K L LH + VI+RD K SN+L++A K+
Sbjct: 93 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKM 151
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL----TTKSDVYSFGVVLLELLS 173
DFG+ +G D G Y APE + + KSD++S G+ ++EL
Sbjct: 152 CDFGI--SGYLVDDVAKDIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208
Query: 174 GR 175
R
Sbjct: 209 LR 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 70/244 (28%), Positives = 106/244 (43%), Gaps = 38/244 (15%)
Query: 4 AVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
AVK LK + + + E L P L +L C + +RL V E++ G
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 428
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L H+ + G AV I A GL FL +IYRD K N++LD+E + K++
Sbjct: 429 LMYHIQQVGRFKEPHAVFYAAEI--AIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIA 484
Query: 119 DFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 176
DFG+ K T T+ GT Y APE + + KS D ++FGV+L E+L+G+
Sbjct: 485 DFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 177 AVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNE 234
P D+ +LF+ IM+ + YP+ + A + +
Sbjct: 541 ------------------PFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKH 580
Query: 235 PKLR 238
P R
Sbjct: 581 PGKR 584
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 2 VVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K++ E Q + L E+ + Q HHPN+V + + LV + + GS+
Sbjct: 42 KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAA------KGLTFLHDAESQVIYRDFKASNILLDAEFN 114
+ + + + + + A +GL +LH ++ I+RD KA NILL + +
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGS 159
Query: 115 AKLSDFGLA---KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLE 170
+++DFG++ G R V +GT + APE + R K+D++SFG+ +E
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 171 LLSGR 175
L +G
Sbjct: 220 LATGA 224
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 33/191 (17%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP- 55
VA+K++K + +E + E++ + +L H N+V+L LV+EFM
Sbjct: 32 YVALKEVKLD----SEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 56 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
K +++ P+ L + +GL F H+ +++++RD K N+L++
Sbjct: 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRG 145
Query: 114 NAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSF 164
KL DFGLA+A P + +V+ T Y AP+ Y +T D++S
Sbjct: 146 QLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPDVLMGSRTY------STSIDIWSC 195
Query: 165 GVVLLELLSGR 175
G +L E+++G+
Sbjct: 196 GCILAEMITGK 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 69/248 (27%), Positives = 105/248 (42%), Gaps = 38/248 (15%)
Query: 4 AVKKLKPEGFQGHKEW----LTEVNYLGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPKG 57
A+K LK + TE L + P LV L Y + E +L L+ +++ G
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGG 144
Query: 58 SLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
L HL +R ++ V I A L LH + +IYRD K NILLD+ +
Sbjct: 145 ELFTHLSQRERFTEHEV-QIYVGEIVLA--LEHLH--KLGIIYRDIKLENILLDSNGHVV 199
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKS-DVYSFGVVLLELLSG 174
L+DFGL+K + GT Y AP+ V G K+ D +S GV++ ELL+G
Sbjct: 200 LTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 175 R---CAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQC 230
+ + ++ R I+ ++ YPQ+ + A L +
Sbjct: 259 ASPFTVDGEKN----------------SQAEISRRILKSEP--PYPQEMSALAKDLIQRL 300
Query: 231 LNNEPKLR 238
L +PK R
Sbjct: 301 LMKDPKKR 308
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 2 VVAVKKLKPEGF-QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
++AVK+++ + K+ L +++ + P +V+ G + + E M S
Sbjct: 49 IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSF 107
Query: 60 EN---HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
+ +++ + + K+ + K L L + ++I+RD K SNILLD N K
Sbjct: 108 DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIK 166
Query: 117 LSDFGLAKAGPTG--DRTHVSTQVMGTHGYAAPEYVATGRL----TTKSDVYSFGVVLLE 170
L DFG++ G + T+ G Y APE + +SDV+S G+ L E
Sbjct: 167 LCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
Query: 171 LLSGR 175
L +GR
Sbjct: 222 LATGR 226
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 16/180 (8%)
Query: 3 VAVK---KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
AVK K + + + L EV L QL HPN++KL + + LV E G L
Sbjct: 54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL 113
Query: 60 ENHLFRRGPQPLSWAVR-MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNA 115
+ + R A R ++ + +T++H ++++RD K N+LL + N
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSG---ITYMHKN--KIVHRDLKPENLLLESKSKDANI 168
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
++ DFGL+ + +GT Y APE V G K DV+S GV+L LLSG
Sbjct: 169 RIIDFGLSTHFEASKKMK---DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 6e-21
Identities = 32/246 (13%), Positives = 60/246 (24%), Gaps = 26/246 (10%)
Query: 10 PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY--CLEGENRLLVYEFMPKGSLEN-----H 62
PE + + L + + P +L N LL+ LE
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLD 182
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
+ + L +++ F N+ + + L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
T YA E++ +T T + + G+ + +
Sbjct: 241 LWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
GI+ + L L TL + LN + + R
Sbjct: 296 VTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346
Query: 241 MSEVLA 246
E +
Sbjct: 347 PLEAME 352
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 6e-21
Identities = 25/182 (13%), Positives = 58/182 (31%), Gaps = 24/182 (13%)
Query: 10 PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPK--GSLENHLFR 65
+ + H ++ + + ++++ + +R +Y M + L
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 66 RGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 123
L R+++ + + L LH +++ + +I+LD L+ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 124 KAGPTGDRTHVSTQVMGTHGYAAPEYVA----------TGRLTTKSDVYSFGVVLLELLS 173
R S G+A PE A +T D ++ G+ + +
Sbjct: 259 V------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 174 GR 175
Sbjct: 313 AD 314
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-21
Identities = 63/290 (21%), Positives = 119/290 (41%), Gaps = 61/290 (21%)
Query: 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
V+AVK+++ G + +K L +++ + + H P +V+ G + + + E M +
Sbjct: 52 VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE 111
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ L +R P+ + K+ + K L +L + + VI+RD K SNILLD KL D
Sbjct: 112 K--LKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 120 FGLAKAGPTG--DRTHVSTQVMGTHGYAAPEYVATGRL-----TTKSDVYSFGVVLLELL 172
FG++ G + G Y APE + ++DV+S G+ L+EL
Sbjct: 169 FGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL---- 228
+G+ PY + + F ++ L + P H +
Sbjct: 224 TGQ------------------FPY-KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV 264
Query: 229 -QCLNNEPKLRPRMSEVLA--------------------ILERLEAPKNS 257
CL + + RP+ +++L ++ + E+P++
Sbjct: 265 KDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSG 314
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 20/187 (10%)
Query: 2 VVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKG 57
V A+K + E + E + L + +L + + EN L LV E+ G
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGG 146
Query: 58 SLENHLFRRGPQ-PLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
L L + G + P A R +A I A + +H ++RD K NILLD +
Sbjct: 147 DLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLDRCGHI 201
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY-------SFGVVL 168
+L+DFG V GT Y +PE + + Y + GV
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 169 LELLSGR 175
E+ G+
Sbjct: 261 YEMFYGQ 267
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 58/251 (23%), Positives = 93/251 (37%), Gaps = 30/251 (11%)
Query: 1 MVVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ + E + E++ L L HPN++KL + + LV EF G L
Sbjct: 74 FDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAK 116
+ R A + I G+ +LH +++RD K NILL ++ N K
Sbjct: 134 FEQIINRHKFDECDAANIMKQI--LSGICYLHKH--NIVHRDIKPENILLENKNSLLNIK 189
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
+ DFGL+ + +GT Y APE V + K DV+S GV++ LL G
Sbjct: 190 IVDFGLSSFFSKDYKLR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNE 234
+ +D+ + ++ K + + A L L +
Sbjct: 246 PF-------------GGQ---NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYD 289
Query: 235 PKLRPRMSEVL 245
R E L
Sbjct: 290 YNKRCTAEEAL 300
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 41/255 (16%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
A+K + + + L EV L L HPN++KL + + N LV E G
Sbjct: 65 RAIKIIRKTSVSTSS---NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFN 114
L + + R A + + G+T+LH +++RD K N+LL + +
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQV--LSGVTYLHKH--NIVHRDLKPENLLLESKEKDAL 177
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
K+ DFGL+ + + +GT Y APE V + K DV+S GV+L LL+G
Sbjct: 178 IKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233
Query: 175 RCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLG--GQYPQKAAHTAATLALQC 230
P +++ R + K + + A L Q
Sbjct: 234 Y------------------PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275
Query: 231 LNNEPKLRPRMSEVL 245
L + + R + L
Sbjct: 276 LQFDSQRRISAQQAL 290
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-20
Identities = 52/188 (27%), Positives = 75/188 (39%), Gaps = 31/188 (16%)
Query: 2 VVAVKKLKPEGFQGHKEW-----LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 56
+VA+KK L E+ L QL HPNLV L+ LV+E+
Sbjct: 30 IVAIKKFLESED---DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
++ + L R + + + + + + F H I+RD K NIL+ K
Sbjct: 87 -TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIK 142
Query: 117 LSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVV 167
L DFG A+ GP+ +V T Y +PE Y DV++ G V
Sbjct: 143 LCDFGFARLLTGPSDYYDD---EVA-TRWYRSPELLVGDTQY------GPPVDVWAIGCV 192
Query: 168 LLELLSGR 175
ELLSG
Sbjct: 193 FAELLSGV 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 22/183 (12%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMP 55
VA+K +L P Q EV + L+HPN+VKL + +E E L L+ E+
Sbjct: 43 VAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYAS 97
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G + ++L G A I +A + + H + ++++RD KA N+LLDA+ N
Sbjct: 98 GGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCH--QKRIVHRDLKAENLLLDADMNI 153
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT--KSDVYSFGVVLLELLS 173
K++DFG + G + G YAAPE + G+ + DV+S GV+L L+S
Sbjct: 154 KIADFGFSNEFTVGGKLDAFC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 174 GRC 176
G
Sbjct: 210 GSL 212
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-20
Identities = 59/182 (32%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMP 55
VAVK K++ G + E+ L HP+++KL Y + +V E++
Sbjct: 39 VAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVS 94
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G L +++ + G A R+ I +A + + H V++RD K N+LLDA NA
Sbjct: 95 GGELFDYICKHGRVEEMEARRLFQQILSA--VDYCH--RHMVVHRDLKPENVLLDAHMNA 150
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLS 173
K++DFGL+ G+ S G+ YAAPE V +GRL + D++S GV+L LL
Sbjct: 151 KIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLC 206
Query: 174 GR 175
G
Sbjct: 207 GT 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 32/195 (16%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRL-LVYEFMP---K 56
A+K+++ G E+ L +L HPN++ L L + ++ L++++
Sbjct: 50 DYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLW 107
Query: 57 GSLENH---LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
++ H + P L + + G+ +LH + V++RD K +NIL+ E
Sbjct: 108 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEG 165
Query: 114 NA----KLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSD 160
K++D G A+ P + V+ T Y APE Y T D
Sbjct: 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHY------TKAID 218
Query: 161 VYSFGVVLLELLSGR 175
+++ G + ELL+
Sbjct: 219 IWAIGCIFAELLTSE 233
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 56/185 (30%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVA+KK+ G Q +++W + EV +L +L HPN ++ G L LV E+ +
Sbjct: 81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 140
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L +PL V GA +GL +LH +I+RD KA NILL KL
Sbjct: 141 SD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLG 196
Query: 119 DFGLAKAGPTGDRTHVSTQ------VMGTHGYAAPEYVATGRLTT---KSDVYSFGVVLL 169
DFG ++ +GT + APE + K DV+S G+ +
Sbjct: 197 DFG------------SASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
Query: 170 ELLSG 174
EL
Sbjct: 245 ELAER 249
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 52/182 (28%), Positives = 78/182 (42%), Gaps = 19/182 (10%)
Query: 2 VVAVKKLKPEGFQGHKEW-----LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 56
+VA+KK + + E+ L QL H NLV L+ C + + LV+EF+
Sbjct: 52 IVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
++ + L P L + V K G+ F H +I+RD K NIL+ K
Sbjct: 109 -TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVK 164
Query: 117 LSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLS 173
L DFG A+ P +V T Y APE V + DV++ G ++ E+
Sbjct: 165 LCDFGFARTLAAPGEVYDD---EVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
Query: 174 GR 175
G
Sbjct: 221 GE 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 41/189 (21%), Positives = 72/189 (38%), Gaps = 27/189 (14%)
Query: 3 VAVKKLKPEGFQGHKEWLT----EVNYLGQLHHPNLVKLIG-YCLEGENRL-LVYEFMPK 56
AVK LK + + E+ L +L H N+++L+ E + ++ +V E+
Sbjct: 33 RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC 92
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAK--------GLTFLHDAESQVIYRDFKASNIL 108
G E + + + A GL +LH ++++D K N+L
Sbjct: 93 GMQE--MLDS-------VPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLL 141
Query: 109 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGV 166
L K+S G+A+A G+ + PE K D++S GV
Sbjct: 142 LTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201
Query: 167 VLLELLSGR 175
L + +G
Sbjct: 202 TLYNITTGL 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
L E L ++ P LVKL + N +V E++ G + +HL R G A R
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYA 147
Query: 80 A-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138
A I +LH + +IYRD K N+L+D + +++DFG AK RT +
Sbjct: 148 AQIVLT--FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---L 198
Query: 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
GT APE + + D ++ GV++ E+ +G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 22 EVNYLGQLHHPNLVKLIGYC-LEGENRL---LVYEFMPKGSLENHLFRRGPQPLSWAVRM 77
E+ L +L HPN+VKL L+ N +V+E + +G + + P A
Sbjct: 86 EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFY 142
Query: 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+ KG+ +LH ++I+RD K SN+L+ + + K++DFG++ G +S
Sbjct: 143 FQDL--IKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLSNT 197
Query: 138 VMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGRC 176
V GT + APE ++ R DV++ GV L + G+C
Sbjct: 198 V-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 10/177 (5%)
Query: 3 VAVKKLKPEGFQGHKEWLT-EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLE 60
VAVK + + E + E+ L+H N+VK G N L E+ G L
Sbjct: 35 VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELF 93
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ + P A R + A + +LH + +RD K N+LLD N K+SDF
Sbjct: 94 DRIEPDIGMPEPDAQRFFHQLMAG--VVYLH--GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 175
GLA +R + ++ GT Y APE + R DV+S G+VL +L+G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 34/191 (17%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP- 55
+VA+KK+K K+ L E+ L +L HPN++ L+ N LV++FM
Sbjct: 37 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 56 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
+ ++++ L+ + + +GL +LH +++RD K +N+LLD
Sbjct: 97 DLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENG 149
Query: 114 NAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSF 164
KL+DFGLAK+ P TH QV+ T Y APE Y D+++
Sbjct: 150 VLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRAPELLFGARMY------GVGVDMWAV 199
Query: 165 GVVLLELLSGR 175
G +L ELL
Sbjct: 200 GCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-19
Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 37/191 (19%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP- 55
+VA+K+++ + E + E++ L +LHHPN+V LI LV+EFM
Sbjct: 47 IVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103
Query: 56 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
K L+ + L + +G+ H ++++RD K N+L++++
Sbjct: 104 DLKKVLDEN-----KTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDG 156
Query: 114 NAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSF 164
KL+DFGLA+A P TH +V+ T Y AP+ Y +T D++S
Sbjct: 157 ALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDVLMGSKKY------STSVDIWSI 206
Query: 165 GVVLLELLSGR 175
G + E+++G+
Sbjct: 207 GCIFAEMITGK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 54/183 (29%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 2 VVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKG 57
V A+K L + + E + + + P +V+L Y + + L +V E+MP G
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGG 154
Query: 58 SLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
L N + P WA R A + A L +H I+RD K N+LLD + K
Sbjct: 155 DLVNLM-SNYDVPEKWA-RFYTAEVVLA--LDAIH--SMGFIHRDVKPDNMLLDKSGHLK 208
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELL 172
L+DFG T V GT Y +PE + G + D +S GV L E+L
Sbjct: 209 LADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 173 SGR 175
G
Sbjct: 268 VGD 270
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-19
Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLSWAVR 76
E L + HP ++++ + ++ ++ +++ G L + L + P P++ +
Sbjct: 54 NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---K 109
Query: 77 MKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 135
A + A L +LH +IYRD K NILLD + K++DFG AK D T+
Sbjct: 110 FYAAEVCLA--LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY-- 161
Query: 136 TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 175
T + GT Y APE V + + KS D +SFG+++ E+L+G
Sbjct: 162 T-LCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 38/191 (19%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP- 55
+VA+K+++ E H+E + EV+ L L H N+V L ++ LV+E++
Sbjct: 29 LVALKEIRLE----HEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 56 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
K L++ ++ +GL + H +V++RD K N+L++
Sbjct: 85 DLKQYLDDC-----GNIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERG 137
Query: 114 NAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSF 164
KL+DFGLA+A PT + +V+ T Y P+ Y +T+ D++
Sbjct: 138 ELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPDILLGSTDY------STQIDMWGV 187
Query: 165 GVVLLELLSGR 175
G + E+ +GR
Sbjct: 188 GCIFYEMATGR 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 22/186 (11%)
Query: 3 VAVK-----KLKPEGFQGHKEWL---TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFM 54
VA++ K + L TE+ L +L+HP ++K+ + + E+ +V E M
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELM 221
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DA 111
G L + + + + + +LH+ + +I+RD K N+LL +
Sbjct: 222 EGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLHE--NGIIHRDLKPENVLLSSQEE 277
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVL 168
+ K++DFG +K + GT Y APE V T D +S GV+L
Sbjct: 278 DCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
Query: 169 LELLSG 174
LSG
Sbjct: 335 FICLSG 340
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-19
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 11/175 (6%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
A+K +K E+ L ++ H N+V L + LV + + G L +
Sbjct: 37 FALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR 96
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSD 119
+ RG A + + + +LH+ + +++RD K N+L + ++D
Sbjct: 97 ILERGVYTEKDASLVIQQV--LSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITD 152
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
FGL+K G + + GT GY APE +A + D +S GV+ LL G
Sbjct: 153 FGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 47/185 (25%), Positives = 72/185 (38%), Gaps = 18/185 (9%)
Query: 2 VVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKG 57
V A+K L E + E + L + L Y + +N L LV ++ G
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGG 159
Query: 58 SLENHLFR-RGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
L L + P A R +A + A + +H + ++RD K NIL+D +
Sbjct: 160 DLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHI 214
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-----DVYSFGVVLLE 170
+L+DFG S V GT Y +PE + D +S GV + E
Sbjct: 215 RLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 171 LLSGR 175
+L G
Sbjct: 274 MLYGE 278
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
AVK K + L EV L +L HPN++KL + + +V E G
Sbjct: 50 YAVKVINKASAKNKDTS---TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106
Query: 58 SLENHLFRRGPQPLSWAVR-MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEF 113
L + + +R A R +K +T++H +++RD K NILL + +
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKH--NIVHRDLKPENILLESKEKDC 161
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ K+ DFGL+ + +GT Y APE V G K DV+S GV+L LLS
Sbjct: 162 DIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
Query: 174 GR 175
G
Sbjct: 218 GT 219
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 8e-19
Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 37/191 (19%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP- 55
A+KK++ E E + E++ L +L H N+VKL + +LV+E +
Sbjct: 28 TFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84
Query: 56 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
K L+ L + G+ + HD +V++RD K N+L++ E
Sbjct: 85 DLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREG 137
Query: 114 NAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSF 164
K++DFGLA+A P TH +++ T Y AP+ Y +T D++S
Sbjct: 138 ELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMGSKKY------STTIDIWSV 187
Query: 165 GVVLLELLSGR 175
G + E+++G
Sbjct: 188 GCIFAEMVNGT 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 10/177 (5%)
Query: 3 VAVKKLKPEGFQGHKEWLT-EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLE 60
VAVK + + E + E+ L+H N+VK G N L E+ G L
Sbjct: 35 VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELF 93
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ + P A R + A + +LH + +RD K N+LLD N K+SDF
Sbjct: 94 DRIEPDIGMPEPDAQRFFHQLMAG--VVYLH--GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 175
GLA +R + ++ GT Y APE + R DV+S G+VL +L+G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMP 55
VAVK K++ G E+ L HP+++KL Y + + + +V E++
Sbjct: 44 VAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVS 99
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G L +++ + G + R+ I + + + H V++RD K N+LLDA NA
Sbjct: 100 GGELFDYICKNGRLDEKESRRLFQQILSG--VDYCH--RHMVVHRDLKPENVLLDAHMNA 155
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLS 173
K++DFGL+ G+ S G+ YAAPE V +GRL + D++S GV+L LL
Sbjct: 156 KIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLC 211
Query: 174 GR 175
G
Sbjct: 212 GT 213
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 37/191 (19%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP- 55
+VA+K+++ + E L E+ L +L H N+V+L + LV+EF
Sbjct: 29 IVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85
Query: 56 --KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
K ++ L + KGL F H V++RD K N+L++
Sbjct: 86 DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNG 138
Query: 114 NAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSF 164
KL++FGLA+A P + +V+ T Y P+ Y +T D++S
Sbjct: 139 ELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLFGAKLY------STSIDMWSA 188
Query: 165 GVVLLELLSGR 175
G + EL +
Sbjct: 189 GCIFAELANAG 199
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 64/263 (24%), Positives = 102/263 (38%), Gaps = 47/263 (17%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIG-----YCLEGENRL-LVYEFM 54
+ A+K + G +E E+N L + HH N+ G +++L LV EF
Sbjct: 51 LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
GS+ + + L + +GL+ LH + +VI+RD K N+LL
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAE 167
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-----TKSDVYSFGVVLL 169
KL DFG++ A +T +GT + APE +A KSD++S G+ +
Sbjct: 168 VKLVDFGVS-AQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 170 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK---RKLFRIMDT---KL-GGQYPQKAAHT 222
E+ G P L D R LF I +L ++ +K
Sbjct: 226 EMAEG-------------------APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSF 266
Query: 223 AATLALQCLNNEPKLRPRMSEVL 245
CL RP +++
Sbjct: 267 IE----SCLVKNHSQRPATEQLM 285
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMP 55
VA+K LK E E++YL L HP+++KL Y + + +V E+
Sbjct: 37 VALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL--YDVITTPTDIVMVIEYA- 91
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G L +++ + R I A + + H ++++RD K N+LLD N
Sbjct: 92 GGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCH--RHKIVHRDLKPENLLLDDNLNV 147
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLS 173
K++DFGL+ G+ S G+ YAAPE V G+L + DV+S G+VL +L
Sbjct: 148 KIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLV 203
Query: 174 GR 175
GR
Sbjct: 204 GR 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-18
Identities = 51/223 (22%), Positives = 77/223 (34%), Gaps = 53/223 (23%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
A+K K++ + + TEV + +LHHPN+ +L + + LV E G
Sbjct: 54 RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG 113
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIG-------------------------------AAK- 85
L + L V +
Sbjct: 114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173
Query: 86 ------GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAK---AGPTGDRTHV 134
L +LH + +RD K N L + KL DFGL+K G+ +
Sbjct: 174 MRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 135 STQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 175
+T+ GT + APE + T K D +S GV+L LL G
Sbjct: 232 TTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-18
Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 18/181 (9%)
Query: 3 VAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+K + + Q E + E+ L L HPN++K+ + N +V E G L
Sbjct: 50 RVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLE 109
Query: 62 HLFRRGPQPLSW-----AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEF 113
+ + + A MK + A L + H V+++D K NIL
Sbjct: 110 RIVSAQARGKALSEGYVAELMKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHS 164
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFGLA+ + + + T GT Y APE V +T K D++S GVV+ LL+
Sbjct: 165 PIKIIDFGLAELFKSDEHS---TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLT 220
Query: 174 G 174
G
Sbjct: 221 G 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-18
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 15/181 (8%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+V V K ++ E + L HP++V+L+ +V+EFM L
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 62 HLFRRGPQPLSW-----AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEF 113
+ +R + + M+ + A L + H ++ +I+RD K +LL +
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEA---LRYCH--DNNIIHRDVKPHCVLLASKENSA 170
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
KL FG+A G+ V+ +GT + APE V DV+ GV+L LLS
Sbjct: 171 PVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 174 G 174
G
Sbjct: 229 G 229
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-18
Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 3 VAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
AVK K + EV L +L HPN++KL + + +V E G
Sbjct: 50 YAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFN 114
L + + +R A R+ + G+T++H +++RD K NILL + + +
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQV--FSGITYMHK--HNIVHRDLKPENILLESKEKDCD 162
Query: 115 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
K+ DFGL+ + +GT Y APE V G K DV+S GV+L LLSG
Sbjct: 163 IKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-18
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 24/197 (12%)
Query: 3 VAVK-----KLKPEGFQGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEF 53
V VK K+ + + + E+ L ++ H N++K++ E + LV E
Sbjct: 52 VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEK 110
Query: 54 MPKGS-LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
G L + R A + + + +L +I+RD K NI++ +
Sbjct: 111 HGSGLDLFAFIDRHPRLDEPLASYIFRQL--VSAVGYLR--LKDIIHRDIKDENIVIAED 166
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT--KSDVYSFGVVLLE 170
F KL DFG A G + GT Y APE V G + +++S GV L
Sbjct: 167 FTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYT 222
Query: 171 LLSGR---CAVDKTKVG 184
L+ C +++T
Sbjct: 223 LVFEENPFCELEETVEA 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 12/178 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ ++ + +E + EV+ L Q+ H N++ L + +L+ E + G L
Sbjct: 44 FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF 103
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---K 116
+ L ++ A I G+ +LH ++ + D K NI+L D K
Sbjct: 104 DFLAQKESLSEEEATSFIKQI--LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
L DFGLA G + GT + APE V L ++D++S GV+ LLSG
Sbjct: 160 LIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 23/190 (12%)
Query: 1 MVVAVK--------KLKPEGFQGHKEWL-TEVNYLGQL-HHPNLVKLIGYCLEGENRLLV 50
AVK E Q +E EV+ L ++ HPN+++L LV
Sbjct: 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 51 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
++ M KG L ++L + ++ A+ + + LH +++RD K NILLD
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRAL--LEVICALHK--LNIVHRDLKPENILLD 158
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSF 164
+ N KL+DFG + G++ +V GT Y APE + D++S
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 165 GVVLLELLSG 174
GV++ LL+G
Sbjct: 216 GVIMYTLLAG 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 45/201 (22%)
Query: 2 VVAVKKLK----PEGFQGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGENRL------ 48
VA+KK+ EGF +T E+ L L H N+V LI C +
Sbjct: 44 KVALKKVLMENEKEGFP-----ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98
Query: 49 --LVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 103
LV++F G L N + + +V GL ++H +++++RD K
Sbjct: 99 IYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMK 151
Query: 104 ASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGR 154
A+N+L+ + KL+DFGLA+A + + T + T Y PE Y
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY----- 206
Query: 155 LTTKSDVYSFGVVLLELLSGR 175
D++ G ++ E+ +
Sbjct: 207 -GPPIDLWGAGCIMAEMWTRS 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 48/176 (27%), Positives = 72/176 (40%), Gaps = 13/176 (7%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
A KK+ + + E+ + L HPN+++L + + LV E G L
Sbjct: 37 RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER 96
Query: 63 LFRRGPQPLSWAVR-MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLS 118
+ + S A R MK + A + + H V +RD K N L + KL
Sbjct: 97 VVHKRVFRESDAARIMKDVLSA---VAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLI 151
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGLA G +GT Y +P+ V G + D +S GV++ LL G
Sbjct: 152 DFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 8/176 (4%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
V K + E++ + QLHHP L+ L + +L+ EF+ G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLS 118
+ + +S A + A +GL +H E +++ D K NI+ + + + K+
Sbjct: 137 DRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKII 193
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGLA + + T +AAPE V + +D+++ GV+ LLSG
Sbjct: 194 DFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ ++ + +E + EV+ L Q+ HPN++ L + +L+ E + G L
Sbjct: 44 FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF 103
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAK 116
+ L ++ A I G+ +LH ++ + D K NI+L + K
Sbjct: 104 DFLAQKESLSEEEATSFIKQI--LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
L DFGLA G + GT + APE V L ++D++S GV+ LLSG
Sbjct: 160 LIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 12/178 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ ++L +E + EVN L ++ HPN++ L + +L+ E + G L
Sbjct: 37 FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNA-K 116
+ L + A + I G+ +LH ++ + D K NI+L + K
Sbjct: 97 DFLAEKESLTEDEATQFLKQI--LDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIK 152
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
L DFG+A G+ + GT + APE V L ++D++S GV+ LLSG
Sbjct: 153 LIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 2 VVAVKKLKPEGFQGHKEW-----LTEVNYLGQLH---HPNLVKLI----GYCLEGENRL- 48
VA+K ++ G + EV L +L HPN+V+L+ + E ++
Sbjct: 36 FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95
Query: 49 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 108
LV+E + + L +L + P L + +GL FLH + +++RD K NIL
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENIL 152
Query: 109 LDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 167
+ + KL+DFGLA+ T V+ T Y APE + T D++S G +
Sbjct: 153 VTSGGTVKLADFGLARIYSYQMALTP---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCI 208
Query: 168 LLELLSGR 175
E+ +
Sbjct: 209 FAEMFRRK 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 1 MVVAVK-------KLKPEGFQGHKEWL-TEVNYLGQLH-HPNLVKLIGYCLEGENRLLVY 51
AVK +L PE + +E E + L Q+ HP+++ LI LV+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 52 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
+ M KG L ++L + + ++ + ++FLH + +++RD K NILLD
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSL--LEAVSFLHA--NNIVHRDLKPENILLDD 235
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFG 165
+LSDFG + G++ ++ GT GY APE + D+++ G
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 166 VVLLELLSG 174
V+L LL+G
Sbjct: 293 VILFTLLAG 301
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 48/177 (27%), Positives = 68/177 (38%), Gaps = 10/177 (5%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL- 59
A K + + E+ + L HP LV L + +++YEFM G L
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKL 117
E AV + KGL +H E+ ++ D K NI+ KL
Sbjct: 243 EKVADEHNKMSEDEAVEYMRQV--CKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKL 298
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGL V GT +AAPE + +D++S GV+ LLSG
Sbjct: 299 IDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 22/183 (12%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEF 53
VA+KKL FQ K E+ + ++H N++ L+ LE + +V E
Sbjct: 53 VAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
M + +L + L RM + G+ LH A +I+RD K SNI++ ++
Sbjct: 112 M-----DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 163
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
K+ DFGLA T + + T + T Y APE + D++S G ++ E++
Sbjct: 164 CTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 173 SGR 175
G
Sbjct: 221 KGG 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-17
Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
++ KKL FQ + E +L HPN+V+L E LV++ + G L
Sbjct: 38 IINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 94
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLS 118
+ R + A I + + + H + +++R+ K N+LL ++ KL+
Sbjct: 95 DIVAREFYSEADASHCIQQI--LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGLA + GT GY +PE + + D+++ GV+L LL G
Sbjct: 151 DFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-17
Identities = 37/180 (20%), Positives = 72/180 (40%), Gaps = 17/180 (9%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
K +K +G E++ L H N++ L E ++++EF+ +
Sbjct: 31 KTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAK----GLTFLHDAESQVIYRDFKASNILLDAEFNA- 115
+ + L+ + + L FLH + + D + NI+ ++
Sbjct: 90 ERINTSAFE-LN----EREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSST 142
Query: 116 -KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
K+ +FG A+ GD + + Y APE ++T +D++S G ++ LLSG
Sbjct: 143 IKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 8e-17
Identities = 55/202 (27%), Positives = 77/202 (38%), Gaps = 37/202 (18%)
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
E L+ + + AKG+ FL A + I+RD A NILL + K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 120 FGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
FGLA+ M APE + T +SDV+SFGV+L E+ S
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 174 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQ 229
+G A PY + + R + K G + P L
Sbjct: 291 ---------LG--------ASPYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLD 331
Query: 230 CLNNEPKLRPRMSEVLAILERL 251
C + EP RP SE++ L L
Sbjct: 332 CWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 23/74 (31%), Positives = 37/74 (50%), Gaps = 3/74 (4%)
Query: 1 MVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLV-YEFMPKG 57
VAVK LK H+ ++E+ L + HH N+V L+G C + L+V EF G
Sbjct: 53 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 112
Query: 58 SLENHLFRRGPQPL 71
+L +L + + +
Sbjct: 113 NLSTYLRSKRNEFV 126
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-17
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 8/176 (4%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ +A K +K G + +E E++ + QL H NL++L + +LV E++ G L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLS 118
+ + L+ + +G+ +H + +++ D K NIL K+
Sbjct: 175 DRIIDES-YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKII 231
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGLA+ ++ GT + APE V ++ +D++S GV+ LLSG
Sbjct: 232 DFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 20/182 (10%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEF 53
VA+KKL FQ K E+ + ++H N++ L+ LE + LV E
Sbjct: 90 VAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M + +L + L + G+ LH A +I+RD K SNI++ ++
Sbjct: 149 M-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 201
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFGLA+ T + + T + T Y APE + D++S G ++ E++
Sbjct: 202 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
Query: 174 GR 175
+
Sbjct: 259 HK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 43/166 (25%), Positives = 65/166 (39%), Gaps = 28/166 (16%)
Query: 22 EVNYLGQLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79
E+ L HPN+V+ + L ++ E+ G L + G R
Sbjct: 66 EIINHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG--------RFSE 115
Query: 80 AIGAAK------GLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDR 131
G+++ H Q+ +RD K N LLD K+ DFG +K+ +
Sbjct: 116 DEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
Query: 132 THVSTQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 175
+ V GT Y APE V + +DV+S GV L +L G
Sbjct: 174 PK--STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 22 EVNYLGQL-HHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLS---W 73
EV++ Q P++V ++ + L++ E M G L + + RG Q +
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGD 130
A M+ A + FLH + +RD K N+L E +A KL+DFG AK
Sbjct: 131 AEIMRDIGTA---IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 131 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
+ T T Y APE + + D++S GV++ LL G
Sbjct: 186 ---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 2 VVAVKKLK----PEGFQGHKEWLT---EVNYLGQLH---HPNLVKLI----GYCLEGENR 47
VA+K+++ EG L+ EV L L HPN+V+L + E +
Sbjct: 39 FVALKRVRVQTGEEGMP-----LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 48 L-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 106
L LV+E + + L +L + + + +GL FLH +V++RD K N
Sbjct: 94 LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQN 150
Query: 107 ILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 165
IL+ + KL+DFGLA+ T V+ T Y APE + T D++S G
Sbjct: 151 ILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 166 VVLLELLSGR 175
+ E+ +
Sbjct: 207 CIFAEMFRRK 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 55/186 (29%), Positives = 82/186 (44%), Gaps = 18/186 (9%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
AVK ++ + EV L Q H N+++LI + E + LV+E M GS+ +
Sbjct: 41 YAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLS 118
H+ +R A + + A L FLH+ + +RD K NIL + K+
Sbjct: 101 HIHKRRHFNELEASVVVQDV--ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKIC 156
Query: 119 DFGLAKA-GPTGDRTHVSTQVM----GTHGYAAPEYVATGRLTTKS-----DVYSFGVVL 168
DF L GD + +ST + G+ Y APE V D++S GV+L
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 169 LELLSG 174
LLSG
Sbjct: 217 YILLSG 222
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 65/293 (22%), Positives = 110/293 (37%), Gaps = 38/293 (12%)
Query: 22 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E+ L + HPN++ L +G+ +V E M G L + + R+ A +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVST 136
I K + +LH V++RD K SNIL D N ++ DFG AK + +
Sbjct: 125 I--TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLM 178
Query: 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 196
T + APE + D++S GV+L +L+G P
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF-------------ANGPD 225
Query: 197 LSDKRKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---I 247
+ + L RI G++ + TA L + L+ +P R + VL I
Sbjct: 226 DTPEEILARIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
Query: 248 LERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 300
+ + P+ + + + S + + +SP+ S L R
Sbjct: 282 VHWDQLPQYQLNRQDAPHLVKGA-MAATYSALNRNQSPVLEPVGRSTLAQRRG 333
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 38/181 (20%), Positives = 74/181 (40%), Gaps = 20/181 (11%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ ++ + E L E+ L P ++ L +L+ E+ G +
Sbjct: 61 FLKKRRRGQDC---RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAK----GLTFLHDAESQVIYRDFKASNILL---DAEF 113
+ + +S I K G+ +LH ++ +++ D K NILL
Sbjct: 118 SLCLPELAEMVS----ENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLG 171
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ K+ DFG+++ +MGT Y APE + +TT +D+++ G++ LL+
Sbjct: 172 DIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
Query: 174 G 174
Sbjct: 229 H 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 47/198 (23%)
Query: 2 VVAVKKLK----PEGFQGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFM 54
VA+K+++ EG T EV+ L +L H N+++L L++E+
Sbjct: 61 TVAIKRIRLEHEEEGVP-----GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115
Query: 55 P---KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
K ++ + +S V G+ F H + ++RD K N+LL
Sbjct: 116 ENDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSV 167
Query: 112 EFNA-----KLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTT 157
+ K+ DFGLA+A P TH +++ T Y PE Y +T
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHY------ST 217
Query: 158 KSDVYSFGVVLLELLSGR 175
D++S + E+L
Sbjct: 218 SVDIWSIACIWAEMLMKT 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ ++ K +E + EV+ L ++ HPN++ L + +L+ E + G L
Sbjct: 43 FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNA-K 116
+ L + A I G+ +LH Q+ + D K NI+L + K
Sbjct: 103 DFLAEKESLTEEEATEFLKQI--LNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
+ DFGLA G+ + GT + APE V L ++D++S GV+ LLSG
Sbjct: 159 IIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 22/186 (11%)
Query: 3 VAVK-----KLKPEGFQGHKEWL---TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFM 54
VA+K K + L TE+ L +L+HP ++K+ + + E+ +V E M
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELM 96
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DA 111
G L + + + + + +LH+ + +I+RD K N+LL +
Sbjct: 97 EGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLHE--NGIIHRDLKPENVLLSSQEE 152
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVL 168
+ K++DFG +K + GT Y APE V T D +S GV+L
Sbjct: 153 DCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 169 LELLSG 174
LSG
Sbjct: 210 FICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 55/279 (19%), Positives = 95/279 (34%), Gaps = 36/279 (12%)
Query: 22 EVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E+ L HPN+VKL + + LV E + G L + ++ + A +
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
+ ++ +HD V++RD K N+L + K+ DFG A+ P +
Sbjct: 115 L--VSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKT 168
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 197
T YAAPE + D++S GV+L +LSG+ +
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRS 215
Query: 198 SDKRKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---IL 248
IM G + + + A L L +P R +MS + +
Sbjct: 216 LTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275
Query: 249 ERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 287
+ + N P + ++ N
Sbjct: 276 DGSQLSSN----PLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 26/187 (13%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-----CLEGENRL-LVYEFMP 55
+VA+KK+ Q + E+ + +L H N+V+L + + E L LV +++P
Sbjct: 81 LVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136
Query: 56 KGSLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
+ ++ + R Q L + +K+ + + L ++H + +RD K N+LLD +
Sbjct: 137 E-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPD 192
Query: 113 FNA-KLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVL 168
KL DFG AK G+ +++ ++ Y APE + T+ DV+S G VL
Sbjct: 193 TAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 169 LELLSGR 175
ELL G+
Sbjct: 248 AELLLGQ 254
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
++ KKL FQ + E +L HPN+V+L E LV++ + G L
Sbjct: 61 IINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLS 118
+ R + A I + + + H + +++R+ K N+LL ++ KL+
Sbjct: 118 DIVAREFYSEADASHCIQQI--LESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGLA + GT GY +PE + + D+++ GV+L LL G
Sbjct: 174 DFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 26/186 (13%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-----CLEGENRL-LVYEFMPK 56
VA+KK+ Q + E+ + + HPN+V L + + E L LV E++P+
Sbjct: 67 VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 57 GSLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
++ + + Q + + +K+ + + L ++H + +RD K N+LLD
Sbjct: 123 -TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPS 178
Query: 114 NA-KLSDFGLAKA-GPTGDRTH-VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLL 169
KL DFG AK + ++ Y APE + TT D++S G V+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 170 ELLSGR 175
EL+ G+
Sbjct: 234 ELMQGQ 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 21 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
TE+ L +L HPN++KL LV E + G L + + +G A
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQ 137
I + + +LH E+ +++RD K N+L + K++DFGL+K
Sbjct: 157 I--LEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KT 209
Query: 138 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
V GT GY APE + + D++S G++ LL G
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 21/185 (11%)
Query: 3 VAVK-----KLKPEGFQGHKEWLT-EVNYLGQLHH--PNLVKLIGYCLEGENRL-LVYEF 53
VA+K ++ G + + EV L ++ +++L+ + E + L+ E
Sbjct: 71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILER 129
Query: 54 -MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
P L + + RG A + A + H+ V++RD K NIL+D
Sbjct: 130 PEPVQDLFDFITERGALQEELARSFFWQVLEA--VRHCHN--CGVLHRDIKDENILIDLN 185
Query: 113 -FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLE 170
KL DFG A GT Y+ PE++ R + V+S G++L +
Sbjct: 186 RGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241
Query: 171 LLSGR 175
++ G
Sbjct: 242 MVCGD 246
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 24/181 (13%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
V VK LKP K+ E+ L L PN++ L + +R F + N
Sbjct: 64 VVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH---VNN 117
Query: 62 HLFRRGPQPLSWA-VR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KL 117
F++ Q L+ +R M + K L + H +++RD K N+++D E +L
Sbjct: 118 TDFKQLYQTLTDYDIRFYMYEIL---KALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRL 172
Query: 118 SDFGLAKAG-PTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 174
D+GLA+ P + V+++ + PE + ++ S D++S G +L ++
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
Query: 175 R 175
+
Sbjct: 228 K 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 22 EVNYLGQL-HHPNLVKLIGYC---LEGENRL-LVYEFMPKGSLENHLFRRGPQPLS---W 73
EV + P++V+++ G L +V E + G L + + RG Q +
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163
Query: 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGD 130
+ MK A + +LH + +RD K N+L NA KL+DFG AK + +
Sbjct: 164 SEIMKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 131 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
++T T Y APE + + D++S GV++ LL G
Sbjct: 219 S--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 12/176 (6%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
++ KKL Q + E L HPN+V+L E + L+++ + G L
Sbjct: 43 IINTKKLSARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE 99
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLS 118
+ R + A I + + H + V++R+ K N+LL A KL+
Sbjct: 100 DIVAREYYSEADASHCIQQI--LEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLA 155
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
DFGLA GT GY +PE + D+++ GV+L LL G
Sbjct: 156 DFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 30/192 (15%)
Query: 2 VVAVKKLKPEGFQGHKEW----LTEVNYLGQLHHPNLVKLI------GYCLEGENRL-LV 50
VA+KK+ Q + L + L LHHPN+V+L G + L +V
Sbjct: 50 SVAIKKV----IQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104
Query: 51 YEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNI 107
E++P +L + R + +KV + + + LH V +RD K N+
Sbjct: 105 MEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNV 162
Query: 108 LLDAEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGTHGYAAPEYVATGRL-TTKSDVYS 163
L++ KL DFG AK P+ + ++ Y APE + + TT D++S
Sbjct: 163 LVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWS 217
Query: 164 FGVVLLELLSGR 175
G + E++ G
Sbjct: 218 VGCIFAEMMLGE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIG----YCLEGENRL-LVYEFM 54
VA+KK+ P F+ + L E+ L + H N++ + +E + +V + M
Sbjct: 55 VAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
+ L + Q LS + + +GL ++H A V++RD K SN+LL+
Sbjct: 113 --ETDLYKLLKT--QHLS-NDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTC 165
Query: 114 NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLEL 171
+ K+ DFGLA+ A P D T T+ + T Y APE + + TKS D++S G +L E+
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
Query: 172 LSGR 175
LS R
Sbjct: 226 LSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 26/191 (13%)
Query: 3 VAVKKLKPEGFQGHKEW-----------LTEVNYLGQLHHPNLVKL----IGYCLEGENR 47
VA+K++ G L E+ L HHPN++ L + + ++
Sbjct: 49 VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 48 L-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKAS 105
L LV E M L + +S ++ + GL LH+A V++RD
Sbjct: 109 LYLVTELMRT-DL-AQVIHDQRIVIS-PQHIQYFMYHILLGLHVLHEAG--VVHRDLHPG 163
Query: 106 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSF 164
NILL + + DF LA+ T + Y APE V + TK D++S
Sbjct: 164 NILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 165 GVVLLELLSGR 175
G V+ E+ + +
Sbjct: 221 GCVMAEMFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEF 53
VA+KKL FQ K E+ L + H N++ L+ L LV F
Sbjct: 52 VAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF 110
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M + L + S + KGL ++H A V++RD K N+ ++ +
Sbjct: 111 M-----QTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDC 163
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELL 172
K+ DFGLA+ +V T+ Y APE + + ++ D++S G ++ E+L
Sbjct: 164 ELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 173 SGR 175
+G+
Sbjct: 219 TGK 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 33/195 (16%)
Query: 2 VVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLI----GYCLEGENRL-LVYEF 53
+VA+KK++P F L E+ L H N++ + E N + ++ E
Sbjct: 38 IVAIKKIEP--FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
M + + + Q LS ++ I + + LH + VI+RD K SN+L+++
Sbjct: 96 M--QTDLHRVIST--QMLS-DDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN 148
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------------GRLTTKSD 160
+ K+ DFGLA+ D + E+VAT + + D
Sbjct: 149 CDLKVCDFGLAR---IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD 205
Query: 161 VYSFGVVLLELLSGR 175
V+S G +L EL R
Sbjct: 206 VWSCGCILAELFLRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEF 53
VA+KKL FQ K E+ L + H N++ L+ L+ LV F
Sbjct: 53 VAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M G+ L + + L + KGL ++H A +I+RD K N+ ++ +
Sbjct: 112 M--GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDC 165
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELL 172
K+ DFGLA+ + +V T+ Y APE + T++ D++S G ++ E++
Sbjct: 166 ELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 173 SGR 175
+G+
Sbjct: 221 TGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 45/201 (22%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLI-------------GYCLEGENRL- 48
VA+KK+ Q K L E+ + +L H N+VK+ L N +
Sbjct: 39 VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 49 LVYEFMPKGSLENHLFRRGP-----------QPLSWAVRMKVAIGAAKGLTFLHDAESQV 97
+V E+M + ++ +GP Q L +GL ++H A V
Sbjct: 99 IVQEYM--ETDLANVLEQGPLLEEHARLFMYQLL-------------RGLKYIHSAN--V 141
Query: 98 IYRDFKASNILLDAEF-NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155
++RD K +N+ ++ E K+ DFGLA+ P ++ + T Y +P + +
Sbjct: 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN 201
Query: 156 TTKS-DVYSFGVVLLELLSGR 175
TK+ D+++ G + E+L+G+
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGK 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 23/187 (12%)
Query: 3 VAVK-----KLKPEGFQGHKEWLT-EVNYLGQLH----HPNLVKLIGYCLEGENRL-LVY 51
VA+K ++ EV L ++ HP +++L+ + E + LV
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVL 117
Query: 52 EF-MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
E +P L +++ +GP + + AA + H V++RD K NIL+D
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA--IQHCHS--RGVVHRDIKDENILID 173
Query: 111 AEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVL 168
KL DFG A + GT Y+ PE+++ + + V+S G++L
Sbjct: 174 LRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYSPPEWISRHQYHALPATVWSLGILL 229
Query: 169 LELLSGR 175
+++ G
Sbjct: 230 YDMVCGD 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 43/215 (20%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL------LVYEF 53
VA+KK+ F+ K L E+ L +L +++L + ++ L +V E
Sbjct: 54 VAIKKV-NRMFEDLIDCKRILREITILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEI 111
Query: 54 MPKGSLENHLFR--RGPQPLSWAVRMKVAIG-AAKGLTFLHDAESQVIYRDFKASNILLD 110
++ L + + P L+ +K + G F+H++ +I+RD K +N LL+
Sbjct: 112 A-----DSDLKKLFKTPIFLT-EEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN 163
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP---------EYVAT--------- 152
+ + K+ DFGLA+ + T++ + +V T
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223
Query: 153 ---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 184
T D++S G + ELL+ +
Sbjct: 224 LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 30/177 (16%), Positives = 55/177 (31%), Gaps = 38/177 (21%)
Query: 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VA+ + P+G +E L+ L ++ P + +++ L+V E++ GS
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L+ + P P+ A+R A H A V S + + + + L+
Sbjct: 118 LQ-EVADTSPSPV-GAIR--AMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLA 171
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
+ D+ G L LL R
Sbjct: 172 YPA----------------------TMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 24/184 (13%)
Query: 3 VAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEF 53
VAVKKL FQ K E+ L + H N++ L+ LE N + LV
Sbjct: 57 VAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
M L N++ + Q L+ ++ I +GL ++H A+ +I+RD K SN+ ++ +
Sbjct: 116 MGA-DL-NNIVKC--QKLT-DDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED 168
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLEL 171
K+ DFGLA+ T + T Y APE + ++ D++S G ++ EL
Sbjct: 169 CELKILDFGLARH-----TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 172 LSGR 175
L+GR
Sbjct: 224 LTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 46/209 (22%)
Query: 2 VVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKL----IGYCLEGENRL-LVYEF 53
VVA+KK+ F+ K L E+ L +L+H ++VK+ I +E + L +V E
Sbjct: 80 VVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138
Query: 54 MPKGSLENHLFR--RGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLD 110
++ + R P L+ + +K + G+ ++H A +++RD K +N L++
Sbjct: 139 A-----DSDFKKLFRTPVYLT-ELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN 190
Query: 111 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP--------------EYVAT---- 152
+ + K+ DFGLA+ + + + +V T
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250
Query: 153 --------GRLTTKSDVYSFGVVLLELLS 173
T DV+S G + ELL+
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 2 VVAVKKLKPEGFQGH---KEWLTEVNYLGQLH-HPNLVKLIGYCLEGENR--LLVYEFMP 55
VVAVKK+ + FQ + E+ L +L H N+V L+ +R LV+++M
Sbjct: 36 VVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM- 93
Query: 56 KGSLENHLFR--RGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
E L R L V + + K + +LH +++RD K SNILL+AE
Sbjct: 94 ----ETDLHAVIRA-NILE-PVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE 145
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP--------EYVAT------------ 152
+ K++DFGL+++ R + + +YVAT
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205
Query: 153 GRLTTKSDVYSFGVVLLELLSGR 175
+ T D++S G +L E+L G+
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGK 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 54/216 (25%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY---------------------- 40
A+KK+ Q + E++ + L H N++KL+ Y
Sbjct: 35 FALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLG 90
Query: 41 ---------------CLEGENRL-LVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI- 81
L ++ E++P +L L F R + + + + I
Sbjct: 91 GKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIY 148
Query: 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMG 140
+ + F+H + +RD K N+L++++ N KL DFG AK + V+
Sbjct: 149 QLFRAVGFIHSL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC-- 203
Query: 141 THGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
+ Y APE + T D++S G V EL+ G+
Sbjct: 204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 38/163 (23%)
Query: 22 EVNYLGQL-HHPNLVKLIGYC----LEGENRLLVYEFMPKGSLENHLFRRGPQPLS--WA 74
EV + P++V+++ + L+V E + G L + + RG Q + A
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDR 131
+ +IG A + +LH + +RD K N+L NA KL+DFG AK
Sbjct: 120 SEIMKSIGEA--IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------- 168
Query: 132 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
+ G Y D++S GV++ LL G
Sbjct: 169 -----ETTG-EKY-----------DKSCDMWSLGVIMYILLCG 194
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 41/195 (21%)
Query: 2 VVAVKKLKP-EGFQGHKEWLTEVNYLGQL--------HHPNLVKLIGY-------CLEGE 45
VA+K +K + F + EV L + ++ +V L + CL E
Sbjct: 81 WVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY--IVHLKRHFMFRNHLCLVFE 136
Query: 46 NRLL---VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 102
+L +Y+ L N FR L+ R K A L FL E +I+ D
Sbjct: 137 --MLSYNLYDL-----LRNTNFR--GVSLN-LTR-KFAQQMCTALLFLATPELSIIHCDL 185
Query: 103 KASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160
K NILL + K+ DFG + + + Y +PE + D
Sbjct: 186 KPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAID 240
Query: 161 VYSFGVVLLELLSGR 175
++S G +L+E+ +G
Sbjct: 241 MWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 32/194 (16%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLH-----------HPNLVKLIGY----CLEGENR 47
VA+K ++ + + E+ L +++ +++KL+ + G +
Sbjct: 47 VAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 105
Query: 48 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
++V+E + +L + + + + +++ GL ++H +I+ D K N+
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENV 163
Query: 108 LLDAE------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161
L++ K++D G A H + + Y +PE + +D+
Sbjct: 164 LMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGADI 218
Query: 162 YSFGVVLLELLSGR 175
+S ++ EL++G
Sbjct: 219 WSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 39/193 (20%)
Query: 2 VVAVKKLK-PEGFQGHKEWLTEVNYLGQL--HHP----NLVKLIGY-------CLEGENR 47
VA+K ++ + F H++ E+ L L N++ ++ C+ E
Sbjct: 124 HVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE-- 179
Query: 48 LL---VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
LL +YE + K Q S + K A + L LH ++I+ D K
Sbjct: 180 LLSMNLYELIKKNKF---------QGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKP 228
Query: 105 SNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 162
NILL + + K+ DFG + + V T + Y APE + R D++
Sbjct: 229 ENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMW 283
Query: 163 SFGVVLLELLSGR 175
S G +L ELL+G
Sbjct: 284 SLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-06
Identities = 48/223 (21%), Positives = 79/223 (35%), Gaps = 38/223 (17%)
Query: 3 VAVK--KLKPEGFQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VA+K +K + Q H E + + + EG+ ++V E + SL
Sbjct: 37 VAIKLECVKTKHPQLHIES----KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SL 91
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK--- 116
E LF + S + +A + ++H I+RD K N L+
Sbjct: 92 E-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVY 148
Query: 117 LSDFGLAKA-GPTGDRTHV----STQVMGTHGYA---APEYVATGRLTTKSDVYSFGVVL 168
+ DFGLAK H+ + + GT YA + R + D+ S G VL
Sbjct: 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR---RDDLESLGYVL 205
Query: 169 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 211
+ G K + ++K RI + K+
Sbjct: 206 MYFNLGSLPWQGLKAA-------------TKRQKYERISEKKM 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 31/177 (17%), Positives = 54/177 (30%), Gaps = 58/177 (32%)
Query: 49 LVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
+V+E + G L + + Q L K+ +GL +LH + ++I+ D K NI
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENI 178
Query: 108 LLDAE-------------------------------------------------FNAKLS 118
LL K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
D G A + T+ Y + E + T +D++S + EL +G
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 48/202 (23%), Positives = 77/202 (38%), Gaps = 32/202 (15%)
Query: 22 EVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80
E L + + + +EG+ +LV + + SLE LF + LS + +A
Sbjct: 52 ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLA 109
Query: 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK---LSDFGLAKA-GPTGDRTHV-- 134
+ F+H ++RD K N L+ A + DFGLAK T H+
Sbjct: 110 DQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 135 --STQVMGTHGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 189
+ + GT YA + R + D+ S G VL+ L G K G
Sbjct: 168 RENKNLTGTARYASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAG----- 219
Query: 190 VDWAKPYLSDKRKLFRIMDTKL 211
+ K+K +I + K+
Sbjct: 220 --------TKKQKYEKISEKKV 233
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 44/223 (19%), Positives = 77/223 (34%), Gaps = 36/223 (16%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K + E L + + + EG + +LV + + SLE
Sbjct: 38 VAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE- 93
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK----- 116
L + S A + +H+ ++YRD K N L+ +
Sbjct: 94 DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIY 151
Query: 117 LSDFGLAKA-GPTGDRTHV----STQVMGTHGYAAPEYVAT--GR-LTTKSDVYSFGVVL 168
+ DFG+ K + H+ + GT Y + + T GR + + D+ + G V
Sbjct: 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVF 208
Query: 169 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 211
+ L G K ++K+K RI + K
Sbjct: 209 MYFLRGSLPWQGLKAA-------------TNKQKYERIGEKKQ 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 14/129 (10%)
Query: 3 VAVK--KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K +K Q H E+ P ++ + G+ +V E + SLE
Sbjct: 37 VAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP---QVYYFGPCGKYNAMVLELLGP-SLE 92
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK---- 116
LF + S + +AI + ++H +IYRD K N L+ N
Sbjct: 93 -DLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVI 149
Query: 117 -LSDFGLAK 124
+ DF LAK
Sbjct: 150 HIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 31/136 (22%), Positives = 59/136 (43%), Gaps = 18/136 (13%)
Query: 3 VAVKKLKPEGFQGHKEWLT--------EVNYLGQLHHPNLV---KLIGY-CLEGENRLLV 50
++K L + + E +VN +L+ L+ +G+ + + R LV
Sbjct: 78 FSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV 136
Query: 51 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 110
+ + SL++ L LS ++VA L FLH E++ ++ + A NI +D
Sbjct: 137 LPSLGR-SLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVD 193
Query: 111 AEFNAK--LSDFGLAK 124
E ++ L+ +G A
Sbjct: 194 PEDQSQVTLAGYGFAF 209
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 51/210 (24%), Positives = 77/210 (36%), Gaps = 60/210 (28%)
Query: 3 VAVKKLKP-EGFQGHKEWLTEVNYLGQL--------HHPNLVKLIGY-------CLEGEN 46
VA+K ++ + + E+N L ++ V + + C+ E
Sbjct: 48 VALKIIRNVGKY--REAARLEINVLKKIKEKDKENKFL--CVLMSDWFNFHGHMCIAFE- 102
Query: 47 RLL---VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 103
LL +EF L+ + F+ P PL VR +A L FLH+ Q+ + D K
Sbjct: 103 -LLGKNTFEF-----LKENNFQ--PYPLP-HVR-HMAYQLCHALRFLHEN--QLTHTDLK 150
Query: 104 ASNILLDAEFNA-------------------KLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144
NIL +++DFG A T D H +T V H Y
Sbjct: 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRH-Y 205
Query: 145 AAPEYVATGRLTTKSDVYSFGVVLLELLSG 174
PE + DV+S G +L E G
Sbjct: 206 RPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 305 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.14 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.04 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.1 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=398.65 Aligned_cols=226 Identities=21% Similarity=0.320 Sum_probs=191.5
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.+|||||||+||+|.+++..+....+++..+..
T Consensus 50 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~ 129 (350)
T 4b9d_A 50 RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129 (350)
T ss_dssp CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHH
T ss_pred CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHH
Confidence 4799999976543 23467999999999999999999999999999999999999999999999877666789999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++...... ......+||+.|||||++.+..|+.+
T Consensus 130 ~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~ 205 (350)
T 4b9d_A 130 WFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNK 205 (350)
T ss_dssp HHHHHHHHHHHHHHT--TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHH
T ss_pred HHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcH
Confidence 999999999999975 59999999999999999999999999998754321 12345679999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|||||||++|+|++|+.||.+.+.. ..+..++.. .....+..++.++.+||.+||..||.+|
T Consensus 206 ~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~~i~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 206 SDIWALGCVLYELCTLKHAFEAGSMK----------------NLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHcC-CCCCCCccCCHHHHHHHHHHccCChhHC
Confidence 99999999999999999999875421 111222222 2234456788999999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 269 ~s~~e~l~h 277 (350)
T 4b9d_A 269 PSVNSILEK 277 (350)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=390.33 Aligned_cols=233 Identities=28% Similarity=0.489 Sum_probs=200.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-----------CCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-----------PQP 70 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~ 70 (305)
.||||+++.......++|.+|+++|++++|||||++++++.+++.+|||||||+||+|.+++.+.+ ...
T Consensus 45 ~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~ 124 (299)
T 4asz_A 45 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE 124 (299)
T ss_dssp EEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCC
T ss_pred EEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCC
Confidence 699999987766667889999999999999999999999999999999999999999999997542 346
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...............||+.|||||++
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~--~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 202 (299)
T 4asz_A 125 LTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 202 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC--CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHH
Confidence 99999999999999999999975 4999999999999999999999999999865443333333345689999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.+..++.++|||||||++|||+| |+.||.+.+. ..+...+........|..++.++.+|+.+
T Consensus 203 ~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~ 265 (299)
T 4asz_A 203 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----------------NEVIECITQGRVLQRPRTCPQEVYELMLG 265 (299)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHH
Confidence 99999999999999999999998 8999987432 12223333344456677899999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhhcC
Q 021947 230 CLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
||+.||++|||+.++.+.|+++..
T Consensus 266 cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 266 CWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999988753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=391.98 Aligned_cols=233 Identities=28% Similarity=0.468 Sum_probs=191.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------C
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-------------P 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~ 68 (305)
.||||+++.......++|.+|+++|++++|||||+++++|.+.+.+|||||||+||+|.+++.... .
T Consensus 73 ~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~ 152 (329)
T 4aoj_A 73 LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152 (329)
T ss_dssp EEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------C
T ss_pred EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccC
Confidence 699999987766666889999999999999999999999999999999999999999999996543 2
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 69 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 69 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
.++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...............||+.|||||
T Consensus 153 ~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 230 (329)
T 4aoj_A 153 GPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230 (329)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChh
Confidence 3589999999999999999999975 49999999999999999999999999998765443333344567999999999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (305)
++.+..++.++|||||||++|||+| |+.||.+... ..+...+........|..++.++.+|+
T Consensus 231 ~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----------------~~~~~~i~~g~~~~~p~~~~~~~~~li 293 (329)
T 4aoj_A 231 SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----------------TEAIDCITQGRELERPRACPPEVYAIM 293 (329)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----------------HHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCcccccHHHHHHH
Confidence 9999999999999999999999999 8999986432 112233333445566778999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 228 LQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.+||+.||++|||+.+|++.|+.+..
T Consensus 294 ~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 294 RGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=384.88 Aligned_cols=231 Identities=24% Similarity=0.399 Sum_probs=196.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (305)
.||||+++.... ...++|.+|+.+|++++|||||+++|++.+.+.++||||||++|+|.++|..+.
T Consensus 58 ~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~ 137 (308)
T 4gt4_A 58 AVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137 (308)
T ss_dssp EEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CC
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccc
Confidence 699999976533 345789999999999999999999999999999999999999999999996542
Q ss_pred -CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccc
Q 021947 68 -PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 146 (305)
Q Consensus 68 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 146 (305)
...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...............||+.|||
T Consensus 138 ~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymA 215 (308)
T 4gt4_A 138 VKSALEPPDFVHLVAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 215 (308)
T ss_dssp EECCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCC
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccC
Confidence 13589999999999999999999975 499999999999999999999999999986544333333445679999999
Q ss_pred hhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 147 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 147 PE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
||++.++.++.++|||||||++|||+| |..||.+.+. ..+...+......+.|..++..+.+
T Consensus 216 PE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~ 278 (308)
T 4gt4_A 216 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----------------QDVVEMIRNRQVLPCPDDCPAWVYA 278 (308)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred HHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCcccchHHHHH
Confidence 999999999999999999999999998 8999987532 1223334444455677889999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 226 LALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
|+.+||+.||.+|||+.+|++.|+.+
T Consensus 279 li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 279 LMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=385.36 Aligned_cols=224 Identities=24% Similarity=0.321 Sum_probs=190.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++........+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++.+. .+++..+..++
T Consensus 100 ~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~ 176 (346)
T 4fih_A 100 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVC 176 (346)
T ss_dssp CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHH
T ss_pred CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHH
Confidence 479999998766667778999999999999999999999999999999999999999999999654 39999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|||||++.+..|+.++|
T Consensus 177 ~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~D 252 (346)
T 4fih_A 177 LAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVD 252 (346)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHC--CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHH
Confidence 9999999999975 499999999999999999999999999987644322 234568999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|+|++|..||.+.+... .+..+... ......+..++.++.+||.+||..||++||
T Consensus 253 iWSlGvilyeml~G~~PF~~~~~~~----------------~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 316 (346)
T 4fih_A 253 IWSLGIMVIEMVDGEPPYFNEPPLK----------------AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 316 (346)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999998754211 11111111 112234567889999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.|++++
T Consensus 317 ta~e~l~H 324 (346)
T 4fih_A 317 TAAELLKH 324 (346)
T ss_dssp CHHHHTTC
T ss_pred CHHHHhcC
Confidence 99999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=376.92 Aligned_cols=232 Identities=26% Similarity=0.415 Sum_probs=184.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
-||||+++.... ...+.|.+|+++|++++|||||++++++.+ +.+|||||||+||+|.+++.... ..+++..+..+
T Consensus 60 ~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i 137 (307)
T 3omv_A 60 DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDI 137 (307)
T ss_dssp EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHH
T ss_pred cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHH
Confidence 489999875432 234679999999999999999999998754 56899999999999999996544 35999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC---CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~ 156 (305)
+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..............+||+.|||||++.+. .|+
T Consensus 138 ~~qia~gL~yLH~~--~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~ 215 (307)
T 3omv_A 138 ARQTAQGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215 (307)
T ss_dssp HHHHHHHHHHHHHT--TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC
T ss_pred HHHHHHHHHHHHHC--CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC
Confidence 99999999999975 5999999999999999999999999999875443333334456899999999999753 589
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc----CCCCChHHHHHHHHHHHhhcc
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++|||||||++|||+||+.||.+.+.. ..+...+.... ....+..++.++.+|+.+||+
T Consensus 216 ~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----------------~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 279 (307)
T 3omv_A 216 FQSDVYSYGIVLYELMTGELPYSHINNR----------------DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVK 279 (307)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCH----------------HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTC
T ss_pred cHHHhHhHHHHHHHHHHCCCCCCCCChH----------------HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcC
Confidence 9999999999999999999999864321 11111221111 123456788999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcC
Q 021947 233 NEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.||++|||+.++++.|+.+..
T Consensus 280 ~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 280 KVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp SSSTTSCCHHHHHHHHHHHHT
T ss_pred CCHhHCcCHHHHHHHHHHHhc
Confidence 999999999999999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=379.57 Aligned_cols=225 Identities=22% Similarity=0.305 Sum_probs=191.4
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++.... ....+.+.+|+++|++++||||++++++|.+.+.+|||||||+||+|.+++.+.+ .+++..+.
T Consensus 58 ~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~ 135 (311)
T 4aw0_A 58 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTR 135 (311)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHH
T ss_pred CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHH
Confidence 479999997532 2445789999999999999999999999999999999999999999999997765 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+..............+||+.|||||++.+..|+.
T Consensus 136 ~~~~qi~~al~ylH~~--~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~ 213 (311)
T 4aw0_A 136 FYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 213 (311)
T ss_dssp HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH
T ss_pred HHHHHHHHHHHHHHHC--CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc
Confidence 9999999999999975 59999999999999999999999999998765444333355678999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.+.+.. ..+..+... ...++..++.++.+||.+||..||.+
T Consensus 214 ~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~dli~~lL~~dp~~ 275 (311)
T 4aw0_A 214 SSDLWALGCIIYQLVAGLPPFRAGNEG----------------LIFAKIIKL--EYDFPEKFFPKARDLVEKLLVLDATK 275 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHT--CCCCCTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcC--CCCCCcccCHHHHHHHHHHccCCHhH
Confidence 999999999999999999999875421 111222222 23456678899999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||++|++.+
T Consensus 276 R~t~~e~~~~ 285 (311)
T 4aw0_A 276 RLGCEEMEGY 285 (311)
T ss_dssp STTSGGGTCH
T ss_pred CcChHHHcCC
Confidence 9999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=377.87 Aligned_cols=227 Identities=26% Similarity=0.287 Sum_probs=186.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||+++.+... .+|+++|++++|||||++++++.+++.+|||||||+||+|.+++.+.+ .+++..+..++
T Consensus 84 ~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~ 156 (336)
T 4g3f_A 84 FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYL 156 (336)
T ss_dssp CEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred CEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 47999999865433 479999999999999999999999999999999999999999997765 49999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCc---ceeecccccccccchhhhhcCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
.|++.||+|||++ ||+||||||+|||++.+| .+||+|||+++........ ......+||+.|||||++.+..|+
T Consensus 157 ~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 157 GQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp HHHHHHHHHHHTT--TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHC--CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC
Confidence 9999999999964 599999999999999987 5999999999876433211 122345799999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc-CCCCChHHHHHHHHHHHhhccCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
.++|||||||++|+|++|+.||.+.+.... +..+..... ....+..++..+.+||.+||..||
T Consensus 235 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 298 (336)
T 4g3f_A 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----------------CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEP 298 (336)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSTTTCCSCC----------------HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSG
T ss_pred cHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHHHcCCCCchhcCccCCHHHHHHHHHHccCCH
Confidence 999999999999999999999987543211 111111111 112456788999999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021947 236 KLRPRMSEVLAILERLE 252 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~ 252 (305)
.+|||+.|++++|....
T Consensus 299 ~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 299 VHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 99999999999887653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=387.67 Aligned_cols=224 Identities=24% Similarity=0.321 Sum_probs=190.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++........+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++... .+++..+..++
T Consensus 177 ~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~ 253 (423)
T 4fie_A 177 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVC 253 (423)
T ss_dssp CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHH
T ss_pred CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHH
Confidence 479999998776677788999999999999999999999999999999999999999999999654 39999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|
T Consensus 254 ~qil~aL~ylH~~--~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~D 329 (423)
T 4fie_A 254 LAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVD 329 (423)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHH
Confidence 9999999999975 599999999999999999999999999987644322 234568999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|+|++|..||.+.+... .+..+... ......+..++.++.+||.+||..||.+||
T Consensus 330 iWSlGvilyeml~G~~PF~~~~~~~----------------~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 393 (423)
T 4fie_A 330 IWSLGIMVIEMVDGEPPYFNEPPLK----------------AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 393 (423)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999998754211 11111111 112234456889999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.|++++
T Consensus 394 ta~ell~H 401 (423)
T 4fie_A 394 TAAELLKH 401 (423)
T ss_dssp CHHHHTTC
T ss_pred CHHHHhcC
Confidence 99999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=370.85 Aligned_cols=224 Identities=24% Similarity=0.387 Sum_probs=181.3
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||+|++..... ...+.|.+|+++|++++|||||+++++|.+ ...+|||||||+||+|.+++.+.+ .+++.
T Consensus 52 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~ 129 (290)
T 3fpq_A 52 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIK 129 (290)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHH
T ss_pred eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHH
Confidence 4699999875432 334679999999999999999999999875 345799999999999999997664 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.||+.||+|||+++.+|+||||||+|||++. +|.+||+|||+|+..... .....+||+.|||||++.+
T Consensus 130 ~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~- 204 (290)
T 3fpq_A 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE- 204 (290)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-
T ss_pred HHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-
Confidence 9999999999999999976556999999999999974 789999999999864332 2345689999999999865
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.|+.++|||||||++|+|++|+.||.+.... ..+...+... .....+..++.++.+||.+||.
T Consensus 205 ~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~ 268 (290)
T 3fpq_A 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNA----------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----------------HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHcc
Confidence 6999999999999999999999999764321 1111222111 1122334566789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.||++|||+.+++++
T Consensus 269 ~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 269 QNKDERYSIKDLLNH 283 (290)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=378.35 Aligned_cols=233 Identities=29% Similarity=0.404 Sum_probs=197.6
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCC-CCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcC-----------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHH-PNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRG----------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----------- 67 (305)
.||||+++..... ..+.|.+|+++|.+++| ||||+++++|.+. +.+|+|||||++|+|.++|+...
T Consensus 96 ~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~ 175 (353)
T 4ase_A 96 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 175 (353)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----
T ss_pred EEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccch
Confidence 6999999866433 34679999999999975 8999999999764 56899999999999999996532
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 68 ---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 68 ---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..............+||+.|
T Consensus 176 ~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~y 253 (353)
T 4ase_A 176 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 253 (353)
T ss_dssp --CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGG
T ss_pred hhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccc
Confidence 234899999999999999999999754 999999999999999999999999999876554444444566799999
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
||||++.+..|+.++|||||||++|||+| |..||.+... ...+...+....+...|..++.++
T Consensus 254 mAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----------------~~~~~~~i~~g~~~~~p~~~~~~~ 317 (353)
T 4ase_A 254 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEFCRRLKEGTRMRAPDYTTPEM 317 (353)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----------------SHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred cCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHHcCCCCCCCccCCHHH
Confidence 99999999999999999999999999998 9999987432 223344455555667788889999
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 318 ~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 318 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-55 Score=360.69 Aligned_cols=221 Identities=25% Similarity=0.376 Sum_probs=176.1
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.... .....+.+|+++|++++||||+++++++.+.+.+|+||||| +|+|.+++.+++ .+++..+.
T Consensus 39 ~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~ 115 (275)
T 3hyh_A 39 QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEAR 115 (275)
T ss_dssp CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHH
T ss_pred CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHH
Confidence 4799999976532 33467999999999999999999999999999999999999 679999997765 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~ 156 (305)
.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+...... .....+||+.|+|||++.+..+ +
T Consensus 116 ~~~~qi~~al~ylH~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~ 190 (275)
T 3hyh_A 116 RFFQQIISAVEYCHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAG 190 (275)
T ss_dssp HHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCC
T ss_pred HHHHHHHHHHHHHHHC--CcccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCC
Confidence 9999999999999975 59999999999999999999999999998654322 2345689999999999998876 5
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|||||||++|+|++|+.||.+.+.. .+.+.+.. ....++..++.++.+||.+||+.||+
T Consensus 191 ~~~DiwSlGvily~lltg~~PF~~~~~~-----------------~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~ 252 (275)
T 3hyh_A 191 PEVDVWSCGVILYVMLCRRLPFDDESIP-----------------VLFKNISN-GVYTLPKFLSPGAAGLIKRMLIVNPL 252 (275)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHH-TCCCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred ChhhhHHHHHHHHHHHHCCCCCCCCCHH-----------------HHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCChh
Confidence 7899999999999999999999865321 11111111 12345667889999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||++|++++
T Consensus 253 ~R~s~~eil~h 263 (275)
T 3hyh_A 253 NRISIHEIMQD 263 (275)
T ss_dssp GSCCHHHHHHC
T ss_pred HCcCHHHHHcC
Confidence 99999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-56 Score=371.00 Aligned_cols=222 Identities=28% Similarity=0.343 Sum_probs=179.4
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||+++.... ....++.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.+++.+.+ .+++..+..
T Consensus 53 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~ 130 (304)
T 3ubd_A 53 QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKF 130 (304)
T ss_dssp CEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHH
T ss_pred EEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 3699999975432 233568899999999999999999999999999999999999999999997765 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.+
T Consensus 131 ~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~ 206 (304)
T 3ubd_A 131 YLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQS 206 (304)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTH
T ss_pred HHHHHHHHHHHHHHC--CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCC
Confidence 999999999999975 599999999999999999999999999986533222 2345689999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|||||||++|+|++|+.||.+.+.. ..+..+... ....|..++.++.+||.+||..||++|
T Consensus 207 ~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R 268 (304)
T 3ubd_A 207 ADWWSFGVLMFEMLTGTLPFQGKDRK----------------ETMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNPANR 268 (304)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CcccchHHHHHHHHhCCCCCCCcCHH----------------HHHHHHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHC
Confidence 99999999999999999999875421 111222222 234567789999999999999999999
Q ss_pred CCH-----HHHHH
Q 021947 239 PRM-----SEVLA 246 (305)
Q Consensus 239 ps~-----~~~l~ 246 (305)
||+ +|+++
T Consensus 269 ~ta~~~~~~eil~ 281 (304)
T 3ubd_A 269 LGAGPDGVEEIKR 281 (304)
T ss_dssp TTCSTTTHHHHHT
T ss_pred CCCCcCCHHHHHc
Confidence 985 56664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=354.00 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=179.9
Q ss_pred EEEEEecccCCccChHHHH--HHHHHHhccCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWL--TEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~--~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.. ....+. .|+..+.+++||||+++++++.+.+ .+|||||||+||+|.+++.+.. +++..
T Consensus 28 ~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---l~~~~ 101 (303)
T 3hmm_A 28 EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEG 101 (303)
T ss_dssp EEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHH
T ss_pred EEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC---CCHHH
Confidence 6999999754 333344 4555667889999999999998654 5799999999999999997653 89999
Q ss_pred HHHHHHHHHHHHhhhhcC------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aP 147 (305)
+..++.|++.||+|||++ ..+|+||||||+|||++.++.+||+|||+++........ ......+||+.||||
T Consensus 102 ~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAP 181 (303)
T 3hmm_A 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCH
Confidence 999999999999999975 237999999999999999999999999999865433221 122345799999999
Q ss_pred hhhhcC------CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhh-hhhcccCCCCCh---
Q 021947 148 EYVATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQ--- 217 (305)
Q Consensus 148 E~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--- 217 (305)
|++.+. .++.++|||||||++|||+||..||........ .+..... .......+.. ......+...+.
T Consensus 182 E~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~~-~~~~~~~~~~~~~~~~~rp~~p~~~~ 259 (303)
T 3hmm_A 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVP-SDPSVEEMRKVVCEQKLRPNIPNRWQ 259 (303)
T ss_dssp HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSC-SSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred HHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchhccc-ccchHHHHHHHHhcccCCCCCCcccc
Confidence 999764 367799999999999999999988865432111 0000000 0001111111 122233333332
Q ss_pred --HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 218 --KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 218 --~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.++..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus 260 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 466789999999999999999999999999998753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=351.77 Aligned_cols=223 Identities=23% Similarity=0.370 Sum_probs=168.6
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCC------------eeEEEEecCCCCCHHHHhhhcC
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------------NRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+ .+|+|||||+||+|.+++..+.
T Consensus 31 ~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~ 110 (299)
T 4g31_A 31 CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC 110 (299)
T ss_dssp CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC
T ss_pred CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC
Confidence 4799999975543 23467899999999999999999999987544 3689999999999999997654
Q ss_pred CC-CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc----------eee
Q 021947 68 PQ-PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH----------VST 136 (305)
Q Consensus 68 ~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~ 136 (305)
.. ...+..++.++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+|+......... ...
T Consensus 111 ~~~~~~~~~~~~i~~qi~~al~ylH~~--~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 188 (299)
T 4g31_A 111 TIEERERSVCLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188 (299)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCCCC-----------------------
T ss_pred CCChhHHHHHHHHHHHHHHHHHHHHHC--cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccC
Confidence 32 355677889999999999999975 59999999999999999999999999998754332111 123
Q ss_pred cccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC
Q 021947 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 216 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (305)
..+||+.|||||++.+..|+.++|||||||++|+|++ ||.+.... ...+... ....++
T Consensus 189 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---------------~~~~~~~----~~~~~p 246 (299)
T 4g31_A 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---------------VRTLTDV----RNLKFP 246 (299)
T ss_dssp ---CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---------------HHHHHHH----HTTCCC
T ss_pred CcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---------------HHHHHHH----hcCCCC
Confidence 4579999999999999999999999999999999996 77542110 0001111 111222
Q ss_pred ---hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 217 ---QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 217 ---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
...++.+.+||.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2445567899999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=349.94 Aligned_cols=242 Identities=24% Similarity=0.280 Sum_probs=180.2
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe------CCeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
+.||||+++.... ...+.+++|+++|++++||||+++++++.. .+.+|||||||+ |+|.+++.+.+ .++
T Consensus 80 ~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~ 156 (398)
T 4b99_A 80 QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLT 156 (398)
T ss_dssp CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCC
T ss_pred CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCC
Confidence 4799999976533 234678899999999999999999998763 357899999996 58999996654 599
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCC--Ccceeecccccccccchhhh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~ 150 (305)
+..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++...... ........+||+.|+|||++
T Consensus 157 ~~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 157 LEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC--cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence 999999999999999999975 59999999999999999999999999998654322 12223456899999999998
Q ss_pred hcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hh-hhhhhcc-----chhhhhhhhccc-CCCC-----C
Q 021947 151 ATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLSD-----KRKLFRIMDTKL-GGQY-----P 216 (305)
Q Consensus 151 ~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~-----~~~~~~~~~~~~-~~~~-----~ 216 (305)
.+. .++.++|||||||++|+|++|+.||.+.+.......+ .. ..+.... .......+.... .... .
T Consensus 235 ~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
T 4b99_A 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY 314 (398)
T ss_dssp TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS
T ss_pred cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC
Confidence 875 5689999999999999999999999876543211111 00 0000000 000001110000 0000 1
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..++.++.+||.+||..||.+|||+.|++++
T Consensus 315 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 315 PGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 2457789999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=340.98 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=177.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++... ....++.+|+++|+.+ +||||++++++|.+.+.+|+|||||+|++|.+++. .+++..+..++
T Consensus 51 ~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~ 123 (361)
T 4f9c_A 51 KIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYM 123 (361)
T ss_dssp EEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHH
T ss_pred EEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHH
Confidence 6999998765 3456788999999998 69999999999999999999999999999999983 38999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCC-CceeeccccccccCCCCCCc--------------------------c
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT--------------------------H 133 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~--------------------------~ 133 (305)
.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+........ .
T Consensus 124 ~qll~al~ylH~~--gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (361)
T 4f9c_A 124 LNLFKALKRIHQF--GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQ 201 (361)
T ss_dssp HHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------------
T ss_pred HHHHHHHHHHHHC--CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccc
Confidence 9999999999975 59999999999999876 79999999999754332110 1
Q ss_pred eeecccccccccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh--hhhhh---------hhh-----
Q 021947 134 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWA---------KPY----- 196 (305)
Q Consensus 134 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~---------~~~----- 196 (305)
.....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.......++. +.... ...
T Consensus 202 ~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~ 281 (361)
T 4f9c_A 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSIL 281 (361)
T ss_dssp ----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEE
T ss_pred cccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccc
Confidence 12235799999999999876 58999999999999999999999996654322110 00000 000
Q ss_pred ------hccchhhhhhh---------------hcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 197 ------LSDKRKLFRIM---------------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 197 ------~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..+.....+.+ ...........+++++.+||.+||..||.+|+|++|++++
T Consensus 282 ~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 282 CSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp ESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 0000111223567889999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=361.45 Aligned_cols=225 Identities=22% Similarity=0.279 Sum_probs=188.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++........+.+.+|+++|+.++||||++++++|.+.+.+|||||||+||+|.+++.... ..+++..+..++
T Consensus 183 ~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~ 261 (573)
T 3uto_A 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYM 261 (573)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHH
T ss_pred CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHH
Confidence 3699999987665666789999999999999999999999999999999999999999999996443 349999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCC--CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+..|+.+
T Consensus 262 ~qi~~al~ylH~~--~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~ 336 (573)
T 3uto_A 262 RQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYY 336 (573)
T ss_dssp HHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHHHHC--CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcH
Confidence 9999999999975 59999999999999854 789999999998765432 2345689999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+|||||||++|+|++|..||.+.+.. ..+..+..... .......++.++.+||.+||..||.
T Consensus 337 ~DiWSlGvilyeml~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~ 400 (573)
T 3uto_A 337 TDMWSVGVLSYILLSGLSPFGGENDD----------------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 400 (573)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGG
T ss_pred HHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999875431 11112221111 1122346788999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.|++++
T Consensus 401 ~R~t~~e~l~H 411 (573)
T 3uto_A 401 TRMTIHQALEH 411 (573)
T ss_dssp GSCCHHHHHHS
T ss_pred HCcCHHHHhcC
Confidence 99999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=356.30 Aligned_cols=224 Identities=26% Similarity=0.336 Sum_probs=181.4
Q ss_pred CEEEEEecccCCc---cChHHHHH---HHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||||+++.... .....+.+ ++.+++.++|||||+++++|.+.+.+|||||||.||+|.+++.+.+ .+++.
T Consensus 215 ~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~ 292 (689)
T 3v5w_A 215 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEA 292 (689)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHH
T ss_pred CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHH
Confidence 4799999864321 22233344 4667778899999999999999999999999999999999997765 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-C
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
.+..++.||+.||.|||++ |||||||||+|||++.+|.+||+|||+|+...... ....+||+.|||||++.+ .
T Consensus 293 ~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~ 366 (689)
T 3v5w_A 293 DMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV 366 (689)
T ss_dssp HHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTC
T ss_pred HHHHHHHHHHHHHHHHHHC--CccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCC
Confidence 9999999999999999964 59999999999999999999999999998754332 335689999999999964 5
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.|+.++|+|||||++|+|++|..||.+........ +.... ......++..++.++.+||.+||..
T Consensus 367 ~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~--------------i~~~i-~~~~~~~p~~~S~~a~dLI~~lL~~ 431 (689)
T 3v5w_A 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRMT-LTMAVELPDSFSPELRSLLEGLLQR 431 (689)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH--------------HHHHH-HHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--------------HHHhh-cCCCCCCCccCCHHHHHHHHHHccC
Confidence 79999999999999999999999997643221111 11111 1123356677899999999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 021947 234 EPKLRPR-----MSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps-----~~~~l~~ 247 (305)
||.+|++ +++++++
T Consensus 432 dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 432 DVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CGGGCTTCSSSTHHHHTTS
T ss_pred CHhHCCCCCCCCHHHHhcC
Confidence 9999998 6888764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=328.77 Aligned_cols=232 Identities=25% Similarity=0.438 Sum_probs=194.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||||+++.... .....+.+|+++++++ +||||+++++++...+..|+||||+.||+|.+++.....
T Consensus 115 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 194 (370)
T 2psq_A 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194 (370)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC----------
T ss_pred eEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccc
Confidence 599999986633 2346789999999999 899999999999999999999999999999999976542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++...............+|+.|+
T Consensus 195 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~ 272 (370)
T 2psq_A 195 VPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 272 (370)
T ss_dssp -CCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceE
Confidence 3478999999999999999999975 59999999999999999999999999998655433222233445788999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|||||||++|+|++ |..||.+... ..+...+........+..++.++.
T Consensus 273 aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~ 335 (370)
T 2psq_A 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----------------EELFKLLKEGHRMDKPANCTNELY 335 (370)
T ss_dssp CHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGHHHHHHTTCCCCCCTTSCHHHH
T ss_pred CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHhcCCCCCCCCCCCHHHH
Confidence 9999999999999999999999999999 9999986432 122233333444456677889999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+||.+||..||.+|||+.++++.|+++.
T Consensus 336 ~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 336 MMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=321.97 Aligned_cols=250 Identities=41% Similarity=0.684 Sum_probs=203.1
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--CCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 78 (305)
..||||++........+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.... ...+++..++.
T Consensus 64 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 143 (321)
T 2qkw_B 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143 (321)
T ss_dssp CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHH
T ss_pred CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHH
Confidence 3699999987766667889999999999999999999999999999999999999999999996543 23489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.+
T Consensus 144 i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 221 (321)
T 2qkw_B 144 ICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEK 221 (321)
T ss_dssp HHHHHHHHHHHHHHT--TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTH
T ss_pred HHHHHHHHHHHhcCC--CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcc
Confidence 999999999999964 599999999999999999999999999986543333333344568999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|+.||.+...........|.... .....+...+........+..++..+.+++.+||..||.+|
T Consensus 222 ~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (321)
T 2qkw_B 222 SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300 (321)
T ss_dssp HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccC
Confidence 99999999999999999999876543322222222111 11112223333444455677899999999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
||+.++++.|+.+..
T Consensus 301 ps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 301 PSMGDVLWKLEYALR 315 (321)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHhh
Confidence 999999999988643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=317.85 Aligned_cols=224 Identities=25% Similarity=0.357 Sum_probs=189.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++........+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++... .+++..+..++
T Consensus 46 ~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~ 122 (297)
T 3fxz_A 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVC 122 (297)
T ss_dssp CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHH
T ss_pred cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHH
Confidence 369999998776667788999999999999999999999999999999999999999999999765 38999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. |++||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|
T Consensus 123 ~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D 198 (297)
T 3fxz_A 123 RECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVD 198 (297)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHH
T ss_pred HHHHHHHHHHHhC--CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHH
Confidence 9999999999975 599999999999999999999999999886544322 233457999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|+|++|..||.+.+.... ..... ........+..++..+.+||.+||..||.+||
T Consensus 199 iwslG~il~ell~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 262 (297)
T 3fxz_A 199 IWSLGIMAIEMIEGEPPYLNENPLRA----------------LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG 262 (297)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCc
Confidence 99999999999999999976542111 11111 11222344567888999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.+++++
T Consensus 263 s~~ell~h 270 (297)
T 3fxz_A 263 SAKELLQH 270 (297)
T ss_dssp CHHHHTTC
T ss_pred CHHHHhhC
Confidence 99999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=319.93 Aligned_cols=234 Identities=30% Similarity=0.471 Sum_probs=185.2
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-CCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 78 (305)
.||||++....... .+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ..+++..++.
T Consensus 62 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 141 (309)
T 3p86_A 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141 (309)
T ss_dssp EEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHH
T ss_pred cEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHH
Confidence 58999987664332 35789999999999999999999999999999999999999999999965432 2389999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||+|||+.+.+++||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.+
T Consensus 142 i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 219 (309)
T 3p86_A 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEK 219 (309)
T ss_dssp HHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCch
Confidence 9999999999999643339999999999999999999999999997543321 11334578999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||.+.... ...............+..++..+.+||.+||..||.+|
T Consensus 220 ~DiwslG~il~elltg~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 220 SDVYSFGVILWELATLQQPWGNLNPA----------------QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHHHHHHHHHHHHHCCCTTTTSCHH----------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999865321 11111122333445667788999999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
||+.++++.|+.+..
T Consensus 284 ps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 284 PSFATIMDLLRPLIK 298 (309)
T ss_dssp CCHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=320.82 Aligned_cols=233 Identities=28% Similarity=0.473 Sum_probs=192.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.... ..+++..++.++
T Consensus 79 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~ 157 (325)
T 3kul_A 79 PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGML 157 (325)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHH
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHH
Confidence 599999986533 334679999999999999999999999999999999999999999999996543 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.+++.||.|||+. ||+||||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+..++.++
T Consensus 158 ~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 235 (325)
T 3kul_A 158 RGVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235 (325)
T ss_dssp HHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHHC--CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHH
Confidence 9999999999965 5999999999999999999999999999876543221 122233467889999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++|+|++ |..||.+... ..+...+........+..++..+.+||.+||..||.+|
T Consensus 236 Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 298 (325)
T 3kul_A 236 DVWSFGVVMWEVLAYGERPYWNMTN-----------------RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhC
Confidence 99999999999999 9999976432 12223333344455667788999999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 021947 239 PRMSEVLAILERLEAP 254 (305)
Q Consensus 239 ps~~~~l~~l~~~~~~ 254 (305)
||+.++++.|+.+...
T Consensus 299 ps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 299 PRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHHHhC
Confidence 9999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=317.59 Aligned_cols=234 Identities=25% Similarity=0.401 Sum_probs=189.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..||+|++........+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.... ..+++..+..++
T Consensus 36 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~ 114 (310)
T 3s95_A 36 EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFA 114 (310)
T ss_dssp CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHH
T ss_pred cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHH
Confidence 3689999876655666789999999999999999999999999999999999999999999997643 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc------------eeecccccccccchh
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH------------VSTQVMGTHGYAAPE 148 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------------~~~~~~~t~~y~aPE 148 (305)
.|++.||+|||+. |++||||||+||+++.++.+||+|||++.......... ......||+.|+|||
T Consensus 115 ~qi~~al~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (310)
T 3s95_A 115 KDIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192 (310)
T ss_dssp HHHHHHHHHHHHT--TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHhC--CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHH
Confidence 9999999999975 49999999999999999999999999998654332211 011457899999999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
++.+..++.++||||||+++|+|++|..||.......... ......... ...+..++..+.+|+.
T Consensus 193 ~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~l~~li~ 257 (310)
T 3s95_A 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----------GLNVRGFLD----RYCPPNCPPSFFPITV 257 (310)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------SBCHHHHHH----HTCCTTCCTTHHHHHH
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------hhhhhcccc----ccCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999987643221110 000011111 1224556778999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhhc
Q 021947 229 QCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+||+.||.+|||+.++++.|+.+.
T Consensus 258 ~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 258 RCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=319.31 Aligned_cols=228 Identities=25% Similarity=0.300 Sum_probs=182.9
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+||||++|++|.+++.... .+++..+..+
T Consensus 33 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 110 (323)
T 3tki_A 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRF 110 (323)
T ss_dssp CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHH
T ss_pred cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHH
Confidence 3699999875533 234678899999999999999999999999999999999999999999996543 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~ 158 (305)
+.|++.||+|||+. |++||||||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.+
T Consensus 111 ~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 188 (323)
T 3tki_A 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188 (323)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHH
T ss_pred HHHHHHHHHHHHHC--CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCc
Confidence 99999999999965 599999999999999999999999999986543332222345679999999999988775 778
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|||||||++|+|++|..||......... ................++..+.+||.+||..||.+|
T Consensus 189 ~DiwslG~il~~ll~g~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp HHHHHHHHHHHHHHHSSCSCSSSCTTSHH---------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCchHHHH---------------HHHHhcccccCCccccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999865432110 111111112222235678889999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 254 ~t~~eil~h 262 (323)
T 3tki_A 254 ITIPDIKKD 262 (323)
T ss_dssp CCHHHHTTC
T ss_pred cCHHHHhhC
Confidence 999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=327.54 Aligned_cols=232 Identities=27% Similarity=0.401 Sum_probs=192.0
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||+++.... .....+.+|+++|++++||||+++++++...+..|+||||++|++|.+++...+ ..++...++.+
T Consensus 140 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~ 218 (377)
T 3cbl_A 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQM 218 (377)
T ss_dssp CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHH
T ss_pred eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 3699999986532 223578899999999999999999999999899999999999999999997543 24899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.|++.||+|||+. |++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++
T Consensus 219 ~~qi~~~l~~LH~~--~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 296 (377)
T 3cbl_A 219 VGDAAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296 (377)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHHHC--CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchh
Confidence 99999999999975 5999999999999999999999999999864332111111222357789999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++|+|++ |..||.+... ......+........+..++..+.+||.+||+.||.+|
T Consensus 297 DvwslG~il~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 359 (377)
T 3cbl_A 297 DVWSFGILLWETFSLGASPYPNLSN-----------------QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359 (377)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999998 9999986432 12223334444555677788999999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 021947 239 PRMSEVLAILERLE 252 (305)
Q Consensus 239 ps~~~~l~~l~~~~ 252 (305)
||+.++++.|+++.
T Consensus 360 ps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 360 PSFSTIYQELQSIR 373 (377)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=318.18 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=186.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||++.... .....+.+|+.++++++||||+++++++.... .+|+||||+++++|.+++.... +++..++
T Consensus 49 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~ 124 (322)
T 3soc_A 49 YVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELC 124 (322)
T ss_dssp EEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHH
T ss_pred EEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHH
Confidence 69999997542 23345667999999999999999999998754 3699999999999999996643 9999999
Q ss_pred HHHHHHHHHHhhhhcC--------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 78 KVAIGAAKGLTFLHDA--------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~--------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.++.|++.||.|||+. ..+++||||||+|||++.++.+||+|||+++...............||+.|+|||+
T Consensus 125 ~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 204 (322)
T 3soc_A 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204 (322)
T ss_dssp HHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhh
Confidence 9999999999999964 11699999999999999999999999999976554333322334578999999999
Q ss_pred hhcC-----CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcccCCCC-----ChH
Q 021947 150 VATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQY-----PQK 218 (305)
Q Consensus 150 ~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~ 218 (305)
+.+. .++.++|||||||++|+|++|+.||.+........+........ ....+.... ........ ...
T Consensus 205 ~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (322)
T 3soc_A 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHA 283 (322)
T ss_dssp HTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSH
T ss_pred cccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-chhhhhhhhhcccCCCCccccccccc
Confidence 9873 45568899999999999999999998754432211111100000 011111111 11111111 125
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.+.++.+||.+||+.||.+|||+.++++.|+++..
T Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 284 GMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 66789999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=317.88 Aligned_cols=222 Identities=25% Similarity=0.376 Sum_probs=185.3
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||||++..... ...+.+.+|+++|+.++||||+++++++...+..|+||||++|++|.+++...+ .+++..+..
T Consensus 41 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~ 118 (328)
T 3fe3_A 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARS 118 (328)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHH
T ss_pred CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 3699999876532 334678899999999999999999999999999999999999999999997664 399999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC-C
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-T 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~ 157 (305)
++.|++.||+|||+. |++||||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+..++ .
T Consensus 119 ~~~qi~~al~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 193 (328)
T 3fe3_A 119 KFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGP 193 (328)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred HHHHHHHHHHHHHHC--CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCc
Confidence 999999999999975 599999999999999999999999999986543321 3455799999999999988775 7
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+.... ...+... ....+..++.++.+|+.+||..||.+
T Consensus 194 ~~DiwslG~il~ell~g~~pf~~~~~~~~----------------~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~ 255 (328)
T 3fe3_A 194 EVDVWSLGVILYTLVSGSLPFDGQNLKEL----------------RERVLRG--KYRIPFYMSTDCENLLKRFLVLNPIK 255 (328)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTT
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC--CCCCCCCCCHHHHHHHHHHCCCChhH
Confidence 89999999999999999999987542111 1111111 22345567889999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+++++++
T Consensus 256 R~t~~eil~h 265 (328)
T 3fe3_A 256 RGTLEQIMKD 265 (328)
T ss_dssp SCCHHHHTTC
T ss_pred CcCHHHHhcC
Confidence 9999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=322.29 Aligned_cols=233 Identities=30% Similarity=0.416 Sum_probs=192.3
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCe-eEEEEecCCCCCHHHHhhhcCC----------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGP---------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~---------- 68 (305)
.||||+++..... ..+.+.+|++++.++ +||||+++++++.+.+. .++||||+.||+|.+++.....
T Consensus 54 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 133 (359)
T 3vhe_A 54 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA 133 (359)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----
T ss_pred EEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccc
Confidence 6999999865332 336799999999999 78999999999987654 8999999999999999965432
Q ss_pred ------------------------------------------------------CCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 69 ------------------------------------------------------QPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 69 ------------------------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
..+++..++.++.|++.||+|||+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~- 212 (359)
T 3vhe_A 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR- 212 (359)
T ss_dssp --------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-
Confidence 1288999999999999999999975
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHh-
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 173 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~- 173 (305)
||+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 213 -~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 291 (359)
T 3vhe_A 213 -KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291 (359)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred -CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhc
Confidence 599999999999999999999999999987654443333445678999999999999999999999999999999998
Q ss_pred CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 174 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
|..||.+.... ..+...+........+..++.++.+++.+||..||.+|||+.+++++|+++.
T Consensus 292 g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 292 GASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp SCCSSTTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccchh----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 99999875421 1222333333444556678889999999999999999999999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=318.66 Aligned_cols=235 Identities=27% Similarity=0.386 Sum_probs=192.9
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||||++.... ......+.+|+++++++ +||||+++++++...+..|+||||+++++|.+++.....
T Consensus 77 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 156 (344)
T 1rjb_A 77 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156 (344)
T ss_dssp EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------
T ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhh
Confidence 59999997653 23457899999999999 899999999999999999999999999999999976432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 69 ----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 69 ----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...............
T Consensus 157 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 234 (344)
T 1rjb_A 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234 (344)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTE
T ss_pred hcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCc
Confidence 2378999999999999999999975 5999999999999999999999999999865444333334445
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.... ......+........+.
T Consensus 235 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~ 298 (344)
T 1rjb_A 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----------------ANFYKLIQNGFKMDQPF 298 (344)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHHHTTCCCCCCT
T ss_pred cCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH----------------HHHHHHHhcCCCCCCCC
Confidence 67889999999999999999999999999999998 99999875421 12223333334445566
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
.++..+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus 299 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 299 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 7788999999999999999999999999999987554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=314.60 Aligned_cols=232 Identities=30% Similarity=0.441 Sum_probs=194.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------ 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------ 68 (305)
.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.....
T Consensus 55 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 134 (314)
T 2ivs_A 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134 (314)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC------
T ss_pred eEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccc
Confidence 589999986532 3346789999999999999999999999999999999999999999999976542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 69 ----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 69 ----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...............
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 212 (314)
T 2ivs_A 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQG 212 (314)
T ss_dssp ----------CEECHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCC
T ss_pred cccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--CCcccccchheEEEcCCCCEEEccccccccccccccceeccCC
Confidence 2388999999999999999999975 5999999999999999999999999999876543332223344
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.... .+...+........+.
T Consensus 213 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~ 275 (314)
T 2ivs_A 213 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE-----------------RLFNLLKTGHRMERPD 275 (314)
T ss_dssp CSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCCT
T ss_pred CCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHhhcCCcCCCCc
Confidence 57889999999999999999999999999999999 99999865421 2223333333445566
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.++..+.+|+.+||..||.+|||+.++++.|+++.
T Consensus 276 ~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 276 NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 78899999999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=321.73 Aligned_cols=233 Identities=27% Similarity=0.443 Sum_probs=196.5
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||||+++..... ...++.+|+++++++ +||||+++++++...+..++||||+++++|.+++.....
T Consensus 103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 182 (382)
T 3tt0_A 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182 (382)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCS
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccccccc
Confidence 5999999866332 336789999999999 899999999999999999999999999999999976542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...............+|..|+
T Consensus 183 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~ 260 (382)
T 3tt0_A 183 NPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 260 (382)
T ss_dssp SCCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGS
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCccee
Confidence 3589999999999999999999975 59999999999999999999999999998765433323334456788999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++|||||||++|+|++ |..||.+... ..+...+........+..++.++.
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~ 323 (382)
T 3tt0_A 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELY 323 (382)
T ss_dssp CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCSSCCHHHH
T ss_pred CHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHH
Confidence 9999999999999999999999999999 9999976432 122333334444455667889999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+||.+||..||.+|||+.++++.|+++..
T Consensus 324 ~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 324 MMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=318.74 Aligned_cols=233 Identities=28% Similarity=0.434 Sum_probs=191.8
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (305)
.||||+++..... ....+.+|++++++++||||+++++++.+++..|+||||+++++|.+++....
T Consensus 79 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 158 (343)
T 1luf_A 79 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158 (343)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------------
T ss_pred eEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccccccc
Confidence 6999999866432 34678999999999999999999999999999999999999999999997642
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 68 ---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 68 ---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...............
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (343)
T 1luf_A 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 236 (343)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----C
T ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCC
Confidence 14589999999999999999999975 5999999999999999999999999999764332222223345
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.... .+...+........+.
T Consensus 237 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~ 299 (343)
T 1luf_A 237 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-----------------EVIYYVRDGNILACPE 299 (343)
T ss_dssp CBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCT
T ss_pred cccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-----------------HHHHHHhCCCcCCCCC
Confidence 67899999999999999999999999999999999 99999764321 1112222223334566
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.++..+.+|+.+||..||.+|||+.++++.|+++..
T Consensus 300 ~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 788899999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=323.56 Aligned_cols=233 Identities=27% Similarity=0.390 Sum_probs=191.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----CCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~ 75 (305)
.||||+++.... ....++.+|+.++++++||||+++++++......|+||||+.|++|.+++..... ..+++..
T Consensus 103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 182 (367)
T 3l9p_A 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182 (367)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHH
T ss_pred eEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHH
Confidence 599999975532 3345789999999999999999999999999999999999999999999976432 3489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC---ceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||+++...............+|+.|+|||++.+
T Consensus 183 ~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 260 (367)
T 3l9p_A 183 LLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260 (367)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC
Confidence 999999999999999975 599999999999998555 499999999975322222222334567899999999999
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++|||||||++|+|++ |..||.+... ..+...+........+..++..+.+|+.+||
T Consensus 261 ~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 323 (367)
T 3l9p_A 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----------------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW 323 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 999999999999999999998 9999986432 1223333333444556678889999999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhcC
Q 021947 232 NNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+.||.+|||+.++++.|+.+..
T Consensus 324 ~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 324 QHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999988754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=326.24 Aligned_cols=226 Identities=28% Similarity=0.459 Sum_probs=192.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC-eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.+. ..+.|.+|+++|++++||||+++++++.... ..|+||||+.+|+|.+++...+...++...++.++
T Consensus 218 ~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 295 (450)
T 1k9a_A 218 KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295 (450)
T ss_dssp EEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHH
T ss_pred eEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 69999998753 5678999999999999999999999987765 78999999999999999987765568999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++|
T Consensus 296 ~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sD 368 (450)
T 1k9a_A 296 LDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSD 368 (450)
T ss_dssp HHHHHHHHHHHHT--TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHH
T ss_pred HHHHHHHHHHHhC--CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHH
Confidence 9999999999975 5999999999999999999999999999854322 12235688999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+... ......+........+..++..+.+||.+||..||.+||
T Consensus 369 vwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rp 431 (450)
T 1k9a_A 369 VWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRP 431 (450)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTSCT-----------------TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999998 9999986532 112233334445566778899999999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021947 240 RMSEVLAILERLEA 253 (305)
Q Consensus 240 s~~~~l~~l~~~~~ 253 (305)
|+.++++.|+.+..
T Consensus 432 t~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 432 TFLQLREQLEHIRT 445 (450)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999988753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=316.23 Aligned_cols=234 Identities=25% Similarity=0.418 Sum_probs=180.5
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCee------EEEEecCCCCCHHHHhhhcC----CC
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRG----PQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~----~~ 69 (305)
.||||+++.... ...+.+.+|++++++++||||+++++++...... ++||||+.+++|.+++.... ..
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 699999986632 3346899999999999999999999999876655 99999999999999995432 22
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
.+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................+++.|+|||+
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 210 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES 210 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcC--CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchh
Confidence 489999999999999999999975 599999999999999999999999999987544333333334456889999999
Q ss_pred hhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 150 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 150 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
+.+..++.++|||||||++|+|++ |..||.+.... .....+........+..++..+.+|+.
T Consensus 211 ~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (323)
T 3qup_A 211 LADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----------------EIYNYLIGGNRLKQPPECMEEVYDLMY 273 (323)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred hcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----------------HHHHHHhcCCCCCCCCccCHHHHHHHH
Confidence 999999999999999999999999 99999865421 122222333334556678889999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 229 QCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+||..||.+|||+.++++.|+++...
T Consensus 274 ~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 274 QCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999987553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=314.06 Aligned_cols=223 Identities=26% Similarity=0.343 Sum_probs=186.5
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.. .......+.+|+++|+.++||||+++++++...+..|+||||++||+|.+++.+.. .+++..+.
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~ 108 (337)
T 1o6l_A 31 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERAR 108 (337)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHH
T ss_pred CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 36999998754 22355678999999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.
T Consensus 109 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 184 (337)
T 1o6l_A 109 FYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCT
T ss_pred HHHHHHHHHHHHHHHC--CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCc
Confidence 9999999999999965 599999999999999999999999999986433221 234567999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+... ....+... ...++..++.++.+||.+||..||.+
T Consensus 185 ~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~ 246 (337)
T 1o6l_A 185 AVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQ 246 (337)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred hhhcccchhHHHHHhcCCCCCCCCCHHH----------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999997643210 11111111 23456678899999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|| ++.+++++
T Consensus 247 R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 247 RLGGGPSDAKEVMEH 261 (337)
T ss_dssp STTCSTTTHHHHHTS
T ss_pred hcCCCCCCHHHHHcC
Confidence 99 89999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=313.20 Aligned_cols=233 Identities=29% Similarity=0.449 Sum_probs=195.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||||+++.... ...+.+.+|+++++++ +||||+++++++..++..++||||+++++|.+++.....
T Consensus 55 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 134 (313)
T 1t46_A 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134 (313)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---------
T ss_pred hhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccc
Confidence 699999986543 3346789999999999 899999999999999999999999999999999976542
Q ss_pred -----CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccc
Q 021947 69 -----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143 (305)
Q Consensus 69 -----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 143 (305)
..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++................+|..
T Consensus 135 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 212 (313)
T 1t46_A 135 MEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212 (313)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGG
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcce
Confidence 2489999999999999999999975 599999999999999999999999999987655443333444567889
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 222 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (305)
|+|||++.+..++.++||||||+++|+|++ |..||.+.... ......+........+..++..
T Consensus 213 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~ 276 (313)
T 1t46_A 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----------------SKFYKMIKEGFRMLSPEHAPAE 276 (313)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----------------HHHHHHHHHTCCCCCCTTSCHH
T ss_pred eeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----------------hHHHHHhccCCCCCCcccCCHH
Confidence 999999999999999999999999999999 99999865421 1122222333334445667889
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+.+|+.+||..||.+|||+.++++.|+++.
T Consensus 277 l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 277 MYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=331.39 Aligned_cols=230 Identities=26% Similarity=0.427 Sum_probs=196.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++.+. ...+.|.+|+++|++++||||+++++++......|+||||+.+|+|.+++.......+++..++.++.
T Consensus 247 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~ 325 (495)
T 1opk_A 247 TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325 (495)
T ss_dssp EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHH
T ss_pred EEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHH
Confidence 69999998653 45678999999999999999999999999999999999999999999999876666799999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||
T Consensus 326 qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 402 (495)
T 1opk_A 326 QISSAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDV 402 (495)
T ss_dssp HHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHhC--CcccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhH
Confidence 999999999975 599999999999999999999999999987543221 11223346788999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
|||||++|+|++ |..||.+.+. ..+...+........+..++..+.+||.+||..||.+|||
T Consensus 403 wSlG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 465 (495)
T 1opk_A 403 WAFGVLLWEIATYGMSPYPGIDL-----------------SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 465 (495)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCG-----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcC
Confidence 999999999999 9999986532 1223334445555667788999999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 021947 241 MSEVLAILERLE 252 (305)
Q Consensus 241 ~~~~l~~l~~~~ 252 (305)
+.++++.|+.+.
T Consensus 466 ~~el~~~L~~~~ 477 (495)
T 1opk_A 466 FAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTSC
T ss_pred HHHHHHHHHHHH
Confidence 999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=314.60 Aligned_cols=232 Identities=23% Similarity=0.389 Sum_probs=188.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||+|.++.... ...+.+.+|+.++++++||||+++++++..+ ..++|+||+.+|+|.+++.... ..+++..++.++
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~ 123 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWC 123 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 579998875432 4557899999999999999999999999875 4789999999999999997654 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|
T Consensus 124 ~qi~~~l~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3poz_A 124 VQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhhC--CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhh
Confidence 9999999999975 59999999999999999999999999998765443333333445788999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+... ..+...+........+..++..+.+|+.+||..||.+||
T Consensus 202 i~slG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 264 (327)
T 3poz_A 202 VWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP 264 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSC
T ss_pred hhhhHHHHHHHHhcCCCCccCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCC
Confidence 9999999999999 9999986432 123333444444556677888999999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 021947 240 RMSEVLAILERLEAP 254 (305)
Q Consensus 240 s~~~~l~~l~~~~~~ 254 (305)
|+.++++.|+.+...
T Consensus 265 s~~ell~~l~~~~~~ 279 (327)
T 3poz_A 265 KFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHHHhh
Confidence 999999999887543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=314.10 Aligned_cols=249 Identities=43% Similarity=0.742 Sum_probs=196.6
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC--CCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~ 78 (305)
.||||++...... ....+.+|++++++++||||+++++++...+..++||||+.+++|.+++..... ..+++..+..
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 135 (326)
T 3uim_A 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135 (326)
T ss_dssp CEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHH
T ss_pred EEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHH
Confidence 5899999866432 334789999999999999999999999999999999999999999999976532 3489999999
Q ss_pred HHHHHHHHHhhhhcC-CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.|++.||.|||+. ..|++||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.
T Consensus 136 i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 214 (326)
T 3uim_A 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSE 214 (326)
T ss_dssp HHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECH
T ss_pred HHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCc
Confidence 999999999999975 11599999999999999999999999999987643322 2234456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccc--hhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGI--EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
++||||||+++|+|++|..||....... ......|..... ....+............+...+..+.+++.+||+.||
T Consensus 215 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 293 (326)
T 3uim_A 215 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293 (326)
T ss_dssp HHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCG
T ss_pred cccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCC
Confidence 9999999999999999999996422111 111112211111 1122333334444556678889999999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 021947 236 KLRPRMSEVLAILERLE 252 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~ 252 (305)
.+|||+.+++++|+...
T Consensus 294 ~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 294 MERPKMSEVVRMLEGDG 310 (326)
T ss_dssp GGSCCHHHHHHHHHTSS
T ss_pred ccCCCHHHHHHHhcCcc
Confidence 99999999999998743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=308.83 Aligned_cols=233 Identities=24% Similarity=0.341 Sum_probs=184.5
Q ss_pred CEEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++....... .+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++...+ .+++..+.
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~ 114 (294)
T 4eqm_A 37 IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAI 114 (294)
T ss_dssp SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHH
T ss_pred CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHH
Confidence 369999886543322 3578899999999999999999999999999999999999999999997665 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.
T Consensus 115 ~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 191 (294)
T 4eqm_A 115 NFTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDE 191 (294)
T ss_dssp HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCT
T ss_pred HHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCc
Confidence 9999999999999965 599999999999999999999999999986543221 1233456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc---CCCCChHHHHHHHHHHHhhccCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL---GGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++||||||+++|+|++|+.||.+...... ....+.... .......++..+.++|.+||..|
T Consensus 192 ~~Di~slG~~l~~ll~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 255 (294)
T 4eqm_A 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSI----------------AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKD 255 (294)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCSSCHHHH----------------HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCChHHH----------------HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCC
Confidence 99999999999999999999987542110 001111100 01123456788999999999999
Q ss_pred CCCCC-CHHHHHHHHHhhcCC
Q 021947 235 PKLRP-RMSEVLAILERLEAP 254 (305)
Q Consensus 235 p~~Rp-s~~~~l~~l~~~~~~ 254 (305)
|.+|| ++.++.+.|..+...
T Consensus 256 p~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 256 KANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp GGGSCSSHHHHHHHHHTSSSS
T ss_pred HhHccccHHHHHHHHHHHHhh
Confidence 99999 899999999886543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=305.06 Aligned_cols=230 Identities=28% Similarity=0.455 Sum_probs=191.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.
T Consensus 36 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ 113 (269)
T 4hcu_A 36 KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCL 113 (269)
T ss_dssp EEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHH
T ss_pred eEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHH
Confidence 58999998653 345789999999999999999999999999999999999999999999996544 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+. |++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||
T Consensus 114 ~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (269)
T 4hcu_A 114 DVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDV 190 (269)
T ss_dssp HHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHhC--CeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhh
Confidence 999999999965 599999999999999999999999999986543211 11223456788999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.... .....+........+..++..+.+|+.+||..||.+|||
T Consensus 191 ~slG~~l~~ll~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 253 (269)
T 4hcu_A 191 WSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPA 253 (269)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcC
Confidence 999999999999 99999864321 122222333344455667889999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
+.+++++|+++..
T Consensus 254 ~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 254 FSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=316.88 Aligned_cols=232 Identities=23% Similarity=0.418 Sum_probs=189.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||+|.+..... .....+.+|+.++++++||||+++++++. ++..++||||+.+++|.+++.... ..+++..++.++
T Consensus 44 kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 121 (325)
T 3kex_A 44 PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWG 121 (325)
T ss_dssp EEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHH
T ss_pred EEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHH
Confidence 488998865432 33467789999999999999999999886 466899999999999999996542 348889999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|
T Consensus 122 ~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 199 (325)
T 3kex_A 122 VQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 199 (325)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHhC--CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhH
Confidence 9999999999975 59999999999999999999999999998865544433344556788999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+.... .+...+........+..++..+.+|+.+||..||.+||
T Consensus 200 i~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 262 (325)
T 3kex_A 200 VWSYGVTVWELMTFGAEPYAGLRLA-----------------EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRP 262 (325)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCTT-----------------HHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSC
T ss_pred hHHhHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCc
Confidence 9999999999999 99999875421 12222333333444556777899999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 021947 240 RMSEVLAILERLEAP 254 (305)
Q Consensus 240 s~~~~l~~l~~~~~~ 254 (305)
|+.++++.|+++...
T Consensus 263 s~~el~~~l~~~~~~ 277 (325)
T 3kex_A 263 TFKELANEFTRMARD 277 (325)
T ss_dssp CHHHHHHHHHHHTTS
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999988653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=320.29 Aligned_cols=233 Identities=27% Similarity=0.461 Sum_probs=181.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...+.|.+|++++++++||||+++++++.+++..|+||||++|++|.+++.... ..+++..++.++
T Consensus 75 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~ 153 (373)
T 2qol_A 75 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGML 153 (373)
T ss_dssp CEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHH
T ss_pred eEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence 599999986532 334679999999999999999999999999999999999999999999996543 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-eeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++......... ......++..|+|||++.+..++.++
T Consensus 154 ~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (373)
T 2qol_A 154 RGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231 (373)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHC--CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchh
Confidence 9999999999975 59999999999999999999999999998754332111 11222357789999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++|+|++ |..||.+... ..+...+........+..++..+.+|+.+||+.||.+|
T Consensus 232 Dv~SlG~il~ellt~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 294 (373)
T 2qol_A 232 DVWSYGIVLWEVMSYGERPYWEMSN-----------------QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294 (373)
T ss_dssp HHHHHHHHHHHHHTTC-CTTTTCCH-----------------HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGS
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhC
Confidence 99999999999998 9999976432 11222233333344456778899999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 021947 239 PRMSEVLAILERLEAP 254 (305)
Q Consensus 239 ps~~~~l~~l~~~~~~ 254 (305)
|++.++++.|+++...
T Consensus 295 Ps~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 295 PKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCHHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHHhC
Confidence 9999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=315.06 Aligned_cols=224 Identities=26% Similarity=0.330 Sum_probs=183.5
Q ss_pred CEEEEEecccCCcc------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||+|+++..... ..+.+.+|+.+|++++||||+++++++.+....|+||||+.|++|.+++...+ .+++.
T Consensus 38 ~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~ 115 (361)
T 2yab_A 38 LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEE 115 (361)
T ss_dssp CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHH
T ss_pred CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHH
Confidence 36999998765332 34678999999999999999999999999999999999999999999996543 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----ceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.+..++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||++........ ....+||+.|+|||++
T Consensus 116 ~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~ 190 (361)
T 2yab_A 116 EATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIV 190 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHH
Confidence 9999999999999999975 599999999999998876 799999999987544321 2345799999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 228 (305)
.+..++.++|||||||++|+|++|..||.+.+... .+..+...... ......++..+.+||.
T Consensus 191 ~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 254 (361)
T 2yab_A 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----------------TLANITAVSYDFDEEFFSQTSELAKDFIR 254 (361)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhcCCCCCchhccCCCHHHHHHHH
Confidence 99999999999999999999999999998754211 01111111110 0112346788999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 255 ~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 255 KLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHSCSSTTTSCCHHHHHTS
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=309.17 Aligned_cols=225 Identities=24% Similarity=0.323 Sum_probs=187.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++........+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++.+. .+++..+..++
T Consensus 71 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~ 147 (321)
T 2c30_A 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVC 147 (321)
T ss_dssp CEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHH
T ss_pred cEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHH
Confidence 469999998776667788999999999999999999999999999999999999999999998543 49999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++|
T Consensus 148 ~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~D 223 (321)
T 2c30_A 148 EAVLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVD 223 (321)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHC--CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhh
Confidence 9999999999975 5999999999999999999999999999865433221 33457899999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++|+.||.+...... ...+.... ........++..+.+||.+||..||.+||
T Consensus 224 v~slG~il~el~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 287 (321)
T 2c30_A 224 IWSLGIMVIEMVDGEPPYFSDSPVQA----------------MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287 (321)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999976432110 00111111 11122345778899999999999999999
Q ss_pred CHHHHHHHH
Q 021947 240 RMSEVLAIL 248 (305)
Q Consensus 240 s~~~~l~~l 248 (305)
|+.+++++.
T Consensus 288 s~~ell~hp 296 (321)
T 2c30_A 288 TAQELLDHP 296 (321)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCh
Confidence 999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=302.46 Aligned_cols=230 Identities=27% Similarity=0.423 Sum_probs=191.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ....++.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.
T Consensus 34 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ 111 (268)
T 3sxs_A 34 DVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCY 111 (268)
T ss_dssp EEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHH
T ss_pred eEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHH
Confidence 58999998653 345779999999999999999999999999999999999999999999997653 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+. |++||||||+||+++.++.+||+|||++......... ......+|..|+|||++.+..++.++||
T Consensus 112 qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di 188 (268)
T 3sxs_A 112 DVCEGMAFLESH--QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDV 188 (268)
T ss_dssp HHHHHHHHHHHT--TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHH
T ss_pred HHHHHHHHHHHC--CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhh
Confidence 999999999965 5999999999999999999999999999865443221 2233446778999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||...... .....+........+..++..+.+++.+||..||.+|||
T Consensus 189 ~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 251 (268)
T 3sxs_A 189 WAFGILMWEVFSLGKMPYDLYTNS-----------------EVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPT 251 (268)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCC
T ss_pred HHHHHHHHHHHcCCCCCccccChH-----------------HHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcC
Confidence 999999999999 99999764321 111122222333445567788999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
+.++++.|+.+..
T Consensus 252 ~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 252 FQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHGGGCC
T ss_pred HHHHHHHHHHhhh
Confidence 9999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=327.85 Aligned_cols=230 Identities=28% Similarity=0.463 Sum_probs=192.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+.|.+|+++|++++||||+++++++. .+..|+||||+.+|+|.+++.......++...++.++.
T Consensus 214 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 291 (454)
T 1qcf_A 214 KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291 (454)
T ss_dssp EEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHH
T ss_pred EEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHH
Confidence 59999998653 45788999999999999999999999986 56789999999999999999755434588999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||++ +++||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||
T Consensus 292 qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 368 (454)
T 1qcf_A 292 QIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDV 368 (454)
T ss_dssp HHHHHHHHHHHT--TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHhC--CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHH
Confidence 999999999975 499999999999999999999999999987543211 11222346788999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |+.||.+... ..+...+........+..++..+.+||.+||..||.+|||
T Consensus 369 wslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt 431 (454)
T 1qcf_A 369 WSFGILLMEIVTYGRIPYPGMSN-----------------PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 431 (454)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999 9999986432 1122233334445566778899999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
+.++++.|+.+..
T Consensus 432 ~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 432 FEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHTSSS
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=311.59 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=191.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||++........+.+.+|++++++++||||+++++++... ...++||||+++++|.+++.... ..+++..++.+
T Consensus 41 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 119 (295)
T 3ugc_A 41 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQY 119 (295)
T ss_dssp EEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHH
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHH
Confidence 6999999876555567899999999999999999999998643 55899999999999999997654 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.+
T Consensus 120 ~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (295)
T 3ugc_A 120 TSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197 (295)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhcC--CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChH
Confidence 99999999999975 5999999999999999999999999999875433221 12233456788999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||.............. .............+........+..++.++.+|+.+||..||.+|
T Consensus 198 ~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 276 (295)
T 3ugc_A 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276 (295)
T ss_dssp HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT-CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc-cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhC
Confidence 9999999999999999999875432111100000 000001112333344445556677889999999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
||+.++++.|+++..
T Consensus 277 ps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 277 PSFRDLALRVDQIRD 291 (295)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHH
Confidence 999999999988743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=314.90 Aligned_cols=233 Identities=28% Similarity=0.421 Sum_probs=192.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||+|+++.... ...+.+.+|+++++++ +||||+++++++..++..|+||||+++++|.+++....
T Consensus 78 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 157 (333)
T 2i1m_A 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157 (333)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC------
T ss_pred HHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhccccccccccccc
Confidence 699999976543 3346789999999999 89999999999999999999999999999999996542
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccch
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 147 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 147 (305)
...+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................+|..|+||
T Consensus 158 ~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 235 (333)
T 2i1m_A 158 NSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP 235 (333)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred ccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence 23589999999999999999999975 5999999999999999999999999999865443333333445678899999
Q ss_pred hhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHH
Q 021947 148 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226 (305)
Q Consensus 148 E~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (305)
|++.+..++.++||||||+++|+|++ |..||.+.... ......+........+..++..+.+|
T Consensus 236 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (333)
T 2i1m_A 236 ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----------------SKFYKLVKDGYQMAQPAFAPKNIYSI 299 (333)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----------------HHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred HHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----------------HHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999998 99999764321 11222333333344556678899999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 227 ALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+.+||+.||.+|||+.++++.|+++.
T Consensus 300 i~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 300 MQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=305.03 Aligned_cols=230 Identities=27% Similarity=0.430 Sum_probs=195.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||++..+. ...+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++.......+++..++.++.
T Consensus 40 ~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ 118 (288)
T 3kfa_A 40 TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118 (288)
T ss_dssp EEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHH
T ss_pred EEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHH
Confidence 68999997643 34578999999999999999999999999999999999999999999999876666799999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
+++.||.|||+. |++|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||
T Consensus 119 ~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 195 (288)
T 3kfa_A 119 QISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDV 195 (288)
T ss_dssp HHHHHHHHHHHH--TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHC--CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhH
Confidence 999999999975 499999999999999999999999999987654322 22334456889999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.+. ......+........+..++..+.+|+.+||..||.+|||
T Consensus 196 ~slG~il~~ll~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 258 (288)
T 3kfa_A 196 WAFGVLLWEIATYGMSPYPGIDL-----------------SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 258 (288)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCG-----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcC
Confidence 999999999999 9999986542 1222333344445566778899999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 021947 241 MSEVLAILERLE 252 (305)
Q Consensus 241 ~~~~l~~l~~~~ 252 (305)
+.++++.|+.+.
T Consensus 259 ~~~~~~~l~~~~ 270 (288)
T 3kfa_A 259 FAEIHQAFETMF 270 (288)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999988753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=302.23 Aligned_cols=229 Identities=23% Similarity=0.389 Sum_probs=190.5
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++..... ..+.+.+|++++++++||||+++++++.+. ...++||||++|++|.+++.......+++..++
T Consensus 35 ~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (271)
T 3kmu_A 35 DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV 114 (271)
T ss_dssp EEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHH
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHH
Confidence 5899999865432 345789999999999999999999999876 778999999999999999987665569999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+.+..++||||||+||+++.++.++|+|||+...... ....||+.|+|||++.+..++.
T Consensus 115 ~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~ 187 (271)
T 3kmu_A 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDT 187 (271)
T ss_dssp HHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGS
T ss_pred HHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCC
Confidence 999999999999996544499999999999999999999999988764322 2346799999999998776554
Q ss_pred ---CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 158 ---KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 158 ---~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++||||||+++|+|++|..||.+... ................+..++..+.+++.+||..|
T Consensus 188 ~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 251 (271)
T 3kmu_A 188 NRRSADMWSFAVLLWELVTREVPFADLSN----------------MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNED 251 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHCSCTTTTSCH----------------HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCchhhHHHHHHHHHHHHhCCCCccccCh----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 79999999999999999999976432 11122333344445566778899999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 021947 235 PKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 235 p~~Rps~~~~l~~l~~~~~ 253 (305)
|.+|||+.++++.|+++..
T Consensus 252 p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 252 PAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp GGGSCCHHHHHHHHHHHCC
T ss_pred hhhCcCHHHHHHHHHHhhc
Confidence 9999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=308.11 Aligned_cols=220 Identities=25% Similarity=0.370 Sum_probs=185.6
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+++.+.. .+++..+.
T Consensus 32 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~ 109 (318)
T 1fot_A 32 RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAK 109 (318)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHH
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 368999987542 2345678899999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.
T Consensus 110 ~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 182 (318)
T 1fot_A 110 FYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNK 182 (318)
T ss_dssp HHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCc
Confidence 999999999999996 45999999999999999999999999999865432 23457999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+.. .....++.. ...++..++.++.+||.+||..||.+
T Consensus 183 ~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~ 244 (318)
T 1fot_A 183 SIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQ 244 (318)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999999999999999764321 111122222 23456678889999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|| ++++++++
T Consensus 245 R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 245 RLGNLQNGTEDVKNH 259 (318)
T ss_dssp CTTSSTTTTHHHHTS
T ss_pred cCCCcCCCHHHHhcC
Confidence 99 88898864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.18 Aligned_cols=231 Identities=26% Similarity=0.375 Sum_probs=183.5
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++.... .....+.+|..++.++ +||||+++++++.+.+..|+||||+.||+|.+++.+.. .+++..+.
T Consensus 79 ~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~ 156 (396)
T 4dc2_A 79 IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHAR 156 (396)
T ss_dssp EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHH
Confidence 689999976532 2335688999999887 89999999999999999999999999999999997654 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.
T Consensus 157 ~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~ 232 (396)
T 4dc2_A 157 FYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGF 232 (396)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHC--CEEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCCh
Confidence 9999999999999975 59999999999999999999999999998633222 1244568999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|+.||......... .......+.+.+. .....++..++.++.+||.+||+.||.+
T Consensus 233 ~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~ 303 (396)
T 4dc2_A 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKE 303 (396)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHHHHHHHHh-ccccCCCCcCCHHHHHHHHHHhcCCHhH
Confidence 999999999999999999999754321100 0001111111111 1233566778899999999999999999
Q ss_pred CCCH------HHHHHH
Q 021947 238 RPRM------SEVLAI 247 (305)
Q Consensus 238 Rps~------~~~l~~ 247 (305)
||++ .+++++
T Consensus 304 R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 304 RLGCHPQTGFADIQGH 319 (396)
T ss_dssp STTCSTTTHHHHHHHS
T ss_pred cCCCCCCCCHHHHhcC
Confidence 9985 566653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=323.81 Aligned_cols=230 Identities=30% Similarity=0.440 Sum_probs=188.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+.|.+|+++|++++||||+++++++.+ +..|+||||+.+|+|.+++.......+++..++.++.
T Consensus 210 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~ 287 (452)
T 1fmk_A 210 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287 (452)
T ss_dssp EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred eEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence 59999998654 356789999999999999999999999866 6789999999999999999754444589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||++ +++||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||
T Consensus 288 qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 364 (452)
T 1fmk_A 288 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDV 364 (452)
T ss_dssp HHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHhC--CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccH
Confidence 999999999975 599999999999999999999999999986543221 11223456789999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+... ......+........+..++..+.+||.+||..||.+|||
T Consensus 365 wslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 427 (452)
T 1fmk_A 365 WSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 427 (452)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999 9999986432 1122333344455667788999999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
++++++.|+.+..
T Consensus 428 ~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 428 FEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHHTTTS
T ss_pred HHHHHHHHHHHhc
Confidence 9999999988753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=304.35 Aligned_cols=229 Identities=27% Similarity=0.368 Sum_probs=178.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...+.+.+|+.++++++||||+++++++. ++..|+||||+.+++|.+++.... ..+++..++.++
T Consensus 45 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 122 (281)
T 1mp8_A 45 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYA 122 (281)
T ss_dssp EEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHH
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 589999876533 23467899999999999999999999984 567899999999999999997553 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++|
T Consensus 123 ~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~D 199 (281)
T 1mp8_A 123 YQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASD 199 (281)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHH
T ss_pred HHHHHHHHHHHhC--CeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccC
Confidence 9999999999965 5999999999999999999999999999875433211 122345678999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+.... .....+........+..++..+.+|+.+||..||.+||
T Consensus 200 i~slG~~l~ell~~g~~pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 262 (281)
T 1mp8_A 200 VWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 262 (281)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred chHHHHHHHHHHhcCCCCCCcCCHH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999999999997 99999865321 11122222233445667889999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|+++.
T Consensus 263 s~~~l~~~l~~~~ 275 (281)
T 1mp8_A 263 RFTELKAQLSTIL 275 (281)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=303.04 Aligned_cols=229 Identities=29% Similarity=0.542 Sum_probs=184.6
Q ss_pred CEEEEEecccCCccCh-------HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGFQGH-------KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
+.||||++........ +.+.+|++++++++||||+++++++.+.. ++||||+++++|.+++.... ..+++
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~ 121 (287)
T 4f0f_A 45 SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKW 121 (287)
T ss_dssp CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCH
T ss_pred eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccH
Confidence 3699999876533222 67889999999999999999999986544 79999999999999886544 35999
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc-----eeeccccccccCCCCCCcceeecccccccccchh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
..++.++.|++.||.|||+++.+++||||||+||+++.++. +||+|||+++..... .....||+.|+|||
T Consensus 122 ~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE 196 (287)
T 4f0f_A 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPE 196 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGG
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCch
Confidence 99999999999999999964333999999999999988776 999999999754321 33457899999999
Q ss_pred hhh--cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHH
Q 021947 149 YVA--TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 226 (305)
Q Consensus 149 ~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (305)
++. +..++.++||||||+++|+|++|..||......... ..............+..++..+.+|
T Consensus 197 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~l 262 (287)
T 4f0f_A 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--------------FINMIREEGLRPTIPEDCPPRLRNV 262 (287)
T ss_dssp GSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--------------HHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred hhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--------------HHHHHhccCCCCCCCcccCHHHHHH
Confidence 984 445788999999999999999999999765432111 1112223334445667788999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 227 ALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
|.+||..||.+|||+.++++.|+++
T Consensus 263 i~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 263 IELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=311.67 Aligned_cols=232 Identities=23% Similarity=0.381 Sum_probs=186.4
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||+|.+.... ......+.+|+.++++++||||+++++++..+. .++|+|++.+++|.+++.... ..+++..++.++
T Consensus 46 kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~ 123 (327)
T 3lzb_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWC 123 (327)
T ss_dssp EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 47889886543 345678999999999999999999999998654 789999999999999997654 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||++ |++||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|
T Consensus 124 ~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3lzb_A 124 VQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhhC--CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHH
Confidence 9999999999975 59999999999999999999999999998765443333333445688999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+... ..+...+........+..++..+.+||.+||..||.+||
T Consensus 202 i~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 202 VWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999 9999986532 123333444444556677888999999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 021947 240 RMSEVLAILERLEAP 254 (305)
Q Consensus 240 s~~~~l~~l~~~~~~ 254 (305)
|+.++++.|+++...
T Consensus 265 s~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 265 KFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHHHhC
Confidence 999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=310.03 Aligned_cols=224 Identities=25% Similarity=0.339 Sum_probs=182.8
Q ss_pred CEEEEEecccCCcc------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||+|+++..... ..+.+.+|+++|++++||||+++++++.+....++||||++|++|.+++.... .+++.
T Consensus 37 ~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~ 114 (326)
T 2y0a_A 37 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEE 114 (326)
T ss_dssp CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHH
T ss_pred cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHH
Confidence 36899998765332 35779999999999999999999999999999999999999999999996543 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----ceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.+..++.|++.||.|||+. |++||||||+|||++.++ .+||+|||++........ .....||+.|+|||++
T Consensus 115 ~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 189 (326)
T 2y0a_A 115 EATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHC--CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceee
Confidence 9999999999999999965 599999999999998887 799999999987643221 2345789999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~ 228 (305)
.+..++.++|||||||++|+|++|..||.+...... +..+..... .......++..+.+||.
T Consensus 190 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (326)
T 2y0a_A 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------------LANVSAVNYEFEDEYFSNTSALAKDFIR 253 (326)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHHHhcCCCcCccccccCCHHHHHHHH
Confidence 999999999999999999999999999976532111 001111000 00111345778999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 254 ~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 254 RLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=310.89 Aligned_cols=233 Identities=25% Similarity=0.437 Sum_probs=193.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||||+++.... .....+.+|+++++++ +||||+++++++...+..|+||||+++++|.+++.....
T Consensus 69 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 148 (334)
T 2pvf_A 69 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148 (334)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC----
T ss_pred EEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccc
Confidence 699999986533 2346789999999999 899999999999999999999999999999999976532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 69 ---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 69 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
..+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................+++.|+
T Consensus 149 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 226 (334)
T 2pvf_A 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 226 (334)
T ss_dssp ----CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCccccee
Confidence 2488999999999999999999975 59999999999999999999999999998765433322233345688999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++||||||+++|+|++ |..||.+... ..+...+........+..++..+.
T Consensus 227 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
T 2pvf_A 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----------------EELFKLLKEGHRMDKPANCTNELY 289 (334)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred ChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----------------HHHHHHHhcCCCCCCCccCCHHHH
Confidence 9999999999999999999999999999 9999976432 112222223333445667888999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+||.+||..||.+|||+.++++.|+++..
T Consensus 290 ~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 290 MMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=315.92 Aligned_cols=223 Identities=28% Similarity=0.378 Sum_probs=181.6
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||+++.. .......+.+|.+++..+ +||||+++++++.+.+..|+||||+.||+|.+++.+.. .+++..+
T Consensus 49 ~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~ 126 (353)
T 3txo_A 49 DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARA 126 (353)
T ss_dssp CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 36999998754 223456788999999988 69999999999999999999999999999999997654 3999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++
T Consensus 127 ~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 202 (353)
T 3txo_A 127 RFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYG 202 (353)
T ss_dssp HHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHHC--CCcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcC
Confidence 99999999999999975 59999999999999999999999999998543222 123456799999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|..||.+.+.. .....+... ...++..++..+.+||.+||..||.
T Consensus 203 ~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~ 264 (353)
T 3txo_A 203 PAVDWWAMGVLLYEMLCGHAPFEAENED----------------DLFEAILND--EVVYPTWLHEDATGILKSFMTKNPT 264 (353)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CccCCCcchHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHH
Confidence 9999999999999999999999875421 111122222 2244566888999999999999999
Q ss_pred CCCCH------HHHHHH
Q 021947 237 LRPRM------SEVLAI 247 (305)
Q Consensus 237 ~Rps~------~~~l~~ 247 (305)
+||++ .+++++
T Consensus 265 ~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 265 MRLGSLTQGGEHAILRH 281 (353)
T ss_dssp GSTTSGGGTCTHHHHTS
T ss_pred HccCCcccCCHHHHhhC
Confidence 99998 777753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.54 Aligned_cols=224 Identities=23% Similarity=0.260 Sum_probs=184.5
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..|+||||+.||+|.+++..++ .+++..+..+
T Consensus 38 ~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i 115 (444)
T 3soa_A 38 EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHC 115 (444)
T ss_dssp EEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHH
T ss_pred EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence 5899998765432 34578999999999999999999999999999999999999999999997664 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeC---CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
+.|++.||.|||+. ||+||||||+|||++ .++.+||+|||++........ ......||+.|+|||++.+..++
T Consensus 116 ~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 116 IQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp HHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCC
Confidence 99999999999975 599999999999998 457899999999986544322 12345799999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
.++|||||||++|+|++|..||.+.+... ....+..... .......++.++.+||.+||..|
T Consensus 192 ~~~DIwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 255 (444)
T 3soa_A 192 KPVDLWACGVILYILLVGYPPFWDEDQHR----------------LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 255 (444)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred CccccHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCC
Confidence 99999999999999999999997654211 1111111111 11222467889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 256 P~~Rpta~e~L~h 268 (444)
T 3soa_A 256 PSKRITAAEALKH 268 (444)
T ss_dssp TTTSCCHHHHHHS
T ss_pred hhHCCCHHHHhcC
Confidence 9999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=312.57 Aligned_cols=224 Identities=23% Similarity=0.303 Sum_probs=183.3
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..|+||||+.|++|.+++.... .+++..+..
T Consensus 55 ~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~ 132 (362)
T 2bdw_A 55 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASH 132 (362)
T ss_dssp CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHH
T ss_pred CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHH
Confidence 36999999765432 33678899999999999999999999999999999999999999999996554 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC---ceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+..+
T Consensus 133 ~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 207 (362)
T 2bdw_A 133 CIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPY 207 (362)
T ss_dssp HHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCC
Confidence 999999999999975 599999999999997654 599999999987543321 234578999999999999899
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhhccC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~ 233 (305)
+.++|||||||++|+|++|..||.+.+... ....+...... ......++.++.+||.+||..
T Consensus 208 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 271 (362)
T 2bdw_A 208 SKPVDIWACGVILYILLVGYPPFWDEDQHR----------------LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 271 (362)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCS
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCC
Confidence 999999999999999999999998653211 01111111111 112246788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
||.+|||+.+++++
T Consensus 272 dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 272 NPKKRITADQALKV 285 (362)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=303.41 Aligned_cols=229 Identities=23% Similarity=0.370 Sum_probs=190.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+++.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++.... ..+++..++.++.
T Consensus 50 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ 127 (283)
T 3gen_A 50 DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCK 127 (283)
T ss_dssp EEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHH
T ss_pred eEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHH
Confidence 58999998653 345789999999999999999999999999999999999999999999996533 3499999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||++ |++||||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||
T Consensus 128 qi~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 204 (283)
T 3gen_A 128 DVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204 (283)
T ss_dssp HHHHHHHHHHHT--TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHH
T ss_pred HHHHHHHHHHHC--CccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhH
Confidence 999999999965 599999999999999999999999999986543211 11223346788999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |+.||...... .....+........+..++..+.+|+.+||+.||.+|||
T Consensus 205 ~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 267 (283)
T 3gen_A 205 WAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 267 (283)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCccccChh-----------------HHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcC
Confidence 999999999998 99999864321 122222333344455667789999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 021947 241 MSEVLAILERLE 252 (305)
Q Consensus 241 ~~~~l~~l~~~~ 252 (305)
+.++++.|.++.
T Consensus 268 ~~~ll~~L~~~~ 279 (283)
T 3gen_A 268 FKILLSNILDVM 279 (283)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=302.21 Aligned_cols=227 Identities=30% Similarity=0.462 Sum_probs=177.3
Q ss_pred EEEEEecccCCc----cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++.... ...+.+.+|+++++.++||||+++++++..++..++||||++|++|.+++... .+++..++
T Consensus 32 ~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~ 108 (271)
T 3dtc_A 32 EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILV 108 (271)
T ss_dssp EEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHH
T ss_pred eEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHH
Confidence 589999875432 23467899999999999999999999999999999999999999999998533 49999999
Q ss_pred HHHHHHHHHHhhhhcCCC-ceeeccCCCCceEeCC--------CCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 78 KVAIGAAKGLTFLHDAES-QVIYRDFKASNILLDA--------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~-~ivH~dlkp~Nil~~~--------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
.++.|++.||.|||+.+. +++||||||+||+++. ++.+||+|||++....... .....||+.|+|||
T Consensus 109 ~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE 184 (271)
T 3dtc_A 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPE 184 (271)
T ss_dssp HHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHH
T ss_pred HHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHH
Confidence 999999999999997532 2899999999999986 6779999999997654322 22346899999999
Q ss_pred hhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 149 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 149 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
++.+..++.++||||||+++|+|++|+.||.+.... ...............+..++..+.+|+.
T Consensus 185 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (271)
T 3dtc_A 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------------AVAYGVAMNKLALPIPSTCPEPFAKLME 248 (271)
T ss_dssp HHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----------------HHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHhhhcCCCCCCCCcccCHHHHHHHH
Confidence 999999999999999999999999999999864321 1122222333344556678889999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhh
Q 021947 229 QCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+||+.||.+|||+.++++.|+++
T Consensus 249 ~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 249 DCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=312.25 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=197.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEE--eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||++........+.+.+|++++++++|+||+++++++. +....|+||||++|++|.+++..... .+++..++.+
T Consensus 54 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i 132 (327)
T 3lxl_A 54 LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 132 (327)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHH
T ss_pred EEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHH
Confidence 69999998776566678999999999999999999999887 45668999999999999999976432 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.+
T Consensus 133 ~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (327)
T 3lxl_A 133 SSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 210 (327)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHHHhC--CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChH
Confidence 99999999999965 5999999999999999999999999999876543322 12233457888999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||............ ..........+...+........+..++..+.+||.+||+.||.+|
T Consensus 211 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 288 (327)
T 3lxl_A 211 SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288 (327)
T ss_dssp HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhC
Confidence 99999999999999999999764321110000 0001111223344445555566677889999999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
||+.++++.|+.+..
T Consensus 289 ps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 289 PSFSALGPQLDMLWS 303 (327)
T ss_dssp CCHHHHHHHHHHC--
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=311.14 Aligned_cols=226 Identities=27% Similarity=0.286 Sum_probs=181.7
Q ss_pred CEEEEEecccCC-----ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCH
Q 021947 1 MVVAVKKLKPEG-----FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 73 (305)
+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++... ....+++
T Consensus 50 ~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~ 129 (351)
T 3c0i_A 50 QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 129 (351)
T ss_dssp CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCH
T ss_pred CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCH
Confidence 369999986421 224578999999999999999999999999999999999999999999888543 2335899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc---eeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
..+..++.|++.||.|||++ ||+||||||+|||++.++. +||+|||++........ .....+||+.|+|||++
T Consensus 130 ~~~~~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~ 205 (351)
T 3c0i_A 130 AVASHYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVV 205 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHH
Confidence 99999999999999999975 5999999999999987654 99999999987654321 23345799999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC--CChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~ 228 (305)
.+..++.++|||||||++|+|++|..||.+..... ...+........ ....++..+.+||.
T Consensus 206 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------------~~~i~~~~~~~~~~~~~~~s~~~~~li~ 268 (351)
T 3c0i_A 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-----------------FEGIIKGKYKMNPRQWSHISESAKDLVR 268 (351)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH-----------------HHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH-----------------HHHHHcCCCCCCccccccCCHHHHHHHH
Confidence 99999999999999999999999999998743211 011111111000 01246788999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 269 ~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 269 RMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHTCSSTTTSCCHHHHHTS
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=305.89 Aligned_cols=245 Identities=28% Similarity=0.380 Sum_probs=193.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++.... .....+.+|++++++++||||+++++++... ...++||||+++++|.+++.... ..+++..++.
T Consensus 52 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 130 (302)
T 4e5w_A 52 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLK 130 (302)
T ss_dssp EEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHH
T ss_pred EEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHH
Confidence 699999986533 3457899999999999999999999999876 66899999999999999996554 3499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.|++.||+|||+. |++||||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.
T Consensus 131 ~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 208 (302)
T 4e5w_A 131 YAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYI 208 (302)
T ss_dssp HHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHhhcC--CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCc
Confidence 999999999999965 5999999999999999999999999999876543321 2233456788899999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|++|..|+.............+ ........+...+........+..++..+.+||.+||..||.+
T Consensus 209 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 286 (302)
T 4e5w_A 209 ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT--HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSN 286 (302)
T ss_dssp HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC--CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred chhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc--ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCC
Confidence 99999999999999999998754321111100000 0011222333444445555667788999999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
|||+.++++.|+++
T Consensus 287 Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 287 RTSFQNLIEGFEAL 300 (302)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHH
Confidence 99999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=308.03 Aligned_cols=228 Identities=26% Similarity=0.363 Sum_probs=183.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++........+.+.+|++++++++||||+++++++..++..++||||++|++|.+++.... ..+++..++.++.
T Consensus 42 ~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ 120 (289)
T 4fvq_A 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAK 120 (289)
T ss_dssp EEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHH
T ss_pred hhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHH
Confidence 589999987666667889999999999999999999999999999999999999999999997654 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCc--------eeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
|++.||.|||+. |++||||||+|||++.++. +||+|||++..... .....++..|+|||++.+
T Consensus 121 qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~ 192 (289)
T 4fvq_A 121 QLAAAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENP 192 (289)
T ss_dssp HHHHHHHHHHHT--TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCG
T ss_pred HHHHHHHHHhhC--CeECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCC
Confidence 999999999975 4999999999999988877 99999999875432 223457899999999987
Q ss_pred CCCCCCCceehhhHHHHHHHhCC-CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++||||||+++|+|++|. .||....... ...... .....+...+.++.+|+.+||
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~l~~li~~~l 253 (289)
T 4fvq_A 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----------------KLQFYE--DRHQLPAPKAAELANLINNCM 253 (289)
T ss_dssp GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----------------HHHHHH--TTCCCCCCSSCTTHHHHHHHS
T ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----------------HHHHhh--ccCCCCCCCCHHHHHHHHHHc
Confidence 67899999999999999999954 4444322110 001111 112233445677899999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhcCCCCC
Q 021947 232 NNEPKLRPRMSEVLAILERLEAPKNS 257 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~~~~~~~ 257 (305)
+.||.+|||+.++++.|+++..+..+
T Consensus 254 ~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 254 DYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp CSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 99999999999999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=314.99 Aligned_cols=225 Identities=24% Similarity=0.322 Sum_probs=185.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.... ..+++..+..++
T Consensus 115 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~ 193 (373)
T 2x4f_A 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFM 193 (373)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHH
T ss_pred cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 3699999987765666789999999999999999999999999999999999999999999886543 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEe--CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+..++.+
T Consensus 194 ~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 268 (373)
T 2x4f_A 194 KQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFP 268 (373)
T ss_dssp HHHHHHHHHHHHT--TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHH
T ss_pred HHHHHHHHHHHHC--CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcH
Confidence 9999999999975 59999999999999 5667899999999987644322 233468999999999998889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhhccCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+|||||||++|+|++|..||.+.+... .+..+...... ......++.++.+||.+||..||.
T Consensus 269 ~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 332 (373)
T 2x4f_A 269 TDMWSVGVIAYMLLSGLSPFLGDNDAE----------------TLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKS 332 (373)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGG
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999998754211 11111111111 111235678999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 333 ~Rps~~e~l~h 343 (373)
T 2x4f_A 333 WRISASEALKH 343 (373)
T ss_dssp GSCCHHHHHHS
T ss_pred hCCCHHHHhcC
Confidence 99999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=314.36 Aligned_cols=225 Identities=23% Similarity=0.288 Sum_probs=185.4
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||+|++..........+.+|+++|++++||||+++++++.+....++||||+.|++|.+++.... ..+++..+..++
T Consensus 77 ~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~ 155 (387)
T 1kob_A 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYM 155 (387)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHH
T ss_pred CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHH
Confidence 3689999987655556688999999999999999999999999999999999999999999996543 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCC--CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
.|++.||.|||+. ||+||||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+..++.+
T Consensus 156 ~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 230 (387)
T 1kob_A 156 RQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFY 230 (387)
T ss_dssp HHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCc
Confidence 9999999999965 5999999999999974 46799999999987644321 334478999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc--ccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+|||||||++|+|++|..||.+...... +..+... .........++.++.+||.+||..||.
T Consensus 231 ~DiwSlG~il~elltg~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 294 (387)
T 1kob_A 231 TDMWAIGVLGYVLLSGLSPFAGEDDLET----------------LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294 (387)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred ccEeeHhHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999987542110 1111111 111222346788999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 295 ~Rpt~~ell~h 305 (387)
T 1kob_A 295 KRLTVHDALEH 305 (387)
T ss_dssp GSCCHHHHHTS
T ss_pred HCcCHHHHhhC
Confidence 99999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=308.58 Aligned_cols=232 Identities=25% Similarity=0.439 Sum_probs=185.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+++..++.++
T Consensus 75 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~ 153 (333)
T 1mqb_A 75 PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGML 153 (333)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHH
T ss_pred cEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence 599999986533 234578999999999999999999999999999999999999999999997643 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++
T Consensus 154 ~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (333)
T 1mqb_A 154 RGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 231 (333)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred HHHHHHHHHHHhC--CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchh
Confidence 9999999999975 5999999999999999999999999999875433211 112223457889999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++|+|++ |..||.+... ..+...+........+..++..+.+|+.+||..||.+|
T Consensus 232 Di~slG~il~ellt~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 294 (333)
T 1mqb_A 232 DVWSFGIVMWEVMTYGERPYWELSN-----------------HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 294 (333)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTS
T ss_pred hhHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhC
Confidence 99999999999998 9999976432 11222223333344556788899999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
|++.++++.|+++..
T Consensus 295 ps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 295 PKFADIVSILDKLIR 309 (333)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999988754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=310.20 Aligned_cols=220 Identities=23% Similarity=0.285 Sum_probs=185.4
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++.+.+ .+++..+.
T Consensus 67 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~ 144 (350)
T 1rdq_E 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHAR 144 (350)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHH
T ss_pred CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 369999986542 2345678999999999999999999999999999999999999999999997654 38999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.
T Consensus 145 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 217 (350)
T 1rdq_E 145 FYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNK 217 (350)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHC--CcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCC
Confidence 9999999999999965 5999999999999999999999999999865432 23457899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+.. .....+... ...++..++..+.+||.+||..||.+
T Consensus 218 ~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~ 279 (350)
T 1rdq_E 218 AVDWWALGVLIYEMAAGYPPFFADQPI----------------QIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTT
T ss_pred cCCEecccHhHhHHhhCCCCCCCCCHH----------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999999999999999864321 111112222 23455678899999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
||+ +++++++
T Consensus 280 R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 280 RFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTSSTTTTHHHHTS
T ss_pred ccCCccCCHHHHHhC
Confidence 998 8888764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=300.25 Aligned_cols=247 Identities=37% Similarity=0.606 Sum_probs=193.3
Q ss_pred CEEEEEecccCCc----cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc-CCCCCCHHH
Q 021947 1 MVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 75 (305)
..||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ....+++..
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 134 (307)
T 2nru_A 55 TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134 (307)
T ss_dssp CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHH
T ss_pred ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHH
Confidence 3689999875421 22467899999999999999999999999999999999999999999998643 234589999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................||+.|+|||++.+ .+
T Consensus 135 ~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 211 (307)
T 2nru_A 135 RCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EI 211 (307)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EE
T ss_pred HHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CC
Confidence 999999999999999965 599999999999999999999999999987654433333344578999999998865 57
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++||||||+++|+|++|..||......... ..+..........+...+.. .....+...+..+.+++.+||..||
T Consensus 212 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p 288 (307)
T 2nru_A 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKK 288 (307)
T ss_dssp CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--THHHHHHHTTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSST
T ss_pred CccchhHHHHHHHHHHHHCCCCcccCcchHHH--HHHHHHhhhhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCc
Confidence 88999999999999999999999875432111 00000001111112222222 2234567788999999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 021947 236 KLRPRMSEVLAILERLEA 253 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~~~~ 253 (305)
.+|||+.++++.|+++.+
T Consensus 289 ~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 289 NKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTSCCHHHHHHHHHHHC-
T ss_pred ccCcCHHHHHHHHHHHhc
Confidence 999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=301.55 Aligned_cols=250 Identities=20% Similarity=0.238 Sum_probs=189.5
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCC--eeEEEEecCCCCCHHHHhhhcCC-CCCCHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~ 76 (305)
+.||||+++.... ...+.+.+|++++++++||||+++++++.... ..++||||++|++|.+++..... ..+++..+
T Consensus 35 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (319)
T 4euu_A 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (319)
T ss_dssp CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHH
T ss_pred cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHH
Confidence 3699999986533 34577889999999999999999999998765 77999999999999999965432 33899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEe----CCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA- 151 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~- 151 (305)
+.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||++.
T Consensus 115 ~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (319)
T 4euu_A 115 LIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYER 189 (319)
T ss_dssp HHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhh
Confidence 99999999999999975 59999999999999 7778899999999987644322 23456899999999986
Q ss_pred -------cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhh----hccchhhhh-h--h--hcccCC
Q 021947 152 -------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPY----LSDKRKLFR-I--M--DTKLGG 213 (305)
Q Consensus 152 -------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~----~~~~~~~~~-~--~--~~~~~~ 213 (305)
+..++.++|||||||++|+|++|..||......... ......... ......... . . ......
T Consensus 190 ~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (319)
T 4euu_A 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269 (319)
T ss_dssp HTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTC
T ss_pred ccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCccc
Confidence 467899999999999999999999999754332111 110000000 000000000 0 0 001122
Q ss_pred CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 021947 214 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 255 (305)
Q Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 255 (305)
.....++..+.+||.+||+.||.+|||+.+++++...-..+.
T Consensus 270 ~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred ccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 445788999999999999999999999999999988765443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=315.77 Aligned_cols=245 Identities=20% Similarity=0.250 Sum_probs=181.9
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||+++.... .....+.+|++++++++||||+++++++.+++..|+||||+++++|.+++.......+++..+..
T Consensus 53 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 132 (389)
T 3gni_B 53 EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY 132 (389)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHH
T ss_pred CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHH
Confidence 3699999976532 22356888999999999999999999999999999999999999999999876555699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-----cceeecccccccccchhhhhc-
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~- 152 (305)
++.|++.||+|||+. ||+||||||+|||++.++.+||+|||.+........ ........||..|+|||++.+
T Consensus 133 ~~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (389)
T 3gni_B 133 ILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210 (389)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT
T ss_pred HHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhcc
Confidence 999999999999975 599999999999999999999999998864322111 111223468999999999987
Q ss_pred -CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhh-hhhhhhhhccc-----h-------------hhhhhh-----
Q 021947 153 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDK-----R-------------KLFRIM----- 207 (305)
Q Consensus 153 -~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~-----~-------------~~~~~~----- 207 (305)
..++.++|||||||++|+|++|+.||.+......... .....+...+. . ......
T Consensus 211 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (389)
T 3gni_B 211 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTP 290 (389)
T ss_dssp SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------
T ss_pred CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCcc
Confidence 5789999999999999999999999987543221100 00000000000 0 000000
Q ss_pred ----hcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 208 ----DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 208 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
........+..++..+.+||.+||..||.+|||+.+++++
T Consensus 291 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 291 RPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0001112344577889999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=308.31 Aligned_cols=233 Identities=30% Similarity=0.414 Sum_probs=191.5
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhcc-CCCCcccEEEEEEeCC-eeEEEEecCCCCCHHHHhhhcCC----------
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGP---------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------- 68 (305)
.||||+++..... ....+.+|++++.++ +||||+++++++...+ ..++||||++|++|.+++.....
T Consensus 59 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 138 (316)
T 2xir_A 59 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138 (316)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-----
T ss_pred EEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccch
Confidence 6899999865432 335789999999999 6999999999988754 48999999999999999976542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 69 ----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 69 ----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
..+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................+|+.|
T Consensus 139 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 216 (316)
T 2xir_A 139 DLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 216 (316)
T ss_dssp --CTTCEEHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGG
T ss_pred hhhccccCHHHHHHHHHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceee
Confidence 1278999999999999999999975 5999999999999999999999999999876544333334455678999
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
+|||++.+..++.++||||||+++|+|++ |..||.+.... ..+...+........+..++..+
T Consensus 217 ~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l 280 (316)
T 2xir_A 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEM 280 (316)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHH
T ss_pred cCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh----------------HHHHHHhccCccCCCCCCCCHHH
Confidence 99999999999999999999999999998 99999764421 11222222333344556678899
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.+++.+||..||.+|||+.+++++|+.+.
T Consensus 281 ~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 281 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=307.86 Aligned_cols=224 Identities=21% Similarity=0.222 Sum_probs=183.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|.++... .....+.+|+++++.++||||+++++++.+.+..++||||++|++|.+++.... ..+++..+..++.
T Consensus 32 ~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~ 109 (321)
T 1tki_A 32 TYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVH 109 (321)
T ss_dssp EEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHH
T ss_pred EEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHH
Confidence 58999987542 344678899999999999999999999999999999999999999999996543 3599999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCC--CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
|++.||.|||+. |++||||||+|||++. ++.+||+|||++....... ......||+.|+|||++.+..++.++
T Consensus 110 qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~ 184 (321)
T 1tki_A 110 QVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184 (321)
T ss_dssp HHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHH
T ss_pred HHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchh
Confidence 999999999965 5999999999999987 7899999999998764432 23445789999999999988889999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC--CChHHHHHHHHHHHhhccCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
||||||+++|+|++|..||.+..... .+..+........ ....++.++.+||.+||..||.+
T Consensus 185 DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 248 (321)
T 1tki_A 185 DMWSLGTLVYVLLSGINPFLAETNQQ----------------IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248 (321)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGG
T ss_pred hHHHHHHHHHHHHhCCCCCcCCCHHH----------------HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999998754211 1111111111111 11246788999999999999999
Q ss_pred CCCHHHHHHHH
Q 021947 238 RPRMSEVLAIL 248 (305)
Q Consensus 238 Rps~~~~l~~l 248 (305)
|||+.+++++-
T Consensus 249 Rpt~~e~l~hp 259 (321)
T 1tki_A 249 RMTASEALQHP 259 (321)
T ss_dssp SCCHHHHHHSH
T ss_pred CcCHHHHhcCh
Confidence 99999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=308.85 Aligned_cols=234 Identities=24% Similarity=0.398 Sum_probs=191.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--------CCCCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~ 72 (305)
.||||++..... .....+.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ...++
T Consensus 57 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 136 (322)
T 1p4o_A 57 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136 (322)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCC
T ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcC
Confidence 589999976532 234578999999999999999999999999999999999999999999996532 13478
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++................+|+.|+|||++.+
T Consensus 137 ~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (322)
T 1p4o_A 137 LSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 214 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC--CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence 999999999999999999975 599999999999999999999999999976533222222233456889999999999
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++||||||+++|+|++ |..||.+.... .....+........+..++..+.+||.+||
T Consensus 215 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (322)
T 1p4o_A 215 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCW 277 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHc
Confidence 999999999999999999999 89999764321 111222222223445678889999999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhcCC
Q 021947 232 NNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
..||.+|||+.++++.|++...+
T Consensus 278 ~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 278 QYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp CSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCcccCcCHHHHHHHHHHhhcc
Confidence 99999999999999999887543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=304.65 Aligned_cols=228 Identities=29% Similarity=0.472 Sum_probs=180.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-CCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~ 80 (305)
.||||++..+ ...+.+.+|++++++++||||+++++++. +..++||||++|++|.+++..... ..++...++.++
T Consensus 33 ~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 108 (307)
T 2eva_A 33 DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108 (307)
T ss_dssp EEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHH
T ss_pred eEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHH
Confidence 5899998754 34578999999999999999999999876 458999999999999999975543 247889999999
Q ss_pred HHHHHHHhhhhcCC-CceeeccCCCCceEeCCCCc-eeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 81 IGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~-~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
.|++.||.|||+.+ +|++||||||+||+++.++. +||+|||++...... .....||+.|+|||++.+..++.+
T Consensus 109 ~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 183 (307)
T 2eva_A 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEK 183 (307)
T ss_dssp HHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTH
T ss_pred HHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcH
Confidence 99999999999733 56999999999999988886 799999999754332 223468999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|+.||........ ..............+..++..+.+|+.+||..||.+|
T Consensus 184 ~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 248 (307)
T 2eva_A 184 CDVFSWGIILWEVITRRKPFDEIGGPAF---------------RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQR 248 (307)
T ss_dssp HHHHHHHHHHHHHHHTCCTTTTTCSSHH---------------HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHHHHCCCCchhhCccHH---------------HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhC
Confidence 9999999999999999999975432111 1111122223334456678899999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
||+.++++.|+.+..
T Consensus 249 ps~~ell~~L~~~~~ 263 (307)
T 2eva_A 249 PSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCHHHHHHHHHHHGG
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=329.07 Aligned_cols=230 Identities=26% Similarity=0.373 Sum_probs=188.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...+++.+|+++|++++||||+++++++.. +..|+||||+.+|+|.+++.... ..+++..+..++
T Consensus 365 ~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~ 442 (613)
T 2ozo_A 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELL 442 (613)
T ss_dssp EEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHH
T ss_pred EEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHH
Confidence 599999987643 355789999999999999999999999876 56899999999999999996543 459999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++
T Consensus 443 ~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~s 520 (613)
T 2ozo_A 443 HQVSMGMKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520 (613)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHC--CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHH
Confidence 9999999999975 5999999999999999999999999999875433221 112223456889999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|||||||++|+|++ |+.||.+... ..+...+........+..++.++.+||.+||..||.+|
T Consensus 521 DvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 521 DVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCS-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 99999999999998 9999987542 12233344444556677889999999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 021947 239 PRMSEVLAILERLE 252 (305)
Q Consensus 239 ps~~~~l~~l~~~~ 252 (305)
||+.++++.|+.+.
T Consensus 584 Ps~~~l~~~L~~~~ 597 (613)
T 2ozo_A 584 PDFLTVEQRMRACY 597 (613)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=311.38 Aligned_cols=224 Identities=24% Similarity=0.334 Sum_probs=183.9
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++.... ......+.+|+++|++++||||+++++++.+.+..|+||||+.||+|.+++.... .+++..+.
T Consensus 41 ~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~ 118 (384)
T 4fr4_A 41 KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVK 118 (384)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHH
T ss_pred CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHH
Confidence 368999986532 2345678999999999999999999999999999999999999999999997654 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc---CC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GR 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~ 154 (305)
.++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||++....... .....+||+.|+|||++.+ ..
T Consensus 119 ~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~ 193 (384)
T 4fr4_A 119 LFICELVMALDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAG 193 (384)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCC
T ss_pred HHHHHHHHHHHHHHHC--CceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCC
Confidence 9999999999999965 59999999999999999999999999998754332 2345679999999999864 45
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++.++|||||||++|+|++|..||........... .... ......++..++..+.+||.+||..|
T Consensus 194 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--------------~~~~-~~~~~~~p~~~s~~~~~li~~lL~~d 258 (384)
T 4fr4_A 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI--------------VHTF-ETTVVTYPSAWSQEMVSLLKKLLEPN 258 (384)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH--------------HHHH-HHCCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred CCccceeechHHHHHHHHhCCCCCCCCCCccHHHH--------------HHHH-hhcccCCCCcCCHHHHHHHHHHhcCC
Confidence 89999999999999999999999976433211111 1111 11223456678899999999999999
Q ss_pred CCCCCC-HHHHHH
Q 021947 235 PKLRPR-MSEVLA 246 (305)
Q Consensus 235 p~~Rps-~~~~l~ 246 (305)
|.+||+ ++++++
T Consensus 259 P~~R~s~~~~l~~ 271 (384)
T 4fr4_A 259 PDQRFSQLSDVQN 271 (384)
T ss_dssp GGGSCCSHHHHHT
T ss_pred HhHhcccHHHHHc
Confidence 999998 777765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=307.35 Aligned_cols=231 Identities=26% Similarity=0.373 Sum_probs=183.5
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++...... ...+.+|..++.++ +||||+++++++.+.+..|+||||+.|++|.+++.+.+ .+++..+.
T Consensus 36 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~ 113 (345)
T 3a8x_A 36 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHAR 113 (345)
T ss_dssp EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 68999997653322 35678999999988 89999999999999999999999999999999997654 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.
T Consensus 114 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 189 (345)
T 3a8x_A 114 FYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGF 189 (345)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCCh
Confidence 9999999999999975 599999999999999999999999999986432221 234567999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||......... .......+.+.+. .....++..++..+.+||.+||..||.+
T Consensus 190 ~~DiwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~ 260 (345)
T 3a8x_A 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKE 260 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHhHHHHHHHHHHHHhCCCCcCCccccccc--------ccccHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhcCCHhH
Confidence 999999999999999999999753221100 0001111111111 1223456678899999999999999999
Q ss_pred CCCH------HHHHHH
Q 021947 238 RPRM------SEVLAI 247 (305)
Q Consensus 238 Rps~------~~~l~~ 247 (305)
||++ .+++++
T Consensus 261 R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 261 RLGCHPQTGFADIQGH 276 (345)
T ss_dssp STTCCTTTHHHHHHTS
T ss_pred CCCCCCcCCHHHHhcC
Confidence 9986 566643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=304.26 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=169.3
Q ss_pred HHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCC
Q 021947 17 KEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 94 (305)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 94 (305)
+.+.+|++++++++||||+++++++.+ ++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.
T Consensus 81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 568999999999999999999999986 5678999999999999887643 3599999999999999999999975
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC---CCCCCceehhhHHHHHH
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLEL 171 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~~l 171 (305)
|++||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|+|
T Consensus 157 -~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 157 -KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp -TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred -CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 599999999999999999999999999987543321 233457899999999997765 36789999999999999
Q ss_pred HhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 172 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++|..||.+...... ...+............++..+.+||.+||..||.+|||+.+++++
T Consensus 234 ~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 234 VFGQCPFMDERIMCL----------------HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHSSCSSCCSSHHHH----------------HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHCCCCCCCccHHHH----------------HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 999999976432100 011111122222334577889999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=301.18 Aligned_cols=231 Identities=26% Similarity=0.376 Sum_probs=190.7
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++||||+.+++|.+++.... ..+++..++.++
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 116 (287)
T 1u59_A 39 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELL 116 (287)
T ss_dssp EEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHH
T ss_pred eEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHH
Confidence 589999987533 3346789999999999999999999999 5567899999999999999996443 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.++
T Consensus 117 ~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 194 (287)
T 1u59_A 117 HQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194 (287)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHHC--CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchh
Confidence 9999999999965 5999999999999999999999999999876433221 112233468899999999988999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
||||||+++|+|++ |..||.+.... .+...+........+..++..+.+||.+||..||.+|
T Consensus 195 Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 257 (287)
T 1u59_A 195 DVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 257 (287)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhC
Confidence 99999999999998 99999764321 1222223333445567788999999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 021947 239 PRMSEVLAILERLEA 253 (305)
Q Consensus 239 ps~~~~l~~l~~~~~ 253 (305)
||+.++++.|+++..
T Consensus 258 ps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 258 PDFLTVEQRMRACYY 272 (287)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999999988743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=300.64 Aligned_cols=229 Identities=29% Similarity=0.402 Sum_probs=186.5
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++...... .+++.+|+++++.++||||+++++++ ..+..++||||+.+++|.+++.... .+++..++.+
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 122 (291)
T 1xbb_A 46 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL 122 (291)
T ss_dssp EEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred eEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHH
Confidence 58999998654333 46789999999999999999999998 5677899999999999999997654 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-eeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.|++.||.|||+. |++||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.+
T Consensus 123 ~~qi~~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 200 (291)
T 1xbb_A 123 VHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 200 (291)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHHHhC--CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChh
Confidence 99999999999975 59999999999999999999999999998764433221 1222346788999999999889999
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+||||||+++|+|++ |..||.+... ..+...+........+..++..+.++|.+||+.||.+
T Consensus 201 ~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 263 (291)
T 1xbb_A 201 SDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 263 (291)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 999999999999999 9999986432 1122223333344556678899999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021947 238 RPRMSEVLAILERLE 252 (305)
Q Consensus 238 Rps~~~~l~~l~~~~ 252 (305)
|||+.++++.|+++-
T Consensus 264 Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 264 RPGFAAVELRLRNYY 278 (291)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=300.60 Aligned_cols=229 Identities=27% Similarity=0.387 Sum_probs=185.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++..... ...+.+.+|++++++++||||+++++++.+ +..|+||||+.+++|.+++.... ..++...+..++
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 119 (281)
T 3cc6_A 42 NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYS 119 (281)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHH
T ss_pred eEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHH
Confidence 599999986632 345678999999999999999999999764 46789999999999999997654 348999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++|
T Consensus 120 ~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (281)
T 3cc6_A 120 LQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASD 196 (281)
T ss_dssp HHHHHHHHHHHHT--TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHC--CcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhc
Confidence 9999999999965 5999999999999999999999999999865433211 123345688999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |+.||...... .....+........+..++..+.+|+.+||..||.+||
T Consensus 197 i~slG~il~~llt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 259 (281)
T 3cc6_A 197 VWMFAVCMWEILSFGKQPFFWLENK-----------------DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 259 (281)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCGG-----------------GHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cHHHHHHHHHHHhCCCCCcccCChH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCc
Confidence 9999999999998 99999754321 11122222333445566788999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|+++.
T Consensus 260 s~~ell~~L~~~~ 272 (281)
T 3cc6_A 260 RFTELVCSLSDVY 272 (281)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=308.79 Aligned_cols=222 Identities=26% Similarity=0.368 Sum_probs=184.3
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++... ......+.+|.+++..+ +||||+++++++.+.+..|+||||++||+|.+++.+.+ .+++..+.
T Consensus 47 ~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~ 124 (353)
T 2i0e_A 47 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAV 124 (353)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 68999987542 23456788999999988 79999999999999999999999999999999997654 39999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||++........ .....+||+.|+|||++.+..++.
T Consensus 125 ~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 200 (353)
T 2i0e_A 125 FYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGK 200 (353)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBST
T ss_pred HHHHHHHHHHHHHHHC--CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCC
Confidence 9999999999999975 599999999999999999999999999986432221 234567999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+.. .....+... ...++..++.++.+||.+||..||.+
T Consensus 201 ~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 201 SVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTS
T ss_pred cccccchHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999999999999999864321 111122222 23456678899999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
||+ +.+++++
T Consensus 263 R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 263 RLGCGPEGERDIKEH 277 (353)
T ss_dssp CTTCSTTHHHHHHTS
T ss_pred cCCCCCCCHHHHhcC
Confidence 995 5777654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=305.51 Aligned_cols=244 Identities=30% Similarity=0.450 Sum_probs=194.5
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++.... .....+.+|++++++++||||+++++++.+. ...++||||+++++|.+++.... +++..++.
T Consensus 62 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~ 138 (318)
T 3lxp_A 62 MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLL 138 (318)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHH
T ss_pred EEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHH
Confidence 599999986633 2346789999999999999999999999874 67899999999999999996654 89999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.
T Consensus 139 i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 216 (318)
T 3lxp_A 139 FAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY 216 (318)
T ss_dssp HHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHHHhC--CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCc
Confidence 999999999999975 5999999999999999999999999999876543321 1233445788899999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|++|..||......... ...+.. .......+...+........+..++..+.+||.+||..||.+
T Consensus 217 ~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 294 (318)
T 3lxp_A 217 ASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQ-GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASF 294 (318)
T ss_dssp HHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCC-HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccc-cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCccc
Confidence 999999999999999999999764321100 000000 001112233444455556667788999999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 021947 238 RPRMSEVLAILERLE 252 (305)
Q Consensus 238 Rps~~~~l~~l~~~~ 252 (305)
|||+.++++.|+.+.
T Consensus 295 Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 295 RPTFENLIPILKTVH 309 (318)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=297.56 Aligned_cols=230 Identities=28% Similarity=0.445 Sum_probs=190.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.
T Consensus 34 ~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 111 (267)
T 3t9t_A 34 KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCL 111 (267)
T ss_dssp EEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHH
T ss_pred eEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHH
Confidence 58999998654 345789999999999999999999999999999999999999999999997653 3589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||+. |++|+||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||
T Consensus 112 ~i~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 188 (267)
T 3t9t_A 112 DVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188 (267)
T ss_dssp HHHHHHHHHHHT--TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHhC--CcccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhch
Confidence 999999999965 59999999999999999999999999998653321 111223456788999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||...... .....+........+..++..+.+|+.+||..||.+|||
T Consensus 189 ~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 251 (267)
T 3t9t_A 189 WSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPA 251 (267)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhHHHHHHHhccCCCCCCCCCHH-----------------HHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcC
Confidence 999999999999 89999764321 111222222333445567889999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
+.++++.|+++..
T Consensus 252 ~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 252 FSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=306.97 Aligned_cols=223 Identities=26% Similarity=0.351 Sum_probs=175.6
Q ss_pred CEEEEEecccCCc----cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.||||+++.... .....+.+|+++|++++||||+++++++..++..|+||||++|++|.+++...+ .+++..+
T Consensus 46 ~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 123 (327)
T 3a62_A 46 KIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTA 123 (327)
T ss_dssp CEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHH
T ss_pred cEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHH
Confidence 3699999986532 234567899999999999999999999999999999999999999999997654 3899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++
T Consensus 124 ~~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 199 (327)
T 3a62_A 124 CFYLAEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHN 199 (327)
T ss_dssp HHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCC
T ss_pred HHHHHHHHHHHHHHHhC--CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCC
Confidence 99999999999999965 599999999999999999999999999875432211 23345789999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++||||||+++|+|++|..||.+.+.. ..+..+... ....+..++..+.+||.+||..||.
T Consensus 200 ~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~ 261 (327)
T 3a62_A 200 RAVDWWSLGALMYDMLTGAPPFTGENRK----------------KTIDKILKC--KLNLPPYLTQEARDLLKKLLKRNAA 261 (327)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGG
T ss_pred CcccchhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHh
Confidence 9999999999999999999999865421 111111111 2234566788999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 021947 237 LRP-----RMSEVLAI 247 (305)
Q Consensus 237 ~Rp-----s~~~~l~~ 247 (305)
+|| ++.+++++
T Consensus 262 ~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 262 SRLGAGPGDAGEVQAH 277 (327)
T ss_dssp GSTTSSTTTHHHHHHS
T ss_pred hccCCCCCCHHHHHcC
Confidence 999 77888864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=303.47 Aligned_cols=232 Identities=26% Similarity=0.434 Sum_probs=180.1
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC-----eeEEEEecCCCCCHHHHhhh----cCCCC
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFR----RGPQP 70 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----~~~~~ 70 (305)
.||||+++..... ..+.+.+|++++++++||||+++++++.+.+ ..++||||+.+++|.+++.. .....
T Consensus 64 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~ 143 (313)
T 3brb_A 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143 (313)
T ss_dssp EEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCC
T ss_pred EEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCcc
Confidence 6999999865332 2367899999999999999999999988654 34999999999999999843 23345
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++................+++.|+|||++
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 221 (313)
T 3brb_A 144 IPLQTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhh
Confidence 99999999999999999999964 5999999999999999999999999999865443322223344578899999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.+..++.++||||||+++|+|++ |..||.+.... .+...+........+..++..+.+||.+
T Consensus 222 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~ 284 (313)
T 3brb_A 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----------------EMYDYLLHGHRLKQPEDCLDELYEIMYS 284 (313)
T ss_dssp HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHHHTTCCCCCBTTCCHHHHHHHHH
T ss_pred cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----------------HHHHHHHcCCCCCCCccccHHHHHHHHH
Confidence 99999999999999999999999 89999764321 1222222333445566788899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhhc
Q 021947 230 CLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
||..||.+|||+.++++.|+++.
T Consensus 285 ~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 285 CWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999998864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=305.52 Aligned_cols=231 Identities=19% Similarity=0.204 Sum_probs=185.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++.... ....+.+|+++++++ +||||+++++++..++..++||||+ +++|.+++.... ..+++..++.++
T Consensus 36 ~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~ 111 (330)
T 2izr_A 36 YVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIA 111 (330)
T ss_dssp EEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred EEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHH
Confidence 69999987653 345688999999999 8999999999999999999999999 889999997643 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc-----eeeccccccccCCCCCCcc-----eeecccccccccchhhh
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~ 150 (305)
.|++.||.|||+. ||+||||||+|||++.++. +||+|||++.......... ......||+.|+|||++
T Consensus 112 ~qi~~~l~~LH~~--~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (330)
T 2izr_A 112 IQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTH 189 (330)
T ss_dssp HHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHhC--CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHH
Confidence 9999999999975 5999999999999998887 9999999998654332211 12356799999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC---CChHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLA 227 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 227 (305)
.+..++.++|||||||++|+|++|..||.+............ +........ ....++ ++.+|+
T Consensus 190 ~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~-------------i~~~~~~~~~~~~~~~~p-~~~~li 255 (330)
T 2izr_A 190 LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK-------------IGDTKRATPIEVLCENFP-EMATYL 255 (330)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH-------------HHHHHHHSCHHHHTTTCH-HHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH-------------HHhhhccCCHHHHhccCh-HHHHHH
Confidence 999999999999999999999999999987543221111100 000000000 011244 899999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 228 LQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.+||..||.+||++.++++.|+.+.
T Consensus 256 ~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 256 RYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=302.15 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=178.6
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||++....... ...+.+|++++++++||||+++++++.+++..++||||+++ +|.+++.... ..+++..+..
T Consensus 46 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~ 123 (311)
T 3niz_A 46 RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKI 123 (311)
T ss_dssp CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHH
T ss_pred CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHH
Confidence 369999997653322 36788999999999999999999999999999999999975 8888886544 3599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 157 (305)
++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+ ..++.
T Consensus 124 ~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 199 (311)
T 3niz_A 124 YLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYST 199 (311)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHHHHC--CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCc
Confidence 999999999999965 599999999999999999999999999987543222 1334568999999999876 46899
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhhh---ccchhhhhhhhcccC--C-----CCChHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYL---SDKRKLFRIMDTKLG--G-----QYPQKAAHTAAT 225 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~~---~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~ 225 (305)
++|||||||++|+|++|+.||.+........ .... ..+.. .....+......... . .....++.++.+
T Consensus 200 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3niz_A 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHH
T ss_pred hHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHH
Confidence 9999999999999999999998765432211 1000 00000 000000000000000 0 011245678999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
||.+||..||.+|||+.+++++
T Consensus 280 li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 280 LLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhHCCCHHHHhcC
Confidence 9999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=310.62 Aligned_cols=221 Identities=28% Similarity=0.391 Sum_probs=183.4
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++... ......+.+|.+++..+ +||||+++++++.+.+..|+||||++||+|.+++.+.+ .+++..+.
T Consensus 44 ~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~ 121 (345)
T 1xjd_A 44 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRAT 121 (345)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 68999987542 23456788999999987 89999999999999999999999999999999997654 38999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.
T Consensus 122 ~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 197 (345)
T 1xjd_A 122 FYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNH 197 (345)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHC--CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCC
Confidence 9999999999999975 599999999999999999999999999986432221 134567999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+.+... ....+... ...++..++.++.+||.+||..||.+
T Consensus 198 ~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~ 259 (345)
T 1xjd_A 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEE----------------LFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEK 259 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred hhhhHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhH
Confidence 9999999999999999999998654211 11111111 22345667889999999999999999
Q ss_pred CCCHH-HHHH
Q 021947 238 RPRMS-EVLA 246 (305)
Q Consensus 238 Rps~~-~~l~ 246 (305)
||++. ++++
T Consensus 260 R~~~~~~i~~ 269 (345)
T 1xjd_A 260 RLGVRGDIRQ 269 (345)
T ss_dssp SBTTBSCGGG
T ss_pred cCCChHHHHc
Confidence 99997 7664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=309.68 Aligned_cols=228 Identities=23% Similarity=0.322 Sum_probs=174.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..||||++.... ...+.+.+|+.++++++||||+++++++...+..|+||||+.|++|.+++...+ .+++..+..++
T Consensus 46 ~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~ 122 (361)
T 3uc3_A 46 ELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFF 122 (361)
T ss_dssp CEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred cEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHH
Confidence 369999997653 334678899999999999999999999999999999999999999999997654 39999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc--eeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
.|++.||+|||++ ||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.+
T Consensus 123 ~ql~~~L~~LH~~--~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (361)
T 3uc3_A 123 QQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGK 197 (361)
T ss_dssp HHHHHHHHHHHHT--TCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHH
T ss_pred HHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCC
Confidence 9999999999965 5999999999999987765 9999999987432221 1234578999999999988887655
Q ss_pred -CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 -SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 -~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+|||||||++|+|++|+.||.+....... ...+..+.......+....++..+.+||.+||..||.+
T Consensus 198 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 265 (361)
T 3uc3_A 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDY------------RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPAT 265 (361)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCC----CCCH------------HHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTT
T ss_pred eeeeehhHHHHHHHHhCCCCCCCCccHHHH------------HHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhH
Confidence 89999999999999999999865432110 01111122222222233356788999999999999999
Q ss_pred CCCHHHHHHHH
Q 021947 238 RPRMSEVLAIL 248 (305)
Q Consensus 238 Rps~~~~l~~l 248 (305)
|||+.+++++-
T Consensus 266 Rps~~ell~hp 276 (361)
T 3uc3_A 266 RISIPEIKTHS 276 (361)
T ss_dssp SCCHHHHHTSH
T ss_pred CcCHHHHHhCc
Confidence 99999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.90 Aligned_cols=230 Identities=30% Similarity=0.440 Sum_probs=192.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+.|.+|+++|++++|+||+++++++.+ +..|+||||+.+++|.+++.......+++..++.++.
T Consensus 293 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 370 (535)
T 2h8h_A 293 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370 (535)
T ss_dssp EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred eEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 59999998754 346789999999999999999999999866 6789999999999999999754434589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++||
T Consensus 371 qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 447 (535)
T 2h8h_A 371 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDV 447 (535)
T ss_dssp HHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHhC--CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhH
Confidence 999999999975 59999999999999999999999999998654321 111223346788999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+... ..+...+........+..++..+.+||.+||..||++|||
T Consensus 448 wSlGv~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 448 WSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp HHHHHHHHHHTTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 999999999999 9999976432 1222333344455566788899999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 021947 241 MSEVLAILERLEA 253 (305)
Q Consensus 241 ~~~~l~~l~~~~~ 253 (305)
+.+|++.|+.+..
T Consensus 511 ~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 511 FEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHTSSC
T ss_pred HHHHHHHHHHHhh
Confidence 9999999988753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=330.60 Aligned_cols=228 Identities=29% Similarity=0.397 Sum_probs=188.2
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++.... ...+++.+|+++|++++||||+++++++. .+..++||||+.+++|.+++.... .+++..++.+
T Consensus 398 ~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i 474 (635)
T 4fl3_A 398 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL 474 (635)
T ss_dssp EEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred EEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHH
Confidence 599999986533 23578999999999999999999999986 456889999999999999997654 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+..++.+
T Consensus 475 ~~qi~~~L~yLH~~--~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~ 552 (635)
T 4fl3_A 475 VHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 552 (635)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHC--CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcH
Confidence 99999999999975 5999999999999999999999999999876443221 12233456789999999999999999
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+|||||||++|+|++ |+.||.+... ..+...+........+..++.++.+||.+||..||.+
T Consensus 553 sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~ 615 (635)
T 4fl3_A 553 SDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 615 (635)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhH
Confidence 999999999999998 9999987532 2233444445555667788999999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
|||+.++++.|+.+
T Consensus 616 RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 616 RPGFAAVELRLRNY 629 (635)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=300.91 Aligned_cols=232 Identities=27% Similarity=0.426 Sum_probs=175.2
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++.... ...+.+.+|++++++++||||++++++. .....++||||+.|++|.+++.... ..+++..++.+
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 125 (289)
T 3og7_A 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDI 125 (289)
T ss_dssp EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHH
T ss_pred ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHH
Confidence 489999876533 2336789999999999999999999965 5567899999999999999996543 45999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~ 156 (305)
+.|++.||.|||+. |++||||||+||+++.++.+||+|||++................||+.|+|||++. +..++
T Consensus 126 ~~qi~~~L~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (289)
T 3og7_A 126 ARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203 (289)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSC
T ss_pred HHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCC
Confidence 99999999999975 59999999999999999999999999997654332222234457899999999986 56788
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc----cCCCCChHHHHHHHHHHHhhcc
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK----LGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++||||||+++|+|++|..||.+..... .+...+... ........++..+.+|+.+||+
T Consensus 204 ~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (289)
T 3og7_A 204 FQSDVYAFGIVLYELMTGQLPYSNINNRD----------------QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267 (289)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCCHH----------------HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTC
T ss_pred cccchHHHHHHHHHHHHCCCCccccchHH----------------HHHHHhcccccCcchhhccccCCHHHHHHHHHHcc
Confidence 89999999999999999999998643211 111111111 1112234678899999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcC
Q 021947 233 NEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.||.+|||+.++++.|+++..
T Consensus 268 ~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 268 KKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSGGGSCCHHHHHHHHHHTTC
T ss_pred CChhhCCCHHHHHHHHHHHhh
Confidence 999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=306.28 Aligned_cols=233 Identities=27% Similarity=0.390 Sum_probs=188.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----CCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~ 75 (305)
.||||++..... ....++.+|+.++++++||||+++++++......|+||||++|++|.+++..... ..+++..
T Consensus 62 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 141 (327)
T 2yfx_A 62 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141 (327)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHH
T ss_pred eEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHH
Confidence 699999975432 3346789999999999999999999999999999999999999999999976542 3489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.++.|++.||.|||+. |++||||||+||+++.+ ..+||+|||++................+++.|+|||++.+
T Consensus 142 ~~~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 219 (327)
T 2yfx_A 142 LLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME 219 (327)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC
Confidence 999999999999999965 59999999999999844 4599999999975433222222334567899999999999
Q ss_pred CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++||||||+++|+|++ |..||...... .....+........+..++..+.+||.+||
T Consensus 220 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 282 (327)
T 2yfx_A 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----------------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCW 282 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 999999999999999999998 99999764321 122222233334455677889999999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhcC
Q 021947 232 NNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
..||.+|||+.++++.|+.+..
T Consensus 283 ~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 283 QHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHhc
Confidence 9999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=308.31 Aligned_cols=222 Identities=25% Similarity=0.358 Sum_probs=183.0
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||++.... ......+.+|+++++.++||||+++++++...+..++||||+ +|+|.+++...+ .+++..+.
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~ 111 (336)
T 3h4j_B 35 QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGR 111 (336)
T ss_dssp CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHH
T ss_pred CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHH
Confidence 369999986432 223467899999999999999999999999999999999999 679999987654 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~ 156 (305)
.++.|++.||.|||+. |++||||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+..+ +
T Consensus 112 ~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 186 (336)
T 3h4j_B 112 RFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAG 186 (336)
T ss_dssp HHHHHHHHHHHHHHHH--TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGC
T ss_pred HHHHHHHHHHHHHHHC--CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCC
Confidence 9999999999999975 499999999999999999999999999986543321 234579999999999988776 6
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++||||||+++|+|++|..||.+..... +...+. ......+..++..+.+||.+||..||.
T Consensus 187 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~ 248 (336)
T 3h4j_B 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------LFKKVN-SCVYVMPDFLSPGAQSLIRRMIVADPM 248 (336)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------CBCCCC-SSCCCCCTTSCHHHHHHHHTTSCSSGG
T ss_pred CccchhHHHHHHHHHHhCCCCCCCccHHH-----------------HHHHHH-cCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 79999999999999999999998643211 111111 112234566788999999999999999
Q ss_pred CCCCHHHHHHHH
Q 021947 237 LRPRMSEVLAIL 248 (305)
Q Consensus 237 ~Rps~~~~l~~l 248 (305)
+|||+.+++++-
T Consensus 249 ~Rpt~~eil~hp 260 (336)
T 3h4j_B 249 QRITIQEIRRDP 260 (336)
T ss_dssp GSCCHHHHTTCH
T ss_pred HCcCHHHHHhCh
Confidence 999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=297.45 Aligned_cols=241 Identities=24% Similarity=0.268 Sum_probs=180.2
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||||+++...... ...+.+|++++++++||||+++++++.+++..++||||+.+ ++.+++.... ..+++..+..
T Consensus 28 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~ 105 (292)
T 3o0g_A 28 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKS 105 (292)
T ss_dssp CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHH
T ss_pred ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHH
Confidence 369999997654333 36788999999999999999999999999999999999976 6766665433 3599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-CCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ 157 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.
T Consensus 106 ~~~ql~~~l~~lH~~--~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 181 (292)
T 3o0g_A 106 FLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYST 181 (292)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred HHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCc
Confidence 999999999999975 599999999999999999999999999987543222 233457899999999997765 799
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchh--hhhh-hhhhhhccchhhhhhhh---------cccCCCCChHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD-WAKPYLSDKRKLFRIMD---------TKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 225 (305)
++|||||||++|+|++|..||......... .... ...+............. ..........++..+.+
T Consensus 182 ~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (292)
T 3o0g_A 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261 (292)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHH
Confidence 999999999999999988886443322111 0000 00000000000000000 00111223457788999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
||.+||+.||.+|||+++++++
T Consensus 262 li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 262 LLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccChhhCCCHHHHhcC
Confidence 9999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=311.31 Aligned_cols=232 Identities=28% Similarity=0.398 Sum_probs=179.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEe-CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.++.... ...+++.+|+.++++++||||+++++++.. .+..++||||+++++|.+++.... ..+++..++.+
T Consensus 119 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i 197 (373)
T 3c1x_A 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGF 197 (373)
T ss_dssp EEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHH
Confidence 589999875432 344689999999999999999999998754 457899999999999999996543 35889999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhcCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
+.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.
T Consensus 198 ~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 275 (373)
T 3c1x_A 198 GLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275 (373)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHC--CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCc
Confidence 99999999999975 5999999999999999999999999999865332211 1122345678999999999999999
Q ss_pred CCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++||||||+++|+|++ |.+||.+..... ....+........+..++..+.+++.+||..||.
T Consensus 276 ~~DvwSlG~il~ellt~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~ 338 (373)
T 3c1x_A 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFD-----------------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAE 338 (373)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999999999 778887643211 1112222233344566788999999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 021947 237 LRPRMSEVLAILERLEA 253 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~~ 253 (305)
+|||+.++++.|+++..
T Consensus 339 ~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 339 MRPSFSELVSRISAIFS 355 (373)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHH
Confidence 99999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=301.97 Aligned_cols=231 Identities=29% Similarity=0.445 Sum_probs=187.3
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||||.++... ......+.+|+++++++ +||||+++++++.+.+..|+||||+++++|.+++....
T Consensus 54 ~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (327)
T 1fvr_A 54 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133 (327)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred ceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccc
Confidence 36899887542 23456789999999999 89999999999999999999999999999999996543
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....... ......++..|+
T Consensus 134 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~ 208 (327)
T 1fvr_A 134 STASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWM 208 (327)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCcccc
Confidence 23589999999999999999999965 59999999999999999999999999997432211 122335688999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.+..++.++||||||+++|+|++ |..||.+.... .+...+........+..++..+.
T Consensus 209 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~ 271 (327)
T 1fvr_A 209 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----------------ELYEKLPQGYRLEKPLNCDDEVY 271 (327)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHGGGTCCCCCCTTBCHHHH
T ss_pred ChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----------------HHHHHhhcCCCCCCCCCCCHHHH
Confidence 9999999899999999999999999998 99999765421 12222223333445667888999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+||.+||..||.+|||+.++++.|.++...
T Consensus 272 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 272 DLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=298.30 Aligned_cols=229 Identities=28% Similarity=0.430 Sum_probs=189.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||+.|++|.+++.......+++..++.++.
T Consensus 39 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 116 (279)
T 1qpc_A 39 KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116 (279)
T ss_dssp EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHH
T ss_pred EEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHH
Confidence 68999987653 35678999999999999999999999886 45689999999999999999654333589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||++ |++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||
T Consensus 117 qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 193 (279)
T 1qpc_A 117 QIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDV 193 (279)
T ss_dssp HHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHHC--CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhh
Confidence 999999999975 599999999999999999999999999987543321 11223356788999999998899999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
||||+++|+|++ |..||.+.... .....+........+..++..+.+|+.+||..||.+|||
T Consensus 194 ~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 256 (279)
T 1qpc_A 194 WSFGILLTEIVTHGRIPYPGMTNP-----------------EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256 (279)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCcccCHH-----------------HHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCC
Confidence 999999999999 99999764321 112222233334455678889999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 021947 241 MSEVLAILERLE 252 (305)
Q Consensus 241 ~~~~l~~l~~~~ 252 (305)
+.++++.|+.+.
T Consensus 257 ~~~l~~~l~~~~ 268 (279)
T 1qpc_A 257 FDYLRSVLEDFF 268 (279)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.55 Aligned_cols=226 Identities=23% Similarity=0.252 Sum_probs=183.8
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||+|+++... ......+.+|+.++..++||||+++++++.+.+.+|+||||++||+|.+++... .+++..+.
T Consensus 95 ~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~ 171 (410)
T 3v8s_A 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWAR 171 (410)
T ss_dssp CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHH
T ss_pred cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHH
Confidence 368999986521 123456889999999999999999999999999999999999999999999654 38999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC---
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--- 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--- 154 (305)
.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++.+..
T Consensus 172 ~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~ 248 (410)
T 3v8s_A 172 FYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 248 (410)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred HHHHHHHHHHHHHHHC--CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCc
Confidence 9999999999999975 599999999999999999999999999987544321 1233567999999999998765
Q ss_pred -CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhc
Q 021947 155 -LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 155 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 231 (305)
++.++|+|||||++|+|++|..||.+.+.. .....++... ...+....++.++.+||.+||
T Consensus 249 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL 312 (410)
T 3v8s_A 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 312 (410)
T ss_dssp EEETHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHS
T ss_pred CCCCcceEecchHHHHHHHhCCCCCCCCChh----------------hHHHHHHhccccccCCCcccccHHHHHHHHHHc
Confidence 788999999999999999999999865421 1111222211 122223357889999999999
Q ss_pred cCCCCC--CCCHHHHHHHH
Q 021947 232 NNEPKL--RPRMSEVLAIL 248 (305)
Q Consensus 232 ~~~p~~--Rps~~~~l~~l 248 (305)
..+|.+ ||++++++++.
T Consensus 313 ~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 313 TDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp SCGGGCTTSSCHHHHHTSG
T ss_pred cChhhhCCCCCHHHHhcCc
Confidence 999988 99999999763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=299.60 Aligned_cols=225 Identities=28% Similarity=0.458 Sum_probs=181.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.+ ...+.+.+|++++++++||||+++++++.+. +..|+||||+++++|.+++.......+++..++.++
T Consensus 46 ~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 123 (278)
T 1byg_A 46 KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123 (278)
T ss_dssp EEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHH
T ss_pred EEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHH
Confidence 6899999765 3557899999999999999999999997654 468999999999999999976544448899999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+. |++||||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++|
T Consensus 124 ~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (278)
T 1byg_A 124 LDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSD 196 (278)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHhC--CccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhc
Confidence 9999999999965 5999999999999999999999999998754332 12235688999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||...... .....+........+..++..+.++|.+||..||.+||
T Consensus 197 i~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 259 (278)
T 1byg_A 197 VWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 259 (278)
T ss_dssp HHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCC
Confidence 9999999999998 99999764321 11222223333455667889999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|+++.
T Consensus 260 s~~~l~~~L~~i~ 272 (278)
T 1byg_A 260 SFLQLREQLEHIK 272 (278)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=299.71 Aligned_cols=236 Identities=16% Similarity=0.154 Sum_probs=186.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++.... ....+.+|+++++.+ +|+||+++++++..+...++||||+ +++|.+++...+ ..+++..+..++
T Consensus 37 ~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~ 112 (298)
T 1csn_A 37 QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAA 112 (298)
T ss_dssp EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred EEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHH
Confidence 69999987542 445688999999999 7999999999999999999999999 889999997654 349999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc-----eeeccccccccCCCCCCc-----ceeecccccccccchhhh
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~ 150 (305)
.|++.||.|||+ .|++||||||+||+++.++. +||+|||++......... .......||+.|+|||++
T Consensus 113 ~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (298)
T 1csn_A 113 KQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 190 (298)
T ss_dssp HHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhh
Confidence 999999999996 45999999999999987776 999999999865443221 113345789999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (305)
.+..++.++||||||+++|+|++|+.||.+.............. ..............++..+.+|+.+|
T Consensus 191 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (298)
T 1csn_A 191 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------EKKQSTPLRELCAGFPEEFYKYMHYA 260 (298)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----------HHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH----------hhccCccHHHHHhhCcHHHHHHHHHH
Confidence 99999999999999999999999999998754322111110000 00000000001124678899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhhcC
Q 021947 231 LNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
|..||.+|||+.++++.|+++..
T Consensus 261 l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 261 RNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hcCCcccCCCHHHHHHHHHHHHH
Confidence 99999999999999999988743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=299.64 Aligned_cols=232 Identities=26% Similarity=0.374 Sum_probs=187.8
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCee-EEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+.. ++||||+.+++|.+++.... ..+++..+..+
T Consensus 51 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i 129 (298)
T 3pls_A 51 QCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISF 129 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHH
T ss_pred eeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHH
Confidence 589999876433 2346789999999999999999999999876655 99999999999999996533 45899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC--cceeecccccccccchhhhhcCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
+.|++.||+|||+. |++||||||+||+++.++.+||+|||+++....... ........++..|+|||.+.+..++.
T Consensus 130 ~~qi~~~l~~LH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 207 (298)
T 3pls_A 130 GLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT 207 (298)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCCh
Confidence 99999999999975 599999999999999999999999999976543221 11123346788999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCc-cCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++||||||+++|+|++|..| |...+. ..+...+........+..++..+.+|+.+||..||.
T Consensus 208 ~~Di~slG~il~~l~~g~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 270 (298)
T 3pls_A 208 KSDVWSFGVLLWELLTRGAPPYRHIDP-----------------FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPA 270 (298)
T ss_dssp HHHHHHHHHHHHHHHHTSCCTTTTSCG-----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred hhchhhHHHHHHHHhhCCCCCCccCCH-----------------HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChh
Confidence 99999999999999995555 443221 122233333334455667788999999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 021947 237 LRPRMSEVLAILERLEA 253 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~~ 253 (305)
+|||+.++++.|+++..
T Consensus 271 ~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 271 VRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHH
Confidence 99999999999988743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=312.45 Aligned_cols=227 Identities=22% Similarity=0.260 Sum_probs=173.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhc-cCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQ-LHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
..||||+++. ...+.+|++++.+ .+||||+++++++.. ...+|+||||++||+|.+++...+...+++..
T Consensus 88 ~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~ 162 (400)
T 1nxk_A 88 EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162 (400)
T ss_dssp CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHH
T ss_pred CEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHH
Confidence 3699999863 3467789998755 489999999999875 56689999999999999999876655699999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++...... .....+||+.|+|||++.+
T Consensus 163 ~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 163 ASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCC
T ss_pred HHHHHHHHHHHHHHHHHC--CccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCC
Confidence 999999999999999975 5999999999999987 7889999999998654322 1334578999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQC 230 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~ 230 (305)
..++.++|||||||++|+|++|..||.+....... ......+...... ......++.++.+||.+|
T Consensus 238 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 305 (400)
T 1nxk_A 238 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305 (400)
T ss_dssp CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC------------CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTT
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc------------HHHHHHHHcCcccCCCcccccCCHHHHHHHHHH
Confidence 99999999999999999999999999765421100 0000111111111 112245788999999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~l~ 249 (305)
|..||.+|||+.+++++..
T Consensus 306 L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 306 LKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp SCSSGGGSCCHHHHHHSHH
T ss_pred CCCChhHCcCHHHHhcCcc
Confidence 9999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=318.82 Aligned_cols=224 Identities=27% Similarity=0.337 Sum_probs=176.4
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.. .......+.+|+++++.++||||+++++++...+..|+||||++|++|.+++.+.. .+++..+.
T Consensus 174 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 251 (446)
T 4ejn_A 174 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRAR 251 (446)
T ss_dssp CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHH
T ss_pred CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHH
Confidence 36999998754 22334667899999999999999999999999999999999999999999997654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. .||+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.
T Consensus 252 ~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 328 (446)
T 4ejn_A 252 FYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGR 328 (446)
T ss_dssp HHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCT
T ss_pred HHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCC
Confidence 9999999999999961 4599999999999999999999999999986433221 234467999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.+.+... ....+.. ....++..++.++.+||.+||..||.+
T Consensus 329 ~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~ 390 (446)
T 4ejn_A 329 AVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILM--EEIRFPRTLGPEAKSLLSGLLKKDPKQ 390 (446)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred ccchhhhHHHHHHHhhCCCCCCCCCHHH----------------HHHHHHh--CCCCCCccCCHHHHHHHHHHcccCHHH
Confidence 9999999999999999999997654211 1111111 122455678889999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|| ++.+++++
T Consensus 391 R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 391 RLGGGSEDAKEIMQH 405 (446)
T ss_dssp STTCSTTTHHHHHTS
T ss_pred hCCCCCCCHHHHHhC
Confidence 99 99999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=294.60 Aligned_cols=220 Identities=22% Similarity=0.319 Sum_probs=182.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||+|++........+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.... .+++..+..++.
T Consensus 36 ~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~ 113 (277)
T 3f3z_A 36 RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMK 113 (277)
T ss_dssp EEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHH
T ss_pred EEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence 689999987766677889999999999999999999999999999999999999999999987654 389999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEe---CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
|++.||.|||+. |++||||||+||++ +.++.+||+|||++....... ......||+.|+|||++.+. ++.+
T Consensus 114 ~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~ 187 (277)
T 3f3z_A 114 DVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPE 187 (277)
T ss_dssp HHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTT
T ss_pred HHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc-CCch
Confidence 999999999965 59999999999999 778899999999998654332 13345689999999998654 8999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh----HHHHHHHHHHHhhccCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ----KAAHTAATLALQCLNNE 234 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~ 234 (305)
+||||||+++|+|++|..||....... ....+.... ...+. .++..+.+||.+||+.|
T Consensus 188 ~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~d 249 (277)
T 3f3z_A 188 CDEWSAGVMMYVLLCGYPPFSAPTDSE----------------VMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTKS 249 (277)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred hhehhHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhCC--CCCCchhhhcCCHHHHHHHHHHccCC
Confidence 999999999999999999998754211 111111111 11222 46788999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 250 p~~R~s~~~~l~h 262 (277)
T 3f3z_A 250 PKQRITSLQALEH 262 (277)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=307.00 Aligned_cols=228 Identities=23% Similarity=0.352 Sum_probs=178.9
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCC--CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHH--PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||++...... ....+.+|+++|++++| +||+++++++...+..|+|||+ .+++|.+++.... .+++..+
T Consensus 34 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~ 110 (343)
T 3dbq_A 34 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWER 110 (343)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHH
T ss_pred CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHH
Confidence 36999998765332 23678999999999986 9999999999999999999995 5779999997654 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc----
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---- 152 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---- 152 (305)
..++.|++.||.|||+. ||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+
T Consensus 111 ~~i~~qi~~al~~lH~~--~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 187 (343)
T 3dbq_A 111 KSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187 (343)
T ss_dssp HHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC--
T ss_pred HHHHHHHHHHHHHHHhC--CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccc
Confidence 99999999999999975 599999999999996 57899999999987654433333445679999999999875
Q ss_pred -------CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 153 -------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 153 -------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
..++.++|||||||++|+|++|+.||...... ...+...+........+...+..+.+
T Consensus 188 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (343)
T 3dbq_A 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISKLHAIIDPNHEIEFPDIPEKDLQD 252 (343)
T ss_dssp ---------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------HHHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred ccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---------------HHHHHHHhcCCcccCCcccCCHHHHH
Confidence 67888999999999999999999999753221 11222333333444556666788999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
||.+||..||.+|||+.+++++..
T Consensus 253 li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 253 VLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHcCCChhHCCCHHHHHhCcc
Confidence 999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=322.16 Aligned_cols=228 Identities=29% Similarity=0.409 Sum_probs=188.9
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||++.... ......+.+|+++|++++||||+++++++.+.+..|+||||++||+|.+++...+...+++..+.
T Consensus 210 ~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~ 289 (576)
T 2acx_A 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289 (576)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHH
T ss_pred CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHH
Confidence 369999986532 23456788999999999999999999999999999999999999999999977665669999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++........ ....+||+.|+|||++.+..++.
T Consensus 290 ~i~~qIl~aL~yLH~~--gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~ 364 (576)
T 2acx_A 290 FYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF 364 (576)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESS
T ss_pred HHHHHHHHHHHHHHHC--CEeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCc
Confidence 9999999999999975 599999999999999999999999999987643321 33457999999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|..||.+....... ..+...+. .....++..++.++.+||.+||..||.+
T Consensus 365 ~~DiwSLGvilyeLltG~~PF~~~~~~~~~-------------~~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~ 430 (576)
T 2acx_A 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAE 430 (576)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-------------HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred cchHHHHHHHHHHHHhCCCCCcccccchhH-------------HHHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHH
Confidence 999999999999999999999875432111 11111111 1223455678899999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|| ++.+++++
T Consensus 431 R~g~~~~sa~eil~H 445 (576)
T 2acx_A 431 RLGCRGGSAREVKEH 445 (576)
T ss_dssp STTCSSSHHHHHHTS
T ss_pred cCCCCCCCHHHHHhC
Confidence 99 78888864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.72 Aligned_cols=223 Identities=25% Similarity=0.313 Sum_probs=168.1
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||++|++|.+++...+ .+++..+..++
T Consensus 79 ~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~ 154 (349)
T 2w4o_A 79 KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAV 154 (349)
T ss_dssp CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHH
T ss_pred cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHH
Confidence 369999998653 44678899999999999999999999999999999999999999999996554 48999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.|++.||.|||+. |++||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.
T Consensus 155 ~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ 229 (349)
T 2w4o_A 155 KQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGP 229 (349)
T ss_dssp HHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCc
Confidence 9999999999965 5999999999999975 7889999999998654321 123457899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
++|||||||++|+|++|..||.+...... ....+..... .......++..+.+||.+||..||
T Consensus 230 ~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (349)
T 2w4o_A 230 EVDMWSVGIITYILLCGFEPFYDERGDQF---------------MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294 (349)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCTTCHHH---------------HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSG
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCcccHH---------------HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCCh
Confidence 99999999999999999999976432110 0111111111 112234678899999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+|||+.+++++
T Consensus 295 ~~Rpt~~e~l~h 306 (349)
T 2w4o_A 295 KKRLTTFQALQH 306 (349)
T ss_dssp GGSCCHHHHHHS
T ss_pred hhCcCHHHHhcC
Confidence 999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=298.16 Aligned_cols=232 Identities=27% Similarity=0.401 Sum_probs=185.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEE-eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|.+..... ...+.+.+|++++++++||||+++++++. .++..++||||+.+++|.+++.... ..++...++.+
T Consensus 55 ~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 133 (298)
T 3f66_A 55 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGF 133 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHH
T ss_pred EEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHH
Confidence 489999876433 33467899999999999999999999865 4567899999999999999996543 45899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhcCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
+.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......+|+.|+|||++.+..++.
T Consensus 134 ~~ql~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (298)
T 3f66_A 134 GLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211 (298)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhC--CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCCh
Confidence 99999999999975 5999999999999999999999999999865432211 1123345788999999999999999
Q ss_pred CCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++||||||+++|+|++ |.+||.+.... ..............+..++..+.+++.+||..||.
T Consensus 212 ~~Di~slG~il~~l~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 274 (298)
T 3f66_A 212 KSDVWSFGVLLWELMTRGAPPYPDVNTF-----------------DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAE 274 (298)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTSCTT-----------------THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHHHhCCCCCCccCCHH-----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999 66666654321 11122222233344556788999999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 021947 237 LRPRMSEVLAILERLEA 253 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~~ 253 (305)
+|||+.++++.|+++..
T Consensus 275 ~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 275 MRPSFSELVSRISAIFS 291 (298)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHH
Confidence 99999999999988643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.98 Aligned_cols=227 Identities=23% Similarity=0.355 Sum_probs=178.6
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccC--CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||++..... .....+.+|+++|+++. |+||+++++++...+..|+||| +.+++|.+++.... .+++..+
T Consensus 81 ~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~ 157 (390)
T 2zmd_A 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWER 157 (390)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHH
T ss_pred CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHH
Confidence 3699999876533 23467899999999996 5999999999999999999999 55789999997654 4889999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc----
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---- 152 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---- 152 (305)
..++.||+.||.|||+. ||+||||||+|||++ ++.+||+|||+++..............+||+.|+|||++.+
T Consensus 158 ~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 234 (390)
T 2zmd_A 158 KSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234 (390)
T ss_dssp HHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC---
T ss_pred HHHHHHHHHHHHHHHHC--CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccc
Confidence 99999999999999964 599999999999995 57899999999987654332222345679999999999875
Q ss_pred -------CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 153 -------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 153 -------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
..++.++|||||||++|+|++|..||...... ...+..++........+...+..+.+
T Consensus 235 ~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (390)
T 2zmd_A 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISKLHAIIDPNHEIEFPDIPEKDLQD 299 (390)
T ss_dssp ---------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---------------HHHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred ccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---------------HHHHHHHhCccccCCCCccchHHHHH
Confidence 36888999999999999999999999764321 11122233333334445556788999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l 248 (305)
||.+||..||.+|||+.+++++.
T Consensus 300 li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 300 VLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHcccChhhCCCHHHHhhCc
Confidence 99999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=315.59 Aligned_cols=222 Identities=27% Similarity=0.392 Sum_probs=184.3
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||++.... ......+.+|+++++.++||||+++++++...+..|+||||++|++|.+++.+.+ .+++..+.
T Consensus 42 ~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~ 119 (476)
T 2y94_A 42 HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESR 119 (476)
T ss_dssp CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHH
T ss_pred CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 369999987542 2344678999999999999999999999999999999999999999999996544 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~ 156 (305)
.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..+ +
T Consensus 120 ~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ 194 (476)
T 2y94_A 120 RLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAG 194 (476)
T ss_dssp HHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCS
T ss_pred HHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCC
Confidence 999999999999996 459999999999999999999999999998754432 1334579999999999988766 6
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|||||||++|+|++|..||.+..... ....+... ....+..++..+.+||.+||..||.
T Consensus 195 ~~~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~ 256 (476)
T 2y94_A 195 PEVDIWSSGVILYALLCGTLPFDDDHVPT----------------LFKKICDG--IFYTPQYLNPSVISLLKHMLQVDPM 256 (476)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSSHH----------------HHHHHHTT--CCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred CcceehhhHHHHHHHhhCCCCCCCCCHHH----------------HHHHHhcC--CcCCCccCCHHHHHHHHHHcCCCch
Confidence 79999999999999999999998654211 01111111 1233456778899999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 257 ~Rpt~~eil~h 267 (476)
T 2y94_A 257 KRATIKDIREH 267 (476)
T ss_dssp TSCCHHHHHTC
T ss_pred hCcCHHHHHhC
Confidence 99999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=301.15 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=181.7
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC----CCCCCHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG----PQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~ 75 (305)
+.||||+++.... .....+.+|++++++++||||+++++++..++..|+||||++| +|.+++.... ...+++..
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~ 109 (317)
T 2pmi_A 31 VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109 (317)
T ss_dssp CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHH
T ss_pred cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHH
Confidence 3699999876533 3346789999999999999999999999999999999999985 9999886532 23489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-R 154 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~ 154 (305)
+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+. .
T Consensus 110 ~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~ 185 (317)
T 2pmi_A 110 VKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRT 185 (317)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHC--CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCC
Confidence 999999999999999965 599999999999999999999999999987543221 12345689999999999764 6
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhh-h---hhccchhhhhh---hhc--------ccCCCCChH
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-P---YLSDKRKLFRI---MDT--------KLGGQYPQK 218 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~---~~~~~~~~~~~---~~~--------~~~~~~~~~ 218 (305)
++.++|||||||++|+|++|..||.+........ +..... + .+.....+... ... .........
T Consensus 186 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2pmi_A 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP 265 (317)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccccc
Confidence 8999999999999999999999998765322111 100000 0 00000000000 000 000011224
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++.++.+||.+||..||.+|||+.+++++
T Consensus 266 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 266 LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 56789999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=303.74 Aligned_cols=230 Identities=25% Similarity=0.355 Sum_probs=173.5
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCe----eEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN----RLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++...... ...+.+|++++++++||||+++++++..... .|+||||++|++|.+++...+ .+++.
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~ 116 (311)
T 3ork_A 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPK 116 (311)
T ss_dssp EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHH
T ss_pred eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHH
Confidence 69999998764433 2468899999999999999999999876543 499999999999999997654 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+.
T Consensus 117 ~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 194 (311)
T 3ork_A 117 RAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC
Confidence 9999999999999999975 5999999999999999999999999999865433221 122345689999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC--CCChHHHHHHHHHHHhhc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCL 231 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 231 (305)
.++.++||||||+++|+|++|..||.+...... ........... .....++.++.+||.+||
T Consensus 195 ~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 258 (311)
T 3ork_A 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV----------------AYQHVREDPIPPSARHEGLSADLDAVVLKAL 258 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHHHHCCCCCHHHHSTTCCHHHHHHHHHHT
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----------------HHHHhcCCCCCcccccCCCCHHHHHHHHHHH
Confidence 999999999999999999999999987542110 01111111000 011246788999999999
Q ss_pred cCCCCCCCCHHHHH-HHHHhh
Q 021947 232 NNEPKLRPRMSEVL-AILERL 251 (305)
Q Consensus 232 ~~~p~~Rps~~~~l-~~l~~~ 251 (305)
+.||.+||+..+++ ..+.++
T Consensus 259 ~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 259 AKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CSSGGGSCSSHHHHHHHHHHH
T ss_pred hcCHhhChhhHHHHHHHHHHH
Confidence 99999999655544 555554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=304.40 Aligned_cols=223 Identities=30% Similarity=0.407 Sum_probs=181.6
Q ss_pred EEEEEecccCCcc---ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++...... ..+.+.+|++++++++||||+++++++..++..|+||||+. |+|.+++.... ..+++..+..
T Consensus 81 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~ 158 (348)
T 1u5q_A 81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAA 158 (348)
T ss_dssp EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHH
T ss_pred EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHH
Confidence 6999998755322 23568899999999999999999999999999999999997 58888885443 3599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh---cCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~ 155 (305)
++.|++.||.|||+. |++||||||+|||++.++.+||+|||++..... .....||+.|+|||++. +..+
T Consensus 159 i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~ 230 (348)
T 1u5q_A 159 VTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY 230 (348)
T ss_dssp HHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCB
T ss_pred HHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCC
Confidence 999999999999975 599999999999999999999999999976533 22346899999999985 4678
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|||||||++|+|++|..||.+.... ..+..+.........+..++..+.+||.+||+.||
T Consensus 231 ~~~~DiwslG~il~ell~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 294 (348)
T 1u5q_A 231 DGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 294 (348)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCh
Confidence 99999999999999999999999764321 11112222222223345677889999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 021947 236 KLRPRMSEVLAILER 250 (305)
Q Consensus 236 ~~Rps~~~~l~~l~~ 250 (305)
.+|||+.+++++..-
T Consensus 295 ~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 295 QDRPTSEVLLKHRFV 309 (348)
T ss_dssp GGSCCHHHHTTCHHH
T ss_pred hhCcCHHHHhhChhh
Confidence 999999999976543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=294.42 Aligned_cols=228 Identities=25% Similarity=0.300 Sum_probs=183.5
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||++..... ...+.+.+|+++++.++||||+++++++.+++..|+||||+++++|.+++.... .+++..+..+
T Consensus 33 ~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 110 (276)
T 2yex_A 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRF 110 (276)
T ss_dssp CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHH
T ss_pred cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHH
Confidence 3689999875433 334678999999999999999999999999999999999999999999996543 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~ 158 (305)
+.|++.||.|||+. |++|+||||+||+++.++.+||+|||++................|+..|+|||++.+..+ +.+
T Consensus 111 ~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (276)
T 2yex_A 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188 (276)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHH
T ss_pred HHHHHHHHHHHHhC--CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCc
Confidence 99999999999965 599999999999999999999999999976543222222334578999999999987765 678
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||......... ................++..+.+||.+||..||.+|
T Consensus 189 ~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (276)
T 2yex_A 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCCCSCSCTTSHH---------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred chHHHHHHHHHHHHhCCCCCCCCchHHHH---------------HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhC
Confidence 99999999999999999999875432110 001111111112234678889999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 254 ps~~~il~~ 262 (276)
T 2yex_A 254 ITIPDIKKD 262 (276)
T ss_dssp CCHHHHTTC
T ss_pred CCHHHHhcC
Confidence 999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=304.96 Aligned_cols=228 Identities=23% Similarity=0.326 Sum_probs=163.0
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||++|++|.+++.... .+++..+..+
T Consensus 37 ~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 111 (325)
T 3kn6_A 37 QAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYI 111 (325)
T ss_dssp CEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHH
T ss_pred CEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 36999998753 4567889999999997 9999999999999999999999999999999997654 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC---ceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
+.|++.||.|||+. ||+||||||+|||++.++ .+||+|||+++....... .....+||+.|+|||++.+..++
T Consensus 112 ~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 112 MRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp HHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCC
T ss_pred HHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCC
Confidence 99999999999965 599999999999997765 799999999986543322 13345689999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc-ccCCC--CChHHHHHHHHHHHhhccC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQ--YPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~ 233 (305)
.++||||||+++|+|++|..||.+....... .....+...+.. ..... ....++.++.+||.+||..
T Consensus 188 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 257 (325)
T 3kn6_A 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV 257 (325)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTC-------C----------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCC
T ss_pred CccchHHHHHHHHHHHhCCCCCCCCcccccc----------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCC
Confidence 9999999999999999999999875431100 000111111111 11111 1134678999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
||.+|||+.+++++
T Consensus 258 dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 258 DPNKRLKMSGLRYN 271 (325)
T ss_dssp CTTTCCCTTTSTTC
T ss_pred ChhHCCCHHHHhcC
Confidence 99999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=305.90 Aligned_cols=240 Identities=18% Similarity=0.151 Sum_probs=182.9
Q ss_pred EEEEEecccCCcc-----------ChHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhc
Q 021947 2 VVAVKKLKPEGFQ-----------GHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRR 66 (305)
Q Consensus 2 ~VaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 66 (305)
.||||++...... ....+.+|+..++.++||||+++++++.. ....|+||||+ |++|.+++...
T Consensus 67 ~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 145 (345)
T 2v62_A 67 RHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN 145 (345)
T ss_dssp CEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG
T ss_pred eEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc
Confidence 5899988765321 12346788899999999999999999987 67889999999 89999999765
Q ss_pred CCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC--ceeeccccccccCCCCCC-----cceeeccc
Q 021947 67 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDR-----THVSTQVM 139 (305)
Q Consensus 67 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~ 139 (305)
+ .+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||+++....... ........
T Consensus 146 ~--~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 221 (345)
T 2v62_A 146 G--TFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221 (345)
T ss_dssp G--BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSC
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccC
Confidence 5 599999999999999999999975 599999999999998877 999999999976532211 11123457
Q ss_pred ccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHH
Q 021947 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 219 (305)
Q Consensus 140 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (305)
||..|+|||++.+..++.++|||||||++|+|++|..||.+.......... ....... .+...+... .....+
T Consensus 222 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~---~~~~~~ 294 (345)
T 2v62_A 222 GTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT-AKTNLLD---ELPQSVLKW---APSGSS 294 (345)
T ss_dssp SCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH-HHHHHHH---TTTHHHHHH---SCTTSC
T ss_pred CCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH-HHHhhcc---cccHHHHhh---cccccc
Confidence 899999999999999999999999999999999999999653222111000 0000000 000000000 001246
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+.++.+||.+||..||.+|||+.++++.|+++..
T Consensus 295 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 295 CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 7789999999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=297.43 Aligned_cols=241 Identities=22% Similarity=0.304 Sum_probs=178.1
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||+|++..... .....+.+|++++++++||||+++++++...+..++||||+.+ +|.+++.... ..+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~ 104 (288)
T 1ob3_A 27 ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKS 104 (288)
T ss_dssp CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHH
T ss_pred CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHH
Confidence 3689999876533 2346788999999999999999999999999999999999976 9999886543 3589999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+. .++.
T Consensus 105 ~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 180 (288)
T 1ob3_A 105 FLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYST 180 (288)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCc
Confidence 999999999999975 599999999999999999999999999976543221 12334689999999998764 5899
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhhhccchhhhhh--hhcccC-------CCCChHHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLSDKRKLFRI--MDTKLG-------GQYPQKAAHTAATL 226 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~l 226 (305)
++|||||||++|+|++|..||.+........ .... ..+........... ...... ......++.++.+|
T Consensus 181 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (288)
T 1ob3_A 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHH
Confidence 9999999999999999999998754321110 0000 00000000000000 000000 01123467889999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||..||.+|||+.+++++
T Consensus 261 i~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 261 LSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCcccCCCHHHHhcC
Confidence 999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=304.10 Aligned_cols=237 Identities=24% Similarity=0.339 Sum_probs=186.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhc--CCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRR--GPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~ 74 (305)
+.||||++........+.+.+|++++++++||||+++++++.. ....|+||||+.+++|.+++... ....+++.
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 134 (317)
T 2buj_A 55 HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134 (317)
T ss_dssp CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHH
T ss_pred cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHH
Confidence 4699999876655566789999999999999999999999873 34679999999999999999652 23459999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-------eeecccccccccch
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-------VSTQVMGTHGYAAP 147 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~t~~y~aP 147 (305)
.++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.......... ......||+.|+||
T Consensus 135 ~~~~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 212 (317)
T 2buj_A 135 QILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred HHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCH
Confidence 9999999999999999975 59999999999999999999999999887543211100 01123569999999
Q ss_pred hhhhcCC---CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 148 EYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 148 E~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|++.+.. ++.++||||||+++|+|++|..||...... ...................++..+.
T Consensus 213 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~ 277 (317)
T 2buj_A 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---------------GDSVALAVQNQLSIPQSPRHSSALW 277 (317)
T ss_dssp GGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---------------TSCHHHHHHCC--CCCCTTSCHHHH
T ss_pred hHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---------------cchhhHHhhccCCCCccccCCHHHH
Confidence 9987654 688999999999999999999999642110 0111111222222333456788999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+||.+||+.||.+|||+.++++.|+.+..+
T Consensus 278 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 278 QLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred HHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=302.10 Aligned_cols=226 Identities=23% Similarity=0.344 Sum_probs=176.2
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCC----------------------------------
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE---------------------------------- 45 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---------------------------------- 45 (305)
+.||||+++.... ...+.+.+|+++|++++||||+++++++.+..
T Consensus 32 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (332)
T 3qd2_B 32 CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVK 111 (332)
T ss_dssp CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------------
T ss_pred cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccc
Confidence 3699999975543 34467999999999999999999999986543
Q ss_pred -----------------------eeEEEEecCCCCCHHHHhhhcCC-CCCCHHHHHHHHHHHHHHHhhhhcCCCceeecc
Q 021947 46 -----------------------NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 101 (305)
Q Consensus 46 -----------------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~d 101 (305)
..++|||||+|++|.+++.+... ....+..++.++.|++.||.|||++ |++|||
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~D 189 (332)
T 3qd2_B 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK--GLMHRD 189 (332)
T ss_dssp --------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT--TEECCC
T ss_pred eeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC--CeeecC
Confidence 27999999999999999976543 2356667899999999999999965 599999
Q ss_pred CCCCceEeCCCCceeeccccccccCCCCCCc----------ceeecccccccccchhhhhcCCCCCCCceehhhHHHHHH
Q 021947 102 FKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171 (305)
Q Consensus 102 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 171 (305)
|||+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 190 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (332)
T 3qd2_B 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269 (332)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHH
T ss_pred CCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHH
Confidence 9999999999999999999999876543211 112345689999999999999999999999999999999
Q ss_pred HhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 172 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++|..|+.... ..................+..+.+||.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 270 LYSFSTQMERV-------------------RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HSCCCCHHHHH-------------------HHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHcCCChhHHH-------------------HHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 99877653211 0111111111111123556778999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=303.76 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=192.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCC--eeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||++........+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++.... ..+++..++.+
T Consensus 72 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 150 (326)
T 2w1i_A 72 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQY 150 (326)
T ss_dssp EEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHH
T ss_pred EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHH
Confidence 69999998765555678999999999999999999999987544 6899999999999999997654 34899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-eeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.|++.||.|||+. |++||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.+
T Consensus 151 ~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 228 (326)
T 2w1i_A 151 TSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 228 (326)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHHHhC--CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCch
Confidence 99999999999964 59999999999999999999999999998765433211 1223456788999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||.............. .........+...+........+..++.++.+||.+||..||.+|
T Consensus 229 ~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 307 (326)
T 2w1i_A 229 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307 (326)
T ss_dssp HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT-CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc-cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhC
Confidence 9999999999999999999875321111000000 000000112223333344445567788999999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 021947 239 PRMSEVLAILERLE 252 (305)
Q Consensus 239 ps~~~~l~~l~~~~ 252 (305)
||+.++++.|+++.
T Consensus 308 ps~~el~~~L~~l~ 321 (326)
T 2w1i_A 308 PSFRDLALRVDQIR 321 (326)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=301.04 Aligned_cols=224 Identities=25% Similarity=0.319 Sum_probs=182.7
Q ss_pred CEEEEEecccCCcc------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.... .+++.
T Consensus 38 ~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~ 115 (321)
T 2a2a_A 38 LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEE 115 (321)
T ss_dssp CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHH
T ss_pred eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHH
Confidence 36899998765332 35679999999999999999999999999999999999999999999996543 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----ceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.+..++.|++.||.|||+. |++||||||+||+++.++ .+||+|||++........ .....||+.|+|||++
T Consensus 116 ~~~~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~ 190 (321)
T 2a2a_A 116 EATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIV 190 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhC--CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccc
Confidence 9999999999999999975 599999999999999887 799999999987544321 2345689999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 228 (305)
.+..++.++||||||+++|+|++|..||.+...... +..+...... ......++..+.+||.
T Consensus 191 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~~~li~ 254 (321)
T 2a2a_A 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------------LANITSVSYDFDEEFFSHTSELAKDFIR 254 (321)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHHTTCCCCCHHHHTTCCHHHHHHHH
T ss_pred cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhcccccChhhhcccCHHHHHHHH
Confidence 999999999999999999999999999976532110 0011110000 0011345678999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 255 ~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 255 KLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTSCSSTTTSCCHHHHHHS
T ss_pred HHcCCChhhCcCHHHHhcC
Confidence 9999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=316.28 Aligned_cols=226 Identities=21% Similarity=0.230 Sum_probs=182.1
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++... ......+.+|..++..++||||+++++++.+.+.+|+||||+.||+|.+++.+.. ..+++..+..
T Consensus 101 ~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~ 179 (437)
T 4aw2_A 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARF 179 (437)
T ss_dssp EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHH
T ss_pred EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHH
Confidence 68999987531 1233458899999999999999999999999999999999999999999997633 3499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TG 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~ 153 (305)
++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....... ......+||+.|+|||++. +.
T Consensus 180 ~~~qi~~aL~~LH~~--giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~ 256 (437)
T 4aw2_A 180 YLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKG 256 (437)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCC
T ss_pred HHHHHHHHHHHHHhC--CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCC
Confidence 999999999999965 599999999999999999999999999976543322 2233467999999999987 45
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC---hHHHHHHHHHHHhh
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQC 230 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~ 230 (305)
.++.++|||||||++|+|++|..||.+.+... ....++.......++ ..++.++.+||.+|
T Consensus 257 ~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~l 320 (437)
T 4aw2_A 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TYGKIMNHKERFQFPTQVTDVSENAKDLIRRL 320 (437)
T ss_dssp EECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTT
T ss_pred CCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH----------------HHHhhhhccccccCCcccccCCHHHHHHHHHH
Confidence 68999999999999999999999998754211 111111111111222 34788999999999
Q ss_pred ccCCCCC--CCCHHHHHHH
Q 021947 231 LNNEPKL--RPRMSEVLAI 247 (305)
Q Consensus 231 l~~~p~~--Rps~~~~l~~ 247 (305)
|..+|++ |+++++++++
T Consensus 321 L~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 321 ICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SSCGGGCTTTTTTHHHHTS
T ss_pred hcccccccCCCCHHHHhCC
Confidence 9888888 9999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=299.38 Aligned_cols=240 Identities=26% Similarity=0.287 Sum_probs=179.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||++..........+.+|++++.++ +||||+++++++.+++..|+||||++|++|.+++.... .+++..+..+
T Consensus 39 ~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 116 (316)
T 2ac3_A 39 QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVV 116 (316)
T ss_dssp CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHH
T ss_pred cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHH
Confidence 36999999877666678899999999985 79999999999999999999999999999999997654 4899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc---eeeccccccccCCCCCC-----cceeecccccccccchhhhh
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~ 151 (305)
+.|++.||+|||+. |++||||||+||+++.++. +||+|||++........ ........||..|+|||++.
T Consensus 117 ~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 117 VQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp HHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHH
T ss_pred HHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhh
Confidence 99999999999975 5999999999999988776 99999999876432211 11122346899999999987
Q ss_pred c-----CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC----hHHHHH
Q 021947 152 T-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHT 222 (305)
Q Consensus 152 ~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 222 (305)
+ ..++.++|||||||++|+|++|..||.+........... .........+...+... ....+ ..++..
T Consensus 195 ~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~ 271 (316)
T 2ac3_A 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG--EACPACQNMLFESIQEG-KYEFPDKDWAHISCA 271 (316)
T ss_dssp HTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCHHHHHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc--ccchhHHHHHHHHHhcc-CcccCchhcccCCHH
Confidence 5 457899999999999999999999998754321000000 00000001111111111 11222 246778
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||.+||..||.+|||+.+++++
T Consensus 272 ~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 272 AKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=297.92 Aligned_cols=234 Identities=23% Similarity=0.370 Sum_probs=178.9
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 75 (305)
+.||||+++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.+++... ....+++..
T Consensus 58 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 137 (310)
T 2wqm_A 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137 (310)
T ss_dssp CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHH
T ss_pred ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHH
Confidence 3699999876432 23467889999999999999999999999999999999999999999998642 234589999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.++.+++.||.|||+. |++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..+
T Consensus 138 ~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 213 (310)
T 2wqm_A 138 VWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGY 213 (310)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHhhC--CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCC
Confidence 999999999999999975 599999999999999999999999999976543221 1234468999999999999999
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh-cccCCCCChHHHHHHHHHHHhhccCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
+.++||||||+++|+|++|..||.+....... +...+. ..........++.++.+|+.+||..|
T Consensus 214 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 278 (310)
T 2wqm_A 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---------------LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278 (310)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTC---CCHHH---------------HHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSS
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcccchhHHH---------------HHHHhhcccCCCCcccccCHHHHHHHHHHcCCC
Confidence 99999999999999999999999764321110 111111 11111223457789999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 021947 235 PKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 235 p~~Rps~~~~l~~l~~~~~ 253 (305)
|.+|||+.++++.|+++..
T Consensus 279 p~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 279 PEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHHH
Confidence 9999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=298.79 Aligned_cols=230 Identities=22% Similarity=0.262 Sum_probs=178.9
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++....... .+.+.+|++++++++||||+++++++...+..|+||||++|++|.+++.... .+++..++.
T Consensus 61 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 138 (309)
T 2h34_A 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVA 138 (309)
T ss_dssp EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHH
T ss_pred EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHH
Confidence 68999997653333 3678899999999999999999999999999999999999999999997654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... ......|+..|+|||++.+..++.+
T Consensus 139 i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 215 (309)
T 2h34_A 139 IVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYR 215 (309)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CC
T ss_pred HHHHHHHHHHHHHHC--cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCch
Confidence 999999999999975 5999999999999999999999999999765432211 1234568999999999999899999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+||||||+++|+|++|..||.+..... +...+.... ....+..++..+.+||.+||+.||.
T Consensus 216 ~Di~slG~il~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 278 (309)
T 2h34_A 216 ADIYALTCVLYECLTGSPPYQGDQLSV-----------------MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPE 278 (309)
T ss_dssp CHHHHHHHHHHHHHHSSCSSCSCHHHH-----------------HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGG
T ss_pred HhHHHHHHHHHHHHHCCCCCCCchHHH-----------------HHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHH
Confidence 999999999999999999998643211 011111110 1123456778899999999999999
Q ss_pred CCC-CHHHHHHHHHhhcC
Q 021947 237 LRP-RMSEVLAILERLEA 253 (305)
Q Consensus 237 ~Rp-s~~~~l~~l~~~~~ 253 (305)
+|| |++++++.|++...
T Consensus 279 ~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 279 DRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GSCSSHHHHHHHHHHTCC
T ss_pred HHHHhHHHHHHHHHHHHH
Confidence 999 99999999988654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=308.73 Aligned_cols=219 Identities=26% Similarity=0.342 Sum_probs=172.4
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHH-HhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNY-LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.||||+++.... .....+.+|..+ ++.++||||+++++++.+.+..|+||||+.||+|.+++.+.. .+++..+
T Consensus 64 ~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~ 141 (373)
T 2r5t_A 64 VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRA 141 (373)
T ss_dssp CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHH
Confidence 3689999976532 233456778777 567899999999999999999999999999999999997654 3899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++
T Consensus 142 ~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 217 (373)
T 2r5t_A 142 RFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYD 217 (373)
T ss_dssp HHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCC
Confidence 99999999999999965 599999999999999999999999999986322211 23456799999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+|||||++|+|++|..||.+.+.. .....++.. ...++..++..+.+||.+||..||.
T Consensus 218 ~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~~~--~~~~~~~~~~~~~~li~~lL~~dp~ 279 (373)
T 2r5t_A 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRT 279 (373)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSBHH----------------HHHHHHHHS--CCCCCSSSCHHHHHHHHHHTCSSGG
T ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhc--ccCCCCCCCHHHHHHHHHHcccCHH
Confidence 9999999999999999999999865321 111122222 2234566888999999999999999
Q ss_pred CCCCHHH
Q 021947 237 LRPRMSE 243 (305)
Q Consensus 237 ~Rps~~~ 243 (305)
+||++.+
T Consensus 280 ~R~~~~~ 286 (373)
T 2r5t_A 280 KRLGAKD 286 (373)
T ss_dssp GSTTTTT
T ss_pred hCCCCCC
Confidence 9998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=295.99 Aligned_cols=228 Identities=24% Similarity=0.360 Sum_probs=183.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-CCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (305)
+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... ...+++..+..+
T Consensus 48 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (295)
T 2clq_A 48 VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127 (295)
T ss_dssp CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHH
T ss_pred eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHH
Confidence 3699999987766667889999999999999999999999999999999999999999999997653 335678899999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC--CC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~ 156 (305)
+.|++.||.|||+. |++|+||||+||+++. ++.+||+|||++........ ......|+..|+|||++.+.. ++
T Consensus 128 ~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (295)
T 2clq_A 128 TKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYG 203 (295)
T ss_dssp HHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCS
T ss_pred HHHHHHHHHHHHhC--CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCC
Confidence 99999999999965 5999999999999987 88999999999986543221 123456899999999997754 78
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++||||||+++|+|++|..||........ ..............+..++..+.+||.+||..||.
T Consensus 204 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 268 (295)
T 2clq_A 204 KAADIWSLGCTIIEMATGKPPFYELGEPQA---------------AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPD 268 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---------------HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTT
T ss_pred cHHHHHHHHHHHHHHHHCCCCccCCCchhH---------------HHHhhccccccccccccCCHHHHHHHHHHccCChh
Confidence 899999999999999999999975432111 01111111223345667888999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 269 ~Rps~~~ll~~ 279 (295)
T 2clq_A 269 KRACANDLLVD 279 (295)
T ss_dssp TSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=297.00 Aligned_cols=233 Identities=21% Similarity=0.332 Sum_probs=177.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhc--cCCCCcccEEEEEEeC----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||++... ....+.+|.+++.. ++||||+++++++... ...|+||||+++++|.+++... .+++..
T Consensus 33 ~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~ 106 (301)
T 3q4u_A 33 NVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVS 106 (301)
T ss_dssp EEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHH
T ss_pred EEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHH
Confidence 6999998754 45566777777776 7899999999986642 4579999999999999999543 499999
Q ss_pred HHHHHHHHHHHHhhhhcC------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc--eeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aP 147 (305)
++.++.|++.||.|||+. ..+++||||||+|||++.++.+||+|||++.......... ......||+.|+||
T Consensus 107 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 186 (301)
T 3q4u_A 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186 (301)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeCh
Confidence 999999999999999932 2469999999999999999999999999997643322211 12234789999999
Q ss_pred hhhhcC------CCCCCCceehhhHHHHHHHhC----------CCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcc
Q 021947 148 EYVATG------RLTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTK 210 (305)
Q Consensus 148 E~~~~~------~~~~~~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 210 (305)
|++.+. .++.++||||||+++|+|++| ..||......... ...+.... ...
T Consensus 187 E~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~------------~~~~~~~~~~~~ 254 (301)
T 3q4u_A 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS------------FEDMRKVVCVDQ 254 (301)
T ss_dssp HHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC------------HHHHHHHHTTSC
T ss_pred hhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc------------hhhhhHHHhccC
Confidence 999876 445689999999999999999 7777553221100 00011111 111
Q ss_pred cCCCC-----ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 211 LGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 211 ~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
..... ...++..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 255 QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 11111 2357889999999999999999999999999998763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=313.01 Aligned_cols=226 Identities=20% Similarity=0.192 Sum_probs=180.3
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++... ......+.+|.+++..++||||+++++++.+.+.+|+||||+.||+|.+++.+.+ ..+++..+.
T Consensus 87 ~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~ 165 (412)
T 2vd5_A 87 QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMAR 165 (412)
T ss_dssp CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHH
T ss_pred CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHH
Confidence 469999987532 1233568899999999999999999999999999999999999999999997654 249999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh------
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------ 151 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------ 151 (305)
.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++.
T Consensus 166 ~~~~qi~~aL~~LH~~--giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~ 242 (412)
T 2vd5_A 166 FYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGP 242 (412)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred HHHHHHHHHHHHHHHC--CeeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCc
Confidence 9999999999999965 599999999999999999999999999987544322 1223457999999999987
Q ss_pred -cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--c-CCCCChHHHHHHHHHH
Q 021947 152 -TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--L-GGQYPQKAAHTAATLA 227 (305)
Q Consensus 152 -~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~li 227 (305)
+..++.++|+|||||++|+|++|+.||.+.+... ....++... . ....+..++.++.+||
T Consensus 243 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~~s~~~~dli 306 (412)
T 2vd5_A 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE----------------TYGKIVHYKEHLSLPLVDEGVPEEARDFI 306 (412)
T ss_dssp TCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHTHHHHCCCC----CCCHHHHHHH
T ss_pred CCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhcccCcCCCccccCCCHHHHHHH
Confidence 3568899999999999999999999998754211 111111111 1 1112346788999999
Q ss_pred HhhccCCCCCC---CCHHHHHHH
Q 021947 228 LQCLNNEPKLR---PRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~R---ps~~~~l~~ 247 (305)
.+||. +|.+| |++++++++
T Consensus 307 ~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 307 QRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHcC-ChhhcCCCCCHHHHhcC
Confidence 99999 99998 589999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.58 Aligned_cols=229 Identities=24% Similarity=0.244 Sum_probs=177.1
Q ss_pred CEEEEEecccC-----CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--------
Q 021947 1 MVVAVKKLKPE-----GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG-------- 67 (305)
Q Consensus 1 ~~VaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 67 (305)
+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++....
T Consensus 52 ~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~ 131 (345)
T 3hko_A 52 AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131 (345)
T ss_dssp CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEE
T ss_pred ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccc
Confidence 36899988643 22445789999999999999999999999999999999999999999999984210
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC--ce
Q 021947 68 ------------------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NA 115 (305)
Q Consensus 68 ------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~ 115 (305)
...+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~ 209 (345)
T 3hko_A 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPENFLFSTNKSFEI 209 (345)
T ss_dssp EEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSCCE
T ss_pred cccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEecCCCceE
Confidence 11235677888999999999999975 599999999999998776 89
Q ss_pred eeccccccccCCCCC--Ccceeecccccccccchhhhhc--CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhh
Q 021947 116 KLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 191 (305)
Q Consensus 116 kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 191 (305)
||+|||++....... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....
T Consensus 210 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 282 (345)
T 3hko_A 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------- 282 (345)
T ss_dssp EECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-------
Confidence 999999997543211 1112334578999999999975 67889999999999999999999999875421
Q ss_pred hhhhhhccchhhhhhhhcccCCCC--ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 192 WAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
............... ...++..+.+||.+||+.||.+|||+.+++++
T Consensus 283 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 283 ---------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp ---------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred ---------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111222222221111 23467899999999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=294.04 Aligned_cols=221 Identities=26% Similarity=0.425 Sum_probs=181.7
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..
T Consensus 36 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~ 113 (279)
T 3fdn_A 36 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTAT 113 (279)
T ss_dssp EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 68999886432 2334678999999999999999999999999999999999999999999997654 389999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.+
T Consensus 114 ~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ 187 (279)
T 3fdn_A 114 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEK 187 (279)
T ss_dssp HHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCcc
Confidence 99999999999995 469999999999999999999999999986543322 234568999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||........ ...+ .......+..++..+.+||.+||..||.+|
T Consensus 188 ~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 249 (279)
T 3fdn_A 188 VDLWSLGVLCYEFLVGKPPFEANTYQET-----------------YKRI-SRVEFTFPDFVTEGARDLISRLLKHNPSQR 249 (279)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHH-HHTCCCCCTTSCHHHHHHHHHHCCSSGGGS
T ss_pred chhHhHHHHHHHHHHCCCCCCCCcHHHH-----------------HHHH-HhCCCCCCCcCCHHHHHHHHHHhccChhhC
Confidence 9999999999999999999986542111 0111 112234456678889999999999999999
Q ss_pred CCHHHHHHHH
Q 021947 239 PRMSEVLAIL 248 (305)
Q Consensus 239 ps~~~~l~~l 248 (305)
||+.+++++.
T Consensus 250 ps~~e~l~h~ 259 (279)
T 3fdn_A 250 PMLREVLEHP 259 (279)
T ss_dssp CCHHHHHHCH
T ss_pred CCHHHHhhCc
Confidence 9999999854
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=297.86 Aligned_cols=232 Identities=28% Similarity=0.414 Sum_probs=183.4
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++.... ...+.+.+|++++++++||||+++++++.... .++||||+.+++|.+++.... ..+++..+..
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 125 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSR 125 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHH
Confidence 589999876532 23467899999999999999999999987654 899999999999999997643 3489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-eeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.
T Consensus 126 ~~~~i~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (291)
T 1u46_A 126 YAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 203 (291)
T ss_dssp HHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHHHhC--CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCc
Confidence 999999999999975 59999999999999999999999999998765433221 122345788899999999988999
Q ss_pred CCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++||||||+++|+|++ |..||.+.... .....+.........+..++..+.+++.+||..||.
T Consensus 204 ~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 267 (291)
T 1u46_A 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 267 (291)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccCCHH----------------HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcc
Confidence 9999999999999999 99999765321 111122222233344567889999999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 021947 237 LRPRMSEVLAILERLEA 253 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~~ 253 (305)
+|||+.++++.|+++..
T Consensus 268 ~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 268 DRPTFVALRDFLLEAQP 284 (291)
T ss_dssp GSCCHHHHHHHHHHHC-
T ss_pred cCcCHHHHHHHHHHhCc
Confidence 99999999999988754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=294.69 Aligned_cols=223 Identities=27% Similarity=0.396 Sum_probs=183.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEe----------------CCeeEEEEecCCCCCHHHHhh
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----------------GENRLLVYEFMPKGSLENHLF 64 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~ 64 (305)
+.||||+++... ..+.+|++++++++||||+++++++.. ....|+||||+++++|.+++.
T Consensus 37 ~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 112 (284)
T 2a19_B 37 KTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112 (284)
T ss_dssp CEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHH
T ss_pred eEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHh
Confidence 368999987542 467799999999999999999998864 345799999999999999997
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 65 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
......+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ .....|++.|
T Consensus 113 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y 187 (284)
T 2a19_B 113 KRRGEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRY 187 (284)
T ss_dssp HGGGSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTT
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccc
Confidence 66555699999999999999999999975 599999999999999999999999999987544322 2334689999
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
+|||++.+..++.++||||||+++|+|++|..||..... ....+. ....+..++..+.
T Consensus 188 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------------------~~~~~~---~~~~~~~~~~~~~ 245 (284)
T 2a19_B 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------------------FFTDLR---DGIISDIFDKKEK 245 (284)
T ss_dssp SCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------------------HHHHHH---TTCCCTTSCHHHH
T ss_pred cChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------------------HHHHhh---cccccccCCHHHH
Confidence 999999999999999999999999999999988753210 001111 1123345677899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
+||.+||..||.+|||+.++++.|..+...
T Consensus 246 ~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 246 TLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999988654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=294.20 Aligned_cols=224 Identities=24% Similarity=0.374 Sum_probs=178.4
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||+|++..... ...+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++.... .+++.
T Consensus 52 ~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~ 129 (290)
T 1t4h_A 52 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIK 129 (290)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHH
T ss_pred eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHH
Confidence 3689998875432 334678999999999999999999999875 355899999999999999997654 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.+++.||.|||+.+.+++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++. +
T Consensus 130 ~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~ 204 (290)
T 1t4h_A 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-E 204 (290)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-T
T ss_pred HHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-c
Confidence 999999999999999996544599999999999997 78899999999997644322 33456899999999886 4
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh-cccCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++||||||+++|+|++|..||.+...... ....+. .......+...+..+.+||.+||.
T Consensus 205 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 268 (290)
T 1t4h_A 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----------------HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----------------HHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence 589999999999999999999999976432111 111111 111112233455789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.||.+|||+.+++++
T Consensus 269 ~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 269 QNKDERYSIKDLLNH 283 (290)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhhCCCHHHHhhC
Confidence 999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.07 Aligned_cols=241 Identities=25% Similarity=0.297 Sum_probs=180.3
Q ss_pred CEEEEEecccCCc-----cChHHHHHHHHHHhccC---CCCcccEEEEEEeCC-----eeEEEEecCCCCCHHHHhhhcC
Q 021947 1 MVVAVKKLKPEGF-----QGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 1 ~~VaiK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
..||||++..... .....+.+|++++++++ ||||+++++++.... ..++||||+.+ +|.+++....
T Consensus 35 ~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~ 113 (308)
T 3g33_A 35 HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP 113 (308)
T ss_dssp CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCC
T ss_pred cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhcc
Confidence 3699999874321 22356778888888775 999999999998765 47999999974 9999998776
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccch
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 147 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 147 (305)
...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++........ .....||+.|+||
T Consensus 114 ~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aP 188 (308)
T 3g33_A 114 PPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAP 188 (308)
T ss_dssp TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCc
Confidence 66699999999999999999999975 499999999999999999999999999986543222 3345789999999
Q ss_pred hhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhhhccchhhhhhhhcccCC-------CCChH
Q 021947 148 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLFRIMDTKLGG-------QYPQK 218 (305)
Q Consensus 148 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~ 218 (305)
|++.+..++.++|||||||++|+|++|..||.+........ ..... .+.................. .....
T Consensus 189 E~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (308)
T 3g33_A 189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE 268 (308)
T ss_dssp HHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCS
T ss_pred hHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCcc
Confidence 99999999999999999999999999999998755322110 00000 00000000000000000000 01124
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++..+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 269 MEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 67789999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=292.35 Aligned_cols=225 Identities=23% Similarity=0.298 Sum_probs=183.2
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||+|++..... .....+.+|++++++++||||+++++++...+..++||||+.|++|.+++.... .+++..+..
T Consensus 32 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~ 109 (284)
T 3kk8_A 32 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASH 109 (284)
T ss_dssp CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHH
T ss_pred ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 3689999876533 233678899999999999999999999999999999999999999999887654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc---eeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.|++.||.|||+. |++||||||+||+++.++. +||+|||++........ .....||+.|+|||++.+..+
T Consensus 110 ~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 184 (284)
T 3kk8_A 110 CIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPY 184 (284)
T ss_dssp HHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHC--CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCC
Confidence 999999999999965 5999999999999987655 99999999976543322 234568999999999999999
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
+.++||||||+++|+|++|..||.+...... ........ ........++..+.+||.+||+.
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (284)
T 3kk8_A 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRL----------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248 (284)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred CcccchHHHHHHHHHHHHCCCCCCCCchhHH----------------HHHHHhccccCCchhhcccCHHHHHHHHHHccc
Confidence 9999999999999999999999976542111 01111111 11122245778899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021947 234 EPKLRPRMSEVLAIL 248 (305)
Q Consensus 234 ~p~~Rps~~~~l~~l 248 (305)
||.+|||+.+++++-
T Consensus 249 dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 249 NPKKRITADQALKVP 263 (284)
T ss_dssp STTTSCCHHHHTTSH
T ss_pred ChhhCCCHHHHhcCc
Confidence 999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=297.17 Aligned_cols=224 Identities=22% Similarity=0.334 Sum_probs=181.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||+++.........+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++...+ .+++..+..++
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 112 (304)
T 2jam_A 35 KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVI 112 (304)
T ss_dssp CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHH
T ss_pred CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHH
Confidence 3699999987654555678999999999999999999999999999999999999999999997654 48999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEe---CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.|++.||.|||+. |++||||||+||++ +.++.+||+|||++...... ......|++.|+|||++.+..++.
T Consensus 113 ~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~ 186 (304)
T 2jam_A 113 QQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSK 186 (304)
T ss_dssp HHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCH
T ss_pred HHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCc
Confidence 9999999999965 59999999999999 67889999999998754322 123346899999999999989999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
++||||||+++|+|++|..||.+...... ...+.... ........++..+.+||.+||..||
T Consensus 187 ~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 250 (304)
T 2jam_A 187 AVDCWSIGVITYILLCGYPPFYEETESKL----------------FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDP 250 (304)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSST
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCCh
Confidence 99999999999999999999976432110 01111111 1122345678899999999999999
Q ss_pred CCCCCHHHHHHHH
Q 021947 236 KLRPRMSEVLAIL 248 (305)
Q Consensus 236 ~~Rps~~~~l~~l 248 (305)
.+|||+.+++++.
T Consensus 251 ~~Rps~~~~l~h~ 263 (304)
T 2jam_A 251 NERYTCEKALSHP 263 (304)
T ss_dssp TTSCCHHHHHTSH
T ss_pred hHCcCHHHHhcCc
Confidence 9999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=316.44 Aligned_cols=228 Identities=24% Similarity=0.363 Sum_probs=185.9
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--CCCCCHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 75 (305)
+.||||++.... ......+.+|++++++++||||+++++++.....+|+||||++||+|.+++.... ...+++..
T Consensus 211 ~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~ 290 (543)
T 3c4z_A 211 KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290 (543)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHH
T ss_pred cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHH
Confidence 469999987542 2344678899999999999999999999999999999999999999999996543 34599999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++......... ....+||+.|+|||++.+..+
T Consensus 291 ~~~~~~qi~~aL~~LH~~--gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~ 366 (543)
T 3c4z_A 291 AIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366 (543)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHc--CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCC
Confidence 999999999999999975 5999999999999999999999999999875433221 234579999999999999999
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|+|||||++|+|++|..||.+....... ..+...+. .....++..++..+.+||.+||..||
T Consensus 367 ~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-------------~~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP 432 (543)
T 3c4z_A 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------------KELKQRVL-EQAVTYPDKFSPASKDFCEALLQKDP 432 (543)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-------------HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred ChHHhcCcchHHHHHHHhCCCCCCCCccchhH-------------HHHHHHHh-hcccCCCcccCHHHHHHHHHhccCCH
Confidence 99999999999999999999999875421110 11111111 11234566788999999999999999
Q ss_pred CCCCCH-----HHHHH
Q 021947 236 KLRPRM-----SEVLA 246 (305)
Q Consensus 236 ~~Rps~-----~~~l~ 246 (305)
.+||++ .++++
T Consensus 433 ~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 433 EKRLGFRDGSCDGLRT 448 (543)
T ss_dssp GGSCCCBTTBSHHHHT
T ss_pred hHCCCCcccCHHHHHc
Confidence 999965 66664
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=302.57 Aligned_cols=224 Identities=27% Similarity=0.353 Sum_probs=179.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++..... ...+|++++.++ +||||+++++++.+++..|+||||++||+|.+++.+.+ .+++..+..++
T Consensus 49 ~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~ 122 (342)
T 2qr7_A 49 EFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVL 122 (342)
T ss_dssp EEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHH
T ss_pred EEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence 689999976532 235788999888 79999999999999999999999999999999997654 49999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCC----CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
.|++.||.|||++ ||+||||||+|||+..+ +.+||+|||++........ .....+||+.|+|||++.+..++
T Consensus 123 ~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 198 (342)
T 2qr7_A 123 FTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYD 198 (342)
T ss_dssp HHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCC
Confidence 9999999999975 59999999999998543 3599999999986543322 13345789999999999888899
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
.++|||||||++|+|++|..||.+........+. ..+.... .....+..++.++.+||.+||..|
T Consensus 199 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 265 (342)
T 2qr7_A 199 AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-------------ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD 265 (342)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-------------HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSS
T ss_pred CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-------------HHHccCCcccCccccccCCHHHHHHHHHHCCCC
Confidence 9999999999999999999999864322111111 1111111 112234568889999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021947 235 PKLRPRMSEVLAIL 248 (305)
Q Consensus 235 p~~Rps~~~~l~~l 248 (305)
|.+|||+.+++++-
T Consensus 266 P~~R~t~~~il~hp 279 (342)
T 2qr7_A 266 PHQRLTAALVLRHP 279 (342)
T ss_dssp TTTSCCHHHHTTSH
T ss_pred hhHCcCHHHHhcCC
Confidence 99999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=300.38 Aligned_cols=215 Identities=22% Similarity=0.257 Sum_probs=180.1
Q ss_pred EEEEEecccCCcc--------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCC-CHHHHhhhcCCCCCC
Q 021947 2 VVAVKKLKPEGFQ--------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG-SLENHLFRRGPQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~ 72 (305)
.||||+++..... ....+.+|++++++++||||+++++++.+.+..++||||+.+| +|.+++.... .++
T Consensus 51 ~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~ 128 (335)
T 3dls_A 51 EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLD 128 (335)
T ss_dssp EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCC
T ss_pred EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCC
Confidence 6999998765321 3346788999999999999999999999999999999998766 9999996554 499
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+
T Consensus 129 ~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 129 EPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcC
Confidence 999999999999999999965 599999999999999999999999999987644322 234578999999999988
Q ss_pred CCC-CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..+ +.++||||||+++|+|++|..||...... .. .....+..++.++.+||.+||
T Consensus 204 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------~~--~~~~~~~~~~~~l~~li~~~L 259 (335)
T 3dls_A 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------VE--AAIHPPYLVSKELMSLVSGLL 259 (335)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------TT--TCCCCSSCCCHHHHHHHHHHT
T ss_pred CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------Hh--hccCCCcccCHHHHHHHHHHc
Confidence 877 78999999999999999999999753210 00 111223446788999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAI 247 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~ 247 (305)
..||.+|||+.+++++
T Consensus 260 ~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 260 QPVPERRTTLEKLVTD 275 (335)
T ss_dssp CSSGGGSCCHHHHHHC
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=299.40 Aligned_cols=228 Identities=20% Similarity=0.264 Sum_probs=182.7
Q ss_pred CEEEEEecccCC--ccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG--FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||+++... ......+.+|+.+++.+. ||||+++++++...+..++||||+.|++|.+++.......+++..++
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 134 (327)
T 3lm5_A 55 QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134 (327)
T ss_dssp CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHH
T ss_pred CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHH
Confidence 369999987543 234578899999999995 69999999999999999999999999999999976555669999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 154 (305)
.++.|++.||+|||+. |++||||||+||+++. ++.+||+|||++........ .....||+.|+|||++.+..
T Consensus 135 ~i~~ql~~~L~~LH~~--givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 209 (327)
T 3lm5_A 135 RLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDP 209 (327)
T ss_dssp HHHHHHHHHHHHHHHT--TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHC--CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCC
Confidence 9999999999999975 5999999999999987 78999999999987543321 23457899999999999999
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++.++||||||+++|+|++|..||.+........ ................++..+.+||.+||..|
T Consensus 210 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 275 (327)
T 3lm5_A 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--------------NISQVNVDYSEETFSSVSQLATDFIQSLLVKN 275 (327)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------------HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--------------HHHhcccccCchhhcccCHHHHHHHHHHcCCC
Confidence 9999999999999999999999997754211100 00011111222333467888999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+++++++
T Consensus 276 P~~Rpt~~~ll~h 288 (327)
T 3lm5_A 276 PEKRPTAEICLSH 288 (327)
T ss_dssp GGGSCCHHHHTTC
T ss_pred hhhCcCHHHHhCC
Confidence 9999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=294.53 Aligned_cols=224 Identities=26% Similarity=0.366 Sum_probs=186.3
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||++..... ...+.+.+|+.++++++||||+++++++......|+||||++|++|.+++... .+++..+..+
T Consensus 48 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 124 (303)
T 3a7i_A 48 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATI 124 (303)
T ss_dssp CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHH
T ss_pred cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHH
Confidence 3699999876543 34578999999999999999999999999999999999999999999998543 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++
T Consensus 125 ~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 200 (303)
T 3a7i_A 125 LREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKA 200 (303)
T ss_dssp HHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred HHHHHHHHHHHHHC--CCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchh
Confidence 99999999999975 599999999999999999999999999976543221 12345689999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||+++|+|++|..||....... ....+........+..++..+.+||.+||..||.+||
T Consensus 201 Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 201 DIWSLGITAIELARGEPPHSELHPMK-----------------VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHH-----------------HHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSC
T ss_pred hhHHHHHHHHHHccCCCCCCCcCHHH-----------------HHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCc
Confidence 99999999999999999997643211 1111112222334556778899999999999999999
Q ss_pred CHHHHHHHH
Q 021947 240 RMSEVLAIL 248 (305)
Q Consensus 240 s~~~~l~~l 248 (305)
|+.+++++.
T Consensus 264 s~~~ll~~~ 272 (303)
T 3a7i_A 264 TAKELLKHK 272 (303)
T ss_dssp CHHHHTTCH
T ss_pred CHHHHhhCh
Confidence 999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=292.30 Aligned_cols=220 Identities=24% Similarity=0.371 Sum_probs=183.9
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++.... ......+.+|++++++++||||+++++++.+++..|+||||+++++|.+++...+ .+++..+..
T Consensus 41 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 118 (284)
T 2vgo_A 41 IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSAT 118 (284)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 58999986432 2334678999999999999999999999999999999999999999999997654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.+
T Consensus 119 ~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ 192 (284)
T 2vgo_A 119 FMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEK 192 (284)
T ss_dssp HHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTT
T ss_pred HHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcc
Confidence 99999999999996 459999999999999999999999999987654322 234568999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||........ ...+.. .....+..++..+.+||.+||..||.+|
T Consensus 193 ~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R 254 (284)
T 2vgo_A 193 VDLWCAGVLCYEFLVGMPPFDSPSHTET----------------HRRIVN--VDLKFPPFLSDGSKDLISKLLRYHPPQR 254 (284)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHT--TCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred cchhhHHHHHHHHHHCCCCCCCCCHhHH----------------HHHHhc--cccCCCCcCCHHHHHHHHHHhhcCHhhC
Confidence 9999999999999999999976432110 111111 1223456678899999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+.+++++
T Consensus 255 ps~~~ll~h 263 (284)
T 2vgo_A 255 LPLKGVMEH 263 (284)
T ss_dssp CCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=303.17 Aligned_cols=240 Identities=16% Similarity=0.129 Sum_probs=180.6
Q ss_pred EEEEEecccCCccC-----------hHHHHHHHHHHhccCCCCcccEEEEEEeC----CeeEEEEecCCCCCHHHHhhhc
Q 021947 2 VVAVKKLKPEGFQG-----------HKEWLTEVNYLGQLHHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRR 66 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~ 66 (305)
.||||++....... ...+..|+..+..++|+||+++++++... ...|+||||+ |++|.+++...
T Consensus 67 ~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~ 145 (364)
T 3op5_A 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN 145 (364)
T ss_dssp SEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT
T ss_pred ceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc
Confidence 58999987653211 12244566677788899999999998764 4579999999 99999999764
Q ss_pred CCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC--CCCceeeccccccccCCCCCCc-----ceeeccc
Q 021947 67 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRT-----HVSTQVM 139 (305)
Q Consensus 67 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~ 139 (305)
. ..+++..++.++.|++.||.|||+. ||+||||||+|||++ .++.+||+|||+++........ .......
T Consensus 146 ~-~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 222 (364)
T 3op5_A 146 A-KRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD 222 (364)
T ss_dssp T-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence 3 4599999999999999999999975 599999999999998 8899999999999765332111 1123345
Q ss_pred ccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHH
Q 021947 140 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 219 (305)
Q Consensus 140 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (305)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........ ...... ....+...+.... ....+
T Consensus 223 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~---~~~~~ 295 (364)
T 3op5_A 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV--RDSKIR--YRENIASLMDKCF---PAANA 295 (364)
T ss_dssp CCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH--HHHHHH--HHHCHHHHHHHHS---CTTCC
T ss_pred CCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH--HHHHHH--hhhhHHHHHHHhc---ccccC
Confidence 9999999999999999999999999999999999999998643321111 000000 0011111111111 11345
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+.++.+|+..||..||.+||++.++++.|+.+.
T Consensus 296 ~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 296 PGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 788999999999999999999999999988764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=294.28 Aligned_cols=234 Identities=23% Similarity=0.356 Sum_probs=178.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc--CCCCcccEEEEEEeC----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL--HHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||++... ....+.+|.+++..+ +||||+++++++... ...|+||||+++++|.+++... .+++..
T Consensus 62 ~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~ 135 (337)
T 3mdy_A 62 KVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKS 135 (337)
T ss_dssp EEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHH
T ss_pred eEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHH
Confidence 6999998643 345566677777665 899999999999887 7889999999999999999654 399999
Q ss_pred HHHHHHHHHHHHhhhhcC------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc--eeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aP 147 (305)
++.++.|++.||.|||+. ..|++||||||+|||++.++.+||+|||++.......... ......||+.|+||
T Consensus 136 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 215 (337)
T 3mdy_A 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215 (337)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeCh
Confidence 999999999999999965 2269999999999999999999999999997654332211 12245789999999
Q ss_pred hhhhcCCCCCC------CceehhhHHHHHHHhC----------CCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcc
Q 021947 148 EYVATGRLTTK------SDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTK 210 (305)
Q Consensus 148 E~~~~~~~~~~------~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 210 (305)
|++.+...+.. +|||||||++|+|++| ..||........ ......... ...
T Consensus 216 E~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~ 283 (337)
T 3mdy_A 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP------------SYEDMREIVCIKK 283 (337)
T ss_dssp HHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSC
T ss_pred hhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC------------chhhhHHHHhhhc
Confidence 99988776665 9999999999999999 455543221100 000111111 111
Q ss_pred cCCCCC-----hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 211 LGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 211 ~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.....+ ..++..+.+|+.+||..||.+|||+.++++.|+++..
T Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 222222 3788899999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=313.98 Aligned_cols=223 Identities=27% Similarity=0.356 Sum_probs=183.7
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||||++.... ......+.+|++++++++||||+++++++.+.+..|+||||+.|++|.+++.... .+++..+.
T Consensus 52 ~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 129 (484)
T 3nyv_A 52 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAA 129 (484)
T ss_dssp CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHH
T ss_pred CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHH
Confidence 369999986543 2345789999999999999999999999999999999999999999999996554 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEe---CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 154 (305)
.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .
T Consensus 130 ~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~ 203 (484)
T 3nyv_A 130 RIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-T 203 (484)
T ss_dssp HHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-C
T ss_pred HHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-C
Confidence 9999999999999975 59999999999999 5678899999999987544322 234579999999999876 6
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC--CCChHHHHHHHHHHHhhcc
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~ 232 (305)
++.++|||||||++|+|++|..||.+.+... .+..+....... +....++..+.+||.+||.
T Consensus 204 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 267 (484)
T 3nyv_A 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYD----------------ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLT 267 (484)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTC
T ss_pred CCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCC
Confidence 8999999999999999999999998754211 111111222211 2224678899999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.||.+|||+.+++++
T Consensus 268 ~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 268 YVPSMRISARDALDH 282 (484)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhHCcCHHHHhhC
Confidence 999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=299.73 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=174.1
Q ss_pred CEEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||++....... ...+.+|++++++++||||+++++++...+..++||||+.| +|.+++...+ ..+++..+..+
T Consensus 28 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~ 105 (324)
T 3mtl_A 28 NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLF 105 (324)
T ss_dssp CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHH
T ss_pred cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcC-CCCCHHHHHHH
Confidence 369999987653322 23556899999999999999999999999999999999975 9999987654 35899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 158 (305)
+.|++.||.|||+. ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+ ..++.+
T Consensus 106 ~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~ 181 (324)
T 3mtl_A 106 LFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQ 181 (324)
T ss_dssp HHHHHHHHHHHHHT--TEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHHHHHC--CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcH
Confidence 99999999999965 599999999999999999999999999986543221 1334568999999999876 568999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhh-hh-hhhhhc------cchhhhhhhhcccCC----CCChHHHHHHHHH
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLS------DKRKLFRIMDTKLGG----QYPQKAAHTAATL 226 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 226 (305)
+|||||||++|+|++|+.||.+.......... .. ..+... ............... .....++.++.+|
T Consensus 182 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (324)
T 3mtl_A 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADL 261 (324)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHH
Confidence 99999999999999999999876533211110 00 000000 000000000000000 0112466789999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||+.||.+|||+++++++
T Consensus 262 i~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 262 LTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCcCcccCCCHHHHhcC
Confidence 999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=306.62 Aligned_cols=241 Identities=24% Similarity=0.308 Sum_probs=175.6
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccC-CCCcccEEEEEEeCC--eeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
..||||++..... .....+.+|+.+++++. ||||+++++++...+ .+|+||||+++ +|.+++... .++...
T Consensus 35 ~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~ 110 (388)
T 3oz6_A 35 EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN---ILEPVH 110 (388)
T ss_dssp CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHHT---CCCHHH
T ss_pred CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHcC---CCCHHH
Confidence 3699999865422 33467889999999997 999999999997544 68999999974 999998654 489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCC-------------------Ccceee
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-------------------RTHVST 136 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------~~~~~~ 136 (305)
+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ......
T Consensus 111 ~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (388)
T 3oz6_A 111 KQYVVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188 (388)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred HHHHHHHHHHHHHHHHhC--CEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccccc
Confidence 999999999999999975 59999999999999999999999999997643211 011123
Q ss_pred cccccccccchhhhhc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-h-hhhhhhccc--------hhhhh
Q 021947 137 QVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D-WAKPYLSDK--------RKLFR 205 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~-~~~~~~~~~--------~~~~~ 205 (305)
..+||++|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........ . ...|..... .....
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 268 (388)
T 3oz6_A 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIE 268 (388)
T ss_dssp -CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 4579999999999977 57899999999999999999999999876532211100 0 000000000 00000
Q ss_pred hhhc-------ccCC------------CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 206 IMDT-------KLGG------------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 206 ~~~~-------~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+.. .... .....++.++.+||.+||..||.+|||+++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 0000 0000 0111456789999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=294.62 Aligned_cols=241 Identities=24% Similarity=0.264 Sum_probs=176.7
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||||++....... .+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .+++..+..
T Consensus 29 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~ 106 (311)
T 4agu_A 29 QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKS 106 (311)
T ss_dssp CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHH
T ss_pred cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHH
Confidence 369999887653322 3568899999999999999999999999999999999999999988876543 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 157 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ......||..|+|||++.+ ..++.
T Consensus 107 i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (311)
T 4agu_A 107 ITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGP 182 (311)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCT
T ss_pred HHHHHHHHHHHHHHC--CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCc
Confidence 999999999999965 599999999999999999999999999987543222 1234578999999999976 56899
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhh-hhhhhccchhhhhh--hhcccCCCC----------ChHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW-AKPYLSDKRKLFRI--MDTKLGGQY----------PQKAAHTAA 224 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~----------~~~~~~~~~ 224 (305)
++||||||+++|+|++|..||.+............ .............. ......... ...++..+.
T Consensus 183 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (311)
T 4agu_A 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHH
T ss_pred chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHH
Confidence 99999999999999999999987654321111000 00000000000000 000000000 124677899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+||.+||..||.+|||+++++++
T Consensus 263 ~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 263 GLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhcCCHHHHhcC
Confidence 99999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=292.28 Aligned_cols=224 Identities=28% Similarity=0.372 Sum_probs=163.4
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++.... ..+++..+.
T Consensus 37 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 115 (278)
T 3cok_A 37 LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEAR 115 (278)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHH
T ss_pred ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHH
Confidence 368999986542 1234678999999999999999999999999999999999999999999996543 458999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.
T Consensus 116 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 191 (278)
T 3cok_A 116 HFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGL 191 (278)
T ss_dssp HHHHHHHHHHHHHHHT--TEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------
T ss_pred HHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCc
Confidence 9999999999999965 5999999999999999999999999999865432211 22356899999999999888999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|++|..||........ +..... .....+..++.++.+||.+||..||.+
T Consensus 192 ~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~ 253 (278)
T 3cok_A 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVVL--ADYEMPSFLSIEAKDLIHQLLRRNPAD 253 (278)
T ss_dssp CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCS--SCCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred hhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHhh--cccCCccccCHHHHHHHHHHcccCHhh
Confidence 99999999999999999999976542110 001111 112345567889999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+.+++++
T Consensus 254 Rps~~~~l~h 263 (278)
T 3cok_A 254 RLSLSSVLDH 263 (278)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=305.42 Aligned_cols=240 Identities=23% Similarity=0.345 Sum_probs=184.5
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||+|++..+.. .....+.+|++++++++||||+++++++..++..|+||||++|++|.+++...+ .+++..+..+
T Consensus 59 ~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 136 (360)
T 3eqc_A 59 LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKV 136 (360)
T ss_dssp CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHH
T ss_pred cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence 3689999886633 234678999999999999999999999999999999999999999999997654 3899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
+.+++.||.|||+. +|++||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+..++.++
T Consensus 137 ~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (360)
T 3eqc_A 137 SIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQS 211 (360)
T ss_dssp HHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHH
T ss_pred HHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchh
Confidence 99999999999973 25999999999999999999999999998643221 12344689999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhh--------------------------hhhhhccchhhhhhhhcccCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--------------------------AKPYLSDKRKLFRIMDTKLGG 213 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~ 213 (305)
|||||||++|+|++|..||.............. ..+.......+..........
T Consensus 212 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (360)
T 3eqc_A 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK 291 (360)
T ss_dssp HHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC
Confidence 999999999999999999987543221110000 000000001111111122222
Q ss_pred CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 214 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....++.++.+||.+||..||.+|||+.+++++
T Consensus 292 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 292 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2233567889999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=304.12 Aligned_cols=233 Identities=23% Similarity=0.309 Sum_probs=168.5
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEE--------eCCeeEEEEecCCCCCHHHHhhh-cCCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCL--------EGENRLLVYEFMPKGSLENHLFR-RGPQP 70 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~-~~~~~ 70 (305)
+.||||++..........+.+|+.+++++. ||||+++++++. .....++||||+. |+|.+++.. .....
T Consensus 54 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~ 132 (337)
T 3ll6_A 54 REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGP 132 (337)
T ss_dssp CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCS
T ss_pred cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCC
Confidence 369999987665555678899999999996 999999999985 3344789999996 599998854 22345
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc----------eeecccc
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH----------VSTQVMG 140 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~ 140 (305)
+++..++.++.|++.||.|||+.+.+++||||||+|||++.++.+||+|||++.......... ......|
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (337)
T 3ll6_A 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccC
Confidence 999999999999999999999654449999999999999999999999999998754432211 1113458
Q ss_pred cccccchhhh---hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 141 THGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 141 t~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
|+.|+|||++ .+..++.++||||||+++|+|++|..||.+.... .............
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------------------~~~~~~~~~~~~~ 272 (337)
T 3ll6_A 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--------------------RIVNGKYSIPPHD 272 (337)
T ss_dssp -----------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------------------------CCCCTTC
T ss_pred CCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--------------------HhhcCcccCCccc
Confidence 9999999998 5667888999999999999999999999754321 1111222222334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
..+..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 273 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 273 TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4556688999999999999999999999999988643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.00 Aligned_cols=238 Identities=24% Similarity=0.277 Sum_probs=180.0
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-----CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-----HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||+++.. ......+..|+++++++. ||||+++++++...+..++||||+ +++|.+++.......++...
T Consensus 61 ~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~ 138 (360)
T 3llt_A 61 KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIED 138 (360)
T ss_dssp CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHH
T ss_pred eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHH
Confidence 36999998743 233456788999999986 999999999999999999999999 88999999877666799999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-------------------------CCceeeccccccccCCCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------------EFNAKLSDFGLAKAGPTGD 130 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-------------------------~~~~kl~Dfg~~~~~~~~~ 130 (305)
+..++.|++.||+|||+. ||+||||||+|||++. ++.+||+|||++......
T Consensus 139 ~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~- 215 (360)
T 3llt_A 139 IKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY- 215 (360)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-
T ss_pred HHHHHHHHHHHHHHHHHC--CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-
Confidence 999999999999999965 5999999999999975 788999999999864432
Q ss_pred CcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhccc------hhh
Q 021947 131 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDK------RKL 203 (305)
Q Consensus 131 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~------~~~ 203 (305)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......... ....+..... ...
T Consensus 216 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 291 (360)
T 3llt_A 216 ----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNG 291 (360)
T ss_dssp ----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGG
T ss_pred ----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccC
Confidence 23457899999999999999999999999999999999999999875432211100 0000000000 000
Q ss_pred hhhhhc-ccC--------------------CCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 204 FRIMDT-KLG--------------------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 204 ~~~~~~-~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
...... ... .......+..+.+||.+||+.||.+|||+.+++++
T Consensus 292 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 292 SKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp GGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 000 00001122678899999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=297.58 Aligned_cols=223 Identities=25% Similarity=0.356 Sum_probs=184.9
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
..||+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..|+||||+++++|.+++.... .+++..++
T Consensus 67 ~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~ 144 (335)
T 2owb_A 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEAR 144 (335)
T ss_dssp CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHH
T ss_pred CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHH
Confidence 3689999875532 234678899999999999999999999999999999999999999999987654 48999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......... .....||..|+|||++.+..++.
T Consensus 145 ~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 220 (335)
T 2owb_A 145 YYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSF 220 (335)
T ss_dssp HHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCT
T ss_pred HHHHHHHHHHHHHHHC--CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCc
Confidence 9999999999999975 5999999999999999999999999999875432221 33456899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|+|++|..||........ ...+.. .....+..++..+.+||.+||..||.+
T Consensus 221 ~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 221 EVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRIKK--NEYSIPKHINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHH--TCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHHhc--CCCCCCccCCHHHHHHHHHHccCChhH
Confidence 99999999999999999999976432110 111111 112345567788999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+.+++++
T Consensus 283 Rps~~ell~~ 292 (335)
T 2owb_A 283 RPTINELLND 292 (335)
T ss_dssp SCCGGGGGGS
T ss_pred CcCHHHHhcC
Confidence 9999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=312.60 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=171.2
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
+.||||++..... ...+++.+|+++|++++||||+++++++... ..+|+||||+. ++|.+++.... .+++
T Consensus 79 ~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~ 155 (458)
T 3rp9_A 79 RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV--YLTE 155 (458)
T ss_dssp CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSC--CCCH
T ss_pred cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCC--CCCH
Confidence 3699999876432 2346789999999999999999999998533 56899999985 69999986543 4999
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc---------------------
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--------------------- 132 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--------------------- 132 (305)
..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus 156 ~~~~~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (458)
T 3rp9_A 156 LHIKTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233 (458)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC----------------
T ss_pred HHHHHHHHHHHHHHHHHHhC--CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccccc
Confidence 99999999999999999975 5999999999999999999999999999875422111
Q ss_pred ----ceeecccccccccchhhh-hcCCCCCCCceehhhHHHHHHHh-----------CCCccCCCcccch----------
Q 021947 133 ----HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLS-----------GRCAVDKTKVGIE---------- 186 (305)
Q Consensus 133 ----~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~-----------g~~pf~~~~~~~~---------- 186 (305)
......+||++|+|||++ .+..++.++|||||||++|+|++ |+++|.+......
T Consensus 234 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~ 313 (458)
T 3rp9_A 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDF 313 (458)
T ss_dssp -----------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-----------------
T ss_pred ccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccc
Confidence 112345789999999976 55679999999999999999999 6666655431100
Q ss_pred --------hh---hhh-hhhhhhcc-----c---hhhhhhhhcccCC---CCChHHHHHHHHHHHhhccCCCCCCCCHHH
Q 021947 187 --------QS---LVD-WAKPYLSD-----K---RKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSE 243 (305)
Q Consensus 187 --------~~---~~~-~~~~~~~~-----~---~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 243 (305)
.. +.. ...+.... . ......+...... .....++.++.+||.+||..||.+|||+++
T Consensus 314 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e 393 (458)
T 3rp9_A 314 KFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE 393 (458)
T ss_dssp ---CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 00 000 00000000 0 0000000000000 011345788999999999999999999999
Q ss_pred HHHH
Q 021947 244 VLAI 247 (305)
Q Consensus 244 ~l~~ 247 (305)
++++
T Consensus 394 ~L~H 397 (458)
T 3rp9_A 394 CLAH 397 (458)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=311.97 Aligned_cols=236 Identities=22% Similarity=0.279 Sum_probs=172.3
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++.... ....+++.+|+++|+.++||||+++++++... ...|+||||+++ +|.+.+.. .+++
T Consensus 89 ~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~ 163 (464)
T 3ttj_A 89 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDH 163 (464)
T ss_dssp EEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCH
T ss_pred EEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCH
Confidence 69999997542 23346788999999999999999999999654 356999999976 67777642 2899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+.
T Consensus 164 ~~~~~~~~qil~aL~~lH~~--~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 238 (464)
T 3ttj_A 164 ERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 238 (464)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHC--CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCC
Confidence 99999999999999999975 59999999999999999999999999998654322 23446789999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhh---hcc-chhhhhhhhccc---CCC----------
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY---LSD-KRKLFRIMDTKL---GGQ---------- 214 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~---~~~-~~~~~~~~~~~~---~~~---------- 214 (305)
.++.++|||||||++|+|++|+.||.+.+...... +.. ...+. ... .......+.... ...
T Consensus 239 ~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (464)
T 3ttj_A 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 318 (464)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGS
T ss_pred CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccc
Confidence 99999999999999999999999998765321110 000 00000 000 000001111000 000
Q ss_pred -----CChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 215 -----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 215 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....+.++.+||.+||..||.+|||+++++++
T Consensus 319 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 319 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011236789999999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=295.26 Aligned_cols=220 Identities=25% Similarity=0.266 Sum_probs=172.4
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++...... ....+..|+..+.++ +|+||+++++++.+++..|+||||+ +++|.+++...+ ..+++..++
T Consensus 83 ~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~ 160 (311)
T 3p1a_A 83 RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVW 160 (311)
T ss_dssp CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHH
T ss_pred eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHH
Confidence 46999998765332 234556677666666 8999999999999999999999999 669999987654 359999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+ .++.
T Consensus 161 ~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~ 234 (311)
T 3p1a_A 161 GYLRDTLLALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGT 234 (311)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCST
T ss_pred HHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCc
Confidence 9999999999999975 599999999999999999999999999886543322 334468999999999876 7899
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..+|.+... .............+..++.++.+||.+||..||.+
T Consensus 235 ~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 295 (311)
T 3p1a_A 235 AADVFSLGLTILEVACNMELPHGGEG-------------------WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295 (311)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhh
Confidence 99999999999999999776654211 00001111111122356788999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+.+++++
T Consensus 296 Rpt~~ell~h 305 (311)
T 3p1a_A 296 RATAEALLAL 305 (311)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHHhC
Confidence 9999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=290.54 Aligned_cols=224 Identities=25% Similarity=0.345 Sum_probs=179.4
Q ss_pred CEEEEEecccCCcc------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
..||+|+++..... ..+.+.+|++++++++||||+++++++.+....++||||+++++|.+++.... .+++.
T Consensus 31 ~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~ 108 (283)
T 3bhy_A 31 KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTED 108 (283)
T ss_dssp CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHH
T ss_pred CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHH
Confidence 36899988754322 35789999999999999999999999999999999999999999999997654 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----ceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.+..++.|++.||.|||+. |++||||||+||+++.++ .+||+|||++........ .....+++.|+|||++
T Consensus 109 ~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 183 (283)
T 3bhy_A 109 EATQFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIV 183 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCccee
Confidence 9999999999999999965 599999999999998877 799999999986543221 2344689999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~ 228 (305)
.+..++.++||||||+++|+|++|..||.+....... ..+..... .......++..+.+|+.
T Consensus 184 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (283)
T 3bhy_A 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL----------------TNISAVNYDFDEEYFSNTSELAKDFIR 247 (283)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHHTTCCCCCHHHHTTCCHHHHHHHH
T ss_pred cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH----------------HHhHhcccCCcchhcccCCHHHHHHHH
Confidence 9999999999999999999999999999875421110 00000000 00111345678999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 248 ~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 248 RLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TTSCSSGGGSCCHHHHHHC
T ss_pred HHccCCHhHCcCHHHHHhC
Confidence 9999999999999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.27 Aligned_cols=224 Identities=27% Similarity=0.342 Sum_probs=181.4
Q ss_pred CEEEEEecccC--CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPE--GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||++... .......+.+|++++++++||||+++++++.+....|+|||||.|++|.+++.... .+++..+..
T Consensus 48 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 125 (486)
T 3mwu_A 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAAR 125 (486)
T ss_dssp CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHH
T ss_pred CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 36999998643 22456789999999999999999999999999999999999999999999987654 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeC---CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.|++.||.|||+. ||+||||||+|||++ .++.+||+|||++....... .....+||+.|+|||++.+ .+
T Consensus 126 i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~ 199 (486)
T 3mwu_A 126 IIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TY 199 (486)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CC
T ss_pred HHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CC
Confidence 999999999999975 599999999999995 45679999999998654332 1334579999999999876 58
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhhccC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~ 233 (305)
+.++|||||||++|+|++|..||.+..... .+..+...... .+....++..+.+||.+||..
T Consensus 200 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 263 (486)
T 3mwu_A 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYD----------------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263 (486)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCS
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCC
Confidence 999999999999999999999998754211 11111111111 122346788999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021947 234 EPKLRPRMSEVLAIL 248 (305)
Q Consensus 234 ~p~~Rps~~~~l~~l 248 (305)
||.+|||+.+++++.
T Consensus 264 dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 264 HPSLRITATQCLEHP 278 (486)
T ss_dssp STTTSCCHHHHHHCH
T ss_pred ChhhCcCHHHHhcCH
Confidence 999999999999853
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=291.32 Aligned_cols=227 Identities=22% Similarity=0.270 Sum_probs=181.1
Q ss_pred CEEEEEecccCC----ccChHHHHHHHHHHhccCCCCcccEEEEEE--eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEG----FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||||+++... ......+.+|++++++++||||+++++++. +....|+||||+.++ |.+++.......+++.
T Consensus 31 ~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~ 109 (305)
T 2wtk_C 31 CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVC 109 (305)
T ss_dssp CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHH
T ss_pred cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHH
Confidence 368999987542 234567899999999999999999999984 445789999999875 8888876655679999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR 154 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 154 (305)
.+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++................|+..|+|||++.+..
T Consensus 110 ~~~~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (305)
T 2wtk_C 110 QAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCS
T ss_pred HHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcc
Confidence 9999999999999999975 59999999999999999999999999998765433333344556899999999997654
Q ss_pred --CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 155 --LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 155 --~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
++.++||||||+++|+|++|..||.+..... ....+.. .....+..++..+.+||.+||.
T Consensus 188 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~~~i~~-~~~~~~~~~~~~l~~li~~~l~ 249 (305)
T 2wtk_C 188 TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-----------------LFENIGK-GSYAIPGDCGPPLSDLLKGMLE 249 (305)
T ss_dssp CEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----------------HHHHHHH-CCCCCCSSSCHHHHHHHHHHTC
T ss_pred cCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----------------HHHHHhc-CCCCCCCccCHHHHHHHHHHcc
Confidence 3679999999999999999999998643211 1111111 1223455678899999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAIL 248 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l 248 (305)
.||.+|||+.+++++.
T Consensus 250 ~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 250 YEPAKRFSIRQIRQHS 265 (305)
T ss_dssp SSTTTSCCHHHHHHSH
T ss_pred CChhhCCCHHHHhcCc
Confidence 9999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=299.36 Aligned_cols=239 Identities=21% Similarity=0.230 Sum_probs=171.0
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++...... ...+.+|++++++++||||+++++++.+++..++||||+.| +|.+++.... .+++..+..+
T Consensus 61 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i 137 (329)
T 3gbz_A 61 TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSF 137 (329)
T ss_dssp EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCT--TCCHHHHHHH
T ss_pred eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcC--CCCHHHHHHH
Confidence 69999997654332 35678999999999999999999999999999999999975 9999997664 3899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeC-----CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLD-----AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG- 153 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 153 (305)
+.|++.||.|||+. ||+||||||+|||++ .++.+||+|||++........ ......+|..|+|||++.+.
T Consensus 138 ~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 138 LYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCC
Confidence 99999999999975 599999999999994 445699999999986543221 13344679999999999875
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhhhccchhh------hhhhhcccC----CCCChHHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKL------FRIMDTKLG----GQYPQKAAH 221 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~ 221 (305)
.++.++|||||||++|+|++|..||.+........ ... ...+........ ......... ...+..++.
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
T 3gbz_A 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDD 293 (329)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCH
Confidence 48999999999999999999999998754321110 000 000000000000 000000000 001123567
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 222 TAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 222 ~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++.+||.+||..||.+|||+.+++++
T Consensus 294 ~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 294 EGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhCC
Confidence 89999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=292.67 Aligned_cols=224 Identities=26% Similarity=0.375 Sum_probs=184.6
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||++... .....+.+|++++++++||||+++++++...+..|+||||+.+++|.+++.... ..+++..+..++
T Consensus 55 ~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~ 131 (314)
T 3com_A 55 QIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATIL 131 (314)
T ss_dssp CEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHH
T ss_pred CEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence 36899998765 345788999999999999999999999999999999999999999999996433 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.+++.||.|||+. |++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|
T Consensus 132 ~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 207 (314)
T 3com_A 132 QSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVAD 207 (314)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHH
T ss_pred HHHHHHHHHHHhC--CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCcccc
Confidence 9999999999965 599999999999999999999999999976543221 123446899999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh-cccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++|..||........ ...... .......+..++..+.+||.+||..||.+||
T Consensus 208 i~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 271 (314)
T 3com_A 208 IWSLGITAIEMAEGKPPYADIHPMRA----------------IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271 (314)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHH----------------HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999976432110 000000 1111223456788999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.+++++
T Consensus 272 t~~~ll~~ 279 (314)
T 3com_A 272 TATQLLQH 279 (314)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 99999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=311.15 Aligned_cols=222 Identities=26% Similarity=0.339 Sum_probs=179.8
Q ss_pred EEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||++.... ......+.+|+.+++.++||||+++++++.+.+..|+|||||.|++|.+++.... .+++..+..+
T Consensus 64 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i 141 (494)
T 3lij_A 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVI 141 (494)
T ss_dssp EEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred EEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 68999987653 2345788999999999999999999999999999999999999999999987664 3899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
+.|++.||.|||+. ||+||||||+|||++.. +.+||+|||++....... .....+||+.|+|||++. ..++
T Consensus 142 ~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~ 215 (494)
T 3lij_A 142 IKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYD 215 (494)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBC
T ss_pred HHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCC
Confidence 99999999999975 59999999999999764 459999999998654322 133457999999999986 5689
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC--CCChHHHHHHHHHHHhhccCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~ 234 (305)
.++|||||||++|+|++|..||.+..... .+..+....... .....++..+.+||.+||..|
T Consensus 216 ~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 279 (494)
T 3lij_A 216 EKCDVWSIGVILFILLAGYPPFGGQTDQE----------------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD 279 (494)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSS
T ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCC
Confidence 99999999999999999999998754211 111111111111 112357788999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 280 p~~R~s~~e~l~h 292 (494)
T 3lij_A 280 SQRRISAQQALEH 292 (494)
T ss_dssp TTTSCCHHHHHTC
T ss_pred hhhCccHHHHhcC
Confidence 9999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=303.41 Aligned_cols=229 Identities=28% Similarity=0.336 Sum_probs=183.0
Q ss_pred CEEEEEecccCC----ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEG----FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||+++... ......+.+|+++++++ +||||+++++++...+..|+||||+++++|.+++.... .+++..
T Consensus 83 ~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 160 (355)
T 1vzo_A 83 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHE 160 (355)
T ss_dssp CEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHH
T ss_pred eEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHH
Confidence 369999987542 23446678899999999 69999999999999999999999999999999997654 489999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC--
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-- 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-- 153 (305)
+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ......+||+.|+|||++.+.
T Consensus 161 ~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 237 (355)
T 1vzo_A 161 VQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDS 237 (355)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCC
Confidence 999999999999999975 599999999999999999999999999986543221 123345799999999999863
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|||||||++|+|++|..||.......... .+..... ......+..++..+.+||.+||..
T Consensus 238 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~ 303 (355)
T 1vzo_A 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-------------EISRRIL-KSEPPYPQEMSALAKDLIQRLLMK 303 (355)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-------------HHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH-------------HHHHHHh-ccCCCCCcccCHHHHHHHHHHhhh
Confidence 47889999999999999999999997643221110 0111111 122345567888999999999999
Q ss_pred CCCCCC-----CHHHHHHHH
Q 021947 234 EPKLRP-----RMSEVLAIL 248 (305)
Q Consensus 234 ~p~~Rp-----s~~~~l~~l 248 (305)
||.+|| |+.+++++.
T Consensus 304 dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 304 DPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp SGGGSTTSSTTTHHHHHTSG
T ss_pred CHHHhcCCCCCCHHHHHcCc
Confidence 999999 899998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=290.06 Aligned_cols=226 Identities=26% Similarity=0.333 Sum_probs=175.3
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc--CCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 77 (305)
..||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||+++++|.+++... ....+++..+.
T Consensus 48 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 127 (285)
T 3is5_A 48 LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127 (285)
T ss_dssp CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHH
T ss_pred ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHH
Confidence 3689999876533 34578999999999999999999999999999999999999999999988543 22459999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEe---CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR 154 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 154 (305)
.++.|++.||.|||+. |++||||||+||++ +.++.+||+|||++....... ......||+.|+|||++. ..
T Consensus 128 ~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~ 201 (285)
T 3is5_A 128 ELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RD 201 (285)
T ss_dssp HHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TC
T ss_pred HHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cC
Confidence 9999999999999965 59999999999999 445789999999997654322 133456899999999885 56
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCC
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
++.++||||||+++|+|++|..||.+............. . .........++..+.+||.+||..|
T Consensus 202 ~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~--------------~-~~~~~~~~~~~~~~~~li~~~L~~d 266 (285)
T 3is5_A 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK--------------E-PNYAVECRPLTPQAVDLLKQMLTKD 266 (285)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------C-CCCCC--CCCCHHHHHHHHHHTCSC
T ss_pred CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC--------------C-cccccccCcCCHHHHHHHHHHccCC
Confidence 888999999999999999999999875432111110000 0 0000111235678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 267 P~~Rps~~e~l~h 279 (285)
T 3is5_A 267 PERRPSAAQVLHH 279 (285)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=291.64 Aligned_cols=223 Identities=25% Similarity=0.355 Sum_probs=184.8
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.... .+++..+..
T Consensus 42 ~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 119 (294)
T 2rku_A 42 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARY 119 (294)
T ss_dssp EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHH
T ss_pred eEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 689998875532 234678899999999999999999999999999999999999999999987654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......... .....|++.|+|||++.+..++.+
T Consensus 120 i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 195 (294)
T 2rku_A 120 YLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 195 (294)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTH
T ss_pred HHHHHHHHHHHHHHC--CccccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCch
Confidence 999999999999965 5999999999999999999999999999875432221 234568999999999999889999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+||||||+++|+|++|..||........ ...... .....+..++..+.+|+.+||..||.+|
T Consensus 196 ~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 196 VDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRIKK--NEYSIPKHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhh--ccCCCccccCHHHHHHHHHHcccChhhC
Confidence 9999999999999999999986542110 111111 1223455677889999999999999999
Q ss_pred CCHHHHHHHH
Q 021947 239 PRMSEVLAIL 248 (305)
Q Consensus 239 ps~~~~l~~l 248 (305)
||+.+++++.
T Consensus 258 ps~~~ll~~~ 267 (294)
T 2rku_A 258 PTINELLNDE 267 (294)
T ss_dssp CCGGGGGGSH
T ss_pred cCHHHHhhCh
Confidence 9999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=298.37 Aligned_cols=224 Identities=26% Similarity=0.365 Sum_probs=179.9
Q ss_pred CEEEEEecccCCcc--------ChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 1 MVVAVKKLKPEGFQ--------GHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
..||||++...... ..+.+.+|+.+++++ +||||+++++++...+..|+||||++|++|.+++.... .+
T Consensus 120 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l 197 (365)
T 2y7j_A 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--AL 197 (365)
T ss_dssp CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SC
T ss_pred cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CC
Confidence 36999998765321 135678999999999 79999999999999999999999999999999997654 48
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ .....||+.|+|||++.
T Consensus 198 ~~~~~~~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 198 SEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILK 272 (365)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhcc
Confidence 9999999999999999999975 599999999999999999999999999986543322 23457899999999986
Q ss_pred cC------CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC--ChHHHHHH
Q 021947 152 TG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 223 (305)
Q Consensus 152 ~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 223 (305)
+. .++.++|||||||++|+|++|..||.+...... +..+......... ...++..+
T Consensus 273 ~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~ 336 (365)
T 2y7j_A 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM----------------LRMIMEGQYQFSSPEWDDRSSTV 336 (365)
T ss_dssp HTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCCCHHHHSSSCHHH
T ss_pred ccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhCCCCCCCcccccCCHHH
Confidence 43 578899999999999999999999976432110 0011111111110 12456789
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||.+||..||.+|||+.+++++
T Consensus 337 ~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 337 KDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=294.77 Aligned_cols=230 Identities=24% Similarity=0.324 Sum_probs=182.7
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhcC--CCCCCHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRG--PQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 74 (305)
+.||+|++..... ...+.+.+|++++++++||||+++++++.+ +...|+||||++|++|.+++.... ...+++.
T Consensus 32 ~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 111 (279)
T 2w5a_A 32 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111 (279)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHH
T ss_pred cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHH
Confidence 3689999876533 234678999999999999999999998854 567899999999999999996532 3458999
Q ss_pred HHHHHHHHHHHHHhhhhcCC---CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
.++.++.|++.||.|||+.+ .+++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.
T Consensus 112 ~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 189 (279)
T 2w5a_A 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMN 189 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhc
Confidence 99999999999999999753 2399999999999999999999999999986543221 123346899999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
+..++.++||||||+++|+|++|..||...... .+...+........+..++.++.+||.+||
T Consensus 190 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 252 (279)
T 2w5a_A 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----------------ELAGKIREGKFRRIPYRYSDELNEIITRML 252 (279)
T ss_dssp CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----------------HHHHHHhhcccccCCcccCHHHHHHHHHHc
Confidence 999999999999999999999999999865321 111112222223445677889999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~ 249 (305)
+.||.+|||+.++++++.
T Consensus 253 ~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 253 NLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CSSGGGSCCHHHHHTSTT
T ss_pred CCCcccCCCHHHHHhChh
Confidence 999999999999997653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.42 Aligned_cols=249 Identities=19% Similarity=0.233 Sum_probs=188.4
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCC--eeEEEEecCCCCCHHHHhhhcCC-CCCCHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE--NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~ 76 (305)
+.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..++||||++|++|.+++..... ..+++..+
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 114 (396)
T 4eut_A 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (396)
T ss_dssp CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHH
T ss_pred cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHH
Confidence 3699999986533 34577889999999999999999999998765 67999999999999999965432 33899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEe----CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+.++.|++.||+|||+. ||+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||++.+
T Consensus 115 ~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 115 LIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp HHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhc
Confidence 99999999999999975 59999999999999 7777899999999987543321 234568999999999875
Q ss_pred --------CCCCCCCceehhhHHHHHHHhCCCccCCCcccch--hhhhhhhhhhh-ccchhhhhhh--------hcccCC
Q 021947 153 --------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE--QSLVDWAKPYL-SDKRKLFRIM--------DTKLGG 213 (305)
Q Consensus 153 --------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~ 213 (305)
..++.++|||||||++|+|++|..||........ ........... .......... ......
T Consensus 190 ~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (396)
T 4eut_A 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269 (396)
T ss_dssp HCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTC
T ss_pred cccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCccc
Confidence 4677899999999999999999999975432211 11110000000 0000000000 001122
Q ss_pred CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 214 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
.....++..+.+++.+||..||++|||+.++++.++.+...
T Consensus 270 ~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 34578899999999999999999999999999999886543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=298.88 Aligned_cols=225 Identities=17% Similarity=0.147 Sum_probs=181.9
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc---CCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR---GPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 74 (305)
+.||||+++.. ...++.+|+++++.++ |+||+.+++++...+..|+||||++||+|.+++... ....+++.
T Consensus 96 ~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~ 172 (365)
T 3e7e_A 96 QKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172 (365)
T ss_dssp CCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHH
T ss_pred cEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHH
Confidence 36899999765 4567778888888886 999999999999999999999999999999999642 23459999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-----------CCceeeccccccccCCCCCCcceeeccccccc
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 143 (305)
.++.++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+++..............+||+.
T Consensus 173 ~~~~i~~qi~~~L~~lH~~--~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 250 (365)
T 3e7e_A 173 LVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250 (365)
T ss_dssp HHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTS
T ss_pred HHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCC
Confidence 9999999999999999964 5999999999999988 89999999999976443333333455679999
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
|+|||++.+..++.++|||||||++|+|++|+.||........ .+ .. ..... ..++.+
T Consensus 251 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------------~~----~~-~~~~~--~~~~~~ 308 (365)
T 3e7e_A 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---------------KP----EG-LFRRL--PHLDMW 308 (365)
T ss_dssp CCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---------------EE----CS-CCTTC--SSHHHH
T ss_pred CCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---------------ee----ch-hcccc--CcHHHH
Confidence 9999999999999999999999999999999999965432100 00 00 00011 236678
Q ss_pred HHHHHhhccCCCCCCC-CHHHHHHHHHhhc
Q 021947 224 ATLALQCLNNEPKLRP-RMSEVLAILERLE 252 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~ 252 (305)
.+++.+||+.+|.+|+ ++.++.+.|+.+.
T Consensus 309 ~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 309 NEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp HHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 8999999999999995 7888888777653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=322.39 Aligned_cols=223 Identities=26% Similarity=0.368 Sum_probs=186.1
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
+.||||+++.. .....+.+..|..++..+ +||||+.+++++.+.+.+|+||||++||+|.+++...+ .+++..+
T Consensus 367 ~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~ 444 (674)
T 3pfq_A 367 ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHA 444 (674)
T ss_dssp CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHH
Confidence 36999998753 223456788999999988 69999999999999999999999999999999997664 3999999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
..++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++
T Consensus 445 ~~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~ 520 (674)
T 3pfq_A 445 VFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYG 520 (674)
T ss_dssp HHHHHHHHHHHHHHHHT--SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBS
T ss_pred HHHHHHHHHHHHHHHhC--CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCC
Confidence 99999999999999975 599999999999999999999999999986433222 23456899999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+||||+++|+|++|..||.+.+.. .....++.. ...++..++.++.+||.+||..||.
T Consensus 521 ~~~DvwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~ 582 (674)
T 3pfq_A 521 KSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPG 582 (674)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHSS--CCCCCTTSCHHHHHHHHHHSCSSST
T ss_pred ccceEechHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhC--CCCCCccCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999875421 111222222 2355677899999999999999999
Q ss_pred CCCCH-----HHHHHH
Q 021947 237 LRPRM-----SEVLAI 247 (305)
Q Consensus 237 ~Rps~-----~~~l~~ 247 (305)
+||++ ++|+++
T Consensus 583 ~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 583 KRLGCGPEGERDIKEH 598 (674)
T ss_dssp TCTTCSTTHHHHHHSS
T ss_pred HCCCCCCCcHHHHhcC
Confidence 99987 677653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=296.08 Aligned_cols=226 Identities=25% Similarity=0.347 Sum_probs=176.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEe------CCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
+.||||++.... .....+.+|+.+++++ +||||+++++++.. .+..|+||||+++++|.+++.......+++
T Consensus 50 ~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 128 (326)
T 2x7f_A 50 QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128 (326)
T ss_dssp CEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCH
T ss_pred CeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCH
Confidence 369999987543 3457889999999999 79999999999987 467899999999999999997655456999
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh--
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-- 151 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-- 151 (305)
..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.
T Consensus 129 ~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 204 (326)
T 2x7f_A 129 EWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACD 204 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--
T ss_pred HHHHHHHHHHHHHHHHHHHC--CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccc
Confidence 99999999999999999965 599999999999999999999999999876543211 123446899999999986
Q ss_pred ---cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 152 ---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 152 ---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
+..++.++|||||||++|+|++|..||.+..... .................++..+.+||.
T Consensus 205 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~ 268 (326)
T 2x7f_A 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----------------ALFLIPRNPAPRLKSKKWSKKFQSFIE 268 (326)
T ss_dssp ------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSCCCCCSCSCSCHHHHHHHH
T ss_pred cccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----------------HHHHhhcCccccCCccccCHHHHHHHH
Confidence 4568899999999999999999999997643211 111111111222223456788999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 269 ~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 269 SCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHCCSSGGGSCCHHHHHTS
T ss_pred HHhccChhhCCCHHHHhhC
Confidence 9999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=290.40 Aligned_cols=219 Identities=17% Similarity=0.233 Sum_probs=178.2
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--CCCCCHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 75 (305)
+.||||+++.... ....++.+|+..+.++ +||||+++++++.+.+..++||||++|++|.+++.... ...+++..
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 116 (289)
T 1x8b_A 37 CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116 (289)
T ss_dssp CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHH
T ss_pred ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHH
Confidence 4699999886533 3346788999999999 89999999999999999999999999999999996542 14589999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-------------------CceeeccccccccCCCCCCcceee
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------FNAKLSDFGLAKAGPTGDRTHVST 136 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-------------------~~~kl~Dfg~~~~~~~~~~~~~~~ 136 (305)
++.++.|++.||.|||++ |++||||||+||+++.+ ..+||+|||.+.......
T Consensus 117 ~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------ 188 (289)
T 1x8b_A 117 LKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------ 188 (289)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------
T ss_pred HHHHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------
Confidence 999999999999999975 59999999999999844 479999999998754322
Q ss_pred cccccccccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC
Q 021947 137 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 215 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (305)
...||..|+|||++.+. .++.++||||||+++|+|++|..++..... ...+........
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------------------~~~~~~~~~~~~ 248 (289)
T 1x8b_A 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--------------------WHEIRQGRLPRI 248 (289)
T ss_dssp CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--------------------HHHHHTTCCCCC
T ss_pred ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--------------------HHHHHcCCCCCC
Confidence 23589999999999776 566799999999999999999877654321 111122222344
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..++..+.+||.+||..||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 56678899999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=300.09 Aligned_cols=236 Identities=24% Similarity=0.296 Sum_probs=179.6
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
+.||||++...... ..+++.+|+++|++++||||+++++++...+ .+|+||||+ |++|.+++... .++
T Consensus 51 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~ 126 (367)
T 1cm8_A 51 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLG 126 (367)
T ss_dssp CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCC
T ss_pred CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCC
Confidence 36999999654322 2367889999999999999999999998653 459999999 78999999653 389
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++..... ....++|..|+|||++.+
T Consensus 127 ~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 127 EDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHC--CccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhC
Confidence 999999999999999999975 5999999999999999999999999999875432 234578999999999887
Q ss_pred -CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhc------c--chhhhhhhhcccC---CCCChH
Q 021947 153 -GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLS------D--KRKLFRIMDTKLG---GQYPQK 218 (305)
Q Consensus 153 -~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-~~~~~~------~--~~~~~~~~~~~~~---~~~~~~ 218 (305)
..++.++|||||||++|+|++|+.||.+.+..... .+... ..+... . .......+..... ......
T Consensus 200 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (367)
T 1cm8_A 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279 (367)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 67999999999999999999999999876532111 00000 000000 0 0000000000000 111235
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+..+.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 280 ASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 67889999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.31 Aligned_cols=235 Identities=20% Similarity=0.231 Sum_probs=183.0
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCC-CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
..||||++.... ...++.+|+++++.++| ++|..+..++..+...++||||+ +++|.+++.... ..+++..++.+
T Consensus 33 ~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i 108 (483)
T 3sv0_A 33 EEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLML 108 (483)
T ss_dssp CEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHH
T ss_pred cEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHH
Confidence 369999887653 33468899999999986 66666777777888899999999 889999997543 35999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEe---CCCCceeeccccccccCCCCCCc-----ceeecccccccccchhhhh
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~ 151 (305)
+.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++........ .......||..|+|||++.
T Consensus 109 ~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 186 (483)
T 3sv0_A 109 ADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186 (483)
T ss_dssp HHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc
Confidence 99999999999975 59999999999999 57889999999999875443221 1123567999999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhh-hhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhh
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA-KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (305)
+..++.++|||||||++|+|++|..||.+............. ..... .... .....++.++.+||.+|
T Consensus 187 ~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~~--------~l~~~~p~~l~~li~~c 255 (483)
T 3sv0_A 187 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---TSIE--------ALCRGYPTEFASYFHYC 255 (483)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH---SCHH--------HHHTTSCHHHHHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc---ccHH--------HHhcCCcHHHHHHHHHH
Confidence 999999999999999999999999999875543221111100 00000 0000 01124567899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhhc
Q 021947 231 LNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
|..||.+||++.+|++.|+.+.
T Consensus 256 l~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 256 RSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHH
T ss_pred hcCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999988763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=297.15 Aligned_cols=242 Identities=26% Similarity=0.275 Sum_probs=178.4
Q ss_pred CEEEEEecccCCccC-----hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQG-----HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++.... ..+++..
T Consensus 36 ~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~ 113 (346)
T 1ua2_A 36 QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSH 113 (346)
T ss_dssp SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSH
T ss_pred cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHH
Confidence 369999997543221 24688999999999999999999999999999999999986 8998886543 3588889
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-R 154 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~ 154 (305)
+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+. .
T Consensus 114 ~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~ 189 (346)
T 1ua2_A 114 IKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARM 189 (346)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCC
Confidence 999999999999999965 599999999999999999999999999987543322 13345789999999998764 5
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hh-hhhhhhhc---cchhhhhhhhcccCCCC-----ChHHHHHHH
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LV-DWAKPYLS---DKRKLFRIMDTKLGGQY-----PQKAAHTAA 224 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (305)
++.++|||||||++|+|++|..||.+........ +. ....+... ......+.......... ...++..+.
T Consensus 190 ~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (346)
T 1ua2_A 190 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 269 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHH
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHH
Confidence 7889999999999999999999998754321110 00 00000000 00000000000000001 134568899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
+||.+||..||.+|||+.+++++.
T Consensus 270 ~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 270 DLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHhccChhhCCCHHHHhcCh
Confidence 999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=310.31 Aligned_cols=224 Identities=26% Similarity=0.343 Sum_probs=180.8
Q ss_pred CEEEEEecccCCc-------------cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC
Q 021947 1 MVVAVKKLKPEGF-------------QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 1 ~~VaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
..||||++..... ...+.+.+|+++|++++||||+++++++.+....|+|||||.|++|.+++....
T Consensus 62 ~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~ 141 (504)
T 3q5i_A 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141 (504)
T ss_dssp CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC
Confidence 3689999875432 234678999999999999999999999999999999999999999999997654
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC---ceeeccccccccCCCCCCcceeecccccccc
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
.+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||++........ .....||+.|
T Consensus 142 --~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y 214 (504)
T 3q5i_A 142 --KFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYY 214 (504)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTT
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCC
Confidence 499999999999999999999975 599999999999998876 699999999987644321 3345799999
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC--ChHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHT 222 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 222 (305)
+|||++. ..++.++|||||||++|+|++|..||.+..... .+..+......... ...++.+
T Consensus 215 ~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~ 277 (504)
T 3q5i_A 215 IAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----------------IIKKVEKGKYYFDFNDWKNISDE 277 (504)
T ss_dssp CCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCCCHHHHTTSCHH
T ss_pred CCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHcCCCCCCccccCCCCHH
Confidence 9999986 468999999999999999999999998754211 11111111111111 1346788
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
+.+||.+||..||.+|||+.+++++-
T Consensus 278 ~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 278 AKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 99999999999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=295.38 Aligned_cols=234 Identities=24% Similarity=0.346 Sum_probs=182.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhc--cCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.. ....+.+|++++.. ++||||+++++++.... ..|+||||+++++|.+++.+. .+++..
T Consensus 67 ~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~ 140 (342)
T 1b6c_B 67 EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEG 140 (342)
T ss_dssp EEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHH
T ss_pred cEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHH
Confidence 6899998754 45678889999887 78999999999998775 789999999999999999654 389999
Q ss_pred HHHHHHHHHHHHhhhhcC------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc--eeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aP 147 (305)
++.++.|++.||.|||+. ..+++||||||+||+++.++.+||+|||++.......... ......||+.|+||
T Consensus 141 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP 220 (342)
T 1b6c_B 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220 (342)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCH
Confidence 999999999999999932 2469999999999999999999999999997654332211 12345689999999
Q ss_pred hhhhcCC------CCCCCceehhhHHHHHHHhC----------CCccCCCcccchhhhhhhhhhhhccchhhhhh-hhcc
Q 021947 148 EYVATGR------LTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTK 210 (305)
Q Consensus 148 E~~~~~~------~~~~~Di~slG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 210 (305)
|++.+.. ++.++||||||+++|+|++| ..||........ ....+... ....
T Consensus 221 E~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~ 288 (342)
T 1b6c_B 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP------------SVEEMRKVVCEQK 288 (342)
T ss_dssp HHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSC
T ss_pred hhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc------------cHHHHHHHHHHHH
Confidence 9997762 33689999999999999999 667755322110 00111111 1222
Q ss_pred cCCCCC-----hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 211 LGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 211 ~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.....+ ..++..+.+|+.+||..||.+|||+.+++++|+++..
T Consensus 289 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 222222 3677899999999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=290.50 Aligned_cols=233 Identities=21% Similarity=0.222 Sum_probs=180.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEE-EeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++.... ....+.+|+++++.++|++++..+..+ ..+...++||||+ +++|.+++.... ..+++..+..++
T Consensus 36 ~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~ 111 (296)
T 4hgt_A 36 EVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLA 111 (296)
T ss_dssp EEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHH
T ss_pred eEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHH
Confidence 68999876543 334688999999999987776666655 6677889999999 889999996543 349999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEe---CCCCceeeccccccccCCCCCCc-----ceeecccccccccchhhhhc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~ 152 (305)
.|++.||.|||++ |++||||||+|||+ +.++.+||+|||++......... .......||..|+|||++.+
T Consensus 112 ~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 112 DQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp HHHHHHHHHHHHT--TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHC--CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC
Confidence 9999999999975 49999999999999 78889999999999865443221 11234578999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC---CChHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~ 229 (305)
..++.++|||||||++|+|++|+.||.+.......... ........... ....++..+.+|+.+
T Consensus 190 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (296)
T 4hgt_A 190 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------------ERISEKKMSTPIEVLCKGYPSEFATYLNF 256 (296)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-------------HHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh-------------hhhhcccccchhhhhhccCCHHHHHHHHH
Confidence 99999999999999999999999999875432211110 00000000000 112356789999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhhcC
Q 021947 230 CLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
||+.||.+|||+.++++.|+++..
T Consensus 257 ~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 257 CRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCHHHHHHHHHHHHH
Confidence 999999999999999999988643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=300.78 Aligned_cols=237 Identities=18% Similarity=0.186 Sum_probs=183.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCccc---------------EEEEEEe-CCeeEEEEecCCCCCHHHHhhh
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVK---------------LIGYCLE-GENRLLVYEFMPKGSLENHLFR 65 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~ 65 (305)
.||||++... ..+.+|++++++++||||++ +++++.. ++..|+||||+ +++|.+++..
T Consensus 77 ~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~ 150 (352)
T 2jii_A 77 KFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV 150 (352)
T ss_dssp CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH
T ss_pred eEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh
Confidence 5899998754 46889999999999999988 6777776 67889999999 8999999977
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC--ceeeccccccccCCCCCCc-----ceeecc
Q 021947 66 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRT-----HVSTQV 138 (305)
Q Consensus 66 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~ 138 (305)
.....+++..++.++.|++.||.|||++ |++||||||+|||++.++ .+||+|||+++........ ......
T Consensus 151 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~ 228 (352)
T 2jii_A 151 SPKHVLSERSVLQVACRLLDALEFLHEN--EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228 (352)
T ss_dssp SGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTT
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccc
Confidence 5345699999999999999999999975 599999999999999998 8999999999765432111 112334
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChH
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK 218 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (305)
.||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .............+ .........
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~ 301 (352)
T 2jii_A 229 EGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI-MKQKQKFVDKPGPF------VGPCGHWIR 301 (352)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH-HHHHHHHHHSCCCE------ECTTSCEEC
T ss_pred cCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH-HHHHHhccCChhhh------hhhccccCC
Confidence 78999999999999999999999999999999999999998754221111 00000000000000 000011124
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
++..+.+||.+||..||.+|||+.++++.|+++..
T Consensus 302 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 302 PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 57889999999999999999999999999988754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=318.76 Aligned_cols=229 Identities=27% Similarity=0.366 Sum_probs=185.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...+.+.+|+.++++++||||+++++++. .+..|+||||+++|+|.+++.... ..+++..++.++
T Consensus 420 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~ 497 (656)
T 2j0j_A 420 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYA 497 (656)
T ss_dssp EEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHH
T ss_pred EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHH
Confidence 589999876533 23367899999999999999999999985 456899999999999999997553 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|
T Consensus 498 ~qi~~aL~~LH~~--givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~D 574 (656)
T 2j0j_A 498 YQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASD 574 (656)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHhC--CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhh
Confidence 9999999999975 5999999999999999999999999999876433221 122345678999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||+++|+|++ |..||.+.... .....+........+..++..+.+||.+||..||.+||
T Consensus 575 iwSlG~il~ellt~g~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RP 637 (656)
T 2j0j_A 575 VWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 637 (656)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHH-----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCc
Confidence 9999999999997 99999864321 11122222333455677889999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|+++.
T Consensus 638 s~~el~~~L~~il 650 (656)
T 2j0j_A 638 RFTELKAQLSTIL 650 (656)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=289.38 Aligned_cols=233 Identities=21% Similarity=0.220 Sum_probs=181.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEE-EeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++.... ...++.+|+++++.++|++++..+..+ ..+...++||||+ +++|.+++.... ..+++..++.++
T Consensus 36 ~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~ 111 (296)
T 3uzp_A 36 EVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLA 111 (296)
T ss_dssp EEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred EEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHH
Confidence 68999987653 345789999999999988766655554 5677889999999 889999996443 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeC---CCCceeeccccccccCCCCCCc-----ceeecccccccccchhhhhc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~ 152 (305)
.|++.||.|||++ |++||||||+||+++ .++.+||+|||++......... .......||..|+|||++.+
T Consensus 112 ~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 112 DQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp HHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC
Confidence 9999999999965 599999999999994 7889999999999865443221 11234578999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCC---CCChHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~ 229 (305)
..++.++||||||+++|+|++|+.||.+.......... ..+....... .....++..+.+|+.+
T Consensus 190 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (296)
T 3uzp_A 190 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------------ERISEKKMSTPIEVLCKGYPSEFATYLNF 256 (296)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-------------HHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh-------------hhhcccccCCchHHHHhhCCHHHHHHHHH
Confidence 99999999999999999999999999875432111100 0000000000 0113467889999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhhcC
Q 021947 230 CLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
||+.||.+|||+.++++.|+++..
T Consensus 257 ~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 257 CRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCcCcCCCHHHHHHHHHHHHH
Confidence 999999999999999999988643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=298.73 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=176.7
Q ss_pred CEEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||++....... .+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+++.... .+++..+..
T Consensus 51 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~ 128 (331)
T 4aaa_A 51 RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQK 128 (331)
T ss_dssp CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHH
T ss_pred ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHH
Confidence 369999986553322 3567899999999999999999999999999999999999988888765443 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ......||..|+|||++.+. .++.
T Consensus 129 ~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 204 (331)
T 4aaa_A 129 YLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGK 204 (331)
T ss_dssp HHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCT
T ss_pred HHHHHHHHHHHHHHC--CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcch
Confidence 999999999999965 599999999999999999999999999976543221 12345689999999999875 7889
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhh-------hccchhhhhhhhcccCCC-----CChHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPY-------LSDKRKLFRIMDTKLGGQ-----YPQKAAHTAA 224 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 224 (305)
++|||||||++|+|++|..||.+........ ........ .................. ....++..+.
T Consensus 205 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 284 (331)
T 4aaa_A 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVI 284 (331)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHH
Confidence 9999999999999999999998765322110 00000000 000000000000000000 0124678899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+||.+||..||.+|||+.+++++
T Consensus 285 ~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 285 DLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.99 Aligned_cols=243 Identities=23% Similarity=0.266 Sum_probs=177.8
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEe--------CCeeEEEEecCCCCCHHHHhhhcCCCC
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE--------GENRLLVYEFMPKGSLENHLFRRGPQP 70 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (305)
+.||||++...... ....+.+|++++++++||||+++++++.. ++..|+||||+++ +|.+.+.... ..
T Consensus 43 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~ 120 (351)
T 3mi9_A 43 QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VK 120 (351)
T ss_dssp CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTT-SC
T ss_pred CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhcc-CC
Confidence 36999998765432 34578899999999999999999999987 4568999999976 8888775543 34
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC--cceeecccccccccchh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPE 148 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE 148 (305)
+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........ ........||+.|+|||
T Consensus 121 ~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 121 FTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCch
Confidence 99999999999999999999975 599999999999999999999999999986542221 11233457899999999
Q ss_pred hhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhh-hh----hhhccc--hhhhhhhhcccCC--CCCh-
Q 021947 149 YVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW-AK----PYLSDK--RKLFRIMDTKLGG--QYPQ- 217 (305)
Q Consensus 149 ~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~----~~~~~~--~~~~~~~~~~~~~--~~~~- 217 (305)
++.+. .++.++|||||||++|+|++|..||.+............ .. ...... ............. ....
T Consensus 199 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
T 3mi9_A 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 278 (351)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHH
T ss_pred hhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHH
Confidence 98764 579999999999999999999999987654321111100 00 000000 0000000000000 0001
Q ss_pred ----HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 ----KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 ----~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..+..+.+||.+||..||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 279 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 124568999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=293.17 Aligned_cols=226 Identities=23% Similarity=0.369 Sum_probs=177.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
..||+|++..........+.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+++..+..++
T Consensus 45 ~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ 123 (302)
T 2j7t_A 45 ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVC 123 (302)
T ss_dssp CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHH
T ss_pred cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHH
Confidence 3689999987766777899999999999999999999999999999999999999999999986543 349999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRL 155 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~ 155 (305)
.+++.||.|||+. |++||||||+||+++.++.+||+|||++...... ........|+..|+|||++. +..+
T Consensus 124 ~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (302)
T 2j7t_A 124 RQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPY 199 (302)
T ss_dssp HHHHHHHHHHHHT--TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTT
T ss_pred HHHHHHHHHHhcC--CcccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCC
Confidence 9999999999965 5999999999999999999999999987532111 01122346899999999984 5678
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhccCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
+.++||||||+++|+|++|..||....... ......... .....+..++..+.+||.+||..|
T Consensus 200 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 263 (302)
T 2j7t_A 200 DYKADIWSLGITLIEMAQIEPPHHELNPMR----------------VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKN 263 (302)
T ss_dssp TTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSC
T ss_pred chhhhHHHHHHHHHHHhcCCCCCccCCHHH----------------HHHHHhccCCcccCCccccCHHHHHHHHHHcccC
Confidence 889999999999999999999998653211 011111111 112234567889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.+++++
T Consensus 264 p~~Rps~~~ll~h 276 (302)
T 2j7t_A 264 PETRPSAAQLLEH 276 (302)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=294.51 Aligned_cols=244 Identities=20% Similarity=0.301 Sum_probs=175.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHH--hccCCCCcccEEEEEEe-----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYL--GQLHHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l--~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++.. ....+..|.+++ ..++|+||+++++.+.. ...+++||||+++++|.+++.... .++.
T Consensus 38 ~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~ 111 (336)
T 3g2f_A 38 PVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWV 111 (336)
T ss_dssp EEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHH
T ss_pred EEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchh
Confidence 6999998754 344555555554 45899999999986542 235689999999999999996654 6888
Q ss_pred HHHHHHHHHHHHHhhhhcC-------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCC------cceeeccccc
Q 021947 75 VRMKVAIGAAKGLTFLHDA-------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------THVSTQVMGT 141 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~-------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t 141 (305)
.+..++.|++.||.|||+. ..||+||||||+|||++.++.+||+|||++........ ........||
T Consensus 112 ~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt 191 (336)
T 3g2f_A 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191 (336)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSC
T ss_pred HHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCc
Confidence 9999999999999999965 11699999999999999999999999999986543211 1112244689
Q ss_pred ccccchhhhhc-------CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-h-h--hhhhhhhccchhhhhhh-hc
Q 021947 142 HGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-L-V--DWAKPYLSDKRKLFRIM-DT 209 (305)
Q Consensus 142 ~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-~--~~~~~~~~~~~~~~~~~-~~ 209 (305)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... . . ....+.. ......+ ..
T Consensus 192 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 268 (336)
T 3g2f_A 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF---EDMQVLVSRE 268 (336)
T ss_dssp GGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCH---HHHHHHHTTS
T ss_pred cceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchH---HHHHhhhccc
Confidence 99999999976 345678999999999999999977765433221110 0 0 0000000 0000111 11
Q ss_pred ccCCCC------ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 210 KLGGQY------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 210 ~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
...... ...++..+.+||.+||..||.+|||+.++++.|+++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 111122 235778899999999999999999999999999987644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=306.10 Aligned_cols=241 Identities=21% Similarity=0.256 Sum_probs=172.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++.... ...+++.+|+++|++++|+||+++++++... ...|+||||+. ++|.+++.... .+++.
T Consensus 53 ~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~ 129 (432)
T 3n9x_A 53 NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI--FLTEE 129 (432)
T ss_dssp EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC--CCCHH
T ss_pred EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC--CCCHH
Confidence 699999976432 2346789999999999999999999999766 56899999996 49999996543 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--------------------ce
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--------------------HV 134 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--------------------~~ 134 (305)
.+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 130 ~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (432)
T 3n9x_A 130 HIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------------
T ss_pred HHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhcc
Confidence 9999999999999999975 4999999999999999999999999999875433211 11
Q ss_pred eecccccccccchhhh-hcCCCCCCCceehhhHHHHHHHhCCCccCC-----------Ccccc---------------hh
Q 021947 135 STQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDK-----------TKVGI---------------EQ 187 (305)
Q Consensus 135 ~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~-----------~~~~~---------------~~ 187 (305)
....+||++|+|||++ .+..++.++|||||||++|+|++|..||.. ..... ..
T Consensus 208 ~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 287 (432)
T 3n9x_A 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287 (432)
T ss_dssp ---CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHH
T ss_pred ccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHH
Confidence 2456789999999986 556799999999999999999986555433 21100 00
Q ss_pred h---hhh-hhhhhhc-----cchhhhhhhhcc-cCCCC-----ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 188 S---LVD-WAKPYLS-----DKRKLFRIMDTK-LGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 188 ~---~~~-~~~~~~~-----~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
. +.. ...+... ........+... ..... ...++.++.+||.+||..||.+|||+++++++
T Consensus 288 ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000 0000000 000111111110 00010 13467889999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=286.74 Aligned_cols=222 Identities=27% Similarity=0.400 Sum_probs=175.5
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++.... ......+.+|+++++.++||||+++++++...+..|+||||+++++|.+++.... .+++..+.
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 114 (276)
T 2h6d_A 37 HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEAR 114 (276)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHH
T ss_pred ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHH
Confidence 368999986542 2345678999999999999999999999999999999999999999999997654 38999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-C
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T 156 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~ 156 (305)
.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++....... ......+++.|+|||++.+..+ +
T Consensus 115 ~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 189 (276)
T 2h6d_A 115 RLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAG 189 (276)
T ss_dssp HHHHHHHHHHHHHHHH--CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCH
T ss_pred HHHHHHHHHHHHHHHC--CCccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCC
Confidence 9999999999999975 49999999999999999999999999998754322 1234468999999999987765 6
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
.++|+||||+++|+|++|..||....... +.+.+.. .....+..++..+.+||.+||+.||.
T Consensus 190 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~ 251 (276)
T 2h6d_A 190 PEVDIWSCGVILYALLCGTLPFDDEHVPT-----------------LFKKIRG-GVFYIPEYLNRSVATLLMHMLQVDPL 251 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCCcHHH-----------------HHHHhhc-CcccCchhcCHHHHHHHHHHccCChh
Confidence 79999999999999999999997643211 1111111 11233456778899999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 252 ~Rps~~~~l~h 262 (276)
T 2h6d_A 252 KRATIKDIREH 262 (276)
T ss_dssp GSCCHHHHHHS
T ss_pred hCCCHHHHHhC
Confidence 99999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=304.16 Aligned_cols=223 Identities=25% Similarity=0.323 Sum_probs=169.0
Q ss_pred CEEEEEecccCCc--------cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGF--------QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
..||||++..... .....+.+|+++|++++||||+++++++. .+..|+||||+.+++|.+++.... .++
T Consensus 161 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~ 237 (419)
T 3i6u_A 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLK 237 (419)
T ss_dssp CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCC
T ss_pred cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCC
Confidence 3699999875421 12235889999999999999999999875 556899999999999999986554 499
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC---ceeeccccccccCCCCCCcceeecccccccccchhh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 149 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 149 (305)
+..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...... .....+||+.|+|||+
T Consensus 238 ~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~ 312 (419)
T 3i6u_A 238 EATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEV 312 (419)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCcee
Confidence 999999999999999999975 599999999999997654 49999999998754322 2334578999999999
Q ss_pred hhc---CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC---ChHHHHHH
Q 021947 150 VAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTA 223 (305)
Q Consensus 150 ~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 223 (305)
+.+ ..++.++|||||||++|+|++|..||.+..... .+...+........ ...++..+
T Consensus 313 ~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~ 376 (419)
T 3i6u_A 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----------------SLKDQITSGKYNFIPEVWAEVSEKA 376 (419)
T ss_dssp TC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----------------CHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred eecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----------------HHHHHHhcCCCCCCchhhcccCHHH
Confidence 853 567889999999999999999999997643211 11111111111111 12467889
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||.+||..||.+|||+.+++++
T Consensus 377 ~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 377 LDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhCC
Confidence 999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.80 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=169.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++..... .....+.+|+.+++.++||||+++++++...+ ..|+||||+++ +|.+++.. .+++
T Consensus 52 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~ 126 (371)
T 2xrw_A 52 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDH 126 (371)
T ss_dssp EEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS----CCCH
T ss_pred eEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh----ccCH
Confidence 699999876432 23357889999999999999999999997654 68999999975 88888842 3899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 127 ~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 201 (371)
T 2xrw_A 127 ERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 201 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCC
Confidence 99999999999999999975 59999999999999999999999999998654321 12345789999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhh---hcc-chhhhhhhhcc-----------------
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY---LSD-KRKLFRIMDTK----------------- 210 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~---~~~-~~~~~~~~~~~----------------- 210 (305)
.++.++|||||||++|+|++|..||.+.+...... ... ...+. ... ...........
T Consensus 202 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (371)
T 2xrw_A 202 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF 281 (371)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccC
Confidence 99999999999999999999999998765321110 000 00000 000 00000000000
Q ss_pred -cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 211 -LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 211 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
.........+..+.+||.+||..||.+|||+.+++++-
T Consensus 282 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 282 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00001123478899999999999999999999999854
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=292.78 Aligned_cols=237 Identities=26% Similarity=0.366 Sum_probs=168.9
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc------CCCCCCH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR------GPQPLSW 73 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~ 73 (305)
..||||++..... .....+.+|++++++++||||+++++++...+..++||||++|++|.+++... ....+++
T Consensus 41 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 120 (303)
T 2vwi_A 41 EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120 (303)
T ss_dssp CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCH
T ss_pred cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCH
Confidence 3699999876532 34467889999999999999999999999999999999999999999998641 2345899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC---cceeecccccccccchhhh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR---THVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~ 150 (305)
..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++........ ........||+.|+|||++
T Consensus 121 ~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (303)
T 2vwi_A 121 STIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC--CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHh
Confidence 99999999999999999965 599999999999999999999999999976543221 1112345689999999998
Q ss_pred hc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 AT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.+ ..++.++||||||+++|+|++|..||............. ....... ............++..+.+||.+
T Consensus 199 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~ 270 (303)
T 2vwi_A 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-----QNDPPSL---ETGVQDKEMLKKYGKSFRKMISL 270 (303)
T ss_dssp HHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-----TSSCCCT---TC-----CCCCCCCHHHHHHHHH
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-----ccCCCcc---ccccccchhhhhhhHHHHHHHHH
Confidence 76 568999999999999999999999998754321110000 0000000 00001112234567789999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||..||.+|||+.+++++
T Consensus 271 ~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 271 CLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HCCSSGGGSCCHHHHHTS
T ss_pred HccCChhhCcCHHHHhhC
Confidence 999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=306.97 Aligned_cols=215 Identities=15% Similarity=0.141 Sum_probs=166.5
Q ss_pred CEEEEEecccC---CccChHHHHHHH---HHHhccCCCCcccEE-------EEEEeCCe-----------------eEEE
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEV---NYLGQLHHPNLVKLI-------GYCLEGEN-----------------RLLV 50 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~---~~l~~l~h~~i~~~~-------~~~~~~~~-----------------~~lv 50 (305)
+.||||++... .....+.+.+|+ +++++++||||++++ +++...+. .|+|
T Consensus 99 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv 178 (377)
T 3byv_A 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178 (377)
T ss_dssp CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEE
T ss_pred cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEE
Confidence 37999999744 223446788999 455556899999998 77665532 7899
Q ss_pred EecCCCCCHHHHhhhcCCC-----CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 51 YEFMPKGSLENHLFRRGPQ-----PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 51 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
|||+ +|+|.+++...+.. .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 179 ~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 179 YPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp EECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred Eecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEechhhee
Confidence 9999 57999999764321 122478888999999999999975 499999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccchhhhhcC-----------CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 021947 126 GPTGDRTHVSTQVMGTHGYAAPEYVATG-----------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 194 (305)
Q Consensus 126 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 194 (305)
... ......| +.|+|||++.+. .++.++|||||||++|+|++|+.||.+......
T Consensus 256 ~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-------- 321 (377)
T 3byv_A 256 DGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-------- 321 (377)
T ss_dssp TTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC--------
T ss_pred cCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc--------
Confidence 332 2334567 999999999887 899999999999999999999999976432110
Q ss_pred hhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 195 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
...+.. ....++.++.+||.+||..||.+|||+.++++
T Consensus 322 --------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 322 --------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp --------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred --------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 001110 11346788999999999999999999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=298.19 Aligned_cols=241 Identities=18% Similarity=0.249 Sum_probs=182.0
Q ss_pred EEEEEecccCCccCh-----------------HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHH--
Q 021947 2 VVAVKKLKPEGFQGH-----------------KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH-- 62 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-- 62 (305)
.||||++........ ..+.+|++++++++||||+++++++.+.+..|+||||+++++|.++
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 135 (348)
T 2pml_X 56 FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135 (348)
T ss_dssp EEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESS
T ss_pred eEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHH
Confidence 689999875422211 7899999999999999999999999999999999999999999999
Q ss_pred ----hhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 63 ----LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 63 ----l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
+.......+++..++.++.|++.||.|||+ ..|++||||||+||+++.++.+||+|||++...... .....
T Consensus 136 ~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~ 210 (348)
T 2pml_X 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGS 210 (348)
T ss_dssp SEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSS
T ss_pred HhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCC
Confidence 655435669999999999999999999996 145999999999999999999999999999865332 23445
Q ss_pred cccccccchhhhhcC-CCCC-CCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhhhhccchhhhhhhhcccCCC
Q 021947 139 MGTHGYAAPEYVATG-RLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSDKRKLFRIMDTKLGGQ 214 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~-~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (305)
.|+..|+|||++.+. .++. ++||||||+++|+|++|..||......... .+.........................
T Consensus 211 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (348)
T 2pml_X 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290 (348)
T ss_dssp CSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC-----
T ss_pred CCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhcccccccccc
Confidence 789999999999887 6666 999999999999999999999875431110 000000000000000000000000011
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 291 ~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred chhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 124577899999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=287.31 Aligned_cols=223 Identities=29% Similarity=0.365 Sum_probs=180.6
Q ss_pred EEEEEecccCCc---------cChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGF---------QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||||++..... ...+.+.+|+++++++. ||||+++++++...+..++||||+++++|.+++.... .+
T Consensus 44 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~ 121 (298)
T 1phk_A 44 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TL 121 (298)
T ss_dssp EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SC
T ss_pred eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CC
Confidence 689999875531 12356789999999995 9999999999999999999999999999999997654 48
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ .....++..|+|||++.
T Consensus 122 ~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 122 SEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhc
Confidence 9999999999999999999965 599999999999999999999999999986543321 23456899999999985
Q ss_pred ------cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHH
Q 021947 152 ------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTA 223 (305)
Q Consensus 152 ------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 223 (305)
...++.++||||||+++|+|++|..||........ ...+...... ......++..+
T Consensus 197 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l 260 (298)
T 1phk_A 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----------------LRMIMSGNYQFGSPEWDDYSDTV 260 (298)
T ss_dssp HHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHTCCCCCTTTGGGSCHHH
T ss_pred cccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH----------------HHHHhcCCcccCcccccccCHHH
Confidence 44678899999999999999999999976432110 1111111111 12224678899
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHH
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||.+||..||.+|||+.+++++
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 261 KDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHccCCcccCCCHHHHHhC
Confidence 999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=290.07 Aligned_cols=234 Identities=19% Similarity=0.243 Sum_probs=178.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||||+.+++|.+++.. ++...+.
T Consensus 62 ~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~ 133 (330)
T 3nsz_A 62 EKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIR 133 (330)
T ss_dssp CEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHH
T ss_pred cEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHH
Confidence 36999998754 4678999999999997 9999999999987 6678999999999999998842 8899999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhhc-CCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRL 155 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~ 155 (305)
.++.|++.||.|||+. |++||||||+|||++.++ .+||+|||++........ .....++..|+|||++.+ ..+
T Consensus 134 ~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 208 (330)
T 3nsz_A 134 FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMY 208 (330)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcC
Confidence 9999999999999965 599999999999999776 899999999986543322 234468999999999877 678
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhh--hhhh-hhhh---------ccchhhhhhh--------hcccCCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL--VDWA-KPYL---------SDKRKLFRIM--------DTKLGGQY 215 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~-~~~~---------~~~~~~~~~~--------~~~~~~~~ 215 (305)
+.++|||||||++|+|++|..||........... .... .+.. .......... ........
T Consensus 209 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (330)
T 3nsz_A 209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 288 (330)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTT
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccc
Confidence 9999999999999999999999965433211100 0000 0000 0000000000 01111222
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..++.++.+||.+||..||.+|||+++++++
T Consensus 289 ~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 289 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp GGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 33478899999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.82 Aligned_cols=173 Identities=24% Similarity=0.296 Sum_probs=150.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhcc------CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL------HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.+ .....++.+|+++++.+ +|+||+++++++...+..++||||+. ++|.+++.......+++..
T Consensus 124 ~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~ 201 (429)
T 3kvw_A 124 HVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPL 201 (429)
T ss_dssp EEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHH
T ss_pred EEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHH
Confidence 6999999764 23345677888888887 57799999999999999999999996 5999999877666799999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc--eeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++...... ....+||+.|+|||++.+.
T Consensus 202 ~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~ 274 (429)
T 3kvw_A 202 VRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGA 274 (429)
T ss_dssp HHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTB
T ss_pred HHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCC
Confidence 999999999999999975 4999999999999999887 999999999765432 2245789999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKV 183 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 183 (305)
.++.++|||||||++|+|++|..||.+.+.
T Consensus 275 ~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 275 RYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.07 Aligned_cols=233 Identities=20% Similarity=0.274 Sum_probs=178.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++|++|.+++.... ..+++..++.+
T Consensus 57 ~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 135 (319)
T 2y4i_B 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQI 135 (319)
T ss_dssp SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHH
T ss_pred eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 378999875432 334567899999999999999999999999999999999999999999996543 35899999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCC---Ccceeecccccccccchhhhhc----
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVAT---- 152 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~---- 152 (305)
+.|++.||.|||++ |++||||||+||+++ ++.+||+|||++....... .........|+..|+|||++.+
T Consensus 136 ~~qi~~al~~lH~~--~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 212 (319)
T 2y4i_B 136 AQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212 (319)
T ss_dssp HHHHHHHHHHHHHT--TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC
T ss_pred HHHHHHHHHHHHhC--CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhcccc
Confidence 99999999999975 599999999999998 6799999999987543211 1111233458999999999875
Q ss_pred -----CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHH
Q 021947 153 -----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 153 -----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (305)
..++.++||||||+++|+|++|..||....... .................++.++.+|+
T Consensus 213 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li 276 (319)
T 2y4i_B 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----------------IIWQMGTGMKPNLSQIGMGKEISDIL 276 (319)
T ss_dssp --CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----------------HHHHHHTTCCCCCCCSSCCTTHHHHH
T ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHhccCCCCCCCcCCCCHHHHHHH
Confidence 357889999999999999999999998643211 01111111111122235677899999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHhhcCC
Q 021947 228 LQCLNNEPKLRPRMSEVLAILERLEAP 254 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~l~~~~~~ 254 (305)
.+||..||.+|||+.++++.|+++...
T Consensus 277 ~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 277 LFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999887653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=299.39 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=180.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC--------CCCcccEEEEEE----eCCeeEEEEecCCCCCHHHHhhhcCCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH--------HPNLVKLIGYCL----EGENRLLVYEFMPKGSLENHLFRRGPQ 69 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~ 69 (305)
.||||+++.. ....+.+.+|++++++++ |+||+++++++. .+...|+||||+ +++|.+++......
T Consensus 64 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~ 141 (397)
T 1wak_A 64 FVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ 141 (397)
T ss_dssp EEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTS
T ss_pred EEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccC
Confidence 6999999754 233467889999999985 788999999987 456789999999 56888877666555
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC------------------------------------
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF------------------------------------ 113 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~------------------------------------ 113 (305)
.+++..+..++.|++.||.|||++ .||+||||||+|||++.++
T Consensus 142 ~~~~~~~~~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (397)
T 1wak_A 142 GLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220 (397)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccc
Confidence 699999999999999999999974 1599999999999998775
Q ss_pred -------------ceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCC
Q 021947 114 -------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180 (305)
Q Consensus 114 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 180 (305)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 221 ~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 221 LVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp SCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 7999999999875432 2334689999999999999999999999999999999999999976
Q ss_pred Ccccchh-------hhhhhhhh--------------hhccchh-----------hhhhhhcccCCCCChHHHHHHHHHHH
Q 021947 181 TKVGIEQ-------SLVDWAKP--------------YLSDKRK-----------LFRIMDTKLGGQYPQKAAHTAATLAL 228 (305)
Q Consensus 181 ~~~~~~~-------~~~~~~~~--------------~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (305)
....... ........ +...... +...+. .....+...+..+.+||.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~ 373 (397)
T 1wak_A 296 HSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV--EKYEWSQEEAAGFTDFLL 373 (397)
T ss_dssp CCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH--HTSCCCHHHHHHHHHHHG
T ss_pred CcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh--hhcccchhhHHHHHHHHH
Confidence 5432110 00000000 0000000 000000 112345678889999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||..||.+|||+.+++++
T Consensus 374 ~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 374 PMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GGGCSSGGGSCCHHHHHTS
T ss_pred HHhccChhhcCCHHHHhhC
Confidence 9999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=290.51 Aligned_cols=237 Identities=22% Similarity=0.248 Sum_probs=182.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCC------CcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP------NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.. ....+.+.+|+++++.++|+ +|+++++++...+..++||||+ +++|.+++...+...++...
T Consensus 42 ~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~ 119 (339)
T 1z57_A 42 HVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDH 119 (339)
T ss_dssp EEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHH
T ss_pred EEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHH
Confidence 6999998754 23346788999999998765 4999999999999999999999 78999999877766799999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-------------------CCceeeccccccccCCCCCCcceee
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------EFNAKLSDFGLAKAGPTGDRTHVST 136 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-------------------~~~~kl~Dfg~~~~~~~~~~~~~~~ 136 (305)
+..++.|++.||+|||++ |++||||||+|||++. ++.+||+|||++...... ..
T Consensus 120 ~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~ 192 (339)
T 1z57_A 120 IRKMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HS 192 (339)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CC
T ss_pred HHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cc
Confidence 999999999999999975 5999999999999987 667999999999864432 23
Q ss_pred cccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhh-hhhhhhc-----------------
Q 021947 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLS----------------- 198 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~----------------- 198 (305)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+......... ...+...
T Consensus 193 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 272 (339)
T 1z57_A 193 TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRL 272 (339)
T ss_dssp SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEE
T ss_pred cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccc
Confidence 4568999999999999999999999999999999999999998765322111100 0000000
Q ss_pred ---cchhhhhhhh-----cccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 199 ---DKRKLFRIMD-----TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 199 ---~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.......... ...........+..+.+||.+||..||.+|||+.+++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 273 DWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0000000000 000112244678899999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.62 Aligned_cols=222 Identities=25% Similarity=0.328 Sum_probs=172.6
Q ss_pred EEEEEecccCCc--------cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--------QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++..... .....+.+|++++++++||||+++++++..+. .|+||||+++++|.+++.... .+++
T Consensus 37 ~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~ 113 (322)
T 2ycf_A 37 KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKE 113 (322)
T ss_dssp EEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCH
T ss_pred EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCH
Confidence 699999875432 12345889999999999999999999987654 899999999999999986543 4899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc---eeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
..+..++.|++.||.|||++ |++||||||+||+++.++. +||+|||++....... ......||+.|+|||++
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 114 ATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhh
Confidence 99999999999999999965 5999999999999987664 9999999998754321 12345689999999997
Q ss_pred h---cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC---ChHHHHHHH
Q 021947 151 A---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAA 224 (305)
Q Consensus 151 ~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 224 (305)
. +..++.++|||||||++|+|++|..||........ +...+........ ...++..+.
T Consensus 189 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (322)
T 2ycf_A 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----------------LKDQITSGKYNFIPEVWAEVSEKAL 252 (322)
T ss_dssp HHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----------------HHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred ccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----------------HHHHHHhCccccCchhhhhcCHHHH
Confidence 4 45688899999999999999999999976432211 1111111110011 124577899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+||.+||..||.+|||+.+++++
T Consensus 253 ~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcccCHhhCCCHHHHhhC
Confidence 99999999999999999999853
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=299.78 Aligned_cols=228 Identities=14% Similarity=0.037 Sum_probs=161.3
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhcc--CCCCcccEE-------EEEEeC-----------------CeeEEEEe
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQL--HHPNLVKLI-------GYCLEG-----------------ENRLLVYE 52 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~lv~e 52 (305)
.||||+++.... ...+.+.+|+++++.+ +||||++++ +++... ...|+|||
T Consensus 89 ~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 168 (371)
T 3q60_A 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168 (371)
T ss_dssp EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEEC
T ss_pred eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEec
Confidence 699999987643 2235677785544444 699988755 555433 23799999
Q ss_pred cCCCCCHHHHhhhcCCCCCCHHHH------HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccC
Q 021947 53 FMPKGSLENHLFRRGPQPLSWAVR------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 53 ~~~~~~L~~~l~~~~~~~~~~~~~------~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
|++ ++|.+++...+. .+....+ +.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 169 ~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DFG~a~~~ 244 (371)
T 3q60_A 169 AAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244 (371)
T ss_dssp CCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--TEEETTCSGGGEEECTTSCEEECCGGGEEET
T ss_pred CCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC--CCccCcCCHHHEEECCCCCEEEEecceeeec
Confidence 998 799999976432 2444455 67789999999999965 4999999999999999999999999999865
Q ss_pred CCCCCcceeecccccccccchhhhhc--CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhh
Q 021947 127 PTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 204 (305)
Q Consensus 127 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (305)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......... .....
T Consensus 245 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~ 310 (371)
T 3q60_A 245 GTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK---------RPSLR 310 (371)
T ss_dssp TCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCC---------BCCTT
T ss_pred CCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchh---------hhhhh
Confidence 431 224457799999999987 67899999999999999999999999876432111000 00000
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 205 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..............++..+.+||.+||..||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 311 VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111122222234678899999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=288.07 Aligned_cols=227 Identities=24% Similarity=0.367 Sum_probs=176.1
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccC--CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
..||||++..... .....+.+|++++++++ |+||+++++++...+..|+|||+ .+++|.+++.... .++...+
T Consensus 53 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~ 129 (313)
T 3cek_A 53 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWER 129 (313)
T ss_dssp CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCS--SCCHHHH
T ss_pred cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcC--CCCHHHH
Confidence 3689999876533 23467899999999997 59999999999999999999994 5779999997654 4899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc----
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---- 152 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---- 152 (305)
..++.|++.||.|||+. |++||||||+||+++ ++.+||+|||++................|++.|+|||++.+
T Consensus 130 ~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 206 (313)
T 3cek_A 130 KSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206 (313)
T ss_dssp HHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC--
T ss_pred HHHHHHHHHHHHHHHHC--CceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccc
Confidence 99999999999999975 599999999999996 47899999999987544332222334578999999999875
Q ss_pred -------CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHH
Q 021947 153 -------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 153 -------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (305)
..++.++||||||+++|+|++|..||....... ..+............+...+..+.+
T Consensus 207 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (313)
T 3cek_A 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------------SKLHAIIDPNHEIEFPDIPEKDLQD 271 (313)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------------HHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred cccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---------------HHHHHHHhcccccCCcccchHHHHH
Confidence 467889999999999999999999997643211 1122223333334455556788999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~l 248 (305)
||.+||..||.+|||+.+++++.
T Consensus 272 li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 272 VLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHccCCcccCcCHHHHhcCc
Confidence 99999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=286.69 Aligned_cols=226 Identities=23% Similarity=0.318 Sum_probs=166.3
Q ss_pred EEEEEecccCCccC-h-HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhh--cCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEGFQG-H-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~ 77 (305)
.||||+++...... . ..+.++...++.++||||+++++++.+++..++||||++| +|.+++.. .....+++..+.
T Consensus 34 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ 112 (290)
T 3fme_A 34 IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG 112 (290)
T ss_dssp EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHH
T ss_pred EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHH
Confidence 69999997653322 2 2344555568888999999999999999999999999975 88887754 233459999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh----hcC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATG 153 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~ 153 (305)
.++.|++.||.|||+. .|++||||||+||+++.++.+||+|||++........ .....||+.|+|||++ .+.
T Consensus 113 ~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 188 (290)
T 3fme_A 113 KIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQK 188 (290)
T ss_dssp HHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC-
T ss_pred HHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCc
Confidence 9999999999999974 1599999999999999999999999999976543221 2334689999999996 456
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++||||||+++|+|++|..||....... ..+...............++..+.+|+.+||..
T Consensus 189 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 253 (290)
T 3fme_A 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPF---------------QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 253 (290)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---------------HHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCccccCchH---------------HHHHHHhccCCCCcccccCCHHHHHHHHHHhhc
Confidence 78889999999999999999999997533211 111222222222333446788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
||.+|||+.+++++
T Consensus 254 ~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 254 NSKERPTYPELMQH 267 (290)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred ChhhCcCHHHHHhC
Confidence 99999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=281.39 Aligned_cols=223 Identities=27% Similarity=0.358 Sum_probs=179.8
Q ss_pred CEEEEEecccCC--ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||++.... ......+.+|++++++++||||+++++++...+..|+||||+.+++|.+++.... .+++..++.
T Consensus 48 ~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 125 (287)
T 2wei_A 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAAR 125 (287)
T ss_dssp CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHH
T ss_pred cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHH
Confidence 368999986543 2456789999999999999999999999999999999999999999999886654 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.|++.||.|||+. |++|+||||+||+++.+ +.+||+|||++........ .....+++.|+|||++.+ .+
T Consensus 126 i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~ 199 (287)
T 2wei_A 126 IIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TY 199 (287)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CC
T ss_pred HHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CC
Confidence 999999999999975 59999999999999764 4699999999986543321 223458999999999865 48
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCC--ChHHHHHHHHHHHhhccC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNN 233 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~ 233 (305)
+.++||||||+++|+|++|..||.+...... ...+......... ...++.++.+||.+||..
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 263 (287)
T 2wei_A 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDI----------------LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263 (287)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCS
T ss_pred CCchhhHhHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHcCCCCCCchhhhhcCHHHHHHHHHHccc
Confidence 8999999999999999999999987542110 1111111111111 235678899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021947 234 EPKLRPRMSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps~~~~l~~ 247 (305)
||.+|||+.+++++
T Consensus 264 dp~~Rps~~ell~h 277 (287)
T 2wei_A 264 HPSLRITATQCLEH 277 (287)
T ss_dssp SGGGSCCHHHHHHS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=294.83 Aligned_cols=240 Identities=25% Similarity=0.307 Sum_probs=178.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||++..... .....+.+|++++++++||||+++++++... ...|+||||+.| +|.+++... .+++..
T Consensus 54 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~---~~~~~~ 129 (364)
T 3qyz_A 54 RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ---HLSNDH 129 (364)
T ss_dssp EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHC---CCCHHH
T ss_pred EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhC---CCCHHH
Confidence 599999975432 2336789999999999999999999998754 368999999975 999998654 399999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhc-C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......... .......||+.|+|||++.+ .
T Consensus 130 ~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 207 (364)
T 3qyz_A 130 ICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207 (364)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC
T ss_pred HHHHHHHHHHHHHHHHHC--CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC
Confidence 999999999999999965 5999999999999999999999999999865432211 11234578999999998755 4
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhhhccch-----hhhhhhhcc-cCCC-----CChHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLSDKR-----KLFRIMDTK-LGGQ-----YPQKAA 220 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~~~~~~-----~~~~~~~~~-~~~~-----~~~~~~ 220 (305)
.++.++|||||||++|+|++|+.||.+........ .... ..+...... ......... .... ....++
T Consensus 208 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (364)
T 3qyz_A 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 287 (364)
T ss_dssp SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC
T ss_pred CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCC
Confidence 58999999999999999999999998765432211 1000 000000000 000000000 0000 113456
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.+||.+||..||.+|||+.+++++
T Consensus 288 ~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 288 SKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 789999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.62 Aligned_cols=243 Identities=21% Similarity=0.273 Sum_probs=168.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhc-------CCCCCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR-------GPQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~ 72 (305)
.||||++.... ....+.+|+++|++++||||+++++++.. +...|+||||+.+ +|.+++... ....++
T Consensus 50 ~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~ 126 (405)
T 3rgf_A 50 DYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP 126 (405)
T ss_dssp CEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CC
T ss_pred EEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCC
Confidence 58999997553 34578899999999999999999999964 6788999999975 888887532 122489
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEe----CCCCceeeccccccccCCCCCC-cceeecccccccccch
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAP 147 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aP 147 (305)
+..+..++.||+.||+|||+. ||+||||||+|||+ +.++.+||+|||+++....... .......+||+.|+||
T Consensus 127 ~~~~~~i~~qi~~al~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 204 (405)
T 3rgf_A 127 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204 (405)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCc
Confidence 999999999999999999975 49999999999999 6778999999999987543221 1123345789999999
Q ss_pred hhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-------hh---hh-hhhhhhccch---------hhhhh
Q 021947 148 EYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SL---VD-WAKPYLSDKR---------KLFRI 206 (305)
Q Consensus 148 E~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~---~~-~~~~~~~~~~---------~~~~~ 206 (305)
|++.+. .++.++|||||||++|+|++|..||.+....... .+ .. ...+...... .+...
T Consensus 205 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 284 (405)
T 3rgf_A 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD 284 (405)
T ss_dssp HHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHH
T ss_pred hhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhh
Confidence 999874 5899999999999999999999999765542110 00 00 0000000000 00000
Q ss_pred hhcc-cCC--------CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 207 MDTK-LGG--------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 207 ~~~~-~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
.... ... ......+..+.+||.+||..||.+|||+++++++-.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 285 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp CCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 0000 000 000112567899999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=291.92 Aligned_cols=175 Identities=25% Similarity=0.260 Sum_probs=150.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CC-----CcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HP-----NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.. .....++.+|+++++.++ |+ +|+.+++++...+..|+||||+.+ +|.+++.......+++..
T Consensus 81 ~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~ 158 (382)
T 2vx3_A 81 WVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 158 (382)
T ss_dssp EEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHH
T ss_pred EEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHH
Confidence 6999999754 223456778999998885 55 499999999999999999999965 999999876655699999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC--CCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
+..++.|++.||.|||+++.||+||||||+|||++. ++.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 159 ~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~ 233 (382)
T 2vx3_A 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGM 233 (382)
T ss_dssp HHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCC
Confidence 999999999999999976678999999999999954 678999999999876432 2345789999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKV 183 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 183 (305)
.++.++|||||||++|+|++|+.||.+.+.
T Consensus 234 ~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 234 PYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=296.41 Aligned_cols=235 Identities=24% Similarity=0.287 Sum_probs=164.8
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++..... .....+.+|+++++.++||||+++++++... ...|+|||++ +++|.+++... .+++
T Consensus 56 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~ 131 (367)
T 2fst_X 56 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTD 131 (367)
T ss_dssp EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C---CCCH
T ss_pred EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC---CCCH
Confidence 699999976432 2346788999999999999999999998754 5679999999 67999988642 4999
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..... .....||..|+|||++.+
T Consensus 132 ~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~ 204 (367)
T 2fst_X 132 DHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNW 204 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHC--CeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCC
Confidence 99999999999999999975 5999999999999999999999999999864332 234578999999999877
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhhhc-----cchhhhhhhhcccC---CCC---ChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLS-----DKRKLFRIMDTKLG---GQY---PQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~~~-----~~~~~~~~~~~~~~---~~~---~~~~ 219 (305)
..++.++|||||||++|+|++|+.||.+.+...... +... ..+... ........+..... ..+ ....
T Consensus 205 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (367)
T 2fst_X 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284 (367)
T ss_dssp CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTC
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCC
Confidence 678999999999999999999999998765321111 0000 000000 00000011111000 000 1234
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+||.+||..||.+|||+.+++++
T Consensus 285 ~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 285 NPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 6789999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=297.26 Aligned_cols=235 Identities=25% Similarity=0.284 Sum_probs=171.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhhh--cCCCCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLFR--RGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~ 72 (305)
..||||++..+. ..+.+|+++|++++||||+++++++... ..+++||||+.+ +|.+.+.. .....++
T Consensus 80 ~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~ 154 (420)
T 1j1b_A 80 ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP 154 (420)
T ss_dssp CEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCC
T ss_pred cEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCC
Confidence 369999986542 2234799999999999999999988642 235799999976 77766642 2334599
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-CceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
+..+..++.|++.||+|||+ .||+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.
T Consensus 155 ~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~ 229 (420)
T 1j1b_A 155 VIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIF 229 (420)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHc
Confidence 99999999999999999996 459999999999999965 5689999999986543222 23457899999999987
Q ss_pred cC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhcc-chhhhhhhhcccCCC------------CCh
Q 021947 152 TG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-KRKLFRIMDTKLGGQ------------YPQ 217 (305)
Q Consensus 152 ~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------------~~~ 217 (305)
+. .++.++|||||||++|+|++|+.||.+...... +.......... ...+........... ++.
T Consensus 230 ~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 307 (420)
T 1j1b_A 230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307 (420)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCT
T ss_pred CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCC
Confidence 65 789999999999999999999999987543211 11100000000 000000000000000 223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.++.+||.+||..||.+|||+.+++++
T Consensus 308 ~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 308 RTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 567889999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=293.05 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=173.3
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC------------------------------------
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------------------------------------ 44 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------------------------------------ 44 (305)
..||||++..+.. ...+|+++++.++||||+++++++...
T Consensus 33 ~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (383)
T 3eb0_A 33 KRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108 (383)
T ss_dssp CEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------------------------------------
T ss_pred CEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCC
Confidence 3699999875422 223799999999999999999998543
Q ss_pred --CeeEEEEecCCCCCHHHHhhh--cCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeecc
Q 021947 45 --ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSD 119 (305)
Q Consensus 45 --~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~D 119 (305)
...++||||+.| +|.+.+.. .....+++..+..++.|++.||+|||+ .||+||||||+|||++ .++.+||+|
T Consensus 109 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~D 185 (383)
T 3eb0_A 109 QNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCD 185 (383)
T ss_dssp -CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECC
T ss_pred CceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEE
Confidence 347899999975 88777753 233459999999999999999999996 4599999999999997 678999999
Q ss_pred ccccccCCCCCCcceeecccccccccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhh
Q 021947 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPY 196 (305)
Q Consensus 120 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-~~~~ 196 (305)
||+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+....... .+... ..+.
T Consensus 186 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~ 262 (383)
T 3eb0_A 186 FGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262 (383)
T ss_dssp CTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999986543322 2344689999999998775 4899999999999999999999999875432111 01000 0000
Q ss_pred hccchhh----hhh-----hhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 197 LSDKRKL----FRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 197 ~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
....... ... .........+..++.++.+||.+||..||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 000 00000011234577889999999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=286.57 Aligned_cols=240 Identities=25% Similarity=0.326 Sum_probs=179.9
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhcc---CCCCcccEEEEEE-----eCCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQL---HHPNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||||+++.... .....+.+|+.+++.+ +||||+++++++. .....++||||+. ++|.+++.......+
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~ 117 (326)
T 1blx_A 39 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGV 117 (326)
T ss_dssp EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCS
T ss_pred EEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCC
Confidence 689998875432 2234677888888777 8999999999987 4567899999997 599999987665669
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....... ......||..|+|||++.
T Consensus 118 ~~~~~~~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~ 192 (326)
T 1blx_A 118 PTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLL 192 (326)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHh
Confidence 9999999999999999999965 59999999999999999999999999997653221 233456899999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhccc-------hhhhhhhhcccCCCCChHHHHH
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDK-------RKLFRIMDTKLGGQYPQKAAHT 222 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 222 (305)
+..++.++||||||+++|+|++|..||.+....... ..... ..+..... ..................++..
T Consensus 193 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 1blx_A 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 272 (326)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHH
T ss_pred cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHH
Confidence 999999999999999999999999999876532111 00000 00000000 0000000000011123457788
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||.+||..||.+|||+.+++++
T Consensus 273 ~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 273 GKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=297.94 Aligned_cols=227 Identities=24% Similarity=0.320 Sum_probs=167.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCC-----CHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPL-----SWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~ 74 (305)
+.||||++..+ ..+.+.+|+++++++ +||||+++++++.+++..|+|||||. ++|.+++........ .+.
T Consensus 40 ~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~ 115 (434)
T 2rio_A 40 RPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEY 115 (434)
T ss_dssp SEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------C
T ss_pred eEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccch
Confidence 47999998754 345678999999986 89999999999999999999999996 599999976543211 222
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-------------CceeeccccccccCCCCCCcc--eeeccc
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKLSDFGLAKAGPTGDRTH--VSTQVM 139 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-------------~~~kl~Dfg~~~~~~~~~~~~--~~~~~~ 139 (305)
.++.++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||++.......... ......
T Consensus 116 ~~~~i~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~ 193 (434)
T 2rio_A 116 NPISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193 (434)
T ss_dssp CHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-------------
T ss_pred hHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCC
Confidence 4567999999999999975 59999999999999754 479999999998765432211 123457
Q ss_pred ccccccchhhhhc-------CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhh-hcc
Q 021947 140 GTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTK 210 (305)
Q Consensus 140 ~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 210 (305)
||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+........ .. ... ...
T Consensus 194 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i-~~-------------~~~~~~~ 259 (434)
T 2rio_A 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-IR-------------GIFSLDE 259 (434)
T ss_dssp -CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHH-HH-------------TCCCCCC
T ss_pred CCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHH-hc-------------CCCCccc
Confidence 9999999999976 568899999999999999999 999997643211100 00 000 001
Q ss_pred cCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 211 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
........++.++.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1112245788999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.35 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=175.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCe-------eEEEEecCCCCCHHHHhhh--cCCCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-------RLLVYEFMPKGSLENHLFR--RGPQPL 71 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~--~~~~~~ 71 (305)
..||||++..+. .....+.+|++.+..++||||+++++++...+. .++||||+.+ +|.+.+.. .....+
T Consensus 49 ~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 126 (360)
T 3e3p_A 49 MSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP 126 (360)
T ss_dssp CEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCC
T ss_pred CEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCC
Confidence 369999886542 334567788999999999999999999875433 7899999986 66554432 233458
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
+...+..++.|++.||.|||.+..||+||||||+|||++. ++.+||+|||++........ .....||+.|+|||++
T Consensus 127 ~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 203 (360)
T 3e3p_A 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELI 203 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHH
Confidence 9999999999999999999954456999999999999997 88999999999987543322 2345689999999998
Q ss_pred hcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh----------------cccCC
Q 021947 151 ATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD----------------TKLGG 213 (305)
Q Consensus 151 ~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~ 213 (305)
.+. .++.++|||||||++|+|++|..||.+........ ................+. .....
T Consensus 204 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
T 3e3p_A 204 FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS 281 (360)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTT
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccc
Confidence 665 48999999999999999999999998765321110 000000000000000000 00011
Q ss_pred CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 214 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
......+.++.+||.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 282 DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1223467899999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=286.00 Aligned_cols=240 Identities=24% Similarity=0.319 Sum_probs=176.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEE--------------eCCeeEEEEecCCCCCHHHHhhhcC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL--------------EGENRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
.||||++........+.+.+|++++++++||||+++++++. +....|+||||+. ++|.+++...
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~- 115 (320)
T 2i6l_A 38 RVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG- 115 (320)
T ss_dssp EEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC-
T ss_pred EEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC-
Confidence 69999988765555678999999999999999999999873 3467899999997 5999998543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeeccccccccCCCCCC-cceeeccccccccc
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYA 145 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~ 145 (305)
.+++..+..++.|++.||+|||+. |++||||||+||+++ .++.+||+|||++........ ........++..|+
T Consensus 116 --~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 191 (320)
T 2i6l_A 116 --PLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191 (320)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTC
T ss_pred --CccHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccccccccc
Confidence 489999999999999999999965 599999999999997 567899999999986543211 11123345789999
Q ss_pred chhhhhc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh--ccchhhh----hhhhcccC-C----
Q 021947 146 APEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL--SDKRKLF----RIMDTKLG-G---- 213 (305)
Q Consensus 146 aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~-~---- 213 (305)
|||++.+ ..++.++||||||+++|+|++|+.||.+..............+.. .....+. ..+..... .
T Consensus 192 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
T 2i6l_A 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL 271 (320)
T ss_dssp CHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCH
T ss_pred CcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCCh
Confidence 9998876 678899999999999999999999998765321111000000000 0000000 00000000 0
Q ss_pred -CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 214 -QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....++.++.+||.+||..||.+|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0113467889999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=288.65 Aligned_cols=227 Identities=21% Similarity=0.263 Sum_probs=154.0
Q ss_pred CEEEEEecccCCccChHHHHHHHH-HHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVN-YLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||++... ....+|+. .++.++||||+++++++.. +...++||||++|++|.+++.......+++..
T Consensus 55 ~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~ 129 (336)
T 3fhr_A 55 QKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129 (336)
T ss_dssp CEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHH
T ss_pred CEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHH
Confidence 47999998643 22233333 4566789999999999876 44579999999999999999877666799999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCC---CceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.++.|++.||.|||+. |++||||||+||+++.+ +.+||+|||++....... .....+|+.|+|||++.+
T Consensus 130 ~~~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 130 AAEIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------
T ss_pred HHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCC
Confidence 999999999999999975 59999999999999764 459999999998654321 234568999999999988
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhcc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (305)
..++.++||||||+++|+|++|..||.......... ....................++..+.+||.+||.
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 273 (336)
T 3fhr_A 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLK 273 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCTTTSTTCCHHHHHHHHHHSC
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhhhccccccCchhhccCCHHHHHHHHHHCC
Confidence 889999999999999999999999997654221100 0000000001111122234678899999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAIL 248 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l 248 (305)
.||.+|||+.+++++.
T Consensus 274 ~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 274 TDPTERLTITQFMNHP 289 (336)
T ss_dssp SSGGGSCCHHHHHHSH
T ss_pred CChhHCcCHHHHhcCc
Confidence 9999999999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=296.41 Aligned_cols=225 Identities=25% Similarity=0.324 Sum_probs=167.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||++..+.. ..+.+|+++|+++ +||||+++++++.+....|+|||||. ++|.+++..... ......+..+
T Consensus 49 ~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i 123 (432)
T 3p23_A 49 RDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITL 123 (432)
T ss_dssp SEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHH
T ss_pred eEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHH
Confidence 4699999976532 3456899999999 79999999999999999999999996 499999975543 3455566789
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCC-----CceeeccccccccCCCCCCc-ceeecccccccccchhhhhc-
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-----FNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~- 152 (305)
+.|++.||.|||+. ||+||||||+|||++.+ ..+||+|||+++........ .......||+.|+|||++.+
T Consensus 124 ~~qi~~aL~~LH~~--~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 201 (432)
T 3p23_A 124 LQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201 (432)
T ss_dssp HHHHHHHHHHHHHT--TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC
T ss_pred HHHHHHHHHHHHHC--cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc
Confidence 99999999999975 49999999999999532 24789999999876433211 12334579999999999974
Q ss_pred --CCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 153 --GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 153 --~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
..++.++|||||||++|+|++ |..||............ . .............+..+.+||.+
T Consensus 202 ~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--------------~-~~~~~~~~~~~~~~~~~~~li~~ 266 (432)
T 3p23_A 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--------------G-ACSLDCLHPEKHEDVIARELIEK 266 (432)
T ss_dssp ---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--------------T-CCCCTTSCTTCHHHHHHHHHHHH
T ss_pred cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--------------c-cCCccccCccccccHHHHHHHHH
Confidence 567789999999999999999 99999654321111000 0 00000111234567778999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||+.||.+|||+.+++++
T Consensus 267 ~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 267 MIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HSCSSGGGSCCHHHHHTS
T ss_pred HHhCCHhhCCCHHHHHhC
Confidence 999999999999999953
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.80 Aligned_cols=237 Identities=20% Similarity=0.213 Sum_probs=179.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCC------cccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN------LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.. ......+.+|++++++++|++ ++.+++++...+..++||||+ +++|.+++.......+++..
T Consensus 47 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~ 124 (355)
T 2eu9_A 47 QVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPH 124 (355)
T ss_dssp EEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHH
T ss_pred EEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHH
Confidence 6999999754 234567889999999997665 999999999999999999999 56888888776656699999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEe-------------------CCCCceeeccccccccCCCCCCcceee
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-------------------DAEFNAKLSDFGLAKAGPTGDRTHVST 136 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~-------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 136 (305)
+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 125 ~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~ 197 (355)
T 2eu9_A 125 VRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HT 197 (355)
T ss_dssp HHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CC
T ss_pred HHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----cc
Confidence 999999999999999964 59999999999999 56788999999999864432 23
Q ss_pred cccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhc----c------------
Q 021947 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS----D------------ 199 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~----~------------ 199 (305)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......... ....+... .
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 277 (355)
T 2eu9_A 198 TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGL 277 (355)
T ss_dssp SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEE
T ss_pred CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccc
Confidence 457899999999999999999999999999999999999999875532211100 00000000 0
Q ss_pred ----chhhhhhhhc-----ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 200 ----KRKLFRIMDT-----KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 200 ----~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.......... ..........+..+.+||.+||..||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 278 VWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00011233567789999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=290.71 Aligned_cols=240 Identities=24% Similarity=0.303 Sum_probs=170.7
Q ss_pred CEEEEEecccCCccC-----------hHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhh
Q 021947 1 MVVAVKKLKPEGFQG-----------HKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLF 64 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~ 64 (305)
..||||++....... .+.+.+|++++++++||||+++++++... ...|+||||+. ++|.+++.
T Consensus 47 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~ 125 (362)
T 3pg1_A 47 IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH 125 (362)
T ss_dssp CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH
T ss_pred CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH
Confidence 369999986543221 26789999999999999999999998542 36799999997 58888886
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 65 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
... ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....... ......+|+.|
T Consensus 126 ~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y 199 (362)
T 3pg1_A 126 DQR-IVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWY 199 (362)
T ss_dssp CTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGG
T ss_pred hcc-cCCCHHHHHHHHHHHHHHHHHHHHC--cCEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceeccccee
Confidence 443 4599999999999999999999975 59999999999999999999999999997543322 13345689999
Q ss_pred cchhhhhc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhhh-hhhhc-----cchhhhhhhhcccCC---
Q 021947 145 AAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLS-----DKRKLFRIMDTKLGG--- 213 (305)
Q Consensus 145 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~~~~--- 213 (305)
+|||++.+ ..++.++|||||||++|+|++|+.||.+....... ...... .+... ...............
T Consensus 200 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
T 3pg1_A 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279 (362)
T ss_dssp CCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC
T ss_pred cCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh
Confidence 99999877 67899999999999999999999999876532111 000000 00000 000001111111100
Q ss_pred ----CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 214 ----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 214 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 280 RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0112456789999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=281.40 Aligned_cols=227 Identities=22% Similarity=0.355 Sum_probs=170.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEe-------------CCeeEEEEecCCCCCHHHHhhhcC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-------------GENRLLVYEFMPKGSLENHLFRRG 67 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~ 67 (305)
+.||||++... ......+.+|++++++++||||+++++++.+ .+..|+||||++|++|.+++....
T Consensus 32 ~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (303)
T 1zy4_A 32 RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110 (303)
T ss_dssp CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC
T ss_pred eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc
Confidence 36899998643 2344678999999999999999999998865 356799999999999999997543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC------------ccee
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR------------THVS 135 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~ 135 (305)
..++...++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ ....
T Consensus 111 -~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (303)
T 1zy4_A 111 -LNQQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187 (303)
T ss_dssp -GGGCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------
T ss_pred -cccchHHHHHHHHHHHHHHHHHHhC--CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccc
Confidence 3478899999999999999999975 599999999999999999999999999986542210 1112
Q ss_pred ecccccccccchhhhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC
Q 021947 136 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 214 (305)
Q Consensus 136 ~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (305)
....|+..|+|||++.+. .++.++||||||+++|+|++ ||....... ... .............
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--~~~-----------~~~~~~~~~~~~~ 251 (303)
T 1zy4_A 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--NIL-----------KKLRSVSIEFPPD 251 (303)
T ss_dssp ------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHH-----------HHHHSTTCCCCTT
T ss_pred ccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--HHH-----------HhccccccccCcc
Confidence 345689999999999865 68999999999999999998 554311100 000 0000011122233
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+...+..+.+||.+||..||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 455677889999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=291.11 Aligned_cols=234 Identities=24% Similarity=0.309 Sum_probs=173.5
Q ss_pred EEEEEecccCCccC--hHHHHHHHHHHhccCCCCcccEEEEEEeCCee------EEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++....... ...+.+|+.++++++||||+++++++...+.. |+||||+. ++|.+++.. .+++
T Consensus 69 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~ 143 (371)
T 4exu_A 69 KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSE 143 (371)
T ss_dssp EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCH
T ss_pred EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCH
Confidence 69999998653322 36788999999999999999999999877655 99999997 588888732 3999
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+
T Consensus 144 ~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~ 216 (371)
T 4exu_A 144 EKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW 216 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHHHHC--CCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCC
Confidence 99999999999999999975 5999999999999999999999999999865332 234568999999999887
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhh------hcc--chhhhhhhhcccCCC---CChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPY------LSD--KRKLFRIMDTKLGGQ---YPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~------~~~--~~~~~~~~~~~~~~~---~~~~~ 219 (305)
..++.++|||||||++|+|++|..||.+.+...... ..... .+. ... .......+....... ....+
T Consensus 217 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (371)
T 4exu_A 217 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA 296 (371)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTS
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhcccc
Confidence 678999999999999999999999998765321110 00000 000 000 000000000000000 11245
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+||.+||..||.+|||+.+++++
T Consensus 297 ~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 297 SPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 7889999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=292.16 Aligned_cols=236 Identities=16% Similarity=0.250 Sum_probs=177.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-----------CCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhc
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-----------HPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRR 66 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~ 66 (305)
.||||++..+ ......+.+|++++++++ |+||+++++++...+ ..++|||++ +++|.+++...
T Consensus 46 ~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 123 (373)
T 1q8y_A 46 HVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY 123 (373)
T ss_dssp EEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT
T ss_pred EEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh
Confidence 6899998754 233467889999999886 899999999988654 689999999 88999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC------CCCceeeccccccccCCCCCCcceeecccc
Q 021947 67 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD------AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 140 (305)
Q Consensus 67 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 140 (305)
....++...+..++.|++.||.|||++ .||+||||||+|||++ ..+.+||+|||++...... .....|
T Consensus 124 ~~~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~ 197 (373)
T 1q8y_A 124 EHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQ 197 (373)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCS
T ss_pred hccCCcHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCC
Confidence 656699999999999999999999974 1599999999999994 3447999999999865432 223468
Q ss_pred cccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccch----hh---hhhhhhh--------------hhcc
Q 021947 141 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE----QS---LVDWAKP--------------YLSD 199 (305)
Q Consensus 141 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~---~~~~~~~--------------~~~~ 199 (305)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+...... .. ....... +...
T Consensus 198 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 277 (373)
T 1q8y_A 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277 (373)
T ss_dssp CGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC
T ss_pred CccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCC
Confidence 9999999999999999999999999999999999999986542110 00 0000000 0000
Q ss_pred chh-----------hhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 200 KRK-----------LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 200 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
... +...+ ......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 278 RGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp --CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cchhcccccccccchhhhh--hhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 000 00000 11224567889999999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.14 Aligned_cols=236 Identities=23% Similarity=0.301 Sum_probs=169.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCe------eEEEEecCCCCCHHHHhhh--cCCCCCCH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFR--RGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~--~~~~~~~~ 73 (305)
.||+|++..+.. ...+|+++++.++||||+++++++...+. .++||||+.+ ++...+.. .....+++
T Consensus 66 ~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 140 (394)
T 4e7w_A 66 EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140 (394)
T ss_dssp EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCH
T ss_pred eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCH
Confidence 378887764421 12379999999999999999999865433 7899999987 44444321 22345999
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
..+..++.|++.||+|||++ ||+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 141 LLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFG 215 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcC
Confidence 99999999999999999975 599999999999998 789999999999987543322 234568999999999876
Q ss_pred C-CCCCCCceehhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhccchhh-hhhhhcccC--------CCCChHHH
Q 021947 153 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDKRKL-FRIMDTKLG--------GQYPQKAA 220 (305)
Q Consensus 153 ~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~ 220 (305)
. .++.++|||||||++|+|++|+.||.+....... .+... ..+........ ......... ..++..++
T Consensus 216 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (394)
T 4e7w_A 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTP 295 (394)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCC
Confidence 5 5899999999999999999999999876532111 01000 00000000000 000000000 01223467
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.+||.+||..||.+|||+.+++++
T Consensus 296 ~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 296 PDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 899999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.87 Aligned_cols=240 Identities=22% Similarity=0.267 Sum_probs=176.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||++..... .....+.+|++++++++||||+++++++... ...|+||||+. ++|.+++... .+++..
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~ 113 (353)
T 2b9h_A 38 IVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDH 113 (353)
T ss_dssp EEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHH
T ss_pred EEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHH
Confidence 699999975432 2345788999999999999999999987754 67899999997 4999998653 499999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc--------eeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--------VSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aP 147 (305)
+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.......... ......||..|+||
T Consensus 114 ~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 114 IQYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCC
Confidence 999999999999999965 59999999999999999999999999998654322111 12234689999999
Q ss_pred hhhhc-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhh-hhhh-hhhhc------cchhhhhhhhcccCC-----
Q 021947 148 EYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWA-KPYLS------DKRKLFRIMDTKLGG----- 213 (305)
Q Consensus 148 E~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~-~~~~~------~~~~~~~~~~~~~~~----- 213 (305)
|++.+ ..++.++|||||||++|+|++|..||.+.+....... .... .+... ...............
T Consensus 192 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
T 2b9h_A 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271 (353)
T ss_dssp HHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH
T ss_pred eeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcch
Confidence 98765 6789999999999999999999999987653211100 0000 00000 000000111000000
Q ss_pred -CCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 214 -QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0113567889999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.79 Aligned_cols=215 Identities=25% Similarity=0.404 Sum_probs=173.5
Q ss_pred CEEEEEecccCCcc------ChHHHHHHHHHHhcc----CCCCcccEEEEEEeCCeeEEEEec-CCCCCHHHHhhhcCCC
Q 021947 1 MVVAVKKLKPEGFQ------GHKEWLTEVNYLGQL----HHPNLVKLIGYCLEGENRLLVYEF-MPKGSLENHLFRRGPQ 69 (305)
Q Consensus 1 ~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~ 69 (305)
+.||||++...... ....+.+|+.++.++ +|+||+++++++...+..++|||+ +.+++|.+++...+
T Consensus 57 ~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-- 134 (312)
T 2iwi_A 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-- 134 (312)
T ss_dssp CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--
T ss_pred eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--
Confidence 36999999765332 234566899999998 899999999999998999999999 78999999997654
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeeccccccccCCCCCCcceeecccccccccchh
Q 021947 70 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 148 (305)
Q Consensus 70 ~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 148 (305)
.+++..++.++.|++.||.|||+. |++||||||+||+++ .++.+||+|||++....... .....|+..|+|||
T Consensus 135 ~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE 208 (312)
T 2iwi_A 135 PLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPE 208 (312)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCce
Confidence 489999999999999999999975 499999999999998 78899999999998764432 23456899999999
Q ss_pred hhhcCCCC-CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHH
Q 021947 149 YVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227 (305)
Q Consensus 149 ~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (305)
++.+..+. .++||||||+++|+|++|+.||..... ... .....+..++..+.+||
T Consensus 209 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------------~~~--~~~~~~~~~~~~~~~li 264 (312)
T 2iwi_A 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------------------ILE--AELHFPAHVSPDCCALI 264 (312)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHH--TCCCCCTTSCHHHHHHH
T ss_pred eeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------------------Hhh--hccCCcccCCHHHHHHH
Confidence 99887764 489999999999999999999975321 000 11234456788899999
Q ss_pred HhhccCCCCCCCCHHHHHHH
Q 021947 228 LQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 228 ~~~l~~~p~~Rps~~~~l~~ 247 (305)
.+||..||.+|||+.+++++
T Consensus 265 ~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 265 RRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHTCSSTTTSCCHHHHHHS
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=286.51 Aligned_cols=234 Identities=24% Similarity=0.308 Sum_probs=174.1
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCe------eEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN------RLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||||++...... ....+.+|+.++++++||||+++++++...+. .|+||||+. ++|.+++.. .+++
T Consensus 51 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~ 125 (353)
T 3coi_A 51 KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSE 125 (353)
T ss_dssp EEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCH
T ss_pred EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCH
Confidence 6999999765322 23678899999999999999999999987654 499999997 488887732 3899
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT- 152 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 152 (305)
..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...... .....+|+.|+|||++.+
T Consensus 126 ~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~ 198 (353)
T 3coi_A 126 EKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW 198 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCc
Confidence 99999999999999999975 5999999999999999999999999999864332 233468999999999877
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhh------hccc--hhhhhhhhcccC---CCCChHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPY------LSDK--RKLFRIMDTKLG---GQYPQKA 219 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~------~~~~--~~~~~~~~~~~~---~~~~~~~ 219 (305)
..++.++||||||+++|+|++|..||.+.+...... ..... .+. .... ......+..... ......+
T Consensus 199 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
T 3coi_A 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA 278 (353)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCc
Confidence 678999999999999999999999998765321110 00000 000 0000 000000111111 1223467
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+..+.+||.+||..||.+|||+.+++++
T Consensus 279 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 279 SPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 8899999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=285.38 Aligned_cols=214 Identities=22% Similarity=0.335 Sum_probs=177.3
Q ss_pred EEEEEecccCCcc------ChHHHHHHHHHHhccC--CCCcccEEEEEEeCCeeEEEEecCCC-CCHHHHhhhcCCCCCC
Q 021947 2 VVAVKKLKPEGFQ------GHKEWLTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~ 72 (305)
.||||++...... ....+.+|+.++++++ |+||+++++++...+..++|||++.+ ++|.+++...+ .++
T Consensus 70 ~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~ 147 (320)
T 3a99_A 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQ 147 (320)
T ss_dssp EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCC
T ss_pred EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCC
Confidence 6999998765332 2356778999999996 59999999999999999999999976 89999997654 489
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
+..+..++.|++.||.|||+. |++||||||+|||++ .++.+||+|||++....... .....||+.|+|||++.
T Consensus 148 ~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 148 EELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC--CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhc
Confidence 999999999999999999965 599999999999998 67899999999998754322 23456899999999998
Q ss_pred cCCC-CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhh
Q 021947 152 TGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 152 ~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (305)
+..+ +.++||||||+++|+|++|..||..... ... .....+..++.++.+||.+|
T Consensus 222 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------------------~~~--~~~~~~~~~~~~~~~li~~~ 277 (320)
T 3a99_A 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIR--GQVFFRQRVSSECQHLIRWC 277 (320)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHH--CCCCCSSCCCHHHHHHHHHH
T ss_pred cCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------------------hhc--ccccccccCCHHHHHHHHHH
Confidence 8776 6789999999999999999999975321 000 01123445778899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021947 231 LNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~ 247 (305)
|..||.+|||+.+++++
T Consensus 278 l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 278 LALRPSDRPTFEEIQNH 294 (320)
T ss_dssp TCSSGGGSCCHHHHHTS
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.61 Aligned_cols=226 Identities=25% Similarity=0.383 Sum_probs=158.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHH-HHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhh---cCCCCCCHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR---RGPQPLSWAVR 76 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~ 76 (305)
.||||+++.... ....++.+|+. +++.++||||+++++++...+..++||||+.+ +|.+++.. .....+++..+
T Consensus 49 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~ 127 (327)
T 3aln_A 49 IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEIL 127 (327)
T ss_dssp EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHH
T ss_pred EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHH
Confidence 699999976533 23345666766 67778999999999999999999999999976 88887753 22345899999
Q ss_pred HHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh----hc
Q 021947 77 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----AT 152 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~ 152 (305)
..++.+++.||.|||+. .|++||||||+||+++.++.+||+|||++........ .....||..|+|||++ .+
T Consensus 128 ~~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~ 203 (327)
T 3aln_A 128 GKITLATVKALNHLKEN-LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASR 203 (327)
T ss_dssp HHHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------
T ss_pred HHHHHHHHHHHHHHhcc-CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCc
Confidence 99999999999999974 1599999999999999999999999999976543221 2234689999999998 45
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc---ccCCCCChHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT---KLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~ 229 (305)
..++.++||||||+++|+|++|..||.+...... .+...... .........++..+.+||.+
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 268 (327)
T 3aln_A 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------------QLTQVVKGDPPQLSNSEEREFSPSFINFVNL 268 (327)
T ss_dssp --CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------------HHHHHhcCCCCCCCCcccccCCHHHHHHHHH
Confidence 6788999999999999999999999976432110 00011110 11111223577889999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||..||.+|||+.+++++
T Consensus 269 ~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 269 CLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HTCSSGGGSCCHHHHTTS
T ss_pred HhhCChhhCcCHHHHHhC
Confidence 999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.26 Aligned_cols=226 Identities=24% Similarity=0.368 Sum_probs=164.6
Q ss_pred CEEEEEecccCCccC-h-HHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQG-H-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||++....... . ..+.++..+++.++||||+++++++...+..|+||||+ ++.+..+.... ...+++..+..
T Consensus 51 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~ 128 (318)
T 2dyl_A 51 HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGK 128 (318)
T ss_dssp CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHH
T ss_pred eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHH
Confidence 369999997654322 2 23444555788889999999999999999999999999 55665555432 34599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TG 153 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~ 153 (305)
++.+++.||.|||+. .|++|+||||+||+++.++.+||+|||++....... ......+++.|+|||++. +.
T Consensus 129 ~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (318)
T 2dyl_A 129 MTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKP 204 (318)
T ss_dssp HHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC-------
T ss_pred HHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhccccccccc
Confidence 999999999999963 259999999999999999999999999997654322 123446899999999984 45
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++||||||+++|+|++|..||........ .+....... ........++..+.+||.+||.
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 269 (318)
T 2dyl_A 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------------VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLT 269 (318)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------------HHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTC
T ss_pred CCccccchhhHHHHHHHHHhCCCCCCCCCccHH---------------HHHHHhccCCCCCCccCCCCHHHHHHHHHHcc
Confidence 688899999999999999999999976332110 111111111 1111223567889999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.||.+|||+.+++++
T Consensus 270 ~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 270 KDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCTTTSCCHHHHTTS
T ss_pred CChhHCcCHHHHhhC
Confidence 999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=269.49 Aligned_cols=203 Identities=17% Similarity=0.177 Sum_probs=161.7
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||++....... ...+.+|++++.+++||||+++++++.+.+..|+||||++|++|.+++.+. .....+..
T Consensus 58 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~ 133 (286)
T 3uqc_A 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIR 133 (286)
T ss_dssp EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHH
T ss_pred eEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHH
Confidence 69999998764433 267899999999999999999999999999999999999999999999532 45567888
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
++.|++.||.|||++ ||+||||||+|||++.+|.+||+++| |++ .++.+
T Consensus 134 i~~ql~~aL~~lH~~--givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~ 182 (286)
T 3uqc_A 134 AMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQ 182 (286)
T ss_dssp HHHHHHHHHHHHHHT--TCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCHH
T ss_pred HHHHHHHHHHHHHHC--CCccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCch
Confidence 999999999999975 59999999999999999999998543 222 36789
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhhccCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+|||||||++|+|++|+.||.+.+..... ............ ......++.++.+||.+||+.||.
T Consensus 183 ~Di~slG~il~elltg~~Pf~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 249 (286)
T 3uqc_A 183 DDIRGIGASLYALLVNRWPLPEAGVRSGL-------------APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGG 249 (286)
T ss_dssp HHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSS
T ss_pred hHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCc
Confidence 99999999999999999999875432100 000000000000 011235778899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 021947 237 LRPRMSEVLAILERLEA 253 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~~ 253 (305)
+| |+.++++.|+++..
T Consensus 250 ~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 250 IR-SASTLLNLMQQATA 265 (286)
T ss_dssp CC-CHHHHHHHHHHHHC
T ss_pred cC-CHHHHHHHHHHHhc
Confidence 99 99999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=293.58 Aligned_cols=242 Identities=22% Similarity=0.289 Sum_probs=181.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEe------CCeeEEEEecCCCCCHHHHhhhcC-CCCCCH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRG-PQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 73 (305)
.||||+++.... ...+.+.+|++++++++||||+++++++.. ++..|+||||++|++|.+++.... ...+++
T Consensus 41 ~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse 120 (676)
T 3qa8_A 41 QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120 (676)
T ss_dssp CEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCS
T ss_pred EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCH
Confidence 689999876532 334678999999999999999999998765 667899999999999999997643 235888
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc---eeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
..++.++.+++.||+|||+. |++||||||+||+++.++. +||+|||++........ .....||..|+|||++
T Consensus 121 ~~i~~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l 195 (676)
T 3qa8_A 121 GPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELL 195 (676)
T ss_dssp SHHHHHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSS
T ss_pred HHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHh
Confidence 89999999999999999975 5999999999999987765 89999999987644322 2345789999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhc---cchhhhhhhhc--------ccCCCCChHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS---DKRKLFRIMDT--------KLGGQYPQKA 219 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~~~ 219 (305)
.+..++.++||||||+++|+|++|..||....... .|...... ........... .........+
T Consensus 196 ~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l 270 (676)
T 3qa8_A 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270 (676)
T ss_dssp CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence 99999999999999999999999999997642211 00000000 00000000000 1112344568
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHH-----HHHHHhhcC
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEV-----LAILERLEA 253 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~-----l~~l~~~~~ 253 (305)
+..+.+||.+||..||.+|||+.++ .+.++.+..
T Consensus 271 s~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp HHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 9999999999999999999999884 455555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=298.51 Aligned_cols=212 Identities=25% Similarity=0.351 Sum_probs=168.3
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCe-----eEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-----RLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||++..... .....+.+|++++.+++||||+++++++...+. .|+||||++|++|.+++.. .+++..
T Consensus 108 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~ 183 (681)
T 2pzi_A 108 PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAE 183 (681)
T ss_dssp EEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHH
T ss_pred EEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHH
Confidence 699999875433 334578899999999999999999999987655 6999999999999988743 499999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 155 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 155 (305)
++.++.|++.||.|||++ ||+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+..
T Consensus 184 ~~~~~~qi~~aL~~lH~~--giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~- 253 (681)
T 2pzi_A 184 AIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP- 253 (681)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-
T ss_pred HHHHHHHHHHHHHHHHHC--CCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-
Confidence 999999999999999975 59999999999999875 8999999999875432 3456899999999987754
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|||||||++|+|++|..||.+..... + .........+..+.+||.+||..||
T Consensus 254 ~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~-------~~~~~~~~~~~~l~~li~~~l~~dP 309 (681)
T 2pzi_A 254 TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------L-------PEDDPVLKTYDSYGRLLRRAIDPDP 309 (681)
T ss_dssp CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------C-------CTTCHHHHHCHHHHHHHHHHTCSSG
T ss_pred CCceehhhhHHHHHHHHhCCCCCccccccc-----------------c-------cccccccccCHHHHHHHhhhccCCh
Confidence 889999999999999999998887532100 0 0001112345789999999999999
Q ss_pred CCCC-CHHHHHHHHHhh
Q 021947 236 KLRP-RMSEVLAILERL 251 (305)
Q Consensus 236 ~~Rp-s~~~~l~~l~~~ 251 (305)
.+|| +++++.+.|..+
T Consensus 310 ~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 310 RQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp GGSCSSHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHH
Confidence 9999 466666655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=266.03 Aligned_cols=203 Identities=21% Similarity=0.292 Sum_probs=159.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHH-hccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYL-GQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||+++. ...+.+|+.++ +.++||||+++++++.. ....|+||||++|++|.+++.......+++..
T Consensus 44 ~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 118 (299)
T 3m2w_A 44 EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118 (299)
T ss_dssp CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHH
T ss_pred cEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHH
Confidence 3699999863 35677899988 55589999999999886 66789999999999999999877666799999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
++.++.|++.||.|||+. |++||||||+||+++. ++.+||+|||++.... +
T Consensus 119 ~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~ 172 (299)
T 3m2w_A 119 ASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------G 172 (299)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------T
T ss_pred HHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------c
Confidence 999999999999999975 4999999999999998 7889999999986432 2
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC----hHHHHHHHHHHH
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLAL 228 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 228 (305)
..++.++|||||||++|+|++|..||.+....... ........ ......+ ..++.++.+||.
T Consensus 173 ~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~ 238 (299)
T 3m2w_A 173 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMKTRIR-MGQYEFPNPEWSEVSEEVKMLIR 238 (299)
T ss_dssp CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSCCSSC-TTCCSSCHHHHTTSCHHHHHHHH
T ss_pred ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HHHHHHHh-hccccCCchhcccCCHHHHHHHH
Confidence 34677899999999999999999999764321100 00000000 0011112 346788999999
Q ss_pred hhccCCCCCCCCHHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~l 248 (305)
+||..||.+|||+.+++++.
T Consensus 239 ~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 239 NLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHTCSSTTTSCCHHHHHTSH
T ss_pred HHcccChhhCCCHHHHhcCh
Confidence 99999999999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=281.44 Aligned_cols=215 Identities=17% Similarity=0.143 Sum_probs=158.1
Q ss_pred CEEEEEecccCCc---cChHHHHHHHHHHhccCC-CCcc---------------------cEEEEEEe-----CCeeEEE
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHH-PNLV---------------------KLIGYCLE-----GENRLLV 50 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-~~i~---------------------~~~~~~~~-----~~~~~lv 50 (305)
..||||+++.... ...+.+.+|+.+++.+.| .|+. .+..++.. ...++++
T Consensus 104 ~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (413)
T 3dzo_A 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183 (413)
T ss_dssp CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEE
T ss_pred CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEE
Confidence 3699999884432 235789999999999987 2211 11111111 2245778
Q ss_pred EecCCCCCHHHHhh-----hcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 51 YEFMPKGSLENHLF-----RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 51 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
|+++ +++|.+++. ......+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 184 ~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~iiHrDiKp~NILl~~~~~~kL~DFG~a~~ 260 (413)
T 3dzo_A 184 YPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260 (413)
T ss_dssp EECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred eehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcccceEEEecCCeEEEEeccceee
Confidence 8877 569999884 22233477889999999999999999975 599999999999999999999999999886
Q ss_pred CCCCCCcceeecccccccccchhhh----------hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 021947 126 GPTGDRTHVSTQVMGTHGYAAPEYV----------ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 195 (305)
Q Consensus 126 ~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 195 (305)
.... ....+| +.|+|||++ .+..++.++|||||||++|+|++|+.||.+.....
T Consensus 261 ~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~---------- 324 (413)
T 3dzo_A 261 DGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG---------- 324 (413)
T ss_dssp TTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS----------
T ss_pred cCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh----------
Confidence 4332 334567 999999999 44457889999999999999999999997643211
Q ss_pred hhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 021947 196 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246 (305)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 246 (305)
....... ....++..+.+||.+||+.||.+|||+.++++
T Consensus 325 ------~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 325 ------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp ------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------hHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111111 11245688999999999999999999888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=269.59 Aligned_cols=216 Identities=16% Similarity=0.147 Sum_probs=163.2
Q ss_pred EEEEEecccCCc--------cChHHHHHHHHHHhccC---------CCCcccEEEEEE----------------------
Q 021947 2 VVAVKKLKPEGF--------QGHKEWLTEVNYLGQLH---------HPNLVKLIGYCL---------------------- 42 (305)
Q Consensus 2 ~VaiK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~~i~~~~~~~~---------------------- 42 (305)
.||||++..... ...+.+.+|++++++++ |+||+++.+++.
T Consensus 45 ~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~ 124 (336)
T 2vuw_A 45 PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124 (336)
T ss_dssp EEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCC
T ss_pred eEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccc
Confidence 699999986532 22377899999999886 888888877653
Q ss_pred --------eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhh-cCCCceeeccCCCCceEeCCCC
Q 021947 43 --------EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEF 113 (305)
Q Consensus 43 --------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~ivH~dlkp~Nil~~~~~ 113 (305)
..+..|+||||+.+|++.+.+.+ ..+++..+..++.|++.||.||| +.+ |+||||||+|||++.++
T Consensus 125 ~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~ 199 (336)
T 2vuw_A 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTS 199 (336)
T ss_dssp SSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECS
T ss_pred cccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccC
Confidence 26789999999999977777644 34899999999999999999999 765 99999999999999887
Q ss_pred --------------------ceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHH-HHHHH
Q 021947 114 --------------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV-LLELL 172 (305)
Q Consensus 114 --------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i-l~~l~ 172 (305)
.+||+|||+++..... ..+||+.|+|||++.+.. +.++||||||++ .++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~ 271 (336)
T 2vuw_A 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRW 271 (336)
T ss_dssp CSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCT
T ss_pred CcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccc
Confidence 8999999999865321 347899999999998766 889999998777 77788
Q ss_pred hCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhc--ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHH-HH
Q 021947 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL-AI 247 (305)
Q Consensus 173 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l-~~ 247 (305)
+|..||.+.. |.. .....+...... ......+..++.++.+||.+||..| |+.+++ ++
T Consensus 272 ~g~~p~~~~~---------~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 272 GEYHPYSNVL---------WLH---YLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp TSCCTHHHHH---------HHH---HHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cccCCCcchh---------hhh---HHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 8999985411 000 000000100000 1111123478999999999999977 999988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=272.79 Aligned_cols=167 Identities=18% Similarity=0.112 Sum_probs=124.1
Q ss_pred EEEEEecccCCc----------cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCC
Q 021947 2 VVAVKKLKPEGF----------QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP 70 (305)
Q Consensus 2 ~VaiK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (305)
.||+|++..+.. ...++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.+.+.
T Consensus 261 ~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~-- 338 (569)
T 4azs_A 261 DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE-- 338 (569)
T ss_dssp SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC--
T ss_pred eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC--
Confidence 478998875421 1225689999999999 699999999999999999999999999999999976653
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
++.. .++.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++
T Consensus 339 l~~~---~I~~QIl~AL~ylH~~--GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 339 IDRE---KILGSLLRSLAALEKQ--GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELF 411 (569)
T ss_dssp CCHH---HHHHHHHHHHHHHHHT--TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC
T ss_pred CCHH---HHHHHHHHHHHHHHHC--CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHh
Confidence 6654 4789999999999965 599999999999999999999999999987544322 23456899999999998
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCcc
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAV 178 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf 178 (305)
.+ .+..++|+|++|++++.+.++..++
T Consensus 412 ~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 412 AE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ------------------CCCCTTHHHH
T ss_pred CC-CCCCcccccccccchhhhccccchh
Confidence 76 4567899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-27 Score=213.93 Aligned_cols=163 Identities=17% Similarity=0.242 Sum_probs=131.5
Q ss_pred EEEEEecccCCccC--------hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLKPEGFQG--------HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.||+|+........ .+++.+|++++++++||||+++..++...+..|+||||++|++|.+++..
T Consensus 361 ~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-------- 432 (540)
T 3en9_A 361 DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-------- 432 (540)
T ss_dssp EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------
T ss_pred eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------
Confidence 47888765432221 24579999999999999999555555577788999999999999999954
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc-----eeecccccccccchh
Q 021947 74 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPE 148 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE 148 (305)
+..++.|++.+|.|||++ +|+||||||+|||++. .+||+|||+++......... ......||+.|+|||
T Consensus 433 --~~~i~~qi~~aL~~LH~~--gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APE 506 (540)
T 3en9_A 433 --NLDIAYKIGEIVGKLHKN--DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDE 506 (540)
T ss_dssp --CTHHHHHHHHHHHHHHHT--TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred --HHHHHHHHHHHHHHHHHC--cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHH
Confidence 467999999999999965 5999999999999988 99999999998764422111 123567999999999
Q ss_pred hhhc--CCCCCCCceehhhHHHHHHHhCCCcc
Q 021947 149 YVAT--GRLTTKSDVYSFGVVLLELLSGRCAV 178 (305)
Q Consensus 149 ~~~~--~~~~~~~Di~slG~il~~l~~g~~pf 178 (305)
++.+ ..|+..+|+|+..+-..+.+.++.+|
T Consensus 507 v~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 507 IWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9987 56888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-22 Score=165.86 Aligned_cols=120 Identities=14% Similarity=0.044 Sum_probs=93.1
Q ss_pred EEEEEecccCCcc------------------ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHh
Q 021947 2 VVAVKKLKPEGFQ------------------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 63 (305)
Q Consensus 2 ~VaiK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 63 (305)
.||||+++..... ....+.+|++++++++ | +++.+++.. +..|+||||++|++|.+ +
T Consensus 116 ~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l 190 (282)
T 1zar_A 116 ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-V 190 (282)
T ss_dssp EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C
T ss_pred EEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-c
Confidence 6999999754221 2356889999999999 4 555554433 55799999999999988 4
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccc
Q 021947 64 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143 (305)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 143 (305)
.. .....++.|++.||.|||+. |++||||||+|||++ ++.+||+|||+++. +..
T Consensus 191 ~~--------~~~~~i~~qi~~~l~~lH~~--giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~ 244 (282)
T 1zar_A 191 RV--------ENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGE 244 (282)
T ss_dssp CC--------SCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTS
T ss_pred ch--------hhHHHHHHHHHHHHHHHHHC--CCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCC
Confidence 21 12446999999999999965 599999999999999 99999999999863 345
Q ss_pred ccchhhhhc
Q 021947 144 YAAPEYVAT 152 (305)
Q Consensus 144 y~aPE~~~~ 152 (305)
+.|||++..
T Consensus 245 ~~a~e~l~r 253 (282)
T 1zar_A 245 EGWREILER 253 (282)
T ss_dssp TTHHHHHHH
T ss_pred CCHHHHHHH
Confidence 788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=136.01 Aligned_cols=96 Identities=18% Similarity=0.130 Sum_probs=75.3
Q ss_pred HHHHHHHHHhccCCCCc--ccEEEEEEeCCeeEEEEecCCC-C----CHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhh
Q 021947 18 EWLTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPK-G----SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 90 (305)
Q Consensus 18 ~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l 90 (305)
.+.+|+++|.++.|++| ..+++. ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHH
Confidence 57899999999988764 444432 356899999942 3 67766532 22345678999999999999
Q ss_pred h-cCCCceeeccCCCCceEeCCCCceeeccccccccC
Q 021947 91 H-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 126 (305)
Q Consensus 91 H-~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 126 (305)
| +.+ |+||||||+|||++. .++|+|||++...
T Consensus 187 H~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 754 999999999999988 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.45 E-value=9.7e-14 Score=119.14 Aligned_cols=94 Identities=13% Similarity=0.095 Sum_probs=67.4
Q ss_pred HHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceee
Q 021947 20 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 99 (305)
Q Consensus 20 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 99 (305)
.+|...|.++.+.++....-+... ..+|||||++|++|..+.. .+ ....++.|++.+|.+||+. ||||
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~--gIVH 228 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKH--GLIH 228 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHT--TEEC
T ss_pred HHHHHHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHC--CCcC
Confidence 357777887765544322222222 3479999999988866542 11 2346789999999999964 5999
Q ss_pred ccCCCCceEeCCCC----------ceeecccccccc
Q 021947 100 RDFKASNILLDAEF----------NAKLSDFGLAKA 125 (305)
Q Consensus 100 ~dlkp~Nil~~~~~----------~~kl~Dfg~~~~ 125 (305)
|||||.|||++++| .+.|+||+-+-.
T Consensus 229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999998876 389999986643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1e-12 Score=108.32 Aligned_cols=116 Identities=12% Similarity=-0.004 Sum_probs=90.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.++||+...........+.+|+++++.+. +..+.++++++...+..|+||||++|.+|.+.+. +......++
T Consensus 39 ~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~ 111 (263)
T 3tm0_A 39 NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKII 111 (263)
T ss_dssp EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHH
T ss_pred cEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHH
Confidence 57889887542234456889999999985 6778899999999899999999999999987641 111234677
Q ss_pred HHHHHHHhhhhcCC---------------------------------------------------------CceeeccCC
Q 021947 81 IGAAKGLTFLHDAE---------------------------------------------------------SQVIYRDFK 103 (305)
Q Consensus 81 ~~i~~~l~~lH~~~---------------------------------------------------------~~ivH~dlk 103 (305)
.+++++|+.||+.. ..++|+|++
T Consensus 112 ~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~ 191 (263)
T 3tm0_A 112 ELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLG 191 (263)
T ss_dssp HHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCC
T ss_pred HHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCC
Confidence 88899999999710 459999999
Q ss_pred CCceEeCCCCceeeccccccc
Q 021947 104 ASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 104 p~Nil~~~~~~~kl~Dfg~~~ 124 (305)
+.||++++++.+.|+||+.+.
T Consensus 192 ~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 192 DSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTSEEEETTEEEEECCCTTCE
T ss_pred cCcEEEECCcEEEEEEchhcc
Confidence 999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=9.3e-11 Score=96.22 Aligned_cols=110 Identities=19% Similarity=0.106 Sum_probs=81.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCC--cccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.++||+.... ....+.+|+.+++.+.+.+ +.++++++..++..|+||||++|.+|. ... .+. ..+
T Consensus 46 ~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~ 112 (264)
T 1nd4_A 46 VLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LAP---AEK 112 (264)
T ss_dssp CEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----CCH---HHH
T ss_pred eEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----CCH---hHH
Confidence 3778887654 2356789999999996544 566888888878899999999998884 211 221 246
Q ss_pred HHHHHHHHhhhhcCC--------------------------------------------------------CceeeccCC
Q 021947 80 AIGAAKGLTFLHDAE--------------------------------------------------------SQVIYRDFK 103 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~--------------------------------------------------------~~ivH~dlk 103 (305)
+.+++..|..||+.. .+++|+|++
T Consensus 113 ~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~ 192 (264)
T 1nd4_A 113 VSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDAC 192 (264)
T ss_dssp HHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCC
Confidence 677777788887532 139999999
Q ss_pred CCceEeCCCCceeeccccccc
Q 021947 104 ASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 104 p~Nil~~~~~~~kl~Dfg~~~ 124 (305)
|.||++++++.+.|+|||.+.
T Consensus 193 ~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 193 LPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGEEEETTEEEEECCCTTCE
T ss_pred CCcEEEECCcEEEEEcchhcc
Confidence 999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.7e-10 Score=99.37 Aligned_cols=120 Identities=13% Similarity=0.194 Sum_probs=88.8
Q ss_pred EEEEEecc--cCC-ccChHHHHHHHHHHhccC--CCCcccEEEEEEeC---CeeEEEEecCCCCCHHHHhhhcCCCCCCH
Q 021947 2 VVAVKKLK--PEG-FQGHKEWLTEVNYLGQLH--HPNLVKLIGYCLEG---ENRLLVYEFMPKGSLENHLFRRGPQPLSW 73 (305)
Q Consensus 2 ~VaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (305)
.+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..|+||||++|..+.+.. ...++.
T Consensus 63 ~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~ 138 (359)
T 3dxp_A 63 TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSP 138 (359)
T ss_dssp EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCH
T ss_pred eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCH
Confidence 35677665 332 123457889999999997 45678888888766 4589999999998775422 123677
Q ss_pred HHHHHHHHHHHHHHhhhhcC--------------------------------------------------------CCce
Q 021947 74 AVRMKVAIGAAKGLTFLHDA--------------------------------------------------------ESQV 97 (305)
Q Consensus 74 ~~~~~~~~~i~~~l~~lH~~--------------------------------------------------------~~~i 97 (305)
.....++.+++..|+.||+. ...+
T Consensus 139 ~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l 218 (359)
T 3dxp_A 139 AERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSI 218 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEE
T ss_pred HHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceE
Confidence 88888999999999999963 2469
Q ss_pred eeccCCCCceEeCCCCc--eeecccccccc
Q 021947 98 IYRDFKASNILLDAEFN--AKLSDFGLAKA 125 (305)
Q Consensus 98 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 125 (305)
+|||+++.||+++.++. +.|+||+.+..
T Consensus 219 vHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 219 VHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp ECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred EeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 99999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.8e-10 Score=96.92 Aligned_cols=165 Identities=20% Similarity=0.210 Sum_probs=104.8
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccC-CCC--cccEEEEEEeCC---eeEEEEecCCCCCHHHHhhhcCCCCCCHHHH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPN--LVKLIGYCLEGE---NRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 76 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (305)
++||+.... .....+.+|+++|+.+. +.. +..++......+ ..|+|||+++|.+|.+.... .++....
T Consensus 43 ~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~ 116 (304)
T 3sg8_A 43 FIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQ 116 (304)
T ss_dssp EEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHH
T ss_pred EEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHH
Confidence 567775432 23467889999998883 332 344554433332 34899999999888653321 2666677
Q ss_pred HHHHHHHHHHHhhhhcC--------------------------------------------------------CCceeec
Q 021947 77 MKVAIGAAKGLTFLHDA--------------------------------------------------------ESQVIYR 100 (305)
Q Consensus 77 ~~~~~~i~~~l~~lH~~--------------------------------------------------------~~~ivH~ 100 (305)
..++.+++..|+.||+. ...++|+
T Consensus 117 ~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg 196 (304)
T 3sg8_A 117 NQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHN 196 (304)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECS
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeC
Confidence 77777888877777751 1358999
Q ss_pred cCCCCceEeCC--CCceeeccccccccCCCCCCcceeecccccccc---cchhhhhc-----CCC---------CCCCce
Q 021947 101 DFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY---AAPEYVAT-----GRL---------TTKSDV 161 (305)
Q Consensus 101 dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y---~aPE~~~~-----~~~---------~~~~Di 161 (305)
|+++.||++++ ++.+.|+||+.+....... . ......+ ..++.... +.. ....+.
T Consensus 197 D~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--D----l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~ 270 (304)
T 3sg8_A 197 DFSSDHILFDTEKNTICGIIDFGDAAISDPDN--D----FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY 270 (304)
T ss_dssp CCCGGGEEEETTTTEEEEECCCTTCEEECTTH--H----HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred CCCcccEEEeCCCCCEEEEEeCCCCccCChHH--H----HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence 99999999988 4567899999886532110 0 0001111 23332211 111 112588
Q ss_pred ehhhHHHHHHHhCCCccC
Q 021947 162 YSFGVVLLELLSGRCAVD 179 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~ 179 (305)
|++|.++|.+.+|..+|-
T Consensus 271 ~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHcCCHHHH
Confidence 999999999999987764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.2e-07 Score=79.55 Aligned_cols=117 Identities=19% Similarity=0.154 Sum_probs=75.7
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccCCC---CcccEEEEEE-eCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHP---NLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+++|+-.. ......+.+|+++|+.+.+. .|.+++.++. ..+..|+|||+++|.++.+.... .++......
T Consensus 42 ~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~ 115 (306)
T 3tdw_A 42 WVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDR 115 (306)
T ss_dssp EEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHH
T ss_pred EEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHH
Confidence 45676422 12346788999999999742 3566666664 34567899999999888663211 133333444
Q ss_pred HHHHHHHHHhhhhcC----------------------------------------------------------CCceeec
Q 021947 79 VAIGAAKGLTFLHDA----------------------------------------------------------ESQVIYR 100 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~----------------------------------------------------------~~~ivH~ 100 (305)
++.+++..|+.||+. ...++|+
T Consensus 116 ~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg 195 (306)
T 3tdw_A 116 LALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHG 195 (306)
T ss_dssp HHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECS
T ss_pred HHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeC
Confidence 444444444444421 2357999
Q ss_pred cCCCCceEeCC---CCc-eeecccccccc
Q 021947 101 DFKASNILLDA---EFN-AKLSDFGLAKA 125 (305)
Q Consensus 101 dlkp~Nil~~~---~~~-~kl~Dfg~~~~ 125 (305)
|+++.||+++. ++. +.|+||+.+..
T Consensus 196 D~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 196 DLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 99999999987 355 48999997764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=9.6e-08 Score=78.67 Aligned_cols=113 Identities=19% Similarity=0.097 Sum_probs=79.5
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
+.||+-... ....+.+|+..|+.+. +--|.++++++.+.+..|+|||+++|.++.+...... .....+..
T Consensus 53 ~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~ 123 (272)
T 4gkh_A 53 LFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVD 123 (272)
T ss_dssp EEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHH
T ss_pred EEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHH
Confidence 456664432 3456788999999885 3336788899999999999999999988776553211 11223445
Q ss_pred HHHHHHhhhhcCC--------------------------------------------------------CceeeccCCCC
Q 021947 82 GAAKGLTFLHDAE--------------------------------------------------------SQVIYRDFKAS 105 (305)
Q Consensus 82 ~i~~~l~~lH~~~--------------------------------------------------------~~ivH~dlkp~ 105 (305)
+++..|..||+.. ..++|+|+.+.
T Consensus 124 ~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~ 203 (272)
T 4gkh_A 124 ALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLD 203 (272)
T ss_dssp HHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTT
T ss_pred HHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCC
Confidence 5555555555311 13899999999
Q ss_pred ceEeCCCCceeeccccccc
Q 021947 106 NILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 106 Nil~~~~~~~kl~Dfg~~~ 124 (305)
||++++++.+-|+||+.+.
T Consensus 204 Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 204 NLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp SEEEETTEEEEECCCTTCE
T ss_pred eEEEECCeEEEEEECcccc
Confidence 9999887777899998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=5.5e-07 Score=77.20 Aligned_cols=58 Identities=2% Similarity=-0.044 Sum_probs=39.1
Q ss_pred EEEEecccCC---ccChHHHHHHHHHHhccC-C--CCcccEEEEEEeC---CeeEEEEecCCCCCHH
Q 021947 3 VAVKKLKPEG---FQGHKEWLTEVNYLGQLH-H--PNLVKLIGYCLEG---ENRLLVYEFMPKGSLE 60 (305)
Q Consensus 3 VaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 60 (305)
+++|+..... ......+.+|+.+++.+. + -.+.+++.++.++ +..|+|||+++|.++.
T Consensus 55 ~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 55 LVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred EEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 5567654332 112356788999999885 3 3567788877655 3568999999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.05 E-value=1.6e-05 Score=61.93 Aligned_cols=141 Identities=14% Similarity=0.044 Sum_probs=91.0
Q ss_pred CCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceee
Q 021947 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 136 (305)
Q Consensus 57 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 136 (305)
-+|.+.|...+ .+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc------------
Confidence 37889887665 579999999999999999877621111 11233457899999999887774 1110
Q ss_pred cccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCC
Q 021947 137 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 216 (305)
Q Consensus 137 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (305)
.....+.+||... ...+.+.-|||||+++|..+--..|= ..+
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------------------------~eE 139 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------------------------NEE 139 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------------------TEE
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------------------ccc
Confidence 1233567888652 33456778999999999988633221 113
Q ss_pred hHHHHHHHHHHHhhccC-------------------------CCCCCCCHHHHHHHHHh
Q 021947 217 QKAAHTAATLALQCLNN-------------------------EPKLRPRMSEVLAILER 250 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~-------------------------~p~~Rps~~~~l~~l~~ 250 (305)
..+++.+..||..|.+- .+..|.++.+|++.-..
T Consensus 140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 35677888888888755 24678899999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.6e-05 Score=65.27 Aligned_cols=32 Identities=16% Similarity=0.201 Sum_probs=28.0
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 46799999999999998888899999987753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=7.8e-05 Score=64.75 Aligned_cols=31 Identities=19% Similarity=0.232 Sum_probs=26.3
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
...++|||+.+.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 4679999999999999776 489999987764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00016 Score=60.55 Aligned_cols=55 Identities=20% Similarity=0.136 Sum_probs=42.5
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC---CCCcccEEEEEEeCCeeEEEEecCCCCCH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGENRLLVYEFMPKGSL 59 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (305)
.++||+.... ....+.+|+..|+.|. ...|.+++.+....+..|+||||++|..+
T Consensus 61 ~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 61 TVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3567776533 3567889999999884 36688888888878889999999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00059 Score=57.63 Aligned_cols=32 Identities=34% Similarity=0.400 Sum_probs=27.6
Q ss_pred CCceeeccCCCCceEeCCC----Cceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~~~~ 125 (305)
...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6789999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00039 Score=60.84 Aligned_cols=31 Identities=10% Similarity=0.206 Sum_probs=27.6
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
...++|||+++.||+++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 46799999999999998776 99999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00028 Score=60.67 Aligned_cols=118 Identities=17% Similarity=0.159 Sum_probs=68.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHH--------------h---
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENH--------------L--- 63 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------l--- 63 (305)
.+.||+... .......+.+|+++++.+. +.-..++++.+.+ .+||||++|.+|..- +
T Consensus 84 ~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~L 158 (379)
T 3feg_A 84 EVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQF 158 (379)
T ss_dssp EEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHH
T ss_pred eEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHH
Confidence 356666432 1234566779999999885 3334666666543 299999998654311 0
Q ss_pred hhcC---CCCCC--HHHHHHHHHHHHH-------------------HHhhh----hc--CCCceeeccCCCCceEeCCC-
Q 021947 64 FRRG---PQPLS--WAVRMKVAIGAAK-------------------GLTFL----HD--AESQVIYRDFKASNILLDAE- 112 (305)
Q Consensus 64 ~~~~---~~~~~--~~~~~~~~~~i~~-------------------~l~~l----H~--~~~~ivH~dlkp~Nil~~~~- 112 (305)
.... ..... +..+..+..++.. .+..| .. ....++|+|+.+.||+++.+
T Consensus 159 H~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~ 238 (379)
T 3feg_A 159 HGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEP 238 (379)
T ss_dssp HTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC
T ss_pred hCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC
Confidence 0000 11122 3344444433321 12222 11 13469999999999999876
Q ss_pred ---Cceeeccccccc
Q 021947 113 ---FNAKLSDFGLAK 124 (305)
Q Consensus 113 ---~~~kl~Dfg~~~ 124 (305)
+.+.|+||..+.
T Consensus 239 ~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 239 ENADSLMLVDFEYSS 253 (379)
T ss_dssp ---CCEEECCCTTCE
T ss_pred CccCcEEEEecccCC
Confidence 689999998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00026 Score=58.95 Aligned_cols=30 Identities=17% Similarity=0.068 Sum_probs=25.3
Q ss_pred CceeeccCCCCceEeCCCCceeecccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 45999999999999 5566789999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00058 Score=59.88 Aligned_cols=52 Identities=17% Similarity=0.147 Sum_probs=33.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCC-cccEEEEEEeCCeeEEEEecCCCCCH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLLVYEFMPKGSL 59 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (305)
.|.+|+.... .....+.+|+.+++.+...+ ..++++.+.+ .+|+||++|.+|
T Consensus 107 ~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 107 KVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp EEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred eEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 3567776432 12256778999999885333 3667765532 389999987443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0011 Score=55.46 Aligned_cols=30 Identities=27% Similarity=0.258 Sum_probs=25.8
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
.+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 469999999999999877656899998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0014 Score=56.19 Aligned_cols=29 Identities=21% Similarity=0.291 Sum_probs=24.4
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
..++|+|+++.|||++.++ +.|+||+.+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4699999999999997654 8999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.007 Score=50.75 Aligned_cols=30 Identities=23% Similarity=0.264 Sum_probs=25.7
Q ss_pred CCceeeccCCCCceEeCCCCceeecccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
...++|||+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45699999999999998 4 799999987754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0045 Score=51.00 Aligned_cols=53 Identities=19% Similarity=0.184 Sum_probs=35.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCC---CCcccEEEEEEeCCeeEEEEecCCCCC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHH---PNLVKLIGYCLEGENRLLVYEFMPKGS 58 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~~ 58 (305)
.|.+|+...........|..|+..|+.|.- --+.+++++. ..++||||++++.
T Consensus 41 ~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 41 PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 577888765544445668899999998842 2345555542 3479999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.022 Score=49.57 Aligned_cols=29 Identities=17% Similarity=0.346 Sum_probs=25.6
Q ss_pred CceeeccCCCCceEeCCCCceeeccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
..++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 35999999999999 777889999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.049 Score=47.99 Aligned_cols=52 Identities=17% Similarity=0.113 Sum_probs=31.2
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccCCCCc-ccEEEEEEeCCeeEEEEecCCCCCH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLLVYEFMPKGSL 59 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 59 (305)
+++|+..... ...-...+|+.+++.|...++ .++++.+. + .+||||++|.+|
T Consensus 136 ~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 136 YLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 5667654321 111122589999999864444 56777662 2 359999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.14 E-value=0.044 Score=46.24 Aligned_cols=31 Identities=19% Similarity=0.201 Sum_probs=27.3
Q ss_pred CceeeccCCCCceEeCCCCceeecccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.04 E-value=0.76 Score=35.80 Aligned_cols=84 Identities=10% Similarity=0.077 Sum_probs=61.0
Q ss_pred CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHh-hhhcCCCceeeccCCCCceE
Q 021947 30 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT-FLHDAESQVIYRDFKASNIL 108 (305)
Q Consensus 30 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~ivH~dlkp~Nil 108 (305)
.||++ -..+-.+++.+.+.++.-+++.=...+ + .++....+.++..++.... ++++ -+|--|+|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~---~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--R---KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--H---TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--H---hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEE
Confidence 57877 344556667766666665333323333 1 2788899999999988777 5653 578899999999
Q ss_pred eCCCCceeeccccccc
Q 021947 109 LDAEFNAKLSDFGLAK 124 (305)
Q Consensus 109 ~~~~~~~kl~Dfg~~~ 124 (305)
++.++.+++.-.|+-.
T Consensus 117 f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE 132 (219)
T ss_dssp ECTTCCEEESCCEETT
T ss_pred EeCCCcEEEEEcCCcc
Confidence 9999999999887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.73 E-value=0.56 Score=36.43 Aligned_cols=117 Identities=5% Similarity=0.021 Sum_probs=76.2
Q ss_pred CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEe
Q 021947 30 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 109 (305)
Q Consensus 30 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~ 109 (305)
.||+.+.. .+-...+.+.+.++.-. +...|-.-. .++....+.++..|+....++++ -+|--|+|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 58888876 55566666556555543 222222111 27888999999999887766663 4788999999999
Q ss_pred CCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCC
Q 021947 110 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180 (305)
Q Consensus 110 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 180 (305)
+.++.+++.-.|+-....... +..|-+ +-.+-|++..++.++..|..
T Consensus 113 ~~~~~p~i~~RGik~~l~P~~--------------~~ee~f----------L~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDPLP--------------VSEAEF----------LTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTTBSCCC--------------CCHHHH----------HHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccCCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHHH
Confidence 999999999877643321110 111211 12456778888888877753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.10 E-value=0.11 Score=44.94 Aligned_cols=29 Identities=28% Similarity=0.332 Sum_probs=24.3
Q ss_pred ceeeccCCCCceEe------CCCCceeeccccccc
Q 021947 96 QVIYRDFKASNILL------DAEFNAKLSDFGLAK 124 (305)
Q Consensus 96 ~ivH~dlkp~Nil~------~~~~~~kl~Dfg~~~ 124 (305)
.++|+|+.+.|||+ +.++.++++||.++.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 345679999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 305 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 9e-67
Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 23/260 (8%)
Query: 3 VAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK L Q + + EV L + H N++ +GY +V ++ SL
Sbjct: 33 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY 91
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+HL + +A A+G+ +LH +I+RD K++NI L + K+ DF
Sbjct: 92 HHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDF 148
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCA 177
GLA +H Q+ G+ + APE + + +SDVY+FG+VL EL++G+
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
+ D + + L +CL +
Sbjct: 209 YS------NINNRDQIIFMVGRGYLSPDLSK------VRSNCPKAMKRLMAECLKKKRDE 256
Query: 238 RPRMSEVLAILERLEA--PK 255
RP ++LA +E L PK
Sbjct: 257 RPLFPQILASIELLARSLPK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 2e-60
Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 20/251 (7%)
Query: 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+ VAVK LK + + +E+L E + ++ HPNLV+L+G C ++ EFM G+L
Sbjct: 43 LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
++L Q +S V + +A + + +L + I+RD A N L+ K++DF
Sbjct: 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADF 159
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GL++ GD + APE +A + + KSDV++FGV+L E+ + +
Sbjct: 160 GLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218
Query: 181 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
D +++ +++ + P+ L C P RP
Sbjct: 219 GI----------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262
Query: 241 MSEVLAILERL 251
+E+ E +
Sbjct: 263 FAEIHQAFETM 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 3e-60
Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 28/253 (11%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLE 60
VAVK +K + + +L E + + QL H NLV+L+G +E + L +V E+M KGSL
Sbjct: 32 KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
++L RG L +K ++ + + +L + ++RD A N+L+ + AK+SDF
Sbjct: 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDF 147
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 180
GL K + + + APE + + +TKSDV+SFG++L E+ S
Sbjct: 148 GLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--- 199
Query: 181 TKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
PY + + ++ P + C + + +RP
Sbjct: 200 --------------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245
Query: 240 RMSEVLAILERLE 252
++ LE ++
Sbjct: 246 SFLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-59
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 21/248 (8%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VAVK LK +G +L E N + QL H LV+L + E ++ E+M GSL +
Sbjct: 39 KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD 96
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
L L+ + +A A+G+ F+ E I+RD +A+NIL+ + K++DFG
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
LA+ + + APE + G T KSDV+SFG++L E+++
Sbjct: 155 LARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 182 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241
++ + ++ P L C P+ RP
Sbjct: 214 M----------------TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257
Query: 242 SEVLAILE 249
+ ++LE
Sbjct: 258 DYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-59
Identities = 56/251 (22%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K +K EG E++ E + L H LV+L G C + ++ E+M G L N
Sbjct: 30 DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+L +++ + + +L Q ++RD A N L++ + K+SDFG
Sbjct: 89 YLREMRH-RFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
L++ D S ++ PE + + ++KSD+++FGV++ E+ S
Sbjct: 146 LSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK----- 199
Query: 182 KVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
PY + + L P A+ T+ C + + RP
Sbjct: 200 ------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247
Query: 241 MSEVLAILERL 251
+L+ + +
Sbjct: 248 FKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 8e-59
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 45/275 (16%)
Query: 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VAVK LK E ++ E + + +PN+VKL+G C G+ L++E+M G L
Sbjct: 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 61 NHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98
L P PLS A ++ +A A G+ +L E + +
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFV 162
Query: 99 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158
+RD N L+ K++DFGL++ + D + PE + R TT+
Sbjct: 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222
Query: 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYP 216
SDV+++GVVL E+ S +PY ++ + ++ + D + P
Sbjct: 223 SDVWAYGVVLWEIFSYGL-----------------QPYYGMAHEEVIYYVRDGNI-LACP 264
Query: 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
+ L C + P RP + IL+R+
Sbjct: 265 ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-58
Identities = 69/269 (25%), Positives = 108/269 (40%), Gaps = 35/269 (13%)
Query: 1 MVVAVKKLKPEGFQGHKE-WLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
M VAVK LKP +E ++E+ L L +H N+V L+G C G L++ E+ G
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 59 LENHLFRRGPQ----------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 102
L N L R+ L + + AKG+ FL I+RD
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDL 171
Query: 103 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 162
A NILL K+ DFGLA+ V + APE + T +SDV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 163 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 222
S+G+ L EL S + P + K ++++ P+ A
Sbjct: 232 SYGIFLWELFSLGSSPY---------------PGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 223 AATLALQCLNNEPKLRPRMSEVLAILERL 251
+ C + +P RP +++ ++E+
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-58
Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 34/272 (12%)
Query: 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
V+A K + E + + E+ L + + P +V G + E M GSL+
Sbjct: 33 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
L + G + + KV+I KGLT+L + + ++++RD K SNIL+++ KL DF
Sbjct: 93 QVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDF 149
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR----- 175
G++ ++ +GT Y +PE + + +SD++S G+ L+E+ GR
Sbjct: 150 GVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 176 -----------CAVDKTKVGIEQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQK 218
C V+ +P S +F ++D + P+
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 219 AAHT----AATLALQCLNNEPKLRPRMSEVLA 246
+ +CL P R + +++
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-57
Identities = 66/250 (26%), Positives = 113/250 (45%), Gaps = 21/250 (8%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA+K ++ EG ++++ E + +L HP LV+L G CLE LV+EFM G L +
Sbjct: 31 KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ R + + + + +G+ +L E+ VI+RD A N L+ K+SDFG
Sbjct: 90 Y-LRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
+ + D+ ST +A+PE + R ++KSDV+SFGV++ E+ S +
Sbjct: 147 MTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 182 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241
+ ++ + T P+ A+ + C P+ RP
Sbjct: 206 R----------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 242 SEVLAILERL 251
S +L L +
Sbjct: 250 SRLLRQLAEI 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-57
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 23/255 (9%)
Query: 1 MVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR-LLVYEFMPKGS 58
+ AVK L G ++LTE + HPN++ L+G CL E L+V +M G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L N + P + + + AKG+ FL + ++RD A N +LD +F K++
Sbjct: 116 LRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVA 172
Query: 119 DFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
DFGLA+ D H T + A E + T + TTKSDV+SFGV+L EL++
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 177 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
+ + D L +R L P+ + L+C + + +
Sbjct: 233 PPYP-----DVNTFDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAE 276
Query: 237 LRPRMSEVLAILERL 251
+RP SE+++ + +
Sbjct: 277 MRPSFSELVSRISAI 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-56
Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 44/274 (16%)
Query: 1 MVVAVKKLKPEGFQGHKE-WLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
+ VAVK LK + +E ++E+ + QL H N+V L+G C L++E+ G
Sbjct: 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 59 LENHLFRRGPQ---------------------PLSWAVRMKVAIGAAKGLTFLHDAESQV 97
L N+L + + L++ + A AKG+ FL
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSC 185
Query: 98 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157
++RD A N+L+ K+ DFGLA+ + V + APE + G T
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQY 215
KSDV+S+G++L E+ S PY + ++++
Sbjct: 246 KSDVWSYGILLWEIFSLGV-----------------NPYPGIPVDANFYKLIQNGFKMDQ 288
Query: 216 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249
P A + C + + RP + + L
Sbjct: 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 9e-56
Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 25/263 (9%)
Query: 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K LK + +++L+E + +GQ HPN++ L G + +++ EFM GSL+
Sbjct: 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 115
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
R+ + + + G A G+ +L D ++RD A NIL+++ K+SDF
Sbjct: 116 -SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDF 172
Query: 121 GLAKAGPTGDRTHVSTQV---MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
GL++ T + APE + + T+ SDV+S+G+V+ E++S
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE- 231
Query: 178 VDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
+PY + + ++ P L L C +
Sbjct: 232 ----------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRN 275
Query: 237 LRPRMSEVLAILERLEAPKNSAK 259
RP+ +++ L+++ NS K
Sbjct: 276 HRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-55
Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 33/270 (12%)
Query: 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 62
VA+K LKP G + +L E + +L H LV+L E +V E+M KGSL +
Sbjct: 44 VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDF 101
Query: 63 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 122
L + L + +A A G+ ++ ++RD +A+NIL+ K++DFGL
Sbjct: 102 LKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGL 159
Query: 123 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 182
A+ + + APE GR T KSDV+SFG++L EL +
Sbjct: 160 ARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG------- 211
Query: 183 VGIEQSLVDWAKPYLSDK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240
+ R++ ++ P + + L QC EP+ RP
Sbjct: 212 -----------RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260
Query: 241 MSEVLAILERLEAPKNSAKLSQSEPHRQTG 270
+ A LE + +EP Q G
Sbjct: 261 FEYLQAFLEDY--------FTSTEPQYQPG 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-55
Identities = 60/264 (22%), Positives = 122/264 (46%), Gaps = 22/264 (8%)
Query: 1 MVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VA+K LK + + ++L E +GQ H N+++L G + + +++ E+M G+
Sbjct: 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA- 95
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ R S + + G A G+ +L ++RD A NIL+++ K+SD
Sbjct: 96 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSD 153
Query: 120 FGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
FGL++ + T+ ++ + APE ++ + T+ SDV+SFG+V+ E+++
Sbjct: 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG--- 210
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
+ ++ + ++ P L +QC E R
Sbjct: 211 -------------ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
Query: 239 PRMSEVLAILERL-EAPKNSAKLS 261
P+ +++++IL++L AP + L+
Sbjct: 258 PKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-55
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 28/272 (10%)
Query: 1 MVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VA+K LK + +E + E + QL +P +V+LIG C + E +LV E G L
Sbjct: 37 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL 95
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
L + + + + ++ + G+ +L + ++RD A N+LL AK+SD
Sbjct: 96 HKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISD 152
Query: 120 FGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
FGL+KA G + + APE + + +++SDV+S+GV + E LS
Sbjct: 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG--- 209
Query: 179 DKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
KPY K ++ ++ + P + L C + +
Sbjct: 210 --------------QKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 255
Query: 238 RPRMSEVLAILERLEAPKNS-AKLSQSEPHRQ 268
RP V +R+ A S A + H
Sbjct: 256 RPDFLTV---EQRMRACYYSLASKVEGHHHHH 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-55
Identities = 69/252 (27%), Positives = 109/252 (43%), Gaps = 26/252 (10%)
Query: 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VAVK LK E E L E N + QL +P +V++IG C E E+ +LV E G L
Sbjct: 36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPL 94
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+L + + +++ + G+ +L + S ++RD A N+LL + AK+SD
Sbjct: 95 NKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISD 150
Query: 120 FGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
FGL+KA + T + APE + + ++KSDV+SFGV++ E S
Sbjct: 151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG--- 207
Query: 179 DKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
KPY K ++ +++ P L C + +
Sbjct: 208 --------------QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 253
Query: 238 RPRMSEVLAILE 249
RP + V L
Sbjct: 254 RPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-55
Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 40/284 (14%)
Query: 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
M A+K++K H+++ E+ L +L HHPN++ L+G C L E+ P G+
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L + L + LS + A A+G+ +L + Q I+RD A
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAA 155
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 164
NIL+ + AK++DFGL++ + T + A E + TT SDV+S+
Sbjct: 156 RNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSY 212
Query: 165 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR-KLFRIMDTKLGGQYPQKAAHTA 223
GV+L E++S PY +L+ + + P
Sbjct: 213 GVLLWEIVSL-----------------GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV 255
Query: 224 ATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPH 266
L QC +P RP +++L L R LE K + E
Sbjct: 256 YDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-54
Identities = 55/252 (21%), Positives = 93/252 (36%), Gaps = 29/252 (11%)
Query: 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFM 54
+ VA +L+ + + E L L HPN+V+ + +LV E M
Sbjct: 35 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-F 113
G+L+ +L R + V KGL FLH +I+RD K NI +
Sbjct: 95 TSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 152
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
+ K+ D GLA R + V+GT + APE + DVY+FG+ +LE+ +
Sbjct: 153 SVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMAT 207
Query: 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233
+ + + R+ + + A + C+
Sbjct: 208 SEYPYSECQNAAQI---------------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252
Query: 234 EPKLRPRMSEVL 245
R + ++L
Sbjct: 253 NKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-54
Identities = 57/253 (22%), Positives = 107/253 (42%), Gaps = 31/253 (12%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
+ A K + + + ++++ E++ L HPN+VKL+ N ++ EF G+++
Sbjct: 39 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ +PL+ + V L +LH ++++I+RD KA NIL + + KL+DFG
Sbjct: 99 VMLELE-RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFG 155
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRC 176
++ + +GT + APE V K+DV+S G+ L+E+
Sbjct: 156 VSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE- 212
Query: 177 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNN 233
P+ L+ R L +I ++ P + + +CL
Sbjct: 213 -----------------PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK 255
Query: 234 EPKLRPRMSEVLA 246
R S++L
Sbjct: 256 NVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-54
Identities = 55/253 (21%), Positives = 112/253 (44%), Gaps = 23/253 (9%)
Query: 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VA+K+L+ + +KE L E + + +P++ +L+G CL L+ + MP G L
Sbjct: 39 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCL 97
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+++ + + AKG+ +L D ++++RD A N+L+ + K++D
Sbjct: 98 LDYVREHKDNI-GSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITD 154
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLAK ++ + + + A E + T +SDV+S+GV + EL++
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG---- 210
Query: 180 KTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
+KPY ++ I++ P + ++C + R
Sbjct: 211 -------------SKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257
Query: 239 PRMSEVLAILERL 251
P+ E++ ++
Sbjct: 258 PKFRELIIEFSKM 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-54
Identities = 52/272 (19%), Positives = 93/272 (34%), Gaps = 26/272 (9%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL----LVYEFMPKG 57
VAVK + E+ L H N++ I + LV ++ G
Sbjct: 28 EVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDA 111
SL ++L R ++ +K+A+ A GL LH + + +RD K+ NIL+
Sbjct: 87 SLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 112 EFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYS 163
++D GLA + T +GT Y APE + ++D+Y+
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
Query: 164 FGVVLLELLSGRCAVDKTKVG----IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 219
G+V E+ + + D + + ++ +A
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263
Query: 220 AHTAATLALQCLNNEPKLRPRMSEVLAILERL 251
A + +C R + L +L
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-54
Identities = 64/255 (25%), Positives = 107/255 (41%), Gaps = 32/255 (12%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKG 57
++ K+L + ++EVN L +L HPN+V+ ++ N L V E+ G
Sbjct: 31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90
Query: 58 SLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLH---DAESQVIYRDFKASNILLDAE 112
L + + + + Q L ++V L H D V++RD K +N+ LD +
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
N KL DFGLA+ T + +GT Y +PE + KSD++S G +L EL
Sbjct: 151 QNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230
+ P+ S K +I + K + P + + + +
Sbjct: 209 ALM------------------PPFTAFSQKELAGKIREGKF-RRIPYRYSDELNEIITRM 249
Query: 231 LNNEPKLRPRMSEVL 245
LN + RP + E+L
Sbjct: 250 LNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (443), Expect = 2e-53
Identities = 66/252 (26%), Positives = 100/252 (39%), Gaps = 36/252 (14%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VVA+KK+ G Q +++W + EV +L +L HPN ++ G L LV E+ +
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ + PL V GA +GL +LH +I+RD KA NILL KL
Sbjct: 102 SDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLG 157
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGR 175
DFG A + +GT + APE + G+ K DV+S G+ +EL +
Sbjct: 158 DFGSAS------IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 176 CAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233
P ++ L+ I + + CL
Sbjct: 212 ------------------PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 234 EPKLRPRMSEVL 245
P+ RP +L
Sbjct: 254 IPQDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-53
Identities = 66/258 (25%), Positives = 109/258 (42%), Gaps = 27/258 (10%)
Query: 1 MVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
+ VAVK LKP+ + +++ EVN + L H NL++L G L + +V E P G
Sbjct: 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
SL + L + + A+ A+G+ +L + I+RD A N+LL K+
Sbjct: 96 SLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKI 152
Query: 118 SDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 176
DFGL +A P D +V + APE + T + SD + FGV L E+ +
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG- 211
Query: 177 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234
+P+ L+ + L +I P+ + +QC ++
Sbjct: 212 ----------------QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHK 255
Query: 235 PKLRPRMSEVLAILERLE 252
P+ RP + L +
Sbjct: 256 PEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-53
Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 33/249 (13%)
Query: 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
++A+K L + EV L HPN+++L GY + L+ E+ P G+
Sbjct: 33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ L + A L++ H +VI+RD K N+LL + K++
Sbjct: 93 VYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIA 148
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFG + P+ RT + GT Y PE + K D++S GV+ E L G+
Sbjct: 149 DFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--- 201
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
P+ ++ + RI + +P A L + L + P
Sbjct: 202 ---------------PPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPS 244
Query: 237 LRPRMSEVL 245
RP + EVL
Sbjct: 245 QRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-52
Identities = 59/246 (23%), Positives = 94/246 (38%), Gaps = 21/246 (8%)
Query: 2 VVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VAVK + + + E+ L+H N+VK G+ EG + L E+ G L
Sbjct: 32 AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 120
+ + + + G+ +LH + +RD K N+LLD N K+SDF
Sbjct: 92 DRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDF 147
Query: 121 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVD 179
GLA +R + ++ GT Y APE + DV+S G+VL +L+G D
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
+ Q DW + +K L + L P R
Sbjct: 208 QPS-DSCQEYSDWKEKKTYLN--------------PWKKIDSAPLALLHKILVENPSARI 252
Query: 240 RMSEVL 245
+ ++
Sbjct: 253 TIPDIK 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-51
Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 27/262 (10%)
Query: 2 VVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K + + E+L E + + + + ++V+L+G +G+ L++ E M +G L+
Sbjct: 52 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111
Query: 61 NHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
++L P P S + +++A A G+ +L+ ++ ++RD A N ++ +
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAED 169
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
F K+ DFG+ + D + + + +PE + G TT SDV+SFGVVL E+
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232
+ + LS+++ L +M+ L P L C
Sbjct: 230 TLA---------------EQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQ 273
Query: 233 NEPKLRPRMSEVLAILERLEAP 254
PK+RP E+++ ++ P
Sbjct: 274 YNPKMRPSFLEIISSIKEEMEP 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 1 MVVAVKKLKPEGFQGH-KEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
VAVK LK + + + ++E+ + + H N++ L+G C + ++ E+ KG+
Sbjct: 46 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 59 LENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L R P + LS + A A+G+ +L + I+RD A
Sbjct: 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAA 163
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 164
N+L+ + K++DFGLA+ D +T + APE + T +SDV+SF
Sbjct: 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 165 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL-SDKRKLFRIMDTKLGGQYPQKAAHTA 223
GV+L E+ + + PY +LF+++ P +
Sbjct: 224 GVLLWEIFTLGGS-----------------PYPGVPVEELFKLLKEGHRMDKPSNCTNEL 266
Query: 224 ATLALQCLNNEPKLRPRMSEVLAILERLEA 253
+ C + P RP +++ L+R+ A
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-49
Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 28/247 (11%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
VA++++ + + + E+ + + +PN+V + L G+ +V E++ GSL +
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 121
+ V + L FLH +QVI+RD K+ NILL + + KL+DFG
Sbjct: 107 VVTETCM---DEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 122 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 181
+ ++GT + APE V K D++S G++ +E++ G
Sbjct: 162 FCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------ 213
Query: 182 KVGIEQSLVDWAKPY--LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
PY + R L+ I + Q P+K + +CL+ + + R
Sbjct: 214 ------------PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 239 PRMSEVL 245
E+L
Sbjct: 262 GSAKELL 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 22/252 (8%)
Query: 1 MVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+ VA+K K +E +L E + Q HP++VKLIG E ++ E G L
Sbjct: 36 LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGEL 94
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ L R L A + A + L +L + ++RD A N+L+ + KL D
Sbjct: 95 RSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGD 151
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGL++ + +++ + APE + R T+ SDV+ FGV + E+L
Sbjct: 152 FGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--- 207
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239
+ + + RI + + P T +L +C +P RP
Sbjct: 208 ------------KPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRP 254
Query: 240 RMSEVLAILERL 251
R +E+ A L +
Sbjct: 255 RFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-49
Identities = 50/258 (19%), Positives = 92/258 (35%), Gaps = 29/258 (11%)
Query: 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
A+K L+ E + + +L HP VKL + E + G
Sbjct: 35 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L ++ + G L +LH +I+RD K NILL+ + + +++
Sbjct: 95 LLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQIT 150
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFG AK + + +GT Y +PE + SD+++ G ++ +L++G
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL--- 207
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
P+ + +I+ + +P+K A L + L +
Sbjct: 208 ---------------PPFRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDAT 250
Query: 237 LRPRMSEVLAILERLEAP 254
R E+ P
Sbjct: 251 KRLGCEEMEGYGPLKAHP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 1e-48
Identities = 60/304 (19%), Positives = 99/304 (32%), Gaps = 28/304 (9%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
A K + + E+ + L HP LV L + +++YEFM G L
Sbjct: 53 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSD 119
+ +S ++ KGL +H+ ++ D K NI+ + + KL D
Sbjct: 113 KVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLID 169
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGL GT +AAPE + +D++S GV+ LLSG
Sbjct: 170 FGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
Query: 180 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKL 237
+D L + + + L +P
Sbjct: 227 GE----------------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270
Query: 238 RPRMSEVLA--ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPL 295
R + + L L AP +++ S + + + + PL S L
Sbjct: 271 RMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSL 330
Query: 296 PSHR 299
HR
Sbjct: 331 RKHR 334
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 69/267 (25%), Positives = 105/267 (39%), Gaps = 34/267 (12%)
Query: 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 58
VAVK LK H+ ++E+ L HH N+V L+G C + L ++ EF G+
Sbjct: 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 59 LENHLFRRGPQ--------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 104
L +L + + L+ + + AKG+ FL + I+RD A
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAA 162
Query: 105 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 164
NILL + K+ DFGLA+ + APE + T +SDV+SF
Sbjct: 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222
Query: 165 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224
GV+L E+ S + P + + R + + P
Sbjct: 223 GVLLWEIFSLGASPY---------------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 267
Query: 225 TLALQCLNNEPKLRPRMSEVLAILERL 251
L C + EP RP SE++ L L
Sbjct: 268 QTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 156 bits (396), Expect = 5e-46
Identities = 59/302 (19%), Positives = 104/302 (34%), Gaps = 40/302 (13%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
V K + E++ + QLHHP L+ L + +L+ EF+ G L +
Sbjct: 56 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSD 119
+ +S A + A +GL +H E +++ D K NI+ + + + K+ D
Sbjct: 116 RIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIID 172
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLA + T +AAPE V + +D+++ GV+ LLSG
Sbjct: 173 FGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL---- 225
Query: 180 KTKVGIEQSLVDWAKPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEP 235
P+ D L + D + + A L EP
Sbjct: 226 --------------SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 271
Query: 236 KLRPRMSEVLA----------ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSP 285
+ R + + L + R+ + + + + + P S
Sbjct: 272 RKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSS 331
Query: 286 LN 287
L
Sbjct: 332 LR 333
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-45
Identities = 58/310 (18%), Positives = 118/310 (38%), Gaps = 37/310 (11%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 61
K +K +G E++ L H N++ L E ++++EF+ +
Sbjct: 32 TYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90
Query: 62 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSD 119
+ L+ + + L FLH + + D + NI+ ++ K+ +
Sbjct: 91 RI-NTSAFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIE 147
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FG A+ GD + + Y APE ++T +D++S G ++ LLSG
Sbjct: 148 FGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI---- 200
Query: 180 KTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEP 235
P+L++ + + IM+ + + ++ + A + L E
Sbjct: 201 --------------NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
Query: 236 KLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTA 292
K R SE L + +++E + S K+ ++ HR+ T+ K + S ++
Sbjct: 247 KSRMTASEALQHPWLKQKIE--RVSTKVIRTLKHRRYYH-TLIKKDLNMVVSAARISCGG 303
Query: 293 SPLPSHRQSP 302
+ S
Sbjct: 304 AIRSQKGVSV 313
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (365), Expect = 3e-42
Identities = 62/263 (23%), Positives = 113/263 (42%), Gaps = 35/263 (13%)
Query: 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFM 54
VAVK L+ + + + + E L+HP +V + G +V E++
Sbjct: 34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93
Query: 55 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 114
+L + + GP ++ ++V A + L F H ++ +I+RD K +NI++ A
Sbjct: 94 DGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNA 149
Query: 115 AKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFG+A+ +G+ + V+GT Y +PE + +SDVYS G VL E+L+
Sbjct: 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 209
Query: 174 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQ 229
G P+ S ++ + D + + + L+
Sbjct: 210 GE------------------PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251
Query: 230 CLNNEPKLRPR-MSEVLAILERL 251
L P+ R + +E+ A L R+
Sbjct: 252 ALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 64/242 (26%), Positives = 91/242 (37%), Gaps = 28/242 (11%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLG-QLHHPNLVKLIGYCLEGENRLLVYEFMPKG 57
A+K LK + + + E L HP L + EN V E++ G
Sbjct: 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88
Query: 58 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 117
L H+ LS A A GL FLH ++YRD K NILLD + + K+
Sbjct: 89 DLMYHIQSCHKFDLSRATFY--AAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKI 144
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
+DFG+ K GD GT Y APE + + D +SFGV+L E+L G+
Sbjct: 145 ADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS- 201
Query: 178 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237
P+ + YP+ A L ++ EP+
Sbjct: 202 -----------------PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 244
Query: 238 RP 239
R
Sbjct: 245 RL 246
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (360), Expect = 2e-41
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 45/265 (16%)
Query: 2 VVAVKKLKPEGF---------QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVY 51
AVK + G + + L EV+ L ++ HPN+++L LV+
Sbjct: 30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89
Query: 52 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
+ M KG L ++L + LS K+ + + LH +++RD K NILLD
Sbjct: 90 DLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDD 145
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL------TTKSDVYSFG 165
+ N KL+DFG + G++ +V GT Y APE + + D++S G
Sbjct: 146 DMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202
Query: 166 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK--LFRIM--DTKLGGQYPQKAAH 221
V++ LL+G P+ K+ L IM + + G +
Sbjct: 203 VIMYTLLAGS------------------PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 222 TAATLALQCLNNEPKLRPRMSEVLA 246
T L + L +P+ R E LA
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 6e-41
Identities = 55/253 (21%), Positives = 103/253 (40%), Gaps = 33/253 (13%)
Query: 2 VVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
+VA+K + + +G + E+ L ++ HPN+V L G + L+ + + G L
Sbjct: 36 LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKL 117
+ + +G + ++ + +LH + +++RD K N+L D + +
Sbjct: 96 DRIVEKG--FYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMI 151
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 177
SDFGL+K D V + GT GY APE +A + D +S GV+ LL G
Sbjct: 152 SDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-- 206
Query: 178 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNN 233
P+ +D + +I+ + + Y + +A +
Sbjct: 207 ----------------PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250
Query: 234 EPKLRPRMSEVLA 246
+P+ R + L
Sbjct: 251 DPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (358), Expect = 2e-40
Identities = 59/252 (23%), Positives = 92/252 (36%), Gaps = 30/252 (11%)
Query: 2 VVAVKKLKPEGF---QGHKEWLTEVN---YLGQLHHPNLVKLIGYCLEGENRLLVYEFMP 55
+ A+K L + QG L E + P +V + + + + M
Sbjct: 31 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G L HL + G + I GL +H V+YRD K +NILLD +
Sbjct: 91 GGDLHYHLSQHGVFSEADMRFYAAEI--ILGLEHMH--NRFVVYRDLKPANILLDEHGHV 146
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 174
++SD GLA +GTHGY APE + G + +D +S G +L +LL G
Sbjct: 147 RISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 175 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 234
+ + DK ++ R+ T + P + +L L +
Sbjct: 203 HSP--------------FRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRD 247
Query: 235 PKLRPRMSEVLA 246
R A
Sbjct: 248 VNRRLGCLGRGA 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-40
Identities = 55/257 (21%), Positives = 94/257 (36%), Gaps = 35/257 (13%)
Query: 2 VVAVKKLKPEGFQGHKEW------LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP 55
A K +K + + EV+ L ++ HPN++ L + +L+ E +
Sbjct: 37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--- 112
G L + L + A G+ +LH Q+ + D K NI+L
Sbjct: 97 GGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVP 152
Query: 113 -FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 171
K+ DFGLA G+ + GT + APE V L ++D++S GV+ L
Sbjct: 153 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209
Query: 172 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQ 229
LSG + + L + + + +Y + A +
Sbjct: 210 LSGASPFLGD----------------TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 230 CLNNEPKLRPRMSEVLA 246
L +PK R + + L
Sbjct: 254 LLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-39
Identities = 60/261 (22%), Positives = 98/261 (37%), Gaps = 22/261 (8%)
Query: 2 VVAVKKLKPEGFQGHKE-----WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 56
+VA+KK+K K+ L E+ L +L HPN++ L+ N LV++FM
Sbjct: 25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
S + +GL +LH + +++RD K +N+LLD K
Sbjct: 85 DLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLK 140
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 175
L+DFGLAK+ + +R + T + T Y APE + R+ D+++ G +L ELL
Sbjct: 141 LADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 176 CAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 225
+ + + W F+ A
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 226 LALQCLNNEPKLRPRMSEVLA 246
L P R ++ L
Sbjct: 259 LIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 136 bits (344), Expect = 8e-39
Identities = 58/250 (23%), Positives = 100/250 (40%), Gaps = 34/250 (13%)
Query: 2 VVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
A+K LK E K+ E L + HP ++++ G + + ++ +++ G
Sbjct: 31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L + L + P A + L +LH +IYRD K NILLD + K++
Sbjct: 91 LFSLLRKSQRFPNPVAKFYAAEV--CLALEYLHSK--DIIYRDLKPENILLDKNGHIKIT 146
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFG AK P T GT Y APE V+T D +SFG+++ E+L+G
Sbjct: 147 DFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY--- 198
Query: 179 DKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
P+ + + +I++ +L ++P L + + +
Sbjct: 199 ---------------TPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLS 241
Query: 237 LRPRMSEVLA 246
R +
Sbjct: 242 QRLGNLQNGT 251
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 59/264 (22%), Positives = 100/264 (37%), Gaps = 25/264 (9%)
Query: 2 VVAVKKLKPEGFQG--HKEWLTEVN---YLGQLHHPNLVKLIGYCL----EGENRLLVYE 52
VA+K+++ + + + EV +L HPN+V+L C + E +L +
Sbjct: 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94
Query: 53 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
L +L + + + +GL FLH +V++RD K NIL+ +
Sbjct: 95 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSS 152
Query: 113 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
KL+DFGLA+ T V+ T Y APE + T D++S G + E+
Sbjct: 153 GQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209
Query: 173 SGRCAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 222
+ + V DW + + R+ F + ++
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV-ALPRQAFHSKSAQPIEKFVTDIDEL 268
Query: 223 AATLALQCLNNEPKLRPRMSEVLA 246
L L+CL P R L+
Sbjct: 269 GKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 66/262 (25%), Positives = 106/262 (40%), Gaps = 19/262 (7%)
Query: 2 VVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+KK+ P Q + + L E+ L + H N++ + + ++ +
Sbjct: 35 RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94
Query: 61 NHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
L++ Q LS +GL ++H + V++RD K SN+LL+ + K+ D
Sbjct: 95 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICD 152
Query: 120 FGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC- 176
FGLA+ A P D T T+ + T Y APE + + TKS D++S G +L E+LS R
Sbjct: 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
Query: 177 -AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAA 224
+ L P D + + P K A A
Sbjct: 213 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL 272
Query: 225 TLALQCLNNEPKLRPRMSEVLA 246
L + L P R + + LA
Sbjct: 273 DLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 5e-38
Identities = 48/259 (18%), Positives = 79/259 (30%), Gaps = 25/259 (9%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLE 60
VA+K + H + E + + I +C EG+ ++V E + +
Sbjct: 34 EVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED 91
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL---LDAEFNAKL 117
F S + +A + ++H I+RD K N L +
Sbjct: 92 LFNFCSRK--FSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYI 147
Query: 118 SDFGLAKA-----GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 172
DFGLAK + + GT YA+ + + D+ S G VL+
Sbjct: 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207
Query: 173 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 232
G K + Y K L YP + A C +
Sbjct: 208 LGSLPWQGLKA------ATKRQKYERISEKKMSTPIEVLCKGYPSEFAT----YLNFCRS 257
Query: 233 NEPKLRPRMSEVLAILERL 251
+P S + + L
Sbjct: 258 LRFDDKPDYSYLRQLFRNL 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-38
Identities = 51/272 (18%), Positives = 99/272 (36%), Gaps = 31/272 (11%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYC----LEGENRLLVYEFMPK 56
A+K L+ + EV + P++V+++ + L+V E +
Sbjct: 39 KFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-- 114
G L + + RG Q + ++ + + +LH + +RD K N+L ++
Sbjct: 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNA 151
Query: 115 -AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
KL+DFG AK + + T Y APE + + D++S GV++ LL
Sbjct: 152 ILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 174 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233
G + + R+ + + + L L
Sbjct: 209 GYPPFYS----------NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT 258
Query: 234 EPKLRPRMSEVLA---ILERLEAPKNSAKLSQ 262
EP R ++E + I++ + P+ S+
Sbjct: 259 EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (335), Expect = 8e-38
Identities = 50/258 (19%), Positives = 102/258 (39%), Gaps = 18/258 (6%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
A+KK++ E + E++ L +L H N+VKL + +LV+E + +
Sbjct: 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ G L + G+ + HD +V++RD K N+L++ E K++D
Sbjct: 88 KLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIAD 143
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLA+A R + +++ A + + + +T D++S G + E+++G
Sbjct: 144 FGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 180 KT----------KVGIEQSLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228
++ + +W L F + + + + + L
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 229 QCLNNEPKLRPRMSEVLA 246
+ L +P R + L
Sbjct: 263 KMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 9e-38
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 17/258 (6%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
VVA+KK++ + + E++ L +L+HPN+VKL+ LV+EF+ + L
Sbjct: 29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-L 87
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ + + + +GL F H +V++RD K N+L++ E KL+D
Sbjct: 88 KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLAD 145
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC--- 176
FGLA+A RT+ + +V+ A + +T D++S G + E+++ R
Sbjct: 146 FGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 177 -------AVDKTKVGIEQSLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 228
+ V W + D + F + + +L
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS 264
Query: 229 QCLNNEPKLRPRMSEVLA 246
Q L+ +P R LA
Sbjct: 265 QMLHYDPNKRISAKAALA 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (331), Expect = 4e-37
Identities = 41/264 (15%), Positives = 75/264 (28%), Gaps = 33/264 (12%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 60
VA+K + E L + + + EG + +LV + + G
Sbjct: 32 QVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSL 87
Query: 61 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----A 115
L + S A + +H E ++YRD K N L+ +
Sbjct: 88 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMI 145
Query: 116 KLSDFGLAK-----AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 170
+ DFG+ K + GT Y + + + D+ + G V +
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 205
Query: 171 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLA 227
L G ++K+K RI + K + A
Sbjct: 206 FLRGSL-------------PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 228 LQCLNNEPKLRPRMSEVLAILERL 251
N P + + ++
Sbjct: 253 HYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-36
Identities = 52/272 (19%), Positives = 101/272 (37%), Gaps = 43/272 (15%)
Query: 1 MVVAVKKLKPEGFQGHKE------WLTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYE 52
+ VA+K ++ + E EV L ++ +++L+ + ++ +L+ E
Sbjct: 30 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89
Query: 53 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
L + + + H V++RD K NIL+D
Sbjct: 90 RPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLN 146
Query: 113 -FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLE 170
KL DFG + V T GT Y+ PE++ R +S V+S G++L +
Sbjct: 147 RGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202
Query: 171 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230
++ G P+ D+ I+ ++ + Q+ + L C
Sbjct: 203 MVCGD------------------IPFEHDE----EIIRGQV--FFRQRVSSECQHLIRWC 238
Query: 231 LNNEPKLRPRMSEVLA--ILERLEAPKNSAKL 260
L P RP E+ ++ + P+ +A++
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 57/264 (21%), Positives = 98/264 (37%), Gaps = 27/264 (10%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMP 55
+VA+KK+ + + E+ + +L H N+V+L + + LV +++P
Sbjct: 47 LVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102
Query: 56 KGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-F 113
+ + R Q L + L ++H + +RD K N+LLD +
Sbjct: 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTA 160
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
KL DFG AK G+ + + + A T+ DV+S G VL ELL
Sbjct: 161 VLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218
Query: 174 GR-----CAVDKTKVGIEQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQKAAHT 222
G+ + V I + L + + + + K +I + +
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 278
Query: 223 AATLALQCLNNEPKLRPRMSEVLA 246
A L + L P R E A
Sbjct: 279 AIALCSRLLEYTPTARLTPLEACA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-34
Identities = 62/250 (24%), Positives = 94/250 (37%), Gaps = 31/250 (12%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
A+K L+ E E +TE L HP L L + V E+ G
Sbjct: 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
L HL R + + L +LH V+YRD K N++LD + + K++
Sbjct: 92 LFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKIT 147
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFGL K G + T GT Y APE + D + GVV+ E++ GR
Sbjct: 148 DFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--- 202
Query: 179 DKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236
P+ +R I+ ++ ++P+ + A +L L +PK
Sbjct: 203 ---------------LPFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 237 LRPRMSEVLA 246
R A
Sbjct: 246 QRLGGGPSDA 255
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 58/272 (21%), Positives = 99/272 (36%), Gaps = 31/272 (11%)
Query: 2 VVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR--------LLVY 51
VA+KK+ E + L E+ L L H N+V LI C + LV+
Sbjct: 37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96
Query: 52 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 111
+F LS R V GL ++H +++++RD KA+N+L+
Sbjct: 97 DFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIH--RNKILHRDMKAANVLITR 152
Query: 112 EFNAKLSDFGLAKAGPTGDRTHVS--TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVL 168
+ KL+DFGLA+A + + T + T Y PE + R D++ G ++
Sbjct: 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
Query: 169 LELLSGR-------------CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 215
E+ + + + L +K +L + K+ +
Sbjct: 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 216 PQKAAHTAAT-LALQCLNNEPKLRPRMSEVLA 246
A L + L +P R + L
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-32
Identities = 56/259 (21%), Positives = 91/259 (35%), Gaps = 19/259 (7%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 59
+VA+K+++ + L E+ L +L H N+V+L + LV+EF +
Sbjct: 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
Query: 60 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 119
+ G + KGL F H V++RD K N+L++ KL++
Sbjct: 89 KYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLAN 144
Query: 120 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 179
FGLA+A R + S +V+ +T D++S G + EL + +
Sbjct: 145 FGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 180 KTKVGIEQ-----------SLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 227
+Q + W L D + T K T L
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 228 LQCLNNEPKLRPRMSEVLA 246
L P R E L
Sbjct: 264 QNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-31
Identities = 54/266 (20%), Positives = 97/266 (36%), Gaps = 31/266 (11%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEF 53
VA+KKL K E+ L + H N++ L+ E LV F
Sbjct: 45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M G+ L + L + KGL ++H + +I+RD K N+ ++ +
Sbjct: 105 M--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDC 158
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFGLA+ + ++ V+ A + R T D++S G ++ E+++
Sbjct: 159 ELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214
Query: 174 GR-------------CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 220
G+ + T + + + K ++ K A+
Sbjct: 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274
Query: 221 HTAATLALQCLNNEPKLRPRMSEVLA 246
A L + L + + R E LA
Sbjct: 275 PLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (289), Expect = 2e-30
Identities = 54/241 (22%), Positives = 89/241 (36%), Gaps = 30/241 (12%)
Query: 2 VVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 58
A+K L + K+ L E L ++ P LVKL + N +V E++ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 118
+ +HL R G S A +LH +IYRD K N+L+D + +++
Sbjct: 128 MFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVT 183
Query: 119 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 178
DFG AK T + GT APE + + D ++ GV++ E+ +G
Sbjct: 184 DFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP-- 236
Query: 179 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238
P+ +D+ ++P + L L + R
Sbjct: 237 ----------------PFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
Query: 239 P 239
Sbjct: 281 F 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (275), Expect = 1e-28
Identities = 50/270 (18%), Positives = 95/270 (35%), Gaps = 38/270 (14%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRL--LVYEFMPKGS 58
V VK LKP K+ E+ L L PN++ L + +R LV+E +
Sbjct: 62 KVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118
Query: 59 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKL 117
+ Q L+ K L + H +++RD K N+++D E +L
Sbjct: 119 FKQLY-----QTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRL 171
Query: 118 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRC 176
D+GLA+ G + + + PE + ++ D++S G +L ++ +
Sbjct: 172 IDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 177 AVDKTKVGIEQ-----------SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT--- 222
+Q L D+ Y + F + + + ++ H+
Sbjct: 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 223 ------AATLALQCLNNEPKLRPRMSEVLA 246
A + L + + R E +
Sbjct: 289 HLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-28
Identities = 68/256 (26%), Positives = 96/256 (37%), Gaps = 34/256 (13%)
Query: 2 VVAVKKLKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPK 56
+ A+K LK + + TE L + P LV L L+ +++
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 57 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 116
G L HL +R I L LH +IYRD K NILLD+ +
Sbjct: 114 GELFTHLSQRERFTEHEVQIYVGEI--VLALEHLHKL--GIIYRDIKLENILLDSNGHVV 169
Query: 117 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSG 174
L+DFGL+K D T + GT Y AP+ V G D +S GV++ ELL+G
Sbjct: 170 LTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 175 RCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQC 230
P+ +K I L + YPQ+ + A L +
Sbjct: 229 A------------------SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 270
Query: 231 LNNEPKLRPRMSEVLA 246
L +PK R A
Sbjct: 271 LMKDPKKRLGCGPRDA 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 3e-24
Identities = 52/264 (19%), Positives = 92/264 (34%), Gaps = 27/264 (10%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG----ENRLLVYEFMP 55
VAVKKL K E+ L + H N++ L+ E +
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 56 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 115
G+ N++ + L+ + +GL ++H + +I+RD K SN+ ++ +
Sbjct: 105 MGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCEL 160
Query: 116 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 175
K+ DFGLA+ ++ V A + D++S G ++ ELL+GR
Sbjct: 161 KILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
Query: 176 C-----AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--------AAHT 222
I + + L + Q P+ A
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276
Query: 223 AATLALQCLNNEPKLRPRMSEVLA 246
A L + L + R ++ LA
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (244), Expect = 4e-24
Identities = 54/277 (19%), Positives = 97/277 (35%), Gaps = 42/277 (15%)
Query: 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVYEF 53
VA+KKL K E+ + ++H N++ L+ E ++ LV E
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 54 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 113
M + + G+ LH + +I+RD K SNI++ ++
Sbjct: 104 MDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 156
Query: 114 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 173
K+ DFGLA+ T T + T Y APE + D++S G ++ E++
Sbjct: 157 TLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 174 GRCA------------------------VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 209
+ + K + + + + K KLF
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 273
Query: 210 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246
++ + A A L + L +P R + + L
Sbjct: 274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.9 bits (219), Expect = 9e-21
Identities = 37/290 (12%), Positives = 90/290 (31%), Gaps = 47/290 (16%)
Query: 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFMPKGSLE 60
VA+K ++ + + E+ L +++ + K +LL + +
Sbjct: 40 HVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98
Query: 61 NHLF-------------RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 107
+ + + + +++ GL ++H +I+ D K N+
Sbjct: 99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENV 157
Query: 108 LLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 166
L++ L +A G T + T Y +PE + +D++S
Sbjct: 158 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 217
Query: 167 VLLELLSGRCAVDKTKVGIEQSLVD---------------------WAKPYLSDKRKLFR 205
++ EL++G + + D + + + + + L
Sbjct: 218 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 277
Query: 206 IMDTKL---------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 246
I K ++ + A + L +P+ R ++
Sbjct: 278 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.1 bits (137), Expect = 2e-10
Identities = 17/132 (12%), Positives = 35/132 (26%), Gaps = 18/132 (13%)
Query: 3 VAVKKLKPEG----------FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYE 52
VK K G + + L KL G + Y
Sbjct: 27 CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV-----YA 81
Query: 53 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 112
+ L + + + +V + + + +++ D N+L+ E
Sbjct: 82 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-E 138
Query: 113 FNAKLSDFGLAK 124
+ DF +
Sbjct: 139 EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 305 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.87 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.81 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=362.81 Aligned_cols=228 Identities=25% Similarity=0.300 Sum_probs=184.9
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||+++.... +..+.+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++..++ .+++..+..+
T Consensus 31 ~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i 108 (271)
T d1nvra_ 31 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRF 108 (271)
T ss_dssp CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHH
T ss_pred CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHH
Confidence 4799999876533 334678999999999999999999999999999999999999999999996544 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCC-CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~ 158 (305)
+.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..+ +.+
T Consensus 109 ~~qi~~al~ylH~~--~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~ 186 (271)
T d1nvra_ 109 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186 (271)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHH
T ss_pred HHHHHHHHHHHHHc--CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCc
Confidence 99999999999975 599999999999999999999999999987644333333455689999999999988876 568
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
+|||||||++|+|++|+.||......... ................++.++.+||.+||+.||++|
T Consensus 187 ~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (271)
T d1nvra_ 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 251 (271)
T ss_dssp HHHHHHHHHHHHHHHSSCSCSSSSTTSHH---------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred eeeeHhHHHHHHHHhCCCCCCCCChHHHH---------------HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999999765432111 111111122222335678899999999999999999
Q ss_pred CCHHHHHHH
Q 021947 239 PRMSEVLAI 247 (305)
Q Consensus 239 ps~~~~l~~ 247 (305)
||+++++++
T Consensus 252 ~t~~eil~h 260 (271)
T d1nvra_ 252 ITIPDIKKD 260 (271)
T ss_dssp CCHHHHTTC
T ss_pred cCHHHHhcC
Confidence 999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=362.72 Aligned_cols=224 Identities=25% Similarity=0.365 Sum_probs=190.7
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||+++.......+.+.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.+++.++ .+++..+..++
T Consensus 46 ~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~ 122 (293)
T d1yhwa1 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVC 122 (293)
T ss_dssp CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHH
T ss_pred CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHH
Confidence 479999998766667788999999999999999999999999999999999999999999988654 39999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|
T Consensus 123 ~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~D 198 (293)
T d1yhwa1 123 RECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVD 198 (293)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHH
T ss_pred HHHHHHHHHHHHC--CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhc
Confidence 9999999999975 599999999999999999999999999987643322 234567999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhh-cccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|+|++|+.||.+.+.. ..+..+.. .......+..++.++.+||.+||..||.+||
T Consensus 199 iwSlGvilyemltG~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 262 (293)
T d1yhwa1 199 IWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262 (293)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSC
T ss_pred eehHhHHHHHHhhCCCCCCCCCHH----------------HHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCc
Confidence 999999999999999999764421 11111111 1223345667889999999999999999999
Q ss_pred CHHHHHHH
Q 021947 240 RMSEVLAI 247 (305)
Q Consensus 240 s~~~~l~~ 247 (305)
|+.|++++
T Consensus 263 s~~eil~H 270 (293)
T d1yhwa1 263 SAKELLQH 270 (293)
T ss_dssp CHHHHTTC
T ss_pred CHHHHhcC
Confidence 99999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-54 Score=360.24 Aligned_cols=231 Identities=26% Similarity=0.407 Sum_probs=198.0
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++.+. ...++|.+|+++|++++||||+++++++.+++..|+|||||++|+|.+++.+.....+++..+..++.
T Consensus 44 ~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~ 122 (287)
T d1opja_ 44 TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122 (287)
T ss_dssp EEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHH
T ss_pred EEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHH
Confidence 69999997653 45678999999999999999999999999999999999999999999999877667799999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||++ ||+||||||+|||++.++.+||+|||+++....... .......|++.|+|||++.+..++.++||
T Consensus 123 qi~~gL~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~Di 199 (287)
T d1opja_ 123 QISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDV 199 (287)
T ss_dssp HHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHH
T ss_pred HHHHHHHHHHHC--CcccCccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhh
Confidence 999999999965 599999999999999999999999999987654322 22334468899999999999999999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
|||||++|+|++|..||.... +...+.+.+........+..++.++.+||.+||+.||.+|||+
T Consensus 200 wS~Gv~l~ell~~~~p~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 263 (287)
T d1opja_ 200 WAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF 263 (287)
T ss_dssp HHHHHHHHHHHTTSCCSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhHHHHHHHHHhCCCCCCCcc----------------hHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCH
Confidence 999999999999766654322 1223344455555667778899999999999999999999999
Q ss_pred HHHHHHHHhhc
Q 021947 242 SEVLAILERLE 252 (305)
Q Consensus 242 ~~~l~~l~~~~ 252 (305)
+++++.|+.+.
T Consensus 264 ~ei~~~L~~~~ 274 (287)
T d1opja_ 264 AEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHH
Confidence 99999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=358.88 Aligned_cols=232 Identities=27% Similarity=0.417 Sum_probs=183.5
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++.... ...+.|.+|+++|++++||||+++++++. ++.+++|||||+||+|.+++.... ..+++..+..+
T Consensus 32 ~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i 109 (276)
T d1uwha_ 32 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDI 109 (276)
T ss_dssp EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHH
T ss_pred EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHH
Confidence 489999975533 33468999999999999999999999875 456899999999999999996544 35999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC---CCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~ 156 (305)
+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .++
T Consensus 110 ~~qi~~gl~yLH~~--~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 187 (276)
T d1uwha_ 110 ARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187 (276)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCC
T ss_pred HHHHHHHHHHHhcC--CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCC
Confidence 99999999999975 5999999999999999999999999999876543333334556799999999998653 478
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC----CCCChHHHHHHHHHHHhhcc
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG----GQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~ 232 (305)
.++|||||||++|||++|+.||.+..... .+...+..... ...+..++.++.+||.+||+
T Consensus 188 ~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----------------~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 251 (276)
T d1uwha_ 188 FQSDVYAFGIVLYELMTGQLPYSNINNRD----------------QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------------HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTC
T ss_pred chhhhhhhHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcC
Confidence 89999999999999999999998753211 11111111111 12345678899999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhcC
Q 021947 233 NEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~l~~~~~ 253 (305)
.||++|||+.++++.|+.+..
T Consensus 252 ~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 252 KKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=354.83 Aligned_cols=221 Identities=27% Similarity=0.416 Sum_probs=187.4
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||++... .......+.+|++++++++||||+++++++.+++..|+|||||+||+|.+++.+.+ .+++..+.
T Consensus 32 ~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~ 109 (263)
T d2j4za1 32 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTA 109 (263)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHH
Confidence 47999998643 22345778999999999999999999999999999999999999999999997655 39999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++....... .....||+.|+|||++.+..++.
T Consensus 110 ~i~~qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~ 183 (263)
T d2j4za1 110 TYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDE 183 (263)
T ss_dssp HHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHC--CeeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCc
Confidence 9999999999999975 59999999999999999999999999998654322 33467999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.+.+... .+..+.. .....+..++.++.+||.+||+.||.+
T Consensus 184 ~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~ 245 (263)
T d2j4za1 184 KVDLWSLGVLCYEFLVGKPPFEANTYQE----------------TYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQ 245 (263)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred hhhhhhHhHHHHHHhcCCCCCCCCCHHH----------------HHHHHHc--CCCCCCccCCHHHHHHHHHHccCCHhH
Confidence 9999999999999999999998654211 1111111 123456678899999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+++++++
T Consensus 246 R~t~~eil~h 255 (263)
T d2j4za1 246 RPMLREVLEH 255 (263)
T ss_dssp SCCHHHHHTC
T ss_pred CcCHHHHHcC
Confidence 9999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-54 Score=361.05 Aligned_cols=233 Identities=25% Similarity=0.442 Sum_probs=185.9
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++..... ...++|.+|+++|++++||||+++++++..++..|+|||||+||+|.+++.... ..+++..++.++
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~ 134 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGML 134 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHH
Confidence 589999876543 334679999999999999999999999999999999999999999999886544 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcc---eeecccccccccchhhhhcCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---VSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.
T Consensus 135 ~qia~gl~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 212 (299)
T d1jpaa_ 135 RGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212 (299)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCH
T ss_pred HHHHHHHHHHhhC--CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCc
Confidence 9999999999975 59999999999999999999999999998754332211 122245789999999999999999
Q ss_pred CCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++|||||||++|||+| |..||.+... ..+...+......+.+..++..+.+|+.+||+.||.
T Consensus 213 ~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 275 (299)
T d1jpaa_ 213 ASDVWSYGIVMWEVMSYGERPYWDMTN-----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRN 275 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred ccccccchHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHh
Confidence 9999999999999998 8999986432 122333344455566778899999999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 021947 237 LRPRMSEVLAILERLEAP 254 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~~~~ 254 (305)
+|||+.++++.|+++...
T Consensus 276 ~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 276 HRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TSCCHHHHHHHHHHHHHS
T ss_pred HCcCHHHHHHHHHHHhcC
Confidence 999999999999887543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=364.46 Aligned_cols=230 Identities=27% Similarity=0.402 Sum_probs=194.1
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCC-----------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------- 68 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (305)
.||+|++.... ......+.+|+.+|.++ +||||+++++++.+.+..|+|||||+||+|.+++..+..
T Consensus 69 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (325)
T d1rjba_ 69 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148 (325)
T ss_dssp EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcc
Confidence 58999987553 34456799999999998 899999999999999999999999999999999965431
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 69 ----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 69 ----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..............
T Consensus 149 ~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 226 (325)
T d1rjba_ 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 226 (325)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTE
T ss_pred ccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccc
Confidence 2488999999999999999999975 5999999999999999999999999999876554444344456
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.||+.|+|||++.+..++.++|||||||++|||++ |..||.+... ...+.+++........+.
T Consensus 227 ~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~----------------~~~~~~~~~~~~~~~~p~ 290 (325)
T d1rjba_ 227 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV----------------DANFYKLIQNGFKMDQPF 290 (325)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----------------SHHHHHHHHTTCCCCCCT
T ss_pred cCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCC
Confidence 78999999999999999999999999999999997 8999986432 223444555556667778
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILE 249 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~ 249 (305)
.+++++.+||.+||+.||++|||+++|+++|.
T Consensus 291 ~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 88999999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=357.33 Aligned_cols=228 Identities=25% Similarity=0.335 Sum_probs=176.1
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEe--CCeeEEEEecCCCCCHHHHhhhc--CCCCCCHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRR--GPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~ 74 (305)
+.||||+++..... ..+.+.+|+++|++++||||+++++++.+ ++.+|+|||||+||+|.+++.+. ....+++.
T Consensus 30 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~ 109 (269)
T d2java1 30 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 109 (269)
T ss_dssp CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHH
T ss_pred CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHH
Confidence 47999999766433 23568999999999999999999999864 45689999999999999998542 23459999
Q ss_pred HHHHHHHHHHHHHhhhhcCC---CceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
.++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 110 ~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~ 187 (269)
T d2java1 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMN 187 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHc
Confidence 99999999999999999754 3599999999999999999999999999987643322 234567999999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
+..++.++|||||||++|+|++|+.||.+.+.. .+...+........+..+++++.+||.+||
T Consensus 188 ~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~s~~l~~li~~~L 250 (269)
T d2java1 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----------------ELAGKIREGKFRRIPYRYSDELNEIITRML 250 (269)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-----------------HHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 999999999999999999999999999864321 111222222223456678899999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 021947 232 NNEPKLRPRMSEVLAI 247 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~ 247 (305)
..||.+|||+.|++++
T Consensus 251 ~~dp~~Rps~~ell~h 266 (269)
T d2java1 251 NLKDYHRPSVEEILEN 266 (269)
T ss_dssp CSSGGGSCCHHHHHTS
T ss_pred CCChhHCcCHHHHHhC
Confidence 9999999999999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=352.52 Aligned_cols=229 Identities=28% Similarity=0.451 Sum_probs=183.1
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++.. ....++|.+|++++++++||||+++++++.+++..|+||||+++|+|.+++.... ..+++..++.++.
T Consensus 31 ~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~ 108 (263)
T d1sm2a_ 31 KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCL 108 (263)
T ss_dssp EEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHH
T ss_pred EEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHH
Confidence 5999999864 3456789999999999999999999999999999999999999999999986543 4589999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.++||
T Consensus 109 qia~gl~~lH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DV 185 (263)
T d1sm2a_ 109 DVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDV 185 (263)
T ss_dssp HHHHHHHHHHHT--TCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHH
T ss_pred HHHHHHHhhhcc--ceeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhh
Confidence 999999999965 5999999999999999999999999999876443322 2334568999999999999999999999
Q ss_pred ehhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
|||||++|||+++ .+||.... ...+...+........+..++.++.+|+.+||+.||++|||
T Consensus 186 wS~Gvil~el~t~~~~~~~~~~-----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps 248 (263)
T d1sm2a_ 186 WSFGVLMWEVFSEGKIPYENRS-----------------NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA 248 (263)
T ss_dssp HHHHHHHHHHHTTSCCTTCSCC-----------------HHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cchHHHHHHHHHCCCCCCCCCC-----------------HHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcC
Confidence 9999999999995 55555432 11222333344445566778899999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 021947 241 MSEVLAILERLE 252 (305)
Q Consensus 241 ~~~~l~~l~~~~ 252 (305)
++++++.|+++.
T Consensus 249 ~~~il~~L~~i~ 260 (263)
T d1sm2a_ 249 FSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=354.53 Aligned_cols=228 Identities=29% Similarity=0.398 Sum_probs=187.9
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++.+..+ ..++|++|+++|++++||||+++++++.. +..++|||||++|+|.+++.+.. .+++..++.+
T Consensus 36 ~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i 112 (277)
T d1xbba_ 36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL 112 (277)
T ss_dssp EEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred EEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHH
Confidence 6999999765333 24679999999999999999999999864 56789999999999999997654 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.+
T Consensus 113 ~~qi~~gl~ylH~~--~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 190 (277)
T d1xbba_ 113 VHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190 (277)
T ss_dssp HHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHHhhHHhC--CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCch
Confidence 99999999999975 5999999999999999999999999999876543322 22334568999999999999999999
Q ss_pred CceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 159 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 159 ~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
+|||||||++|||++ |+.||.+... ..+...+........+..++.++.+||.+||+.||.+
T Consensus 191 sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~ 253 (277)
T d1xbba_ 191 SDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 253 (277)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred hhhccchhhhhHHhhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhH
Confidence 999999999999998 8999986432 1233334444556677788999999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 021947 238 RPRMSEVLAILERL 251 (305)
Q Consensus 238 Rps~~~~l~~l~~~ 251 (305)
|||++++++.|+..
T Consensus 254 RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 254 RPGFAAVELRLRNY 267 (277)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHhhCH
Confidence 99999999887653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=358.48 Aligned_cols=226 Identities=25% Similarity=0.384 Sum_probs=187.8
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..|+|||||+||+|.+++.+.. ..+++..+..++
T Consensus 38 ~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~ 116 (288)
T d2jfla1 38 VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVC 116 (288)
T ss_dssp CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHH
T ss_pred eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence 4799999987766677889999999999999999999999999999999999999999999986544 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh-----cCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRL 155 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~ 155 (305)
.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++. +..+
T Consensus 117 ~qi~~gL~ylH~~--~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y 192 (288)
T d2jfla1 117 KQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPY 192 (288)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSST
T ss_pred HHHHHHHHHHHHC--CEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCC
Confidence 9999999999975 59999999999999999999999999997542211 1123457999999999984 4567
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhccCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
+.++|||||||++|+|++|+.||.+.+.. ..+..+.... .....+..++.++.+||.+||+.|
T Consensus 193 ~~k~DiwSlGvilyemltg~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~d 256 (288)
T d2jfla1 193 DYKADVWSLGITLIEMAEIEPPHHELNPM----------------RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKN 256 (288)
T ss_dssp TTHHHHHHHHHHHHHHHHSSCTTTTSCGG----------------GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSS
T ss_pred ChhhhHHHHHHHHHHHhhCCCCCCCCCHH----------------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCC
Confidence 89999999999999999999999875421 1112222221 123345678899999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||+.|++++
T Consensus 257 p~~R~t~~ell~h 269 (288)
T d2jfla1 257 VDARWTTSQLLQH 269 (288)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=351.64 Aligned_cols=224 Identities=24% Similarity=0.387 Sum_probs=180.5
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||+|++..... ...+.+.+|+++|++++||||+++++++.+ ...+|+|||||+||+|.+++.+.. .+++.
T Consensus 35 ~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~ 112 (270)
T d1t4ha_ 35 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIK 112 (270)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHH
T ss_pred eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccHH
Confidence 3699999876532 334678999999999999999999999875 345799999999999999997654 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeC-CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.|++.||.|||+++.+|+||||||+|||++ .++.+||+|||+++..... .....+||+.|+|||++.+
T Consensus 113 ~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~- 187 (270)
T d1t4ha_ 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE- 187 (270)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-
T ss_pred HHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-
Confidence 999999999999999997555599999999999996 4789999999999864332 2345689999999999865
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc-cCCCCChHHHHHHHHHHHhhcc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLN 232 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 232 (305)
.++.++|||||||++|+|++|+.||.+.... ..+.+.+... .....+...++++.+||.+||+
T Consensus 188 ~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (270)
T d1t4ha_ 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNA----------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251 (270)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----------------HHHHHHHHcCCCCcccCccCCHHHHHHHHHHcc
Confidence 5999999999999999999999999764321 1111111111 1122334567789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 021947 233 NEPKLRPRMSEVLAI 247 (305)
Q Consensus 233 ~~p~~Rps~~~~l~~ 247 (305)
.||++|||++|++++
T Consensus 252 ~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 252 QNKDERYSIKDLLNH 266 (270)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CCHhHCcCHHHHhCC
Confidence 999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=354.11 Aligned_cols=229 Identities=27% Similarity=0.382 Sum_probs=192.4
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.... ...++|++|+++|++++||||+++++++.. +.+|+|||||+||+|.+++.... ..+++..+..++
T Consensus 38 ~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~ 115 (285)
T d1u59a_ 38 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELL 115 (285)
T ss_dssp EEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHH
T ss_pred EEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHH
Confidence 699999986543 334689999999999999999999999864 56899999999999999985443 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++
T Consensus 116 ~qi~~gL~ylH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks 193 (285)
T d1u59a_ 116 HQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193 (285)
T ss_dssp HHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHhC--CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccc
Confidence 9999999999975 5999999999999999999999999999876543322 222345689999999999999999999
Q ss_pred ceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCC
Q 021947 160 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 238 (305)
Q Consensus 160 Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (305)
|||||||++|||+| |+.||.+... ..+...+..+.....+..++.++.+||.+||+.||++|
T Consensus 194 DVwS~Gv~l~E~lt~G~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 194 DVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCT-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred hhhcchHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHC
Confidence 99999999999998 9999986432 12233344455566778899999999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 021947 239 PRMSEVLAILERL 251 (305)
Q Consensus 239 ps~~~~l~~l~~~ 251 (305)
||+.++++.|+..
T Consensus 257 Ps~~~i~~~L~~~ 269 (285)
T d1u59a_ 257 PDFLTVEQRMRAC 269 (285)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=355.95 Aligned_cols=225 Identities=21% Similarity=0.289 Sum_probs=185.6
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++... ....+.+.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.+++...+ .+++..+.
T Consensus 34 ~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~ 111 (288)
T d1uu3a_ 34 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTR 111 (288)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHH
T ss_pred CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHH
Confidence 369999987432 2345679999999999999999999999999999999999999999999987665 49999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.
T Consensus 112 ~~~~qi~~al~ylH~~--~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~ 189 (288)
T d1uu3a_ 112 FYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189 (288)
T ss_dssp HHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHHhhccc--cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCc
Confidence 9999999999999975 59999999999999999999999999998765443333344567999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|..||.+.+.. .....+... ...++..++.++.+||.+||+.||.+
T Consensus 190 ~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~ 251 (288)
T d1uu3a_ 190 SSDLWALGCIIYQLVAGLPPFRAGNEY----------------LIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATK 251 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGG
T ss_pred ccceehhhHHHHHHhhCCCCCCCcCHH----------------HHHHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhH
Confidence 999999999999999999999875321 111112221 23456678899999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||++|+++.
T Consensus 252 R~t~~e~~~~ 261 (288)
T d1uu3a_ 252 RLGCEEMEGY 261 (288)
T ss_dssp STTSGGGTCH
T ss_pred CcCHHHHcCC
Confidence 9999998654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=351.56 Aligned_cols=229 Identities=27% Similarity=0.411 Sum_probs=190.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+.|.+|+++|++++||||+++++++. .+..|+||||+++|+|.+++.......+++..++.++.
T Consensus 39 ~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~ 116 (272)
T d1qpca_ 39 KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116 (272)
T ss_dssp EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHH
T ss_pred EEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 69999997653 45678999999999999999999999875 45679999999999999988655545699999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++||
T Consensus 117 qi~~gl~~lH~~--~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDv 193 (272)
T d1qpca_ 117 QIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDV 193 (272)
T ss_dssp HHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHhC--CcccCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhh
Confidence 999999999975 599999999999999999999999999987644322 22334568999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
|||||++|||+||..|+.... ....+...+........+..++.++.+|+.+||+.||++|||+
T Consensus 194 wS~Gvvl~ellt~~~~~~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~ 257 (272)
T d1qpca_ 194 WSFGILLTEIVTHGRIPYPGM----------------TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257 (272)
T ss_dssp HHHHHHHHHHHTTTCCSSTTC----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhhHHHHHHHHhCCCCCCCCC----------------CHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCH
Confidence 999999999999655543321 1122333344445556677889999999999999999999999
Q ss_pred HHHHHHHHhh
Q 021947 242 SEVLAILERL 251 (305)
Q Consensus 242 ~~~l~~l~~~ 251 (305)
+++++.|+.+
T Consensus 258 ~ei~~~L~~~ 267 (272)
T d1qpca_ 258 DYLRSVLEDF 267 (272)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHhhhh
Confidence 9999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=360.09 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=185.1
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||+|+++.+.... ..++.+|+++|++++||||++++++|.+.+.+|+|||||+||+|.+++.+.+ .+++..+..++
T Consensus 33 ~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~ 110 (322)
T d1s9ja_ 33 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVS 110 (322)
T ss_dssp EEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHH
T ss_pred EEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHH
Confidence 69999997654333 4678999999999999999999999999999999999999999999997665 39999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. +||+||||||+|||++.+|.+||+|||+|+..... .....+||+.|+|||++.+..++.++|
T Consensus 111 ~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~D 185 (322)
T d1s9ja_ 111 IAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185 (322)
T ss_dssp HHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHH
T ss_pred HHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHH
Confidence 9999999999963 35999999999999999999999999999864321 123468999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCccCCCcccchhhhhhhh--------------------------hhhhccchhhhhhhhcccCCC
Q 021947 161 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA--------------------------KPYLSDKRKLFRIMDTKLGGQ 214 (305)
Q Consensus 161 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~ 214 (305)
||||||++|+|++|+.||.+.+........... .+...................
T Consensus 186 iWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (322)
T d1s9ja_ 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265 (322)
T ss_dssp HHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccC
Confidence 999999999999999999876543211100000 000000000001111111111
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 215 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.....+.++.+||.+||..||.+|||++|++++
T Consensus 266 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 122457789999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=349.84 Aligned_cols=233 Identities=25% Similarity=0.420 Sum_probs=187.4
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||||+++..... ...+|++|+++|++++||||+++++++.+.+..++||||+.++++.+++.... ..+++..++.++
T Consensus 38 ~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~ 116 (283)
T d1mqba_ 38 PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGML 116 (283)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHH
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHH
Confidence 6999999765433 33578999999999999999999999999999999999999999999886544 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-cceeecccccccccchhhhhcCCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.++.++.++
T Consensus 117 ~~i~~gl~~lH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s 194 (283)
T d1mqba_ 117 RGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194 (283)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred HHHHHhhhhcccc--ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcc
Confidence 9999999999975 499999999999999999999999999987544322 1223345689999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
|||||||++|||++|..||.... ....+...+......+.+..++..+.+||.+||+.||++||
T Consensus 195 DI~S~Gvil~el~t~~~~~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 258 (283)
T d1mqba_ 195 DVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP 258 (283)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTC----------------CHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred cccccHHHHHHHHhCCCCccccC----------------CHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCc
Confidence 99999999999999665554321 11223344455556667778899999999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 021947 240 RMSEVLAILERLEA 253 (305)
Q Consensus 240 s~~~~l~~l~~~~~ 253 (305)
|+.++++.|+++..
T Consensus 259 t~~eil~~L~~l~~ 272 (283)
T d1mqba_ 259 KFADIVSILDKLIR 272 (283)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=343.34 Aligned_cols=227 Identities=23% Similarity=0.376 Sum_probs=193.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++.+. ...++|++|++++++++||||+++++++.+.+..++||||+.+|+|.+++.... ..+++..++.++.
T Consensus 30 ~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~ 107 (258)
T d1k2pa_ 30 DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCK 107 (258)
T ss_dssp EEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHH
T ss_pred EEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHH
Confidence 69999998754 356789999999999999999999999999999999999999999999975544 3489999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||+. ||+||||||+||+++.++.+||+|||+++........ ......||..|+|||++.+..++.++||
T Consensus 108 qi~~gl~~LH~~--~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDi 184 (258)
T d1k2pa_ 108 DVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDI 184 (258)
T ss_dssp HHHHHHHHHHHT--TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhhc--CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceee
Confidence 999999999964 5999999999999999999999999999865443222 2334568999999999999999999999
Q ss_pred ehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCC
Q 021947 162 YSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 240 (305)
Q Consensus 162 ~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 240 (305)
|||||++|||+| |+.||.+.+. ..+...+........|..++.++.+||.+||+.||++|||
T Consensus 185 wS~G~~l~el~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt 247 (258)
T d1k2pa_ 185 WAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247 (258)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred cccchhhHhHHhcCCCCCCCCCH-----------------HHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcC
Confidence 999999999998 8999987542 1222333344555667788899999999999999999999
Q ss_pred HHHHHHHHHh
Q 021947 241 MSEVLAILER 250 (305)
Q Consensus 241 ~~~~l~~l~~ 250 (305)
+++++++|..
T Consensus 248 ~~eil~~L~d 257 (258)
T d1k2pa_ 248 FKILLSNILD 257 (258)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHhhC
Confidence 9999999854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=353.05 Aligned_cols=224 Identities=23% Similarity=0.379 Sum_probs=170.7
Q ss_pred CEEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 1 ~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
+.||||++...... ....+.+|+++|++++||||+++++++.+++.+|+|||||+||+|.+++.+.+ .+++..+..+
T Consensus 35 ~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~ 112 (307)
T d1a06a_ 35 KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112 (307)
T ss_dssp CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHH
T ss_pred CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHH
Confidence 47999999765432 34568899999999999999999999999999999999999999999997654 4999999999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeC---CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 156 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 156 (305)
+.|++.||+|||++ ||+||||||+|||+. +++.+||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 113 ~~qi~~al~ylH~~--~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~ 187 (307)
T d1a06a_ 113 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYS 187 (307)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCC
T ss_pred HHHHHHHHHhhhhc--eeeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCC
Confidence 99999999999965 599999999999995 46889999999998654322 23346799999999999999999
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNE 234 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (305)
.++|||||||++|+|++|..||.+..... ....+.... ........++.++.+||.+||..|
T Consensus 188 ~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 251 (307)
T d1a06a_ 188 KAVDCWSIGVIAYILLCGYPPFYDENDAK----------------LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251 (307)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred cHHHhhhhhHHHHHHHhCCCCCCCCCHHH----------------HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCC
Confidence 99999999999999999999998654211 111122222 222334578899999999999999
Q ss_pred CCCCCCHHHHHHH
Q 021947 235 PKLRPRMSEVLAI 247 (305)
Q Consensus 235 p~~Rps~~~~l~~ 247 (305)
|.+|||++|++++
T Consensus 252 P~~R~s~~eil~h 264 (307)
T d1a06a_ 252 PEKRFTCEQALQH 264 (307)
T ss_dssp GGGSCCHHHHHHS
T ss_pred HhHCcCHHHHhcC
Confidence 9999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=353.28 Aligned_cols=220 Identities=29% Similarity=0.414 Sum_probs=183.2
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++...... .+.+.+|+++|++++||||+++++++.+.+..|+|||||.||+|..++..++ .+++..+..
T Consensus 42 ~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~ 119 (309)
T d1u5ra_ 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAA 119 (309)
T ss_dssp EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHH
T ss_pred EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHH
Confidence 69999997654322 3568899999999999999999999999999999999999998877765543 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc---CCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRL 155 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~ 155 (305)
++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..... .....||+.|+|||++.+ ..|
T Consensus 120 i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y 191 (309)
T d1u5ra_ 120 VTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY 191 (309)
T ss_dssp HHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCB
T ss_pred HHHHHHHHHHHHHhC--CEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCc
Confidence 999999999999975 599999999999999999999999999986533 234579999999999864 458
Q ss_pred CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCC
Q 021947 156 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 235 (305)
Q Consensus 156 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (305)
+.++|||||||++|+|++|..||.+... ...+..+.........+..++.++.+||.+||+.||
T Consensus 192 ~~~~DiwSlGvilyel~~g~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 255 (309)
T d1u5ra_ 192 DGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255 (309)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSG
T ss_pred CchhhhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCCh
Confidence 8999999999999999999999976432 112223333333333445678899999999999999
Q ss_pred CCCCCHHHHHHH
Q 021947 236 KLRPRMSEVLAI 247 (305)
Q Consensus 236 ~~Rps~~~~l~~ 247 (305)
.+|||+++++++
T Consensus 256 ~~Rpt~~ell~H 267 (309)
T d1u5ra_ 256 QDRPTSEVLLKH 267 (309)
T ss_dssp GGSCCHHHHTTC
T ss_pred hHCcCHHHHHhC
Confidence 999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-52 Score=355.88 Aligned_cols=224 Identities=22% Similarity=0.282 Sum_probs=187.6
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||++........+.+.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.+++.+.. ..+++..+..++.
T Consensus 53 ~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~ 131 (350)
T d1koaa2 53 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMR 131 (350)
T ss_dssp EEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHH
T ss_pred EEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHH
Confidence 699999987766666789999999999999999999999999999999999999999999985443 3499999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCC--CCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++
T Consensus 132 qi~~aL~ylH~~--~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~ 206 (350)
T d1koaa2 132 QVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYT 206 (350)
T ss_dssp HHHHHHHHHHHT--TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHH
T ss_pred HHHHHHHHHHhc--CCeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhH
Confidence 999999999975 5999999999999964 5789999999998765432 23456799999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
|||||||++|+|++|+.||.+.+.. ..+..+..... .......++.++.+||.+||..||.+
T Consensus 207 DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 270 (350)
T d1koaa2 207 DMWSVGVLSYILLSGLSPFGGENDD----------------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270 (350)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGG
T ss_pred hhhhhhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999865321 11111211111 11223467889999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+++++++
T Consensus 271 R~t~~eil~h 280 (350)
T d1koaa2 271 RMTIHQALEH 280 (350)
T ss_dssp SCCHHHHHHS
T ss_pred CcCHHHHhcC
Confidence 9999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-52 Score=356.17 Aligned_cols=225 Identities=23% Similarity=0.298 Sum_probs=189.2
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+.||||+++.........+.+|+++|++++||||++++++|.+++.+|+|||||+||+|.+++...+ ..+++..+..++
T Consensus 55 ~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~ 133 (352)
T d1koba_ 55 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYM 133 (352)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHH
T ss_pred CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHH
Confidence 4799999987765666788999999999999999999999999999999999999999999885543 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeC--CCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCC
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 158 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 158 (305)
.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+..++.+
T Consensus 134 ~qi~~aL~ylH~~--~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (352)
T d1koba_ 134 RQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFY 208 (352)
T ss_dssp HHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHHHHC--CeeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCc
Confidence 9999999999964 599999999999997 56889999999998765432 2345678999999999999999999
Q ss_pred CceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcc--cCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 159 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 159 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
+|||||||++|+|++|+.||.+.+.. ..+..+.... ........++.++.+||.+||..||.
T Consensus 209 ~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 272 (352)
T d1koba_ 209 TDMWAIGVLGYVLLSGLSPFAGEDDL----------------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 272 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999875421 1111222221 12233456889999999999999999
Q ss_pred CCCCHHHHHHH
Q 021947 237 LRPRMSEVLAI 247 (305)
Q Consensus 237 ~Rps~~~~l~~ 247 (305)
+|||+.+++++
T Consensus 273 ~R~s~~eil~H 283 (352)
T d1koba_ 273 KRLTVHDALEH 283 (352)
T ss_dssp GSCCHHHHHTS
T ss_pred HCcCHHHHhcC
Confidence 99999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=348.16 Aligned_cols=223 Identities=26% Similarity=0.332 Sum_probs=188.5
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++... ....+++.+|+.+|++++||||+++++++.+.+.+|+|||||+||+|.+++.+.+. +++..+.
T Consensus 31 ~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~ 108 (337)
T d1o6la_ 31 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERAR 108 (337)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHH
T ss_pred CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC--CcHHHHH
Confidence 479999987542 23457789999999999999999999999999999999999999999999977653 8999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.
T Consensus 109 ~~~~qil~al~ylH~~--~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~ 184 (337)
T d1o6la_ 109 FYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCT
T ss_pred HHHHHHhhhhhhhhhc--CccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCCh
Confidence 9999999999999975 599999999999999999999999999986543322 234568999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|+|||||++|+|++|+.||.+.+... ....+.. ....+|..++.++.+||.+||+.||.+
T Consensus 185 ~~DiwSlGvilyeml~G~~pf~~~~~~~----------------~~~~i~~--~~~~~p~~~s~~~~dli~~~L~~dP~~ 246 (337)
T d1o6la_ 185 AVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQ 246 (337)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred hhcccchhhHHHHHHHCCCCCCCcCHHH----------------HHHHHhc--CCCCCCccCCHHHHHHHHhhccCCchh
Confidence 9999999999999999999998754211 1111111 223566778999999999999999999
Q ss_pred CCC-----HHHHHHH
Q 021947 238 RPR-----MSEVLAI 247 (305)
Q Consensus 238 Rps-----~~~~l~~ 247 (305)
|++ +.+++++
T Consensus 247 R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 247 RLGGGPSDAKEVMEH 261 (337)
T ss_dssp STTCSTTTHHHHHTS
T ss_pred hcccccccHHHHHcC
Confidence 995 7888764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=341.28 Aligned_cols=230 Identities=29% Similarity=0.407 Sum_probs=186.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... ...+.|.+|+.+|++++||||+++++++. .+..|+||||+++|+|.+++.......+++..++.++.
T Consensus 43 ~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~ 120 (285)
T d1fmka3 43 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120 (285)
T ss_dssp EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred EEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHH
Confidence 59999997653 45678999999999999999999999985 45689999999999999998765545699999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCce
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 161 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 161 (305)
|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++||
T Consensus 121 ~i~~gl~~LH~~--~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI 197 (285)
T d1fmka3 121 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDV 197 (285)
T ss_dssp HHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhhh--heecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhh
Confidence 999999999964 599999999999999999999999999986543322 22334568999999999999999999999
Q ss_pred ehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCH
Q 021947 162 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 241 (305)
Q Consensus 162 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 241 (305)
|||||++|||++|..||.... ....+...+......+.+..++.++.+||.+||+.||++|||+
T Consensus 198 ~S~Giil~el~t~~~p~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 261 (285)
T d1fmka3 198 WSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 261 (285)
T ss_dssp HHHHHHHHHHHTTTCCSSTTC----------------CHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hcchHHHHHHHhCCCCCCCCC----------------CHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCH
Confidence 999999999999665554322 1122333344445556778889999999999999999999999
Q ss_pred HHHHHHHHhhc
Q 021947 242 SEVLAILERLE 252 (305)
Q Consensus 242 ~~~l~~l~~~~ 252 (305)
++|++.|+.+-
T Consensus 262 ~~i~~~L~~~~ 272 (285)
T d1fmka3 262 EYLQAFLEDYF 272 (285)
T ss_dssp HHHHHHHHTTT
T ss_pred HHHHHHHhhhh
Confidence 99999988754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=341.21 Aligned_cols=228 Identities=27% Similarity=0.374 Sum_probs=180.5
Q ss_pred EEEEEecccCCcc-ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++..... ..+.|.+|+++|++++||||+++++++. .+..|+||||+.+|+|.+++.... ..+++..++.++
T Consensus 37 ~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~ 114 (273)
T d1mp8a_ 37 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYA 114 (273)
T ss_dssp EEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHH
Confidence 5899998765433 3467999999999999999999999985 467899999999999999876544 358999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|
T Consensus 115 ~qi~~gl~ylH~~--~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~D 191 (273)
T d1mp8a_ 115 YQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASD 191 (273)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHH
T ss_pred HHHHHHhhhhccc--CeeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccc
Confidence 9999999999975 499999999999999999999999999987543322 2233456899999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|||++ |..||.+... ..+...+......+.+..++.++.+||.+||..||.+||
T Consensus 192 iwSlGvil~e~lt~g~~P~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 254 (273)
T d1mp8a_ 192 VWMFGVCMWEILMHGVKPFQGVKN-----------------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 254 (273)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cccchHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCc
Confidence 9999999999998 8999986532 122233333444566778999999999999999999999
Q ss_pred CHHHHHHHHHhh
Q 021947 240 RMSEVLAILERL 251 (305)
Q Consensus 240 s~~~~l~~l~~~ 251 (305)
|+.+|++.|+.+
T Consensus 255 s~~ei~~~L~~i 266 (273)
T d1mp8a_ 255 RFTELKAQLSTI 266 (273)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=346.67 Aligned_cols=230 Identities=23% Similarity=0.393 Sum_probs=190.2
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
+||+|+++... ....++|.+|+++|++++||||+++++++.++ ..++++|++.+++|.+++.... ..+++..++.++
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~ 117 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWC 117 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHH
Confidence 68999987543 34567899999999999999999999999764 5678889999999999886654 459999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|
T Consensus 118 ~qi~~gl~yLH~~--~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 195 (317)
T d1xkka_ 118 VQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195 (317)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHc--CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhh
Confidence 9999999999975 59999999999999999999999999998765544443344556899999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|||+| |..||.+... ..+...+..+.....+..++..+.+|+.+||..||.+||
T Consensus 196 vwS~Gvil~el~t~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RP 258 (317)
T d1xkka_ 196 VWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP 258 (317)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCG-----------------GGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCc
Confidence 9999999999998 8899876432 223344445555667778899999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|..+.
T Consensus 259 s~~eil~~l~~~~ 271 (317)
T d1xkka_ 259 KFRELIIEFSKMA 271 (317)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=339.58 Aligned_cols=225 Identities=28% Similarity=0.463 Sum_probs=184.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++.+ ...+.|.+|++++++++||||+++++++.+. +.+|+||||+++|+|.+++..+....+++..++.++
T Consensus 32 ~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~ 109 (262)
T d1byga_ 32 KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 109 (262)
T ss_dssp EEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHH
T ss_pred EEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence 6999999765 3557899999999999999999999998654 568999999999999999976554458999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCCc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 160 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 160 (305)
.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++|
T Consensus 110 ~~i~~al~ylH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sD 182 (262)
T d1byga_ 110 LDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSD 182 (262)
T ss_dssp HHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHhhccccccC--ceeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHH
Confidence 9999999999975 5999999999999999999999999999864332 23346789999999999999999999
Q ss_pred eehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCC
Q 021947 161 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 239 (305)
Q Consensus 161 i~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (305)
||||||++|||++ |+.||...+. ..+...+........+..++.++.+||.+||..||.+||
T Consensus 183 IwSfG~il~el~t~~~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp 245 (262)
T d1byga_ 183 VWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245 (262)
T ss_dssp HHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCc
Confidence 9999999999998 7888876432 122333444555667778889999999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 021947 240 RMSEVLAILERLE 252 (305)
Q Consensus 240 s~~~~l~~l~~~~ 252 (305)
|+.++++.|+++.
T Consensus 246 s~~~l~~~L~~i~ 258 (262)
T d1byga_ 246 SFLQLREQLEHIK 258 (262)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=343.18 Aligned_cols=224 Identities=25% Similarity=0.335 Sum_probs=184.2
Q ss_pred CEEEEEecccCCc------cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF------QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||||+++.... ...+.+.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.+++.+.+ .+++.
T Consensus 36 ~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~ 113 (293)
T d1jksa_ 36 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEE 113 (293)
T ss_dssp CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHH
T ss_pred CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc--ccchh
Confidence 4799999865422 235679999999999999999999999999999999999999999999997665 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC----ceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
.+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++........ .....||+.|+|||++
T Consensus 114 ~~~~~~~qi~~al~yLH~~--~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~ 188 (293)
T d1jksa_ 114 EATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 188 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHhhhhc--ceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHH
Confidence 9999999999999999975 499999999999998776 499999999987644322 3345789999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHH
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLAL 228 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 228 (305)
.+..++.++|||||||++|+|++|..||.+.+... .+..+...... ...+..++..+.+||+
T Consensus 189 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 252 (293)
T d1jksa_ 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----------------TLANVSAVNYEFEDEYFSNTSALAKDFIR 252 (293)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----------------HHHHHHhcCCCCCchhcCCCCHHHHHHHH
Confidence 99999999999999999999999999998754211 11111111111 1112356788999999
Q ss_pred hhccCCCCCCCCHHHHHHH
Q 021947 229 QCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 229 ~~l~~~p~~Rps~~~~l~~ 247 (305)
+||+.||.+|||+++++++
T Consensus 253 ~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 253 RLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=339.73 Aligned_cols=230 Identities=28% Similarity=0.415 Sum_probs=185.7
Q ss_pred EEEEEecccCCc---cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++.+.. ...++|.+|+++|++++||||+++++++.+ ...++||||++++++.+++..+.. .+++..++.
T Consensus 38 ~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~ 115 (273)
T d1u46a_ 38 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSR 115 (273)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHH
T ss_pred EEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccC-CCCHHHHHH
Confidence 689999976533 223679999999999999999999999965 567899999999999998865443 499999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc-ceeecccccccccchhhhhcCCCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++........ .......|+..|+|||++.+..++.
T Consensus 116 ~~~qi~~gl~ylH~~--~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 193 (273)
T d1u46a_ 116 YAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193 (273)
T ss_dssp HHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHhhhC--CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCc
Confidence 999999999999975 4999999999999999999999999999976544322 2233446788999999999999999
Q ss_pred CCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCC
Q 021947 158 KSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 236 (305)
Q Consensus 158 ~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (305)
++||||||+++|||++ |..||.+.+. ......+.......+.+..++..+.+||.+||+.||+
T Consensus 194 ~~Di~S~Gvil~emlt~G~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 257 (273)
T d1u46a_ 194 ASDTWMFGVTLWEMFTYGQEPWIGLNG----------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257 (273)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred chhhhhhHHHHHHHHhCCCCCCCCcCH----------------HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChh
Confidence 9999999999999998 8999986532 1222333344455566778889999999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 021947 237 LRPRMSEVLAILERL 251 (305)
Q Consensus 237 ~Rps~~~~l~~l~~~ 251 (305)
+|||+.+|++.|.+.
T Consensus 258 ~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 258 DRPTFVALRDFLLEA 272 (273)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHhc
Confidence 999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.9e-51 Score=342.56 Aligned_cols=220 Identities=25% Similarity=0.375 Sum_probs=186.6
Q ss_pred CEEEEEecccC---CccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPE---GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+.+|+|||||.||+|..++..... +++..+.
T Consensus 30 ~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~ 107 (316)
T d1fota_ 30 RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAK 107 (316)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHH
T ss_pred CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc--ccccHHH
Confidence 47999998753 223457899999999999999999999999999999999999999999999876653 8888999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.
T Consensus 108 ~~~~qi~~al~~lH~~--~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~ 180 (316)
T d1fota_ 108 FYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNK 180 (316)
T ss_dssp HHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCT
T ss_pred HHHHHHHHhhhhhccC--cEEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCc
Confidence 9999999999999964 5999999999999999999999999999876433 23467999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.+.+.. .....+... ....+..++.++.+++.+||..||.+
T Consensus 181 ~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~ 242 (316)
T d1fota_ 181 SIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQ 242 (316)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred hhhccccchhHHHHHhCCCCCCCcCHH----------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHh
Confidence 999999999999999999999875421 111122222 23456678899999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|+ |+++++++
T Consensus 243 R~~~~r~t~~~il~H 257 (316)
T d1fota_ 243 RLGNLQNGTEDVKNH 257 (316)
T ss_dssp CTTSSTTTTHHHHTS
T ss_pred ccccchhhHHHHHcC
Confidence 96 89999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=342.32 Aligned_cols=232 Identities=29% Similarity=0.404 Sum_probs=183.0
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcC-----------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRG----------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----------- 67 (305)
.||||+++.... ...+.+.+|..++.++ +|+||+.+++++... ..+++|||||++|+|.+++....
T Consensus 45 ~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (299)
T d1ywna1 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124 (299)
T ss_dssp EEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC------
T ss_pred EEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchh
Confidence 699999986543 3346788899988887 589999999988764 46899999999999999996542
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccc
Q 021947 68 ---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 144 (305)
Q Consensus 68 ---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 144 (305)
...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...............||+.|
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y 202 (299)
T d1ywna1 125 DLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 202 (299)
T ss_dssp -----CBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGG
T ss_pred hhhcccCCHHHHHHHHHHHHHHHHHHHhC--CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccc
Confidence 23488999999999999999999975 4999999999999999999999999999876544433334456799999
Q ss_pred cchhhhhcCCCCCCCceehhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHH
Q 021947 145 AAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 223 (305)
Q Consensus 145 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (305)
+|||++.+..++.++|||||||++|+|++| ..||.+... ...+...+........+..++.++
T Consensus 203 ~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l 266 (299)
T d1ywna1 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEFCRRLKEGTRMRAPDYTTPEM 266 (299)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----------------SHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred cchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhcCCCCCCCccCCHHH
Confidence 999999999999999999999999999986 567765432 122334444455556677888999
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 224 ATLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 224 ~~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
.+||.+||+.||.+|||+.+++++|+++
T Consensus 267 ~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 267 YQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-50 Score=341.28 Aligned_cols=232 Identities=28% Similarity=0.429 Sum_probs=192.4
Q ss_pred EEEEEecccCCccC-hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC-------------
Q 021947 2 VVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------- 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (305)
+||||+++...... .++|.+|+++|++++||||+++++++...+..+++|||+.+|+|.+++....
T Consensus 45 ~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 124 (301)
T d1lufa_ 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124 (301)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------------
T ss_pred EEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccc
Confidence 69999998654333 4679999999999999999999999999999999999999999999996432
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecc
Q 021947 68 ---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 138 (305)
Q Consensus 68 ---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 138 (305)
...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..............
T Consensus 125 ~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~ 202 (301)
T d1lufa_ 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 202 (301)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----C
T ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCC
Confidence 23488899999999999999999975 4999999999999999999999999999865443333334456
Q ss_pred cccccccchhhhhcCCCCCCCceehhhHHHHHHHhCC-CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCCh
Q 021947 139 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 217 (305)
Q Consensus 139 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (305)
.+++.|+|||++.+..++.++|||||||++|||++|. .||.+... ..+...+........+.
T Consensus 203 ~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-----------------~e~~~~v~~~~~~~~p~ 265 (301)
T d1lufa_ 203 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-----------------EEVIYYVRDGNILACPE 265 (301)
T ss_dssp CBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHTTCCCCCCT
T ss_pred CcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCc
Confidence 7899999999999999999999999999999999985 57765432 12223333444455677
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 218 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 218 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
.++.++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 266 ~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 266 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 88899999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=339.65 Aligned_cols=232 Identities=27% Similarity=0.429 Sum_probs=198.2
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||||+++.+.. ....++.+|+..+.++ +||||+++++++.+++..|+|||||++|+|.+++..+.
T Consensus 47 ~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~ 126 (299)
T d1fgka_ 47 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126 (299)
T ss_dssp EEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC----------
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccccccc
Confidence 599999987654 3346789999999998 79999999999999999999999999999999996553
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 68 --PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 68 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 127 ~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 204 (299)
T d1fgka_ 127 NPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 204 (299)
T ss_dssp --CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGS
T ss_pred CccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhh
Confidence 234899999999999999999999754 9999999999999999999999999998765544433345567899999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||++.++.++.++||||||+++|+|++ |..||.+... ..+...+........+..++..+.
T Consensus 205 aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~ 267 (299)
T d1fgka_ 205 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----------------EELFKLLKEGHRMDKPSNCTNELY 267 (299)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHTTCCCCCCSSCCHHHH
T ss_pred hhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----------------HHHHHHHHcCCCCCCCccchHHHH
Confidence 9999999999999999999999999998 7888876432 123344445556667778889999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
+||.+||+.||.+|||+.++++.|+++.
T Consensus 268 ~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 268 MMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 9999999999999999999999998874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=339.11 Aligned_cols=232 Identities=29% Similarity=0.447 Sum_probs=197.1
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC------------
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------ 67 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (305)
.||||+++.... .....|.+|+.+++++ +||||+++++++.+....++|||||++|+|.+++.+..
T Consensus 55 ~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~ 134 (311)
T d1t46a_ 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134 (311)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---------
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccccccc
Confidence 699999987643 3345789999999999 69999999999999999999999999999999996543
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccc
Q 021947 68 ----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 143 (305)
Q Consensus 68 ----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 143 (305)
...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+|++|||+++...............||+.
T Consensus 135 ~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~ 212 (311)
T d1t46a_ 135 MEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212 (311)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGG
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChH
Confidence 23588999999999999999999975 499999999999999999999999999998765554444556789999
Q ss_pred ccchhhhhcCCCCCCCceehhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHH
Q 021947 144 YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 222 (305)
Q Consensus 144 y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (305)
|+|||++.+..++.++|||||||++|+|+| |.+||.+.. ....+.+.+........+..++..
T Consensus 213 y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~ 276 (311)
T d1t46a_ 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP----------------VDSKFYKMIKEGFRMLSPEHAPAE 276 (311)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------SSHHHHHHHHHTCCCCCCTTSCHH
T ss_pred HcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC----------------HHHHHHHHHhcCCCCCCcccccHH
Confidence 999999999999999999999999999999 555555432 122344455556666677778899
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+.+||.+||+.||.+|||++++++.|+++
T Consensus 277 l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 277 MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-50 Score=342.01 Aligned_cols=220 Identities=23% Similarity=0.285 Sum_probs=186.2
Q ss_pred CEEEEEecccCC---ccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 1 MVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 1 ~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
+.||||+++... ....+.+.+|+++|+.++||||+++++++.+....++||||+.||+|.+++.+.+ .+++..+.
T Consensus 67 ~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~ 144 (350)
T d1rdqe_ 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHAR 144 (350)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHH
T ss_pred CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC--CCCHHHHH
Confidence 369999986432 2345678999999999999999999999999999999999999999999997765 39999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+..++.
T Consensus 145 ~i~~qi~~aL~yLH~~--~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~ 217 (350)
T d1rdqe_ 145 FYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNK 217 (350)
T ss_dssp HHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHhC--CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCc
Confidence 9999999999999975 4999999999999999999999999999876432 23457999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.+.+.. ..+..+... ....+..++.++.+||.+||..||.+
T Consensus 218 ~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~k 279 (350)
T d1rdqe_ 218 AVDWWALGVLIYEMAAGYPPFFADQPI----------------QIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTT
T ss_pred cccccchhHHHHHHHhCCCCCCCcCHH----------------HHHHHHhcC--CCCCCccCCHHHHHHHHHHhhhCHHh
Confidence 999999999999999999999865321 111112221 22445678899999999999999999
Q ss_pred CC-----CHHHHHHH
Q 021947 238 RP-----RMSEVLAI 247 (305)
Q Consensus 238 Rp-----s~~~~l~~ 247 (305)
|+ |+++++++
T Consensus 280 R~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 280 RFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTSSTTTTHHHHTS
T ss_pred ccccccccHHHHHcC
Confidence 94 89999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-50 Score=332.92 Aligned_cols=231 Identities=25% Similarity=0.352 Sum_probs=180.7
Q ss_pred EEEEEecccCCccC---hHHHHHHHHHHhccCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++.....+ ...+.+|+++|++++||||+++++++...+ .+|+|||||+|++|.+++...+ .+++.
T Consensus 34 ~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~ 111 (277)
T d1o6ya_ 34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPK 111 (277)
T ss_dssp EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHH
T ss_pred EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHH
Confidence 69999998664433 356899999999999999999999987643 3789999999999999997665 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-cceeecccccccccchhhhhcC
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATG 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~ 153 (305)
.+..++.|++.||+|||+. ||+||||||+|||++.++..+++|||.+........ .......+||+.|+|||++.+.
T Consensus 112 ~~~~i~~qi~~al~~lH~~--~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 189 (277)
T d1o6ya_ 112 RAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhC--CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCC
Confidence 9999999999999999965 599999999999999999999999999876533222 2224456799999999999999
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccC--CCCChHHHHHHHHHHHhhc
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (305)
.++.++|||||||++|+|++|+.||.+.+... .+...+..... ......++.++.+||.+||
T Consensus 190 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 253 (277)
T d1o6ya_ 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------------VAYQHVREDPIPPSARHEGLSADLDAVVLKAL 253 (277)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHT
T ss_pred CCCcceecccchHHHHHHHhCCCCCCCcCHHH----------------HHHHHHhcCCCCCchhccCCCHHHHHHHHHHc
Confidence 99999999999999999999999998754211 11111111111 1223467889999999999
Q ss_pred cCCCCCCC-CHHHHHHHHHhhc
Q 021947 232 NNEPKLRP-RMSEVLAILERLE 252 (305)
Q Consensus 232 ~~~p~~Rp-s~~~~l~~l~~~~ 252 (305)
..||.+|| |++++++.|.++.
T Consensus 254 ~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 254 AKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999 8999999888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.4e-50 Score=330.74 Aligned_cols=224 Identities=29% Similarity=0.368 Sum_probs=184.9
Q ss_pred CEEEEEecccCCccC---------hHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCC
Q 021947 1 MVVAVKKLKPEGFQG---------HKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP 70 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (305)
+.||||+++...... .+.+.+|+.++++++ ||||+++++++.+++..|+|||||+||+|.+++..++ .
T Consensus 29 ~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~ 106 (277)
T d1phka_ 29 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--T 106 (277)
T ss_dssp EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--S
T ss_pred CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC--C
Confidence 369999987653321 235889999999997 9999999999999999999999999999999997665 4
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....... .....||..|+|||.+
T Consensus 107 l~e~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~ 181 (277)
T d1phka_ 107 LSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEII 181 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHh
Confidence 99999999999999999999965 599999999999999999999999999987654322 3345799999999998
Q ss_pred hc------CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhccc--CCCCChHHHHH
Q 021947 151 AT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHT 222 (305)
Q Consensus 151 ~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 222 (305)
.+ ..++.++||||+||++|+|++|+.||.+.+.. .....+..... .......++++
T Consensus 182 ~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~ 245 (277)
T d1phka_ 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----------------LMLRMIMSGNYQFGSPEWDDYSDT 245 (277)
T ss_dssp HHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTCCCCCTTTGGGSCHH
T ss_pred hccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH----------------HHHHHHHhCCCCCCCcccccCCHH
Confidence 64 34678999999999999999999999875421 11112222222 22334578899
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+|+.+||+.||++|||+++++++
T Consensus 246 ~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 246 VKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHccCChhHCcCHHHHHcC
Confidence 9999999999999999999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=334.87 Aligned_cols=233 Identities=27% Similarity=0.397 Sum_probs=190.3
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhccCCCCcccEEEEEEeC-CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHH
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 79 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (305)
.||||+++... ....++|.+|+++|++++||||+++++++.+. +..++|||||++++|.+++.... ...++..++.+
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i 135 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGF 135 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHH
Confidence 58999997543 33447899999999999999999999998764 57899999999999999886544 35788899999
Q ss_pred HHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchhhhhcCCCCC
Q 021947 80 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 80 ~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
+.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++........ .......||..|+|||.+.+..++.
T Consensus 136 ~~qia~gL~~lH~~--~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 213 (311)
T d1r0pa_ 136 GLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213 (311)
T ss_dssp HHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHhhhhhccc--CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCC
Confidence 99999999999965 5999999999999999999999999999875433221 1223356899999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++||||||+++|||++|..||..... ...+...+..+.....+..++.++.+||.+||..||.+
T Consensus 214 ksDI~SfGivl~El~t~~~p~~~~~~----------------~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~ 277 (311)
T d1r0pa_ 214 KSDVWSFGVLLWELMTRGAPPYPDVN----------------TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEM 277 (311)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSCC----------------------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hhHhhhhHHHHHHHHHCCCCCCCCCC----------------HHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhH
Confidence 99999999999999998888765321 11122233333445566778899999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 021947 238 RPRMSEVLAILERLEA 253 (305)
Q Consensus 238 Rps~~~~l~~l~~~~~ 253 (305)
|||+.|++++|+++..
T Consensus 278 RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 278 RPSFSELVSRISAIFS 293 (311)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999998854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=335.38 Aligned_cols=230 Identities=28% Similarity=0.436 Sum_probs=188.7
Q ss_pred EEEEEecccCC-ccChHHHHHHHHHHhcc-CCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhc-------------
Q 021947 2 VVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR------------- 66 (305)
Q Consensus 2 ~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------- 66 (305)
.||||+++... ....+.|.+|+++|.++ +||||+++++++.+++..|+||||++||+|.+++...
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 58899886543 33556899999999999 6999999999999999999999999999999999654
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeeccccccccc
Q 021947 67 -GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 145 (305)
Q Consensus 67 -~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 145 (305)
....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....... .....||..|+
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~ 193 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWM 193 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTC
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcC--CccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCccc
Confidence 234589999999999999999999975 599999999999999999999999999986443221 23446899999
Q ss_pred chhhhhcCCCCCCCceehhhHHHHHHHhCC-CccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHH
Q 021947 146 APEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA 224 (305)
Q Consensus 146 aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (305)
|||.+.+..++.++|||||||++|+|++|. .||.+.+. ..+...+........+..+++++.
T Consensus 194 aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----------------~~~~~~i~~~~~~~~~~~~~~~~~ 256 (309)
T d1fvra_ 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------------AELYEKLPQGYRLEKPLNCDDEVY 256 (309)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHGGGTCCCCCCTTBCHHHH
T ss_pred chHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHhcCCCCCCccCCHHHH
Confidence 999999999999999999999999999975 56765431 223333334445566778899999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+||.+||+.||++|||++++++.|+++..
T Consensus 257 ~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 257 DLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-49 Score=340.52 Aligned_cols=224 Identities=26% Similarity=0.339 Sum_probs=180.5
Q ss_pred CEEEEEecccCCc---cChHHHHH---HHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 1 MVVAVKKLKPEGF---QGHKEWLT---EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 1 ~~VaiK~~~~~~~---~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
+.||||++..... .....+.+ |+++++.++||||+++++++.+.+.+|+|||||+||+|.+++.+.. .+++.
T Consensus 30 ~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~ 107 (364)
T d1omwa3 30 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEA 107 (364)
T ss_dssp CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHH
T ss_pred CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHH
Confidence 4699999864321 22233444 4777788899999999999999999999999999999999997665 48999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc-C
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
.+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++...... ....+||+.|+|||++.+ .
T Consensus 108 ~~~~~~~qi~~aL~ylH~~--~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~ 181 (364)
T d1omwa3 108 DMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV 181 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTC
T ss_pred HHHHHHHHHHHHHHHHHHC--CccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCC
Confidence 9999999999999999965 59999999999999999999999999998754432 334579999999999864 5
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|||||||++|+|++|+.||.+........ +.. .........+..++.++.+||.+||..
T Consensus 182 ~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--------------~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~ 246 (364)
T d1omwa3 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDR-MTLTMAVELPDSFSPELRSLLEGLLQR 246 (364)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--------------HHH-HSSSCCCCCCSSSCHHHHHHHHHHTCS
T ss_pred CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--------------HHH-hcccCCCCCCCCCCHHHHHHHHHHccc
Confidence 68999999999999999999999998754321111 111 111223344567889999999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 021947 234 EPKLRPR-----MSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps-----~~~~l~~ 247 (305)
||.+||| +++++++
T Consensus 247 dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 247 DVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp STTTSTTTSSSTHHHHHTS
T ss_pred CHHHhCCCcccCHHHHHcC
Confidence 9999998 6888864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=340.33 Aligned_cols=224 Identities=22% Similarity=0.274 Sum_probs=179.5
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhcc-CCCCcccEEEEEEe----CCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||+++. ...+.+|++++.++ +||||++++++|.+ +..+|+|||||+||+|.+++.+++...+++..
T Consensus 38 ~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~ 112 (335)
T d2ozaa1 38 EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112 (335)
T ss_dssp CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHH
T ss_pred CEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHH
Confidence 4799999863 35678999997665 79999999999875 35689999999999999999876666799999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..++.|++.||+|||+. ||+||||||+|||++. .+.+||+|||+++....... ....+||+.|+|||++.+
T Consensus 113 ~~~i~~qi~~al~ylH~~--~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 113 ASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCG
T ss_pred HHHHHHHHHHHHHHHHHc--CCccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcC
Confidence 999999999999999965 5999999999999976 45699999999987654322 334579999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhh-hhhhcccCC--CCChHHHHHHHHHHHh
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF-RIMDTKLGG--QYPQKAAHTAATLALQ 229 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~li~~ 229 (305)
..++.++|||||||++|+|++|+.||.+....... ..+. .+....... .....++.++.+||.+
T Consensus 188 ~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 254 (335)
T d2ozaa1 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254 (335)
T ss_dssp GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------CCCSCSSSCCTTHHHHSCHHHHHHHHH
T ss_pred CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-------------HHHHHHHhcCCCCCCCcccccCCHHHHHHHHH
Confidence 99999999999999999999999999765421100 0000 011111111 1123678899999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||..||++|||+.+++++
T Consensus 255 ~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 255 LLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HSCSSTTTSCCHHHHHHS
T ss_pred HccCChhHCcCHHHHHcC
Confidence 999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=335.68 Aligned_cols=223 Identities=21% Similarity=0.232 Sum_probs=183.9
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
.||||+++... .+...+.+|+++|+.++||||+++++++.+.+.+|+|||||+||+|.+++...+ ..+++..+..++.
T Consensus 32 ~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~ 109 (321)
T d1tkia_ 32 TYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVH 109 (321)
T ss_dssp EEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHH
T ss_pred EEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence 69999998653 334568899999999999999999999999999999999999999999996554 3599999999999
Q ss_pred HHHHHHhhhhcCCCceeeccCCCCceEeCCC--CceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCCCC
Q 021947 82 GAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 159 (305)
Q Consensus 82 ~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 159 (305)
||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++...... ......+|+.|+|||.+.+..++.++
T Consensus 110 qi~~al~yLH~~--~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~ 184 (321)
T d1tkia_ 110 QVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184 (321)
T ss_dssp HHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHH
T ss_pred HHHHHHHHHHHc--CCCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchh
Confidence 999999999975 59999999999999854 479999999998754332 23445789999999999999999999
Q ss_pred ceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCC--CChHHHHHHHHHHHhhccCCCCC
Q 021947 160 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 160 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
|||||||++|+|++|..||.+.+.. ..+..+........ ....++.++.+||.+||..||.+
T Consensus 185 DiWSlGvily~ll~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 248 (321)
T d1tkia_ 185 DMWSLGTLVYVLLSGINPFLAETNQ----------------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248 (321)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGG
T ss_pred hcccHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999875421 11112222211111 11246788999999999999999
Q ss_pred CCCHHHHHHH
Q 021947 238 RPRMSEVLAI 247 (305)
Q Consensus 238 Rps~~~~l~~ 247 (305)
|||+.|++++
T Consensus 249 R~s~~eil~h 258 (321)
T d1tkia_ 249 RMTASEALQH 258 (321)
T ss_dssp SCCHHHHHHS
T ss_pred CcCHHHHhcC
Confidence 9999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=335.42 Aligned_cols=221 Identities=28% Similarity=0.413 Sum_probs=183.5
Q ss_pred EEEEEecccCC---ccChHHHHHHHHHHh-ccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHH
Q 021947 2 VVAVKKLKPEG---FQGHKEWLTEVNYLG-QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 77 (305)
Q Consensus 2 ~VaiK~~~~~~---~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (305)
.||||+++... ....+.+.+|..++. .++||||+++++++.+++..|+|||||+||+|.+++..... +++..+.
T Consensus 29 ~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~ 106 (320)
T d1xjda_ 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRAT 106 (320)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHH
T ss_pred EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHH
Confidence 69999997532 234566777887765 68999999999999999999999999999999999976653 8999999
Q ss_pred HHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCCCCC
Q 021947 78 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 157 (305)
Q Consensus 78 ~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 157 (305)
.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 107 ~~~~qi~~al~ylH~~--~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 182 (320)
T d1xjda_ 107 FYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNH 182 (320)
T ss_dssp HHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHhC--CeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCc
Confidence 9999999999999975 499999999999999999999999999986543322 234467999999999999999999
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCC
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 237 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (305)
++|||||||++|+|++|+.||.+.+.. .+...+.. .....+..++.++.+||.+||..||.+
T Consensus 183 ~~DiwSlGvilyemltG~~PF~~~~~~-----------------~~~~~i~~-~~~~~p~~~s~~~~dli~~~L~~dP~~ 244 (320)
T d1xjda_ 183 SVDWWSFGVLLYEMLIGQSPFHGQDEE-----------------ELFHSIRM-DNPFYPRWLEKEAKDLLVKLFVREPEK 244 (320)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHH-CCCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred hhhhhhhhHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHc-CCCCCCccCCHHHHHHHHHhcccCCCC
Confidence 999999999999999999999875421 11111111 123456678899999999999999999
Q ss_pred CCCHH-HHHH
Q 021947 238 RPRMS-EVLA 246 (305)
Q Consensus 238 Rps~~-~~l~ 246 (305)
|||+. ++++
T Consensus 245 R~s~~~~l~~ 254 (320)
T d1xjda_ 245 RLGVRGDIRQ 254 (320)
T ss_dssp SBTTBSCGGG
T ss_pred CcCHHHHHHh
Confidence 99985 6764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=330.61 Aligned_cols=241 Identities=25% Similarity=0.253 Sum_probs=177.1
Q ss_pred CEEEEEecccCCccC-----hHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGFQG-----HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||+++...... .+.+.+|+++|++++||||+++++++..++..|+||||+.|+++..+.... ..+++..
T Consensus 24 ~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~--~~l~~~~ 101 (299)
T d1ua2a_ 24 QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSH 101 (299)
T ss_dssp SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC--SSCCSSH
T ss_pred cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc--cCCCHHH
Confidence 369999997553322 256899999999999999999999999999999999999987766665433 3488899
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-R 154 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~ 154 (305)
+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++........ ....+||+.|+|||++.+. .
T Consensus 102 ~~~~~~qil~aL~~lH~~--~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 177 (299)
T d1ua2a_ 102 IKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARM 177 (299)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHHhhcc--ceecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCC
Confidence 999999999999999975 5999999999999999999999999999876543322 3345789999999998654 6
Q ss_pred CCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhh---hccchhhhhhhhcccCCCC-----ChHHHHHHH
Q 021947 155 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPY---LSDKRKLFRIMDTKLGGQY-----PQKAAHTAA 224 (305)
Q Consensus 155 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~-~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (305)
++.++|||||||++|+|++|..||.+........ +... ..+. ................... ...++.++.
T Consensus 178 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 257 (299)
T d1ua2a_ 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 257 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHH
T ss_pred CChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHH
Confidence 7999999999999999999999998754321110 0000 0000 0000000000000000001 124567899
Q ss_pred HHHHhhccCCCCCCCCHHHHHHH
Q 021947 225 TLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 225 ~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+||.+||..||++|||++|++++
T Consensus 258 dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 258 DLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhCC
Confidence 99999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=331.43 Aligned_cols=233 Identities=24% Similarity=0.383 Sum_probs=193.6
Q ss_pred EEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcC--------CCCCC
Q 021947 2 VVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLS 72 (305)
Q Consensus 2 ~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~ 72 (305)
.||||+++.... .....|.+|++++++++||||+++++++...+..++||||+.+|+|.+++.... ...++
T Consensus 52 ~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~ 131 (308)
T d1p4oa_ 52 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131 (308)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCC
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCC
Confidence 589999975532 333568999999999999999999999999999999999999999999985431 23478
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.+++.||.|||++ +|+||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+
T Consensus 132 ~~~~~~i~~~ia~gl~~LH~~--~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~ 209 (308)
T d1p4oa_ 132 LSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhC--CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc
Confidence 899999999999999999975 499999999999999999999999999986544433333444568999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++||||||+++|||++| ..||.+.+. ......+........+..++..+.+||.+||
T Consensus 210 ~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 272 (308)
T d1p4oa_ 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCW 272 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHhCCCCCCcccchHHHHHHHHHHc
Confidence 9999999999999999999998 577765431 1222333344445567788899999999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhcC
Q 021947 232 NNEPKLRPRMSEVLAILERLEA 253 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~~~ 253 (305)
+.||++|||+.++++.|++...
T Consensus 273 ~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 273 QYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCChhHCcCHHHHHHHHHHhcC
Confidence 9999999999999999987644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=326.38 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=179.8
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||+++.+... ..+++.+|+++|++++||||+++++++.+++..|+||||+.+ ++.+++.......+++..+..
T Consensus 28 ~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~ 106 (298)
T d1gz8a_ 28 EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 106 (298)
T ss_dssp CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHH
T ss_pred CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHH
Confidence 47999999765432 357899999999999999999999999999999999999965 666666555556699999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-CCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ 157 (305)
++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.... ++.
T Consensus 107 ~~~qil~~L~yLH~~--~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~ 182 (298)
T d1gz8a_ 107 YLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYST 182 (298)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCT
T ss_pred HHHHHHHHHHHhhcC--CEEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCc
Confidence 999999999999975 499999999999999999999999999987543322 233457899999999887765 478
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh--hhhhhhhhhccchhhhhh---hhcc---cCCC---CChHHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRI---MDTK---LGGQ---YPQKAAHTAATL 226 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~---~~~~---~~~~~~~~~~~l 226 (305)
++|||||||++|+|++|+.||.+.+...... ......+........... .... .... ....++.++.+|
T Consensus 183 ~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 262 (298)
T d1gz8a_ 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHH
T ss_pred cccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHH
Confidence 9999999999999999999998754321100 000000000000000000 0000 0000 012456789999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|.+||..||.+|||+.|++++
T Consensus 263 l~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 263 LSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhCC
Confidence 999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=323.89 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=178.5
Q ss_pred EEEEEecccCCccChHHHHHHH--HHHhccCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEV--NYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~--~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.||||+++.+ ....+.+|. ..+.+++||||+++++++.+.+ .+|+|||||++|+|.+++++.. +++..
T Consensus 28 ~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---l~~~~ 101 (303)
T d1vjya_ 28 EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEG 101 (303)
T ss_dssp EEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHH
T ss_pred EEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC---CCHHH
Confidence 6999999754 334444444 4556789999999999998653 5799999999999999997653 89999
Q ss_pred HHHHHHHHHHHHhhhhcC------CCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccch
Q 021947 76 RMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAP 147 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aP 147 (305)
++.++.+++.||.|+|+. .+||+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus 102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aP 181 (303)
T d1vjya_ 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCCh
Confidence 999999999999999963 357999999999999999999999999999865433221 123346799999999
Q ss_pred hhhhcCC------CCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhh-hhcccCCCCC----
Q 021947 148 EYVATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYP---- 216 (305)
Q Consensus 148 E~~~~~~------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---- 216 (305)
|++.+.. ++.++|||||||++|||++|..||.......... .... ........+... .....+...+
T Consensus 182 E~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~ 259 (303)
T d1vjya_ 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQ 259 (303)
T ss_dssp HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred hhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-hhcc-cccchHHHHHHHHhccccCCCCCcccC
Confidence 9987653 5678999999999999999998886543221110 0000 000011111111 1122222222
Q ss_pred -hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 021947 217 -QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 252 (305)
Q Consensus 217 -~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 252 (305)
......+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus 260 ~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 245677999999999999999999999999998874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=323.65 Aligned_cols=215 Identities=22% Similarity=0.341 Sum_probs=177.1
Q ss_pred CEEEEEecccCCcc------ChHHHHHHHHHHhccC--CCCcccEEEEEEeCCeeEEEEecCCC-CCHHHHhhhcCCCCC
Q 021947 1 MVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPL 71 (305)
Q Consensus 1 ~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~ 71 (305)
+.||||+++..... ...++.+|+.+|++++ ||||+++++++.+.+..|+||||+.+ +++.+++..+. .+
T Consensus 30 ~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l 107 (273)
T d1xwsa_ 30 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--AL 107 (273)
T ss_dssp CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SC
T ss_pred CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CC
Confidence 47999998754322 2245678999999996 89999999999999999999999976 57888886654 49
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCC-CCceeeccccccccCCCCCCcceeecccccccccchhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 150 (305)
++..+..++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++...... .....||+.|+|||++
T Consensus 108 ~e~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~ 181 (273)
T d1xwsa_ 108 QEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWI 181 (273)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHC--CCccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHH
Confidence 9999999999999999999965 5999999999999985 4789999999998654322 3346799999999999
Q ss_pred hcCCC-CCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHh
Q 021947 151 ATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 229 (305)
Q Consensus 151 ~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (305)
.+..+ +.++|||||||++|+|++|+.||.+.+. +... ...++..++.++.+||.+
T Consensus 182 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------------i~~~--~~~~~~~~s~~~~~li~~ 237 (273)
T d1xwsa_ 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIRG--QVFFRQRVSSECQHLIRW 237 (273)
T ss_dssp HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHHC--CCCCSSCCCHHHHHHHHH
T ss_pred cCCCCCCcccccccceeeehhHhhCCCCCCCchH----------------------Hhhc--ccCCCCCCCHHHHHHHHH
Confidence 88776 5678999999999999999999975321 0111 123445678899999999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 021947 230 CLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 230 ~l~~~p~~Rps~~~~l~~ 247 (305)
||..||.+|||++|++++
T Consensus 238 ~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 238 CLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HTCSSGGGSCCHHHHHTS
T ss_pred HccCCHhHCcCHHHHhcC
Confidence 999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=318.51 Aligned_cols=240 Identities=24% Similarity=0.304 Sum_probs=177.0
Q ss_pred EEEEEecccCCc--cChHHHHHHHHHHhcc---CCCCcccEEEEEEe-----CCeeEEEEecCCCCCHHHHhhhcCCCCC
Q 021947 2 VVAVKKLKPEGF--QGHKEWLTEVNYLGQL---HHPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPL 71 (305)
Q Consensus 2 ~VaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (305)
.||||+++.... .....+.+|+++|+.+ +||||++++++|.. ....+++|||+.++.+.... ......+
T Consensus 35 ~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~ 113 (305)
T d1blxa_ 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGV 113 (305)
T ss_dssp EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCS
T ss_pred EEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhh-hccCCCC
Confidence 689999875432 2334677888888776 79999999999863 24678999999886554443 3444569
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 72 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 72 ~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.
T Consensus 114 ~~~~~~~~~~qi~~aL~yLH~~--~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~ 188 (305)
T d1blxa_ 114 PTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLL 188 (305)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHhC--CEEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhc
Confidence 9999999999999999999975 4999999999999999999999999998764322 2244567999999999999
Q ss_pred cCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhhhhh-h---hhccchhhhhh-hh---cccCCCCChHHHHH
Q 021947 152 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-P---YLSDKRKLFRI-MD---TKLGGQYPQKAAHT 222 (305)
Q Consensus 152 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~-~---~~~~~~~~~~~-~~---~~~~~~~~~~~~~~ 222 (305)
+..++.++|||||||++|+|++|+.||.+.+...... +..... + ........... .. ..........++..
T Consensus 189 ~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 268 (305)
T d1blxa_ 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268 (305)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHH
T ss_pred CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHH
Confidence 9999999999999999999999999998765322111 000000 0 00000000000 00 00111223456788
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 223 AATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 223 ~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
+.+||.+||..||++|||+.|++++
T Consensus 269 ~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 269 GKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-46 Score=312.91 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=178.1
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
..||||+++.+... ..+++.+|+++|++++||||+++++++...+..+++||++.++.+..+.... ..+++..+..
T Consensus 27 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~ 104 (286)
T d1ob3a_ 27 ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKS 104 (286)
T ss_dssp CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHH
T ss_pred CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHH
Confidence 36999999765432 3478999999999999999999999999999999999999876665555433 3599999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 157 (305)
++.|++.||.|||+. +|+||||||+|||++.++.+||+|||.+........ ......+++.|+|||.+.+. .++.
T Consensus 105 i~~qi~~~L~~LH~~--~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~ 180 (286)
T d1ob3a_ 105 FLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYST 180 (286)
T ss_dssp HHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHhccC--cEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCc
Confidence 999999999999975 599999999999999999999999999987543322 13344689999999998765 5689
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchhh--hhhhhhhh---hccchhhhhhhh------cccCCCCChHHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPY---LSDKRKLFRIMD------TKLGGQYPQKAAHTAATL 226 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l 226 (305)
++|||||||++|+|++|+.||.+.+...... ......+. ............ ...........+..+.+|
T Consensus 181 ~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 260 (286)
T d1ob3a_ 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260 (286)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHH
T ss_pred ceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHH
Confidence 9999999999999999999998754322110 00000000 000000000000 000011233567889999
Q ss_pred HHhhccCCCCCCCCHHHHHHH
Q 021947 227 ALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 227 i~~~l~~~p~~Rps~~~~l~~ 247 (305)
|++||..||++|||++|++++
T Consensus 261 i~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 261 LSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=314.60 Aligned_cols=228 Identities=28% Similarity=0.323 Sum_probs=182.7
Q ss_pred CEEEEEecccCC----ccChHHHHHHHHHHhccCC-CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEG----FQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
.+||||+++... ....+.+.+|+++|++++| |||+++++++.+....+++|||+.|++|.+++...+. +++..
T Consensus 53 ~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~ 130 (322)
T d1vzoa_ 53 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130 (322)
T ss_dssp CEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHH
T ss_pred cEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc--ccHHH
Confidence 369999987542 2345678899999999976 8999999999999999999999999999999976654 78889
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC--
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-- 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-- 153 (305)
+..++.|++.||.|+|+. +++||||||+|||++.++.+||+|||+++........ ......|++.|++||.+.+.
T Consensus 131 ~~~~~~Qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~ 207 (322)
T d1vzoa_ 131 VQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDS 207 (322)
T ss_dssp HHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHhhcC--CEEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCc
Confidence 999999999999999965 4999999999999999999999999999865433222 23456789999999999765
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhccC
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 233 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (305)
.++.++|||||||++|+|++|..||.+....... ..+... ........+..++.++.+||.+||.+
T Consensus 208 ~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-------------~~i~~~-~~~~~~~~~~~~s~~~~~li~~~l~~ 273 (322)
T d1vzoa_ 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AEISRR-ILKSEPPYPQEMSALAKDLIQRLLMK 273 (322)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HHHHHH-HHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHHh-cccCCCCCcccCCHHHHHHHHHHccc
Confidence 4677999999999999999999999875432111 001111 11122345667899999999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 021947 234 EPKLRPR-----MSEVLAI 247 (305)
Q Consensus 234 ~p~~Rps-----~~~~l~~ 247 (305)
||.+||| ++|++++
T Consensus 274 dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 274 DPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SGGGSTTSSTTTHHHHHTS
T ss_pred CHHHcCCCCcccHHHHHcC
Confidence 9999994 7888753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=315.62 Aligned_cols=236 Identities=24% Similarity=0.308 Sum_probs=178.3
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCC------eeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE------NRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
+.||||+++..... ..+.+.+|+++|++++||||++++++|...+ .+|+||||+ |.+|..++... .++
T Consensus 44 ~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~ 119 (346)
T d1cm8a_ 44 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLG 119 (346)
T ss_dssp CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCC
T ss_pred CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---ccc
Confidence 46999999865332 2357899999999999999999999998654 469999999 66888777543 399
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.|++.||.|||++ ||+||||||+|||++.++.+|++|||+++..... .....||+.|+|||++.+
T Consensus 120 ~~~~~~~~~qi~~aL~~LH~~--~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 120 EDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhC--CCcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcC
Confidence 999999999999999999965 5999999999999999999999999999876443 234578999999999876
Q ss_pred C-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhh-hh---hhc-----cchhhhhhhhcccC---CCCChH
Q 021947 153 G-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA-KP---YLS-----DKRKLFRIMDTKLG---GQYPQK 218 (305)
Q Consensus 153 ~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~-~~---~~~-----~~~~~~~~~~~~~~---~~~~~~ 218 (305)
. .++.++|||||||++|+|++|+.||.+.+........ ... .+ ... ........+..... ......
T Consensus 193 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (346)
T d1cm8a_ 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272 (346)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccC
Confidence 4 5689999999999999999999999876532211000 000 00 000 00000000000000 112235
Q ss_pred HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 219 AAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 219 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
++..+.+||.+||..||.+|||+.|++++
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 67789999999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=307.27 Aligned_cols=244 Identities=22% Similarity=0.239 Sum_probs=172.4
Q ss_pred CEEEEEecccCCc--cChHHHHHHHHHHhccCCCCcccEEEEEEe--------CCeeEEEEecCCCCCHHHHhhhcCCCC
Q 021947 1 MVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--------GENRLLVYEFMPKGSLENHLFRRGPQP 70 (305)
Q Consensus 1 ~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (305)
+.||||++..+.. ....++.+|+++|++++||||+++++++.. .+..|+||||+.++.+..+... ...
T Consensus 36 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~ 113 (318)
T d3blha1 36 QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVK 113 (318)
T ss_dssp CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCC
T ss_pred CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccc
Confidence 4799999875533 334678999999999999999999999864 3457999999987655544432 345
Q ss_pred CCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCc--ceeecccccccccchh
Q 021947 71 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPE 148 (305)
Q Consensus 71 ~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE 148 (305)
+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++........ ......+||+.|+|||
T Consensus 114 ~~~~~~~~i~~qil~~l~~lH~~--~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 114 FTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred cccHHHHHHHHHHHHHHHHhccC--CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHH
Confidence 89999999999999999999965 5999999999999999999999999999765432221 2233457999999999
Q ss_pred hhhcC-CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhhhh----hhcc--chhhhhhhhcccCCCCC----
Q 021947 149 YVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKP----YLSD--KRKLFRIMDTKLGGQYP---- 216 (305)
Q Consensus 149 ~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~----~~~~--~~~~~~~~~~~~~~~~~---- 216 (305)
++.+. .++.++|||||||++|+|++|+.||.+.+........ ..... .... .................
T Consensus 192 ~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (318)
T d3blha1 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271 (318)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHH
T ss_pred HHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhh
Confidence 98765 6899999999999999999999999875532221111 00000 0000 00000000000000100
Q ss_pred ---hHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 021947 217 ---QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 248 (305)
Q Consensus 217 ---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~l 248 (305)
...+..+.+||.+||..||++|||++|++++-
T Consensus 272 ~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 272 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 12245778999999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=308.09 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=173.5
Q ss_pred CEEEEEecccCCccChHHHHHHHHHHhccCCCCcccEEEEEEeC------CeeEEEEecCCCCCHHHHhh--hcCCCCCC
Q 021947 1 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG------ENRLLVYEFMPKGSLENHLF--RRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~--~~~~~~~~ 72 (305)
+.||||+++.+.. .+.+|+++|++++||||++++++|... ..+|+|||||.++ +.+.+. ......++
T Consensus 46 ~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~ 120 (350)
T d1q5ka_ 46 ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLP 120 (350)
T ss_dssp CEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCC
T ss_pred CEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCC
Confidence 4799999976532 234799999999999999999998643 3478999999765 444332 12344699
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhh
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 151 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 151 (305)
+..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++....... ....+||..|+|||.+.
T Consensus 121 ~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 121 VIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIF 195 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhh
Confidence 99999999999999999996 4599999999999998775 799999999987543322 33457899999999887
Q ss_pred c-CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhhhccchhhh-hhhhcc--------cCCCCChHH
Q 021947 152 T-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLF-RIMDTK--------LGGQYPQKA 219 (305)
Q Consensus 152 ~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~ 219 (305)
+ ..++.++|||||||++|+|++|+.||.......... ... ...+......... ...... .........
T Consensus 196 ~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (350)
T d1q5ka_ 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275 (350)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTS
T ss_pred cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCC
Confidence 5 468999999999999999999999998755321110 000 0000000000000 000000 001122356
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhc
Q 021947 220 AHTAATLALQCLNNEPKLRPRMSEVLAI--LERLE 252 (305)
Q Consensus 220 ~~~~~~li~~~l~~~p~~Rps~~~~l~~--l~~~~ 252 (305)
+.++.+||.+||..||.+|||+.|++++ ++++.
T Consensus 276 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 7889999999999999999999999974 44443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=312.93 Aligned_cols=242 Identities=24% Similarity=0.272 Sum_probs=176.2
Q ss_pred CEEEEEecccCCc-cChHHHHHHHHHHhccCCCCcccEEEEEEeCC----eeEEEEecCCCCCHHHHhhhcCCCCCCHHH
Q 021947 1 MVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAV 75 (305)
Q Consensus 1 ~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (305)
+.||||+++.... ...+++++|+++|++++||||+++++++.... ..+++++++.|++|.+++..+ .+++..
T Consensus 34 ~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~ 110 (345)
T d1pmea_ 34 VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDH 110 (345)
T ss_dssp SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHH
T ss_pred cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC---CCCHHH
Confidence 3699999976533 33467899999999999999999999987543 234445556688999999654 399999
Q ss_pred HHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCC-cceeecccccccccchhhhhc-C
Q 021947 76 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT-G 153 (305)
Q Consensus 76 ~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~ 153 (305)
+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++........ .......+||+.|+|||++.. .
T Consensus 111 i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 188 (345)
T d1pmea_ 111 ICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188 (345)
T ss_dssp HHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC
T ss_pred HHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCC
Confidence 999999999999999965 599999999999999999999999999986543221 112344578999999999854 5
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhh--hhhhhc-----cchhhhhhhhc-ccCCC-----CChHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLS-----DKRKLFRIMDT-KLGGQ-----YPQKAA 220 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~-~~~~~-----~~~~~~ 220 (305)
.++.++||||+||++|+|++|+.||.+............ ..+... ........... ..... ....++
T Consensus 189 ~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 268 (345)
T d1pmea_ 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 268 (345)
T ss_dssp SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC
T ss_pred CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCC
Confidence 678899999999999999999999987653221111000 000000 00000000000 00000 012456
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.+|+.+||..||.+|||+.+++++
T Consensus 269 ~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 269 SKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 789999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=303.00 Aligned_cols=233 Identities=19% Similarity=0.172 Sum_probs=175.4
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCC-cccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||++..+. ...++.+|+++++.++|+| |+.+.+++.+++..++||||+ +++|.+.+.... ..+++..+..++
T Consensus 34 ~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~ 109 (299)
T d1ckia_ 34 EVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLA 109 (299)
T ss_dssp EEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred EEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHH
Confidence 69999987653 3356889999999998665 555566667888899999999 457777765443 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCC---CCceeeccccccccCCCCCCc-----ceeecccccccccchhhhhc
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~ 152 (305)
.|++.||+|||++ ||+||||||+|||++. +..+||+|||+++........ .......||+.|+|||++.+
T Consensus 110 ~qi~~~l~~lH~~--~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 110 DQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp HHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred HHHHHHHHHHHHC--CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC
Confidence 9999999999975 4999999999999864 456999999999876433221 12345579999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhhc
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 231 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (305)
..++.++|||||||++|+|++|..||............ ....... ..........++.++.+|+.+||
T Consensus 188 ~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~p~~~~~li~~cl 256 (299)
T d1ckia_ 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-----------STPIEVLCKGYPSEFATYLNFCR 256 (299)
T ss_dssp BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-----------HSCHHHHTTTSCHHHHHHHHHHH
T ss_pred CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-----------CCChhHhccCCCHHHHHHHHHHc
Confidence 99999999999999999999999999875432211100 0000000 00000112356788999999999
Q ss_pred cCCCCCCCCHHHHHHHHHhh
Q 021947 232 NNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 232 ~~~p~~Rps~~~~l~~l~~~ 251 (305)
+.||++||+++++.+.|+.+
T Consensus 257 ~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 257 SLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HSCTTCCCCHHHHHHHHHHH
T ss_pred cCChhHCcCHHHHHHHHHHH
Confidence 99999999999998887765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=299.68 Aligned_cols=241 Identities=23% Similarity=0.246 Sum_probs=182.6
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
+.||||+++..... ...++.+|+.+|++++||||+++++++.+....++|+|++.|++|..++...+ .+++..+..
T Consensus 28 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~ 105 (292)
T d1unla_ 28 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKS 105 (292)
T ss_dssp CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHH
T ss_pred cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc--ccchhHHHH
Confidence 46999999765433 24688999999999999999999999999999999999999988888775443 489999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcCC-CCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTT 157 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ 157 (305)
++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++........ .....++..|+|||++.+.. ++.
T Consensus 106 ~~~q~~~aL~~lH~~--~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~ 181 (292)
T d1unla_ 106 FLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYST 181 (292)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred HHHHHHHHHHHhhcC--CEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCc
Confidence 999999999999964 5999999999999999999999999999876543322 33345788999999987765 688
Q ss_pred CCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhh-hhhccchhhhhh---------hhcccCCCCChHHHHHHHH
Q 021947 158 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAK-PYLSDKRKLFRI---------MDTKLGGQYPQKAAHTAAT 225 (305)
Q Consensus 158 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~ 225 (305)
++|||||||++|+|++|+.||.......+. .+..... +........... .............+..+.+
T Consensus 182 ~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 261 (292)
T d1unla_ 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261 (292)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHH
T ss_pred hhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHH
Confidence 999999999999999999997544322111 0000000 000000000000 0011112233466788999
Q ss_pred HHHhhccCCCCCCCCHHHHHHH
Q 021947 226 LALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 226 li~~~l~~~p~~Rps~~~~l~~ 247 (305)
||.+||..||.+|||++|++++
T Consensus 262 ll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 262 LLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-44 Score=300.57 Aligned_cols=234 Identities=16% Similarity=0.155 Sum_probs=182.8
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCC-CCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 80 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (305)
.||||+++... ....+.+|++.++.++| +||+.+++++..+...++||||+ |++|.+++...+ ..++...+..++
T Consensus 32 ~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~ 107 (293)
T d1csna_ 32 QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAA 107 (293)
T ss_dssp EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred EEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHH
Confidence 69999986543 34567889999999975 99999999999999999999999 679999886554 359999999999
Q ss_pred HHHHHHHhhhhcCCCceeeccCCCCceEeCC-----CCceeeccccccccCCCCCCc-----ceeecccccccccchhhh
Q 021947 81 IGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYV 150 (305)
Q Consensus 81 ~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~-----~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~ 150 (305)
.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++........ ......+||+.|+|||++
T Consensus 108 ~q~~~~l~~lH~~--giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~ 185 (293)
T d1csna_ 108 KQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185 (293)
T ss_dssp HHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHC--CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHh
Confidence 9999999999964 5999999999999964 567999999999875432211 123345799999999999
Q ss_pred hcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhccchhhhhhhhcccCCCCChHHHHHHHHHHHhh
Q 021947 151 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 230 (305)
Q Consensus 151 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (305)
.+..++.++||||||+++|+|++|..||.+.............. ..............++.++.+++..|
T Consensus 186 ~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~----------~~~~~~~~~~l~~~~p~~l~~ii~~~ 255 (293)
T d1csna_ 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------EKKQSTPLRELCAGFPEEFYKYMHYA 255 (293)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----------HHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH----------hccCCCChHHhcCCCCHHHHHHHHHH
Confidence 99999999999999999999999999998755432221110000 00000000011234667899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhh
Q 021947 231 LNNEPKLRPRMSEVLAILERL 251 (305)
Q Consensus 231 l~~~p~~Rps~~~~l~~l~~~ 251 (305)
+..+|++||+++.+.+.|+++
T Consensus 256 ~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 256 RNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHCCTTCCCCHHHHHHHHHHH
T ss_pred hcCCcccCcCHHHHHHHHHHH
Confidence 999999999999998887765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-44 Score=305.35 Aligned_cols=233 Identities=19% Similarity=0.248 Sum_probs=176.7
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeC--CeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHH
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 78 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (305)
.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|||||.+++|..+. ..+++..+..
T Consensus 62 ~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~ 133 (328)
T d3bqca1 62 KVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF 133 (328)
T ss_dssp EEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHH
T ss_pred EEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHH
Confidence 6999999754 4678899999999995 99999999999843 5689999999999987764 2399999999
Q ss_pred HHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCC-ceeeccccccccCCCCCCcceeecccccccccchhhhhcC-CCC
Q 021947 79 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLT 156 (305)
Q Consensus 79 ~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~ 156 (305)
++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++....... ....++|+.|+|||.+.+. .++
T Consensus 134 i~~qil~aL~~LH~~--gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 208 (328)
T d3bqca1 134 YMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYD 208 (328)
T ss_dssp HHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCC
T ss_pred HHHHHHHHHHHHhhc--ccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCC
Confidence 999999999999975 499999999999998655 589999999987544322 3345789999999998775 479
Q ss_pred CCCceehhhHHHHHHHhCCCccCCCcccchhh--hhhhh-hhh---------hccchhhhhhh--------hcccCCCCC
Q 021947 157 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWA-KPY---------LSDKRKLFRIM--------DTKLGGQYP 216 (305)
Q Consensus 157 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~---------~~~~~~~~~~~--------~~~~~~~~~ 216 (305)
.++|||||||++|+|++|+.||.......... ..... .+. ........... .........
T Consensus 209 ~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (328)
T d3bqca1 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288 (328)
T ss_dssp THHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTG
T ss_pred cccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccccccc
Confidence 99999999999999999999997755432211 00000 000 00000000000 111122233
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 217 QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..++.++.+||++||..||.+|||++|++++
T Consensus 289 ~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 289 HLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4577889999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=303.29 Aligned_cols=237 Identities=22% Similarity=0.258 Sum_probs=170.0
Q ss_pred CEEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEe------CCeeEEEEecCCCCCHHHHhhhcCCCCCC
Q 021947 1 MVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLS 72 (305)
Q Consensus 1 ~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (305)
+.||||++...... ...++.+|+.+|++++||||++++++|.. ...+|+|||||.+ ++.+.+.. .++
T Consensus 43 ~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~----~~~ 117 (355)
T d2b1pa1 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELD 117 (355)
T ss_dssp EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCC
T ss_pred CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhhc----CCC
Confidence 36999999865432 23568899999999999999999999963 3678999999976 55555532 389
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhc
Q 021947 73 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 152 (305)
Q Consensus 73 ~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 152 (305)
+..+..++.|++.||.|||+. ||+||||||+|||++.++.+|++|||+++...... .....++|+.|+|||++.+
T Consensus 118 ~~~i~~~~~qil~gl~~LH~~--giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 118 HERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhhhc--ccccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcC
Confidence 999999999999999999975 59999999999999999999999999988654332 2344578999999999999
Q ss_pred CCCCCCCceehhhHHHHHHHhCCCccCCCcccchh--hhhhhhhh---hhc-cchhhhhhhhc-----------------
Q 021947 153 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKP---YLS-DKRKLFRIMDT----------------- 209 (305)
Q Consensus 153 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~---~~~-~~~~~~~~~~~----------------- 209 (305)
..++.++||||+||++|+|++|+.||.+.+..... .......+ ... ...........
T Consensus 193 ~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (355)
T d2b1pa1 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272 (355)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG
T ss_pred CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc
Confidence 99999999999999999999999999876432111 00000000 000 00000000000
Q ss_pred -ccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 210 -KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 210 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
..........+.++.+||++||..||++|||++|++++
T Consensus 273 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00111123578889999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=304.16 Aligned_cols=236 Identities=24% Similarity=0.261 Sum_probs=172.3
Q ss_pred EEEEEecccCCcc--ChHHHHHHHHHHhccCCCCcccEEEEEEeC-----CeeEEEEecCCCCCHHHHhhhcCCCCCCHH
Q 021947 2 VVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 74 (305)
Q Consensus 2 ~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (305)
.||||+++..... ..+++.+|+++|++++||||+++++++... ...+++++++.||+|.+++..+ .+++.
T Consensus 45 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~ 121 (348)
T d2gfsa1 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDD 121 (348)
T ss_dssp EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHH
T ss_pred EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHH
Confidence 6999999865432 335788999999999999999999998633 3446677778899999999543 49999
Q ss_pred HHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccchhhhhcC-
Q 021947 75 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG- 153 (305)
Q Consensus 75 ~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 153 (305)
.+..++.||+.||+|||++ ||+||||||+|||++.+|.+|++|||++...... .....|+..|+|||++.+.
T Consensus 122 ~~~~i~~qil~aL~~LH~~--giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~ 194 (348)
T d2gfsa1 122 HVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM 194 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHHhC--CCcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCc
Confidence 9999999999999999965 5999999999999999999999999999764322 3345789999999987765
Q ss_pred CCCCCCceehhhHHHHHHHhCCCccCCCcccchhhhh--hhhhhh---h--ccchhhhhhhhcccCCC------CChHHH
Q 021947 154 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKPY---L--SDKRKLFRIMDTKLGGQ------YPQKAA 220 (305)
Q Consensus 154 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~---~--~~~~~~~~~~~~~~~~~------~~~~~~ 220 (305)
.++.++|||||||++|+|++|+.||.+.+........ ....+. . ................. ....++
T Consensus 195 ~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 274 (348)
T d2gfsa1 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274 (348)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCC
T ss_pred cCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCC
Confidence 4688999999999999999999999876533211100 000000 0 00000000000000000 012467
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 221 HTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 221 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
.++.+||.+||..||.+|||+.|++++
T Consensus 275 ~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 275 PLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 789999999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-37 Score=267.59 Aligned_cols=237 Identities=16% Similarity=0.229 Sum_probs=168.3
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccC-----------CCCcccEEEEEEeC--CeeEEEEecCCCC-CHHHHhhhcC
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLH-----------HPNLVKLIGYCLEG--ENRLLVYEFMPKG-SLENHLFRRG 67 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~--~~~~lv~e~~~~~-~L~~~l~~~~ 67 (305)
.||||+++.+. ...+.+.+|++++++++ |+||+++++++... ...+++|+++..+ ..........
T Consensus 40 ~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (362)
T d1q8ya_ 40 HVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118 (362)
T ss_dssp EEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT
T ss_pred EEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccccc
Confidence 69999998653 23467788999988875 57899999887643 4556666666544 3334444445
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCceeeccCCCCceEeCCCCc------eeeccccccccCCCCCCcceeeccccc
Q 021947 68 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN------AKLSDFGLAKAGPTGDRTHVSTQVMGT 141 (305)
Q Consensus 68 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH~dlkp~Nil~~~~~~------~kl~Dfg~~~~~~~~~~~~~~~~~~~t 141 (305)
...+++..+..++.|++.||.|||+ ..||+||||||+|||++.++. ++++|||.+...... ....+||
T Consensus 119 ~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt 192 (362)
T d1q8ya_ 119 HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQT 192 (362)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSC
T ss_pred ccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeeccCcccccceeeEeecccccccccc-----ccccccc
Confidence 5568999999999999999999997 256999999999999976653 899999999765332 2345789
Q ss_pred ccccchhhhhcCCCCCCCceehhhHHHHHHHhCCCccCCCcccchh----hhhhhhhh-----------------hhccc
Q 021947 142 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----SLVDWAKP-----------------YLSDK 200 (305)
Q Consensus 142 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~-----------------~~~~~ 200 (305)
+.|+|||++.+..++.++|+|||||++++|++|+.||......... ........ .....
T Consensus 193 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~ 272 (362)
T d1q8ya_ 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272 (362)
T ss_dssp GGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred ccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccc
Confidence 9999999999999999999999999999999999999764332110 00000000 00000
Q ss_pred h-----------hhhhhhhcccCCCCChHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 021947 201 R-----------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 247 (305)
Q Consensus 201 ~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 247 (305)
. ...... ..........+.++.+||.+||..||.+|||++|++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 273 GLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp -CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hhhhccccccCCchhhhc--ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 01223456788899999999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=1.3e-20 Score=146.30 Aligned_cols=122 Identities=14% Similarity=0.073 Sum_probs=88.9
Q ss_pred HHHHHHHHhccCCCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHHHHHHHHhhhhcCCCcee
Q 021947 19 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 98 (305)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 98 (305)
+.+|+..+.++.|.+++..+++. ..+++|||+++..+.+ ++......++.|++.+|.|||++ ||+
T Consensus 61 ~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~--gii 125 (191)
T d1zara2 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR--GIV 125 (191)
T ss_dssp HHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT--TEE
T ss_pred HHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC--CEE
Confidence 45688999999999999987653 2379999998865533 23334567899999999999975 599
Q ss_pred eccCCCCceEeCCCCceeeccccccccCCCCCCcceeecccccccccch------hhhhcCCCCCCCceehhhHH
Q 021947 99 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP------EYVATGRLTTKSDVYSFGVV 167 (305)
Q Consensus 99 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~Di~slG~i 167 (305)
||||||+|||+++++ ++|+|||.+........ ..|... +.+ ...|+.++|+||+.--
T Consensus 126 HrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 126 HGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CSCCSTTSEEEETTE-EEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EccCChhheeeeCCC-EEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 999999999998664 89999999876432211 111111 111 3567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.67 E-value=3.2e-08 Score=79.16 Aligned_cols=115 Identities=14% Similarity=0.021 Sum_probs=78.5
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCHHHHhhhcCCCCCCHHHHHHHHH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 81 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 81 (305)
+.||+...........+.+|+..+..+. +--+.+++++...++..|+||++++|.++.+..... .. ...++.
T Consensus 40 ~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~ 112 (263)
T d1j7la_ 40 LYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIE 112 (263)
T ss_dssp EEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHH
T ss_pred EEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc----cc---HHHHHH
Confidence 4577766554445556788999988774 434677888888889999999999998876544211 11 122333
Q ss_pred HHHHHHhhhhcC---------------------------------------------------------CCceeeccCCC
Q 021947 82 GAAKGLTFLHDA---------------------------------------------------------ESQVIYRDFKA 104 (305)
Q Consensus 82 ~i~~~l~~lH~~---------------------------------------------------------~~~ivH~dlkp 104 (305)
++++.++.||+. ...++|+|+.|
T Consensus 113 ~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~ 192 (263)
T d1j7la_ 113 LYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGD 192 (263)
T ss_dssp HHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCT
T ss_pred HHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccC
Confidence 444444444421 12489999999
Q ss_pred CceEeCCCCceeeccccccc
Q 021947 105 SNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 105 ~Nil~~~~~~~kl~Dfg~~~ 124 (305)
.||++++++.+.|+||+.+.
T Consensus 193 ~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 193 SNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TSEEEETTEEEEECCCTTCE
T ss_pred cceeecCCceEEEeechhcc
Confidence 99999877666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=7.4e-06 Score=64.57 Aligned_cols=55 Identities=18% Similarity=0.105 Sum_probs=39.3
Q ss_pred EEEEecccCCccChHHHHHHHHHHhccCC--CCcccEEEEEEeCCeeEEEEecCCCCCHH
Q 021947 3 VAVKKLKPEGFQGHKEWLTEVNYLGQLHH--PNLVKLIGYCLEGENRLLVYEFMPKGSLE 60 (305)
Q Consensus 3 VaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 60 (305)
+.+|...... ...+..|+..++.+.. -.+.+++.+..+.+..|+||++++|.++.
T Consensus 38 ~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 38 LFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp EEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 5667665443 3346788888887743 33577788888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=0.00023 Score=59.56 Aligned_cols=30 Identities=20% Similarity=0.239 Sum_probs=25.8
Q ss_pred CceeeccCCCCceEeCCCCceeecccccccc
Q 021947 95 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 125 (305)
Q Consensus 95 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 125 (305)
..++|||+.+.|||++++ .++|+||..+.+
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 459999999999999876 489999988764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0018 Score=52.47 Aligned_cols=121 Identities=18% Similarity=0.124 Sum_probs=67.2
Q ss_pred EEEEEecccCCccChHHHHHHHHHHhccCCCCc-----ccE--EEEEEeCCeeEEEEecCCCCCHHH----Hhhh-----
Q 021947 2 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-----VKL--IGYCLEGENRLLVYEFMPKGSLEN----HLFR----- 65 (305)
Q Consensus 2 ~VaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~--~~~~~~~~~~~lv~e~~~~~~L~~----~l~~----- 65 (305)
.|++|+.+++. .+.+++..|...+..|....| +.. -..+..++..+.+++++.|..+.. .+..
T Consensus 48 ~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~L 126 (325)
T d1zyla1 48 RFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYL 126 (325)
T ss_dssp CEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHH
T ss_pred EEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHH
Confidence 47789887653 356778889998888753222 111 112345677889999997643210 0000
Q ss_pred ---------cC---CCCCCH----------------------HHHHHHHHHHHHHHhhh--hcCCCceeeccCCCCceEe
Q 021947 66 ---------RG---PQPLSW----------------------AVRMKVAIGAAKGLTFL--HDAESQVIYRDFKASNILL 109 (305)
Q Consensus 66 ---------~~---~~~~~~----------------------~~~~~~~~~i~~~l~~l--H~~~~~ivH~dlkp~Nil~ 109 (305)
.. ....+. ......+..+...+.-. .....++||+|+.+.|||+
T Consensus 127 A~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~ 206 (325)
T d1zyla1 127 GRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILW 206 (325)
T ss_dssp HHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEE
T ss_pred HHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEE
Confidence 00 001111 11222233333333222 1223579999999999999
Q ss_pred CCCCceeecccccccc
Q 021947 110 DAEFNAKLSDFGLAKA 125 (305)
Q Consensus 110 ~~~~~~kl~Dfg~~~~ 125 (305)
+++ ..++||+.+..
T Consensus 207 ~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 207 RDG--PMFVDLDDARN 220 (325)
T ss_dssp SSS--EEECCCTTCCE
T ss_pred eCC--ceEEechhccc
Confidence 743 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.87 E-value=0.0016 Score=54.35 Aligned_cols=41 Identities=20% Similarity=0.149 Sum_probs=28.7
Q ss_pred ChHHHHHHHHHHhccC-CCCcccEEEEEEeCCeeEEEEecCCCCCH
Q 021947 15 GHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSL 59 (305)
Q Consensus 15 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (305)
......+|..+++.+. +.-..++++++.+ ++|+||++|.++
T Consensus 87 ~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 87 TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3345668999999885 4444577777642 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.81 E-value=0.0014 Score=52.87 Aligned_cols=31 Identities=26% Similarity=0.245 Sum_probs=27.3
Q ss_pred CCceeeccCCCCceEeCCCCceeeccccccc
Q 021947 94 ESQVIYRDFKASNILLDAEFNAKLSDFGLAK 124 (305)
Q Consensus 94 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 124 (305)
..|+||+|+.++||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3579999999999999988777899999875
|